<?xml version="1.0" encoding="utf-8"?>
<rdf:RDF
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
  xmlns:ddiem="http://ddiem.phenomebrowser.net/"
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:obo="http://purl.obolibrary.org/obo/"
  xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
  xmlns:owl="http://www.w3.org/2002/07/owl#"
>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/20f5acc3-6aaf-46dd-bd6a-7f59318b81f0">
    <rdfs:label>Beta-1,4-glucuronyltransferase 1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/37b57bb2-61ff-4728-af8c-04f55ee61249">
        <rdfs:label>B4GAT1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/11041</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>O43505</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/8da8670b-f559-4f31-b729-cf71cc42be16">
        <rdfs:label>MT-TK</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/""</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/612937">
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/387</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/612937</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseAccessionNumber>387</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7a724ed6-ef0d-4364-913a-c9b7056f1f33">
        <rdfs:label>DPM3</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/54344</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0004020>
    <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15</rdfs:label>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/1b9728be-41f3-4230-b857-026735066102">
    <rdfs:label>lamins ( Lamins A and C)</rdfs:label>
    <ddiem:uniprotId>P02545</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/eb1c1702-9908-4f68-b543-344324b9fb47">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4000</dc:identifier>
        <rdfs:label>LMNA</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/6924d3a9-3793-437d-8395-1e7634e65596">
    <ddiem:ecNumber>2.7.7.40</ddiem:ecNumber>
    <rdfs:label>D-ribitol-5-phosphate cytidylyltransferase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/23b06041-b7c3-4454-8995-d8fdc11f0c47">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/""</dc:identifier>
        <rdfs:label>ISPD</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/b7542c3d-28bf-4791-9d39-aaac8f16a9ee">
    <ddiem:ecNumber>3.2.1.183</ddiem:ecNumber>
    <rdfs:label>glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase</rdfs:label>
    <ddiem:ecNumber>2.7.1.60</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/48647d15-7b09-4554-a954-3c753df04581">
        <rdfs:label>GNE</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/10020</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/1068b8c2-a4a4-45f7-9f38-56a0a0d7cbe1">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/2f323cf6-6d36-455e-bbda-5f8d1772c646">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5277</dc:identifier>
        <rdfs:label>PIGA</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.4.1.198</ddiem:ecNumber>
    <rdfs:label>Phosphatidylinositol N-acetylglucosaminyltransferase subunit A</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e522a839-e17d-4e9e-91e1-a51a8332d257">
    <obo:RO_0002558>
      <ddiem:Evidence rdf:about="http://ddiem.phenomebrowser.net/ECO:0000352">
        <dc:identifier>ECO:0000352</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/ECO_0000352</ddiem:url>
      </ddiem:Evidence>
    </obo:RO_0002558>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6f88c736-3777-4eab-9441-031e773f3fc6">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002353</ddiem:url>
        <rdfs:label>Abnormal EEG (focal epileptiform activity)</rdfs:label>
        <dc:identifier>HP:0002353</dc:identifier>
        <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d8b43393-6031-4d2c-a928-254bb334feec"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3a14dca1-301b-463c-bcf8-0e9608bac012">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002401</ddiem:url>
        <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
        <dc:identifier>HP:0002401</dc:identifier>
        <rdfs:label>Stroke-like attacks</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Idebenone+Riboflavin</rdfs:comment>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/11fd0681-3446-4c24-ad0a-336f208cdb57"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/10a33722-0d69-47bf-a6ee-112c8a5a1d41"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f64ca9e9-5ef0-4bb6-9e95-0c637a924ce4"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/729d86cd-b7f0-4748-a5e4-cf19392fba9f"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8757046</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7b72d650-4386-4642-ad24-1f1c50b63855">
        <dc:identifier>HP:0030890</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0030890</ddiem:url>
        <rdfs:label>Hyperintensity of cerebral white matter on MRI</rdfs:label>
        <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/540000">
        <dc:identifier>https://www.omim.org/entry/540000</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/8c31831b-e9ed-443c-bc1a-253f1da8dc5b"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/399</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/2cfded52-40b9-4675-b6f0-50b5d3bf0d9d"/>
        <rdfs:label>MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/2eaef29d-9759-4377-ac2b-b70f3a8bee24"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b02bd70d-0690-49bb-a99c-94ef8c6617f9"/>
        <rdfs:comment>MELAS syndrome can be caused by mutation in several genes, including MT-TL1/ MT-TQ /MT-TH/MT-TK / MTTC/ MTTS1/ MTND1/ MTND5/ MTND6/ MTTS2. https://www.omim.org/entry/540000</rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/34261d71-d09a-4483-b5f1-b07ee0072a47"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/75d2b0ad-5416-4ad5-b9b9-a06fe2801067"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/8da8670b-f559-4f31-b729-cf71cc42be16"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b5ad4ebb-6b98-476a-8c65-8db0909e7471"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/942dc48c-e1d9-4ade-bf16-9e2f168ca1d7"/>
        <ddiem:iembaseAccessionNumber>399</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/deae5878-d4cf-432c-8448-2094bf456216"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11382201</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d2b23f09-5cf9-4b3e-9839-40ffcb18bf8f">
        <rdfs:label>Neurological abnormality</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000707</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e5bea7f8-801a-41f1-8ec8-d00a573413a3">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6acaba01-3b7c-4d84-ae50-6be6a3fc40c9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa">
        <rdfs:label>Symptomatic (C)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8ec9bcc1-4be6-4cdd-a8af-7648d5167cc1">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0a9fc84c-1e69-4df0-bced-068cb693ea60">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/08b82475-5a29-4d86-80f5-2879fba902af"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Probenecid+Allopurinol</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8842764</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/162000">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1405</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/66297d90-9bbe-40ad-8368-ce6cc499a5bb"/>
        <dc:identifier>https://www.omim.org/entry/162000</dc:identifier>
        <ddiem:iembaseAccessionNumber>1405</ddiem:iembaseAccessionNumber>
        <rdfs:label>HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02527343</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/96abab13-51ab-4618-abdf-6684c5b3dd5c">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d6a09491-5812-42c3-93f1-85ab8d591539"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/49c061fd-a7a6-469f-ac4e-bcab98f09ecb"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fa2ab50d-525a-4059-9f35-e3b061ea0697">
        <rdfs:label>Hyperurecemia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/done</ddiem:url>
        <dc:identifier>done</dc:identifier>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4a297a6d-abd6-4046-b021-1fa334c6d48b">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ad1b77fd-6221-4909-b7eb-d3ca21026a9a"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2c80e395-e35d-4844-b93b-8219dee57c69">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003657</ddiem:url>
        <dc:identifier>HP:0003657</dc:identifier>
        <rdfs:label>granular osmiophilic deposits (GROD)</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>N-Acetylcysteine+cysteamine bitartrate</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/28951bd1-232c-4416-a51d-848abaa1c0a4"/>
    </obo:RO_0000057>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65">
        <rdfs:label>Functional interaction ( Mechanistic B)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/256730">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/2c543781-ebe9-48b6-9d83-a00a0945ce93"/>
        <rdfs:label>CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1</rdfs:label>
        <ddiem:iembaseAccessionNumber>305</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/305</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/256730</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1d9593bb-94eb-4172-af06-eaf00771c785">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/5cda6137-94c1-4c3d-97e9-e4456eaad7e3"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0802ee16-ec48-467a-884c-978d109fd089">
        <rdfs:label>irritability</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000737</ddiem:url>
        <dc:identifier>HP:0000737</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558>
      <ddiem:Evidence rdf:about="http://ddiem.phenomebrowser.net/ECO:0007121">
        <dc:identifier>ECO:0007121</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/ECO_0007121</ddiem:url>
      </ddiem:Evidence>
    </obo:RO_0002558>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3a6e9fff-7d19-41d1-ab60-9a002385bef3"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/36378db6-72d2-4a5f-8023-a1c3ca950ce1">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6240d189-1def-4b04-8304-cf06068f619f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00028262</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/78cc7d2f-3d07-448c-9f2f-8d491cdda885">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0004372</dc:identifier>
        <rdfs:label>Defected alertness</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004372</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3b2be27e-a5e8-47ea-bc37-8a8dcb012220">
        <dc:identifier>HP:0002353</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Isoelectric electroencephalogram</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002353</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/23b30f24-11bb-4697-95db-1ae4f7ab0b76"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24997880</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fe764bcb-de4e-46fc-8890-a2e11abb9d0d">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/613839">
        <dc:identifier>https://www.omim.org/entry/613839</dc:identifier>
        <rdfs:label>MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4911760a-41c0-4a2f-9f4f-515f7cf99502"/>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a48d4417-25f3-42b4-abed-702601b53e07">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
        <rdfs:label>seizure</rdfs:label>
        <dc:identifier>HP:0001250</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5ca28c24-9eac-4f3c-aebe-d4fc037deded">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/401855c5-f345-445c-88e2-4376c8c3e954"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21310277</dc:provenance>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/523cc3f7-b66c-49fe-aced-70272c9a4f80"/>
    </obo:RO_0000057>
    <rdfs:comment>Phenobarbitone+levetiracetam</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cb6d935c-97ca-4752-9652-5786a9767154">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/92e8e4f1-9d1b-4cfd-aef5-489adad8d5bf"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21310276</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/71d3b67f-01dd-40b4-a942-abbd2526f438">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/795875bf-e40e-440e-ac94-c956e986e35f">
        <rdfs:label>NPC2</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/10577</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>NPC2 protein</rdfs:label>
    <ddiem:uniprotId>Q9VQ62</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/47509107-f02b-462c-add1-45664e2f6107">
    <rdfs:comment>fenofibrate + atorvastatin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3162680</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/84677421-7469-4c60-9f40-b1166715ffba">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6dc1dcb7-4307-4323-9ba7-cc67bb375844"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/efccfec3-4442-4ad4-9f47-81bde0ab4e77">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001677</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>stenotic coronary atherosclerosis</rdfs:label>
        <dc:identifier>HP:0001677</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs11883-014-0440-2</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/86e82f20-d8da-470c-adb7-b90fad9c1c54"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b72a581a-8b62-474a-922b-a8c93dd15b2e">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/10c33a6c-d0f6-466f-9880-63cd64130ec8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ebbb70cc-15bf-48e7-9ec9-de5074980a5c">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001681</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <dc:identifier>HP:0001681</dc:identifier>
        <rdfs:label>angina pectoris</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2">
        <rdfs:label>Functional interaction (B)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a56ce8cc-62eb-4836-ba6e-eb7c95ed9b40"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/617347">
        <ddiem:iembaseAccessionNumber>507</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/617347</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/6507bd4f-3507-4b99-862e-e798785f87fd"/>
        <rdfs:label>HYPERLIPOPROTEINEMIA, TYPE III</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/507</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2065040</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a07a2e4d-af69-4b82-801b-c5fbde420deb"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bfe221cb-1a74-4b41-b96f-ce044d08202c">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000991</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <dc:identifier>HP:0000991</dc:identifier>
        <rdfs:label>xanthomas</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25079293</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a7473fed-9168-46cb-85e3-f58327bd6334">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/873a62e3-7f54-46b9-8d98-76d7277f38ed">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/e873742d-bcbe-42c1-a9ac-63337c8059c0"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/89fdd0e0-a33e-4303-b9d4-dcaf6df4e853">
        <rdfs:label>Osteoporosis</rdfs:label>
        <rdfs:comment>Preventive calcium and vitamin D3 supplementation is also recommended to prevent osteoporosis.</rdfs:comment>
        <dc:identifier>HP:0000939</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000939</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20631546</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/58235d61-91ab-490f-a381-601fc05496ad">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/56b49892-bb44-4dae-a23d-26c4421aab78"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24613482</dc:provenance>
    <rdfs:comment>calcium and vitamin D</rdfs:comment>
    <dc:provenance>https://www.nature.com/articles/gim201069</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/232400">
        <dc:identifier>https://www.omim.org/entry/232400</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f8385674-5633-4b6b-a90f-5d7c52df0b6e"/>
        <ddiem:iembaseAccessionNumber>487</ddiem:iembaseAccessionNumber>
        <rdfs:comment>Managment guidelines for treating GSD3 can be accessed through https://www.ncbi.nlm.nih.gov/pubmed/20631546</rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/487</ddiem:iembaseUrl>
        <rdfs:label>GLYCOGEN STORAGE DISEASE III; GSD3</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/47208b49-ab03-4083-a90e-b54ec7742b96"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25153581</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/7373530d-2f7a-4597-816f-3fd8b27bf777">
    <ddiem:ecNumber>2.1.1.13</ddiem:ecNumber>
    <rdfs:label>Methionine synthase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/bb96e655-44eb-4230-9e99-e13cb3d4a015">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4548</dc:identifier>
        <rdfs:label>MTR</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4be96d9d-9e7a-48c8-9421-d9188be3b997">
    <ddiem:uniprotId>Q8WZ55</ddiem:uniprotId>
    <rdfs:label>barttin</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/4b55082a-9118-4178-9fb0-93add7af5733">
        <rdfs:label>BSND</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/7809</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/94ee053b-c7f5-4a4d-a5b0-31d34c84e287">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/0cfe30fe-5e2a-4970-8407-e1964a22cb45">
        <rdfs:label>l‐dopa+carbidop+5-hydroxytryptophan+selegiline</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18425437</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7760062</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/fd930177-3e81-49e3-a2b6-45c9ff516717"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>l‐dopa+carbidop+5-hydroxytryptophan+aselegiline</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ac06a685-6de0-4b4d-a07c-5ea08f25b673">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/53829b7a-4de5-4ff5-b599-d7898c11990e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6ef1e31d-760c-402f-b93c-b7a210c194f3">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b6495443-58fe-43ca-968d-236e7d6a7012"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/23f852d1-da7c-49f2-8e77-9d6cc78944a6">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>high plasma phenylalanine level</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004923</ddiem:url>
        <dc:identifier>HP:0004923</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26817292</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5843539d-75a9-490f-aae2-391e3fae9904">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/31b94bfa-ec0a-4b71-8d81-c02139193f7d"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/521b6b68-e793-4634-9048-7ac211625b71"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/261630">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/5</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>5</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/87ac6684-45c1-4a16-a592-67c633a96fec"/>
        <dc:identifier>https://www.omim.org/entry/261630</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/3ad441a5-d1e7-44b8-8c82-7717d2773937">
    <rdfs:label>Dihydrofolate reductase</rdfs:label>
    <ddiem:ecNumber>1.5.1.3</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/4911760a-41c0-4a2f-9f4f-515f7cf99502">
        <rdfs:label>DHFR</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1719</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/40964ef1-d4e9-474d-8965-22d77f227bf7">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fa84c9a7-4bb0-4583-a3de-438273dac57d">
        <rdfs:label>Abnormal serum fast ORAC(oxygen reduced absorbance capacity)</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f48af385-bc39-408c-ac6f-f29222d83951"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9b474b28-76d7-44f5-89ce-91f0eaf3d571">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7a6f5459-0e3c-44b1-a2e4-e8287f31048d"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27906067</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/208900">
        <dc:identifier>https://www.omim.org/entry/208900</dc:identifier>
        <rdfs:label>ATAXIA-TELANGIECTASIA; AT</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/7d24f891-8165-4fd4-8b8d-479948806954"/>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f1b7bfd8-0743-478c-a735-daa83d21eb16"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1b7d779a-3e96-4986-a51a-687e6ab4346d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/44b0a845-4c29-4989-bded-9bcdf8faa8f6"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <rdfs:comment>Alpha-lipoic acid + nicotinamide</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5f40330d-fb4e-4c0b-905d-cf61a3233f7b">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040088</ddiem:url>
        <rdfs:label>Abnormal lymphocyte counts</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0040088</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/e0abcac6-b654-4caa-8c57-691b9ce85d55">
    <rdfs:label>glycogen synthase 2</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/21e6ff8b-921a-45a4-9996-32b54d51106a">
        <rdfs:label>GYS2</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2998</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.4.1.11</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/575286f3-3466-4bd0-af5f-51601eb831c6">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/66297d90-9bbe-40ad-8368-ce6cc499a5bb">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/7369</dc:identifier>
        <rdfs:label>UMOD</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>uromodulin</rdfs:label>
    <ddiem:uniprotId>P07911</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/ede8a5b0-c26f-45e3-a951-6bcd531a419c">
    <rdfs:label>dopamine beta (β)-hydroxylase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b8b77c6e-5b66-4a90-8969-3d2bff1352d1">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1621</dc:identifier>
        <rdfs:label>DBH</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4724519d-af5b-45e1-915d-b16f2058cc7b">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d7f28737-2c4c-4059-833f-1ddbc1cc4c9a">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003074</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Hyperglycemia</rdfs:label>
        <dc:identifier>HP:0003074</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/47d2f2e1-5d2a-4733-a5c4-943f6345148d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9f3b4042-be5e-4a21-8011-56fc3fb0212e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0003304>W464X</obo:RO_0003304>
    <rdfs:comment>Insulin aspart+Fibrate(gemfibrozil)+ ω-3 fatty acids</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19820022</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/246650">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/e7aece5d-5a00-4b14-a68a-2fcb13cfd310"/>
        <rdfs:label>LIPASE DEFICIENCY, COMBINED</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1085</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>1085</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/246650</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/622737b9-25a9-43c3-bc5a-70e2bc7a4799">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/64f01144-6c1b-432d-8747-000bf1941225"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/262cc661-72ec-41e4-88eb-7049bae58d47">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002155</ddiem:url>
        <rdfs:label>Hypertriglycridemia</rdfs:label>
        <dc:identifier>HP:0002155</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3bece274-4336-43ca-b15d-a9928ba80d31"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a6ec4fb8-4bbf-49a8-bcc6-e7ae50eff90f">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1a4e34b2-b334-40d5-894d-c889dac0ebe2"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f3456c16-037c-463b-b818-5c5243b6c443"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16635485</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/d7e9a792-fc6c-400d-8c06-23c994cb79db">
    <ddiem:ecNumber>1.5.1.20</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/e9e57ce6-fc1c-4c97-8a2f-ff53cae17180">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4524</dc:identifier>
        <rdfs:label>MTHFR</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>methylenetetrahydrofolate reductase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4d70be79-77f7-4e46-b1c7-259edc02b230">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/2cfded52-40b9-4675-b6f0-50b5d3bf0d9d">
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-ND6</dc:identifier>
        <rdfs:label>MT-ND6</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>4.2.1.17</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/942dc48c-e1d9-4ade-bf16-9e2f168ca1d7">
        <rdfs:label>MT-ND1</rdfs:label>
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-ND1</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.1.1.211</ddiem:ecNumber>
    <rdfs:label>mitochondrially encoded NADH dehydrogenase 1/mitochondrially encoded NADH 4L dehydrogenase/ mitochondrially encoded NADH dehydrogenase 6</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/df905e65-f472-4938-94d6-b333f6043a22">
        <rdfs:label>MT-ND4L</rdfs:label>
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-ND4L</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6ddd7dab-5272-430f-ad7d-e0d3ed484581">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b6d06603-dfef-41aa-8d04-29d3bbf57545">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7c2573dd-918f-4f6a-96e6-a9f7e7fd76fe"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b4ad8cff-6fa9-4758-b2c0-8916f628af39"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15670720</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6c37d423-92c1-45fa-96c6-3440a6085ae1">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0001987</dc:identifier>
        <rdfs:label>hyperammonemia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001987</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/85c7e682-7ddb-440c-be61-a05245280ec3"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bfb1639a-1c81-406c-bf2b-f885b47cf9e4"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f5a73591-13ba-4634-826f-b8ea01fa447d">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011966</ddiem:url>
        <rdfs:label>Elevated plasma citrulline level</rdfs:label>
        <dc:identifier>HP:0011966</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1181</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b7c15590-af6c-422a-8df4-76c37a12af58"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/26d2cab7-88dd-4e67-8adf-fb55a66fa745"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fa9d137d-08be-4093-af3e-13f0f18897ce"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c22d9ce3-e0fb-45a4-ac09-01eef6cbc7a9">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001254</ddiem:url>
        <rdfs:label>lethargy</rdfs:label>
        <dc:identifier>HP:0001254</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.sciencedirect.com/science/article/abs/pii/S1386634602003315</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e15a4658-58a3-4c8a-9120-83e879a8974d">
        <rdfs:label>Elevated threonine-to-serine ratio ( Abnormality of amino acid metabolism)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004337</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0004337*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18958581</dc:provenance>
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4cbb661e-f0bd-479c-a437-30eef419f17e">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012378</ddiem:url>
        <dc:identifier>HP:0012378</dc:identifier>
        <rdfs:label>fatigue</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7525db2f-afc6-4ff5-b7f7-a79e8153035d">
        <rdfs:label>anorexia</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0002039</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002039</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>L-Arginine+Pyruvic acid</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3af03e44-4810-4bc0-b50e-0d8150264dae">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001510</ddiem:url>
        <dc:identifier>HP:0001510</dc:identifier>
        <rdfs:label>Poor growth</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/603471">
        <rdfs:comment>Liver transplantation is the only radical treatment for CTLN2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783980/</rdfs:comment>
        <ddiem:iembaseAccessionNumber>18</ddiem:iembaseAccessionNumber>
        <rdfs:label>CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/78724edc-07ba-4883-b944-d12e44e8041f"/>
        <dc:identifier>https://www.omim.org/entry/603471</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/18</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/713bba9f-7573-4494-8529-d0ef2b2d34c5"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6c1ab060-239c-42a4-b2f7-9131cd3318da">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d883bc14-cb26-4fb6-aec6-eb004d9b4bea"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/89e03db3-d0d1-473c-bccb-e415219ce2ec"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/25ca2ec9-a94a-4052-9ec0-68800f5f745f">
        <rdfs:label>Elevated serum pancreatic secretory trypsin inhibitor</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/78f496ba-a24d-4345-bacb-6c965b783d2f">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/26305041</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b11da811-7f32-4bc5-876d-aceb6144ca5f">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b1114590-3f0b-4084-9403-2d2f4c44cc5c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/65bb4eba-644d-4017-a757-79804f618962"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <rdfs:comment>Prednisone +Cyclosporine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e">
        <rdfs:label>Functional interaction(Mechanistic B)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/26758319</dc:provenance>
    <dc:provenance>https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.13632</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/105650">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/74cf8618-c672-4187-bee6-830cf6c462ca"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/50aa29fb-74a9-4dc4-a57d-ff10e93e06b6"/>
        <dc:identifier>https://www.omim.org/entry/105650</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/d83ffc63-d471-4b10-a398-98b344b65d48"/>
        <rdfs:label>DIAMOND-BLACKFAN ANEMIA 1; DBA1</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a5220b4f-7cb1-462e-96cd-e1154fb3d5b5"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f62a8dd4-558a-4bda-a566-a1d2d4ddfd1d"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/fbfb37d2-dabd-4e6e-aadd-f8d12d3b46a4"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ef5285ac-41b8-4c8b-9d91-244449a20530"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/71c8af6a-1f2f-413f-8294-2adb6b9fb59c"/>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f43d51f5-51b2-48d1-8407-245852a46313"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/21242e65-9090-41b3-b37b-61af8d0e78d3"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/595b467b-c2ef-434f-bc7d-6adfd60dd499"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs12185-016-2044-9</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7318fc96-98c7-4a8d-ba82-1726120fcace">
        <rdfs:label>low Hb level</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001903</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001903</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ef4720c8-6d94-49bb-b501-2bf28ce742cd">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/fe2d9cd3-cc30-400e-a56a-7f7f3e9b13dd"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/eb2f8560-88c0-4dc5-a819-e9fbbbcf4ea8">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <rdfs:comment>Glycosade</rdfs:comment>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/232200">
        <ddiem:iembaseAccessionNumber>484</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/d2b99377-9958-47f9-b99c-88110faf380a"/>
        <rdfs:label>GLYCOGEN STORAGE DISEASE Ia; GSD1A</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/484</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/232200</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9c6de9b9-bd77-4c2e-a0d9-846a12cd9b7d">
        <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002360</ddiem:url>
        <rdfs:label>Sleep disturbance,Poor sleep quality</rdfs:label>
        <dc:identifier>HP:0002360</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02054832</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/dec7e701-6c0a-4d0c-bda0-587a611326b0"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fed9fdb3-ac5f-4231-9446-2fdeca4376ea">
        <rdfs:label>Fasting hypoglycemia</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003162</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003162</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2c4a2d48-1267-446c-9efd-2767b7cda6ed">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/265442c0-aba5-4dab-88ce-4fe0f01dae7c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29223626</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/12ea1cfc-9ee7-4890-984b-dd2304cad846"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/22790dfe-712f-475b-87e8-38b8d8b99379"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6efbb158-172f-4fa2-91b9-5882cb151a4a">
        <dc:identifier>HP:0025142*</dc:identifier>
        <rdfs:label>Low quality of life(Constitutional symptoms)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025142</ddiem:url>
        <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18996862</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/d18ffd73-d1f9-4444-8df6-aa2fce367b5a">
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/11ef2ea0-a05a-4279-a858-1008e07bdc19">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/23474</dc:identifier>
        <rdfs:label>ETHE1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>persulfide dioxygenase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000016">
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000007"/>
    <rdfs:label xml:lang="en">functional complementation or a defective protein by stimulation</rdfs:label>
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure that stimulates a component of the pathway or network in which a genetically defective defective protein is found, compensating for alteration of activity of that protein. [PNS]</obo:IAO_0000115>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T18:09:20+00:00</dc:date>
    <dc:creator>leechuck</dc:creator>
  </owl:Class>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e4a1d5b2-27f5-4ff4-b53b-dd283daaf604">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1fc9266c-bc02-4d52-943c-f3e7ac666b3e"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2e1b6ccd-a467-4de3-afca-875fddb3ce64">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/13d5976d-580a-4edb-bd27-6b4cfd444059"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0021915015001379</dc:provenance>
    <rdfs:comment>lovastatin and clofibrate</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/898115c7-2054-4893-b291-24af656d4ae9">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d85b42e7-3474-4a47-9796-810281becede"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28098593</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3162680</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/331be076-8833-4d99-965f-c159452f2335">
        <dc:identifier>HP:0003124</dc:identifier>
        <rdfs:label>hypercholesterolemia</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003124</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25768710</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4da867b0-ca80-452b-b6dc-e3210b4b8076">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/2cfded52-40b9-4675-b6f0-50b5d3bf0d9d"/>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b02bd70d-0690-49bb-a99c-94ef8c6617f9">
        <rdfs:label>MT-TS2</rdfs:label>
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-TS2</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/942dc48c-e1d9-4ade-bf16-9e2f168ca1d7"/>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/2eaef29d-9759-4377-ac2b-b70f3a8bee24">
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-ND5</dc:identifier>
        <rdfs:label>MT-ND5</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>NA</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f793a0c2-2320-49ec-a4d8-58578ac60d82">
        <rdfs:label>MT-TE</rdfs:label>
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-TE</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/8da8670b-f559-4f31-b729-cf71cc42be16"/>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b5ad4ebb-6b98-476a-8c65-8db0909e7471">
        <rdfs:label>MTTC</rdfs:label>
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MTTC</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/34261d71-d09a-4483-b5f1-b07ee0072a47">
        <rdfs:label>MT-TH</rdfs:label>
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-TH</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/75d2b0ad-5416-4ad5-b9b9-a06fe2801067">
        <rdfs:label>MT-TS1</rdfs:label>
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-TS1</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>tRNA-LEU MITOCHONDRIAL 1/tRNA-GLU MITOCHONDRIAL/tRNA-LYS MITOCHONDRIAL</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/deae5878-d4cf-432c-8448-2094bf456216">
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-TQ</dc:identifier>
        <rdfs:label>MT-TQ</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/8c31831b-e9ed-443c-bc1a-253f1da8dc5b">
        <rdfs:label>MT-TL1</rdfs:label>
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-TL1</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e08e69a7-8341-431f-ad3a-1e081a522272">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2d270d71-7b5b-403f-b49a-fba182db16c5"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cbdfd36a-8602-4983-9949-85ef10bba2ec">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b6daf903-ddf7-4909-aadb-adaa816a341d"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28057010</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/593c0421-6629-46a3-b02e-8ba9c925a0ae">
        <dc:identifier>HP:0000817</dc:identifier>
        <rdfs:label>lack eye-eye contact</rdfs:label>
        <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000817</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27567650</dc:provenance>
    <rdfs:comment>Sodium benzoate+ L-carnitine+ low dose citrulline</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a9979a0f-2db7-44d9-bbdf-7091e1d64f4c">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001433</ddiem:url>
        <dc:identifier>HP:0001433</dc:identifier>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <rdfs:label>Hepatosplenomegaly</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301535</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/dee025fa-282a-413e-83c8-9694fbec91a1"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23430827</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bda4b943-5e3b-40e3-ab23-a03792c92217">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/fc712031-13ed-4cce-ae3a-373f24d14502"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/222700">
        <rdfs:label>LYSINURIC PROTEIN INTOLERANCE; LPI</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/51</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/91d7f8e3-9fe4-4ab4-b752-29e86e49d2f9"/>
        <ddiem:iembaseAccessionNumber>51</ddiem:iembaseAccessionNumber>
        <rdfs:comment>General therapeutic management remains empirical with 3 major axes: prevention of hyperammonemia, nutritional supplementation and prevention of specific complications. There is a general consensus that a hypoproteinemic regimen should be initiated with an objective of 1 g/kg/d. associated with L-citrulline supplementation, L-carnitine 20-50 mg/kg/d., vitamins and other nutritional supplementation, if necessary. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217205/  https://www.ncbi.nlm.nih.gov/pubmed/21308987/.  https://www.ncbi.nlm.nih.gov/pubmed/22402328/</rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/222700</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c85b04d4-9928-475d-81ac-eac84e85c65a"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0fc59988-0c34-44f1-9cf4-2e9b90075025"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/09ab7406-f5f1-4928-aad3-4c2d70fe411f"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bcbc9378-0696-4809-ac62-9bc65b08978c">
        <dc:identifier>HP:0000708</dc:identifier>
        <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000708</ddiem:url>
        <rdfs:label>episodic behavioral abnormalities</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/68cdfb42-1d86-414d-966b-47df4ca1787a">
        <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000735</ddiem:url>
        <rdfs:label>social interaction defect</rdfs:label>
        <dc:identifier>HP:0000735</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/861994ec-670f-4b2b-b56a-d587d9505fc3">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24613482</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02054832</dc:provenance>
    <rdfs:comment>Glycosade</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2c4a2d48-1267-446c-9efd-2767b7cda6ed"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8ae4aadc-82ae-484a-9ed3-863d9bf329e3"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1222d2ff-c9fb-4430-9c99-3697118de709"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232400"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c01071cf-5747-472e-b70d-4bb1e33a5bff">
        <rdfs:label>Sleep disturbance</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002360</ddiem:url>
        <dc:identifier>HP:0002360</dc:identifier>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29223626</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fed9fdb3-ac5f-4231-9446-2fdeca4376ea"/>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/a2c3d2a8-b2ea-4bb6-af38-dbc4dd130023">
    <rdfs:label>3-hydroxyacyl-CoA dehydrogenase/enoyl-CoA hydratase</rdfs:label>
    <ddiem:ecNumber>1.1.1.211</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/549244da-33b7-46f2-847d-6e5ae2a90910">
        <rdfs:label>HADHA</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3030</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>4.2.1.17</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/69bf7f2c-5f1f-41a4-b382-ec681e8c7b2c">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28283348</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b93e405f-4ecc-4d84-a810-a2d5c3dcd5ee">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/64202417-a68d-4123-9ba2-4c399fbd2895"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/aae3dcff-3f8f-4306-bdf0-5f3fe49c8885">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/0ef03e4f-5a82-4a4c-8ef7-90923ba409f1"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a98a6787-19be-4d50-b837-3450d0ec3bfb">
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
        <dc:identifier>HP:0002014</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002014</ddiem:url>
        <rdfs:label>Watery Diarrhea</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27775558</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10404446</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/606824">
        <ddiem:iembaseAccessionNumber>482</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/606824</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/482</ddiem:iembaseUrl>
        <rdfs:label>GLUCOSE/GALACTOSE MALABSORPTION; GGM</rdfs:label>
        <rdfs:comment>Treatment rests with the avoidance of Glucse and galactose dietary sugars.https://www.ncbi.nlm.nih.gov/pubmed/28283348.  https://www.ncbi.nlm.nih.gov/pubmed/28753187</rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a469ea2b-9e45-4596-acd8-f31f7a2e1cbf"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808885</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/72dd96ca-c61d-4e7c-b2aa-c0fe721d6980"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5094ed01-7369-45c6-8f58-a685201737af"/>
    </obo:RO_0000057>
    <rdfs:comment>Fructose +Carbohydrate free formula</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/60fb2681-1dfc-4bdd-8868-9c803a4ed807">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001944</ddiem:url>
        <rdfs:label>Dehydration</rdfs:label>
        <dc:identifier>HP:0001944</dc:identifier>
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20486940</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bcf08b7a-b264-4b90-9e0f-6f4d0d6a16a8">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bd733de5-08c1-4c3e-b649-0b740fa1bd0b">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/712e2d69-e286-48e4-9ede-74269ed033f7"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14517515</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/218800">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/636b5338-d064-4a7e-8e3b-93b09908ac39"/>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>CRIGLER-NAJJAR SYNDROME, TYPE I</rdfs:label>
        <ddiem:iembaseAccessionNumber>661</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/218800</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/661</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00461799</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03466463</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a15916a2-f9b1-42fb-8a0f-70ae93123f9e"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d">
        <rdfs:label>Direct Interaction (A)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <rdfs:comment>GNT0003</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/99df848a-4758-43c0-9b33-129348772f7f">
        <rdfs:label>Study is still recruiting</rdfs:label>
        <dc:identifier>HP:0002904</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002904</ddiem:url>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/06026693-2a6c-44ff-9d8e-1e58b64b042e">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7a0f16c2-2b4f-4467-940e-b186148785ee">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/56172</dc:identifier>
        <rdfs:label>ANKH</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Progressive ankylosis protein homolog</rdfs:label>
    <ddiem:uniprotId>Q9HCJ1</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c714706a-cdc0-4084-93bf-403978c0e37c">
    <rdfs:label>solute carrier family 36 member 2 +solute carrier family 6 member 20 or solute carrier family 6 member 19</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a7544cb1-3af7-4d86-9793-f4e08b234124">
        <rdfs:label>SLC6A20</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/54716</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.2.1.183</ddiem:ecNumber>
    <ddiem:ecNumber>2.7.1.60</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/8a4bb2af-4867-47d4-a088-fe00bcf38f43">
        <rdfs:label>SLC6A19</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/340024</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a01b6f8f-47a0-4ccb-b5a3-37ae862065ab">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/153201</dc:identifier>
        <rdfs:label>SLC36A2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/12319238-e18f-497d-a9ea-77645aa31602">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/257220">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/303</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/70e2504e-c6f8-4d41-ab09-3ea07fdf8612"/>
        <rdfs:label>NIEMANN-PICK DISEASE, TYPE C1; NPC1</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>303</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/257220</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/05c9c072-2020-4297-92bb-5b13ab89f31a"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e5ae14fa-aeb1-441b-ad93-ce9cc5768cb6">
        <rdfs:label>elevated intraneuronal cholesterol(Abnormality of cholesterol metabolism)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003107</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003107*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>N-butyldeoxynojirimycin +allopregnanolone</rdfs:comment>
    <dc:provenance>https://www.tandfonline.com/doi/full/10.3109/0886022X.2014.900422</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c7a11941-2d00-4d77-8190-1589b6729c29">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/11f70c63-07d3-44cf-b96d-75a867cee7c4"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736622</dc:provenance>
    <obo:RO_0002558>
      <ddiem:Evidence rdf:about="http://ddiem.phenomebrowser.net/ECO:0005542">
        <dc:identifier>ECO:0005542</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/ECO_0005542</ddiem:url>
      </ddiem:Evidence>
    </obo:RO_0002558>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/56215552-6406-476a-8150-6a52edf8a20d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7e934252-f3ef-4411-8263-b3ecbd8b96b9"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0ee56bd7-3956-4a26-a824-6affca825899">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25488886</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/893e9b46-735c-4ed8-85b2-be3eecee373d"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30731125</dc:provenance>
    <rdfs:comment>Medium-chain fatty acid supplements+Vitamin A+Vitamin D+Vitamin E+Vitamin K</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ecddc9ea-d303-4951-b729-b2bc1adab4f6">
        <rdfs:label>Disease progression (Progressive)</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0003676</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003676</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/af9bcc02-798b-41dd-b1a6-bbe58296adc3">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ae06b559-77a1-449e-9081-48912b37b3cc"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/58235d61-91ab-490f-a381-601fc05496ad"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/367914ff-d0f1-4852-82ab-2847f2103108">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0000707</dc:identifier>
        <rdfs:label>Neurological abnormalities</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/200100">
        <rdfs:label>ABETALIPOPROTEINEMIA; ABL</rdfs:label>
        <rdfs:comment>The mainstays of treatment include adherence to a low-fat diet, and supplementation with essential fatty acids and high oral doses of fat soluble vitamins. https://www.ncbi.nlm.nih.gov/pubmed/24288038</rdfs:comment>
        <ddiem:iembaseAccessionNumber>371</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a7400853-964a-4d7a-bd58-afb4541f271f"/>
        <dc:identifier>https://www.omim.org/entry/200100</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/371</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/369e2d68-3b59-4a4f-9422-0a8eb69cbe01">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6d8330ec-1a6a-4268-86ce-6bc517a9c65e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fe61e9d4-a733-4f06-8e49-dc209916b79b"/>
    </obo:RO_0000057>
    <dc:provenance>https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-3-20</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6928fd06-bf16-452f-9adf-21667d147ab8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67">
        <rdfs:label>Supportive (C)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/116387c9-2a90-4990-bb34-1e6d972eafa9">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/16736b5f-3112-4a24-b01f-3719c33c4079"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/db1d8335-e91b-4254-bba6-40d02dd2fe17">
    <rdfs:comment>hepcidin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <obo:RO_0002558>
      <ddiem:Evidence rdf:about="http://ddiem.phenomebrowser.net/ECO:0007764">
        <dc:identifier>ECO:0007764</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/ECO_0007764</ddiem:url>
      </ddiem:Evidence>
    </obo:RO_0002558>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00001203</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b04bbbc1-beb9-46e1-bb50-119894dcde41"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895089</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/604250">
        <ddiem:iembaseAccessionNumber>582</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/604250</dc:identifier>
        <rdfs:label>HEMOCHROMATOSIS, TYPE 3; HFE3</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ec0ce96f-846d-4293-a29f-57987127b142"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/582</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/80e6f50b-1ef7-4323-aff6-6d641c7ec192">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1f518ece-3566-4eca-a453-2e97b6c9f48a"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/46a12f85-3ec5-4790-8d40-4bce816dd0a9">
        <rdfs:label>Increased plasma iron concentration(Increased serum iron)</rdfs:label>
        <dc:identifier>HP:0003452</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003452</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4f6a78e9-3643-4208-bd32-269262d2e2c7">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/83dfa1cb-ce68-44b9-abc9-93b27288ebaf">
        <rdfs:label>RET</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5979</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.7.10.1</ddiem:ecNumber>
    <rdfs:label>Proto-oncogene tyrosine-protein kinase receptor Ret</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/9ba9187a-8a1b-444c-afd2-e42ca9d9bfd1">
    <rdfs:label>lecithin-cholesterol acyltransferase</rdfs:label>
    <ddiem:ecNumber>2.3.1.43</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/fb4f3a1b-6601-43be-90e0-5bc8d25d9530">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3931</dc:identifier>
        <rdfs:label>LCAT</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/be178bc2-c8cd-4119-964a-2162ce06e536">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29526615</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/602473">
        <dc:identifier>https://www.omim.org/entry/602473</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>172</ddiem:iembaseAccessionNumber>
        <rdfs:label>ENCEPHALOPATHY, ETHYLMALONIC; EE</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/11ef2ea0-a05a-4279-a858-1008e07bdc19"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/172</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/03851be3-fe3d-4a40-bf8c-8cb2611c7644">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/768689e4-d6cd-4b53-9d5f-fea090d496c1"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0022202X15352507</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20657580</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b07d20d7-b26c-46fc-ad89-c93e431f2c74"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26917598</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <rdfs:comment>carnitine+metronidazole</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000013">
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/metabolic_disease_treatment"/>
    <dc:creator>leechuck</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T18:07:49+00:00</dc:date>
    <rdfs:label xml:lang="en">symptomatic treatment procedure</rdfs:label>
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure aimed at amelioration of one or more abnormal phenotypes generated as a consequence of a defective protein or process by a means unrelated to the immediate pathway or network environment of the defective protein. Generally working at the level of the tissue or overall organismal physiology. [PNS]</obo:IAO_0000115>
  </owl:Class>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/3dfffac2-d3b1-4250-bd61-20821b32eaaa">
    <ddiem:uniprotId>Q9VQ62</ddiem:uniprotId>
    <rdfs:label>NPC intracellular cholesterol transporter 1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/70e2504e-c6f8-4d41-ab09-3ea07fdf8612">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4864</dc:identifier>
        <rdfs:label>NPC1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/b14e8972-3b2f-46e7-abcc-c0ef1e942d99">
    <rdfs:label>gastric intrinsic factor</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b2ccfdf7-aa5e-447e-8ddb-3e5427ebd913">
        <rdfs:label>GIF</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/""</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>4.1.1.9</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/9fe3e31e-a7ae-4d28-b251-afbf76d12564">
    <ddiem:ecNumber>4.4.1.1</ddiem:ecNumber>
    <rdfs:label>cystathionine gamma-lyase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/28d5ffd8-d9a2-41f2-93eb-f39b8830ce9b">
        <rdfs:label>CTH</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1491</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0f453afa-7b94-4a08-a4fa-843cd5a96276">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564511</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC324959</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/306000">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/6e44f694-1c06-40f4-9290-4bcf8724692c"/>
        <ddiem:iembaseAccessionNumber>492</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/306000</dc:identifier>
        <rdfs:label>GLYCOGEN STORAGE DISEASE IXa1; GSD9A1</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/492</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ef75701a-a6e2-48ad-bbbf-5331b9be3a4b">
        <rdfs:label>Elevated hepatic transaminases</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002910</ddiem:url>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <dc:identifier>HP:0002910</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25266922</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f045daf4-9a93-40fb-8246-2116bd9f0e82">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c31f00d4-e2e6-409b-b679-6a1973b85f49"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/aae3dcff-3f8f-4306-bdf0-5f3fe49c8885"/>
    <rdfs:comment>Uncooked cornstarch+ Beneprotein+CoCarbs(Complex carbohydrate)</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cdeaa249-a7a9-43dc-9fd8-78b2feb997a9"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0fed2a94-fd7e-46f3-98b9-080b38f8d139">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/162300">
        <dc:identifier>https://www.omim.org/entry/162300</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/83dfa1cb-ce68-44b9-abc9-93b27288ebaf"/>
        <rdfs:label>MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18381602</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26170630</dc:provenance>
    <rdfs:comment>bortezomib + vandetanib</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00923247</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fe6025eb-ac3f-4217-a78c-7b1456c2ba70"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b4a53029-1cb1-47d6-9650-68669e735d46">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9fca88c6-8cb2-4841-87c6-f56d1f0c4bb7"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/18bdc0c8-7cc6-44b4-92d3-c754df4c8426">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/460cb535-6d75-4973-9534-99bc24895903"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30297385</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b07e3c26-6303-4963-b80c-9c8c4a64b721">
        <rdfs:label>neoplastic growth</rdfs:label>
        <dc:identifier>HP:0002664</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002664</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/74dc4431-b609-49ed-b15b-87a27baf5ff7">
    <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/884d3b1f-346a-4e65-a587-590af6b226e9"/>
    </obo:RO_0000057>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00345605</dc:provenance>
    <rdfs:comment>Sodium Phenylbutyrate +Arginin</rdfs:comment>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S109671921200265X</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6c1ab060-239c-42a4-b2f7-9131cd3318da"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8582405</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/207900">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/15</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/207900</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/0c18bcaa-5531-4252-9069-575caadc4db4"/>
        <rdfs:label>ARGININOSUCCINIC ACIDURIA</rdfs:label>
        <ddiem:iembaseAccessionNumber>15</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3ee032dc-c022-4a8e-92f6-dd40d135ecdb">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/110ba0d8-10f6-4a18-8b2f-3c920c57f88d"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9f4da0b7-bc68-4593-a7c4-e98ccf7624da">
        <dc:identifier>HP:0001987</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Hyperammonemia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001987</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7b6bb139-d144-4ece-9079-b8e0829130d8">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/da7c2662-bfe5-4463-a63e-057b003f3e3a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f8a53a4c-ab5b-4754-b275-120708abea66"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8a509ece-86c5-46a4-8cd0-e8dd64315108">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004322</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0004322</dc:identifier>
        <rdfs:label>Short stature</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Potassium+Indomethacin±Spironolactone</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/63d340ba-deef-467f-8e78-273fa94cda48">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8b5093be-5162-49ca-8b26-a75bca147333"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28288174</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d1db5564-91b4-449a-85e2-4f099b6062c1">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/dda5461f-8211-43a9-bc67-cdc15a0b111c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/607364">
        <dc:identifier>https://www.omim.org/entry/607364</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/49c2578e-e493-4316-95e7-d4d5244bc56c"/>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>BARTTER SYNDROME, TYPE 3; BARTS3</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/66c098a1-3517-4bae-8f2e-994b9cc12fa1"/>
    </obo:RO_0000057>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/978a9a95-be3f-4c00-9ce2-889dcdfb46bd">
    <ddiem:ecNumber>2.7.1.11</ddiem:ecNumber>
    <rdfs:label>ATP-dependent 6-phosphofructokinase, muscle type</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/15dd9613-2934-4881-b48c-68d3ecb7331e">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5213</dc:identifier>
        <rdfs:label>PFKM</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/2b1f91a8-7da9-4daf-ad01-9e7679e52623">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/88ba3735-64c4-4787-83a9-b9278116d8a4">
        <rdfs:label>PCBD1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5092</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.1.3.1</ddiem:ecNumber>
    <rdfs:label>pterin-4 alpha-carbinolamine dehydratase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/b9d5d172-2012-4703-9b4c-72d6c6282393">
    <rdfs:label>Glutamate dehydrogenase, mitochondrial</rdfs:label>
    <ddiem:ecNumber>1.4.1.3</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/dcdbcddb-c479-477c-b24d-91e8ad74ad55">
        <rdfs:label>GLUD1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2746</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b5e2bc74-5bce-4ce9-b11f-2797a79dcb87">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1d9593bb-94eb-4172-af06-eaf00771c785"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15938133</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9783d6fb-0dd1-4d60-b2c4-6d62d7a7eede"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bfa4e3df-5eac-41db-acba-ba9eb7fb4acd"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4b644f36-10d1-4416-b39e-9fa8dab29d10">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001328</ddiem:url>
        <rdfs:label>Learning impairment</rdfs:label>
        <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
        <dc:identifier>HP:0001328</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/8d31d238-aa6e-4300-a793-db3a8ce4dc5a">
        <rdfs:label>Symptomatic ( C)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <rdfs:comment>N-acetylcysteine +deferoxamine</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3221dd31-98b4-4447-b38f-8fd197ae3fb2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/805b702e-77cf-4343-93db-cefc88abf9df"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2e8db51b-2ae1-4cfc-b4ae-a748b2e3b0e2"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/49d2a1bc-b04e-4467-a979-8900fd493c43"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b8f2a777-1aba-44ce-a9c2-fa6da5e55ba9"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/67f54535-ca86-4412-b313-8a8ede1ce5fa">
        <dc:identifier>HP:0000708</dc:identifier>
        <rdfs:label>Behavioural abnormalites</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000708</ddiem:url>
        <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28919799</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0025464</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025464</ddiem:url>
        <rdfs:label>Oxidative stress</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c1cb13fa-aeb5-47cb-bc6c-38918e463bfd">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100543</ddiem:url>
        <dc:identifier>HP:0100543</dc:identifier>
        <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
        <rdfs:label>cognitive imapirment</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0166432812001830</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/439f97f0-80a8-4858-b786-dc2a368e33e6">
        <dc:identifier>HP:0002354</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002354</ddiem:url>
        <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
        <rdfs:label>Memory impairment</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12927581</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/246900">
        <dc:identifier>https://www.omim.org/entry/246900</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ed382291-2fab-497a-bdc9-8dd04fa10bd7"/>
        <rdfs:label>DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY; DLDD</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/37f321b6-0575-4443-bf10-89864efd97da">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30723321</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00925301</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cb69277a-870e-4779-81d6-e7ac83dddd5d"/>
    </obo:RO_0000057>
    <rdfs:comment>Riboflavin and thiamine</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01458119</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/22186859-4065-462a-ba51-b3b3c7a0efb8">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/e8e90270-e143-4299-82aa-b124c48435d8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.nature.com/articles/s41436-019-0451-z</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01218659</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/612073">
        <ddiem:iembaseAccessionNumber>503</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/612073</dc:identifier>
        <rdfs:label>MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/cd5cbb26-224c-4099-8312-3f63154f5c49"/>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/503</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19666145</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK6803</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c06a5c6b-d666-44b0-811b-6c3ce0b4357b">
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0c761dce-206d-4f31-9645-105ad614bce0">
        <rdfs:label>Abnormal MCV level</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025065</ddiem:url>
        <dc:identifier>HP:0025065</dc:identifier>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21310276</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5">
        <rdfs:label>Functional interaction (Mechanistic B)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c1aacd29-9245-4f42-ac07-bb83eaed4b35">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025546</ddiem:url>
        <rdfs:label>Abnormal hemoglobin level</rdfs:label>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <dc:identifier>HP:0025546</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/613839"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3d5433c0-4e1d-44a6-b0d1-8ffa2f4a517d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/eb911b11-cc41-41b2-ac22-04c8e2370c45"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a76f954f-875c-45b6-abaa-334260a49483"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/34101d64-08c5-415b-b02e-399803061228">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ddb7a833-b7ff-4598-abad-7f3abaae3483"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Hydroxycobalamin + Folic acid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21310277</dc:provenance>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d3b41f2e-92d1-4193-a27e-f41b04757c54"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/430cd861-f744-4698-955b-a5075e052dbc">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/cf5e34fd-598c-4854-b262-883c4b8bcccc"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1b7d779a-3e96-4986-a51a-687e6ab4346d"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/75ce9c8d-20f3-46a2-8fab-dbfe1a1e49ab">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003287</ddiem:url>
        <dc:identifier>HP:0003287</dc:identifier>
        <rdfs:label>Ankle weakness progression(Disease progression)*</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17275787</dc:provenance>
    <rdfs:comment>Coenzyme Q10+L-carnitine+ lipoic acid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17080429</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/545000">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/8da8670b-f559-4f31-b729-cf71cc42be16"/>
        <rdfs:label>MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERRF</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/400</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/545000</dc:identifier>
        <rdfs:comment>Mitochondrion-toxic agents, including mitochondrion-toxic AEDs, such as valproate, carbamazepine, phenytoin, and barbiturates, should be avoided as well as AEDs potentially enhancing the frequency of myoclonus, such as phenytoin, carbamazepine, lamotrigine, vigabatrin, tiagabine, gabapentin, pregabalin, and oxcarbazepine.</rdfs:comment>
        <ddiem:iembaseAccessionNumber>400</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/097df95a-53ea-4ebf-9b9f-2f14a2488942">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003288</ddiem:url>
        <dc:identifier>HP:0003288</dc:identifier>
        <rdfs:label>High resting plasma lactate concentration</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/369297c2-c334-43bd-8ee8-1ad2cfe40928"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/16103177-b099-4204-bd96-b698869ee98e"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/df5d169b-a235-4cd9-a097-352c4ec067d6">
    <ddiem:ecNumber>3.2.1.196</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/d80e514d-803e-403c-b3e3-a863d2cc6012">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2632</dc:identifier>
        <rdfs:label>GBE1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Limit dextrin alpha-1,6-maltotetraose-hydrolase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/47e6ab97-59ba-4cf9-bde5-8c867766f6c7">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/98a39e7f-4eea-496a-be31-ea8658a381cf">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1806</dc:identifier>
        <rdfs:label>DPYD</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.3.1.2</ddiem:ecNumber>
    <rdfs:label>dihydropyrimidine dehydrogenase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/04f06784-e9ef-4a4e-8fd4-baacaba8ce33">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a9b1bc84-1a7c-4311-9930-552bf74db896">
        <rdfs:label>Abnormal EEG</rdfs:label>
        <dc:identifier>HP:0002353</dc:identifier>
        <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002353</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/540000"/>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e5bea7f8-801a-41f1-8ec8-d00a573413a3"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/87cdf746-bddc-4458-b0a5-ce6cf26371e6"/>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/0022510X89901123</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8757046</dc:provenance>
    <rdfs:comment>Idebenone+Coenzyme Q10</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/bd0fa516-e6b5-4277-b12d-79bf6c6ce465">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a959edda-95ac-41f4-8375-8a385a286e3d">
        <rdfs:label>SLC35C1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/55343</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>GDP-fucose transporter 1</rdfs:label>
    <ddiem:uniprotId>Q96A29</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2bd8e2d8-d2e1-481a-9df0-7e8ce03baf60">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1d99c2af-1a1b-4d70-b554-9cc13a23c934"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/76c92114-07a7-4500-85d9-b53c66ce7b00">
        <rdfs:label>Metabolic acidosis</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001942</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001942</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e3ec17c7-13d7-4216-ad9e-9b1b7bda0822">
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <rdfs:label>Elevated urine 5-oxoproline</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d6c1137f-c24a-4d72-9c84-5068df3a1623">
        <dc:identifier>HP:0001943</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001943</ddiem:url>
        <rdfs:label>Hypoglycemia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/13f1fdd2-eb98-4ef9-a008-46b40acd6ca3"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/05e0e82a-9bed-4b0a-bef4-d3b2b940f041">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9ce317ca-757f-427d-8120-a4d1e38f2fc7"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7375069</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e49b96c8-dccb-4ac6-8b47-dc129157aa2d">
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008315</ddiem:url>
        <rdfs:label>Decreased blood free carnitine</rdfs:label>
        <dc:identifier>HP:0008315</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/266130">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/7be2a042-b06e-41d4-9234-94f1d109809c"/>
        <rdfs:label>GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/512</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>512</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/266130</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>L-carnitine+vitamin B1+B2+ B12+ C+E + sodium bicarbonate</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/18d743df-a56f-4189-a89b-78393fc3b371">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/caa301d2-eaa1-4413-b0f8-910f81e0eddf"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9a8bff87-603f-45bb-b076-ce19c0113e40"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/22186859-4065-462a-ba51-b3b3c7a0efb8"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25851806</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bd791b0f-53fd-4b98-b132-d46e9ab14c04">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2f4f2c7e-0e6e-4406-a091-eb173dd2979f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2e02a7c8-a702-458d-a84c-fbbc46bab154"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/b9adea66-a4ac-4b71-b61f-6cd53044da3d">
    <ddiem:ecNumber>1.1.1.31</ddiem:ecNumber>
    <rdfs:label>3-hydroxyisobutyrate dehydrogenase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/928a54cd-f1e2-463e-91e9-aaecd5062190">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4329</dc:identifier>
        <rdfs:label>ALDH6A1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/835dfefe-a63e-4e08-933a-1cb5cac7392e">
    <dc:provenance>https://www.nature.com/articles/nm1059</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/613153">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/645</ddiem:iembaseUrl>
        <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/613153</dc:identifier>
        <ddiem:iembaseAccessionNumber>645</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/234caa85-64f6-40c6-ac2f-99f4ad49bf43"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/578fb905-e833-48e8-9855-b814c142bb9b">
        <rdfs:label>Direct interaction (Mechanistic A) +Functional interaction ( Mechanisitc B)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/60bce3e1-e52b-4d63-abff-5212dc63ef7c">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/17120c5a-1606-4d17-b9c4-85eb34af7380"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e8e178e9-32fb-4e57-bd6d-c629216a3a19"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a72baa14-1fd0-4130-84da-f78ba33c216d">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0006785</ddiem:url>
        <dc:identifier>HP:0006785</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Muscle dystrophy</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Ad5-LARGE-eGFP</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/67f5f159-090e-4f0a-bc4d-cd42eddf0441">
    <ddiem:ecNumber>3.5.1.26</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/6a88c72c-03e1-4ef7-87ee-395dd15194a0">
        <rdfs:label>AGA</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/175</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/d3d6e87b-9312-4850-a862-def72609e0e4">
    <rdfs:label>solute carrier family 1 member 1</rdfs:label>
    <ddiem:ecNumber>1.3.1.2</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/5ec74b8a-de94-4998-ac75-3bb4ba2c77af">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6505</dc:identifier>
        <rdfs:label>SLC1A1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0fe5b8f9-f203-4f93-b13e-e3a90d21cf0f">
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5ca28c24-9eac-4f3c-aebe-d4fc037deded"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0ea1009e-03b6-4447-918c-71b69f5508fe">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3e17c77d-963f-4cf9-801e-9db05d8a58e6"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5a4214d7-77e9-4b9a-8f47-7af0dad0e30c"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/97dbfbc8-24f1-4d70-9f93-04cbe7d7dc3b">
        <dc:identifier>HP:0001250*</dc:identifier>
        <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
        <rdfs:label>Mitochondrial epilepsy(Epilepsy)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Phenytoin+oxcarbazepine+levetiracetam</rdfs:comment>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/dc9b8c52-3c02-4a6a-a96e-110d87571cfc">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d4a7883b-8e26-4c3e-849f-68f97913d061"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e030ce4f-fbe0-4473-9eb0-d877fdbe3d33"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23248042</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01793090</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/610131">
        <rdfs:label>PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4</rdfs:label>
        <ddiem:iembaseAccessionNumber>942</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/610131</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/942</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/55436c22-6ad4-473c-a49a-fc1285d2adfb"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/a8a72a77-2d34-44ed-87de-d6c452edeead">
        <rdfs:label>Symptomatic(c)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/87160ffd-2981-4629-a013-c8b3242dadb9">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8e045f30-fe3a-4946-aab7-d0adefd2d933">
        <rdfs:label>Difficulty walking</rdfs:label>
        <dc:identifier>HP:0002355</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002355</ddiem:url>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0ba389c7-b02e-4e8a-bfa7-a610efad66c3">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100543</ddiem:url>
        <rdfs:label>Mental impairment</rdfs:label>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <dc:identifier>HP:0100543</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17431913</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/34101d64-08c5-415b-b02e-399803061228"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/243d0564-7c59-468e-9f21-a6a3b30a3e0a"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f83d5c37-d04a-4b57-bc63-ff547aba4853">
        <rdfs:label>Dementia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000726</ddiem:url>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <dc:identifier>HP:0000726</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/caa4fe0b-e6ba-43c6-8d8f-8ba11c714932">
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <dc:identifier>HP:0000712</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000712</ddiem:url>
        <rdfs:label>Emotional lability</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6cd8dd19-6bc2-494f-94ab-05974800f7d1">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/cb4c052d-bc30-4f72-b73c-7b658eab59ae"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25511120</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/277400">
        <ddiem:iembaseAccessionNumber>90</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/90</ddiem:iembaseUrl>
        <rdfs:label>METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/277400</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4efcce94-5fcf-4204-b45a-7a1165f6ad5f"/>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f0a94a1e-1f1c-4082-a527-c31466578938"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a8418b0b-fc55-4afa-b92e-ab3bbea46248"/>
    </obo:RO_0000057>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530304</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/94026c50-93b9-4f66-8ef5-473765a56fa0"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bf200f82-975f-4bba-898c-91de778fc2c5"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d830f059-c8b4-4611-a8b3-4a2f143a3547"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/18ca9287-1e59-47cb-9e32-dde834052271"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/773e4b1c-b947-4902-9d31-1577060c2370"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d1d23f03-b9b5-426f-95ca-351a93a3235b">
        <dc:identifier>HP:0000708</dc:identifier>
        <rdfs:label>Psychiatric disturbances</rdfs:label>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000708</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/454ffc98-3c61-4fe2-862a-7eb6304ec157">
        <rdfs:label>Functional interaction ( Mechanistic B)+Symptomatic (c)+Symptomatic (c)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/335b4e61-420b-4f1a-b6b7-04dcce33053b">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0006958</ddiem:url>
        <dc:identifier>HP:0006958</dc:identifier>
        <rdfs:label>Abnormal brain stem auditory evoked potentials</rdfs:label>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Hydroxicobalamin + betaine+ carnitine</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dff6c03a-63d3-4cfd-8d12-60320bc91fd0">
        <dc:identifier>HP:0002160</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002160</ddiem:url>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <rdfs:label>Elevated total plasma homocysteine</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c5e84d03-f0a9-4584-a59c-420cfa90943d"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2873525</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7d3898dc-aa87-48a3-9108-f31c80c9e8f2"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/285a5437-573e-4915-9c55-e9c6bd89a49c"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6f7c52f8-958c-47a4-bd55-a68f4a538d1f">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000649</ddiem:url>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <rdfs:label>Abnormal visual evoked potentials</rdfs:label>
        <dc:identifier>HP:0000649</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b12f2634-e2b9-4379-baf4-086bd4c80d9c">
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <rdfs:label>High urine methylmalonic acid level</rdfs:label>
        <dc:identifier>HP:0012120</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012120</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/32fc741d-58a8-4f3e-ba7d-2f5c6bc16682">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3229565</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19249206</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4494408b-79a4-4b11-acf8-1700e5b0cd6c">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001324</ddiem:url>
        <dc:identifier>HP:0001324</dc:identifier>
        <rdfs:label>Muscle weakness</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/231680">
        <ddiem:iembaseAccessionNumber>1257</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/2157bb83-1e34-49c5-869e-829f7eef13e5"/>
        <rdfs:label>MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/231680</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/c3babda0-4230-4128-b8b0-d1f29b4c2c95"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1257</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/739df0b7-2371-4ca5-999c-68960a91bb50"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2a670529-dd20-49ff-9fa0-05f19bd47c1f">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/78e0f5d4-b326-4c8d-899e-889c72330514"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/96b177ba-46a9-4a89-9673-1734e36167fe"/>
    </obo:RO_0000057>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/1c191ecf-6c18-4e8e-bb8c-21dcb9aebb01">
        <rdfs:label>Symptomatic (C)+Direct Interaction (A)+Functional interaction (B)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <rdfs:comment>Glycine+Riboflavin+Carnitine</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/5a9ea3bf-1c72-401a-a4b0-add56ac54298">
    <ddiem:ecNumber>4.2.3.12</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a378bdac-5a06-45d0-b77f-8c6894513bac">
        <rdfs:label>PTPS</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/""</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>6-pyruvoyl-tetrahydropterin synthase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/1d3517c5-b42d-435d-9e0a-c2f2e13aceec">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/6f7698b0-15df-4d47-aa55-b024fad13232">
        <rdfs:label>L2HGDH</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/79944</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>L-2-hydroxyglutarate dehydrogenase.</rdfs:label>
    <ddiem:ecNumber>1.1.99.2</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/procedure_to_mitigate_dominant_effects_of_a_genetically_abnormal_protein">
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000005"/>
    <dc:creator>ORCID: 0000-0002-5111-7263</dc:creator>
    <dc:date>4.10.19</dc:date>
    <obo:IAO_0000115>a procedure to suppress or mitigate the effects of a dominant alteration in a genetically abnormal protein by reducing or suppressing  transcription or translation of the abnormal protein gene or rna, or destabilising or otherwise inhibiting an abnormally increased activity or neoactivity of the abnormal protein.</obo:IAO_0000115>
  </owl:Class>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/550500">
    <rdfs:label>MYOGLOBINURIA, RECURRENT</rdfs:label>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/67a98b07-c0e0-4b01-a035-b0226015ce12">
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-CO3</dc:identifier>
        <rdfs:label>MT-CO3</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0004020>
    <dc:identifier>https://www.omim.org/entry/550500</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b7cc90fb-b69f-4b61-ac7a-fde4767fb16a">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/271245">
        <rdfs:label>MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/944</ddiem:iembaseUrl>
        <rdfs:comment>Conventional antiepileptic drugs (phenytoin and phenobarbital) are ineffective in most affected individuals.</rdfs:comment>
        <ddiem:iembaseAccessionNumber>944</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/271245</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f358e0bb-188e-4d78-91cc-c9350d2bf03d"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a2422a26-a782-42cc-b2e6-76f4bffd7651"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d8562063-debe-47b1-90ec-02096b47fe97">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d06309f1-d28f-49b2-b047-9ca02d887394"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27551684</dc:provenance>
    <rdfs:comment>Topiramate + pyridoxine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468">
        <dc:identifier>HP:0001250</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
        <rdfs:label>Seizures</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/823d2d79-dc0b-4916-a5a6-7c3cc3e32d70"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19304794</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/251ee797-597a-47fc-91ee-4a65dba2abe3">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e6dd7c60-6533-4e98-889e-38e3577b3242"/>
    </obo:RO_0000057>
    <rdfs:comment>Vitamin A+ Vitamin E</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b9b3b285-f555-4035-a1cd-267a590caf97"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23329770</dc:provenance>
    <dc:provenance>https://www.nature.com/articles/nrrheum.2010.182</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c085fdc8-9062-4f31-a649-eee2d0e2867e">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Muscular abnormality</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012638</ddiem:url>
        <dc:identifier>HP:0012638</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d2b23f09-5cf9-4b3e-9839-40ffcb18bf8f"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19285442</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956717</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/246700">
        <ddiem:iembaseAccessionNumber>1083</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/246700</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1083</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/582bb6e5-9b5f-47cf-b21a-903b1ce4d34b"/>
        <rdfs:label>CHYLOMICRON RETENTION DISEASE; CMRD</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ac1dfaf5-7c95-417e-ab4c-b0c86624cfcd">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000505</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000505</ddiem:url>
        <rdfs:label>Minor visual abnormalities</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5e354de6-4103-4b21-9d8a-5f2936a60708"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/116387c9-2a90-4990-bb34-1e6d972eafa9"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ebc27e05-e097-414a-8e46-3a781bfa2ad5">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d27643ff-d12e-4be7-9ea2-29f035b17b1e">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
        <rdfs:label>Epilepsy</rdfs:label>
        <dc:identifier>HP:0001250</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e0887c48-268c-4110-89bf-c0a6bfdf4d55"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/20d74904-54c4-47e6-9623-f5624a49bca9"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261630"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e4ef1cd4-790c-4c9e-b816-cdfa0286f386">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/39ec466e-b8b4-4293-b216-335e4f674e32"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/58693fbb-ddbd-4c3a-987e-89a8398d598c"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26817292</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/69654acc-8e1c-4620-a805-022f0b8fa3bc">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001285</ddiem:url>
        <dc:identifier>HP:0001285</dc:identifier>
        <rdfs:label>Spastic tetraparesis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f0968ad1-949e-4447-ab70-bde6fc1532c8"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18060820</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7760062</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <rdfs:comment>Phenobarbital + Valproate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18425437</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cb6d935c-97ca-4752-9652-5786a9767154"/>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/27cbd84d-06c8-4d8e-b791-c1b8689f4800">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/08c64cf9-06aa-4cc3-b0cb-8598100707e8">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/55624</dc:identifier>
        <rdfs:label>POMGNT1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1</rdfs:label>
    <ddiem:uniprotId>Q8WZA1</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b92d2e38-cd17-4d2d-aee7-8f123f0d39de">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29526615</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/95dddbf7-78b0-4f64-96c0-c204fc027016"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bfa22fd5-a3c3-4c73-baa9-a4764ebf057d"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11916321</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a2da8d50-6aed-4571-800e-9f53ea1df447"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dfad68fe-4687-4744-a762-2b07c75ffc8a">
        <dc:identifier>HP:0004302</dc:identifier>
        <rdfs:label>Functional motor deficit</rdfs:label>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004302</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c0f06aae-88b2-41f9-819e-9f95f7ac1b9a">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100543</ddiem:url>
        <rdfs:label>Cognitive impairment</rdfs:label>
        <dc:identifier>HP:0100543</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/490cd477-d91f-4876-bc89-baa59a52c0ff"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6d3f44b3-8284-465b-819b-41b470d22a24">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Elevated plasma acylcarnitine levels</rdfs:label>
        <dc:identifier>HP:0045045</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0045045</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602473"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17712735</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8831db0c-24ba-4296-aee7-5d75b693af36">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000967</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000967</dc:identifier>
        <rdfs:label>Petechiae</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/58646a43-33e1-4465-a8f7-b3d27ff57f95"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0022202X15352507</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/00cd37ab-9234-44d5-bcd2-daeebc72d06d">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025356</ddiem:url>
        <dc:identifier>HP:0025356</dc:identifier>
        <rdfs:label>Psychomotor retardation</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Riboflavin and/or coenzyme Q10</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ee5cbbbc-218d-4377-b0b1-31a8cf2000c3">
        <rdfs:label>Chronic mucoid diarrhea</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002028</ddiem:url>
        <dc:identifier>HP:0002028</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/90f129ba-e16d-4499-9258-cba83ddc60f2"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3da5fc67-f701-47df-bb79-b27f9c96858b">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/49bffb10-3f28-4064-aa10-51a9cede4fe8">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>hypoglycemia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001943</ddiem:url>
        <dc:identifier>HP:0001943</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <rdfs:comment>Carglumic acid + diazoxide+ Glucose</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/54086350-24fc-42f0-9bfa-49b31b5b9fd2"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28621098</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/143052ab-60ff-415d-b706-9dc598cf9c69">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/979b6e9e-09f3-4c96-814b-3229d09ef9e6"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25781533</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/74f687a3-e9fa-4ec4-8786-9e0a9d4f4678">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ead0f128-7268-43fa-81d9-d0c4d41f7123"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26962538</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/606762">
        <ddiem:iembaseAccessionNumber>567</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/dcdbcddb-c479-477c-b24d-91e8ad74ad55"/>
        <rdfs:comment>Treatments for hyperammonemia such as dietary protein limitation, arginine, benzoate, carbamoyl synthase activators (carglumic acid), and N-carbamoylglutamate have not been effective in reducing ammonia levels. https://www.ncbi.nlm.nih.gov/pubmed/15050973/</rdfs:comment>
        <rdfs:label>HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/567</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/606762</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0aa47d20-1e2a-4a5d-828e-fb1f24e2cc0c">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/5a4c1e33-d23d-4270-a86a-659c08cff7ec"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/21bd99d9-857f-446a-aaf0-08ce137adf9f">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18996862</dc:provenance>
    <dc:provenance>https://www.semanticscholar.org/paper/Glycogen-storage-diseases%3A-Diagnosis%2C-treatment-and-Chen-Weinstein/439025d057229db1b3a117cb02b3c7e6f2bd3580</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/77232b6e-d19c-4f59-aa2c-52ad17210836">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/5c71c3ca-8851-4940-a4e4-a799556c51f9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5e64a8d3-8b07-4a74-a89d-1f78874cc126">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8978dcb2-fea9-4485-b149-f48ed40c71b6"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f81e2854-173c-48f9-b286-9656136e0377"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15963056</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007764"/>
    <rdfs:comment>Antioxidant + ACE inhibitors</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/89277781-fd8d-4745-8e18-53132657ad95">
        <rdfs:label>Nephropathy</rdfs:label>
        <dc:identifier>HP:0000112</dc:identifier>
        <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000112</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/03f2b3c4-3a94-4f2e-bf21-a92b0e88ab4f">
    <ddiem:uniprotId>Q9Y2B1</ddiem:uniprotId>
    <rdfs:label>Ribitol-5-phosphate xylosyltransferase 1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/45660979-ab31-4292-ba60-121dd4f4292d">
        <rdfs:label>RXYLT1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/10329</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/eeb70bfa-9ec5-4fae-8eb5-b5f24ccebc45">
    <rdfs:label>mitochondrial ribosomal protein L44</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a01b9f7f-2cd1-4753-bcf1-3671596eabca">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/65080</dc:identifier>
        <rdfs:label>MRPL44</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>Q9H9J2</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/1c2197e2-a19f-4d4e-840d-9d9dec890084">
    <ddiem:ecNumber>4.2.1.17</ddiem:ecNumber>
    <rdfs:label>leucine-rich pentatricopeptide repeat-containing protein</rdfs:label>
    <ddiem:ecNumber>1.1.1.211</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/d302afdf-f12d-4c7a-b300-a3aadd9dfd1c">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/10128</dc:identifier>
        <rdfs:label>LRPPRC</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7e833fb7-826b-4a7e-bd6f-affccf56de80">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cf8a413b-fc65-47f0-a4bb-455176be093d">
        <dc:identifier>HP:0002180</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002180</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Myoclonus</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17275787</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/545000"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fc27b7a5-3c28-4103-a8af-b4b6c53fb28b">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002123</ddiem:url>
        <rdfs:label>Low quality of life (Constitutional symptoms)*</rdfs:label>
        <dc:identifier>HP:0002123</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5ca28c24-9eac-4f3c-aebe-d4fc037deded"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>Levetiracetam+ l-carnitine +CoQ10</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28686997</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1392ed7a-0fc1-4ef0-90ff-0ec1a72e1a9f"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f415768d-feab-4a65-80e7-efbd055fcfc6"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/d4f8d7d8-83ba-4b49-9760-6662779c22dd">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f358e0bb-188e-4d78-91cc-c9350d2bf03d">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/56652</dc:identifier>
        <rdfs:label>TWNK</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Twinkle protein, mitochondrial</rdfs:label>
    <ddiem:ecNumber>3.6.4.12</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c4a82f76-9c54-45a0-9e11-3bda59cde027">
    <rdfs:label>d-glycerate kinase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/beeb1a6a-5eed-4801-ac11-37cac1597223">
        <rdfs:label>GLYCTK</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/132158</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.7.1.31</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8e69d47f-b4af-49be-9c5a-3cb8b123b35e">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/93114130-d4a2-435e-bec4-1e31a9dd50a6">
        <rdfs:label>VX‐like lesions</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5331d018-ac3d-4fe5-bc0b-97f6f0d210f5">
        <dc:identifier>HP:0000989</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000989</ddiem:url>
        <rdfs:label>Itchy skin</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909487</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e9abd6ed-6ee0-4c4f-b870-c39dcbd32da8">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2d249db9-f424-4118-992c-429768af092c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ab93b7cd-697f-455e-9abd-1e13ad5ce8d4"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ea5955ad-c114-458d-a5a5-e44eb8a24c2e">
        <dc:identifier>HP:0007431</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007431</ddiem:url>
        <rdfs:label>Ichthyosiform erythroderma</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>"ENB-0040</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/39ad81e5-b983-426c-a27b-bfd6a381f8aa"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/62c66bd4-fd2d-43c0-8b49-42c7c7d5bf5d"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ae74419c-a2c4-41b7-b5a9-d487ef7bddde">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040189</ddiem:url>
        <rdfs:label>Scaling Skin</rdfs:label>
        <dc:identifier>HP:0040189</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1d4c0c91-ae94-4791-8f30-99cd57e103b3"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b3c4afc9-72ef-4997-bb9c-dae2e4acaa69">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/37e6a791-ba00-4b04-b3df-7e04f29f4bba"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>an enzyme-replacement therapy</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/36e03973-635b-4916-8425-b34e719e7aaa"/>
    </obo:RO_0000057>
    <rdfs:comment>simvastatin+cholesterol</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6048f59d-239c-4392-a750-9e3befdfa775"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096504</dc:provenance>
    <dc:provenance>https://www.researchgate.net/publication/8668575_A_successful_treatment_with_pyridoxal_phosphate_for_West_syndrome_in_hypophosphatasia</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29341259</dc:provenance>
    <dc:provenance>NCT00744042.)."</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7fa61949-b6e0-4da2-99a1-d22e6690f132">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010783</ddiem:url>
        <dc:identifier>HP:0010783</dc:identifier>
        <rdfs:label>Erythema</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/308050">
        <dc:identifier>https://www.omim.org/entry/308050</dc:identifier>
        <ddiem:iembaseAccessionNumber>194</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/71163de8-daeb-4a79-af0e-1901cded59d2"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/194</ddiem:iembaseUrl>
        <rdfs:label>CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5c30342c-87d8-40b1-933d-4f299bc71664">
        <dc:identifier>HP:0031517*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Verruciform plaques(verruciform xanthomas)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0031517</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ef2c7dba-3239-41cb-b77e-2eaccf95b722">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/610768">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/8ccedd65-7266-452c-a4bd-e3e85e488800"/>
        <ddiem:iembaseAccessionNumber>342</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/342</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/610768</dc:identifier>
        <rdfs:label>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3">
        <dc:identifier>HP:0001250</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>seizures</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10590041</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/49600587-9d2b-41dc-a7dc-a3829be42d48"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9732974</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e0867496-530c-4284-849e-e8a64e44497b">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8ae01d77-d96a-4959-a70e-e7620bb060f5"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23890587</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/18d0909a-0c1f-4c79-b11d-8483d4d9f6f4">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/dd97cb35-c269-4ca3-827b-408664b3b411"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>clonazepam+vigabatrin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/6ed0cd9c-2276-4ff8-abf7-149ac103f230">
    <ddiem:uniprotId>Q9H9J2</ddiem:uniprotId>
    <rdfs:label>MITOCHONDRIAL RIBOSOMAL PROTEIN L44</rdfs:label>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/a01b9f7f-2cd1-4753-bcf1-3671596eabca"/>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/992e12d6-6eef-4b6e-a771-2aaf5096188e">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/66064cfb-3ba7-4647-9f1a-f633c46ed9cf">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/10585</dc:identifier>
        <rdfs:label>POMT1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>protein O-mannosyltransferase 1</rdfs:label>
    <ddiem:ecNumber>2.4.1.109</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/70fdad17-8e8f-43c5-a803-47255060ae96">
    <ddiem:uniprotId>Q3US15*</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/71163de8-daeb-4a79-af0e-1901cded59d2">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/50814</dc:identifier>
        <rdfs:label>NSDHL</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>NAD(P) dependent steroid dehydrogenase-like</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2333bf1c-e416-402c-b824-d4e77018b822">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6ef1e31d-760c-402f-b93c-b7a210c194f3"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/300322">
        <ddiem:iembaseAccessionNumber>145</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/145</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/300322</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/c4fdb61e-39bb-46b6-9dc9-902fa572e8e2"/>
        <rdfs:label>LESCH-NYHAN SYNDROME; LNS</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0aed1bf3-9196-4035-8143-c3d5b149a672"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5303126a-693e-49be-8b09-49e969acf57b">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Chorea</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002072</ddiem:url>
        <dc:identifier>HP:0002072</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2455472</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fd8cf6e3-3371-48f8-aa90-cbf69bfcf2fe">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001332</ddiem:url>
        <dc:identifier>HP:0001332</dc:identifier>
        <rdfs:label>Dystonia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27179999</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7b6a1717-d229-4cbb-8740-556502d735cb"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12593632</dc:provenance>
    <rdfs:comment>Carbidopa‐levodopa</rdfs:comment>
    <dc:provenance>https://rarediseases.org/rare-diseases/lesch-nyhan-syndrome</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ee7d6620-ec46-4ca7-bce3-16e669a324a8"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/536e15bd-f2bd-4a65-87a0-c1492a5b9285">
    <rdfs:label>Choline/ethanolamine kinase</rdfs:label>
    <ddiem:ecNumber>2.7.1.32</ddiem:ecNumber>
    <ddiem:ecNumber>2.7.1.82</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/5748a034-2668-43ed-afdb-f72b750d894b">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1120</dc:identifier>
        <rdfs:label>CHKB</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/19ccee51-4442-4d29-9678-c2ab8ca6b211">
    <rdfs:label>DNA topoisomerase 3-alpha</rdfs:label>
    <ddiem:ecNumber>5.6.2.2</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/11885817-f3a7-4920-bcdc-8acd216c6b25">
        <rdfs:label>TOP3A</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/7156</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/71efe483-7c6b-4cb4-8e00-8cdc384f9ab0">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/2b660442-6b34-4946-8348-fd590ff0d8c0">
        <rdfs:label>ADCK3</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/""</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Atypical kinase COQ8A, mitochondrial</rdfs:label>
    <ddiem:ecNumber>1.3.5.1</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/17be3ffe-b9f7-4b62-9030-ec0ad9f739c6">
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/ce6f0598-b3a9-45a6-865a-d442dba86d94">
        <rdfs:label>Direct interaction &gt;&gt;&gt; activity modification</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S109037980800010X</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e0d5c181-e7e0-4563-a452-961aad42f343"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f30f235c-f708-41cd-b3d9-baabc76272b7"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26208971</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2e3beba0-9630-413c-93bb-4ea7751bb472">
        <rdfs:label>Neurological impairment</rdfs:label>
        <dc:identifier>HP:0000707</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8c5406fa-17cb-43a4-9ee3-169710a7a011">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b6bb4990-a910-42ea-8ef5-41fa68cf0bc3"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/236792">
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/165</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/236792</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/6f7698b0-15df-4d47-aa55-b024fad13232"/>
        <rdfs:label>L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA</rdfs:label>
        <ddiem:iembaseAccessionNumber>165</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>FAD+Riboflavin</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/9f612363-56b5-449f-9305-fcb431071339">
    <rdfs:label>Frataxin, mitochondrial</rdfs:label>
    <ddiem:ecNumber>1.16.3.1</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/465c09b7-4337-42e5-8a4b-7e88d1b0b03d">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2395</dc:identifier>
        <rdfs:label>FXN</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/209b8379-0967-4c02-bc29-79c3aac70dd3">
    <rdfs:label>Fukutin</rdfs:label>
    <ddiem:uniprotId>O75072</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/5fd877a4-ce97-4299-8ea9-37035ab06a8c">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2218</dc:identifier>
        <rdfs:label>FKTN</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/6a82ce0e-d534-43a7-b68f-f6587add4579">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/0434fa79-f3bc-4ec4-b7a8-75d409ce1f38">
        <rdfs:label>CLN6</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/54982</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>Human</ddiem:uniprotId>
    <rdfs:label>CLN6, transmembrane ER protein</rdfs:label>
    <ddiem:uniprotId>NO</ddiem:uniprotId>
    <ddiem:uniprotId>id</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8b8ddb40-1f01-4e35-9fce-1ea82ac2e4ea">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/94abd509-c64f-483f-b8ad-f44a7c8107b1"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/6d47296a-278c-45ef-b55e-0cd9375ac198">
        <rdfs:label>Functional interaction (B)+Direct Interaction (A)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <rdfs:comment>Carnitine+ riboflavin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19249206</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3230af07-02fe-45b9-af21-59fda35121f7">
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
        <rdfs:label>High serum creatine kinase</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003236</ddiem:url>
        <dc:identifier>HP:0003236</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b9ee0a2b-829f-4a2d-ad3c-196828d2c017"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4494408b-79a4-4b11-acf8-1700e5b0cd6c"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/65743f4c-f02b-43e3-8d98-d1d75c906e1e"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6013024e-d764-4c60-9b48-b7b2271cfef0">
        <rdfs:comment>Early diagnosis can prevent the phenotype, Initiation of treatment after the onset of symptoms is generally not effective in preventing permanent damage. https://www.ncbi.nlm.nih.gov/pubmed/21431622. https://www.ncbi.nlm.nih.gov/pubmed/10630918</rdfs:comment>
        <dc:identifier>HP:0003234*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003234</ddiem:url>
        <rdfs:label>Secondary Carnitine deficiency( Carnitine deficiency)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10723193</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231680"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/12c6e566-2002-4194-b4b7-5c45e687f9b7">
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/36a63cd9-5106-4040-9582-523715a974c0"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/38506d80-a332-499a-b536-a012195e123c">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003234</ddiem:url>
        <dc:identifier>HP:0003234</dc:identifier>
        <rdfs:label>Hypocarnitinemia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/41219239-fa3e-4bf8-ae38-2b085350c38a"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/25588dfe-5897-40bb-97c8-0a01c4fb7018"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7b1075db-03c7-48a3-949c-3289819ef1e2">
        <dc:identifier>HP:0045045</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0045045</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>High plasma long-chain acylcarnitines</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>carnitine+Medium-chain triglycerides</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/369e2d68-3b59-4a4f-9422-0a8eb69cbe01"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19452263</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17508264</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/28f9aa83-f122-4837-9b0f-8e567977df85">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001263</ddiem:url>
        <rdfs:label>developmental delay</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001263</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/212138">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/84414203-447d-4bca-8636-9bfe70e704f1"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/229</ddiem:iembaseUrl>
        <rdfs:label>CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>229</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/212138</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4303f7d0-a18b-4c96-ba1e-4b77d03ae9ea">
    <ddiem:ecNumber>7.2.2.8</ddiem:ecNumber>
    <rdfs:label>Copper-transporting ATPase 1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b6427500-8679-46c1-b9c7-7bbfc691968d">
        <rdfs:label>ATP7A</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/538</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/activity_modification_of_a_genetically_defective_protein_by_transcriptional_or_translational_modification">
    <dc:date>3.10.19</dc:date>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000012"/>
    <obo:IAO_0000115>modification of the amount or stability of a transcript or the efficiency of translation of a transcript in order to reduce or increase the expression of a  genetically abnormal protein.</obo:IAO_0000115>
    <dc:creator>ORCID: 0000-0002-5111-7263</dc:creator>
    <rdfs:label>activity_modification_of_a_genetically_defective_protein_by_transcriptional_or_translational_modification</rdfs:label>
    <obo:IAO_0000115>any procedure designed to suppress or mitigate the effects of a recessive genetic change in an abnormal protein by modification of its transcription or translation, excluding those strategies which involve epigenetic modification or modification of the germline or somatic genome sequence. For example an abnormal Vmax of reaction, alteration of KM, failure to respond to positive  feedback, acquisition of neofunction.</obo:IAO_0000115>
  </owl:Class>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/652a131a-a66f-49fb-bb40-231c02e9fe1d">
    <rdfs:label>solute carrier family 17 member 5</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/4ee68861-88b3-46fe-bb6b-9d8ac535aa99">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/26503</dc:identifier>
        <rdfs:label>SLC17A5</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>Q9NRA2</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2581a949-fb1b-47f8-96a0-a7c82eda8889">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26984560</dc:provenance>
    <rdfs:comment>Vitamin C+Vitamin E+Selenium</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22830360</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27775558</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bd791b0f-53fd-4b98-b132-d46e9ab14c04"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7de815b7-d34f-4609-8760-31b313ccaaf4">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c74b4ce4-efc7-45f3-878a-35d0b004ec88"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0a68a4dd-61e4-46be-9bf6-993a20384f8e"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25896882</dc:provenance>
  </ddiem:TheraputicProcedure>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000009">
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000008"/>
    <rdfs:label xml:lang="en">dietary exclusion</rdfs:label>
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure in which the diet is depleted in molecules closely related to the products or end processes of a genetically defective protein which occur naturally in the diet. [PNS]</obo:IAO_0000115>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T18:04:24+00:00</dc:date>
    <dc:creator>leechuck</dc:creator>
  </owl:Class>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/33666964-140f-432f-93b7-028bb0e0f29e">
    <rdfs:comment>Vitamin E+L-carnitine+Dichloroacetate+Creatine</rdfs:comment>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/615156">
        <ddiem:iembaseAccessionNumber>946</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6; PEOA6</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/615156</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/946</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/20b2aeed-9ced-484b-be74-f9cd4c70e9ec"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12872260</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8e045f30-fe3a-4946-aab7-d0adefd2d933"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f24a6cb0-fc7a-4229-8c3b-98c78cc27199">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f0243d95-d0cc-4afd-b2f6-e970dac7dc82"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a8a72a77-2d34-44ed-87de-d6c452edeead"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728770</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/75550c54-6a8a-4052-a7e6-2674e5502885"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5dc4bd81-c687-4889-81f9-6abed11c8507">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/398ada33-d63a-4560-bbff-2538698c5016"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/2a569f8b-a959-4e6f-b609-bdd794d98931">
    <rdfs:label>Hormone ( Arginine vasopressin)</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/06e6bdad-51f5-4e85-9515-b2366f4f8238">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/551</dc:identifier>
        <rdfs:label>AVP</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.5.1.20</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/8613abc9-fab8-40f8-9f36-28921d8e9af0">
    <rdfs:label>Ferroxidase</rdfs:label>
    <ddiem:ecNumber>1.16.3.1</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/24738f41-8098-4b90-8a15-a2e3e216d0b3">
        <rdfs:label>CP</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1356</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e7cd93f6-72c8-44d0-8856-0f861a85b610">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14517515</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <rdfs:comment>AT342</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/218800"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03223194</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/33f5a24a-dc1d-4504-a26f-812642c78c8a"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3bba9fdb-ce64-4720-8d33-35744e8e17cb">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002904</ddiem:url>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <dc:identifier>HP:0002904</dc:identifier>
        <rdfs:label>Study was suspended based on Sponsor Decision.</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/341d9b18-dfc2-4be9-922b-52fd1b185a26">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/31c71dfa-335d-46fb-a526-db69257c77f2"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00461799</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/96394252-b57a-4174-820d-f362a82c49a9">
    <dc:provenance>https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.448</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cfc69159-18e5-4c54-96b7-7f2a2a4ecfcc"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0003304>W99L</obo:RO_0003304>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/602485">
        <dc:identifier>https://www.omim.org/entry/602485</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3</rdfs:label>
        <ddiem:iembaseAccessionNumber>1289</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ec43d1e8-01f7-4958-a2ff-43dd9e5c347e"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1289</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <rdfs:comment>Dextrose +Diazoxide</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8410522</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d6c1137f-c24a-4d72-9c84-5068df3a1623"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0aa47d20-1e2a-4a5d-828e-fb1f24e2cc0c"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8537c04e-14c0-4d93-b69a-244a4e310081">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/da712ab0-a54b-40df-acd6-29c8c8c74cca"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25781533</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/6135d6f4-c801-4986-8452-c0627714ed83">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/5fd877a4-ce97-4299-8ea9-37035ab06a8c"/>
    <rdfs:label>fukutin</rdfs:label>
    <ddiem:uniprotId>O75072</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/a91f266c-1bdc-4a1e-b0c6-3951869e3739">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/49c2578e-e493-4316-95e7-d4d5244bc56c">
        <rdfs:label>CLCNKB</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1188</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>P51801</ddiem:uniprotId>
    <rdfs:label>Chloride channel protein ClC-Kb</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/615041">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/615041</dc:identifier>
    <ddiem:iembaseAccessionNumber>640</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/45660979-ab31-4292-ba60-121dd4f4292d"/>
    <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10; MDDGA10</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/640</ddiem:iembaseUrl>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4334cbbc-03ba-4b8b-85f2-c5945f215a3b">
    <rdfs:label>hepatic lipase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/693340af-03ce-4beb-9e7f-84b136e3f7ad">
        <rdfs:label>LIPC</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3990</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.1.1.3</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/fd4d0c30-e9c5-48c9-8fb5-905ce26f1df1">
    <ddiem:uniprotId>P00414</ddiem:uniprotId>
    <rdfs:label>Cytochrome c oxidase subunit 1/Cytochrome c oxidase subunit 2/Cytochrome c oxidase subunit 3</rdfs:label>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/67a98b07-c0e0-4b01-a035-b0226015ce12"/>
    <ddiem:ecNumber>1.9.3.1</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/0c15ce76-dbc0-45f1-ba5e-efd4141a768e">
        <rdfs:label>MT-CYB</rdfs:label>
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-CYB</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>P00403</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7b0811cd-181f-4909-b057-07521ef9d179">
        <rdfs:label>MT-CO1</rdfs:label>
        <dc:identifier>https://ghr.nlm.nih.gov/gene/MT-CO1</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/23d01e33-ccce-46d9-a97d-86b28fec8c1a">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16857760</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cfade6d4-fa72-47e0-af91-e4853c4875e5"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/611283">
        <rdfs:comment>It is as yet uncertain whether IBD deficiency may cause significant morbidity in affected children and whether treatment is necessary. In view of the limited experience worldwide, careful monitoring of the children is recommended. https://www.ncbi.nlm.nih.gov/pubmed/15505379</rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/7e198bae-34e6-45f7-9dce-e09e7dc9823f"/>
        <rdfs:label>ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY; IBDD</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/135</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>135</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/611283</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>L- carnitine+valine-restricted diet+riboflavin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9889013</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19210957</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12359132</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/89f8b23a-c3f6-4ef2-a7c1-f0d4f370106f">
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
        <dc:identifier>HP:0001507</dc:identifier>
        <rdfs:label>Growth abnormality</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001507</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9f8c92cf-6edd-4bcb-a279-b9ecc9b0ec02">
    <rdfs:comment>Ascorbate + N-acetylcysteine</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fa4a0e45-9f16-45b6-a82e-d6b8b1157375"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bd791b0f-53fd-4b98-b132-d46e9ab14c04"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1d9593bb-94eb-4172-af06-eaf00771c785"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27207470</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8301428</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5e1173d2-06b3-435e-9fd5-03edb3d0d125">
        <rdfs:label>High erythrocyte turnover(Abnormality of erythrocytes)*</rdfs:label>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <dc:identifier>HP:0001877*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001877</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a183d5c3-edcc-42e8-84b4-f81b29d4e921">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/40106fa3-947e-477c-b6d4-cadd95ae8050"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503963</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/94024323-6d96-4884-9316-b90cbed5cae0">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002910</ddiem:url>
        <dc:identifier>HP:0002910</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Abnormal liver function tests</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20619503</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/235555">
        <rdfs:label>BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/5f2bc0e7-c41d-43af-8bb7-17a98d44909c"/>
        <dc:identifier>https://www.omim.org/entry/235555</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/09b50e42-4464-4c4e-b762-0472523e44d9">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Abnormal bilirubin level</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002630</ddiem:url>
        <dc:identifier>HP:0002630*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/906349f4-ea1c-4d48-9d89-f1cd884a7221">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/96217615-b29c-40f0-a123-3de3babf92a9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <rdfs:comment>Chenodeoxycholic acid + cholic acid.</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18570303</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8c6d4986-4e49-497a-ba43-3178c58ec295">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d5bef24f-7f2a-47d6-ac8d-3fecd4854f61"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6db92aab-79c5-474d-8509-36e91b0f303c"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8707100</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19087156</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8101bb03-29e6-43c8-a024-38448deae1f1"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b844683e-af3a-4b48-a856-7b0708ac5faa">
        <rdfs:label>Liver biopsy abnormalities</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0002630*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002630</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/19e5330b-5a06-4f9a-bea5-00b537107644">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/234caa85-64f6-40c6-ac2f-99f4ad49bf43">
        <rdfs:label>FKRP</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/79147</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>fukutin-related protein (FKRP)</rdfs:label>
    <ddiem:ecNumber>1.1.1.211</ddiem:ecNumber>
    <ddiem:ecNumber>4.2.1.17</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/616538">
    <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/616538</dc:identifier>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/cb8fed54-d397-48b3-afe3-88d67770bdf9">
        <rdfs:label>DAG1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1605</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0004020>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fcfbc31b-a62e-406a-8638-341b3943c7e6">
    <obo:RO_0002558>
      <ddiem:Evidence rdf:about="http://ddiem.phenomebrowser.net/ECO:0001565">
        <dc:identifier>ECO:0001565</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/ECO_0001565</ddiem:url>
      </ddiem:Evidence>
    </obo:RO_0002558>
    <dc:provenance>https://emedicine.medscape.com/article/1178391-treatment</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/631b5dbd-8a2b-4d14-beeb-9e8a7225740b">
        <dc:identifier>HP:0012444</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012444</ddiem:url>
        <rdfs:label>brain atrophy</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/42b57f55-f261-406b-b7bc-9e1251238c86"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e8e00fab-aa94-4883-b42d-d1a1eaddd547">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/66d5f44e-3fd3-4e12-b06c-b26df80a0cc9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01907087</dc:provenance>
    <rdfs:comment>hydroxypropyl-β-cyclodextrin (HPBCD)</rdfs:comment>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/204500">
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/306</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>306</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/204500</dc:identifier>
        <rdfs:label>CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4fca3534-0289-44d9-88ea-bac49398b33c"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891977</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28589525</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/a80f2efb-d637-481d-a27b-66e194f495a4">
    <rdfs:label>myosin heavy chain 2</rdfs:label>
    <ddiem:ecNumber>2.7.1.60</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/66b86ef2-0545-4762-a6fe-a84d001fa0a6">
        <rdfs:label>MYH2</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4620</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.2.1.183</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/37d0b050-ce86-4582-896d-416907a2db30">
    <rdfs:label>Tricarboxylate transport protein, mitochondrial</rdfs:label>
    <ddiem:uniprotId>P53007</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7c21eac7-22d4-4bb3-a450-5aa533e1d70d">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6576</dc:identifier>
        <rdfs:label>SLC25A1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/614202">
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/611</ddiem:iembaseUrl>
    <rdfs:label>MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15</rdfs:label>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f3522a85-e213-4bd5-9ddb-10e7e86fda05">
        <rdfs:label>MAN1B1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/11253</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0004020>
    <ddiem:iembaseAccessionNumber>611</ddiem:iembaseAccessionNumber>
    <dc:identifier>https://www.omim.org/entry/614202</dc:identifier>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8c314c09-f5c1-4d75-9081-e3f8c2359747">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/274270">
        <rdfs:label>DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/159</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/274270</dc:identifier>
        <ddiem:iembaseAccessionNumber>159</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/98a39e7f-4eea-496a-be31-ea8658a381cf"/>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <rdfs:comment>Valpric acid + carbamazepine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27622829</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9d059244-0c53-4fae-af73-6e795ee03d50">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/86f4aae6-1c69-4478-a5b8-3fc9241fdc72"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <dc:provenance>https://link.springer.com/chapter/10.1007%2F8904_2017_14</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d391f7c3-07da-4b1a-a6b3-7f1632012edb"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e4ef1cd4-790c-4c9e-b816-cdfa0286f386"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30349988</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/cb2b18ec-28da-45b9-9b36-eed685f9afb2">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/540f7f3f-895b-467b-93a8-6d2ea5f65b9e">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/825</dc:identifier>
        <rdfs:label>CAPN3</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>calpain 3</rdfs:label>
    <ddiem:ecNumber>3.4.22.17</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c85bb73b-33bb-44d4-9cbb-f119a88172fd">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277400"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ad026084-5faf-444b-a1bc-0935afac26c2"/>
    </obo:RO_0000057>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/730382a2-caa5-40f5-94fe-c2b95a5639c4">
        <rdfs:label>Functional interaction ( Mechanistic B)+Symptomatic (c)+Symptomatic (c)+Symptomatic (c)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6cd8dd19-6bc2-494f-94ab-05974800f7d1"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b12f2634-e2b9-4379-baf4-086bd4c80d9c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25511120</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ab77f8f7-af95-49bd-a101-6a5cb132e5ac">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/fc0ed840-97c3-4a86-9814-9eb907700e82"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Hydroxicobalamin + betaine+Folinic acid+ carnitine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/34101d64-08c5-415b-b02e-399803061228"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dff6c03a-63d3-4cfd-8d12-60320bc91fd0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18848477</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d0daccde-de0a-4d32-b799-0274a10221ed"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/ac59d016-57a7-4f8a-891c-f2bce8e7c93a">
    <ddiem:uniprotId>O60931</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a30daaf6-37e8-411a-9318-d232651f09b8">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1497</dc:identifier>
        <rdfs:label>CTNS</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>cystinosin</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b637f8ca-3a06-4b77-8949-ca336e3b0bf6">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b8518e35-c60b-46ed-bc46-d66ffbec7fe9">
        <rdfs:label>Disease progression</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003678</ddiem:url>
        <dc:identifier>HP:0003678</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Carnitine+ Riboflavin+baclofen</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6013024e-d764-4c60-9b48-b7b2271cfef0"/>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3335963</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1fdcd7b2-1ec1-4ce0-ba28-ae47f1329cba"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/76c92114-07a7-4500-85d9-b53c66ce7b00"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a895f806-31ec-4ad7-816b-ddbe826777da">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b138065e-ba93-47c0-9586-15852cdd9334"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8473b659-07f4-4aba-a5bb-33f7d8b139c8">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/62144a4f-836f-4a10-afa3-e5f4ef1db031"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d5dab327-2740-47e0-9f73-1bb148336c6a"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/231670">
        <ddiem:iembaseAccessionNumber>163</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/231670</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/163</ddiem:iembaseUrl>
        <rdfs:label>GLUTARIC ACIDEMIA I; GA1</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/15622aa8-3342-456b-863c-147ed05b8d67"/>
        <rdfs:comment>It has been shown that in the majority of neonatally diagnosed patients striatal injury can be prevented by combined metabolic treatment. Metabolic treatment that includes a low lysine diet, carnitine supplementation and intensified emergency treatment during acute episodes of intercurrent illness should be introduced and monitored by an experienced interdisciplinary team. https://www.ncbi.nlm.nih.gov/pubmed/21431622</rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/99d0df18-9046-4bb6-8309-600d30d21721"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/272200">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/272200</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/301</ddiem:iembaseUrl>
    <ddiem:iembaseAccessionNumber>301</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a8628247-0167-4118-acb7-f2c1e8455e4b">
        <rdfs:label>SUMF1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/285362</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0004020>
    <rdfs:label>MULTIPLE SULFATASE DEFICIENCY; MSD</rdfs:label>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/f1988c2b-d1cd-459d-96c3-22366bb94cd8">
    <rdfs:label>carnitine-acylcarnitine translocase</rdfs:label>
    <ddiem:ecNumber>1.5.1.20</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/84414203-447d-4bca-8636-9bfe70e704f1">
        <rdfs:label>SLC25A20</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/788</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/21a9c4ef-346e-477b-b754-4468ca6cd8da">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c8452fc1-9424-42f9-b2e0-8ea6e8a7451d"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/441bd6b8-3b52-4674-8919-9175cb53edd8">
        <rdfs:label>Glutaric acidemia</rdfs:label>
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003530</ddiem:url>
        <dc:identifier>HP:0003530</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Carnitine+Riboflavin+L-Arginine+clofibrate</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6c1ab060-239c-42a4-b2f7-9131cd3318da"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2e1b6ccd-a467-4de3-afca-875fddb3ce64"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231670"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20923787</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8473b659-07f4-4aba-a5bb-33f7d8b139c8"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/cb01d873-9444-4d14-aaf7-0250dafde860">
    <ddiem:ecNumber>3.1.3.36</ddiem:ecNumber>
    <ddiem:ecNumber>3.1.3.86</ddiem:ecNumber>
    <rdfs:label>inositol polyphosphate 5-phosphatase OCRL-1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/1d1634e8-d28d-45e1-8672-e5ab56d3c8e8">
        <rdfs:label>OCRL</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4952</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.1.3.56</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/612933">
    <rdfs:label>GLYCOGEN STORAGE DISEASE XI; GSD11</rdfs:label>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ece2856f-b3c7-4db7-9161-a8b3724df7db">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3939</dc:identifier>
        <rdfs:label>LDHA</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0004020>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/499</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/612933</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseAccessionNumber>499</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6bffe7df-52b8-45d1-96f0-9ade02e61d60">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8c6d4986-4e49-497a-ba43-3178c58ec295"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <rdfs:comment>chenodeoxycholic acid+cholic acid</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/62007282-aac4-4f04-8732-536b37e29265"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/261515">
        <dc:identifier>https://www.omim.org/entry/261515</dc:identifier>
        <ddiem:iembaseAccessionNumber>274</ddiem:iembaseAccessionNumber>
        <rdfs:comment>No proven treatments exist to address the underlying biochemical defect in this disorder, although dietary phytanic acid restriction and/or bile acid supplementation may warrant further study.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001/</rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/12ab86ee-2f26-4ae8-9d15-95a51cf71773"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/274</ddiem:iembaseUrl>
        <rdfs:label>D-BIFUNCTIONAL PROTEIN DEFICIENCY</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/906349f4-ea1c-4d48-9d89-f1cd884a7221"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00004442</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cbdfaec6-a5fa-4f9c-b55e-14effdf6db35">
        <dc:identifier>HP:0001942</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001942</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>The study was terminated</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/239510">
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseAccessionNumber>38</ddiem:iembaseAccessionNumber>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/38</ddiem:iembaseUrl>
    <rdfs:label>HYPERPROLINEMIA, TYPE II; HYRPRO2</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/239510</dc:identifier>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ffb64159-869c-41f3-abb3-e326e58a1b40">
        <rdfs:label>ALDH4A1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/8659</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0004020>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/3bb6149f-00a3-452a-8fc8-19a1e6cd1175">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ec43d1e8-01f7-4958-a2ff-43dd9e5c347e">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2645</dc:identifier>
        <rdfs:label>GCK</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>glucokinase-4</rdfs:label>
    <ddiem:ecNumber>2.7.1.1</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/1ca1c0d3-de7d-40dd-8ee2-0a3dd8efd171">
    <ddiem:ecNumber>5.3.1.8</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/cf4b76c1-bf0a-486c-9f0b-864c953d99ee">
        <rdfs:label>MPI</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4351</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Mannose-6-phosphate isomerase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/01243ad3-bf9a-4e3a-8669-5b815bc89ac7">
    <ddiem:ecNumber>1.1.1.27</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/195ba370-9643-4b6b-addf-8de91c2f838c">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3945</dc:identifier>
        <rdfs:label>LDHB</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>lactate dehydrogenase-A, which is one piece (subunit) of the lactate dehydrogenase enzyme</rdfs:label>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/ece2856f-b3c7-4db7-9161-a8b3724df7db"/>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/85942176-8d8e-4a3f-aa2f-ee01c60973c2">
    <rdfs:label>Dystroglycan</rdfs:label>
    <ddiem:uniprotId>Q14118</ddiem:uniprotId>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/cb8fed54-d397-48b3-afe3-88d67770bdf9"/>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/dd943893-0d18-42ae-b252-6352e693f465">
    <ddiem:ecNumber>2.1.4.1</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/3da4d3db-e1d2-487c-9c78-b8d88c37d8b6">
        <rdfs:label>GATM</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2628</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>arginine:glycine amidinotransferase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/14f4c931-caa1-46be-ab5d-ece3aee247dd">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/d77db7ea-56a9-4490-9f2f-d9ad35ad7533">
        <rdfs:label>CBS</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/875</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>4.2.1.22</ddiem:ecNumber>
    <rdfs:label>cystathionine beta-synthase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/515d2878-94af-41e5-b4af-38ccd9c60081">
    <ddiem:uniprotId>Q30201</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7a366813-ed9b-456f-8761-4f37c12b97f4">
        <rdfs:label>HAMP</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/57817</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/35293dd3-c447-41e0-9cb6-2932052a37e5">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/148738</dc:identifier>
        <rdfs:label>HJV</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>hemojuvelin/hepcidin</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/17afa6d9-8ee4-43c8-a491-bcec40c6ded4">
    <ddiem:uniprotId>P48048</ddiem:uniprotId>
    <rdfs:label>ATP-sensitive inward rectifier potassium channel 1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ed90939b-895b-4211-8ec3-38a264ad21d4">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3758</dc:identifier>
        <rdfs:label>KCNJ1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/819367ff-02e5-409b-b5bc-39e7ef9f707d">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28649527</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29058386</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5132af8c-7ec3-446f-9c9a-f5fe6a4b8d6c">
        <dc:identifier>HP:0000793</dc:identifier>
        <rdfs:label>membranoproliferative glomerulonephritis</rdfs:label>
        <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000793</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/093d7368-eb93-4906-b527-2e0e32b1ef9e"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1efe4db5-b496-4018-ba56-9cebf5e9a8de">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/fa61a112-99bf-49a6-ac05-b5c53765fc71"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/db78bec9-3b2f-468c-bbaa-4c104b2eba97">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/26998626-5a1f-47ca-ae18-2ffa99baa865"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28087478</dc:provenance>
    <rdfs:comment>prednisolone+mycophenolate mofetil</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21110863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/614023f1-152e-458d-9cc3-253463f7c16d">
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/967f8e69-cb8e-4cd2-a256-7d34d1a0d4cf">
        <rdfs:label>DPM2</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/8818</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>dolichyl-phosphate mannosyltransferase subunit 2</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/be17e277-9b2c-4f59-950f-01ab4a09c544">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261630"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1161781e-1c00-4ce1-8d18-e28b508e967c"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/aaca418b-47e8-4ffb-ae03-5efdb961cfeb"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2e3beba0-9630-413c-93bb-4ea7751bb472"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/928214ea-cd79-4af8-9876-2b285791d753">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/0ac6ca08-ea5d-4046-8928-bbd79563311c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c1d28c82-72dd-45f2-917f-1eea9583452f">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/16be995f-4d6e-47e2-a10a-d11741cc73a8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23138986</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b30108ca-1524-4586-a7b2-b052c1c03fd3"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ac06a685-6de0-4b4d-a07c-5ea08f25b673"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1ad6a57d-7618-4a2f-8a3a-abd225e9fb7d">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010863</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0010863</dc:identifier>
        <rdfs:label>Delayed receptive language</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7110811</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/94894b43-b499-4703-976f-48d9d5115b82"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755580</dc:provenance>
    <rdfs:comment>BH4+L-dopa/carbidopa+5-hydroxytryptophan+Folinic acid</rdfs:comment>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/600f9630-83b1-4a24-a752-2ec66a36aa83">
        <rdfs:label>Hyperphenylalaninemia</rdfs:label>
        <dc:identifier>HP:0004923</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004923</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/56866be6-5dd7-460b-84b7-73208cc82bec">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001263</ddiem:url>
        <rdfs:label>Developmental delay</rdfs:label>
        <dc:identifier>HP:0001263</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/270185ee-3fb3-4d69-891a-faac77ddee04">
    <rdfs:label>codanin 1</rdfs:label>
    <ddiem:ecNumber>1.3.1.3</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/c84d44c9-237c-443f-8916-ddc29898c51e">
        <rdfs:label>CDAN1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/146059</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/d14ee42a-61b6-494c-9030-bc7748cb9ed7">
    <rdfs:label>anoctamin 5</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b1f1334e-9fda-4eff-9114-41298123b2b3">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/203859</dc:identifier>
        <rdfs:label>ANO5</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>Q75V66</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9d6d1fbd-76c3-4c58-a921-6022772da469">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/232700">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/490</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4a1b1213-6316-426e-8d8c-887425960285"/>
        <dc:identifier>https://www.omim.org/entry/232700</dc:identifier>
        <rdfs:label>GLYCOGEN STORAGE DISEASE VI; GSD6</rdfs:label>
        <ddiem:iembaseAccessionNumber>490</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25266922</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f045daf4-9a93-40fb-8246-2116bd9f0e82"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/50748751-1b2c-4cb7-97ff-78153b537c8b">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002910</ddiem:url>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <dc:identifier>HP:0002910</dc:identifier>
        <rdfs:label>Elevated Hepatic transaminases</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/834eb9bf-3722-4d39-b62a-4be7f5d4f120"/>
    </obo:RO_0000057>
    <rdfs:comment>Uncooked cornstarch+Beneprotein</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/aae3dcff-3f8f-4306-bdf0-5f3fe49c8885"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/584520c2-f30a-41e7-a22f-69d78e9b08a1">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <rdfs:comment>Betaine+Folinic acid</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6cd8dd19-6bc2-494f-94ab-05974800f7d1"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/603174">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/603174</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/e9e57ce6-fc1c-4c97-8a2f-ff53cae17180"/>
        <rdfs:label>HOMOCYSTEINEMIA</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3f69fe87-e4b7-4772-8044-e2a585871401">
        <dc:identifier>HP:0010919</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010919</ddiem:url>
        <rdfs:label>Abnormality of homocysteine metabolism</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ab77f8f7-af95-49bd-a101-6a5cb132e5ac"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25024447</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a065ccce-fef1-4904-a726-a1981ed2c0af">
        <dc:identifier>HP:0001290</dc:identifier>
        <rdfs:label>low muscle tone</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001290</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a2ef3785-19d9-4d53-b05f-65177137bba2"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c37f823d-5c5f-4be2-ab19-0855d4eddff1"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00638547</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30081189</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/03a80716-0468-48eb-9b4c-48d9e1b9192a">
    <ddiem:uniprotId>P12235</ddiem:uniprotId>
    <rdfs:label>ADP/ATP translocase 1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/9b3d51d1-8b89-4d03-863d-3fb61162ace7">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/291</dc:identifier>
        <rdfs:label>SLC25A4</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/34c40abc-1805-4737-b26f-ddfa8b005bc7">
    <ddiem:ecNumber>1.16.1.8</ddiem:ecNumber>
    <rdfs:label>Methionine synthase reductase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7e3f82f7-1261-4d94-bbc7-f5d2bf28efdf">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4552</dc:identifier>
        <rdfs:label>MTRR</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/e2404027-7337-4546-846b-85dc53cdbef7">
    <ddiem:ecNumber>6.3.1.2</ddiem:ecNumber>
    <rdfs:label>formiminotransferase cyclodeaminase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/655248d0-8a82-4c61-a634-5a38d4157302">
        <rdfs:label>FTCD</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/10841</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/677f225c-4d21-4ada-aff3-7cd8c96e1680">
    <rdfs:label>kynureninase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f0dbf82e-3665-4c41-9035-771968640580">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/8942</dc:identifier>
        <rdfs:label>KYNU</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.7.1.36</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/2a6ca42b-8697-4580-9846-d1e72546df5f">
    <ddiem:ecNumber>3.5.4.16</ddiem:ecNumber>
    <rdfs:label>GTP cyclohydrolase 1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ed3ada91-26ac-4c19-be7b-99681d6777af">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2643</dc:identifier>
        <rdfs:label>GCH1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/609308">
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/352</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/66064cfb-3ba7-4647-9f1a-f633c46ed9cf"/>
    <dc:identifier>https://www.omim.org/entry/609308</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1</rdfs:label>
    <ddiem:iembaseAccessionNumber>352</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/a0a3a44f-de9d-4fc0-acd7-1488f7a2d270">
    <ddiem:ecNumber>3.1.3.1</ddiem:ecNumber>
    <rdfs:label>apolipoprotein B-48 + apolipoprotein B-100</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/e3928e64-a8f6-4174-a1ae-b2fec8d42653">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/338</dc:identifier>
        <rdfs:label>APOB</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/9d75fa11-26d0-42bd-8d5a-4ade43b1a036">
    <ddiem:ecNumber>4.2.1.17</ddiem:ecNumber>
    <rdfs:label>mitochondrially encoded NADH dehydrogenase 4</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/3ce6773e-d262-483a-ba3a-9dc6ff660ec7">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/""</dc:identifier>
        <rdfs:label>MT-ND4</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.1.1.211</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/7aadef4a-0d3f-4bb9-80c6-b62b705bb80e">
    <rdfs:label>Carbamoyl-phosphate synthase (ammonia</rdfs:label>
    <ddiem:ecNumber>6.3.4.16</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/e9856a4b-0fb7-44fc-b96b-ee1219c90fa4">
        <rdfs:label>CPS1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1373</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/0a5debab-5fd5-482b-bbc5-5678356eb885">
    <ddiem:ecNumber>2.3.1.21</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/1626b85b-505b-4674-ae78-67b04ace6d63">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1375</dc:identifier>
        <rdfs:label>CPT1B</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>carnitine O-palmitoyltransferase 1, muscle isoform</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1c8cb3f7-2d6f-4e1d-ba37-033947646386">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2cd1716b-f238-43a3-883f-359c4427944f"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12003346</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7110811</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5e44a605-1b9b-4408-a2f5-a701436aee42">
        <dc:identifier>HP:0004923</dc:identifier>
        <rdfs:label>Elevated blood phenylalanine concentration</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004923</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c986b6b3-2af2-4272-91b0-e45978033c3e">
        <dc:identifier>HP:0012535</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012535</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Abnormality of neurotransmitter metabolism</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ac06a685-6de0-4b4d-a07c-5ea08f25b673"/>
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/35e66770-eb75-4bad-af39-79619055db29"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d2b23f09-5cf9-4b3e-9839-40ffcb18bf8f"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23138986</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c1d28c82-72dd-45f2-917f-1eea9583452f"/>
    <rdfs:comment>BH4+L-dopa+5-hydroxytryptophan</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261630"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/02a90200-173b-4d12-9699-bc50d0801bea"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0969730c-fe5b-48a6-a83e-3c719297bd87">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15624372</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/243500">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b83cc0b6-5289-42f7-b942-fd449b68279f"/>
        <ddiem:iembaseAccessionNumber>56</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/56</ddiem:iembaseUrl>
        <rdfs:label>ISOVALERIC ACIDEMIA; IVA</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/243500</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ac17d74b-9159-4e5b-b5a9-451bd814566b"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/76c92114-07a7-4500-85d9-b53c66ce7b00"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5b8ada98-6cb0-4a51-be27-6bd593a20bb2">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>"abnormal Na+,K+-ATPase activity"</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3a5927d9-f0eb-4b02-94a1-1c4faa44260d">
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001942</ddiem:url>
        <dc:identifier>HP:0001942</dc:identifier>
        <rdfs:label>Metabolic stress</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/56866be6-5dd7-460b-84b7-73208cc82bec"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12069539</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b3b6a429-1d6b-40e3-b537-8208daadde2d"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2a670529-dd20-49ff-9fa0-05f19bd47c1f"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/342eb631-f821-4cb8-b388-00e1b0a05ba9"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21290185</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17299485</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8804338</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16602101</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/dcb7ef72-4e7d-46a5-8325-485cc72a9a2d"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20807522</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19210957</dc:provenance>
    <rdfs:comment>L-carnitine +L- glycine</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d67f7bc4-adb9-421b-bbcb-2cdd8c7e4319"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4a8f9c17-4643-4a60-bd54-370d1d249146">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>High 3-hydroxyisovaleric acid level (C5)</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ea392b9a-2ad8-4363-a512-1180e6b10ba9"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b4915e19-1570-4903-a724-bc1d4962e7fd">
        <rdfs:label>High toxic acyl-CoA level</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d55bbab4-e023-42c9-8e37-74dea8c56020">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f045daf4-9a93-40fb-8246-2116bd9f0e82"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/aae3dcff-3f8f-4306-bdf0-5f3fe49c8885"/>
    <rdfs:comment>Uncooked cornstarch</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d6c1137f-c24a-4d72-9c84-5068df3a1623"/>
    <dc:provenance>https://www.researchgate.net/publication/307584174_Glycogen_storage_diseases_Diagnosis_treatment_and_outcome</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20975743</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/25200b85-c261-48ef-80f6-81abe6a3432f"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <dc:provenance>https://www.semanticscholar.org/paper/Glycogen-storage-diseases%3A-Diagnosis%2C-treatment-and-Chen-Weinstein/439025d057229db1b3a117cb02b3c7e6f2bd3580</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/8d123cbb-3d8e-4f92-ac0d-cc7013400595">
    <rdfs:label>Phosphorylase b kinase gamma catalytic chain, liver/testis isoform</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ce7e9c63-2853-4457-aaa9-836999eaec97">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5261</dc:identifier>
        <rdfs:label>PHKG2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>P15735</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/a2ef04cc-1538-4a03-90fc-fc5fe8dbca25">
    <rdfs:label>glycine N-methyltransferase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/3ea72cf2-2697-4de1-8ca9-e4f345962d07">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/27232</dc:identifier>
        <rdfs:label>GNMT</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.1.1.20</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/de72905c-6268-4c67-a66c-95ddb13ae3e2">
    <rdfs:label>beta-1,4-galactosyl transferase.</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ae813101-c5b3-4d28-8a1b-120f8e2f96e1">
        <rdfs:label>GALT1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/""</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.4.1.274</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c116e118-6d23-4705-96d0-c14f68b95a9c">
    <ddiem:ecNumber>2.7.1.36</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/3e1abf48-b1ab-4188-ba39-e217d7d16cbb">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3425</dc:identifier>
        <rdfs:label>IDUA</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>alpha-L-iduronidase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/614128">
    <rdfs:label>LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/916</ddiem:iembaseUrl>
    <ddiem:iembaseAccessionNumber>916</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/195ba370-9643-4b6b-addf-8de91c2f838c"/>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ece2856f-b3c7-4db7-9161-a8b3724df7db"/>
    <dc:identifier>https://www.omim.org/entry/614128</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/25a2da39-cbb2-44fb-aea5-5ec4a96f4cb6">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11001192</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e5bea7f8-801a-41f1-8ec8-d00a573413a3"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <rdfs:comment>Idebenone+Vitamin C+Vitamin B12</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bd791b0f-53fd-4b98-b132-d46e9ab14c04"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21788663</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5929383e-e733-4e9a-9cea-5b14dc400709"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/535000">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/3ce6773e-d262-483a-ba3a-9dc6ff660ec7"/>
        <rdfs:label>LEBER OPTIC ATROPHY</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/402</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/535000</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>402</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01495715</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02771379</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/05e0e82a-9bed-4b0a-bef4-d3b2b940f041"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/571e4eb2-d3c8-4732-b04c-b78ae260eb03">
        <dc:identifier>HP:0012823*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Slow recovery</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012823</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/18188db6-1729-4459-a1a5-84e7a401702c">
    <ddiem:ecNumber>2.6.1.13</ddiem:ecNumber>
    <rdfs:label>ornithine aminotransferase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/02487219-50fb-430a-abfa-a1ec02536b06">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4942</dc:identifier>
        <rdfs:label>OAT</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/0295783f-1604-485c-b979-40184c910068">
    <ddiem:ecNumber>3.5.4.6</ddiem:ecNumber>
    <rdfs:label>AMP deaminase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b18000f2-d0f3-494c-aeb9-0dad0b360ab6">
        <rdfs:label>AMPD1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/270</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/222748">
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/268</ddiem:iembaseUrl>
    <ddiem:iembaseAccessionNumber>268</ddiem:iembaseAccessionNumber>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/222748</dc:identifier>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/bb34eb0e-86e9-49ad-92d3-e1c39fa6a501">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1807</dc:identifier>
        <rdfs:label>DPYS</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0004020>
    <rdfs:label>DIHYDROPYRIMIDINASE DEFICIENCY; DPYSD</rdfs:label>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/47d65aa9-19a8-455e-8b74-68583a3e2535">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00214604</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/899aec42-15c1-4ac0-9850-7e549d6507e2"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2681858</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/06aa3e54-a667-4043-a027-bcd2c6fa70f4">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/673c1938-6f0c-48b1-a5a4-45e17517e835"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Rosuvastatin+Pravastatin</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/33f3804f-3c77-4b5f-a61c-c015ebb44798">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002155</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>hypertriglycernemia</rdfs:label>
        <dc:identifier>HP:0002155</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1211d4c5-c5f8-47d5-b2d1-59477d0292e0">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/05e01909-416a-463b-83d5-3721c0f6f426"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/7ed698ae-09a6-47f0-b704-2668fdb7a7ea">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/658edc4b-2650-44c1-8300-77fd32c54765">
        <rdfs:label>ST3GAL5</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/8869</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.4.99.9</ddiem:ecNumber>
    <rdfs:label>GM3 synthase/sialyltransferase-9/Lactosylceramide alpha-2,3-sialyltransferase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/f84e8347-dc6b-4715-9165-4b15429edde2">
    <rdfs:label>ferrochelatase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/dff78ac3-6977-475f-b310-774ccd18bcf7">
        <rdfs:label>FECH</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2235</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/cab31a0c-1683-4941-9712-22f94c065f93">
    <rdfs:label>lipoic acid synthetase</rdfs:label>
    <ddiem:ecNumber>2.8.1.8</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/c1e43e28-224e-4dfb-a186-5e621b67f688">
        <rdfs:label>LIAS</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/11019</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/33bbd193-9b88-4227-9439-ee24b99a1835">
    <ddiem:ecNumber>3.2.1.25</ddiem:ecNumber>
    <rdfs:label>Beta-mannosidase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/534dc7cc-bd99-4a94-852c-86fb1676453f">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4126</dc:identifier>
        <rdfs:label>MANBA</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7e11bda3-9f03-4be9-b824-fe76475a631a">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/5301410</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25896882</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22830360</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3d5433c0-4e1d-44a6-b0d1-8ffa2f4a517d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/229100">
        <rdfs:label>GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY</rdfs:label>
        <rdfs:comment>The majority of individuals with FTCD deficiency detected by newborn screening are asymptomatic. https://www.ncbi.nlm.nih.gov/pubmed/30740726</rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/655248d0-8a82-4c61-a634-5a38d4157302"/>
        <dc:identifier>https://www.omim.org/entry/229100</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/47</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>47</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27775558</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/34fe216e-6e58-432a-808c-c2e1b33903ea">
        <dc:identifier>HP:0001889</dc:identifier>
        <rdfs:label>Megaloblastic anemia</rdfs:label>
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001889</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>pyridoxine +folic acid</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6dec1d4a-28f5-4731-b26d-77ea7aed8988"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1079dd5a-2942-486f-9712-50218d5692be">
    <dc:provenance>https://reader.elsevier.com/reader/sd/pii/S0140673615000768</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0a3114c6-ed27-4ed6-8394-f7d02a590733">
        <rdfs:label>Anorexia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002039</ddiem:url>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <dc:identifier>HP:0002039</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6cd8dd19-6bc2-494f-94ab-05974800f7d1"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277400"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a7140ddc-033d-4180-8b83-e136b63ddde5">
        <dc:identifier>HP:0031258</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0031258</ddiem:url>
        <rdfs:label>Delirium</rdfs:label>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/12a48cd1-c75a-4b24-91d5-5b3d413a7a4d"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cb391742-9db4-4db5-b1bf-741c0c108502"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ad832ad4-6e96-4b6b-8735-98db820948b6">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002395</ddiem:url>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <dc:identifier>HP:0002395</dc:identifier>
        <rdfs:label>Lower limb hyperreflexia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/52d3508d-2f63-454a-a3b6-d3f286e99641">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012211</ddiem:url>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <dc:identifier>HP:0012211</dc:identifier>
        <rdfs:label>Impaired renal function</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368212</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e9bbd90a-e10f-4c03-84aa-26ebd8a13beb"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a8429eda-827a-4a97-b2e0-d5942f2de107"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/14c19164-97c1-4be1-a4ed-c7f64e01dd8f"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24210590</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24210589</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ab77f8f7-af95-49bd-a101-6a5cb132e5ac"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/892c6087-dbd0-4dba-8642-5b5c22637baf"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/454ffc98-3c61-4fe2-862a-7eb6304ec157"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cefa5609-067b-4fb0-81a7-5a24ff1f5c38">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Fatigue</rdfs:label>
        <dc:identifier>HP:0011025</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011025</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9511979</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f8b55671-472e-4a1d-b4ed-b9fda12b2f95">
        <dc:identifier>HP:0001257</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001257</ddiem:url>
        <rdfs:label>Spasticity</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/34101d64-08c5-415b-b02e-399803061228"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b3eb74b4-9ace-4038-8d18-79008c08f7c7"/>
    </obo:RO_0000057>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <rdfs:comment>Hydroxicobalamin + betaine+ Folinic acid</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9fcda903-ffdb-4c5f-bade-e557cbcd1658"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/42e3f2f6-59b2-49e9-a525-01a548ee58a8">
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <dc:identifier>HP:0012213</dc:identifier>
        <rdfs:label>decreased glomerular filtration rate</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012213</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/58810d34-2b07-495c-8f5c-45e884f3fed4"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dff6c03a-63d3-4cfd-8d12-60320bc91fd0"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8909f1e4-c087-4289-9c73-5608c36098d7"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b12f2634-e2b9-4379-baf4-086bd4c80d9c"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bf2c840e-0f02-48da-ab29-a95e892d15aa">
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <dc:identifier>HP:0001878</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001878</ddiem:url>
        <rdfs:label>Haemolysis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/70b697db-170a-4386-a413-905d291f43fe">
    <ddiem:uniprotId>Q14739</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/21d31c56-a0ea-40bd-bd48-29b8f558411e">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3930</dc:identifier>
        <rdfs:label>LBR</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>lamin B receptor</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0aab7e35-0a80-4009-97ff-937df1217190">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/90992cf7-fe77-4085-95dd-c531382eb03d"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/608747">
        <rdfs:label>INSULIN-LIKE GROWTH FACTOR I DEFICIENCY</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/608747</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/421abb88-1906-4c35-91be-3b4d9f8bfcc4"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>Increlex® (Mecasermin [rDNA origin] injection) + NutropinAq® (Somatropin [rDNA origin])</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8a509ece-86c5-46a4-8cd0-e8dd64315108"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7d2e48de-9e12-476c-810e-8638521e0472">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/faea8728-ba7d-4e76-94b4-73ccd8c2fb25"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/study/NCT00572156</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27884013</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/341cb69d-951b-4061-9460-1b8ed6c1ceb7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ae9917e1-d813-40a4-b444-a45c4838987c"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/06040ab6-9938-4c0c-85c9-e3d6c0b81b53">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/21242e65-9090-41b3-b37b-61af8d0e78d3">
        <rdfs:label>RPL5</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6125</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/595b467b-c2ef-434f-bc7d-6adfd60dd499">
        <rdfs:label>RPS17</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6218</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a5220b4f-7cb1-462e-96cd-e1154fb3d5b5">
        <rdfs:label>RPS7</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6201</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/74cf8618-c672-4187-bee6-830cf6c462ca">
        <rdfs:label>RPL35A</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6165</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f43d51f5-51b2-48d1-8407-245852a46313">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6231</dc:identifier>
        <rdfs:label>RPS26</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>40S ribosomal protein S19</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ef5285ac-41b8-4c8b-9d91-244449a20530">
        <rdfs:label>RPL11</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6135</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>P39019</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/d83ffc63-d471-4b10-a398-98b344b65d48">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6223</dc:identifier>
        <rdfs:label>RPS19</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/50aa29fb-74a9-4dc4-a57d-ff10e93e06b6">
        <rdfs:label>GATA1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2623</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/fbfb37d2-dabd-4e6e-aadd-f8d12d3b46a4">
        <rdfs:label>and</rdfs:label>
        <dc:identifier>https://ghr.nlm.nih.gov/gene/and</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/71c8af6a-1f2f-413f-8294-2adb6b9fb59c">
        <rdfs:label>RPS10</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6204</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f62a8dd4-558a-4bda-a566-a1d2d4ddfd1d">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6229</dc:identifier>
        <rdfs:label>RPS24</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/312f9ca0-cd10-4b92-bc2b-0a20658ba198">
    <rdfs:label>Ribonuclease H1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/d2f55d20-2388-48fd-b8e8-1491f60e223c">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/246243</dc:identifier>
        <rdfs:label>RNASEH1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.1.26.4</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/cfa726ba-4b09-4f88-9905-8f700613fd69">
    <ddiem:ecNumber>1.3.1.2</ddiem:ecNumber>
    <rdfs:label>3-beta-hydroxysterol delta-24-reductase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/68bbc5c0-b2d4-4b2a-86f1-9e4e69408c1a">
        <rdfs:label>DHCR24</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1718</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0112c535-f916-4e8a-a4b3-bf21f2170607">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/11878157-60ad-4fd1-93e9-70f40682813e"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
    <rdfs:comment>Chlorpropamide + carbamazepine</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e31c91ea-9d86-48e7-bb0e-39ae3cd6707a">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000103</dc:identifier>
        <rdfs:label>Polyuria</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000103</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/38fc51a5-e642-49ed-ae42-9ba3e5f0eae9">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001943</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>chlorpropamide-induced hypoglycaemia (Hypoglycemia)*</rdfs:label>
        <dc:identifier>HP:0001943*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9d059244-0c53-4fae-af73-6e795ee03d50"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/125700">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/06e6bdad-51f5-4e85-9515-b2366f4f8238"/>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/125700</dc:identifier>
        <rdfs:label>DIABETES INSIPIDUS, NEUROHYPOPHYSEAL</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1220254</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7800d039-a51f-43b2-bbe3-6407774b3776">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/46fccbf9-3280-4ec5-b7aa-4c9a4c8b5ff9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d8060138-c0a6-4e8e-9b0d-46a8504c29d7"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1316120</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c81ca8e6-be86-4ca3-b6b3-52e829fbb89f">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/0bdc02d5-2d24-4d39-9638-ae11eac5c352">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4143</dc:identifier>
        <rdfs:label>MAT1A</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.5.1.6</ddiem:ecNumber>
    <rdfs:label>S-adenosylmethionine synthase isoform type-1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/d675291b-69aa-4d06-a376-1704a8d9c2a7">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/56e7ff5e-f85a-4c5a-8b1c-21f880304bb1">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/36</dc:identifier>
        <rdfs:label>ACADSB</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>3-hydroxy-2-methylbutyryl-CoA dehydrogenase</rdfs:label>
    <ddiem:ecNumber>1.1.1.178</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0b3a606c-5cba-4fbe-a543-8160a0dde415">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23570448</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/238700">
        <rdfs:label>HYPERLYSINEMIA, TYPE I</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/238700</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b8fc1040-6751-46f7-ba9b-ccbc546fe46e"/>
        <rdfs:comment>Lysine-restricted diet achieved a mild improvement of some signs but did not reverse cognitive impairment. The moderate decrease of plasma lysine concentrations after dietary treatment in our patients supports the need of increase lysine restriction.https://www.ncbi.nlm.nih.gov/pubmed/23890588</rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2fdab51f-fd79-4d0c-a25d-ff751a3c07ac">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0010818</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010818</ddiem:url>
        <rdfs:label>Generalized tonic convulsions</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24204001</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/361c5f70-56bd-459e-95ba-2ae35e9449b4"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e4ef1cd4-790c-4c9e-b816-cdfa0286f386"/>
    <rdfs:comment>valproate+carbamazepine</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9d059244-0c53-4fae-af73-6e795ee03d50"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a9c84e59-3f98-465b-8c32-6c7b911ad3ee"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/e9d82fed-9eaa-4f1b-8c46-628e3e82a0f9">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ac9c1b63-982c-43d2-9a76-cb366956a2af">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/617</dc:identifier>
        <rdfs:label>BCS1L</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>ubiquinol-cytochrome c reductase complex chaperone</rdfs:label>
    <ddiem:uniprotId>Q9Y276</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4f676b35-2748-458d-9788-555567b9bd28">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25851806</dc:provenance>
    <rdfs:comment>L-carnitine+ vitamin B1+B12+C + E</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e49b96c8-dccb-4ac6-8b47-dc129157aa2d"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bd791b0f-53fd-4b98-b132-d46e9ab14c04"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/05e0e82a-9bed-4b0a-bef4-d3b2b940f041"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/22186859-4065-462a-ba51-b3b3c7a0efb8"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8253c26f-e621-4bbf-a04d-bfb951ccd036"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9eeccca2-2059-40f9-bf12-74b9666f8f35"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7375069</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e3ec17c7-13d7-4216-ad9e-9b1b7bda0822"/>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/b74d7d16-fb6f-4f26-a0c2-694ddf07ed69">
    <ddiem:uniprotId>Q30201</ddiem:uniprotId>
    <rdfs:label>transferrin receptor 2</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ec0ce96f-846d-4293-a29f-57987127b142">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/7036</dc:identifier>
        <rdfs:label>TFR2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/008cd541-37a9-4076-911e-d88a5db53208">
    <ddiem:ecNumber>2.3.1.43</ddiem:ecNumber>
    <rdfs:label>mitochondrial dynamin like GTPase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/3f6ceb3e-ec5c-4724-8b3d-93627fd9741d">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4976</dc:identifier>
        <rdfs:label>OPA1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/614643">
    <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7</rdfs:label>
    <ddiem:iembaseAccessionNumber>641</ddiem:iembaseAccessionNumber>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/23b06041-b7c3-4454-8995-d8fdc11f0c47"/>
    <dc:identifier>https://www.omim.org/entry/614643</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/641</ddiem:iembaseUrl>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/33f58bb9-d3ad-445c-910f-c09e8fefb4bc">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/234caa85-64f6-40c6-ac2f-99f4ad49bf43"/>
    <rdfs:label>Fukutin-related protein</rdfs:label>
    <ddiem:uniprotId>Q9H9S5</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/58d417c7-9f51-4b81-9377-8c61e5c52f27">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/324d467e-c91d-43ec-a776-5b8007b65691">
        <rdfs:label>LIPA</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3988</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>P38571</ddiem:uniprotId>
    <rdfs:label>lysosomal acid lipase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f77be38d-2f12-4dbd-b697-4ba83acfd3d4">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16635485</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/608896">
        <dc:identifier>https://www.omim.org/entry/608896</dc:identifier>
        <rdfs:label>SARCOGLYCAN, GAMMA; SGCG</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/499c136d-9d2d-419e-81ef-c0a7e9003ce9"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15252120</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2ca20d70-a2ba-4ee2-8c6c-91c079b54142"/>
    </obo:RO_0000057>
    <rdfs:comment>AAV2/1-MCK-Sgca</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5aa769b7-e948-43fe-9dd4-89464ba91657">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a6b77e8a-b547-4e22-8d88-9e5a8a1dc017"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4576ed1f-61d5-493e-8801-5a2860967d18">
    <rdfs:label>uroporphyrinogen decarboxylase</rdfs:label>
    <ddiem:ecNumber>4.1.1.37</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/0f77c68d-8104-4570-b1ed-5a9cb6f7e6e8">
        <rdfs:label>UROD</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/7389</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/01893034-03d7-4da3-b764-df2518bfd390">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/23f852d1-da7c-49f2-8e77-9d6cc78944a6"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261630"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18425437</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/709e8aea-010a-4706-aa6d-154c1b3bc697"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7760062</dc:provenance>
    <rdfs:comment>Phe-restricted diet +folinic acid+L-dopa+5-hydroxytryptophan</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ac06a685-6de0-4b4d-a07c-5ea08f25b673"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/367914ff-d0f1-4852-82ab-2847f2103108"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9012abb2-0d0d-4b63-af59-bc710f494b83"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6e5b4994-d25c-4657-99bb-3f308ff9ae42">
        <dc:identifier>HP:0010893</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>abnormal blood Phe levels</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010893</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c70994e6-07fb-4b82-ba29-062d67d77180"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26817292</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ab77f8f7-af95-49bd-a101-6a5cb132e5ac"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d7f7d29f-1a1f-40e0-ab45-e6271f1d6351">
        <dc:identifier>HP:0040086</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040086</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>High serum  prolactin</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/40b808b4-0e71-4af6-9904-7f3a97c39835"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/327ddfce-5bdc-4cf8-870e-f5d3ea4a26f5">
    <rdfs:label>Phosphorylase b kinase regulatory subunit alpha, liver isoform</rdfs:label>
    <ddiem:uniprotId>P46019</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/6e44f694-1c06-40f4-9290-4bcf8724692c">
        <rdfs:label>PHKA2</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5256</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/direct_complementation_of_a_genetically_defective_protein_by_gene_therapy">
    <rdfs:label xml:lang="en">direct complementation of a genetically defective protein by gene therapy</rdfs:label>
    <dc:creator>https://orcid.org/0000-0002-5111-7263</dc:creator>
    <obo:IAO_0000115 xml:lang="en">Insertion of one or more normal copies of a genetically defective gene into the genome of affected cells.</obo:IAO_0000115>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000004"/>
  </owl:Class>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/0761f5d7-f53d-40ab-bf14-49cd9041ddf2">
    <ddiem:ecNumber>2.4.1.313</ddiem:ecNumber>
    <rdfs:label>UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/093e37b2-7300-4bd5-9476-b922a1a41b43">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/148789</dc:identifier>
        <rdfs:label>B3GALNT2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/57050294-2cf4-496c-9504-738c3d47475a">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7aea93ca-2975-46cd-803a-867f35e85a42">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/383</dc:identifier>
        <rdfs:label>ARG1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.5.3.1</ddiem:ecNumber>
    <rdfs:label>Arginase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/71e64e42-43a4-4986-9d40-58f177f3b128">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ed382291-2fab-497a-bdc9-8dd04fa10bd7">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1738</dc:identifier>
        <rdfs:label>DLD</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Dihydrolipoyl dehydrogenase, mitochondrial</rdfs:label>
    <ddiem:ecNumber>1.8.1.4</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/611307">
    <rdfs:label>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12; LGMDR12</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/611307</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b1f1334e-9fda-4eff-9114-41298123b2b3"/>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/3fe5a379-c0c1-4a63-b6c8-57bbfdaba40d">
    <ddiem:ecNumber>1.1.1.211</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/c4fdb61e-39bb-46b6-9dc9-902fa572e8e2">
        <rdfs:label>HPRT1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3251</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>4.2.1.17</ddiem:ecNumber>
    <rdfs:label>hypoxanthine phosphoribosyltransferase 1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/230200">
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/6c17c354-7df9-4c71-affe-7f5e9dec22ad">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2584</dc:identifier>
        <rdfs:label>GALK1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0004020>
    <ddiem:iembaseAccessionNumber>474</ddiem:iembaseAccessionNumber>
    <rdfs:label>GALACTOKINASE DEFICIENCY</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/230200</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/474</ddiem:iembaseUrl>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/f1807678-121b-4656-9732-0311984b43a8">
    <rdfs:label>Adenine phosphoribosyltransferase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f29ff502-cb7d-4a29-af80-649e25620201">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/353</dc:identifier>
        <rdfs:label>APRT</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.4.2.7</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/42e3bf51-72c3-4b6b-8e9f-36832961b685">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/962fbddc-2688-43c1-9b49-1ea3eee2ac97">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1201</dc:identifier>
        <rdfs:label>CLN3</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>battenin</rdfs:label>
    <ddiem:uniprotId>Q13286</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/5bd98464-0328-4c33-86e3-66a31775f988">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ac8cc855-94ef-4edd-8df3-cc2716bfe943">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/7390</dc:identifier>
        <rdfs:label>UROS</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>4.2.1.75</ddiem:ecNumber>
    <rdfs:label>uroporphyrinogen III synthase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/f349cd59-2e1f-46ab-9a36-e071a2c7147c">
    <ddiem:ecNumber>3.5.4.6</ddiem:ecNumber>
    <rdfs:label>adrenoleukodystrophy protein</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a8b69757-d9ef-489f-a39b-8799bb9c572f">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/215</dc:identifier>
        <rdfs:label>ABCD1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/7c3c8e99-5189-4b88-8ad4-d03b3a009e29">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/4fca3534-0289-44d9-88ea-bac49398b33c">
        <rdfs:label>TPP1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1200</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>EC</ddiem:uniprotId>
    <ddiem:ecNumber>3.4.14.9</ddiem:ecNumber>
    <rdfs:label>TRIPEPTIDYL PEPTIDASE I</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/222730">
    <ddiem:iembaseAccessionNumber>49</ddiem:iembaseAccessionNumber>
    <rdfs:label>DICARBOXYLIC AMINOACIDURIA; DCBXA</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/49</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/222730</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/5ec74b8a-de94-4998-ac75-3bb4ba2c77af"/>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/ac19dec2-80e2-41ac-a4af-163d174f94b7">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/e6b30d21-9303-4727-9957-d450267381cd">
        <rdfs:label>ADA</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/100</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Adenosine deaminase</rdfs:label>
    <ddiem:ecNumber>3.5.4.4</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/67b3e0b6-2c6c-42d3-98e5-04bef51051dd">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/67e07a4e-210d-4b9a-b71e-df375917f6be">
        <rdfs:label>BCKDHA</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/593</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.2.4.4</ddiem:ecNumber>
    <rdfs:label>2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/966170c7-7416-4f08-ba40-b281d927305e">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/8dd4f398-f928-40ae-9032-ef6441ee45d5">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/226</dc:identifier>
        <rdfs:label>ALDOA</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>4.1.2.13</ddiem:ecNumber>
    <rdfs:label>aldolase, fructose-bisphosphate A</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/179850">
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/94dc4c7f-6fda-4ecf-8d4d-c08ac63c851c">
        <rdfs:label>POGLUT1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/56983</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0004020>
    <rdfs:label>DOWLING-DEGOS DISEASE 1; DDD1</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/179850</dc:identifier>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/6314b376-1578-4945-bb9f-45903b8a924b">
    <ddiem:ecNumber>2.8.2.35</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/1ba54d9d-6041-4894-a6cb-a607a77b3464">
        <rdfs:label>CHST14</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/113189</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Dermatan-4-sulfotransferase-1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/428efc84-98a1-46b7-a9a4-d0ebae3b9c5e">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a14b9595-0c87-4ae8-8e2c-f0d5330623a1"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <rdfs:comment>Ad5-LARGE-eGFP</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/578fb905-e833-48e8-9855-b814c142bb9b"/>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/60bce3e1-e52b-4d63-abff-5212dc63ef7c"/>
    <dc:provenance>https://www.nature.com/articles/nm1059</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a72baa14-1fd0-4130-84da-f78ba33c216d"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/613154">
        <dc:identifier>https://www.omim.org/entry/613154</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1125</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/65af0f79-9afc-4dc9-8ef0-25277c5ec3ae"/>
        <ddiem:iembaseAccessionNumber>1125</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2e3e50cc-79f5-4fb7-aec1-5b96823e9fc9">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a347146a-e2a0-4c34-aa80-28507a23cad8">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002360</ddiem:url>
        <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
        <rdfs:label>Sleep disturbance,Poor sleep qaulity</rdfs:label>
        <dc:identifier>HP:0002360</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e01e8eeb-a854-4bad-bf9b-30567ef3e200"/>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02054832</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/de88b8e7-be0f-4994-bdd1-ede9eedcc404"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29223626</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6efbb158-172f-4fa2-91b9-5882cb151a4a"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2c4a2d48-1267-446c-9efd-2767b7cda6ed"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18996862</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/057807f2-1b7a-48ea-9e00-13ed28974c86"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <rdfs:comment>Glycosade</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fed9fdb3-ac5f-4231-9446-2fdeca4376ea"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/232220">
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>485</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/485</ddiem:iembaseUrl>
        <rdfs:label>GLYCOGEN STORAGE DISEASE Ib; GSD1B</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/232220</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4baf6448-a383-41f4-a87d-ca783f6b5fdd"/>
      </ddiem:Disease>
    </obo:RO_0002606>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/b904cc54-3798-4ecd-b792-b3ef7d6f5f93">
    <ddiem:ecNumber>1.3.8.6</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/739df0b7-2371-4ca5-999c-68960a91bb50">
        <rdfs:label>ETFB</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2109</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>electron transfer flavoprotein (Alpha subunit), electron transfer flavoprotein (Beta subunit), electron transfer flavoprotein dehydrogenase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/c3babda0-4230-4128-b8b0-d1f29b4c2c95">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2110</dc:identifier>
        <rdfs:label>ETFDH</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/2157bb83-1e34-49c5-869e-829f7eef13e5">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2108</dc:identifier>
        <rdfs:label>ETFA</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/f0c2f222-dd0e-41c7-98f0-d433d2bd7cca">
    <rdfs:label>GABA-transaminase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/4ac0f5b8-1476-4629-8c76-94758602bc2d">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/18</dc:identifier>
        <rdfs:label>ABAT</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.6.1.19</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/2da6d951-e123-47fb-9681-0184ec77a900">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/10a070a8-88df-44df-8baa-69e4c9f47d47">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/81693</dc:identifier>
        <rdfs:label>AMN</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.2.1.183</ddiem:ecNumber>
    <rdfs:label>cubilin/amnion associated transmembrane protein</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/0797763a-449d-4278-aa21-87bd21bef416">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/8029</dc:identifier>
        <rdfs:label>CUBN</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.7.1.60</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/5e097e9a-e0aa-4be5-bac6-4971df7db86e">
    <rdfs:label>prosaposin</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b2303e49-9319-4ef2-9626-7733e6fe586e">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5660</dc:identifier>
        <rdfs:label>PSAP</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4bc7d6d6-bc9a-4714-8017-450dd4054daa">
    <ddiem:uniprotId>O95427</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f9c8cb7b-0e47-4363-973f-6863b11c0d5a">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/23556</dc:identifier>
        <rdfs:label>PIGN</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>GPI ethanolamine phosphate transferase 1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/fcb2229d-c247-4cf2-94ac-69e68b6d7531">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/6c17c354-7df9-4c71-affe-7f5e9dec22ad"/>
    <rdfs:label>galactokinase 1</rdfs:label>
    <ddiem:ecNumber>2.7.1.6</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/7393cf0e-4709-4539-ba95-76862639b831">
    <rdfs:label>GTP cyclohydrolase 1/ tyrosine hydroxylase/sepiapterin reductase</rdfs:label>
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/c0358a64-ede1-4e97-b17c-6045f25fc312">
        <rdfs:label>SPR</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6697</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/2722719d-176e-4e5f-919c-d96ca1a9a031">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/7054</dc:identifier>
        <rdfs:label>TH</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/ed3ada91-26ac-4c19-be7b-99681d6777af"/>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4446cbf0-96d1-4fda-bf1d-876a894401d2">
    <ddiem:uniprotId>Q93100</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/8d1fa3c4-a2eb-4872-87cc-9aed9f830fb2">
        <rdfs:label>PHKB</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5257</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Phosphorylase b kinase regulatory subunit beta</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/0c21ca35-9eef-4a0d-9e43-0eeb4a84c9de">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/65163055-9983-4e90-832f-2b1c1507d473">
        <rdfs:label>HFE</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3077</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>Q30201</ddiem:uniprotId>
    <rdfs:label>Hereditary hemochromatosis protein</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/764cbb75-8278-4a8f-a7b2-cd741c5c561e">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/2c543781-ebe9-48b6-9d83-a00a0945ce93">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5538</dc:identifier>
        <rdfs:label>PPT1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.1.2.22</ddiem:ecNumber>
    <rdfs:label>PALMITOYL-PROTEIN THIOESTERASE</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/d113fbd3-6dda-4ac3-8de5-775da1e0cc4b">
    <rdfs:label>ATP binding cassette subfamily C member 8</rdfs:label>
    <ddiem:ecNumber>4.2.1.17</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/4bb04de0-e887-46a7-8d79-a2f9ff6fb945">
        <rdfs:label>ABCC8</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6833</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.1.1.211</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/42e9a58b-63a0-40ba-8309-6f6f88950544">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3d5433c0-4e1d-44a6-b0d1-8ffa2f4a517d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30081189</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/05e0e82a-9bed-4b0a-bef4-d3b2b940f041"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29246599</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6cd8dd19-6bc2-494f-94ab-05974800f7d1"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8ebb6a41-feac-4157-9fd0-8682df6d8a55">
        <rdfs:label>High plasma homocysteine level(Abnormal homocysteine level)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010919</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <dc:identifier>HP:0010919</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/603174"/>
    <rdfs:comment>Betaine, Folic acid, Vitamin B6 , Vitamin B12</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00638547</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5f96b74a-097e-4108-bf64-060db7548ebc"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c547c975-a996-4b2d-be1a-fa09f38258f0">
    <rdfs:label>Thymidine kinase 2, mitochondrial</rdfs:label>
    <ddiem:ecNumber>2.7.1.21</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/5b48f004-fddf-48c0-9803-62b4fb6ae872">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/7084</dc:identifier>
        <rdfs:label>TK2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/11b232db-5ce9-40c1-b2b7-f70b714ba310">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/3a0473e1-c35d-43d5-8864-584b90e7ca78">
        <rdfs:label>BCKDHB</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/594</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.2.4.4</ddiem:ecNumber>
    <rdfs:label>2-oxoisovalerate dehydrogenase subunit beta, mitochondrial</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/38b8d1fb-6075-4f41-85d2-e62d1512b3f1">
    <rdfs:label>dolichol-P-mannose synthase 1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/eab2d039-a8c4-448e-8028-93e98e7a7a7f">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/8813</dc:identifier>
        <rdfs:label>DPM1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4922ac9d-4327-46f7-aaf0-aac9bd65dcf1">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7dc61fac-cd3e-43ca-808f-08770e2705de">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1384</dc:identifier>
        <rdfs:label>CRAT</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.3.1.7</ddiem:ecNumber>
    <rdfs:label>Carnitine acetyltransferase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/e40983ba-6d9d-4aec-85b7-cd4ee18675cf">
    <ddiem:ecNumber>3.1.1.3</ddiem:ecNumber>
    <rdfs:label>adipose triglyceride lipase (ATGL)</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/c87624d8-4f59-4997-886a-5aefc90efa54">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/51099</dc:identifier>
        <rdfs:label>ABHD5</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/970523d8-6cad-46fb-9831-cc5d811cb1dc">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/578fb905-e833-48e8-9855-b814c142bb9b"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a72baa14-1fd0-4130-84da-f78ba33c216d"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/60bce3e1-e52b-4d63-abff-5212dc63ef7c"/>
    <dc:provenance>https://www.nature.com/articles/nm1059</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/236670">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/352</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/66064cfb-3ba7-4647-9f1a-f633c46ed9cf"/>
        <ddiem:iembaseAccessionNumber>352</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/236670</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b8ce406b-434f-4284-80e6-ebed59bb2d25"/>
    </obo:RO_0000057>
    <rdfs:comment>Ad5-LARGE-eGFP</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/90f1f7d3-986c-4758-96eb-d9e74c610d0e">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/57486a65-e6df-462c-8153-670517dc6472">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/249</dc:identifier>
        <rdfs:label>ALPL</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>tissue-nonspecific alkaline phosphatase (TNSALP)</rdfs:label>
    <ddiem:ecNumber>3.1.3.1</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/63bdb579-f822-41d7-99ab-f9ab3e5b1cf5">
    <rdfs:label>Lysosomal protective protein protein/cathepsin A or PPCA/β-galactosidase/ neuraminidase</rdfs:label>
    <ddiem:ecNumber>3.4.16.5</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/e2ee7aa4-13df-40eb-af80-05557e6f6d2d">
        <rdfs:label>CTSA</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5476</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/494bd543-829e-42b3-9b3a-fd8bd53f3ad2">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/12ab86ee-2f26-4ae8-9d15-95a51cf71773">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3295</dc:identifier>
        <rdfs:label>HSD17B4</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>17β-hydroxysteroid dehydrogenase type 4</rdfs:label>
    <ddiem:ecNumber>2.7.1.31</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c805f675-82f9-4527-a0de-bda5efe04f3d">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b7916840-c874-4acf-a053-39a0b3c82a6a">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6559</dc:identifier>
        <rdfs:label>SLC12A3</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>P51801</ddiem:uniprotId>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/49c2578e-e493-4316-95e7-d4d5244bc56c"/>
    <rdfs:label>sodium chloride co-transporter/ chloride channel called ClC-Kb</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/83785b46-23fe-45b3-b5a5-24fa54470475">
    <ddiem:ecNumber>4.3.2.1</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/0c18bcaa-5531-4252-9069-575caadc4db4">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/435</dc:identifier>
        <rdfs:label>ASL</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>argininosuccinate lyase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000011">
    <rdfs:label xml:lang="en">metabolite replacement</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000006"/>
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure involving enteral, parenteral or transdermal provision of small molecules closely related to the products or end processes of a genetically defective protein. [PNS]</obo:IAO_0000115>
    <dc:creator>leechuck</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T18:06:25+00:00</dc:date>
  </owl:Class>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/aa7fc174-3c74-46aa-afe0-b69793a42489">
    <ddiem:ecNumber>3.1.1.4</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f94e5fcc-1485-42ab-a4ec-3735672bccd9">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/8398</dc:identifier>
        <rdfs:label>PLA2G6</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Phospholipase A(2)</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/ebb0e430-e8cc-4d2e-9a86-0c0f9f3c8d0d">
    <ddiem:ecNumber>2.3.2.2</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/172f6cdd-1243-4b4d-94cb-304d0512aa63">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2678</dc:identifier>
        <rdfs:label>GGT1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.4.19.13</ddiem:ecNumber>
    <rdfs:label>Glutathione hydrolase 1 proenzyme/Gamma-glutamyltranspeptidase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/6f180a51-a37c-4338-8c06-2343908726f5">
    <ddiem:ecNumber>1.14.15.15</ddiem:ecNumber>
    <rdfs:label>Cholestanetriol 26-monooxygenase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/07c850c9-abe5-44eb-ba05-165746dc1db0">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1593</dc:identifier>
        <rdfs:label>CYP27A1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4d62cdc8-57a4-4302-99ed-4db21fcaa9d0">
    <rdfs:label>dolichol kinase</rdfs:label>
    <ddiem:ecNumber>2.7.1.108</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/8ccedd65-7266-452c-a4bd-e3e85e488800">
        <rdfs:label>DOLK</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/22845</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/600627">
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/86fe40ce-126d-4a24-8e99-05f36bb4d753">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6999</dc:identifier>
        <rdfs:label>TDO2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0004020>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseAccessionNumber>618</ddiem:iembaseAccessionNumber>
    <dc:identifier>https://www.omim.org/entry/600627</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/618</ddiem:iembaseUrl>
    <rdfs:label>HYPERTRYPTOPHANEMIA; HYPTRP</rdfs:label>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/57e1cb00-b273-432f-a7df-fe42b53a6540">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/024bd978-5a30-4ab0-9682-46b2ea51c72c">
        <rdfs:label>ASAH1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/427</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.5.1.23</ddiem:ecNumber>
    <rdfs:label>acid ceramidase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/3c60ad8d-83d4-45d2-823d-5cadb87e8408">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/b2303e49-9319-4ef2-9626-7733e6fe586e"/>
    <ddiem:uniprotId>P07602</ddiem:uniprotId>
    <rdfs:label>Prosaposin</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/151e78a7-e929-401a-8c21-c79ce6431730">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/8e866274-773c-49dd-8d05-df5fc75f464b">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/686</dc:identifier>
        <rdfs:label>BTD</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>biotinidase</rdfs:label>
    <ddiem:ecNumber>3.5.1.12</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/ae6fe3d5-be23-4f3b-8a04-15fc4ecc3854">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/e7aece5d-5a00-4b14-a68a-2fcb13cfd310">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/64788</dc:identifier>
        <rdfs:label>LMF1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>Q96S06</ddiem:uniprotId>
    <rdfs:label>lipase maturation factor 1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/fcf93b7f-2134-4d29-8e0d-e2445877be53">
    <rdfs:label>Alpha-mannosidase</rdfs:label>
    <ddiem:ecNumber>3.2.1.24</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/2696acca-9544-45e1-bed5-afcbfef2c901">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4125</dc:identifier>
        <rdfs:label>MAN2B1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/d23c2c2a-1874-4a01-a8e4-46e1dd6f1f30">
    <rdfs:label>3-hydroxylacyl-CoA dehydrogenase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/095c454f-8eb7-46dc-89eb-83c3e10e9063">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3033</dc:identifier>
        <rdfs:label>HADH</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.1.1.35</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/77ac4d8a-5c76-4a4c-9b8c-496e2978b491">
    <ddiem:ecNumber>6.4.1.4</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7095007f-e9e2-4831-bcdc-a2e7a5b3bcf5">
        <rdfs:label>MCCC1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/56922</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>3 Methylcrotonyl-CoA carboxylase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f65d1232-c233-43fd-abbc-7e786a09803a">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/64087</dc:identifier>
        <rdfs:label>MCCC2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/357ae1d9-ec5e-4a0e-beb1-cbc2b091ab0a">
    <ddiem:ecNumber>4.2.1.17</ddiem:ecNumber>
    <rdfs:label>sterol carrier protein 2</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/1e486f19-b18d-4786-abea-06033405f8f0">
        <rdfs:label>SCP2</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6342</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.1.1.211</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/615042">
    <rdfs:label>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/967f8e69-cb8e-4cd2-a256-7d34d1a0d4cf"/>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/604</ddiem:iembaseUrl>
    <ddiem:iembaseAccessionNumber>604</ddiem:iembaseAccessionNumber>
    <dc:identifier>https://www.omim.org/entry/615042</dc:identifier>
  </ddiem:Disease>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/614830">
    <dc:identifier>https://www.omim.org/entry/614830</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1120</ddiem:iembaseUrl>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/934deade-adc9-4a47-8b3f-e0ed0ba17696">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/84892</dc:identifier>
        <rdfs:label>POMGNT2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0004020>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8; MDDGA8</rdfs:label>
    <ddiem:iembaseAccessionNumber>1120</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c1b6988a-1245-40bc-b7b4-2ef264876ad2">
    <ddiem:ecNumber>6.3.1.2</ddiem:ecNumber>
    <rdfs:label>sodium/glucose cotransporter protein called SGLT1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a469ea2b-9e45-4596-acd8-f31f7a2e1cbf">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6523</dc:identifier>
        <rdfs:label>SLC5A1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/35354c81-024b-45af-8c5d-f086f2d2afa3">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19820022</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/eacc7df1-6c05-45d8-9253-a93fd0061caf"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16635485</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/262cc661-72ec-41e4-88eb-7049bae58d47"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a6ec4fb8-4bbf-49a8-bcc6-e7ae50eff90f"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246650"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>gemfibrozil+ω-3 fatty acids</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/47d2f2e1-5d2a-4733-a5c4-943f6345148d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3023f73a-89f9-4274-90db-2330d23f0696">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0bce8f4c-bfb7-4f47-b442-2e67871efc85"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10723193</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8e045f30-fe3a-4946-aab7-d0adefd2d933"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26236614</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <rdfs:comment>Carnitine+ riboflavin+Coenzyme Q</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c7bafef6-de2e-4663-80ad-a632fade5629"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19249206</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/ab2611b2-2e11-482e-b3b2-3b37bcd59c0b">
        <rdfs:label>Functional interaction (B)+Direct Interaction (A)+symptomatic</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4331b19d-c9c3-4336-977a-491dd578adf6">
        <rdfs:label>Dysphagia</rdfs:label>
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002015</ddiem:url>
        <dc:identifier>HP:0002015</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231680"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6013024e-d764-4c60-9b48-b7b2271cfef0"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a992c549-ff3f-4cec-971e-4f370ffc7490"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/3fdc3f56-438b-4086-892a-aac94ab988c3">
    <ddiem:uniprotId>Q9UM01</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/91d7f8e3-9fe4-4ab4-b752-29e86e49d2f9">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/9056</dc:identifier>
        <rdfs:label>SLC7A7</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Y+L amino acid transporter 1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/612932">
    <ddiem:iembaseAccessionNumber>501</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/44eb1b8c-4d56-4559-b3c7-eff721e47c46">
        <rdfs:label>ENO3</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2027</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0004020>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/501</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/612932</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>GLYCOGEN STORAGE DISEASE XIII; GSD13</rdfs:label>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4aa2636d-a4ef-402f-a44c-a60aba1c44c8">
    <rdfs:label>alpha subunit of muscle phosphorylase kinase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/4d0195ef-3e26-44b4-a974-4e0d239206b6">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5255</dc:identifier>
        <rdfs:label>PHKA1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.7.11.19</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/608799">
    <rdfs:label>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E</rdfs:label>
    <ddiem:iembaseAccessionNumber>336</ddiem:iembaseAccessionNumber>
    <dc:identifier>https://www.omim.org/entry/608799</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/336</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/eab2d039-a8c4-448e-8028-93e98e7a7a7f"/>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/510506a2-e4ee-4cf8-8102-377d812f03a8">
    <ddiem:ecNumber>4.1.1.28</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/07192a15-102f-4e09-a393-3e02f109ffe5">
        <rdfs:label>DDC</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1644</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Aromatic-L-amino-acid decarboxylase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/7aab4b6a-028e-4df4-a601-0752c0560a32">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/f3522a85-e213-4bd5-9ddb-10e7e86fda05"/>
    <ddiem:ecNumber>4.1.1.9</ddiem:ecNumber>
    <rdfs:label>mannosidase alpha class 1B member 1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/300868">
    <ddiem:iembaseAccessionNumber>1141</ddiem:iembaseAccessionNumber>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1141</ddiem:iembaseUrl>
    <rdfs:comment>Ketogenic diet - A novel treatment for early epileptic encephalopathy due to PIGA deficiency. https://www.ncbi.nlm.nih.gov/pubmed/27126216</rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/2f323cf6-6d36-455e-bbda-5f8d1772c646"/>
    <dc:identifier>https://www.omim.org/entry/300868</dc:identifier>
    <rdfs:label>MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2</rdfs:label>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/b0f181e0-461a-434d-a5ee-9dbccb9d6452">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/bee451f6-bc28-49b9-9b2a-9d8ee702555e">
        <rdfs:label>SLC19A3</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/80704</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>thiamine transporter</rdfs:label>
    <ddiem:uniprotId>available</ddiem:uniprotId>
    <ddiem:uniprotId>not</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/5e1ee385-fa75-43d2-affe-83f408689b2f">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/65af0f79-9afc-4dc9-8ef0-25277c5ec3ae">
        <rdfs:label>LARGE</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/""</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>O95461</ddiem:uniprotId>
    <rdfs:label>LARGE xylosyl- and glucuronyltransferase 1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c20e8ddd-5586-4240-a4d5-46574eabdf17">
    <dc:provenance>https://link.springer.com/article/10.1007/BF00710419</dc:provenance>
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8831079</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a1e319e1-11d3-41e2-9196-1d04366b661a">
        <rdfs:label>Accumulation of 3-methylcrotonyl-CoA metabolite level ( Metabolism abnormality)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939 </ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001939 *</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
    <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2a670529-dd20-49ff-9fa0-05f19bd47c1f"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9cbae92f-1b03-4107-8535-b9b2affb4f96"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fb2970c5-5906-4ef3-9f93-886d5485c050">
        <dc:identifier>HP:0001939 *</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939 </ddiem:url>
        <rdfs:label>Acute metabolic crisis ( Metabolism abnormality)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Glycine +L-Carnitine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18155630</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7a7b4729-a60d-4db5-92b1-41145db19585"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/210200">
        <rdfs:label>3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1284</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f65d1232-c233-43fd-abbc-7e786a09803a"/>
        <dc:identifier>https://www.omim.org/entry/210200</dc:identifier>
        <ddiem:iembaseAccessionNumber>1284</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/7095007f-e9e2-4831-bcdc-a2e7a5b3bcf5"/>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/848775ee-118a-46e2-8257-eecc122f5ad6">
    <ddiem:uniprotId>Q96RR1</ddiem:uniprotId>
    <rdfs:label>twinkle mtDNA helicase</rdfs:label>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/f358e0bb-188e-4d78-91cc-c9350d2bf03d"/>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/0b719c00-6dee-4213-8c2b-ac0d7e8fde44">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/8da8670b-f559-4f31-b729-cf71cc42be16"/>
    <ddiem:uniprotId>P00403</ddiem:uniprotId>
    <ddiem:uniprotId>P00414</ddiem:uniprotId>
    <ddiem:ecNumber>1.9.3.1</ddiem:ecNumber>
    <rdfs:label>Mitochondrially encoded tRNA lysine</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/0893b643-8041-40a8-83c4-33c937599da0">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7ae57c49-2f70-4649-8b23-bb68fe50e185">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/7274</dc:identifier>
        <rdfs:label>TTPA</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>α-tocopherol transfer protein</rdfs:label>
    <ddiem:uniprotId>P49638</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/81fba116-0556-4fa7-aa67-e0f1f538bd7f">
    <rdfs:label>guanidinoacetate methyltransferase</rdfs:label>
    <ddiem:ecNumber>2.1.1.2</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/bdd044cf-6842-4f46-b71f-1eee00e8f425">
        <rdfs:label>GAMT</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2593</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/616896">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/3f6ceb3e-ec5c-4724-8b3d-93627fd9741d"/>
    <rdfs:label>MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE); MTDPS14</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/616896</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c60d91b5-df54-4497-bc89-1ad75b8fae8a">
    <rdfs:label>3-BETA-HYDROXY-DELTA-5-C27-STEROID OXIDOREDUCTASE</rdfs:label>
    <ddiem:uniprotId>Q9H2F3</ddiem:uniprotId>
    <ddiem:ecNumber>1.1.1.181</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/fd39b3a3-a779-4e36-9ebb-15c2f26a7b1b">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/80270</dc:identifier>
        <rdfs:label>HSD3B7</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/05f3d891-6498-4357-93d3-386e7e555c83">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/4e6c036c-6258-4dfb-a209-e90068731fd6">
        <rdfs:label>SLC2A2</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6514</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>P11168</ddiem:uniprotId>
    <rdfs:label>Solute carrier family 2, facilitated glucose transporter member 2</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/23dca804-7f43-4952-8d7b-5d64dd13f3fc">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/190837c8-3d69-44ad-b507-8126ab6356ea">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3242</dc:identifier>
        <rdfs:label>HPD</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>4-hydroxyphenylpyruvate dioxygenase</rdfs:label>
    <ddiem:uniprotId>Q9VQ62</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/248510">
    <dc:identifier>https://www.omim.org/entry/248510</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/534dc7cc-bd99-4a94-852c-86fb1676453f"/>
    <rdfs:label>MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB</rdfs:label>
    <ddiem:iembaseAccessionNumber>261</ddiem:iembaseAccessionNumber>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/261</ddiem:iembaseUrl>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/74e1519b-8de1-4770-8ba3-8ca49ab8390a">
    <rdfs:label>Phosphatidate phosphatase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/724415d4-8699-4639-a9fb-cf3aefa1350c">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/23175</dc:identifier>
        <rdfs:label>LPIN1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.1.3.4</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/adb474c8-1d7f-4ab7-97d5-46c0d28be738">
    <rdfs:label>Phospholipid-transporting ATPase ABCA1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/0f59eb95-852a-41f6-825b-3055ecc525ce">
        <rdfs:label>ABCA1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/19</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/fe5141fb-7064-4ce2-85ec-7d37a022fb0e">
    <rdfs:label>iduronidase, alpha-L</rdfs:label>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/3e1abf48-b1ab-4188-ba39-e217d7d16cbb"/>
    <ddiem:ecNumber>2.7.1.36</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/a89d1b27-ae1d-48fc-b9e5-474431b18328">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b20ead8f-1954-46bb-9e9a-df4167d0c00a">
        <rdfs:label>AP2S1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1175</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>P53680</ddiem:uniprotId>
    <rdfs:label>adaptor protein-2 σ-subunit</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/55183d4b-e160-42e3-8f66-e7cdd9b093d6">
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
    <rdfs:label>Multidrug resistance protein-2</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/e84580de-7f26-42ec-91e7-fc37f24f939b">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1244</dc:identifier>
        <rdfs:label>ABCC2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/2181de02-5b6b-47da-b44a-1283534ade89">
    <ddiem:ecNumber>6.3.1.2</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7be2a042-b06e-41d4-9234-94f1d109809c">
        <rdfs:label>GLUL</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2752</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Glutamine synthetase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/613724">
    <dc:identifier>https://www.omim.org/entry/613724</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1114</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/1e486f19-b18d-4786-abea-06033405f8f0"/>
    <ddiem:iembaseAccessionNumber>1114</ddiem:iembaseAccessionNumber>
    <rdfs:label>LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY; LKDMN</rdfs:label>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/34742b77-cf30-4fb5-a049-2bb4a536792f">
    <ddiem:ecNumber>3.1.12.2</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/3807b6ee-194d-496d-b16b-b0296033c574">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/54840</dc:identifier>
        <rdfs:label>APTX</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Aprataxin</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/611722">
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/292</ddiem:iembaseUrl>
    <rdfs:label>KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY</rdfs:label>
    <ddiem:iembaseAccessionNumber>292</ddiem:iembaseAccessionNumber>
    <dc:identifier>https://www.omim.org/entry/611722</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b2303e49-9319-4ef2-9626-7733e6fe586e"/>
  </ddiem:Disease>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/615249">
    <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12</rdfs:label>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a80f8ad1-d7f9-430a-9aaf-322669886d5f">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/84197</dc:identifier>
        <rdfs:label>POMK</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0004020>
    <ddiem:iembaseAccessionNumber>1122</ddiem:iembaseAccessionNumber>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1122</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/615249</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/e90e3524-4572-449d-941f-788be11ec6b9">
    <ddiem:uniprotId>P02787</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/ac8d33c8-d2fe-46ed-8499-bacbe9074a3b">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/7018</dc:identifier>
        <rdfs:label>TF</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>transferrin</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/2afae1e1-58b9-4f18-9b85-c4cb4bfd1acc">
    <ddiem:ecNumber>1.5.1.9</ddiem:ecNumber>
    <ddiem:ecNumber>1.5.1.8</ddiem:ecNumber>
    <rdfs:label>Aminoadipic semialdehyde synthase, mitochondrial  including Lysine ketoglutarate reductase +Saccharopine dehydrogenase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b8fc1040-6751-46f7-ba9b-ccbc546fe46e">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/10157</dc:identifier>
        <rdfs:label>AASS</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/605637">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/605637</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/66b86ef2-0545-4762-a6fe-a84d001fa0a6"/>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/9843ca44-100f-4453-b572-8f84a2d09823">
    <rdfs:label>GPI transamidase component PIG-T</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/97f33aaf-31c7-48ed-9fba-558103d2098d">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/51604</dc:identifier>
        <rdfs:label>PIGT</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>Q969N2</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/31bbbbbd-e890-4630-bf0a-fac821546576">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a7400853-964a-4d7a-bd58-afb4541f271f">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4547</dc:identifier>
        <rdfs:label>MTTP</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>microsomal triglyceride transfer protein</rdfs:label>
    <ddiem:uniprotId>P55157</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4450d18b-2776-4dbf-a973-88a323979e75">
    <rdfs:label>ATM serine/threonine kinase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7d24f891-8165-4fd4-8b8d-479948806954">
        <rdfs:label>ATM</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/472</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.7.11.21</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/1a795d21-519b-4e80-abbb-3209a9b2e3b3">
    <rdfs:label>3-beta-hydroxy-delta-5-C27 steroid oxidoreductase</rdfs:label>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/fd39b3a3-a779-4e36-9ebb-15c2f26a7b1b"/>
    <ddiem:uniprotId>Q9H9J2</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/b7340fd2-fe89-40eb-ad5e-fac091fdad8f">
    <rdfs:label>Methylmalonic aciduria and homocystinuria type D protein, mitochondrial</rdfs:label>
    <ddiem:uniprotId>Q9H3L0</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/3692e5e8-aff8-4787-a456-8560c9d7d632">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/27249</dc:identifier>
        <rdfs:label>MMADHC</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/616479">
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/d2f55d20-2388-48fd-b8e8-1491f60e223c"/>
    <rdfs:label>PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/616479</dc:identifier>
  </ddiem:Disease>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/215140">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/21d31c56-a0ea-40bd-bd48-29b8f558411e"/>
    <ddiem:iembaseAccessionNumber>197</ddiem:iembaseAccessionNumber>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/197</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/215140</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>GREENBERG DYSPLASIA; GRBGD</rdfs:label>
  </ddiem:Disease>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000014">
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T18:08:30+00:00</dc:date>
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure to mitigate the immediate or future effects of the presence of a genetically defective protein which involves physical conditioning or anatomical modification.[PNS]</obo:IAO_0000115>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/metabolic_disease_treatment"/>
    <rdfs:label xml:lang="en">surgical or physical treatment procedure</rdfs:label>
    <dc:creator>leechuck</dc:creator>
  </owl:Class>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/69920039-c345-4a22-8f6b-de1243d089d5">
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/cd5cbb26-224c-4099-8312-3f63154f5c49">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/8803</dc:identifier>
        <rdfs:label>SUCLA2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Succinyl-CoA synthetase ( beta subunit)</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/2cfd72a4-1754-4b87-adb8-1fb755e4c6bc">
    <rdfs:label>alpha-1-antitrypsin (major plasma serine protease inhibitor)</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/2a37e14d-b090-443e-a6bd-533932001a1b">
        <rdfs:label>SERPINA1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5265</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>P01009</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/1c9c9146-e402-4773-9577-3d27b1b27c41">
    <rdfs:label>Formylglycine-generating enzyme</rdfs:label>
    <ddiem:ecNumber>1.8.3.7</ddiem:ecNumber>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/a8628247-0167-4118-acb7-f2c1e8455e4b"/>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/745dba97-7a5c-435b-bbb0-fbeb8152af12">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/c8b1bfec-3719-4130-8dc9-755b17f2e911">
        <rdfs:label>POMT2</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/29954</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.4.1.109</ddiem:ecNumber>
    <rdfs:label>Protein O-mannosyl-transferase 2</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/0c0d71fd-6f4e-4d27-903d-d894c7b9f23b">
    <ddiem:uniprotId>P15328</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/32b0cf40-3ced-4c69-b0e3-8631c88fbc0d">
        <rdfs:label>FOLR1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2348</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Folate receptor alpha</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/d986b098-9085-45b1-902c-c8b6d61267a1">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/df2578ae-6240-4119-bf17-00a99d7060c8">
        <rdfs:label>HSD17B10</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3028</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.1.1.51</ddiem:ecNumber>
    <ddiem:ecNumber>1.1.1.178</ddiem:ecNumber>
    <rdfs:label>3-hydroxyacyl-CoA dehydrogenase type II</rdfs:label>
    <ddiem:ecNumber>1.1.1.35</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/24f56cd4-cd18-45b2-beb2-549bc24a967c">
    <rdfs:label>isobutyryl-CoA dehydrogenase</rdfs:label>
    <ddiem:ecNumber>4.1.1.9</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/7e198bae-34e6-45f7-9dce-e09e7dc9823f">
        <rdfs:label>ACAD8</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/27034</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/54a0876a-60bc-4cdf-938b-b72c2e189aa1">
    <rdfs:label>cytochrome c oxidase assembly factor</rdfs:label>
    <ddiem:ecNumber>1.9.3.1</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/04c63ea4-01f5-4227-9bea-9efb47b21956">
        <rdfs:label>D2HGDH</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/728294</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/8e2f46cb-3fd5-470f-ac68-703e96cd3bb6">
    <rdfs:label>enolase 3</rdfs:label>
    <ddiem:ecNumber>4.2.1.11</ddiem:ecNumber>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/44eb1b8c-4d56-4559-b3c7-eff721e47c46"/>
  </ddiem:ProtienOrEnzyme>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/04121836-3ffe-4ccd-a8da-404da0ad00a4">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7318fc96-98c7-4a8d-ba82-1726120fcace"/>
    <rdfs:comment>Metoclopramide+prednisolone</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12351372</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cd37784d-50b5-44ad-95de-5cbcae003e5c">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/59af31be-4f62-487a-97f4-c4d9347c7d63"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/105650"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24744655</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17921858</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6827956b-9a1e-40b1-9bb0-8b183b453fd9"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b11da811-7f32-4bc5-876d-aceb6144ca5f"/>
    <dc:provenance>https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.13632</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/7debd752-0347-4c6e-a330-846dfa421a00">
    <rdfs:label>glutaryl-CoA dehydrogenase, mitochondrial</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/15622aa8-3342-456b-863c-147ed05b8d67">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2639</dc:identifier>
        <rdfs:label>GCDH</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.3.8.6</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/39dfa9c0-76b5-46d4-8250-46e89144eaf8">
    <ddiem:ecNumber>2.3.1.43</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/0f533fe1-dfda-48f2-bddb-5922bc9197aa">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/79152</dc:identifier>
        <rdfs:label>FA2H</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>fatty acid 2-hydroxylase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/d4ea6835-d16e-4657-9963-ef8651261e09">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b83cc0b6-5289-42f7-b942-fd449b68279f">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3712</dc:identifier>
        <rdfs:label>IVD</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>4.1.1.9</ddiem:ecNumber>
    <rdfs:label>isovaleryl-CoA dehydrogenase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/3c6a01ff-675d-4512-8d39-8a9cc16c61bd">
    <rdfs:label>cathepsin C</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/e412280d-3598-4ddc-8041-c17d961a95c6">
        <rdfs:label>CTSC</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1075</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>Q9VQ62</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/611209">
    <ddiem:iembaseAccessionNumber>344</ddiem:iembaseAccessionNumber>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/344</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/611209</dc:identifier>
    <rdfs:label>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G</rdfs:label>
    <obo:RO_0004020>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/1de369b7-4a68-456c-b127-e3c788db56b6">
        <rdfs:label>COG1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/9382</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0004020>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/f44a1276-dbe3-4291-b9ca-2183a0896d21">
    <rdfs:label>Fructose-1,6-bisphosphatase 1</rdfs:label>
    <ddiem:ecNumber>3.1.3.11</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/1d6a8f53-3d17-4b7d-89ff-3ae0077fd9ec">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2203</dc:identifier>
        <rdfs:label>FBP1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/690e526c-a7a7-415a-b711-42e7e793fb74">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/a959edda-95ac-41f4-8375-8a385a286e3d"/>
    <ddiem:uniprotId>Q96A29</ddiem:uniprotId>
    <rdfs:label>guanosine 5'-diphosphate (GDP)-fucose transporter</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/f7603858-8983-4989-be3d-b361279eeb63">
    <rdfs:label>Aldo-keto reductase family 1 member D1</rdfs:label>
    <ddiem:ecNumber>1.3.1.3</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/5f2bc0e7-c41d-43af-8bb7-17a98d44909c">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6718</dc:identifier>
        <rdfs:label>AKR1D1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/6b002081-7150-415b-9903-411ca05fc21b">
    <rdfs:label>(α) &amp;(β)GlcNAc-1-phosphotransferas</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/68e7581e-43d9-4bee-ad08-4e61f18a59a3">
        <rdfs:label>GNPTAB</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/79158</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.7.1.60</ddiem:ecNumber>
    <ddiem:ecNumber>3.2.1.183</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000015">
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T18:08:56+00:00</dc:date>
    <rdfs:label xml:lang="en">functional complementation of a defective protein by inhibition</rdfs:label>
    <dc:creator>leechuck</dc:creator>
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure that inhibits  a component of the pathway or network in which a genetically defective protein is found, compensating for alteration of activity of that protein.[PNS]</obo:IAO_0000115>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000007"/>
  </owl:Class>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/ce1372ad-6a82-4d1e-879b-5d67eafdf6c0">
    <rdfs:label>Alkaline phosphatase</rdfs:label>
    <ddiem:ecNumber>3.1.3.1</ddiem:ecNumber>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/57486a65-e6df-462c-8153-670517dc6472"/>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/cc1afb45-a23b-4670-961f-fba65169c866">
    <rdfs:label>beta-glucocerebrosidase</rdfs:label>
    <ddiem:ecNumber>3.2.1.45</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b4c7f310-1e02-4bfd-8cbc-931b7c324369">
        <rdfs:label>GBA</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2629</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/baceb1da-66e4-47cc-b24d-3c44974d4c01">
    <rdfs:label>DNA polymerase subunit gamma-1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/d2d2d0c0-9a5b-4b2e-a876-f1784eb97054">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5428</dc:identifier>
        <rdfs:label>POLG</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.7.7.7</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/43378e07-609e-49de-ac3a-5432d98bf627">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/636b5338-d064-4a7e-8e3b-93b09908ac39">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/54658</dc:identifier>
        <rdfs:label>UGT1A1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>O60931</ddiem:uniprotId>
    <rdfs:label>uridine diphosphate–glucuronyl transferase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c7d02ea1-01a7-4da5-bd5c-50ff9bd21b4f">
    <ddiem:uniprotId>O43826</ddiem:uniprotId>
    <rdfs:label>Glucose-6-phosphate exchanger SLC37A4 (glucose 6-phosphate translocase)</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/4baf6448-a383-41f4-a87d-ca783f6b5fdd">
        <rdfs:label>SLC37A4</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2542</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/80fd2df4-f15d-4c15-9ff0-33086e707ed0">
    <ddiem:ecNumber>4.1.1.9</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a765a16e-3ee4-44a8-ae48-99cd441d2013">
        <rdfs:label>NAGA</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4668</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>alpha-N-acetylgalactosaminidase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4ac488ff-723e-4b33-af8e-0b1d13413967">
    <ddiem:ecNumber>3.6.4.12</ddiem:ecNumber>
    <rdfs:label>DNA replication ATP-dependent helicase/nuclease DNA2</rdfs:label>
    <ddiem:ecNumber>3.1.-.-</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/20b2aeed-9ced-484b-be74-f9cd4c70e9ec">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1763</dc:identifier>
        <rdfs:label>DNA2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/a84e7f76-0937-4e66-ade1-96cbf8733ab9">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a8f05d4d-cbf8-4925-bb5f-1e3beb03c69d">
        <rdfs:label>TAZ</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6901</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>available</ddiem:uniprotId>
    <ddiem:uniprotId>Not</ddiem:uniprotId>
    <rdfs:label>tafazzin ( Protein)</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c98ece47-3b00-4762-8f9c-c0e17d426d02">
    <rdfs:label>dihydropyrimidinase</rdfs:label>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/bb34eb0e-86e9-49ad-92d3-e1c39fa6a501"/>
    <ddiem:ecNumber>1.3.1.2</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/a61f2d10-7054-4319-a9c4-07454ee6b90c">
    <rdfs:label>DnaJ homolog subfamily C member 5(cysteine string PROTEIN)</rdfs:label>
    <ddiem:uniprotId>Q9H3Z4</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/9af18533-de24-4d05-a064-81bbe4e7650e">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/80331</dc:identifier>
        <rdfs:label>DNAJC5</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/aca157e6-bd33-4633-be64-8b27a0974e1c">
    <ddiem:ecNumber>2.7.1.30</ddiem:ecNumber>
    <rdfs:label>Glycerol kinase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f05819ff-c21d-4f04-938e-44de0ba93dea">
        <rdfs:label>GK</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2710</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/e3e823ac-4ac3-40e5-8aa3-ca3d29a4a014">
    <rdfs:label>carnitine palmitoyltransferase 1A</rdfs:label>
    <ddiem:ecNumber>2.3.1.21</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/96c6778c-73fa-4a72-9efe-0c87a359b4e3">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1374</dc:identifier>
        <rdfs:label>CPT1A</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/dde2bb44-7563-4c64-ad92-7cbc93ab14ad">
    <ddiem:ecNumber>2.7.7.7</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/55436c22-6ad4-473c-a49a-fc1285d2adfb">
        <rdfs:label>POLG2</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/11232</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>DNA polymerase subunit gamma-2, mitochondrial</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/e0193129-47c2-4fab-ae45-3edba516bc3e">
    <ddiem:ecNumber>2.7.1.31</ddiem:ecNumber>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/04c63ea4-01f5-4227-9bea-9efb47b21956"/>
    <rdfs:label>D-2-hydroxyglutarate dehydrogenase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/8e5a3d32-9a1b-474e-9c09-ac24735e20d2">
    <ddiem:ecNumber>3.1.1.4</ddiem:ecNumber>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/f94e5fcc-1485-42ab-a4ec-3735672bccd9"/>
    <rdfs:label>85/88 kDa calcium-independent phospholipase A2</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/93148c61-fd20-4d36-b93b-7dfb80e6c38a">
    <rdfs:label>dysferlin</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/348a0c39-b65c-426f-99a8-b75998a229bc">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/8291</dc:identifier>
        <rdfs:label>DYSF</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>O75923</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/e2e34397-5054-4691-be11-1d22488e1765">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/94dc4c7f-6fda-4ecf-8d4d-c08ac63c851c"/>
    <rdfs:label>keratin 5/protein O-glucosyltransferase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/394fa4c9-36b8-43e5-9a1f-a33b0d65e013">
        <rdfs:label>KRT5</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3852</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c93c2cc4-7125-445e-9b07-964e89f6712c">
    <ddiem:ecNumber>2.7.1.30</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/840540d2-6223-46ce-a4e8-92011ddd0cef">
        <rdfs:label>PIGM</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/93183</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>GPI mannosyltransferase 1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/6945adc4-2d78-4cd7-adfa-2ca92dc6fd61">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/447595d3-160d-4ed0-811c-efb6cee30d8e">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2937</dc:identifier>
        <rdfs:label>GSS</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>6.3.2.3</ddiem:ecNumber>
    <rdfs:label>glutathione synthetase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/ea7c8329-a1ba-43ff-b348-025160ae8657">
    <rdfs:label>tryptophan 2,3-dioxygenase</rdfs:label>
    <ddiem:ecNumber>3.1.3.1</ddiem:ecNumber>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/86fe40ce-126d-4a24-8e99-05f36bb4d753"/>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/1dd0eb8f-c6b0-4e87-b4a1-eae3ddef7daa">
    <ddiem:ecNumber>1.17.4.1</ddiem:ecNumber>
    <rdfs:label>Ribonucleoside-diphosphate reductase subunit M2 B</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/3b7eb5ee-bed5-410a-8d3c-a38b3ff8a593">
        <rdfs:label>RRM2B</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/50484</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/33cc2214-fa28-433d-9af8-77ad537fa121">
    <rdfs:label>Steroid 17-alpha-hydroxylase</rdfs:label>
    <ddiem:ecNumber>1.14.14.19</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/621b510f-a5e0-4620-8ba4-e259d036c234">
        <rdfs:label>CYP17A1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1586</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/252500">
    <rdfs:label>MUCOLIPIDOSIS II ALPHA/BETA</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/252500</dc:identifier>
    <ddiem:iembaseAccessionNumber>299</ddiem:iembaseAccessionNumber>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/299</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/68e7581e-43d9-4bee-ad08-4e61f18a59a3"/>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/6a99bfb0-caa1-40dd-bb5b-9130d5750644">
    <ddiem:ecNumber>4.2.1.2</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/a6a44fa3-ef89-412e-9ca3-ce70f2f6bda0">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2271</dc:identifier>
        <rdfs:label>FH</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Fumarate hydratase, mitochondrial</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/cc983941-ebad-4e9d-8815-89a3733076e0">
    <rdfs:label>Methylglutaconyl-CoA hydratase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/36a0c86b-3426-486d-bc0d-480697e83445">
        <rdfs:label>AUH</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/549</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>4.2.1.18</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/a9913c6b-1f38-46c6-85fa-5ec66b7a9b68">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f0cab8d2-a988-4848-9611-461fe290e03c">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2767</dc:identifier>
        <rdfs:label>GNA11</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>guanine nucleotide-binding protein (Gα11)</rdfs:label>
    <ddiem:uniprotId>P21278</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/19206aff-eac8-409a-b53d-8e7c205d0b31">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/ffb64159-869c-41f3-abb3-e326e58a1b40"/>
    <rdfs:label>Δ1-pyrroline 5-carboxylate dehydrogenase</rdfs:label>
    <ddiem:ecNumber>3.1.3.1</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/activity_modification_of_a_genetically_defective_protein_by_epigenetic_manipulation">
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000012"/>
    <dc:creator>https://orcid.org/0000-0002-5111-7263</dc:creator>
    <rdfs:label xml:lang="en">activity modification of a genetically defective protein by epigenetic manipulation</rdfs:label>
    <obo:IAO_0000115 xml:lang="en">Modulation of the level or specificity of expression of a genetically defective gene through modification of an epigenetic mark or process using chemical, biological or genetic means.</obo:IAO_0000115>
  </owl:Class>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4baa2b29-4d57-40d3-820c-ffb7f89221b4">
    <rdfs:label>alpha-galactosidase A</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/542093ba-0d47-40b6-a8b4-5f99581d5533">
        <rdfs:label>GLA</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2717</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/42fde862-f4d1-4c9f-aa63-0803e6941914">
    <ddiem:ecNumber>2.4.1.1</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/4a1b1213-6316-426e-8d8c-887425960285">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5836</dc:identifier>
        <rdfs:label>PYGL</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Glycogen phosphorylase, liver form</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/5de7070b-f11f-4d94-807c-e9281068a2e7">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/24c45db9-b220-448e-8b52-1e2e7c5a72c0">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1893</dc:identifier>
        <rdfs:label>ECM1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>extracellular matrix protein 1</rdfs:label>
    <ddiem:uniprotId>Q16610</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <owl:Ontology rdf:about="http://purl.obolibrary.org/obo/">
    <owl:imports rdf:resource="https://github.com/OGMS/ogms/releases/tag/v2019-04-30"/>
  </owl:Ontology>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/899d4179-c634-484e-b8d7-132c304c951e">
    <ddiem:ecNumber>3.1.3.9</ddiem:ecNumber>
    <rdfs:label>Glucose 6-phophatase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/d2b99377-9958-47f9-b99c-88110faf380a">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2538</dc:identifier>
        <rdfs:label>G6PC</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/a8e82f07-732d-4a9a-bdca-03c1bfaa6b19">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/499c136d-9d2d-419e-81ef-c0a7e9003ce9">
        <rdfs:label>SGCG</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6445</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>Q16586</ddiem:uniprotId>
    <rdfs:label>sarcoglycan gamma</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/162350">
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/309</ddiem:iembaseUrl>
    <rdfs:label>CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B</rdfs:label>
    <ddiem:iembaseAccessionNumber>309</ddiem:iembaseAccessionNumber>
    <dc:identifier>https://www.omim.org/entry/162350</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/9af18533-de24-4d05-a064-81bbe4e7650e"/>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/ab00ed34-1a2b-4dfa-badf-72ed048c30cf">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/879be4f5-b2c7-4af9-b477-b440c4db8080">
        <rdfs:label>SLC2A1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6513</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>6.3.1.2</ddiem:ecNumber>
    <rdfs:label>glucose transporter protein type 1 (GLUT1)</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/b83d6301-c4b2-4f26-84c5-fb9fb01a9811">
    <ddiem:ecNumber>3.2.1.51</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/87c37869-20d4-4381-a0df-13303a97697a">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2517</dc:identifier>
        <rdfs:label>FUCA1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>a-L-fucosidase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/3b931c3f-0d02-4726-8c5e-ae5027d6c79e">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/64a86466-786a-4375-9def-0076ce8d6250">
        <rdfs:label>ACAT1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/38</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Acetyl-CoA C-acetyltransferase.</rdfs:label>
    <ddiem:ecNumber>2.3.1.9</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/abb65acf-3a08-4ec0-af53-502a48b1bf18">
    <rdfs:label>system B(0) neutral amino acid transporter 1 (B0AT1)</rdfs:label>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/8a4bb2af-4867-47d4-a088-fe00bcf38f43"/>
    <ddiem:uniprotId>Q9VQ62</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/242600">
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a7544cb1-3af7-4d86-9793-f4e08b234124"/>
    <ddiem:iembaseAccessionNumber>798</ddiem:iembaseAccessionNumber>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/798</ddiem:iembaseUrl>
    <rdfs:label>IMINOGLYCINURIA</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/242600</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/8a4bb2af-4867-47d4-a088-fe00bcf38f43"/>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/94cb10f4-87d9-4a59-a4c2-8f6957c4f1c0">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/07b2f925-48e3-4d03-a598-f4a8cc554e14">
        <rdfs:label>ATN1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1822</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.3.1.2</ddiem:ecNumber>
    <rdfs:label>atrophin 1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/606812">
    <dc:identifier>https://www.omim.org/entry/606812</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/174</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a6a44fa3-ef89-412e-9ca3-ce70f2f6bda0"/>
    <rdfs:comment>The high fat, low carbohydrate diet may has a possible disease modifying effect. https://www.ncbi.nlm.nih.gov/pubmed/29052812</rdfs:comment>
    <ddiem:iembaseAccessionNumber>174</ddiem:iembaseAccessionNumber>
    <rdfs:label>FUMARASE DEFICIENCY; FMRD</rdfs:label>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/46f0e0a0-ac90-4b22-9f37-c319c10358b3">
    <ddiem:ecNumber>2.4.1.25</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/f8385674-5633-4b6b-a90f-5d7c52df0b6e">
        <rdfs:label>AGL</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/178</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.2.1.33</ddiem:ecNumber>
    <rdfs:label>Glycogen debranching enzyme (4-alpha-glucanotransferase+Amylo-1,6-glucosidase)</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/78265f75-e502-478d-b77f-f08cd94f39cc">
    <rdfs:label>DnaJ heat shock protein family (Hsp40) member C19</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/4ed2e0c8-20d6-4bb3-8f99-aa04c200373d">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/131118</dc:identifier>
        <rdfs:label>DNAJC19</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>Q96DA6</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c496b8e6-a058-48a8-bf50-cfdab688ba76">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/97638dc7-0e83-454a-ae20-2175b4fa1337">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/55157</dc:identifier>
        <rdfs:label>DARS2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>mitochondrial aspartyl-tRNA synthetase</rdfs:label>
    <ddiem:ecNumber>4.2.1.17</ddiem:ecNumber>
    <ddiem:ecNumber>1.1.1.211</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/8b346463-d411-413d-9389-5a601df0e841">
    <rdfs:label>DNA polymerase subunit gamma-2</rdfs:label>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/d2d2d0c0-9a5b-4b2e-a876-f1784eb97054"/>
    <ddiem:ecNumber>2.7.7.7</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/90e0da67-59ab-4143-9fb9-e8be71c775a5">
    <ddiem:uniprotId>Q9HCJ1</ddiem:uniprotId>
    <rdfs:label>Sar1b protein</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/582bb6e5-9b5f-47cf-b21a-903b1ce4d34b">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/51128</dc:identifier>
        <rdfs:label>SAR1B</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/f0aaef0e-7854-42f2-a42c-96c8806fe5ae">
    <ddiem:uniprotId>P05019</ddiem:uniprotId>
    <rdfs:label>insulin like growth factor 1</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/421abb88-1906-4c35-91be-3b4d9f8bfcc4">
        <rdfs:label>IGF1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3479</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/d3867620-8a60-432f-ab83-5d8a404ecabd">
    <rdfs:label>Solute carrier family 12 member 1</rdfs:label>
    <ddiem:uniprotId>Q13621</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/587d9996-3e22-4ba2-b531-7c892d2b704b">
        <rdfs:label>SLC12A1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6557</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/abe187c8-97af-4a68-b851-15d039cb81fe">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/934deade-adc9-4a47-8b3f-e0ed0ba17696"/>
    <rdfs:label>Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2</rdfs:label>
    <ddiem:ecNumber>2.4.1.312</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/27ca9afe-f546-4633-91af-77d279ae37b0">
    <rdfs:label>citrin ( protein)</rdfs:label>
    <ddiem:uniprotId>Q9UJS0</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/78724edc-07ba-4883-b944-d12e44e8041f">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/10165</dc:identifier>
        <rdfs:label>SLC25A13</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/057bb332-9151-45dc-874a-21942ea9bf47">
    <rdfs:label>Homogentisate 1,2-dioxygenase.</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/884f1569-1d10-406f-a8bb-07755a7448a3">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3081</dc:identifier>
        <rdfs:label>HGD</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.13.11.5</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/215720">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/582bb6e5-9b5f-47cf-b21a-903b1ce4d34b"/>
    <dc:identifier>https://www.omim.org/entry/215720</dc:identifier>
    <rdfs:label>CITRULLINE TRANSPORT DEFECT</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/084ee98f-d737-44c5-9b6e-aedb46c3d836">
    <ddiem:ecNumber>7.6.2.1</ddiem:ecNumber>
    <rdfs:label>dolichyl-phosphate mannosyltransferase subunit 3</rdfs:label>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/7a724ed6-ef0d-4364-913a-c9b7056f1f33"/>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/10a14cd1-4f19-457b-b714-2d9786f63d9a">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/636b5338-d064-4a7e-8e3b-93b09908ac39"/>
    <ddiem:uniprotId>O60931</ddiem:uniprotId>
    <rdfs:label>UDP glucuronosyltransferase family 1 member A1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/f6f9397e-c75d-4194-9c6b-10bc1267a36b">
    <rdfs:label>Dihydropteridine reductase</rdfs:label>
    <ddiem:ecNumber>1.5.1.34</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/87ac6684-45c1-4a16-a592-67c633a96fec">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5860</dc:identifier>
        <rdfs:label>QDPR</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/65758451-170f-4b35-91fc-18bbfa95aea3">
    <rdfs:label>apolipoprotein E</rdfs:label>
    <ddiem:uniprotId>Q6Q788</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/6507bd4f-3507-4b99-862e-e798785f87fd">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/348</dc:identifier>
        <rdfs:label>APOE</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/9353a79d-3c27-465f-97df-07181b2d246f">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/a80f8ad1-d7f9-430a-9aaf-322669886d5f"/>
    <rdfs:label>Protein O-mannose kinase</rdfs:label>
    <ddiem:ecNumber>2.7.1.183</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/79c2ae0b-b2ce-4375-a214-d597b230488e">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/93e60839-fc53-4c3e-9721-ee1a3819f669">
        <rdfs:label>CASR</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/846</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>calcium-sensing receptor</rdfs:label>
    <ddiem:uniprotId>P41180</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/2f9b40c8-dafb-4efc-9bf6-16fef5576f21">
    <rdfs:label>dihydrolipoamide dehydrogenase</rdfs:label>
    <ddiem:ecNumber>1.3.1.2</ddiem:ecNumber>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/ed382291-2fab-497a-bdc9-8dd04fa10bd7"/>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/2827aa06-6d18-4f61-950a-17685288d182">
    <ddiem:ecNumber>1.14.16.2</ddiem:ecNumber>
    <rdfs:label>Tyrosine hydroxylase</rdfs:label>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/2722719d-176e-4e5f-919c-d96ca1a9a031"/>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/a9c9e39d-3038-4750-8b94-b8b98c48944c">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/4efcce94-5fcf-4204-b45a-7a1165f6ad5f">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/25974</dc:identifier>
        <rdfs:label>MMACHC</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>Q9Y4U1</ddiem:uniprotId>
    <rdfs:label>Methylmalonic aciduria and homocystinuria type C protein</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000010">
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure in which the diet is supplemented with foodstuffs containing molecules closely related to the products or end processes of a genetically defective protein, which occur naturally in the diet. [PNS]</obo:IAO_0000115>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T18:04:54+00:00</dc:date>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000008"/>
    <dc:creator>leechuck</dc:creator>
    <rdfs:label xml:lang="en">dietary supplementation</rdfs:label>
  </owl:Class>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/85b424ad-a082-450a-8f17-b11a9a7382a5">
    <ddiem:uniprotId>EC</ddiem:uniprotId>
    <rdfs:label>DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE</rdfs:label>
    <ddiem:ecNumber>1.3.1.3</ddiem:ecNumber>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/5f2bc0e7-c41d-43af-8bb7-17a98d44909c"/>
  </ddiem:ProtienOrEnzyme>
  <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000115"/>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/7bcf575b-ce51-4121-b6c8-2d05d8011598">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/0f0ec6ca-fb20-4c6a-b0fa-666ef2238f46">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/23417</dc:identifier>
        <rdfs:label>MLYCD</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>malonyl-CoA decarboxylase</rdfs:label>
    <ddiem:ecNumber>4.1.1.9</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/77bb1ab2-1e92-4f37-8037-c5ab349a3cf0">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/33636784-6435-482f-80fc-b8b835aaf95e">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1716</dc:identifier>
        <rdfs:label>DGUOK</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Deoxyguanosine kinase, mitochondrial</rdfs:label>
    <ddiem:ecNumber>2.7.1.113</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/96e1dfed-eddf-44c1-a865-42296fa70250">
    <ddiem:ecNumber>2.5.1.61</ddiem:ecNumber>
    <rdfs:label>Hydroxymethylbilane synthase.</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/9e49c15c-01e9-41f8-903d-d217043eb542">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3145</dc:identifier>
        <rdfs:label>HMBS</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/c2489f22-b238-4a4a-ad09-c5638f4d80c6">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/87ac6684-45c1-4a16-a592-67c633a96fec"/>
    <ddiem:ecNumber>1.3.1.2</ddiem:ecNumber>
    <rdfs:label>quinoid dihydropteridine reductase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/05733374-34cb-464d-8643-b275f32662ea">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/08d0e46f-eb28-4e86-b6c0-d3ed563af859">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5625</dc:identifier>
        <rdfs:label>PRODH</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.1.3.1</ddiem:ecNumber>
    <rdfs:label>proline dehydrogenase 1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/5fdc01b5-7d13-4fb9-80aa-2318dd60374f">
    <ddiem:ecNumber>5.4.2.2</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/df167332-9809-49b3-a078-be46ca8cab4f">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5236</dc:identifier>
        <rdfs:label>PGM1</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Phosphoglucomutase-1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/4f561dfa-94f7-4dcd-b30c-dd73ee3f6a60">
    <rdfs:label>Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial</rdfs:label>
    <ddiem:ecNumber>2.3.1.168</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/adef4dd0-9d16-4db4-a606-ee9a73abe698">
        <rdfs:label>DBT</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/1629</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/611881">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/611881</dc:identifier>
    <ddiem:iembaseAccessionNumber>500</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/8dd4f398-f928-40ae-9032-ef6441ee45d5"/>
    <rdfs:label>GLYCOGEN STORAGE DISEASE XII; GSD12</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/500</ddiem:iembaseUrl>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/b1e905a6-1665-40a7-908b-a6a700e659bd">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/110a8446-5aec-47fd-be63-98f750d735cd">
        <rdfs:label>SC5D</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6309</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>1.1.1.27</ddiem:ecNumber>
    <rdfs:label>3-beta-hydroxysteroid-delta-5-desaturase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/22f49d02-961d-44ea-bd50-075162864d18">
    <ddiem:uniprotId>Q6Q788</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/3fc32b95-cf49-42f5-bdbd-31907de13098">
        <rdfs:label>APOA5</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/116519</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Apolipoprotein A-V</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/dc3f0540-4f35-4628-8183-eed2903b7ca4">
    <ddiem:ecNumber>2.7.1.60</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/6f327b7c-41a7-4424-918f-ede50b7add95">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/3155</dc:identifier>
        <rdfs:label>HMGCL</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.2.1.183</ddiem:ecNumber>
    <rdfs:label>HMG-CoA lyase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/56996277-397b-47ab-a92c-bfd0453cf087">
    <rdfs:label>zinc/iron-regulated transporter-like protein</rdfs:label>
    <ddiem:uniprotId>Q6P5W5</ddiem:uniprotId>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/1ac80a26-c5ab-4592-a729-8f8e18db4a32">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/55630</dc:identifier>
        <rdfs:label>SLC39A4</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/df26acf8-9d71-487b-b28d-2e315ae306b4">
    <ddiem:ecNumber>2.7.6.1</ddiem:ecNumber>
    <rdfs:label>Ribose-phosphate diphosphokinase</rdfs:label>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/9e593953-1877-4e32-b6d9-9ee40b10dd54">
        <rdfs:label>PRPS1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5631</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/8a81416a-a13a-43b2-bb74-85f45d00998d">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/bb221422-7916-48dc-b7c8-f56b2d739aa3">
        <rdfs:label>MVK</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/4598</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.7.1.36</ddiem:ecNumber>
    <rdfs:label>mevalonate kinase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/d478032b-2034-47be-946a-0d7e5ae383e8">
    <ddiem:ecNumber>2.7.1.30</ddiem:ecNumber>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/840540d2-6223-46ce-a4e8-92011ddd0cef"/>
    <rdfs:label>beta-alanine-alpha-ketoglutarate transaminase.</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/0797dde5-5125-4625-8068-142a853162ba">
    <ddiem:ecNumber>1.4.3.5</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/079acc1e-a9c5-4bc1-a86f-72a1047063dc">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/55163</dc:identifier>
        <rdfs:label>PNPO</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Pyridoxamine 5'-phosphate oxidase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/df1a7371-b52f-40c3-938e-e99cf2e237fc">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b1e3e3e8-a5e9-453e-a947-0d77e8dd2b22">
        <rdfs:label>GLB1</rdfs:label>
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/2720</dc:identifier>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>3.2.1.23</ddiem:ecNumber>
    <rdfs:label>beta-galactosidase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/48766590-d450-4a40-9371-bca98b97e44a">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/b8201ee7-2920-44e9-a3b7-79c6284745fa">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/6442</dc:identifier>
        <rdfs:label>SGCA</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:uniprotId>Q16586</ddiem:uniprotId>
    <rdfs:label>sarcoglycan alpha</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/9c33ae97-22cf-4e8c-8fe6-822a53f8c3bf">
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/3fc32b95-cf49-42f5-bdbd-31907de13098"/>
    <ddiem:uniprotId>Q6Q788</ddiem:uniprotId>
    <rdfs:label>apolipoprotein A5</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/615287">
    <ddiem:iembaseAccessionNumber>1124</ddiem:iembaseAccessionNumber>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1124</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/615287</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/37b57bb2-61ff-4728-af8c-04f55ee61249"/>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13</rdfs:label>
  </ddiem:Disease>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/6089495c-e45d-491b-8f6f-522e008d8113">
    <rdfs:label>Methylenetetrahydrofolate reductase</rdfs:label>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/e9e57ce6-fc1c-4c97-8a2f-ff53cae17180"/>
    <ddiem:ecNumber>1.5.1.20</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/ca8e9518-2677-4818-a587-561a8d895e91">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/c5165daa-daba-47af-bf0e-10c09e09feca">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5053</dc:identifier>
        <rdfs:label>PAH</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>PHENYLALANINE HYDROXYLASE</rdfs:label>
    <ddiem:ecNumber>1.14.16.1</ddiem:ecNumber>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/346de609-d6f9-4c5a-b35e-d46e1454d39c">
    <ddiem:ecNumber>2.4.1.1</ddiem:ecNumber>
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/83c6904c-db83-4ecf-9e0f-ce81abaacad6">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/5837</dc:identifier>
        <rdfs:label>PYGM</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Glycogen phosphorylase, Muscle form</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/1819db94-6c38-4d2b-a2df-888cb6a4e820">
    <ddiem:uniprotId>Q9HCJ1</ddiem:uniprotId>
    <obo:RO_0002204 rdf:resource="http://ddiem.phenomebrowser.net/1de369b7-4a68-456c-b127-e3c788db56b6"/>
    <rdfs:label>component of oligomeric golgi complex 1</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/7cb08a2e-fa07-4d47-8a96-1c839db99d32">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/366801cd-db53-4d14-abbb-29df212c1c88">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/79783</dc:identifier>
        <rdfs:label>SUGCT</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <ddiem:ecNumber>2.8.3.13</ddiem:ecNumber>
    <rdfs:label>succinate-hydroxymethylglutarate coA-transferase</rdfs:label>
  </ddiem:ProtienOrEnzyme>
  <ddiem:ProtienOrEnzyme rdf:about="http://ddiem.phenomebrowser.net/ef50ec6b-8b7e-4a42-9b4a-1710436bc0d3">
    <obo:RO_0002204>
      <ddiem:Gene rdf:about="http://ddiem.phenomebrowser.net/50bee4b8-98ce-4fe8-95d7-dd0841681cad">
        <dc:identifier>https://www.ncbi.nlm.nih.gov/gene/10916</dc:identifier>
        <rdfs:label>MAGED2</rdfs:label>
      </ddiem:Gene>
    </obo:RO_0002204>
    <rdfs:label>Melanoma-associated antigen D2</rdfs:label>
    <ddiem:uniprotId>Q9UNF1</ddiem:uniprotId>
  </ddiem:ProtienOrEnzyme>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/activity_modification_of_a_genetically_defective_protein_by_genome_editing">
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000012"/>
    <dc:creator>https://orcid.org/0000-0002-5111-7263</dc:creator>
    <rdfs:label xml:lang="en">activity modification of a genetically defective protein by genome editing</rdfs:label>
    <obo:IAO_0000115 xml:lang="en">Modulation of the activity or stability of a genetically defective gene through direct modification of one or both endogenous alleles of the gene, using genome editing techniques such as CRISPR/Cas</obo:IAO_0000115>
  </owl:Class>
  <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/creator"/>
  <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/date"/>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ce3592b2-7983-469e-b55f-debcb2d475cd">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28480302</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/607155">
        <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/234caa85-64f6-40c6-ac2f-99f4ad49bf43"/>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/607155</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4494408b-79a4-4b11-acf8-1700e5b0cd6c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28931339</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28107841</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/db78bec9-3b2f-468c-bbaa-4c104b2eba97"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f48276b1-4d1e-4dd1-99e7-8ed43a27c2bc">
        <rdfs:label>Rapid progression</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003678</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003678</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8e045f30-fe3a-4946-aab7-d0adefd2d933"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007764"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17446099</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/563aaf2e-781e-4d5e-9226-5804786bba44">
        <rdfs:label>Abnormal serum creatine kinase</rdfs:label>
        <dc:identifier>HP:0040081</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040081</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/39a4e44b-d630-4e81-8ccc-8b8f595bed3c">
        <rdfs:label>Myositis</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100614</ddiem:url>
        <dc:identifier>HP:0100614</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Prednisolone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23817215</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25048216</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28334834</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a72baa14-1fd0-4130-84da-f78ba33c216d"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3c016ca8-d572-421e-aa3d-5e99c8851b73">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011804</ddiem:url>
        <dc:identifier>HP:0011804</dc:identifier>
        <rdfs:label>Abnormal muscle function</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9868dc31-4394-4f57-ada7-5828ee19a238">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/16c56de2-47af-4c47-b210-1a9f6b33de88">
        <rdfs:label>Urea</rdfs:label>
        <dc:identifier>DB03904</dc:identifier>
        <ddiem:url>https://www.drugbank.ca/drugs/DB03904</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/53b5f489-775d-48b4-9843-4cbd98ab0f41"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2ae9ab72-c9d7-42ce-ad0e-3e20b973e4ee">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/bc27515c-e24c-4320-8624-9c32031b65e4">
        <rdfs:label>Indapamide</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8676234d-5fc4-49b4-ad6b-87972d904b52"/>
        <ddiem:url>https://www.drugbank.ca/drugs/DB00808</ddiem:url>
        <dc:identifier>DB00808</dc:identifier>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8d858f21-a336-45e4-886d-521178973a5f">
    <rdfs:label>Chronic kidney disease</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012622</ddiem:url>
    <dc:identifier>HP:0012622</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/84178bc5-35f1-4c95-8aec-c28d3f0a6c33">
    <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003800</ddiem:url>
    <dc:identifier>HP:0003800</dc:identifier>
    <rdfs:label>Muscle abnormality related to mitochondrial dysfunction</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/810399d4-98c2-474b-8b7b-b3af626bd29e">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/08c30b9b-aca7-4145-806f-7a3ec205c55f"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26358771</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0">
        <rdfs:label>Direct interaction ( Mechanistic A)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0925fa30-fb22-4337-b64e-8c231b0e143c">
        <dc:identifier>HP:0010909*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010909</ddiem:url>
        <rdfs:label>Elevated blood arginine levels( Abnorality in arginie metabolism)*</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c4417832-d291-4bde-9761-9dfd8cbb17aa">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Disease progression (Rapidly progressive)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003678</ddiem:url>
        <dc:identifier>HP:0003678*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508465</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7deab3d7-dacf-4979-937a-657e95221ba8"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/79cdb238-6c39-460a-b404-402fc1689a07"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/207800">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/7aea93ca-2975-46cd-803a-867f35e85a42"/>
        <ddiem:iembaseAccessionNumber>16</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/207800</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>ARGININEMIA</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/16</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03378531</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/754dc975-66db-453a-8883-d9a4cc54dda9">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8e5e25d2-6c80-4c31-80f7-be6e8307ddb8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382922</dc:provenance>
    <rdfs:comment>AEB1102(Pegzilarginase) – Co-ArgI-PEG modified human Arginase I</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/44d68fa6-9a4b-40f5-9da6-2ef40b536588">
        <dc:identifier>HP:0000707*</dc:identifier>
        <rdfs:label>Unstable neurological function (Abnormality of the nervous system)*</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1d31008c-9f28-4c0c-980a-904cc7eba515">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19210957</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28053874</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5cf30e54-4834-48ad-ba4f-de993e9294f3">
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <rdfs:label>Carnitine deficiency</rdfs:label>
        <dc:identifier>HP:0003234</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003234</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9889013</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>L-carnitine</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8727391c-c9c5-4d48-822f-95d234aad8b5">
        <rdfs:label>Failure to thrive</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001508</ddiem:url>
        <dc:identifier>HP:0001508</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12359132</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/611283"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b44e26a0-e21b-4fd2-a0e8-e49264b14e5c">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10590041</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e0867496-530c-4284-849e-e8a64e44497b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/306d99e8-a0f9-41e9-8232-c0d05872b960">
        <dc:identifier>HP:0002069</dc:identifier>
        <rdfs:label>Generalized tonic–clonic seizure</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002069</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23890587</dc:provenance>
    <rdfs:comment>vigabatrin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9732974</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/610768"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/98771066-46d6-4dcf-8ee0-c3e826b6a236">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0007359</dc:identifier>
        <rdfs:label>Focal seizures</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007359</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3d0a710a-96db-48ec-9115-248835cdd561">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30811537</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/20c66069-9462-47c2-b798-f51687d5b254">
        <dc:identifier>HP:0004348</dc:identifier>
        <rdfs:label>Defect of bone mineralisation</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004348</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ec9a1ba0-f1f4-4161-a7e6-8a09c376557e">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007015</ddiem:url>
        <rdfs:label>gross motor dysfunction</rdfs:label>
        <dc:identifier>HP:0007015</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e8dc89fc-2ff7-4437-8182-32889411f40d">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>delayed growth(stature)</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000002</ddiem:url>
        <dc:identifier>HP:0000002</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <rdfs:comment>asfotase alfa</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/55eb21be-aadd-4416-83de-36d47ae585fe">
        <dc:identifier>HP:0002748</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002748</ddiem:url>
        <rdfs:label>rickets</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0929693X18300174</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bf89bff4-129e-4ccf-9efc-7fa676de2c4d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2d327911-1078-4005-81a1-3d6af8f43512"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/258606c4-1f54-4967-8857-7ac2041599bf">
        <rdfs:label>cognitive impairment</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0100543</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100543</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/26b42350-d9a5-45df-a4ec-c7b4afdfd760">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001324</ddiem:url>
        <dc:identifier>HP:0001324</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>muscle weakness</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://cdn.intechopen.com/pdfs/56869.pdf</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/657b5dbc-234b-4164-a392-bd352db48c28">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007010</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0007010</dc:identifier>
        <rdfs:label>fine motor dysfunction</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/241500">
        <ddiem:iembaseAccessionNumber>561</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/561</ddiem:iembaseUrl>
        <rdfs:label>HYPOPHOSPHATASIA, INFANTILE</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/241500</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/57486a65-e6df-462c-8153-670517dc6472"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29405935</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4cbb661e-f0bd-479c-a437-30eef419f17e"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cb3c8a46-55e4-4be0-8e54-eeffef85b1ac">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001510</ddiem:url>
        <rdfs:label>growth delay</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001510</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fd53f16a-135f-48b6-964d-c0f99d1b91c0">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002093</ddiem:url>
        <rdfs:label>respiratory insufficiency</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002093</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26744272</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30083035</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fdb7874b-8a23-4337-9f6b-c4abcf501aa1">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0006462</ddiem:url>
        <dc:identifier>HP:0006462</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>poor skeletal mineralization</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b6bb4990-a910-42ea-8ef5-41fa68cf0bc3">
    <dc:identifier>DB03147</dc:identifier>
    <rdfs:label>Flavin adenine dinucleotide</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a3633672-aea1-4a2a-acec-6913c3763cce">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dc2ce1ce-8264-4042-9abb-91a8f3414d03"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/5d24f87b-e26f-42fc-a5c5-a94d89969411"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d8580f77-8038-4ecd-a460-e0aba75a8efc"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/81b3448f-a5ef-46c8-81ba-9dbc659b1722"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ec696bba-7235-4763-89ec-6e3d8b42d45b"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/07e62a0f-3e67-4d2b-8ae5-b8bd6104354f"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ff0fdbac-5589-49c5-a3b2-cb2aff951cbf"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00151710</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/236792"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8c5406fa-17cb-43a4-9ee3-169710a7a011"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2e3beba0-9630-413c-93bb-4ea7751bb472"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18362286</dc:provenance>
        <dc:provenance>https://n.neurology.org/content/70/13/1051</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0da41c19-b94c-47bb-bb06-2d855ce50cd3"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22391998</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3eff8236-b725-4b9c-8fc7-39ba14ce690f"/>
        <rdfs:comment>Flavin adenine dinucleotide + levocarnitine chloride.</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c9995b56-6fa7-4d75-ae52-ff750ad6d92e"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB03147</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/abf6d12f-b307-45b5-be88-ec8fc89ed757">
    <dc:identifier>HP:0001946,HP:0025212</dc:identifier>
    <rdfs:label>fasting ketogenesis</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001946,HP_0025212</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6a5df735-3272-4021-875f-393bbdfa6bdb">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>High circulating HGA (homogentisic acid)level</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d3521986-1e63-4df6-811d-cee5a400af91">
    <rdfs:label>Poor weight gain</rdfs:label>
    <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001508</ddiem:url>
    <dc:identifier>HP:0001508</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f1b57978-1ca9-4b85-b4f6-6aadd6ca2fd7">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02693119</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02805790</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00528151</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/78fe494a-c13f-45fb-a06a-c3aae2d9bd9a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/fc361ea4-a4cd-4bcf-b5fb-91b0a2cbd3d9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/535000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21788663</dc:provenance>
    <rdfs:comment>Curcumin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a02bc2c4-07fa-465c-bccc-5e028c4099f2">
    <dc:identifier>HP:0002015</dc:identifier>
    <rdfs:label>dysphagia</rdfs:label>
    <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002015</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/192d8da9-536a-40c8-94ef-97d855a7d682">
    <dc:provenance>https://www.paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/59/33</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/309000">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/1d1634e8-d28d-45e1-8672-e5ab56d3c8e8"/>
        <rdfs:label>LOWE OCULOCEREBRORENAL SYNDROME; OCRL</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1061</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/309000</dc:identifier>
        <ddiem:iembaseAccessionNumber>1061</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/65e6da7d-939d-43af-a159-2bb3772c5a2d">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002148</ddiem:url>
        <dc:identifier>HP:0002148</dc:identifier>
        <rdfs:label>Hypophosphatasia</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>pamidronate +growth hormone</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/341cb69d-951b-4061-9460-1b8ed6c1ceb7"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/89fdd0e0-a33e-4303-b9d4-dcaf6df4e853"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19773212</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ceaedc43-88e5-4e63-ac38-a30b01522b36"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7295469f-26ac-47d2-870e-bd4259561533"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5d575654-9379-4774-99f1-b3e40b0f5e66">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f26bf665-cd45-4a0a-bac3-9eb87847c4e9"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/46a23563-9f5a-42e6-8291-4d4aa3e09ddb">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC442441</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/278000">
        <dc:identifier>https://www.omim.org/entry/278000</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/302</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>302</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/324d467e-c91d-43ec-a776-5b8007b65691"/>
        <rdfs:label>LYSOSOMAL ACID LIPASE DEFICIENCY</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/491c52c1-bc27-4e16-8359-bf618911e9f0">
        <rdfs:label>Increased LDL cholesterol</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003141</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003141</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/79a49b1c-0ae4-4bf0-bca4-dd7179343750">
        <rdfs:label>Increased plasma triglycerides</rdfs:label>
        <dc:identifier>HP:0002155</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002155</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27878737</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/898115c7-2054-4893-b291-24af656d4ae9"/>
    <rdfs:comment>Lovastatin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4314c749-8582-44b0-ba80-41e1ac505c62">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003124</ddiem:url>
        <dc:identifier>HP:0003124</dc:identifier>
        <rdfs:label>Increased total cholesterol</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ad373fdc-2457-4426-a2bc-e02d11d2f7fd">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Elevated urine mevalonate levels</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fb67538b-e232-4bac-9ab6-e8f00cfe2d81">
    <dc:identifier>HP:0011025</dc:identifier>
    <rdfs:label>defective heart function</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011025</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/01c3a5b4-6130-4570-af7b-d883daeddfb2">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/145750">
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/3fc32b95-cf49-42f5-bdbd-31907de13098"/>
        <rdfs:label>HYPERTRIGLYCERIDEMIA, FAMILIAL</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/145750</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8c6d4986-4e49-497a-ba43-3178c58ec295"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12114919</dc:provenance>
    <rdfs:comment>Chenodeoxycholic acid</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19770656</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002155</ddiem:url>
        <rdfs:label>Hypertriglyceridemia</rdfs:label>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <dc:identifier>HP:0002155</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28225998</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00465751</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8b7a927c-5606-4d5f-8190-a97c9edfac32">
    <dc:identifier>HP:0001336</dc:identifier>
    <rdfs:label>Myoclonus jerk</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001336</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d655dab0-95fc-45a5-93df-5a163eedb7c5">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002621</ddiem:url>
    <rdfs:label>Atherosclerosis</rdfs:label>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <dc:identifier>HP:0002621</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c1dd0f48-2a48-453d-af23-2e2e1ca203b3">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0012378*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012378</ddiem:url>
    <rdfs:label>Extreme frailty (Fatigue)*</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/79b33eb4-ac2e-4413-8eee-d9a4a5177224">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/7800d039-a51f-43b2-bbe3-6407774b3776"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/684dad52-6b1c-4dc8-ac7d-7e84592df67a"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1316120</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3a3cf42a-d98f-4dec-93de-e00776d320b4"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/46b444f7-450d-4071-8f56-18338cb8ed09">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000103</ddiem:url>
        <rdfs:label>Ployuria</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000103</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1220254</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e6c8c680-c5ad-4184-bea3-335299f97369"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/125700"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b15afb4c-ffca-4609-854a-fdd37acecb69">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b26aa589-2ddc-4c8f-93cd-69e1fb98b2f2"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <rdfs:comment>chlorpropamide+Hydrochlorothiazide</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/089459d1-ef48-427d-99c1-de072ac61fd0">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608747"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <rdfs:comment>NutropinAq® (Somatropin [rDNA origin]</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8a509ece-86c5-46a4-8cd0-e8dd64315108"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/341cb69d-951b-4061-9460-1b8ed6c1ceb7"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/study/NCT00572156</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27884013</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/057ffa77-dd63-4501-b30c-241b350cf973">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2d71ff43-cae1-4101-b7a8-8d978203011d">
        <rdfs:label>polyuria</rdfs:label>
        <dc:identifier>HP:0000103</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000103</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1316120</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b9f70af8-1074-43d2-a70f-bb4671c45287">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000103</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Increased urine output</rdfs:label>
        <dc:identifier>HP:0000103</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/626447</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f03049fd-d583-4b3b-8c2d-705b5d29d76a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/e38eedfe-7cbe-4a30-9846-a88c9a8a944e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Desmopressin</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01280188</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/125700"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12016800</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2c5d8a23-777d-41bf-9059-bb1dd964be68">
    <rdfs:label>Autoimmune encephalopathy(Encephalopathy)*,(Autoimmune disorder)*</rdfs:label>
    <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001298,HP_0002960</ddiem:url>
    <dc:identifier>HP:0001298*,HP:0002960*</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/58dc334e-f502-42df-88bb-0f64c998518d">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002904</ddiem:url>
    <dc:identifier>HP:0002904</dc:identifier>
    <rdfs:label>hyperbilirunbinemia</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1b1fb53b-ff79-4600-99aa-4e86f212abff">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c9718f8f-065b-4e20-ba10-96965b6ce38b">
        <dc:identifier>HP:0025303</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025303</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Recurrent repisode of flares (Recurrent)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/41dee10b-c01d-4b82-a413-3c294380b7e1">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/4da219ce-af41-4e42-9b5b-8c00e7db2379"/>
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7de6702b-82ef-4b39-ad4c-1df81865fd97"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29675606</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/24aca383-1435-4f3f-b21e-11a10f9e24f4">
        <dc:identifier>HP:0100769</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100769</ddiem:url>
        <rdfs:label>Synovitis</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/118600">
        <dc:identifier>https://www.omim.org/entry/118600</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/7a0f16c2-2b4f-4467-940e-b186148785ee"/>
        <rdfs:label>CHONDROCALCINOSIS 2; CCAL2</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22341584</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ee56d78d-7cc0-4547-b7cc-c893f8f6a108">
        <rdfs:label>Refractory Arthritis</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0031375</ddiem:url>
        <dc:identifier>HP:0031375</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
    <dc:provenance>https://acrabstracts.org/abstract/anakinra-compared-to-prednisone-on-the-treatment-of-acute-cppd-crystal-arthritis-a-randomized-controlled-double-blind-study</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
    <rdfs:comment>Anakinra/canakinuma</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18240249</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368924</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23022422</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22658375</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19289295</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2d4427da-ba30-489f-8f07-724480217642">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001369</ddiem:url>
        <dc:identifier>HP:0001369</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Arthritis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25922564</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9f3b4042-be5e-4a21-8011-56fc3fb0212e">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/78c1a07b-a95e-408c-a219-ab87fe83b6c7">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/145750"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22142470</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25993639</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15251700</dc:provenance>
        <rdfs:comment>Gemfibrozil+dietary fat restriction</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/47d2f2e1-5d2a-4733-a5c4-943f6345148d"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6a1143ce-76be-428c-a858-3b76ecf681d9">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/144650"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c8993b5c-a44d-4819-b144-c37a8a06365d"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c93a9304-ae08-48d1-8c28-ff16900430eb"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/65e3caed-1414-4493-9310-f37dc554ebb3"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:comment>Gemfibrozil</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2681858</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/76290e91-0f76-4eda-ada7-a1db22f78cdd"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6bdf1821-f881-4c40-8fa1-18ec9dc1c245"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/47d2f2e1-5d2a-4733-a5c4-943f6345148d"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2702860</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e380cedc-e73f-4323-893a-0a7dbd67e7b3"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/89677c58-ebd8-4733-9db1-d64242cc72ec">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9493705</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/604091"/>
        <dc:provenance>https://www.clinicaltrials.gov/ct2/show/NCT01942291</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19770656</dc:provenance>
        <rdfs:comment>Gemfibrozil</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28225998</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3dad3439-0d4b-46b5-b8d3-c3a969efac73"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/47d2f2e1-5d2a-4733-a5c4-943f6345148d"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Gemfibrozil</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7da817ec-4c89-40e9-9fdf-72beabf579bb">
        <rdfs:comment>gemfibrozil</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28098593</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0021915015001379</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25768710</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/47d2f2e1-5d2a-4733-a5c4-943f6345148d"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3bf6c992-71de-460c-8e7f-272b250296d0"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/af4a382c-d530-4a2c-90fd-45e36835c99b"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10385780</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB01241</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01241</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/cdfddc98-19c7-4994-8d3e-c188916255ca">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <rdfs:comment>Complex carbohydrates+Beneprotein+Low fats</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b2419b63-0e91-4167-b9ee-b076618914d3"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ef75701a-a6e2-48ad-bbbf-5331b9be3a4b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25266922</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/261750">
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1258</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>1258</ddiem:iembaseAccessionNumber>
        <rdfs:label>GLYCOGEN STORAGE DISEASE IXb; GSD9B</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/261750</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/8d1fa3c4-a2eb-4872-87cc-9aed9f830fb2"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC324959</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/710d32d6-8aca-45cd-95b7-0762335a3603">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/4d90dfc2-3f82-4b1d-b10d-331a1d3eb748"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564511</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d4f486f5-3eb3-490a-966b-246fe5f52e32">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22149023</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <rdfs:comment>oxcarbazepine</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/dc9b8c52-3c02-4a6a-a96e-110d87571cfc"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/220110">
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>937</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/04c63ea4-01f5-4227-9bea-9efb47b21956"/>
        <dc:identifier>https://www.omim.org/entry/220110</dc:identifier>
        <rdfs:label>MITOCHONDRIAL COMPLEX IV DEFICIENCY</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/937</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6dc1dcb7-4307-4323-9ba7-cc67bb375844">
    <ddiem:url>https://www.drugbank.ca/drugs/DB13873</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/177eab04-0c97-4387-a746-d4fc71b1598c">
        <rdfs:comment>fenofibrates</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:00007121"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2653622</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ea8aa992-da03-4bfd-a1bc-cd7f6b1ee536"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/84677421-7469-4c60-9f40-b1166715ffba"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a5c37584-f6d1-4e6a-8906-ac47803bddcb"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22129523</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d12013bc-3d9f-43fb-8aaa-fc02dd3ffdd9"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/144650"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dcf5b822-064e-491f-95ce-421ac69b4aa0"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/59479989-8e3f-4651-ac94-00e8fa0dba6a">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/84677421-7469-4c60-9f40-b1166715ffba"/>
        <dc:provenance>https://link.springer.com/article/10.1007%2Fs11883-014-0440-2</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25079293</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <rdfs:comment>Fenofibrate</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3162680</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28098593</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB13873</dc:identifier>
    <rdfs:label>Fenofibric acid</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ac60c5c2-0e7b-43c2-953b-2987a19b098f">
    <rdfs:label>Oculogyric crisis</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0010553</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010553</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8c60209e-2b24-49a1-953b-eb89fefe9e7f">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17702040</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ecb29b50-cec6-4360-a15d-a7d88aa91f32">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003254</ddiem:url>
        <dc:identifier>HP:0003254</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>High urinary 8-hydroxydeoxyguanosine level(Abnormality of DNA repair)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/de8caeb6-4c8e-43e8-9af5-966156e3ecdb">
        <dc:identifier>HP:0012378</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012378</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Tiredness</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/833c397b-7674-499e-b5c1-8bac2d234545">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b3b7de6b-3b78-4b60-a25f-643bb18c4524"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21597884</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <rdfs:comment>recombinant human erythropoietin (rhuEPO)</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2e3beba0-9630-413c-93bb-4ea7751bb472"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/229300">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1241</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/465c09b7-4337-42e5-8a4b-7e88d1b0b03d"/>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>1241</ddiem:iembaseAccessionNumber>
        <rdfs:label>FRIEDREICH ATAXIA 1; FRDA</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/229300</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16269021</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/93fbe42d-00d3-4c72-8818-e138ca2593e4">
        <rdfs:label>Low Frataxin expression level</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18759345</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d">
        <rdfs:label>Functional interaction( Mechanistic B)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/48478af3-d19c-46c5-93b6-3e747bb8971a">
        <dc:identifier>HP:0003287</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003287</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Low NADH,NAD ratio(Mitochondrial dysfunction)</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4eb66bda-c604-4014-ab16-d03970e7b964">
        <dc:identifier>HP:0003281</dc:identifier>
        <rdfs:label>High ferritin level</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003281</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/601780">
    <rdfs:label>CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseAccessionNumber>311</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/0434fa79-f3bc-4ec4-b7a8-75d409ce1f38"/>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/311</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/601780</dc:identifier>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e4e120eb-9891-464f-9407-8e148c3e3eb8">
    <rdfs:label>Exercise-induced myalgia</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0003738</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003738</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3f4bf587-b2d6-4659-9dd5-bf17ea2f56cf">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19744342</dc:provenance>
    <rdfs:comment>zinc</rdfs:comment>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/22092997</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4ebcd69f-43cf-473a-add9-d52b69283352">
        <rdfs:label>Increased ROS formation</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0025464</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025464</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19656325</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22092997</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1dba9972-ef39-4ae3-ab56-a5474843ecac">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7ad09945-bdeb-422d-81a7-1d6ce6361f38"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/177000">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/dff78ac3-6977-475f-b310-774ccd18bcf7"/>
        <dc:identifier>https://www.omim.org/entry/177000</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/107</ddiem:iembaseUrl>
        <rdfs:label>PROTOPORPHYRIA, ERYTHROPOIETIC, 1; EPP1</rdfs:label>
        <ddiem:iembaseAccessionNumber>107</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23884489</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26979527</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/39f95278-a587-4b34-a1d1-2bc9cc2c8cef">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0025142</ddiem:url>
    <rdfs:label>Abnormal walking distance</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0025142*</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ce46f4b3-1e9b-44d3-86ba-c59206b26b36">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/280544</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC324959</dc:provenance>
    <rdfs:comment>Dextrothyroxine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/10d95961-0bb8-43eb-9bb1-3a20003bfc87">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001943</ddiem:url>
        <dc:identifier>HP:0001943</dc:identifier>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <rdfs:label>Mild asymptomatic hypoglycemia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ef75701a-a6e2-48ad-bbbf-5331b9be3a4b"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261750"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/167e4d70-21e7-433a-8188-b67967fa1392">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6140ab9d-9ed0-4e5c-bf97-6e8132a0ce54"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b6b1b260-a41d-411d-a6bd-f2e8a75a6b75">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0002630*</dc:identifier>
        <rdfs:label>Hepatomegaly</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002630</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564511</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f5412a39-0463-40aa-b57b-0f40f55573f2">
    <ddiem:url>https://www.drugbank.ca/drugs/DB12319</ddiem:url>
    <rdfs:label>Benzbromarone</rdfs:label>
    <dc:identifier>DB12319</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c0078a1b-a581-4544-a61f-8d3019fbc38a">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
        <rdfs:comment>Allopurinal+Benzbromarone</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11068651</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/804d30ee-2898-46d1-ae94-5998d616d782"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/162000"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b7cef933-ca1c-4c95-bcaf-de6edd3c744c"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9678437</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fa2ab50d-525a-4059-9f35-e3b061ea0697"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/96abab13-51ab-4618-abdf-6684c5b3dd5c"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02527343</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/10d7ecb7-6f61-447e-8b77-435c2b2b79b7">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/202110">
        <ddiem:iembaseAccessionNumber>125</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/621b510f-a5e0-4620-8ba4-e259d036c234"/>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/202110</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/125</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18458702#</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2c0e2db6-de71-4097-a328-6d5dd457768d">
        <dc:identifier>HP:0008373</dc:identifier>
        <rdfs:label>Puberty and gonadal disorders</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008373</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26161337#</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/292a25f4-0d21-45d6-8e41-7f6cfb3e9aa4">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/16f7928c-9b0e-43d0-bf03-d07ef4c55bef"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Testosterone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18458702</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d7330462-56bd-48f7-b533-4286354d0b98">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/602541">
        <ddiem:iembaseAccessionNumber>1047</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/5748a034-2668-43ed-afdb-f72b750d894b"/>
        <rdfs:label>MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/602541</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1047</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/22186859-4065-462a-ba51-b3b3c7a0efb8"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ad80f96f-a5f8-460d-a992-2fc0364ad7d1">
        <rdfs:label>Neurological disorder of mitochondrail dysfunction(mitochondrail dysfunction)*</rdfs:label>
        <dc:identifier>HP:0003287*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003287</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Thiamine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26006750</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/09ff8776-d01d-4f16-9273-c0869fe882b3">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4481ac75-9791-473f-bb4e-17a27718eb96">
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <dc:identifier>HP:0002625</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002625</ddiem:url>
        <rdfs:label>Deep venous thrombosis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25511120</dc:provenance>
    <rdfs:comment>Coumadin</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277400"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3d555c96-4d13-406f-97bb-01ad7e294b62">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f8223eed-e9fc-4e4d-8f5d-19a6701d9134"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11320193</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/da9e83e3-8f3d-4b72-aba8-d571da5e1cc7">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/805b19f8-730d-4d0a-9017-3e699d7b12be">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012100</ddiem:url>
        <rdfs:label>Abnormal circulating creatinine level</rdfs:label>
        <dc:identifier>HP:0012100</dc:identifier>
        <rdfs:comment>The hypoglycemia is not a disesae phenotype, rather its a side effect of Mecasermin medication.The new combination in Mecasermin rinfabate has over come this side effect.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30373890</dc:provenance>
    <rdfs:comment>creatine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007764"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/271245"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19304794</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9e1aeea8-5ca2-4ca5-b2d3-a4440532ff30">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <rdfs:comment>Deferasirox</rdfs:comment>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/604290">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/872</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>872</ddiem:iembaseAccessionNumber>
        <rdfs:label>ACERULOPLASMINEMIA</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/604290</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/24738f41-8098-4b90-8a15-a2e3e216d0b3"/>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1493</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415789</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/18f71ab1-19d5-472b-bec6-4b91935fef27">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7272d6da-b3c0-4894-947f-54bc58a0f009"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12044538</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fe3d8e7c-3b7a-43bf-ae42-9312bcc64501">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0003281*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003281</ddiem:url>
        <rdfs:label>high brain and liver iron stores</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0a92501c-11a0-4b00-89a2-561bb18b7747">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003281</ddiem:url>
        <rdfs:label>high serum ferritin concentration</rdfs:label>
        <dc:identifier>HP:0003281</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bfbeb87a-c12d-45f0-8f48-3d251b99f579">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/306e44ad-6754-4882-aebf-8b5d19035b1f">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/75ac782c-316f-443c-9320-38031ab0a941"/>
        <rdfs:label>Recombinant human palmitoyl-protein thioesterase 1 ( PPT1)</rdfs:label>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/22312179-21ec-4a8d-8367-094d25cc15da">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/88e8f9f7-d44b-4897-bfa6-02cc3457d7ff">
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010836</ddiem:url>
        <dc:identifier>HP:0010836*</dc:identifier>
        <rdfs:label>Low brain copper levels (Abnormal copper levels)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Recombinant adeno-associated virus serotype 9 (rAAV9)-ATP7A +sc copper histidine</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e6e7abd9-fb7c-4b89-9071-d69937c3030b">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
        <dc:identifier>HP:0000707</dc:identifier>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <rdfs:label>Neurological abnormalties</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/671cb3c8-0f81-4335-9eef-2cd1d0dd6eb3">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7d0df96a-b02e-4780-bafd-9f07097be66c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5ecd9869-21b2-460b-af18-4ff2b913bcf3">
        <dc:identifier>HP:0001507</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001507</ddiem:url>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <rdfs:label>Abnormal growth</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a9bdec54-636c-447a-a031-b5d25c94baf9"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/099e8d33-806d-41e7-a7ea-dfc3111342de">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000708</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000708</ddiem:url>
        <rdfs:label>Behavioral abnormality</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/94ce791c-441e-4fc9-862c-933fe05f6011"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7bce02dc-f737-45de-bec2-61a3c230bb50"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/309400">
        <rdfs:label>MENKES DISEASE</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/309400</dc:identifier>
        <ddiem:iembaseAccessionNumber>199</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/199</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b6427500-8679-46c1-b9c7-7bbfc691968d"/>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30090842</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c065cc0e-b893-4480-a025-30afba3c9b4e"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9511979</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/abs/pii/088789949190052M</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a2fa5341-6dbc-48b0-b252-10cca3489b1d"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/39ceb092-7c25-4a4a-b786-bcb0df6c1fed"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3a1ac8a1-4d54-4af9-9ee0-89d590a629c5">
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <dc:identifier>HP:0003287*</dc:identifier>
        <rdfs:label>Brain mitochondrial abnormalities (Mitochondrial dysfunction)</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003287</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30384011</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5eca140c-bac5-4c6f-a1e8-6324759df7dd">
        <rdfs:label>Abnormal brain neurochemical levels (Abnormality of neurotransmitter metabolism)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012535</ddiem:url>
        <dc:identifier>HP:0012535*</dc:identifier>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1a964572-5df3-4028-a96a-30c946d253d0">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c2aa043e-c33f-4d4a-b193-a0e01b0e7688"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <rdfs:comment>CER 001, a recombinant high-density lipoprotein (HDL)</rdfs:comment>
    <obo:RO_0002558>
      <ddiem:Evidence rdf:about="http://ddiem.phenomebrowser.net/ECO:00055442">
        <dc:identifier>ECO:00055442</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/ECO_00055442</ddiem:url>
      </ddiem:Evidence>
    </obo:RO_0002558>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25561459</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/604091">
        <dc:identifier>https://www.omim.org/entry/604091</dc:identifier>
        <ddiem:iembaseAccessionNumber>379</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/0f59eb95-852a-41f6-825b-3055ecc525ce"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/379</ddiem:iembaseUrl>
        <rdfs:label>HYPOALPHALIPOPROTEINEMIA, PRIMARY</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/86205d43-9869-4581-b016-1010151a7596"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d6d69f1c-a564-4f0c-bd34-6c3c69a6da54">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002621</ddiem:url>
        <rdfs:comment>Niacin was the only effective drug to increase HDL cholesterol.</rdfs:comment>
        <rdfs:label>Arterial pluque</rdfs:label>
        <dc:identifier>HP:0002621</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/719ecd1b-f386-46f0-9d10-9dffa7d5d4b6">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/904f06bc-cb56-444c-bae5-77c6b05c9ec1"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/288f24a4-cf19-48f2-824c-6e9665a1f182">
        <dc:identifier>HP:0003233</dc:identifier>
        <rdfs:label>Decreased plasma HDL-c levels</rdfs:label>
        <rdfs:comment>Niacin was the only effective drug to increase HDL cholesterol.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003233</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bd937aea-8beb-47aa-89f6-e5911cea3ebf"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4ff03ef3-89f2-44ed-9f8b-c85800d546e7">
        <rdfs:comment>Niacin was the only effective drug to increase HDL cholesterol.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002633</ddiem:url>
        <dc:identifier>HP:0002633</dc:identifier>
        <rdfs:label>Vasculitis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8fd293b6-273e-4487-ae89-0a6fe371ab64">
        <dc:identifier>HP:0031799</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0031799</ddiem:url>
        <rdfs:comment>Niacin was the only effective drug to increase HDL cholesterol.</rdfs:comment>
        <rdfs:label>Decreased apolipoprotein AI level</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18993152</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e1bb0fcd-cde5-4442-8ee1-240a45152c89"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.clinicaltrials.gov/ct2/show/NCT02697136</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28213743</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/77cb83f5-1de3-410d-a8db-3be61f3a204d">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7e067ded-0b16-47fa-a09c-8af9097edc46"/>
    </obo:RO_0000057>
    <obo:RO_0003304>N1304S</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9511979</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/52093cc6-4165-47c5-a898-3253d56424c8"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ca59deef-521d-4c9d-8fbd-87895e78279f"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3af8788a-fc32-483e-a203-4b30d21004ef"/>
    </obo:RO_0000057>
    <ddiem:failedToContributeToCondition>Q1385X</ddiem:failedToContributeToCondition>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <obo:RO_0003304>"IVS9,DS,+6T→G"</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341272</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ea4b76b2-09a3-46ee-aa08-e5d8a1394c42">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6373a4c0-f58e-446b-8c20-c53474aeb752"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7f318854-14ab-4231-b15e-ab1bd8e0de03">
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <dc:identifier>HP:0000707</dc:identifier>
        <rdfs:label>Neurological abnormalities.</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/02ba76dc-461c-44f6-a31c-3be192c306cb"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d50671ed-f938-4065-ae1f-195f8f961a62">
        <dc:identifier>HP:0012759*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012759</ddiem:url>
        <rdfs:label>Socio-cognitive abnormality(Neurodevelopmental abnormality)*</rdfs:label>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/22a9c3f3-c93d-4c33-8ccf-d398071144d3">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001010</ddiem:url>
        <dc:identifier>HP:0001010</dc:identifier>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <rdfs:label>Hypopigmented skin</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/218d5960-7668-49da-88d4-dd585fb7d352"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d3521986-1e63-4df6-811d-cee5a400af91"/>
    <ddiem:failedToContributeToCondition>Del ex20–23</ddiem:failedToContributeToCondition>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/05de88a5-876d-4fec-935d-24454b6b9fa2">
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002344</ddiem:url>
        <dc:identifier>HP:0002344</dc:identifier>
        <rdfs:label>Neurologic burden</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4733e533-f98c-4718-95a7-dc49980f510b">
        <dc:identifier>HP:0012389</dc:identifier>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012389</ddiem:url>
        <rdfs:label>Appendicular hyoptonia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7a361c4e-0cd4-4e77-a460-dce93a019437">
        <dc:identifier>HP:0003678</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003678</ddiem:url>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <rdfs:label>Rapid disease progression</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c89c0eda-e32b-40bb-9287-a0d2f6bff9d5"/>
    </obo:RO_0000057>
    <ddiem:failedToContributeToCondition>2757delAG</ddiem:failedToContributeToCondition>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
    <rdfs:comment>Copper Histidine</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c3ab13f1-5729-4924-a576-2e8f68584e95"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4f55a929-50f8-47d3-9dbd-8248b2256427"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/aa5b92d5-4aa1-4dc1-afc9-015381d46db7"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10401004</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT00001262</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20652413</dc:provenance>
    <obo:RO_0003304>G666R</obo:RO_0003304>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/309400"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f50ffe5d-1729-467b-a3c2-95ce4cfd8871"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f2d9b95e-33c3-449d-bbe6-7d079eb9f151">
        <dc:identifier>HP:0002353</dc:identifier>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <rdfs:label>Abnormal brain electrical activity</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002353</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477514</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8223785</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/69aa8565-e895-42e5-9543-bc881801f5be"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2bea7509-1c04-4d38-84bd-a45289c245c9">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001290</ddiem:url>
        <dc:identifier>HP:0001290</dc:identifier>
        <rdfs:label>Low muscular tone</rdfs:label>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/75f49e22-88ac-4f38-8ecc-a6e77d9e864f">
        <rdfs:label>Eplieptic discharge (Interictal EEG abnormality)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025373</ddiem:url>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <dc:identifier>HP:0025373</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30384011</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/533bd348-93aa-40d1-9320-e85b77911b95">
        <rdfs:label>Woolly hair</rdfs:label>
        <dc:identifier>HP:0002224</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002224</ddiem:url>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d90a04b5-1e00-4b03-840c-997911b3fd55">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/600721">
        <dc:identifier>https://www.omim.org/entry/600721</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/166</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>166</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/04c63ea4-01f5-4227-9bea-9efb47b21956"/>
        <rdfs:label>D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28396261</dc:provenance>
    <rdfs:comment>L- carnitine</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/88ef86ab-4950-4b3b-a68d-b731692b0720">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Protein oxidation</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/706016c2-c6a0-439f-aa8d-a0f2f71ecfef">
        <rdfs:label>lipid peroxidation</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8dde2c03-c10d-415f-9f7a-b9f4b6c8d8ab">
        <dc:identifier>HP:0025463</dc:identifier>
        <rdfs:label>oxidative injury*</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025463</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/806f11da-630f-47d9-991a-90b29825d06c">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003254</ddiem:url>
        <dc:identifier>HP:0003254*</dc:identifier>
        <rdfs:label>DNA damage (Abnormality of DNA repair)*</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8fdf0f17-b8bc-42a6-ab95-50af656a333b">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26516243</dc:provenance>
    <rdfs:comment>tocilizumab</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24561416</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b9413849-2b14-4667-b8cf-d006f85bb125">
        <dc:identifier>HP:0012531</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012531</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Pain</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/43d8156c-c2c0-4034-a743-fb11d12f482a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/4e044425-b830-4c94-b97a-703230238b43"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25173351</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8fd77c87-3f64-49de-b84f-4eba755ede4a">
        <dc:identifier>HP:0012649</dc:identifier>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012649</ddiem:url>
        <rdfs:label>Inflammation</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30225156</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8d2238db-0752-4394-b08d-d861394bf1d2">
        <rdfs:label>Fever</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001945</ddiem:url>
        <dc:identifier>HP:0001945</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cefa5609-067b-4fb0-81a7-5a24ff1f5c38"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/260920">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>HYPER-IgD SYNDROME; HIDS</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/260920</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/191</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/bb221422-7916-48dc-b7c8-f56b2d739aa3"/>
        <ddiem:iembaseAccessionNumber>191</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/47c1fb13-3eeb-4e34-82a9-6e0dc0af1e21">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001945</ddiem:url>
        <dc:identifier>HP:0001945</dc:identifier>
        <rdfs:label>Oral ulceration</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2f4f2c7e-0e6e-4406-a091-eb173dd2979f">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/cb849db1-f026-491c-a9d3-20c4efc235ae">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bd791b0f-53fd-4b98-b132-d46e9ab14c04"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10540864</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26516243</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24561416</dc:provenance>
        <rdfs:comment>ascorbic acid</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/236800"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Ascorbic acid</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/18681848-2edd-4c58-aa8a-47028cfe43d1">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20657580</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0022202X15352507</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602473"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29526615</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f774c71b-84b1-44c7-af8d-6512ef46010d"/>
        <rdfs:comment>Ascorbic acid</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bd791b0f-53fd-4b98-b132-d46e9ab14c04"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4de7f531-cc33-466b-ac6f-e7443b289c8c">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a5bd2304-0523-44f7-ac59-c7041dc451ac"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/203500"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508465</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9718357</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30477028</dc:provenance>
        <rdfs:comment>ASCORBIC ACID</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30049652</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a4aca3ba-e2e3-4d66-99aa-ecfc320050f2"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c4417832-d291-4bde-9761-9dfd8cbb17aa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bd791b0f-53fd-4b98-b132-d46e9ab14c04"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28813744</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00126</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/668f4d23-f9d3-40cf-9c97-ddcb7d33540d">
        <rdfs:comment>ascorbic acid</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fd942d1b-c0ea-4247-8840-1d544659dc4c"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27207470</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bd791b0f-53fd-4b98-b132-d46e9ab14c04"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8301428</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00126</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bb89de1d-e7ab-47ed-b6f8-ab1852db1cab">
        <rdfs:comment>Ascorbic acid</rdfs:comment>
        <dc:provenance>https://www.degruyter.com/view/j/jpem.2016.29.issue-1/jpem-2015-0132/jpem-2015-0132.xml</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/0ad70eb7-90f3-487c-875c-31d2d4a0ae7d"/>
        <dc:provenance>http://www.scielo.br/pdf/jiems/v5/2326-4594-jiems-5-e170016.pdf</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/140350"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bd791b0f-53fd-4b98-b132-d46e9ab14c04"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5309c679-ef78-4694-bec7-8180b45eb138"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/675600c9-5c20-4597-859f-2e2a4275eaeb">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/227810">
        <ddiem:iembaseAccessionNumber>481</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4e6c036c-6258-4dfb-a209-e90068731fd6"/>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>FANCONI-BICKEL SYNDROME; FBS</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/227810</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/481</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23456528</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/56c59939-e4bf-45b8-8025-88728b3347a7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/e13f3a96-9186-41f2-a7c0-b1e3eecfb878"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27155573</dc:provenance>
    <rdfs:comment>Insulin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/29116606</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bf38ed6c-5354-4081-ab91-20fbe2222697">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000819</ddiem:url>
        <rdfs:label>Diabetes mellitus</rdfs:label>
        <dc:identifier>HP:0000819</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b2a61aa8-d78c-4b25-9885-55fee1a08e70">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2218bafc-c47d-45d7-825a-ef68f570f777">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004923</ddiem:url>
        <rdfs:label>High plasma phenylalanine level</rdfs:label>
        <dc:identifier>HP:0004923</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c1d28c82-72dd-45f2-917f-1eea9583452f"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30349988</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4ead0f4c-1826-4c1d-97f2-cab7f55bc10c">
        <rdfs:label>Receptive language delay</rdfs:label>
        <dc:identifier>HP:0010863</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010863</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261630"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23430801</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27622829</dc:provenance>
    <rdfs:comment>BH4+L-dopa/carbidopa +5-hydroxytryptophan+ folinic acid</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6ef1e31d-760c-402f-b93c-b7a210c194f3"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/28f9aa83-f122-4837-9b0f-8e567977df85"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ab77f8f7-af95-49bd-a101-6a5cb132e5ac"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ac06a685-6de0-4b4d-a07c-5ea08f25b673"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4b115baf-c407-4b10-bdf6-2461426fe1f7">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002329</ddiem:url>
        <dc:identifier>HP:0002329*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>unalertencess</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26817292</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b3c3ca5c-4eec-4f26-8737-2fefeabf2982">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24613099</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8c18f14b-a40d-4583-a72a-8e7cc59bdcab">
        <dc:identifier>HP:0031544</dc:identifier>
        <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
        <rdfs:label>High blood malonylcarnitine level</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0031544</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/248360">
        <ddiem:iembaseAccessionNumber>177</ddiem:iembaseAccessionNumber>
        <rdfs:label>MALONYL-CoA DECARBOXYLASE DEFICIENCY</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/177</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/0f0ec6ca-fb20-4c6a-b0fa-666ef2238f46"/>
        <dc:identifier>https://www.omim.org/entry/248360</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/369e2d68-3b59-4a4f-9422-0a8eb69cbe01"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/677e1166-1aa4-4f76-9c49-abf948ca93cb">
        <dc:identifier>HP:0001508</dc:identifier>
        <rdfs:label>Failurre to thrive</rdfs:label>
        <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001508</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26858006</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28781843</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/df51fb1a-9761-4128-bfd3-e841b2e13c26">
        <rdfs:label>Cardiomyopathy progrssion</rdfs:label>
        <dc:identifier>HP:0003679</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003679</ddiem:url>
        <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Medium‐chain triglycerides</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/533f3a5c-9bce-4c55-a39a-7cf17d4cd3ec">
        <rdfs:label>Low endurance</rdfs:label>
        <dc:identifier>HP:0025142</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025142</ddiem:url>
        <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28649527</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d5a47fe4-0713-47b6-9e64-89e63445724c">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0025142*</dc:identifier>
    <rdfs:label>low quality of ife</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0025142</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f29d0d8c-74a5-4ba0-bc85-58d0832d8993">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28277561</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27906067</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a10d9d61-37eb-43be-9bbd-ebda7aab6211">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003750</ddiem:url>
        <dc:identifier>HP:0003750</dc:identifier>
        <rdfs:label>lack of strenght</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>CoQ10</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/208920">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/3807b6ee-194d-496d-b16b-b0296033c574"/>
        <rdfs:label>ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/208920</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6e356c50-1e0f-4813-ae1d-d256ff267a33">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/63e72343-9046-48de-baed-f9e6e199ade0">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>High remnant-like particle (RLP)-cholesterol</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3162680</dc:provenance>
    <rdfs:comment>Atrovastatin</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12181212</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ea6f6665-2678-4dd3-8506-27e10d2ae2bf">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002155</ddiem:url>
        <dc:identifier>HP:0002155</dc:identifier>
        <rdfs:label>High serum triglyceride</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b72a581a-8b62-474a-922b-a8c93dd15b2e"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a08ffceb-2132-4f33-a1db-bc3a93798c43">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>Elevated VLDL-cholesterol,serum TG ratio</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003362</ddiem:url>
        <dc:identifier>HP:0003362</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7fe7a3f9-a5f7-4704-9765-fa983812e599">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003124</ddiem:url>
        <rdfs:label>High serum total cholesterol</rdfs:label>
        <dc:identifier>HP:0003124</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2065040</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/32ca8a85-9159-4c34-8085-e231c0d3fda1">
        <rdfs:label>High remnant-like particle (RLP)-TG</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12801620</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cab1f093-46e7-4faf-9a5a-cefb13aef5e0">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0031798</ddiem:url>
        <dc:identifier>HP:0031798</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>Elevated apolipoprotein B level</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9ddd9d1e-d8cc-4dac-be40-e10348f96155">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23364648</dc:provenance>
    <rdfs:comment>methylcobalamin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26040326</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26958680</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/261100">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/0797763a-449d-4278-aa21-87bd21bef416"/>
        <rdfs:label>MEGALOBLASTIC ANEMIA 1</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/83</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>83</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/261100</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/10a070a8-88df-44df-8baa-69e4c9f47d47"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/be39123c-a511-4518-86dd-8fd6104820d5">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1793a1a2-9f11-47c7-add8-008995553dbb"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6e8a6ce4-3523-49ae-82b1-bb3351a54ec4">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0040126</dc:identifier>
        <rdfs:label>Low level of serum B12</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040126</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7cc4ef85-5ba7-4000-b2b6-bd0d860d7ad4">
        <rdfs:label>Increased liver enzyme activities</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002910</ddiem:url>
        <dc:identifier>HP:0002910</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/81899b14-a765-4b4e-88da-27484be7f2ff">
        <rdfs:label>Megalobalstic anaemia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001889</ddiem:url>
        <dc:identifier>HP:0001889</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22219566</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18768530</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14593474</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9f4da0b7-bc68-4593-a7c4-e98ccf7624da"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c7cfd81f-df95-4915-88ed-7fcf48c21d6c">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012120</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0012120</dc:identifier>
        <rdfs:label>Abnormal methylmalonic acid level.</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/367914ff-d0f1-4852-82ab-2847f2103108"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c4ac2476-4707-49b0-b03d-6e4407f3edf2">
        <dc:identifier>HP:0000953</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Hyperpigmentation</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000953</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27942180</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29572946</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d0bfca95-509e-4fb2-8986-e8cc61043a22">
        <dc:identifier>HP:0001897</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001897</ddiem:url>
        <rdfs:label>Normocytic anemia</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24222293</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/036af790-e5d9-46e4-b8a8-b717a3c75eef">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6d2716d2-8b4c-44d5-8bce-dbf2b6e01238">
        <dc:identifier>HP:0002630</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002630</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>fat soluble vitamin malabsorption*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>cholic acid</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3047068e-9b97-4e6e-917a-71d72f3bb077">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0001939*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <rdfs:label>biochemical abnormalities</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bc0a5077-037c-45f3-a79a-06e432cb3bf3">
        <rdfs:label>Histologic abnormalities in liver(Abnormal test result)*</rdfs:label>
        <dc:identifier>HP:0500014</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0500014</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/719bef2d-e8db-4960-8817-c2697de06a70">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001396</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001396</ddiem:url>
        <rdfs:label>Defected bile flow(Cholestasis)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503963</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/69e33faa-ecd4-4e7e-9e22-365f03f67e4e">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>synthesis of atypical bile acids</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bd9bdb27-1aef-4396-8b4f-3c0f5833046b">
        <dc:identifier>HP:0001939</dc:identifier>
        <rdfs:label>Liver biochemical abnormalities (Laboratory abnormalities)*</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2d6eb5c0-b5fa-4ae7-991f-5f10d889501d">
        <dc:identifier>HP:0500014</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0500014</ddiem:url>
        <rdfs:label>Histological abnormalities (Abnormal test result)*</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://rarediseases.info.nih.gov/diseases/10045/congenital-bile-acid-synthesis-defect-type-2</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c4417832-d291-4bde-9761-9dfd8cbb17aa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19087156</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1bdc9411-f6ff-4df6-9eae-4cae142579c8">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0001396</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001396</ddiem:url>
        <rdfs:label>Bile flow defect</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18570303</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/07740be5-aa73-4fb3-8097-6aefcf5743bd">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>production of bile acid toxic intermediates</rdfs:label>
        <dc:identifier>HP:0001939*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8e362065-98e8-46a1-a759-46de892b2572">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>production of toxic bile acid metabolic intermediates</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f2b452cc-6d4f-4435-98c0-a6ebfe35ab38">
        <rdfs:label>Atypical bile acid synthesis</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8225213</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/906349f4-ea1c-4d48-9d89-f1cd884a7221"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1aa70209-243f-4769-a4c0-656f89423f73">
        <rdfs:label>fat soluble vitamin malabsorption (Fat malabsorption)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002630</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0002630*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20619503</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/235555"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/17f2e59e-d6f4-42f5-b086-d1287d482ebc">
    <ddiem:url>http://purl.obolibrary.org/obo/MP_0004144</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Drawing inabiliity</rdfs:label>
    <dc:identifier>MP:0004144</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/477cb185-55c2-40ac-a782-37a74e1a8b13">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003281</ddiem:url>
    <dc:identifier>HP:0003281</dc:identifier>
    <rdfs:label>high plasma ferritin</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/672eace9-0392-4c67-9a57-9c22ce3cb4e2">
    <rdfs:comment>Recombinant alpha 1-antitrypsin (rAAT)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15978931</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508465</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361470</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0f5ea12d-6321-4ccf-8ba8-7a2374803109">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Recurrent infection</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002719</ddiem:url>
        <dc:identifier>HP:0002719</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/765683de-8847-4a69-be09-cd31c2035aa6">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1ed0b517-71ff-460d-8e5d-03625ffb7d1a"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/613490">
        <dc:identifier>https://www.omim.org/entry/613490</dc:identifier>
        <rdfs:label>ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/2a37e14d-b090-443e-a6bd-533932001a1b"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/89e79bac-427b-4b70-893d-201fdc7c8eed">
        <rdfs:label>Progressive emphysema</rdfs:label>
        <dc:identifier>HP:0002097</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002097</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30049652</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02900183</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9a7e3f80-92c5-46e3-9bf1-7389201156e0">
        <dc:identifier>HP:0005952</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0005952</ddiem:url>
        <rdfs:label>Decreased lung function</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30477028</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/da55f146-1acd-4221-bde8-4814f0616457">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14739681</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16619244</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7cb14c35-b269-4465-8615-3883dcf38e81">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b2561baa-3400-4f82-b11a-2500be0479e6"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>serine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24355692</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/236200">
        <ddiem:iembaseAccessionNumber>27</ddiem:iembaseAccessionNumber>
        <rdfs:label>HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/27</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/236200</dc:identifier>
        <rdfs:comment>Current treatment includes (i) the administration of pyridoxine to putatively stimulate the residual CBSactivity; (ii)restriction of dietary methionine intake to decrease the load in the affected pathway; (iii) supplementation of cystine to correct cysteine deficiency; and (iv)administration of betaine, folic acid and cobalamin to facilitate the remethylationof homocysteine back to methionine.</rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/d77db7ea-56a9-4490-9f2f-d9ad35ad7533"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007764"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/605820">
    <ddiem:iembaseAccessionNumber>1299</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/48647d15-7b09-4554-a954-3c753df04581"/>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1299</ddiem:iembaseUrl>
    <rdfs:label>NONAKA MYOPATHY; NM</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/605820</dc:identifier>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8bbf9e32-cf77-453f-8faa-445c62d1ac1c">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20089986</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/300100">
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/280</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a8b69757-d9ef-489f-a39b-8799bb9c572f"/>
        <ddiem:iembaseAccessionNumber>280</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/300100</dc:identifier>
        <rdfs:label>ADRENOLEUKODYSTROPHY; ALD</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15670720</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3b94842a-4e52-484b-8f4b-e0696ba86836">
        <rdfs:label>High plasma levels of hexacosanoic acid</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>Lovastatin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16949688</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10870849</dc:provenance>
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1c2978db-c8b3-4ac3-a9a7-d11f31f64ff6">
        <rdfs:label>High plasma level of very-long-chain fatty acids</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003455</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0003455</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/898115c7-2054-4893-b291-24af656d4ae9"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2ed69e11-fc5b-4347-b0ce-60bf217edecd">
    <rdfs:label>dementia</rdfs:label>
    <dc:identifier>HP:0000726</dc:identifier>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000726</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/942a2f6c-3733-42d8-8d37-cce983650a65">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/21a78484-b5a3-410c-a446-4bef7e938326">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3585a2cd-7ec4-4ba3-82d0-271d79deb8db"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4683a92f-4019-41fd-abaa-3ebde8d6ccba">
        <dc:identifier>HP:0003107*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003107</ddiem:url>
        <rdfs:label>Cholesterol sequestration (Abnormality of cholesterol metabolism)*</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a6637108-0dc4-4e48-ab87-6b9931466f18">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040006</ddiem:url>
        <dc:identifier>HP:0040006*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Reduced life span (Mortality)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>2-hydroxypropyl-beta-cyclodextrin (Adrabetadex)</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9050af6a-f198-4d69-9f44-57fa272d8082">
        <dc:identifier>HP:0001392</dc:identifier>
        <rdfs:label>Liver injury</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001392</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26027824</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f2b26f79-9721-4415-b892-8f4e68285a4d">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Poor swallowing</rdfs:label>
        <dc:identifier>HP:0002015</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002015</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/257220"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7d37feac-9056-4884-bfc3-df2833627a08">
        <rdfs:label>Fine motor impairment</rdfs:label>
        <dc:identifier>HP:0007010</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007010</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29429782</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2162b5ee-6aae-4131-b398-b7531ccf59b6">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003119*</dc:identifier>
        <rdfs:label>Increased free sphingosine accumulation(Abnormality of lipid metabolism)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003119</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c0f06aae-88b2-41f9-819e-9f95f7ac1b9a"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02534844</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cc018caf-58af-44fd-9df1-8f960008ea90">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>High intraneuronal GSL storage</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/32af2e6a-8fa6-415b-9cc3-3e8efae063bd">
        <rdfs:label>Neurodegeneration</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002180</ddiem:url>
        <dc:identifier>HP:0002180</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e1c04b7a-ddf6-4635-8fc5-707ab948d2ff">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.degruyter.com/downloadpdf/j/pteridines.1995.6.issue-3/pteridines.1995.6.3.144/pteridines.1995.6.3.144.pdf</dc:provenance>
    <dc:provenance>https://www.researchgate.net/publication/233414693_Deprenyl_in_6-Pyruvoyl_Tetrahydropterin_Synthase_Deficiency</dc:provenance>
    <rdfs:comment>selective monoamine oxidase (MAO) B inhibitor</rdfs:comment>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/52c000a0-6bad-4003-93c6-6afc3fe0c75c">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a11c9b61-5ac3-49cc-b5a1-09775a96efa8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3a4f1638-40f4-4be4-b97d-7f038c2e55f5">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012656</ddiem:url>
        <rdfs:label>Low dopamine level</rdfs:label>
        <dc:identifier>HP:0012656</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://rarediseases.org/rare-diseases/tetrahydrobiopterin-deficiency</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/261640">
        <dc:identifier>https://www.omim.org/entry/261640</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/4</ddiem:iembaseUrl>
        <rdfs:label>HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a378bdac-5a06-45d0-b77f-8c6894513bac"/>
        <ddiem:iembaseAccessionNumber>4</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a5b49164-a20c-4d56-81df-078fc5a7c201">
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S109671921200265X</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052756/#S10title</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22541557</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b856213e-3c60-4426-8a47-060bc0262b1e">
        <rdfs:label>Cardiac hypertrophy</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c5ca01f1-fcbf-438e-bf5b-c6c7d368bab1">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0000822</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000822</ddiem:url>
        <rdfs:label>hypertension</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/207900"/>
    <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/385394d6-9785-4045-a9bf-229ea6b6bf6f">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>absence of flow-mediated dilatation of brachial artery</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f2a3b83a-fcf6-4d78-af6e-8825b57c2151">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/449e24cf-7137-46ab-8f88-757610bbbc14"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1fa26897-668d-41ce-81b2-c42365b5d618">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>endothelial dysfunction</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <rdfs:comment>Nitric oxide supplement</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/222b1090-4d65-4da3-8aca-04b7e9b4430b">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24189473</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
    <rdfs:comment>Tanespimycin</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b5c49bc9-18e7-4a8b-9eb1-eccc07415050">
        <rdfs:label>Sensorineural hearing impairment</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000407</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000407</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c240a69e-5d95-44d7-8f00-1eb919f9c067">
        <rdfs:label>Mislocalization of R8L</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c20e1970-9d55-431f-88e9-5b58d65e178c">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002900</ddiem:url>
        <dc:identifier>HP:0002900</dc:identifier>
        <rdfs:label>Hypokalemia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4e35b730-d1a5-41cf-b474-299e0113b47d">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Low plasma membrane expression of R8Lin kidney</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/dc771d4d-ba4e-4fe0-9820-67e1233bb478">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7ddcbbfd-b944-408e-aac4-357eb6d6c390"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dd1cd505-08b7-4c9b-b737-d58d4052af8a">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0200114</ddiem:url>
        <rdfs:label>Metabolic alkalosis</rdfs:label>
        <dc:identifier>HP:0200114</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/450278f0-f334-438a-a46f-5da9891a05d6">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>ER-associated degradation of R8L</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/602522">
        <rdfs:label>BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4A</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/602522</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4b55082a-9118-4178-9fb0-93add7af5733"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/32620431-e0cc-4431-b97b-ac601623a350">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29247835</dc:provenance>
    <obo:RO_0003304>T122K</obo:RO_0003304>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2d6c6b2b-4563-45f5-af34-3329617a5690">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Unstable AGA enzyme</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/208400">
        <rdfs:label>ASPARTYLGLUCOSAMINURIA; AGU</rdfs:label>
        <rdfs:comment>As by 2016 Banning et al. mentioned "Currently, no treatment for AGU is available, although several preclinical studies aiming at enzyme replacement (ERT) or gene therapy have been published. Neither of these treatment options is expected to be available within the next few years</rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/6a88c72c-03e1-4ef7-87ee-395dd15194a0"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/258</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>258</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/208400</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1ca63e55-900e-4d6c-9d3c-752e98b2ae3a">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Low AGA activity</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28967191</dc:provenance>
    <dc:provenance>https://www.nature.com/articles/srep37583/figures/5</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850427</dc:provenance>
    <rdfs:comment>betaine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120323</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7759868e-0f91-4955-a147-dfed2931de6d">
        <rdfs:label>Misfolded AGA</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b8dbee9f-be36-4bc1-a011-e9b10a3f2805">
        <rdfs:label>Abnormal AGA processing</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6cd8dd19-6bc2-494f-94ab-05974800f7d1"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/827529f9-5b7a-4b63-b7ab-48177f77aedc">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25485164</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/aa747a73-482b-4e5c-82ff-a0981464e978">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/75dc3a97-3526-4c47-9f3e-662ac19e411f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a0795eda-45a1-4630-aff9-ea2c79490b93">
        <dc:identifier>HP:0000789</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000789</ddiem:url>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <rdfs:label>infertility</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5bd555c5-0942-4a7e-9896-e9e0b1d49b4b">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002311</ddiem:url>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <rdfs:label>incoordination</rdfs:label>
        <dc:identifier>HP:0002311</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c15756bf-9144-4a49-95d9-ceecf48cf79c"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4b030481-679c-446f-8fb1-8da86ee6c4e2"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/256540">
        <rdfs:label>GALACTOSIALIDOSIS; GSL</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/e2ee7aa4-13df-40eb-af80-05557e6f6d2d"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/319</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/256540</dc:identifier>
        <ddiem:iembaseAccessionNumber>319</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d7161330-a72b-4cd4-ae31-8cd1420cb5e5">
        <rdfs:label>gait abnormality</rdfs:label>
        <dc:identifier>HP:0001288</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001288</ddiem:url>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/aea54d7e-7c8c-4f40-bccc-a6e6471b9595">
        <dc:identifier>HP:0000969</dc:identifier>
        <rdfs:label>edematous</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000969</ddiem:url>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15895716</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15084520</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b6e0094a-e9f1-470b-be2a-c6c4c4a33967"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cdd8d284-252a-4fc3-9993-b399bb66650d"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0cbf991f-c4d3-4a15-a84f-8404384014f4"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22008912</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7814809</dc:provenance>
    <rdfs:comment>rAAV-PPCR</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461780</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29358012</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2100017f-a1d0-4fc9-94b0-d8cf65d8052a">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0a06f709-190e-43d1-8ae6-b03f1a49dc95">
        <dc:identifier>HP:0002148</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002148</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Hypophosphatemia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/140350">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/22</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>HAWKINSINURIA</rdfs:label>
        <ddiem:iembaseAccessionNumber>22</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/190837c8-3d69-44ad-b507-8126ab6356ea"/>
        <dc:identifier>https://www.omim.org/entry/140350</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b7df14dd-7d8b-4968-bce7-b22304299939">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3abe31fb-291d-47eb-a46a-26312e1cba7c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>http://www.scielo.br/pdf/jiems/v5/2326-4594-jiems-5-e170016.pdf</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs10545-016-9963-8</dc:provenance>
    <rdfs:comment>phosphate</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3118f935-e2a2-430e-986c-a85897b52d66">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a21eabc9-90d3-433f-8a15-85569b339871"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b00614dc-164b-444f-8926-0a93734ca30b">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/27781c84-466a-44e1-970a-64149cf5ce5c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cbdeeed1-fcb2-4b06-8672-26b0412b9fe5">
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <rdfs:label>Lower extremity weakness</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007340</ddiem:url>
        <dc:identifier>HP:0007340</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d1d23f03-b9b5-426f-95ca-351a93a3235b"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c55f17f2-c698-4782-907b-d3e2129af827"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3da1e6a9-14ee-41fe-9e2c-f48d734c6440"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ab77f8f7-af95-49bd-a101-6a5cb132e5ac"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6cd8dd19-6bc2-494f-94ab-05974800f7d1"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/34101d64-08c5-415b-b02e-399803061228"/>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277400"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/dcbb92a9-9a0d-4460-b62e-9a316e72d56c"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://reader.elsevier.com/reader/sd/pii/S0140673615000768</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f702757c-cf23-41a8-8952-0679eead0bec">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002317</ddiem:url>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <dc:identifier>HP:0002317</dc:identifier>
        <rdfs:label>Gait instability</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Hydroxicobalamin + betaine+ Folinic acid+Vitamin B complex</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/730382a2-caa5-40f5-94fe-c2b95a5639c4"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391119</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ab84cc33-5693-44ea-bff3-caffdd56f95d">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a895f806-31ec-4ad7-816b-ddbe826777da"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8881997</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231670"/>
    <rdfs:comment>Carnitine+Thioridazine Hcl+Chloral hydrate+Baclofen</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fd8cf6e3-3371-48f8-aa90-cbf69bfcf2fe"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fb514c51-c752-44e9-bd53-f396f41430fa"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7b98b5b1-6e8d-4023-9fa9-d891598abac8">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/513157ea-a217-411a-afbc-a94c18bbe4e1"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ca2cecdc-bf4a-4467-9c0e-7b2383d2d928">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9a2b840b-fafd-4940-bd27-8a29acd39960"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/5c71c3ca-8851-4940-a4e4-a799556c51f9">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3d525b3e-dc35-43f7-b696-f47d1ebf1271">
        <rdfs:comment>ACE‐inhibitors</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/77232b6e-d19c-4f59-aa2c-52ad17210836"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18996862</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5edd71a5-bb74-4b4e-bf50-9cf73f1270e1"/>
        <dc:provenance>https://www.semanticscholar.org/paper/Glycogen-storage-diseases%3A-Diagnosis%2C-treatment-and-Chen-Weinstein/439025d057229db1b3a117cb02b3c7e6f2bd3580</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15963056</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>C09C</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4aed2288-65ef-4a85-91aa-272271f5b9a1">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9a683f47-2633-424c-95dc-eadbe3a12cf4"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/77232b6e-d19c-4f59-aa2c-52ad17210836"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8124fb2a-5963-486f-a7b3-3bc70127025a"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27491218</dc:provenance>
        <rdfs:comment>ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs)</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/eefb9cb7-62e4-4958-a173-5ce3ccc15ceb"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/136120"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dfd511e1-23c5-4c8e-ac2d-c323cfd043bf"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23522979</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29390242</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN</rdfs:label>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=C09C</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/05eb34ca-0f46-4acd-b21b-5a04a3be74a4">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27928778</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/764c4cf7-d28c-4c5d-86c9-46831142b419"/>
        <rdfs:comment>Angiotensin-converting enzyme (ACE) inhibitors+digoxin+furosemide</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564511</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/77232b6e-d19c-4f59-aa2c-52ad17210836"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC324959</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f26eb273-01b2-4a18-9276-81be638da73f"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/610198"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d6cec5ba-eb4b-4c5b-a28d-e395bc44b47b"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2051ff2f-447d-495a-8d11-3ac84fa1af75"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a4e4a049-f87c-41c8-8dbd-b506b0221a99">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7936305</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fbf52ffc-f79e-4720-81fd-337418817a62">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ef4b3a04-2b81-47c6-a080-5608f7cbe597"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/55f24359-fa6b-4441-86a1-eb0cbab7594b">
        <rdfs:label>Abnormality of immune system physiology</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010978</ddiem:url>
        <dc:identifier>HP:0010978</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/6198500</dc:provenance>
    <rdfs:comment>anti-TNF-alpha (Adalimumab)+Etanercept</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8e90416f-46e2-418f-9578-7fa212144578">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001954</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <dc:identifier>HP:0001954</dc:identifier>
        <rdfs:label>periodic fever</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d065f858-bc08-400d-8fc8-99e410d203d5"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/260920"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24935455</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f68c2fd3-00be-4071-998f-e62fe783cbf2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/03b69c45-9c30-453b-9e86-01f2e32c11ce"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e5400711-913d-4d3d-9b9a-1597c2298aba"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c44e8dcb-2540-4e25-be1c-6500a3f902d9">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7c3be9ad-f688-4d7d-b2cb-68feb122bede">
        <dc:identifier>HP:0001947</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001947</ddiem:url>
        <rdfs:label>Renal tubular acidosis</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>bicarbonate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27155573</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/227810"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24912437</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18d743df-a56f-4189-a89b-78393fc3b371"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7564233</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/261600">
    <rdfs:comment>Dietary treatment has proved to be very effective in preventing the devastating consequences of PAH deficiency when started early in lifeDrug name: Tetrahydrobiopterin stimulates phenylalanine hydroxylase activity in about 20% of patients, and in those patients serves as a useful adjunct to the phenylalanine-restricted diet because it increases phenylalanine tolerance and allows some dietary freedom.. A striking normalisation (within 8 h) in phenylalanine concentrations after drug administartion indicates BH4 deficiency whereas very little or no reduction in phenylalanine indicates BH4-non-responsive phenylketonuria. https://www.sciencedirect.com/science/article/pii/S0140673610609610?via%3Dihub</rdfs:comment>
    <rdfs:label>PHENYLKETONURIA; PKU</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/261600</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/c5165daa-daba-47af-bf0e-10c09e09feca"/>
    <ddiem:iembaseAccessionNumber>1</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b3ac5274-74da-4beb-bbaa-fe3f26372567">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002354</ddiem:url>
    <dc:identifier>HP:0002354</dc:identifier>
    <rdfs:label>working spatial memory impairment*</rdfs:label>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e1baee43-1eef-4088-8a3b-daa6f40b7a14">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/dad75bfb-c6ab-47bf-91b5-0b165737425f">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/aa85314e-1e1a-430b-8c80-74e8ce674a9c"/>
        <rdfs:label>Isoniazid</rdfs:label>
        <ddiem:url>https://www.drugbank.ca/drugs/DB00951</ddiem:url>
        <dc:identifier>DB00951</dc:identifier>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/67c15365-f415-4fa6-97e7-004e3f682666">
    <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0032367</ddiem:url>
    <dc:identifier>HP:0032367</dc:identifier>
    <rdfs:label>Abnormal circulating GH level</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9754d464-e922-4729-9249-536199793554">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/66bc6d2a-c9f0-4bc2-863a-0ac949b48e56">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8c3afdc3-ad81-451a-a4bf-87664b1d8e01"/>
        <dc:provenance>https://www.clinicaltrials.gov/ct2/show/NCT02697136</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25885911</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25561459</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ac98262e-4437-4bf2-a4b6-8917bae72413"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01218659</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a2e4bb6d-141b-4ee1-9461-89f14c899aea"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/0ad70eb7-90f3-487c-875c-31d2d4a0ae7d"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/study/NCT02795676</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <rdfs:comment>Fabrazyme ( agalsidase beta) + pegunigalsidase alfa ( PRX-102)</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/eac1250d-b60d-4d8d-8932-7eccc9163f52"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/301500"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d4c1065a-6260-43b6-a7e4-0de04757bed7">
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01218659</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25885911</dc:provenance>
        <dc:provenance>https://www.clinicaltrials.gov/ct2/show/NCT02697136</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03018730</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ee75335f-78ac-4c28-ad0e-a3e3b880ce80"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ec486280-2dbf-4257-a84b-ed693d389cef"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/301500"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/eac1250d-b60d-4d8d-8932-7eccc9163f52"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/668bedf3-30f7-477e-bc40-3a31641bb203"/>
        <rdfs:comment>REPLAGAL (Agalsidase Alfa)</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/0ad70eb7-90f3-487c-875c-31d2d4a0ae7d"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Agalsidase beta</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00103</ddiem:url>
    <dc:identifier>DB00103</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6e176d4f-e463-4947-9aaf-1d5dc93ee823">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ce1fbd64-abd9-405f-bc66-157d5619f096">
        <rdfs:label>https:,www.ncbi.nlm.nih.gov,pubmed,19336674</rdfs:label>
        <dc:identifier>HP:0001943</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001943</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <ddiem:failedToContributeToCondition>ins454A</ddiem:failedToContributeToCondition>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602485"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/49bffb10-3f28-4064-aa10-51a9cede4fe8"/>
    <obo:RO_0003304>W99R</obo:RO_0003304>
    <ddiem:failedToContributeToCondition>Y214C</ddiem:failedToContributeToCondition>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d6c1137f-c24a-4d72-9c84-5068df3a1623"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.448</dc:provenance>
    <obo:RO_0003304>G68V</obo:RO_0003304>
    <rdfs:comment>diazoxide</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15133749</dc:provenance>
    <obo:RO_0003304>T65I</obo:RO_0003304>
    <obo:RO_0003304>A456V</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25781533</dc:provenance>
    <obo:RO_0003304>M197I</obo:RO_0003304>
    <obo:RO_0003304>V452L</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15277402</dc:provenance>
    <obo:RO_0003304>S64Y</obo:RO_0003304>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <ddiem:failedToContributeToCondition>GK-Y214C(De novo muttation)</ddiem:failedToContributeToCondition>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0aa47d20-1e2a-4a5d-828e-fb1f24e2cc0c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8410522</dc:provenance>
    <obo:RO_0003304>(Val455Met) at codon 455</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19336674</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/72c9c490-c390-4642-9d74-e5f0e7a6b10b">
    <dc:identifier>HP:0000114</dc:identifier>
    <rdfs:label>Proximal tubular dysfunction</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000114</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/72f1a9bd-da50-4d22-a991-1e11e8d0ec27">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/125ed772-677a-4687-94f5-8bd8ee2542ec">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003528</ddiem:url>
        <rdfs:label>Elevated calcitonin</rdfs:label>
        <dc:identifier>HP:0003528</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00923247</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/160fefc4-87da-4313-b5fc-dff791e401df">
        <rdfs:label>Direct interaction (Mechanistis A)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7d1f6503-a11f-40e2-8ea4-8ea8958d76c1">
        <rdfs:label>phospholylation of RET</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2c5582a2-0f51-43c6-b60f-908f82d35d02">
        <dc:identifier>MP:    ....</dc:identifier>
        <rdfs:comment>Overall survival (OS), was found to be statistically insignificant. Despite being insignificant, patients receiving cabozantinib had a median OS of 26.6 months vs. a median OS of just 21.1 months for placebo patients (HR 0.85; 95% CI 0.64 to1.12; p = 0.24), resulting in an actual difference of 5.5 months. This provides patients treated with cabozantinib a 20.68% longer survival period compared to the placebo group. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214082/</rdfs:comment>
        <rdfs:label>overall survival( premature death)</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/MP_    ....</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00704730</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4af4892e-3fd9-4c0c-a683-847ad90552c5">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/5809aebe-821c-4641-8f79-91da7a0b66c0"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21606412</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5e0d21a5-dc91-49f7-b426-e75ffb361f95">
        <rdfs:label>Short Progression-free survival</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/162300"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00215605</dc:provenance>
    <rdfs:comment>cabozantinib ( XL184)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30297385</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24002501</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/73699859-3509-4842-b724-8294f6dd5e0a">
        <rdfs:comment>The estimated tumor response rate for cabozantinib and placebo is 28% and 0%, respectively, with results varying independently on RET-status, thus making it a promising treatment option. https://www.ncbi.nlm.nih.gov/pubmed/24002501</rdfs:comment>
        <rdfs:label>Low tumor response rate</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f8c725f9-f803-46e7-9140-58db876c8278">
    <dc:identifier>HP:0200125</dc:identifier>
    <rdfs:label>High lactate ,pyruvate ratio(Mitochondrial respiratory chain defects)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0200125</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fff9f841-6bde-466b-aaea-7119127203ff">
    <rdfs:comment>AAV2 /1-mSeAP-propmyoD76A</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/253600">
        <rdfs:label>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1; LGMDR1</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/253600</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/540f7f3f-895b-467b-93a8-6d2ea5f65b9e"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5e28a6f4-9c2e-47ef-80a3-50cd2e098a2b">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Muscle atrophy</rdfs:label>
        <dc:identifier>HP:0003797</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003797</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/56a92bf5-bd1b-431c-9889-d430a49e86ab"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a2e04219-71b0-43ea-9e41-127b863c6cf7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2969634b-0c34-40b4-aa77-9b9ef1abc751"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17330087</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/72a84bdc-ce07-48f9-9978-4932fa283907">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001324</dc:identifier>
        <rdfs:label>abnormal muscle strenght</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001324</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5f69aa89-1587-4d88-8b30-b512cba21fce"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9174ffee-721d-4ea4-8cea-7cbfddaaacdc">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25511120</dc:provenance>
    <rdfs:comment>Hydroxicobalamin</rdfs:comment>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f702757c-cf23-41a8-8952-0679eead0bec"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277400"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17431913</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/283a1fc2-141b-4e51-82b6-07c026f84d23">
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012120</ddiem:url>
        <rdfs:label>Methylmalonic aciduria</rdfs:label>
        <dc:identifier>HP:0012120</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/6749192</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9868d293-57df-4ec9-93f9-07a15d98bf6f">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002196</ddiem:url>
        <dc:identifier>HP:0002196</dc:identifier>
        <rdfs:label>Myelopathy</rdfs:label>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7357085</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/34101d64-08c5-415b-b02e-399803061228"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/156d5716-722b-4063-aec0-ff8902c365ff">
        <rdfs:label>Elevated blood homocystine</rdfs:label>
        <dc:identifier>HP:0002160</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002160</ddiem:url>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/34fe216e-6e58-432a-808c-c2e1b33903ea"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f83d5c37-d04a-4b57-bc63-ff547aba4853"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ee0e16f1-7930-4c93-b3a9-2332e28a8eb0">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/258870">
        <rdfs:label>GYRATE ATROPHY OF CHOROID AND RETINA; GACR</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/258870</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/02487219-50fb-430a-abfa-a1ec02536b06"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/562</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>562</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5efc9422-826f-4b38-b75a-43a5cb42f7e1">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/cb47d691-3314-4043-bdf4-9ea68788a24b"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/609c80d7-2c9c-429f-be22-6a56c2810e55">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/36ccadaf-1a5e-4dcf-967e-825fcd418fbd"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/34a17c4a-bbe7-4f32-bbd2-42728a8ed49e">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011505</ddiem:url>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <dc:identifier>HP:0011505</dc:identifier>
        <rdfs:label>cystoid macular edema</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29654911</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28388263</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/158ec28e-dc95-40ee-9491-55a7d00a1323"/>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01328587</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17921858</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28708224</dc:provenance>
    <rdfs:comment>topical NSAIDs +systemic CAI</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/86c51a33-3ee0-427a-a227-bf65b3f0f64c">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c49ccb15-b578-43fb-b99d-8a8e1feead42">
        <rdfs:label>Torcetrapib</rdfs:label>
        <ddiem:url>https://www.drugbank.ca/drugs/DB06281</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/814b1e28-30b3-406f-a110-b733463cc37d"/>
        <dc:identifier>DB06281</dc:identifier>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/60eb4008-cfaf-4437-a86b-1d5c83e64118"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/de6a6845-3f24-4f5c-825b-6ab98954d993">
    <dc:identifier>DB00213</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e3bcd0dd-371b-4875-8823-21e76355dc8b">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01524757</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28624580</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9ad3fddf-71d5-484b-9a95-bf2d719fe69d"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1756082d-433f-40cb-9195-5635ade8890c"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/235200"/>
        <rdfs:comment>Pantoprazole</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Pantoprazole</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00213</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1f377c5b-1e52-492b-a2c5-a9e9f5c4f0ac">
    <dc:identifier>HP:0003648</dc:identifier>
    <rdfs:label>high lactic acid level</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003648</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1e327fe9-d2bb-4abe-9aa5-4070e20df1ac">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b6b1b260-a41d-411d-a6bd-f2e8a75a6b75"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8225213</dc:provenance>
    <rdfs:comment>Chenodeoxycholic acid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18570303</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2170dc7c-c3d5-495d-972e-7abd19374be5">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002630</ddiem:url>
        <rdfs:label>Abnormal liver function</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0002630*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19087156</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8844a1d1-6c27-4bdd-896a-ede775073ff5">
        <rdfs:label>abnormal liver function</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002910</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002910</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d4168336-c772-4e77-ab06-2a76bb700a68">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002240</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002240</dc:identifier>
        <rdfs:label>hepatomegaly</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503963</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/235555"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20619503</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8c6d4986-4e49-497a-ba43-3178c58ec295"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28697823</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e944fa7e-d96b-4362-b221-88dfc375d0df">
    <rdfs:label>abnormal porphyrin accumulation in urine</rdfs:label>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010473</ddiem:url>
    <dc:identifier>HP:0010473</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/53829b7a-4de5-4ff5-b599-d7898c11990e">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/10723a88-0c59-4307-826b-1af819162243">
        <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ac06a685-6de0-4b4d-a07c-5ea08f25b673"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c986b6b3-2af2-4272-91b0-e45978033c3e"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261640"/>
        <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16601879</dc:provenance>
        <rdfs:comment>Oxitriptan</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d8f04159-dbee-4d11-935d-45b79278f4e5"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25304915</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Oxitriptan</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7b0102a4-d87a-4034-88f3-b151ead2befc">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/084e6735-84a1-4b6c-bd74-a34da3c06513"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25304915</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ac06a685-6de0-4b4d-a07c-5ea08f25b673"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c986b6b3-2af2-4272-91b0-e45978033c3e"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/aa194167-715a-44e0-8d35-53ebed9bf312"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178724</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4187796c-f13f-4b3d-bd5d-553140f3476f"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16601879</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/251f7b8d-3481-4cc0-85f3-dd229e50814b"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261640"/>
        <rdfs:comment>BH4+L-Dopa+5HTP</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/600f9630-83b1-4a24-a752-2ec66a36aa83"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f3653224-2445-4568-9104-b270b4e798d8"/>
        <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c0156041-29bd-4a95-b5bc-7b16c02780a5"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f81387c6-9510-4547-847d-752c89866546"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e8d4b7a5-defd-4b32-b4e5-9e9a3f630d16"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d2b23f09-5cf9-4b3e-9839-40ffcb18bf8f"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/342143b3-0fd3-45bf-9c3b-38c3c0db9372"/>
        <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c1d28c82-72dd-45f2-917f-1eea9583452f"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB02959</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/533e5be7-dc98-4136-aa9f-8abbf52b8490">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/128230"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ea476127-db1d-4659-b2c3-3f1acb2c9750"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16361586</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e6a37d8b-9da8-4b53-adbc-376a4c0c5ede"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ac06a685-6de0-4b4d-a07c-5ea08f25b673"/>
        <rdfs:comment>5‐hydroxytryptophan</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11346370</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB02959</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2619994f-072f-4e09-80a8-0de0f6dba4e7"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/56784e39-7342-4230-b680-31ff278f9701">
    <rdfs:label>Partial correction of neutrophil dysfunction</rdfs:label>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <dc:identifier>HP:0011990</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011990</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fef3cab2-d697-4892-9a75-0375d901fffa">
    <rdfs:label>Disaess progression(Progressive)*</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003676</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003676</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2da21aad-62dd-4d2c-955e-a726b92a65ac">
    <dc:identifier>HP:0008344</dc:identifier>
    <rdfs:comment>Study ws done in pups: Administering norleucine to heterozygous mothers of classic maple syrup urine disease pups reduced branched-chain amino acid accumulation in milk as well as blood and brain of these pups to enhance survival.</rdfs:comment>
    <rdfs:label>Branched-chain amino acid accumulation</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0008344</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b0ea1251-bb53-4727-a5fd-64bdac27f633">
    <ddiem:url>https://www.drugbank.ca/drugs/DB11981</ddiem:url>
    <rdfs:label>Elamipretide</rdfs:label>
    <dc:identifier>DB11981</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5ac9085a-b4de-4cc5-8834-e4492c8d25af">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104515</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02805790</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6d718d78-3f80-4ee2-9cea-edff9addf399"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/545b5ad7-e3c9-49a3-a611-fefc6e49192d"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/535000"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d045cd97-8d78-4052-8809-46854d184580"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02693119</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21788663</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
        <rdfs:comment>elamipretide (MTP-131)</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7e982e3e-4812-4d12-af24-76ba0b47297e">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cefa5609-067b-4fb0-81a7-5a24ff1f5c38"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03098797</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e74c0831-b9ed-4203-83e2-f4793905a130"/>
        <rdfs:comment>Elamipretide</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
        <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6d718d78-3f80-4ee2-9cea-edff9addf399"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fd942d1b-c0ea-4247-8840-1d544659dc4c"/>
        <dc:provenance>https://mitochondrialdiseasenews.com/2018/03/09/stealth-biotherapeutics-completes-enrollment-elamipretide-trial-barth-syndrome</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/302060"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/60a44075-77cf-4d55-9972-e2d3542e6603">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/22186859-4065-462a-ba51-b3b3c7a0efb8"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/79f38dc3-9925-4c1e-b0dc-e44ab9e18c80">
        <rdfs:label>recurrent vomiting</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002572</ddiem:url>
        <dc:identifier>HP:0002572</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK220444</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246900"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1567724914001299</dc:provenance>
    <rdfs:comment>Thiamine</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a185ab55-aae6-48c7-961a-53c5ca05d2ac">
    <dc:identifier>HP:0100660</dc:identifier>
    <rdfs:label>Dyskinesia</rdfs:label>
    <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100660</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/95857702-adb6-404e-ba87-02d3e4618260">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/aa9df42c-d603-4fa7-8027-00bf3da99b2b">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Abnormal Golgi located fucosylation</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a346171e-fa80-434f-96f4-9de43b180c55">
        <rdfs:label>recurrent infection</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002719</ddiem:url>
        <dc:identifier>HP:0002719</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7caaf8f0-18ea-47bd-a455-2a6fd6f0690d">
        <rdfs:label>Neutropenia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001875</ddiem:url>
        <dc:identifier>HP:0001875</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c6fdcfc9-7dfa-4434-8837-3d706faf0cd0">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6052b753-9030-49b8-9679-8fbc7b114725"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://pdfs.semanticscholar.org/7753/abad26acee41547592d5a3a65b0483eff767.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29702557</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/14e93871-7c9b-4cf9-8e74-deff63d3126f">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010977</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>defected phagocytic function</rdfs:label>
        <dc:identifier>HP:0010977</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>fucose therapy</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9732974</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d7aac689-c4f6-49a1-929e-d1d808ca0dfe">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001875</ddiem:url>
        <rdfs:label>low neutrophil count</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001875</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c1b7aff9-9af1-4503-9ddb-5b2c4abcea5b">
        <rdfs:label>Abnormal selectin ligand function</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/94/12/3976.abstract</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/266265">
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a959edda-95ac-41f4-8375-8a385a286e3d"/>
        <dc:identifier>https://www.omim.org/entry/266265</dc:identifier>
        <rdfs:label>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C</rdfs:label>
        <ddiem:iembaseAccessionNumber>341</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/341</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>the patient showed significant psychomotor improvement while on fucose therapy."</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6cd631fc-ab4a-45ec-81e6-6aad81f9b337">
        <rdfs:label>Abnormal fucosylation state of glycoconjugates.</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12756558</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17276979</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ed32d7a4-95d4-413c-883e-c47ee9c9a334">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001263*</dc:identifier>
        <rdfs:label>atypical psychomotor development</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001263</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <dc:provenance>"espite the successful correction of immunodeficiency-related defects in CDG IIc (LAD II)</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10590041</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ae9203da-8163-4456-9260-c7bae78a0736">
        <rdfs:label>abnormal expression of E- and P-selectin ligands</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>correction of the delayed psychomotor development was expected to be more difficult to achieve. However</dc:provenance>
    <dc:provenance>http://www.jbc.org/content/282/14/10762.long#ref-14</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c5c6a5da-44e9-41c1-bcb2-cb749521569a">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2c0aeb02-7b5d-4809-90f3-38f379107c32">
        <rdfs:label>high serum ionized calcium concentrations</rdfs:label>
        <dc:identifier>HP:0003072*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003072</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367245</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27050234</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25993639</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f38083ce-b15e-47fa-8350-5893809680a9">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/deec2e37-1619-457b-aa71-69041b762c15"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/26b3b73d-5588-43b3-b0be-cd193240c370">
        <rdfs:label>low calcium urine excretion</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003127</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003127</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22142470</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/600740">
        <dc:identifier>https://www.omim.org/entry/600740</dc:identifier>
        <rdfs:label>HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b20ead8f-1954-46bb-9e9a-df4167d0c00a"/>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/38568331-74c5-48f6-beba-0316122e888d">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003165</ddiem:url>
        <dc:identifier>HP:0003165</dc:identifier>
        <rdfs:label>abnormal parathyroid hormone level</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Cinacalcet</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/09c23282-33fb-4d16-93cc-ae451c49916a">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29203193</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27491218</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/229700">
        <dc:identifier>https://www.omim.org/entry/229700</dc:identifier>
        <rdfs:label>FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY; FBP1D</rdfs:label>
        <ddiem:iembaseAccessionNumber>483</ddiem:iembaseAccessionNumber>
        <rdfs:comment>The therapy is based on avoiding prolonged fasts, glucose infusion, and a specific diet, rich in glucose without fructose intake. https://www.ncbi.nlm.nih.gov/pubmed?Db=pubmed&amp;Cmd=Retrieve&amp;list_uids=29390242&amp;dopt=abstractplus
Fructose, glycerol and oral medicines that may contain sucrose and sorbitol should not be given during acute illness. https://link.springer.com/chapter/10.1007/978-3-642-15720-2_9</rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/1d6a8f53-3d17-4b7d-89ff-3ae0077fd9ec"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/483</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/143052ab-60ff-415d-b706-9dc598cf9c69"/>
    <rdfs:comment>Glucose</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d6c1137f-c24a-4d72-9c84-5068df3a1623"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29390242</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1240dbad-78b1-4d74-b6a7-17b0cdff40ec">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26922636</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d9d9bc51-c1ab-4328-b635-d782500b0df8">
        <dc:identifier>HP:0100716</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100716</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Self-injurious Behavior</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/85371d8c-1fd3-422c-90cf-050107faf68a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/bcb8f70a-5840-4bad-8d21-35cfd2deb1a2"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300322"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27179999</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT01065558</dc:provenance>
    <rdfs:comment>Ecopipam ((PSYRX 101)</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT01751802</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/84d17594-adb3-4c03-8b33-d585be516b16">
    <rdfs:label>Restricted diffusion in the corpus callosum in MRI(Abnormality of the nervous system)*</rdfs:label>
    <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
    <dc:identifier>HP:0000707</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/42b59791-5555-4fbe-8987-88306acfd83d">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24055166</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e79998b0-0b2f-49dd-ab1c-bf03a9826c46">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000718</ddiem:url>
        <dc:identifier>HP:0000718</dc:identifier>
        <rdfs:label>Aggressive behavior</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/aba4b48c-2594-4eef-be42-c70d3675ac9a">
        <dc:identifier>HP:0100716</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100716</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Self-injurious behaviour</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>SAM</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24001191</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6bcff7f7-430a-4692-ac54-05fc63b0813b">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d41236c5-7ea4-462f-bfdc-16cf265bafde"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16906475</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27179999</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300322"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/706ee753-5ffe-484a-9972-8fd51b0e56a5">
    <rdfs:comment>Velaglucerase alfa</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28381550</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e9880d1f-dfa8-468f-878c-59e876c1c19c">
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001873</ddiem:url>
        <dc:identifier>HP:0001873</dc:identifier>
        <rdfs:label>thrombocytopenia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8f9f221d-5857-4378-bd7f-a3f4283fd461">
        <dc:identifier>HP:0100712</dc:identifier>
        <rdfs:label>changes in lumbar spine (LS)</rdfs:label>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100712</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/230800">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/288</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/230800</dc:identifier>
        <ddiem:iembaseAccessionNumber>288</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b4c7f310-1e02-4bfd-8cbc-931b7c324369"/>
        <rdfs:label>GAUCHER DISEASE, TYPE I</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21503667</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/941aeec2-7aff-411b-a413-30c86839ccfa">
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004348</ddiem:url>
        <dc:identifier>HP:0004348</dc:identifier>
        <rdfs:label>abnormality in bone mineral density</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3bd87000-77a4-45a2-add8-083df8ed70d7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/986cb047-1b68-4c82-956f-b65c81449470"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b14c9f20-eb03-450f-9122-5767b82fa4ba">
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <dc:identifier>HP:0010885</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010885</ddiem:url>
        <rdfs:label>avascular osteonecrosis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/19c62efa-d75a-4e48-aff0-f5316fda0bb0">
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <rdfs:label>Bone pain</rdfs:label>
        <dc:identifier>HP:0002653</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002653</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00391625</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29503270</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fa3373c4-0fb0-4d9e-a1db-570404c20fb1">
        <rdfs:label>growth faliure</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001510</ddiem:url>
        <dc:identifier>HP:0001510</dc:identifier>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02574286</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25801797</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29471850</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/81e1419e-62bf-436a-bd47-1390125ea3c2">
        <rdfs:label>anaemia</rdfs:label>
        <dc:identifier>HP:0001903</dc:identifier>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001903</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1ac79ba2-c46f-4df4-9c6b-1eefadf4e40d">
        <dc:identifier>HP:0001433</dc:identifier>
        <rdfs:label>hepatosplenomegaly</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001433</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0a597cee-225a-435b-bda4-118451baaaf0">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4c9f5f4d-c243-46f7-a861-fc3157b80435"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f608827a-53bc-4e36-9fbe-bb21382cf5d8">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001263</ddiem:url>
        <dc:identifier>HP:0001263</dc:identifier>
        <rdfs:label>Delayed mental development</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/664a6be2-927f-4cc3-9863-9219dacbebd9"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/605407">
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/2722719d-176e-4e5f-919c-d96ca1a9a031"/>
        <dc:identifier>https://www.omim.org/entry/605407</dc:identifier>
        <rdfs:label>SEGAWA SYNDROME, AUTOSOMAL RECESSIVE</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/52e84f02-2a1b-449e-a38b-0598705232d1"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10753262</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/eb2ab32b-f72c-4c72-9a61-4aad73cdb98d">
        <dc:identifier>HP:0002421</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002421</ddiem:url>
        <rdfs:label>Poor head control</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/020651a6-ad82-46c2-aae7-92b25d6cfb40"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8b7a927c-5606-4d5f-8190-a97c9edfac32"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/524a8d45-8ebb-4aa0-9850-fe5448a2540b">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003785</dc:identifier>
        <rdfs:label>Decreased CSF homovanillic acid</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003785</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7d17c812-ed71-4e23-89ab-e1482a327160">
        <dc:identifier>HP:0000817</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000817</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>lack of eye contact</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8817341</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/81487904-0685-46fa-9fb8-26ab13318e98"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10585338</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11241071</dc:provenance>
    <ddiem:failedToContributeToCondition>(926T&gt;C</ddiem:failedToContributeToCondition>
    <rdfs:comment>selegiline+L-dopa</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20399390</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10407773</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/81460a55-9a71-4f69-8e0f-631be947fa33"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d5c1bfc8-742e-4846-9c3a-fd642bd3ef2f"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/44cb7c0d-273e-4153-9cce-daf3273901b8">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002194</ddiem:url>
        <dc:identifier>HP:0002194</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>lack of gross motor function</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4e78b318-85ab-4f3d-9986-f51080d979c6"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/79703b69-2540-4566-adaf-dd2ae7b18695">
        <rdfs:label>Abnormal epinephrine,norepinephrin ratio</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/39b2225a-31f9-4582-b167-bce4433808e8">
        <dc:identifier>HP:0002375</dc:identifier>
        <rdfs:label>Hypokinesia</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002375</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9732974</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5843539d-75a9-490f-aae2-391e3fae9904"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/64c086ad-eb5c-4b64-82fd-87bb5fee94c9"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9ec91f3c-190c-4f9f-8abf-4a6732508c8e"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/30c024ae-1f87-415e-999f-240999482024"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9cc7748c-12c4-4622-9973-330691354eed">
        <dc:identifier>HP:0002194</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002194</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Delayed motor skills</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/900e95b3-f90c-4d39-bf9c-8d7585f75984"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fd8cf6e3-3371-48f8-aa90-cbf69bfcf2fe"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22815559</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/744e09a0-d46d-4ee4-992a-2d951947c857">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/632345ee-45e5-4c9f-9b36-e9241dec679f">
        <rdfs:label>Oprozomib</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/38a30cce-9f1a-4033-8fdb-336514ca6ac3"/>
        <dc:identifier>DB11991</dc:identifier>
        <ddiem:url>https://www.drugbank.ca/drugs/DB11991</ddiem:url>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e9f9ff5d-b0d6-4f07-877e-3c9c319f8186">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/448ec094-bf28-47cc-a0cd-2be641fd8bc9">
        <dc:identifier>HP:0040189</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040189</ddiem:url>
        <rdfs:label>scaling</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28636073</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5b3e197b-79bb-4c14-bee9-e8174c667f70">
        <rdfs:label>erythema</rdfs:label>
        <dc:identifier>HP:0010783</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010783</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Emollients</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c8b7817c-8cee-4999-aaea-6e7cc8654d6e">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/215b9cea-f4d2-4ccd-bbcf-e61fd97e041d"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>"ENB-0040</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d20d0a12-8d0a-4c8f-a842-6afe8e7cb1b1">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000989</ddiem:url>
        <rdfs:label>Pruritis</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000989</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>an enzyme-replacement therapy</dc:provenance>
    <dc:provenance>NCT00744042.)."</dc:provenance>
    <dc:provenance>was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/275630">
        <ddiem:iembaseAccessionNumber>753</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/275630</dc:identifier>
        <rdfs:label>CHANARIN-DORFMAN SYNDROME; CDS</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/c87624d8-4f59-4997-886a-5aefc90efa54"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/753</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9d022f05-7cd1-413d-bb20-7bdbcce56b0a">
        <rdfs:label>Ichthyosis</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0008064</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008064</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.researchgate.net/publication/8668575_A_successful_treatment_with_pyridoxal_phosphate_for_West_syndrome_in_hypophosphatasia</dc:provenance>
    <dc:provenance>https://onlinelibrary.wiley.com/doi/abs/10.1111/pde.12170</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c5b4238f-3887-4ddd-8806-b17b19d3e43e">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/71a2c47f-d86e-408e-b0f8-93d47fac4df2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1734c3a3-21f9-4829-9293-eb4f435c0ffe"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <ddiem:failedToContributeToCondition>A209D-alpha</ddiem:failedToContributeToCondition>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11507102</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/248600">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1252</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/248600</dc:identifier>
        <ddiem:iembaseAccessionNumber>1252</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/adef4dd0-9d16-4db4-a606-ee9a73abe698"/>
        <rdfs:comment>In vitro study in which a discussion about activation of MSUD E1 mutants by TMAO treatment was studied further by titrating the osmolyte concentration. The activation of E1 activity for the three type IA MSUD mutants Y368C- , F364C- , and Y393N- is insignificant below 0.4 M TMAO. Rapid rises in residual E1 activity were obtained at 0.5 M or higher TMAO concentrations. The highest degree of activation occurs at 1 M TMAO concentration for all three MSUD mutants, with Y368C- at 50%, F364C- at 39%, and Y393N- at 17% of the wild type specific activity. At higher than 1 M TMAO concentrations, elevated residual E1 activities decline precipitously.</rdfs:comment>
        <rdfs:label>MAPLE SYRUP URINE DISEASE; MSUD</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>Natural osmolyte trimethylamine N-oxide (TMAO)</rdfs:comment>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/128fb3bb-d53f-4dc8-a57b-cd5b31ac2cd4">
        <rdfs:label>Direct interaction( Mechanistic A)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f83f4dfa-7698-4875-83e6-d4c7a035df90">
        <rdfs:label>No phenotypes were mentioned in the study. In vitro Study.</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0003304>Y368C- alpha</obo:RO_0003304>
    <obo:RO_0003304>F364C- alpha</obo:RO_0003304>
    <obo:RO_0003304>Y393N- alpha</obo:RO_0003304>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3756d2f0-45a0-41dd-9c3c-b3f47932590b"/>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/cb81c0bd-645d-42d7-b1ba-74928b2390d7">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b62b964e-1db8-4b96-836c-c17c91f28bc9">
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004322</ddiem:url>
        <dc:identifier>HP:0004322</dc:identifier>
        <rdfs:label>short stature</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Beneprotein</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25266922</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/edea7536-cbeb-493e-809a-5854314cd883"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232700"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ff356404-f9eb-4411-9c94-91bb8522a3ee">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/01b774ba-14cf-4a13-9164-c51d5260f5a9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/affbe6f4-51c1-40da-8ebe-071894857659">
    <rdfs:comment>Magnesium</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21503667</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28381550</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3137dac7-e95a-4db2-8f2c-c90720d66eb0">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/186e10cb-f0d7-4a78-a831-4770f3cc3f1c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4abf0f12-373c-48e3-95fb-7cb92f7e3229">
        <dc:identifier>HP:0002917</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002917</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>hypomagnesemia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507263</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23196212</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/263800">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b7916840-c874-4acf-a053-39a0b3c82a6a"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/49c2578e-e493-4316-95e7-d4d5244bc56c"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/889</ddiem:iembaseUrl>
        <rdfs:label>GITELMAN SYNDROME; GTLMNS</rdfs:label>
        <ddiem:iembaseAccessionNumber>889</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/263800</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/670acb99-6e38-4255-9348-8231c93932f4">
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <rdfs:label>chondrocalcinosis</rdfs:label>
        <dc:identifier>HP:0000934</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000934</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518128</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25012174</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9348ec55-4e7d-444c-b7a1-dbb12f974e03">
    <dc:identifier>HP:0002529</dc:identifier>
    <rdfs:label>Neuronal death</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002529</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/61cedf62-c21f-442f-8c5d-e6a27b7c5fb7">
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/86ee66fb-4ed6-4a3f-be48-7938f9c9eb6b">
        <dc:identifier>HP:0003546</dc:identifier>
        <rdfs:label>Exercise intolerance</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003546</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/143052ab-60ff-415d-b706-9dc598cf9c69"/>
    <rdfs:comment>Glucose</rdfs:comment>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/300559">
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4d0195ef-3e26-44b4-a974-4e0d239206b6"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/563</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/300559</dc:identifier>
        <rdfs:label>GLYCOGEN STORAGE DISEASE, TYPE IXd; GSD9D</rdfs:label>
        <ddiem:iembaseAccessionNumber>563</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18401027</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bd7cf5ce-2d27-4cf5-96dd-9d0d36780e60">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Alopecia</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001596</ddiem:url>
    <dc:identifier>HP:0001596</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/56b49892-bb44-4dae-a23d-26c4421aab78">
    <rdfs:label>Vitamin D</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/51b095de-80d4-4cbd-8c79-3831ae856bee">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/200100"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25488886</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26086616</dc:provenance>
        <dc:provenance>https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-3-20</dc:provenance>
        <rdfs:comment>Vitamin D</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/58235d61-91ab-490f-a381-601fc05496ad"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26396722</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e0bc1445-06c8-4b36-98f8-93b182eb1049"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/cbfbe2da-4111-49b5-b00d-6c407e65fa6a">
        <rdfs:comment>Vitamin D</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/241500"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30811537</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1ac7c98e-baee-424d-b447-079dea5d443a"/>
        <dc:provenance>https://cdn.intechopen.com/pdfs/56869.pdf</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/58235d61-91ab-490f-a381-601fc05496ad"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0929693X18300174</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB11094</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7db4681a-9fe2-45b7-b465-303f0cc060d7">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956717</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/579f1212-5009-4cb7-abbd-746865777d10"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246700"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8215eb86-27b6-40f1-9700-5714f8d73da0"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23329770</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
        <dc:provenance>https://www.nature.com/articles/nrrheum.2010.182</dc:provenance>
        <rdfs:comment>vitamin D</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/58235d61-91ab-490f-a381-601fc05496ad"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4c12c33e-9a81-42cb-b0d3-1ace12484e68">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/177000"/>
        <rdfs:comment>vitamin D</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/58235d61-91ab-490f-a381-601fc05496ad"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c5a300ae-51ad-440d-8ff6-5169675a906b"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB11094</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c14c099c-4082-4b2b-a2c9-e1811a9db48c">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/239500"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/58235d61-91ab-490f-a381-601fc05496ad"/>
        <rdfs:comment>Vitamin D</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f2ad6f99-cb55-499c-8457-46de51986dcb"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24980685</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044915</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/136e9c3b-bf62-4ea4-bc0e-3d2c956437ee">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27155573</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8a509ece-86c5-46a4-8cd0-e8dd64315108"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/58235d61-91ab-490f-a381-601fc05496ad"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7564233</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24912437</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/227810"/>
        <rdfs:comment>Vitamin D</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a7ca6dd8-d0f1-498c-a3af-b2013ffb3554">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0025201</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0025201*</dc:identifier>
    <rdfs:label>low APO A level</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/530000">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b2303e49-9319-4ef2-9626-7733e6fe586e"/>
    <rdfs:label>KEARNS-SAYRE SYNDROME; KSS</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/398</ddiem:iembaseUrl>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/530000</dc:identifier>
    <ddiem:iembaseAccessionNumber>398</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/44a34bc9-b702-435e-a4f7-dfbe3ba3bc80">
    <dc:identifier>DB09046</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ccceb4ff-3cce-474f-a560-8b8c2a53c8a6">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/daf4be0e-450d-430e-81ec-9711deaf315d"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29044799</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/77e98115-9019-4bb2-9658-219fdb3b18cf"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/706bbca3-88ac-4f77-8ab6-158528151409"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/151660"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25734254</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27155573</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/aedf5679-926d-4abc-84a4-2e83fe1b2a6f"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00025883</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26584826</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/7199c277-e274-40f1-b74e-be9b419517f4"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28993984</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f93413e2-9289-49e2-a616-6512ab9a02b7"/>
        <rdfs:comment>Metreleptin(A-100)</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09046</ddiem:url>
    <rdfs:label>Metreleptin</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9c8d6591-d793-4e7c-aef4-22d1ec756755">
    <dc:identifier>HP:0011804</dc:identifier>
    <rdfs:label>Abnormality of muscle physiology</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011804</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c27ae143-ad60-4cb9-9565-a8f4a21a55a3">
    <rdfs:comment>mannose supply</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a9b87e56-9d5b-4f5b-bf77-2a859a230035">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002243</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>protein-losing enteropathy</rdfs:label>
        <dc:identifier>HP:0002243</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12756558</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0ab01a55-299f-41c4-8a7c-ace7ed53d9d9">
        <ddiem:url>http://purl.obolibrary.org/obo/MP_0005567</ddiem:url>
        <rdfs:label>hypoproteinemia</rdfs:label>
        <dc:identifier>MP:0005567</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://pdfs.semanticscholar.org/7753/abad26acee41547592d5a3a65b0483eff767.pdf</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/602579">
        <dc:identifier>https://www.omim.org/entry/602579</dc:identifier>
        <ddiem:iembaseAccessionNumber>322</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/322</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/cf4b76c1-bf0a-486c-9f0b-864c953d99ee"/>
        <rdfs:label>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ff79ec60-4214-45fc-9dc2-74382aa39a95">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Metabolism abnormality</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <dc:identifier>HP:0001939</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263309</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8117d019-00e1-4ccc-b7c2-0d64d5ae39d8">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001943</ddiem:url>
        <rdfs:label>hypoglycaemia</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001943</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427298</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0b6ae4cc-eae5-4832-8600-d13a2dd3d8e2">
        <dc:identifier>HP:0001928</dc:identifier>
        <rdfs:label>blood coagulation</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001928</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/54884e8b-7fd4-4d59-917e-32f1afa8dd83">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000010</dc:identifier>
        <rdfs:label>urinary tract infection</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000010</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fbea0144-eb54-4e28-8c7e-2e599cd545a0">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/63e15758-86a6-47b7-b5da-ca1f80c25e7a"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9525984</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10484808</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/416046af-43a0-4b7e-9134-b77017becb96">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Hypoglycosylation of serum glycoproteins</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/34198391-b22c-48de-b665-f0db8c0f2cb3">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28318733</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/341cb69d-951b-4061-9460-1b8ed6c1ceb7"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5ad24800-b38c-4e1a-8855-ff6c0ef907d4">
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <rdfs:label>Short Stature</rdfs:label>
        <dc:identifier>HP:0004322</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004322</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27718492</dc:provenance>
    <rdfs:comment>Growth Hormone</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/530000"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b8748fa1-9141-4a7e-af91-aa67d21aa0fa">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>spastic bladder</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0005340</ddiem:url>
    <dc:identifier>HP:0005340</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/94977730-3d28-46ac-aa87-b75c2701f3b5">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9926c265-d084-4b8d-a0c8-cf1c566cbab6"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/49bffb10-3f28-4064-aa10-51a9cede4fe8"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3e0f89f8-fea7-468e-8110-d340b69e4149"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f91c8f7c-45bf-4102-911e-7a31f08848ed"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/17e99bcb-3af9-410b-bfdc-f2b92c85b8f1">
        <rdfs:label>lactic acidemia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003128</ddiem:url>
        <dc:identifier>HP:0003128</dc:identifier>
        <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/47f28651-4914-44ec-912d-8b912db8fdaa"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232220"/>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/28973635</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/21a200aa-148b-4bf9-9e6c-5845b254db41">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001513</ddiem:url>
        <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
        <dc:identifier>HP:0001513</dc:identifier>
        <rdfs:label>obesity</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fed7592e-e6b3-45bf-b3cc-f318bd214b76">
        <dc:identifier>HP:0003077</dc:identifier>
        <rdfs:label>hyperlipidemia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003077</ddiem:url>
        <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8f5c6ff7-0b96-4a7a-9201-6a82628aff5f">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002149</ddiem:url>
        <rdfs:label>hyperuricemia</rdfs:label>
        <dc:identifier>HP:0002149</dc:identifier>
        <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4276d8b6-6d10-4c20-8118-c6780f0c1c50">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7e0bd5ec-07c1-44d8-b75a-34961a271a09"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0e03f29b-9398-438e-9fb5-fed65a95091b"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/53f8d4d6-fcf9-4884-a79e-a044cbb2f8ac">
        <rdfs:label>age-related insulin resistance(Insulin resistance)*</rdfs:label>
        <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
        <dc:identifier>HP:0000855*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000855</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18996862</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/25fe3dfb-9b32-44a8-ba28-70eeef9029bb"/>
    </obo:RO_0000057>
    <rdfs:comment>rAAV-GPE-G6PT</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d0b9db3a-13da-49f2-ae86-0ecc117c42a9">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12593632</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27179999</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300322"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2455472</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <rdfs:comment>Tetrabenazin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f9c78bd3-095b-4d99-9fc6-652b37a5e406">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/05e498fe-0722-40b8-9a8f-308fc21d9310"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5303126a-693e-49be-8b09-49e969acf57b"/>
    <dc:provenance>https://rarediseases.org/rare-diseases/lesch-nyhan-syndrome</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fd8cf6e3-3371-48f8-aa90-cbf69bfcf2fe"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c48a6d60-579c-4eaa-9c36-422d6e7d41bb">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d20d0a12-8d0a-4c8f-a842-6afe8e7cb1b1"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7758200</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/79732879-d850-4260-ad89-9fd2868e959a">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000989</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000989</dc:identifier>
        <rdfs:label>Hepatotoxicity</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6f04075c-c0ed-42c6-8978-748b81d72861">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000992</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Photosenstivity</rdfs:label>
        <dc:identifier>HP:0000992</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3d0fd185-86b5-4ba1-8813-409dee0c3168">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f3e5a8bc-4a27-4d4c-978c-3a3600d0040d"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10189233</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20375647</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/613178be-26a8-4db6-a8e2-41ea57ac51b9">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002027</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002027</dc:identifier>
        <rdfs:label>Abdominal pain</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4a001667-c84d-4d67-8420-27bb3034d866">
        <dc:identifier>HP:0000969</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000969</ddiem:url>
        <rdfs:label>Fluid retention</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22092997</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19656325</dc:provenance>
    <rdfs:comment>activated charcoal</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26979527</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23884489</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3335288</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e14a6778-2f10-4a80-9709-56186deaa701">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002910</ddiem:url>
        <rdfs:label>Abnormal liver function test</rdfs:label>
        <dc:identifier>HP:0002910</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/177000"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/5cda6137-94c1-4c3d-97e9-e4456eaad7e3">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ecb839f7-ec0d-477d-a6a7-9ff7bbeb42eb">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6cee1c0b-ed78-4c4d-85af-805157e65ed2"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602473"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27830356</dc:provenance>
        <rdfs:comment>Acetylcysteine</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0022202X15352507</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16376514</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1d9593bb-94eb-4172-af06-eaf00771c785"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29526615</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/15619540-9855-4efd-b9d5-5b5098a3886a">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/203500"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508465</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1d9593bb-94eb-4172-af06-eaf00771c785"/>
        <rdfs:comment>N-ACETYL-CYSTEINE</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30049652</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01828463</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28813744</dc:provenance>
        <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30477028</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/bc459685-6919-4160-b6f4-32077d2a883f"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB06151</dc:identifier>
    <rdfs:label>Acetylcysteine</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0147a167-67ac-4dfd-84ea-afa463004992">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11089562</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5009fba6-bef1-4ce8-ab06-6035325ac1c4"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20868666</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1d9593bb-94eb-4172-af06-eaf00771c785"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231950"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC38850</dc:provenance>
        <rdfs:comment>N-acetylcysteine</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7f0cb351-9f34-4b83-9d5d-0c618f85ca88"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2931ebdf-9ae3-4cce-9411-610530b5a399"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27207470</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11095909</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB06151</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7d0f1b42-d46c-4c9c-9083-a64f7146fda3">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8fd77c87-3f64-49de-b84f-4eba755ede4a"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02583672</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28381550</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/230800"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/bbdcfba7-ca49-4954-946b-c0f15dd18899"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/04630f70-0cb2-478d-af84-9b53fc99627e"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00962260</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1d9593bb-94eb-4172-af06-eaf00771c785"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <rdfs:comment>N-acetylcysteine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21503667</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27499018</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01427517</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23860343</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3d8d66a5-d786-424f-8357-a2ac94fe4990"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/092aaa37-adf7-4943-a804-255f87ecb9c6">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/140350"/>
        <dc:provenance>https://link.springer.com/article/10.1007%2Fs10545-016-9963-8</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9e6f5158-bc7c-4d2b-bfad-611d35fff08f"/>
        <dc:provenance>http://www.scielo.br/pdf/jiems/v5/2326-4594-jiems-5-e170016.pdf</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/666346c2-bf4b-4339-8fe7-07fc9c61681a"/>
        <rdfs:comment>N-acetyl-L-cysteine</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/025e3e77-ea17-40c2-92ef-88a7a32e5c9d"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d2b20689-7817-4a56-b94f-d9c3f79ccfe5"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1d9593bb-94eb-4172-af06-eaf00771c785"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3e9dee9b-8a7e-4885-95cb-6bec39e90b02">
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
    <rdfs:label>high serum bilirubin level</rdfs:label>
    <dc:identifier>HP:0002904</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002904</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b0bbe3a5-abbb-4900-a1f8-c13cce70fa5d">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a71f2b7f-9b87-4433-bbf5-e7f706de42f7">
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <rdfs:label>No result is  added</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs11011-018-0236-1</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15895716</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/230900">
        <rdfs:label>GAUCHER DISEASE, TYPE II</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b4c7f310-1e02-4bfd-8cbc-931b7c324369"/>
        <rdfs:comment>By Knocking out RIPK3, we show that modulating the receptor-interacting protein kinase-3 (Ripk3) pathway markedly improves neurological and systemic disease in a mouse model of GD. https://www.ncbi.nlm.nih.gov/pubmed/24441827
Notably, Ripk3 deficiency substantially improved the clinical course of GD mice, with increased survival and motor coordination and salutary effects on cerebral as well as hepatic injury.</rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/230900</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9a24cde2-8c8a-4b26-a791-e6193698d21e">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d5462090-2c91-43c3-a208-eb821385e1aa"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7814809</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/654e775a-f530-4c6e-8b5c-3e354bbd4b6b">
        <rdfs:label>Direct interaction ( Mechanistic A) ERT</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23085429</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24441827</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00244582</dc:provenance>
    <rdfs:comment>Glucocerebrosidase+ gadolinium-diethylenetriamine penta-acetic acid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18952590</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/32b758fc-5790-4086-80c8-56d6b9224db3">
    <rdfs:comment>cysteamine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/36378db6-72d2-4a5f-8023-a1c3ca950ce1"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/21897743</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1929112</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/219750">
        <dc:identifier>https://www.omim.org/entry/219750</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/525</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>CYSTINOSIS, ADULT NONNEPHROPATHIC</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a30daaf6-37e8-411a-9318-d232651f09b8"/>
        <ddiem:iembaseAccessionNumber>525</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12488257</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12370309</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/110e9847-19e7-494a-a855-766348dc8f05">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000531</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>corneal crystals</rdfs:label>
        <dc:identifier>HP:0000531</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/606664">
    <rdfs:comment>Treatment recommendations could be regular monitoring and low-methionine diet if symptoms appear or if methionine is very high. https://www.ncbi.nlm.nih.gov/pubmed/27207470.                                                                                                                                                                                                                                                                                            The necessity for treatment of this asymptomatic seemingly benign disorder is presently questionable, careful follow-up being the main parameter for optimal care. https://www.ncbi.nlm.nih.gov/pubmed/27671891. No treatment needed in most cases.</rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/606664</dc:identifier>
    <ddiem:iembaseAccessionNumber>25</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/3ea72cf2-2697-4de1-8ca9-e4f345962d07"/>
    <rdfs:label>GLYCINE N-METHYLTRANSFERASE DEFICIENCY</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/25</ddiem:iembaseUrl>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a18a41cc-4c26-48ca-979a-c68409616e1d">
    <dc:identifier>HP:0001507*</dc:identifier>
    <rdfs:label>Low growth rate (Abnormal growth)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001507</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6e3eb3d9-a85f-4dfb-9e0b-3dcd0375b502">
    <rdfs:label>Periodic fever</rdfs:label>
    <dc:identifier>HP:0001954</dc:identifier>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001954</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/14a3a730-6046-4611-98a9-313e8e1ce6c2">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/066013dd-837b-423d-9603-0fa2ac8d3f32">
        <rdfs:label>Drug wasn't effective (Insignificant effect)</rdfs:label>
        <dc:identifier>HP:0002904</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002904</ddiem:url>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19752526</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282099</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <rdfs:comment>Fenofibrate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26692114</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/606785">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/636b5338-d064-4a7e-8e3b-93b09908ac39"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/661</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/606785</dc:identifier>
        <ddiem:iembaseAccessionNumber>661</ddiem:iembaseAccessionNumber>
        <rdfs:comment>Treatment of CNS type 2 is usually conservative with avoidance of drugs that displace bilirubin from albumin like penicillin, sulphonamides, salicylates, ceftriaxone and furosemide. https://www.ncbi.nlm.nih.gov/pubmed/23162302/
Affected patients should also avoid drugs that displace bilirubin from albumin such as penicillines, sulphonamides, salicylates, ceftriaxone and furosemide.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300/</rdfs:comment>
        <rdfs:label>CRIGLER-NAJJAR SYNDROME, TYPE II</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16830281</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5dbdb316-39f7-4c9b-a777-b03f8a078bfa">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8736fc24-e724-49e3-9877-145186bb0512"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/45e79756-6cf6-4ce5-9eb6-27042aaafaf0">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29923092</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9e1b1470-993b-4a49-a6d7-c74d848b2418">
        <rdfs:label>Blood-brain barrier (BBB) impairment</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29631617</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01399047</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3c18e95c-6fee-4192-9e99-cea094f5cbeb">
        <rdfs:label>membrane fluidity alterations</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29660499</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/72957ea8-5534-4edd-b844-27d2689771e6">
        <dc:identifier>HP:0011018</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011018</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>extended G1 interval</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/204200">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/962fbddc-2688-43c1-9b49-1ea3eee2ac97"/>
        <rdfs:label>CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/307</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/204200</dc:identifier>
        <ddiem:iembaseAccessionNumber>307</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5b37993d-4164-42ee-baf2-43f792999891">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9ea5d425-3dfd-427a-9b60-3169e0112cc7"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>carbenoxolone</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/da0c1ac0-f711-44fc-a2b7-91fa1072b7d6">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Low cell autofluorescence</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/021bcbc3-4d95-4134-8edb-e7bfd4e35de4">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5cf30e54-4834-48ad-ba4f-de993e9294f3"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25851806</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7375069</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18d743df-a56f-4189-a89b-78393fc3b371"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/870eb670-f02c-4db3-9a87-e030c82ac841">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100786</ddiem:url>
        <dc:identifier>HP:0100786</dc:identifier>
        <rdfs:label>Hypersomnia</rdfs:label>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/22186859-4065-462a-ba51-b3b3c7a0efb8"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fbf30458-d2db-4f83-822c-2f3c4b6dc8bd">
        <dc:identifier>HP:0001290</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001290</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Hypotonia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e98d1f3d-22b1-41c1-adc7-a02e556a6f28"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0837a1d0-8501-4d1b-8a08-654a0ad7a891"/>
    </obo:RO_0000057>
    <rdfs:comment>L-carnitine+vitamin E+vitamin B1+ cobalamin</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c99af7d1-7b05-4a2f-bacc-814e9ec59196">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000952</ddiem:url>
        <rdfs:label>Jaundice</rdfs:label>
        <dc:identifier>HP:0000952</dc:identifier>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9243c914-ef17-4700-bc33-fd8ca63554fd"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/aa2c66f0-3e7d-4324-9fb1-1f7edbc5591a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3dc5c559-eb74-49ee-b334-aaaad0b67b08"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5ea11511-204b-4599-93ed-ab23a0ed977a"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bc81a2fd-b16f-4dd0-974c-c7bc128da15f">
    <dc:identifier>HP:0001019</dc:identifier>
    <rdfs:label>Exfoliative erythema</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001019</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fbb34413-a4d8-448d-9171-8dd0788f7695">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28641925</dc:provenance>
    <rdfs:comment>ManNac (N-acetylmannosamine)</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/55cefd59-bf13-4bcf-86ab-f1f86afd2dca">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012363</ddiem:url>
        <rdfs:comment>In the mouse model syudy</rdfs:comment>
        <dc:identifier>HP:0012363</dc:identifier>
        <rdfs:label>Low circulating levels of free sialic acids</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26546927</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21517694</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/410bf561-5769-4325-bf07-f42fd5e266f7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/003592cd-8bb6-4c1c-ac6e-f9df77a651d5"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/605820"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/64652a89-e266-4ede-a9eb-b532a1a8f0fa">
        <dc:identifier>HP:0003216*</dc:identifier>
        <rdfs:comment>In the mouse model syudy</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003216</ddiem:url>
        <rdfs:label>Amyloid deposition</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/269622ab-4c3e-4f00-bf22-a1c18149b7c3">
        <rdfs:comment>In the mouse model syudy</rdfs:comment>
        <dc:identifier>HP:0012350</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012350</ddiem:url>
        <rdfs:label>Decreased sialylation of muscle glycans</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0853e8af-42ff-40c2-80ef-c1a7a44ecff3">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003805</ddiem:url>
        <rdfs:label>Rimmed vacuoles</rdfs:label>
        <rdfs:comment>In the mouse model syudy</rdfs:comment>
        <dc:identifier>HP:0003805</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02346461</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/96476521-af9d-48d9-bf98-d72604948a57">
    <dc:identifier>DB00114</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/65dfb81d-335f-44aa-b2c0-d95ed7a97f18">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8757046</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:comment>Pyridoxal phosphate</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12747882</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
        <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
        <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6f0a2163-07ac-4055-9d88-be28c319b46a"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/56866be6-5dd7-460b-84b7-73208cc82bec"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/610090"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00114</ddiem:url>
    <rdfs:label>Pyridoxal phosphate</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/737c7050-0000-464b-af36-8ad7c1c9fff7">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955971</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3427f497-df05-4dba-8d10-5930df197bfc"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608643"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073162</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01395641</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
        <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6f0a2163-07ac-4055-9d88-be28c319b46a"/>
        <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
        <rdfs:comment>Pyrodixal 5 phosphate</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25001633</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2a7689bf-05f5-488f-ad12-0d9b7f6ee2cf">
    <rdfs:label>Ketoconazole</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/cd3a4f4a-e5b7-41b1-8a33-fbf2025565d9">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2d532444-c84b-4397-bb17-05f06dcc11af"/>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <dc:provenance>NCT00744042.)."</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909487</dc:provenance>
        <rdfs:comment>ketoconazole</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/be6d3e84-a74a-4adf-9b65-31938bc240af"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/308050"/>
        <dc:provenance>was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number</dc:provenance>
        <dc:provenance>an enzyme-replacement therapy</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <dc:provenance>"ENB-0040</dc:provenance>
        <dc:provenance>https://www.researchgate.net/publication/8668575_A_successful_treatment_with_pyridoxal_phosphate_for_West_syndrome_in_hypophosphatasia</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096504</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01026</ddiem:url>
    <dc:identifier>DB01026</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/261cc9c0-ed6f-4f66-9e81-53dfe17f8b58">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001946</ddiem:url>
    <rdfs:label>Ketosis</rdfs:label>
    <dc:identifier>HP:0001946</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e2ba1c8f-7aa3-4039-afa2-a19fe76d6487">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/607015">
        <rdfs:label>HURLER-SCHEIE SYNDROME</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/607015</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>241</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/3e1abf48-b1ab-4188-ba39-e217d7d16cbb"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/241</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26516243</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d76b8648-e6ad-498b-89ae-362dc22ac366">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/e0f49fbd-9068-4be9-b207-ce620c95d067"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fa4132cd-3a98-4439-ae8d-af7819595927">
        <dc:identifier>HP:0004371</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004371</ddiem:url>
        <rdfs:label>glycosaminoglycan accumulation</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>GNeo-IDUA</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28958576</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24561416</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/cfc6b333-03a6-4b97-a867-eb80d30921e2">
        <rdfs:label>Direct interaction (A)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/59243965-3539-4c45-adcc-941d0ebae056">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <dc:identifier>HP:0002180*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002180</ddiem:url>
        <rdfs:label>neurodegenerative astrogliosis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/77424d3a-e583-47fc-b764-1a9f764c6ad3"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/12e5ea34-c86d-4f36-85a5-83a9cf333568"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d2e795ec-5e90-4a61-97bc-a9688f5b0452">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/445d9b90-818b-4ffc-a473-efaf43516448">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/02897969-28ff-49a1-8a1b-91e2f364b193"/>
        <ddiem:url>https://www.drugbank.ca/drugs/DB00700)</ddiem:url>
        <dc:identifier>DB00700)</dc:identifier>
      </ddiem:Drug>
    </rdf:li>
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7e3a0845-d0a4-49fa-b06d-a54a59456259">
        <rdfs:label>Amiloride</rdfs:label>
        <dc:identifier>DB00594</dc:identifier>
        <ddiem:url>https://www.drugbank.ca/drugs/DB00594</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/02897969-28ff-49a1-8a1b-91e2f364b193"/>
      </ddiem:Drug>
    </rdf:li>
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/741afbff-9d5a-4e7a-a721-72044e3eac1c">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/02897969-28ff-49a1-8a1b-91e2f364b193"/>
        <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=(DB00328</ddiem:url>
        <dc:identifier>(DB00328</dc:identifier>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/29cca417-b968-4f7b-8b8b-dfe2eea93ddf">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01022</ddiem:url>
    <rdfs:label>Phylloquinone</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/cab96a2e-cfb7-44a9-bbd8-c4e218fc9dbb">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
        <rdfs:comment>vitamin K</rdfs:comment>
        <dc:provenance>https://www.nature.com/articles/nrrheum.2010.182</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fa64800d-46ae-4d34-9935-72a60ec0e440"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23329770</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/11e93ecd-6c07-4368-bb80-fb940e42a179"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3ecf4b0b-2aa7-4627-88c1-c95837b02081"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246700"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956717</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB01022</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/701b1564-1028-40d7-8bca-f1916ec59100">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19087156</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/de60022c-caad-4500-87b6-89a046d3f726"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607765"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/65dd3260-0893-4e08-92a2-67b2e208f92e"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18570303</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/58235d61-91ab-490f-a381-601fc05496ad"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/116387c9-2a90-4990-bb34-1e6d972eafa9"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f344ce94-b33a-4227-a8c9-d6d023c22296"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8c6d4986-4e49-497a-ba43-3178c58ec295"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20619503</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4494408b-79a4-4b11-acf8-1700e5b0cd6c"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a84eb9c5-7786-437e-95b7-5a8b9a11fef1"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a8232704-bbb7-4df3-b015-368acaa147bb"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1ef01055-b2a5-4638-83c7-9f8afb534f85"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5dfdb19c-2a01-4a8e-9051-ca6a3315a184"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296980</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503963</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3ecf4b0b-2aa7-4627-88c1-c95837b02081"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
        <rdfs:comment>VitaminA+Vitamin D+Vitamin K+Vitamin E+ursodeoxycholic acid+chenodeoxycholic acid</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/aa9b15e7-006d-4681-a982-f3ed1338bf74">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c9ebb1f3-81a3-4adc-93b7-21052c9f12bd">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/5e819523-0fee-4600-bbad-dbaf00c1f988"/>
        <rdfs:label>Uncooked cornstarch+ Beneprotein</rdfs:label>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5009fba6-bef1-4ce8-ab06-6035325ac1c4">
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000518</ddiem:url>
    <rdfs:label>Cataract</rdfs:label>
    <dc:identifier>HP:0000518</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7ca427da-30e0-45c8-be75-425c37da906a">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/af7d67a1-dc64-4baf-9eb2-f1effe3fc7fc">
        <dc:identifier>HP:0012187</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012187</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>high erythrocyte protoporphyrin levels</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/20528d4e-7bb3-401d-9739-c276c15f5ae5">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/04a5b731-1351-4dd3-9aab-276ebf58133f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22092997</dc:provenance>
    <rdfs:comment>Iron</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/177000"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23884489</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00004940</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02979249</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26979527</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31395332</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a15bb48b-afae-4d3d-93cc-5296f5ed01f3">
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <rdfs:comment>Pyruvic acid</rdfs:comment>
    <dc:provenance>https://www.sciencedirect.com/science/article/abs/pii/S1386634602003315</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b6d06603-dfef-41aa-8d04-29d3bbf57545"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783980</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15670720</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1181</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6c37d423-92c1-45fa-96c6-3440a6085ae1"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/603471"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9ca00b7e-ab23-4677-862d-489761cd7125">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/MP_0002647</ddiem:url>
    <rdfs:label>decreased cholesterol absorption</rdfs:label>
    <dc:identifier>MP:0002647</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/27463883-5b44-48d3-8859-b3daec2c2816">
    <rdfs:comment>D-Thyroxine</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/167e4d70-21e7-433a-8188-b67967fa1392"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3483883</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232700"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8727391c-c9c5-4d48-822f-95d234aad8b5"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25266922</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0eed7ec7-1fa6-4704-9acc-a3d9a3ca9bde">
        <dc:identifier>HP:0002240</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002240</ddiem:url>
        <rdfs:label>Hepatomeglay</rdfs:label>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f8abf350-e7ca-44a4-bd33-db66b62d6387">
        <rdfs:label>Increased erythrocyte glycogen content</rdfs:label>
        <dc:identifier>HP:0001939</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/50748751-1b2c-4cb7-97ff-78153b537c8b"/>
    <dc:provenance>https://www.nature.com/articles/pr19842087</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/50270b54-1945-4b65-a100-08015083d68e">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f4caeb6b-9122-4dbc-a8cf-7296d7ea74ec">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Neuronal vacuolation</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4d07dc44-301f-4978-a23a-5d498152bac7">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002062</ddiem:url>
        <rdfs:label>Pyramidal neuron loss</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002062*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8f58896b-fede-4954-9e6d-e1307d2947bd">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Astrocytosis</rdfs:label>
        <dc:identifier>MP:0003354</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/MP_0003354</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/988e03d1-c00f-40c1-8738-0048da454033"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c25b542e-28fe-4fd4-89d1-ce9bee11152e">
        <rdfs:label>High level of fucosyl-linked oligosaccharide accumulation</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100614</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0100614</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27491218</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21575633</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2969e61c-bb60-47bf-a88a-4e44f4addb54"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f7325cbe-1a6d-4ff2-b6cb-f5e1fa8cd517">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0004356*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004356</ddiem:url>
        <rdfs:label>Lysosomal expansion in neurons of deep cortex</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3715af79-fa46-4bd2-b3f3-0cdc55c08852"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/278e27be-3e47-42ed-bbc1-af3c1fa24d74">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Abnormal lysosomal membrane associated protein-1 (LAMP-1) gene expression</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2aecd4fc-8c15-4f00-bd56-7c33d57da033"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e9acfee0-a6e9-41c5-93bf-f1147266e1ff">
        <ddiem:url>http://purl.obolibrary.org/obo/MP_0013438</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Hypomyelination</rdfs:label>
        <dc:identifier>MP:0013438</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5cac8e7f-29cf-4d2f-9de1-1f6ff35341cb"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/583a2f76-d19d-4938-9e57-ec943ecbf837">
        <rdfs:label>Abnormal neurololgical function</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000707</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4e9f7b4b-5cbe-4e94-b082-21a02590a3f6"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/35673df0-485b-4f4c-8084-a0fdff134dc4">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002446</ddiem:url>
        <dc:identifier>HP:0002446</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Astrocytosis in cerebral cortex</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26537923</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e687f933-4004-4f6f-b7c3-ac8c41250645"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/85380c53-ffd2-40ee-9088-57800f6ce171"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cc81ea9e-8213-4f98-b286-b7d31d9ee8ec"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/88473072-ed5f-40ba-a978-bd7836a8d402">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Oligodendrocyte loss</rdfs:label>
        <dc:identifier>HP:0100709</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100709</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/859a9a0c-8bb3-4608-921d-7af6d7e3033f"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0b64a23f-7762-43a9-82bd-8b3b429174e1"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fc8739b5-ac07-4cd9-83af-6f8a8090df89">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6fb113d5-4f43-4a33-9a8d-74d832f83453"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ae30218c-015a-4eda-82b6-1a9bc719a8a4">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100708</ddiem:url>
        <dc:identifier>HP:0100708</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Microgliosis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2b7f03e7-91d2-4889-b015-81f174b2eb84">
        <ddiem:url>http://purl.obolibrary.org/obo/MP_0000880</ddiem:url>
        <rdfs:label>Purkinji cells apoptosis</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>MP:0000880</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/509a0290-3fff-4b09-a845-5b3b7e6d8908"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/230000">
        <dc:identifier>https://www.omim.org/entry/230000</dc:identifier>
        <ddiem:iembaseAccessionNumber>259</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/87c37869-20d4-4381-a0df-13303a97697a"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/259</ddiem:iembaseUrl>
        <rdfs:label>FUCOSIDOSIS</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>recombinant canine α-l-fucosidase enzyme</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/120ad4fd-d1ec-4da8-9c4d-36c8857b318f">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17921858</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0ba249f0-e02d-47c6-b633-b22c6cfcfe03">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c52c8fe6-4f3c-495b-80b6-524766b324fb"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24744655</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7318fc96-98c7-4a8d-ba82-1726120fcace"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/41ccba98-2a20-4e5d-b22a-b129aa7a3cbb">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001873</ddiem:url>
        <dc:identifier>HP:0001873</dc:identifier>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <rdfs:label>Thrombocytopenia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01328587</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/105650"/>
    <dc:provenance>https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.13632</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <rdfs:comment>Eltrombopag</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <dc:provenance>http://www.bloodjournal.org/content/128/22/2682</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7de6702b-82ef-4b39-ad4c-1df81865fd97">
    <ddiem:url>https://www.drugbank.ca/drugs/DB06168</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1b1fb53b-ff79-4600-99aa-4e86f212abff"/>
    <rdfs:label>Canakinumab</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a6a1e174-6dfa-41ae-8771-7bf875ee12ed">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/260920"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25758134</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22740624</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5228d50f-c225-4507-933d-5bc47176c52f"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8d2238db-0752-4394-b08d-d861394bf1d2"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d30ce5e3-fc1b-450c-9f82-9d3b3dfaa1b4"/>
        <rdfs:comment>Canakinumab</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7936305</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0852cdd1-90fc-4d47-8560-a5a9a2110264"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB06168</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/678b1e46-af9c-462d-a8ce-bea94a089ecd">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/369e2d68-3b59-4a4f-9422-0a8eb69cbe01"/>
    <dc:provenance>https://www.semanticscholar.org/paper/Glycogen-storage-diseases%3A-Diagnosis%2C-treatment-and-Chen-Weinstein/439025d057229db1b3a117cb02b3c7e6f2bd3580</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f4206553-2250-464f-a5cf-3f4030d5e10d">
        <dc:identifier>HP:0001510</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001510</ddiem:url>
        <rdfs:comment>Preventive calcium and vitamin D3 supplementation is also recommended to prevent osteoporosis.</rdfs:comment>
        <rdfs:label>Growth failure</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20357432</dc:provenance>
    <rdfs:comment>medium chain triglycerides</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20975743</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8a4d084b-f26d-427d-af59-c486ea6bf149">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>done</dc:identifier>
        <rdfs:label>Hyperuricemia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/done</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a069889d-fea1-4688-8e0b-21c8e8102419">
    <dc:identifier>HP:0003678*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003678</ddiem:url>
    <rdfs:label>development of extra-renal pathologies ( Progressive disorder)*</rdfs:label>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/26390bda-97dc-4709-8a99-cb6e38f3ca40">
    <dc:identifier>HP:0030098</dc:identifier>
    <rdfs:label>Abnormal fukutin mRNA expression</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0030098</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b77fa45e-6c4f-486c-a8c1-f9a60164bac5">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12794688</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cb6d935c-97ca-4752-9652-5786a9767154"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <rdfs:comment>Phenobarbital</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301643</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/604369">
        <dc:identifier>https://www.omim.org/entry/604369</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4ee68861-88b3-46fe-bb6b-9d8ac535aa99"/>
        <ddiem:iembaseAccessionNumber>1369</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1369</ddiem:iembaseUrl>
        <rdfs:label>SALLA DISEASE; SD</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/40f3614a-177a-487d-83e6-282ac6ec6265">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0002540</dc:identifier>
    <rdfs:label>inability to walk</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002540</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/86559b6f-2581-41e3-9eaf-7541f8e83404">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10870849</dc:provenance>
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00004450</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3eae6ad8-b7d3-4a03-83d7-14c8fdb45b21"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c29adba9-9008-43e3-9559-09d9d37f25ce">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/62dd20aa-4332-46e0-89f5-29ab65212687"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0acc0750-bf8d-431a-b7a9-419f6406e435">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/0131c157-65ce-4423-97c9-29f9b8f4af00"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9d057fc2-5cd8-462d-9759-3cc815cd03e2"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300100"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dfc31fe2-706c-450f-b640-68bb2934a153">
        <rdfs:label>NO revealed clinical benefit</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <rdfs:comment>interferon beta + thalidomide</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15670720</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d737e973-7bed-4401-809d-497fe18fb6a5">
    <rdfs:comment>Metoclopramide</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/105650"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24744655</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15795909</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/75d047a5-9be3-4f32-8f5d-89109aaeac61">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0031851</ddiem:url>
        <dc:identifier>HP:0031851</dc:identifier>
        <rdfs:label>Reduced hematocrit</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17921858</dc:provenance>
    <dc:provenance>https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.13632</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7318fc96-98c7-4a8d-ba82-1726120fcace"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12351372</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cd37784d-50b5-44ad-95de-5cbcae003e5c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/10ba66d2-b547-4a9f-8957-401c4395062b">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
    <rdfs:label>neurological disease</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0000707</dc:identifier>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fd64661b-584f-4e5c-bce3-08355d33c303"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8447598d-ad70-48ee-8d1b-9ecd2b0504f3">
    <rdfs:label>Excretion of heme precursors(Abnormality of the heme biosynthetic pathway)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010472</ddiem:url>
    <dc:identifier>HP:0010472</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/eb5c5f1c-1b39-4ace-837f-cb219b72f54c">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503963</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18570303</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/615395">
        <rdfs:label>COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/615395</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/961</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a01b9f7f-2cd1-4753-bcf1-3671596eabca"/>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>961</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>creatine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20938027</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19087156</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3728726c-59e7-4cf4-a017-a99f56135196">
        <dc:identifier>HP:0025142</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025142</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Low physical capacity (Constitutional symptom)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20619503</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25797485</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f24a6cb0-fc7a-4229-8c3b-98c78cc27199"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3dd03047-4d2d-4ef8-897d-afe4384eb683">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0003304>R1353H</obo:RO_0003304>
    <obo:RO_0003304>delSer1387</obo:RO_0003304>
    <dc:provenance>https://rarediseases.org/rare-diseases/lesch-nyhan-syndrome</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/49bffb10-3f28-4064-aa10-51a9cede4fe8"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27179999</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12593632</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15356046</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/240800">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4bb04de0-e887-46a7-8d79-a2f9ff6fb945"/>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>HYPOGLYCEMIA, LEUCINE-INDUCED; LIH</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/240800</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0003304>E1506K</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <rdfs:comment>diazoxide</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0aa47d20-1e2a-4a5d-828e-fb1f24e2cc0c"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e901a3ff-3aa7-411c-8f1b-8fd34e3f0018">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01907087</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/631b5dbd-8a2b-4d14-beeb-9e8a7225740b"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24938720</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29688815</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263309</dc:provenance>
    <dc:provenance>https://emedicine.medscape.com/article/1178391-treatment</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/08ba9657-fd93-43d5-a691-9b2f620df8af">
        <dc:identifier>HP:0100543</dc:identifier>
        <rdfs:label>cognitive dysfunction</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100543</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28589525</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f1fcc3f8-665e-4bff-9016-c97e304a2db3">
        <dc:identifier>HP:0000707</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
        <rdfs:label>neurologic deficits</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8ddeee2a-ec85-46cd-90e8-3609c32a0d8c">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3baf30a6-a395-4233-aabc-cc5d9cb455db"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1006cbbe-199e-4ee2-9a8a-e1c715bcf2fe">
        <rdfs:label>loss of ambulation</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002540</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002540</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/204500"/>
    <rdfs:comment>cerliponase alfa</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/218f8009-2c3e-4420-9796-e60207a87b98">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <rdfs:comment>Bromocriptine</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01395641</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955971</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/eb2ab32b-f72c-4c72-9a61-4aad73cdb98d"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1d67c8a9-ca0d-49a0-beca-fb6db18778c1">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001266</ddiem:url>
        <dc:identifier>HP:0001266</dc:identifier>
        <rdfs:label>choreoathetosis</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241937</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/568701e3-c74e-441b-bf31-4db45c8d1ca0">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002375</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0002375</dc:identifier>
        <rdfs:label>hypokinesia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/487c9629-db04-4e7e-b535-aa6b6512ebba">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/93f809f9-7214-4c36-85ac-77ffdcd904db"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a3b6f768-173c-4f95-8105-38e4788387df">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0010553</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010553</ddiem:url>
        <rdfs:label>Oculogyric crises</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/608643">
        <dc:identifier>https://www.omim.org/entry/608643</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/07192a15-102f-4e09-a393-3e02f109ffe5"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/100</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>100</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e0b8e415-235b-40a0-aa46-e0ddac1a572f">
        <rdfs:label>Autonomic dysfunction</rdfs:label>
        <dc:identifier>HP:0002459</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002459</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4bc93521-e918-4ec9-884e-1ca5d542dfdf">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100022</ddiem:url>
        <rdfs:label>Abnormalitilty in voluntary movements(Abnormality of movement)*</rdfs:label>
        <dc:identifier>HP:0100022*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/925607af-61a8-42df-a07f-649263a736bd">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>axial hypotonia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008936</ddiem:url>
        <dc:identifier>HP:0008936</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ff0fdbac-5589-49c5-a3b2-cb2aff951cbf">
        <dc:identifier>HP:0001332</dc:identifier>
        <rdfs:label>dystonia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001332</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073162</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cad1191d-c548-450f-af22-83345e6af769">
        <dc:identifier>HP:0002509</dc:identifier>
        <rdfs:label>limb hypertonia</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002509</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/48954f3f-c451-4a18-9f4e-6a229dd33dc4">
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30731125</dc:provenance>
    <rdfs:comment>Vitamin B12+iron</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4873312d-60f0-4ecd-8eac-5c490850935d">
        <dc:identifier>HP:0001903</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001903</ddiem:url>
        <rdfs:label>Anemia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/20528d4e-7bb3-401d-9739-c276c15f5ae5"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/200100"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25488886</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-3-20</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/23fe19e2-2546-42b5-bb46-d8ec4512c6e6"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/05e0e82a-9bed-4b0a-bef4-d3b2b940f041"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/5809aebe-821c-4641-8f79-91da7a0b66c0">
    <ddiem:url>https://www.drugbank.ca/drugs/DB08875</ddiem:url>
    <rdfs:label>Cabozantinib</rdfs:label>
    <dc:identifier>DB08875</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/72f1a9bd-da50-4d22-a991-1e11e8d0ec27"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/95c29982-69b4-42a3-92a7-3a9d2e8d5143">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02805790</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21788663</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/535000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2456ef19-169f-4dca-b60b-9ca499ec58d7"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1ce9e96f-cdf7-4fab-a4fd-d217f32d126d"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f91ec501-79bf-457f-8c9e-12365586ad35"/>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02176733</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/378657ca-4c08-4a5b-9dbc-1ffebf138340">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ccb197cc-ba82-4d1b-9351-3a071b40db93"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11723211</dc:provenance>
    <rdfs:comment>Corticosteroid+Antiaggregates</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/61d7b1db-605d-42d8-80ce-8afbfe743a12"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0c24203d-3758-47ec-8c19-b47ee47d4adf">
        <dc:identifier>HP:0001129</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001129</ddiem:url>
        <rdfs:label>Large central visual field defect</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2393224e-09fe-4075-a95f-287cb93174ad">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/4c1a45f1-1182-4fec-bc83-328eb519edd5"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c1acebea-cb82-45bf-9089-797a4da69445">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03726996</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/256600">
        <dc:identifier>https://www.omim.org/entry/256600</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A</rdfs:label>
        <ddiem:iembaseAccessionNumber>760</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f94e5fcc-1485-42ab-a4ec-3735672bccd9"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/760</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <rdfs:comment>Desipramine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29909971</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b8957a50-208c-45ef-8d5d-299b4d155841">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004356</ddiem:url>
        <dc:identifier>HP:0004356</dc:identifier>
        <rdfs:label>Lysosomal stress (Abnormality of lysosomal metabolism)*</rdfs:label>
        <rdfs:comment>In the mouse model syudy</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/32af2e6a-8fa6-415b-9cc3-3e8efae063bd"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/41f8cfe4-0075-44c2-9ccd-df4e595fb765">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7a495771-c0b8-4ac0-ab3b-f2cc0d74cd83"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c14aae48-b9d6-4c49-bc54-a80165aeefbd">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0007663</ddiem:url>
    <rdfs:label>impaired Visual acuity</rdfs:label>
    <dc:identifier>HP:0007663</dc:identifier>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7a495771-c0b8-4ac0-ab3b-f2cc0d74cd83">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6436e1b8-ff8a-416a-a6b2-5220440c534d">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03726996</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/269920"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/41f8cfe4-0075-44c2-9ccd-df4e595fb765"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
        <rdfs:comment>Treatment of manifestations:Management is symptomatic and supportive: rehabilitation to optimize mobility and communication; provision of adequate nutrition; standard treatment of seizures. Surveillance: Regular evaluation by a rehabilitation specialist to identify potentially helpful interventions.</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301643</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01151</ddiem:url>
    <rdfs:label>Desipramine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c1acebea-cb82-45bf-9089-797a4da69445"/>
    <dc:identifier>DB01151</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8736fc24-e724-49e3-9877-145186bb0512">
    <dc:identifier>DB01039</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1bbbb865-5803-43ca-9694-dbc419436419">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5dbdb316-39f7-4c9b-a777-b03f8a078bfa"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
        <rdfs:comment>fenofibrate +niacin+omega‐3 fatty acids</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22142470</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24524914</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/145750"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25993639</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c9997dbc-350e-4113-bbd7-222c21ad6ec6">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <rdfs:comment>fenofibrate</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930475</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/278000"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27878737</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/79a49b1c-0ae4-4bf0-bca4-dd7179343750"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5dbdb316-39f7-4c9b-a777-b03f8a078bfa"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/14a3a730-6046-4611-98a9-313e8e1ce6c2"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01039</ddiem:url>
    <rdfs:label>Fenofibrate</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c9ceb2f6-6caf-4174-ad15-75f1494a4f67">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607015"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/df3c10e1-06bf-4a08-83f7-3a4eb87db9fa"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29122734</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/cfc6b333-03a6-4b97-a867-eb80d30921e2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24561416</dc:provenance>
    <rdfs:comment>Nanotechnology-based gene therapy</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/36d84cb9-a1bf-496f-90cf-73965c70d24e">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9261acf8-63a9-47d4-a0ac-d6241e8bd8e5"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/12049abb-c881-4b54-ae96-a24b615f1522">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>Low IDUA activity(Abnormal enzyme activity)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012379</ddiem:url>
        <dc:identifier>HP:0012379</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26516243</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2f335099-b729-4c25-b7c2-4e1c57eccc77"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b532794d-485a-4c2d-92e9-f79c5a324e97"/>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6e5bb0b8-8b0c-4c99-b7c6-d53cfc66c5bf">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs11883-014-0440-2</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2065040</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ffa75e0c-b145-4e9f-9b04-0eebe78b067a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c8afce85-cbde-418b-94f9-cc6e8719ee4a"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25079293</dc:provenance>
    <rdfs:comment>Fish oil</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3162680</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8c5b258c-898d-4458-ab02-07be0133fb66">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/161b9961-54b6-4521-ad6f-95d1e2672625">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040063</ddiem:url>
        <rdfs:label>Decreased adipose tissue</rdfs:label>
        <dc:identifier>HP:0040063</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18bdc0c8-7cc6-44b4-92d3-c754df4c8426"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27650489</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/19c62efa-d75a-4e48-aff0-f5316fda0bb0"/>
    <obo:RO_0003304>M918T</obo:RO_0003304>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5e0d21a5-dc91-49f7-b426-e75ffb361f95"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3491070</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3bfda9c3-48ed-45be-88ba-414e0a09c82a">
        <rdfs:label>Increased plasma CEA</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0031029</ddiem:url>
        <dc:identifier>HP:0031029</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00514046</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23543666</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23766359</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/701191dd-dc4b-4c69-a6d5-310ca4fa1e52">
        <dc:identifier>HP:0025142*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>low quality of life ( Constitutional symptom)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025142</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/da3e4219-ff12-4607-8be7-0df09090bd90">
        <rdfs:label>Weight loss</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001824</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001824</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/502e7244-1f43-4cf7-8701-a6075c7fc3b1">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003199</ddiem:url>
        <rdfs:label>Low skeletal muscle mass</rdfs:label>
        <dc:identifier>HP:0003199</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/17e62a7a-4e1c-47a6-8989-00660b76d5bd">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003678</ddiem:url>
        <rdfs:label>disease control rate(  Rapid disease progression)</rdfs:label>
        <dc:identifier>HP:0003678</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b9413849-2b14-4667-b8cf-d006f85bb125"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307225</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214082</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22665903</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/162300"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/125ed772-677a-4687-94f5-8bd8ee2542ec"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <rdfs:comment>vandetanib</rdfs:comment>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/c65d621b-fe04-4175-9c41-acdc4f5e036e">
        <rdfs:label>Direct interaction (Mechanistis A)&gt;&gt;&gt;Activity modification</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22025146</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20371662</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/66dccf2d-1118-4b66-89ac-6a609851a808">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Objective response rate (ORR)</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ae63ed05-10b7-47da-bbea-d7d4c7c1defe">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003656</ddiem:url>
    <dc:identifier>HP:0003656</dc:identifier>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
    <rdfs:label>abnormal glucocerebroside level</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/aaf54191-e861-4676-9de5-4d6760c5d5da">
    <dc:identifier>DB14502</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14502</ddiem:url>
    <rdfs:label>Sodium phosphate, dibasic</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1b367bae-9501-4f84-96fb-19416240ecb4">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/219800"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3550461</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8444253</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/194ad692-87c0-4c6e-b87f-bdc41cc1efce"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27102039</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/58235d61-91ab-490f-a381-601fc05496ad"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/7d436344-19c2-4974-a067-bfef20261f74"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016220</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505515</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <rdfs:comment>neutral phosphate+Vitamin D</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e1cf5c61-3601-4d51-98e3-42093a6b041e">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5794bbe0-910e-4900-b449-bc2b3762b2f9">
        <dc:identifier>HP:0001939</dc:identifier>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <rdfs:label>Abnormality of metabolism</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10603107</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0ebe9306-830f-4a9b-8542-a8a878c0e2e8">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/0f5ae389-dd4d-43e0-bf5d-5dd1e6c715d3"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e09f6ed0-58dd-4e3a-a472-66937479e6be"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2761b8ee-5469-4a36-8a1e-b986aa43364c"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d7bf55c5-3c48-434b-ac99-d760e608b7fd"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282099</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26692114</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606785"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/61c4d02e-7f24-41ff-80f1-c628fdf5b679"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2170dc7c-c3d5-495d-972e-7abd19374be5"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15753292</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/34668001-8d53-4d09-85f3-319690159aab">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012649</ddiem:url>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <rdfs:label>Increased inflammatory response</rdfs:label>
        <dc:identifier>HP:0012649</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c5d3d937-936d-48df-854a-4b2d287516bd">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002904</ddiem:url>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <dc:identifier>HP:0002904</dc:identifier>
        <rdfs:label>High serum  bilirubin concentration</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>AAV-mediated gene therapy</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1f8bcb99-69ba-425e-8121-0ff097d1a5c8">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27884013</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8dd4c7c7-193c-431c-af5c-85132c7d4755">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001943</ddiem:url>
        <rdfs:comment>The hypoglycemia is not a disesae phenotype, rather its a side effect of Mecasermin medication.The new combination in Mecasermin rinfabate has over come this side effect.</rdfs:comment>
        <rdfs:label>Low serum ICFBP level</rdfs:label>
        <dc:identifier>HP:0001943</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608747"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1338f724-1eca-4b8b-8bc8-571c627704c3">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a3130b01-5ab0-40c4-81a0-630af38de29e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/49bffb10-3f28-4064-aa10-51a9cede4fe8"/>
    <rdfs:comment>Mecasermin rinfabate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/70e3adaa-d339-4065-991b-0b6c32e86cf5">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/614723">
        <dc:identifier>https://www.omim.org/entry/614723</dc:identifier>
        <rdfs:label>ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY; APRTD</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f29ff502-cb7d-4a29-af80-649e25620201"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02752633</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15767622</dc:provenance>
    <rdfs:comment>febuxostat</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK100238</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c95bb30d-30ea-4b6c-b21b-1d469c4a5d59">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000112</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0000112</dc:identifier>
        <rdfs:label>crystalline nephropathy</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0c60442d-2216-4830-bce9-82a95d7e259f">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0100518</dc:identifier>
        <rdfs:label>Dysuria</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100518</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c94b730b-118b-4845-bc60-db7803d46608">
        <rdfs:label>urolithiasis</rdfs:label>
        <dc:identifier>HP:0000787</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000787</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7371c4d5-8d20-49c3-8bb8-67e00562ca18">
        <rdfs:label>Hematuria</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0000790</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000790</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29241594</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6e0cb1c3-868c-4065-9f1b-00213930f434">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a57abbcd-455f-481f-914c-ae87c1ac22d2"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8d858f21-a336-45e4-886d-521178973a5f"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dbfa5a46-1f7b-495e-b543-48b66dc9ac57">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Recurrent urinary tract infections</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000010</ddiem:url>
        <dc:identifier>HP:0000010</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/81bd1bb5-5160-4b34-912d-f3687bf6093b">
        <dc:identifier>HP:0012622</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012622</ddiem:url>
        <rdfs:label>Elevated Urinary DHA excretion</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/12d5b691-f03f-4fca-952c-3b7556f61396">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c1a0339a-77d8-44eb-bf99-52ba723f6752">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19704083</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0f1ff3c6-7c09-4b1d-bdad-fec75336de2f"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16601879</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/96360fc9-bab5-492a-a25c-ee37dbb998b4"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f9a70f46-8096-4f39-9d4c-cfb6cb5a08d8"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
        <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261640"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d0b9c968-a9f8-41e5-9d75-a09ec890b34f"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2503885e-dd5f-48ed-9dfc-f74a717790c8"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/07f1336e-136b-487a-ba6d-eb6c1a02ecfe"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b03839b4-a6f4-4bf0-a431-2c77c0e6858c"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/eb937ac7-1884-4c52-ab91-9e57aaaed1b7"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1c7df7aa-92af-4bc8-8a73-1e47f9e5a743"/>
        <rdfs:comment>pramipexole + L- dopa</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Pramipexole</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/31b15313-ec1b-4709-be47-6814a3787e0d">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261630"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/96360fc9-bab5-492a-a25c-ee37dbb998b4"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/af3ed0ba-e98e-4bf1-adb2-259b4f7c2413"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0022510X16303495</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22325981</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b1d9328e-65b3-4487-a446-bf24ece96ff8"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18425437</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b64deeee-b485-4754-9b2b-9a92a3e78376"/>
        <rdfs:comment>pramipexole</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26817292</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/de78ee14-d30b-474a-a088-896e16756333"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25707872</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00413</ddiem:url>
    <dc:identifier>DB00413</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ffd43e83-794f-4974-85ed-0654f71adde0">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26979527</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23884489</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1a9aaa07-3326-4267-b8ae-9071b877eab2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/46b645c4-08a4-40ac-bb56-6b1936de58b9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/67f05141-2df5-4de6-973a-ba839f9813d3">
        <dc:identifier>HP:0012187</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012187</ddiem:url>
        <rdfs:label>Abnormal  protoporphyrin enterhepatic circulation</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/177000"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7758200</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19656325</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22092997</dc:provenance>
    <rdfs:comment>Cholestyramine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10189233</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/788d45b9-d096-4e79-9b53-639cc432c628">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/cfc6b333-03a6-4b97-a867-eb80d30921e2"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/26b1c6b0-eb96-457f-bb4e-d595afdccae7">
        <rdfs:label>Decreased pulmonary function</rdfs:label>
        <dc:identifier>HP:0005952</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0005952</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/840d830d-0fc6-45b7-9fc0-78ec9e6447df">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>Six Minute Walk Test</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b6b1b260-a41d-411d-a6bd-f2e8a75a6b75"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/748a5212-81fc-4b8c-8f11-2279015f524f">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/5792da5b-f8c2-41f1-863f-4debf60efa2b"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c2379e8b-e2b8-401f-aba7-e1997aff7994">
        <dc:identifier>HP:0002111</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002111</ddiem:url>
        <rdfs:label>Low Forced Vital Capacity</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607015"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT00912925</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2e3ca5ad-32c3-4ba2-b5ca-a818e2f9736c">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001376</ddiem:url>
        <rdfs:label>Limitation of the Joint range of motion</rdfs:label>
        <dc:identifier>HP:0001376</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d3d445f6-9c7c-4f0f-83ee-d2d97a8f05aa">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>High Apnea,Hypopnea Index(sleep apnea)*</rdfs:label>
        <dc:identifier>HP:0010535*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010535</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Laronidase</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24561416</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26516243</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7ccd2605-17d8-40fd-bd92-0a493429ed98">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01399047</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d51e1dd4-1b23-48d8-a331-dc3d8e7ccb01"/>
    </obo:RO_0000057>
    <rdfs:comment>scAVV9.CB.CLN6</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29631617</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bbd6abbb-c8cc-4af1-a891-37e8628a0a50">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c0f1f7d9-06b8-4254-a6b8-05fdb3f2c024"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/601780"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31331814</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02725580</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/323ef25b-ab85-41c4-bfad-fa934cb454cf">
    <rdfs:comment>sodium benzoate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052756/#S10title</dc:provenance>
    <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/207800"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11148549</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bda4b943-5e3b-40e3-ab23-a03792c92217"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508465</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9f4da0b7-bc68-4593-a7c4-e98ccf7624da"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382922</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e859b253-aa0f-41fe-a428-a48293daec8f">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568973</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ec23eac1-882e-43eb-8423-7cdd7d4a4631">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/350adb89-8c25-4662-a590-7407f2853855"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24746802</dc:provenance>
    <rdfs:comment>Immunosuppressent +Carbonic anhydrase inhibitors</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9d1ff78a-ed54-466e-811f-a727cc83961f"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c7e4d537-9587-47ce-b108-7113c802ba50">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8017db44-0dd8-43de-8380-437d2be503fa"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/520000">
        <rdfs:label>DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/520000</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/8da8670b-f559-4f31-b729-cf71cc42be16"/>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/8c31831b-e9ed-443c-bc1a-253f1da8dc5b"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/409</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f793a0c2-2320-49ec-a4d8-58578ac60d82"/>
        <ddiem:iembaseAccessionNumber>409</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4f79355d-6ee7-4117-8de5-fe4b0d7adcab">
        <dc:identifier>HP:0008028</dc:identifier>
        <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
        <rdfs:label>Macular cystoid changes</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008028</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/11ab0a58-05ad-4f8d-a028-a98187979726">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8757046</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/613839"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d163d122-d62a-4f46-b77a-3e139fa52a97">
        <dc:identifier>HP:0025454*</dc:identifier>
        <rdfs:label>Abscent 5-MTHF(Abnormal CSF metabolite level)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025454</ddiem:url>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21310276</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/80e4fb7e-24e8-40cd-90dc-c0e63fb3e122">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012446</ddiem:url>
        <rdfs:label>Low 5-MTHF level</rdfs:label>
        <dc:identifier>HP:0012446</dc:identifier>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a13d8e55-e5eb-4571-bacd-398d32012099">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040087</ddiem:url>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <dc:identifier>HP:0040087</dc:identifier>
        <rdfs:label>Low total RBC folate level</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8b047b78-ce3f-4563-87e7-7e966d1d2713">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001980</ddiem:url>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <dc:identifier>HP:0001980</dc:identifier>
        <rdfs:label>Bone marrow megaloblastic changes</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Folinic acid</rdfs:comment>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ab77f8f7-af95-49bd-a101-6a5cb132e5ac"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/287695b4-86e4-4fa3-a99f-eafc2d51f0dd">
        <dc:identifier>HP:0012446</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012446</ddiem:url>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <rdfs:label>Abnormal CSF folate level</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/34fe216e-6e58-432a-808c-c2e1b33903ea"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21310277</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1a9dfd0b-8c1d-47a8-b885-d0822ebcf930">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12937245</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/309000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/59/33</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18d743df-a56f-4189-a89b-78393fc3b371"/>
    <rdfs:comment>sodium bicarbonate</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/72c9c490-c390-4642-9d74-e5f0e7a6b10b"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3609a5d7-4f9d-4836-9cee-05035c17f245">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7f210050-85fe-4bca-9f85-d2a10756484f">
        <dc:identifier>HP:0000822</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000822</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Hypertension</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Hydrocortisone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26161337</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e6037bf0-feb2-4270-9207-8589a2f51e41">
        <dc:identifier>HP:0011042</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Abnormality of potassium homeostasis</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011042</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f22489fd-f754-49c7-ba87-120807f24acf">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0040084</dc:identifier>
        <rdfs:label>Abnormal circulating renin</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040084</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/202110"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/033799ec-2fce-41fd-9fc2-7c561dd1bf92">
        <rdfs:label>Abnormal plasma aldosterone</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0040085</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040085</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18458702</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8c3bdbeb-7e1f-444f-92fa-17f8b887ff7f">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/996e6932-a829-43b1-a0ef-22960b90de81"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bedd1c1d-7692-4958-95bd-e2c18803c5ec">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1480</dc:provenance>
    <dc:provenance>https://pdfs.semanticscholar.org/3a8e/bd8dda73113f384215ca26d7df0fe61441a1.pdf</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/98181753-a1e9-444f-8621-e0fb5a206403">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003234</ddiem:url>
        <dc:identifier>HP:0003234</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>secondary carnitine deficiency (Carnitine deficiency)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <rdfs:comment>L-carnitine</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/309000"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4f3e8b1f-464d-4057-94fa-9e9865d2186e">
    <rdfs:label>Lysosomal storage abnormalities(Abnormality of lysosomal metabolism)*</rdfs:label>
    <dc:identifier>HP:0004356</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004356</ddiem:url>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/acedbc0c-51c1-46e8-9ecf-4a9b553bdac9">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15670720</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/263570">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM; APBN</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/d80e514d-803e-403c-b3e3-a863d2cc6012"/>
        <dc:identifier>https://www.omim.org/entry/263570</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/476d1f38-af00-44ff-bb54-29a30c04f226">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012378</ddiem:url>
        <rdfs:label>Lack of energy</rdfs:label>
        <dc:identifier>HP:0012378</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fb67538b-e232-4bac-9ab6-e8f00cfe2d81"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00947960</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10870849</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2f6bceb7-a939-4851-ab93-e5fb2081387a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/51a2540f-8f09-4c98-9cfe-aaaf56bb67f3"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/39b45159-225a-4006-b183-68fd31c0ce44">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003326</ddiem:url>
        <dc:identifier>HP:0003326</dc:identifier>
        <rdfs:label>muscle pain</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Triheptanoin</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/38a47102-b026-4c24-a572-b136d38e04af">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012075</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0012075</dc:identifier>
    <rdfs:label>Personality disorder</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/51a2540f-8f09-4c98-9cfe-aaaf56bb67f3">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/14758fa4-d5ff-43e9-8d71-2384c8e9d39a">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5878500a-556f-4b57-bfa3-69d19ea40912"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/255120"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ffd76157-6d39-443d-9ab4-270bc6aaf525"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>PMC2676979</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2f6bceb7-a939-4851-ab93-e5fb2081387a"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18645163</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/39b45159-225a-4006-b183-68fd31c0ce44"/>
        <rdfs:comment>Triheptanoin</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB11677</dc:identifier>
    <rdfs:label>Triheptanoin</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/29aefa8d-6dc9-4b67-adf6-6e112a52db61">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88b23ae1-3b09-4c5f-8470-21c4e414dccc"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29303961</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d329df45-ffe7-4866-a634-9a05d389e8b0"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26982753</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01993186</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02014883</dc:provenance>
        <rdfs:comment>UX007 (triheptanoin)</rdfs:comment>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02960217</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22812641</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a185ab55-aae6-48c7-961a-53c5ca05d2ac"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02036853</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2f6bceb7-a939-4851-ab93-e5fb2081387a"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/12abaeef-1566-4be1-bea2-8e478861d8f7"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23196212</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02000960</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606777"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/acedbc0c-51c1-46e8-9ecf-4a9b553bdac9"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1d3356dd-be9e-45e9-9d9d-d6b33101efb3">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://link.springer.com/article/10.1007%2Fs11940-017-0473-2</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25762569</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7dd89407-ae91-46b1-9031-6905a6e55532"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02432768</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232600"/>
        <rdfs:comment>Triheptanoin</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4cad9017-039d-4f83-a700-4b9c5eedd631"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2f6bceb7-a939-4851-ab93-e5fb2081387a"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25455802</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6cb4fdd0-c6b9-4e39-abe8-2a3c45716829">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cefa5609-067b-4fb0-81a7-5a24ff1f5c38"/>
        <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <rdfs:comment>Triheptanoin</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2f6bceb7-a939-4851-ab93-e5fb2081387a"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3dc8dd57-2ebf-47c5-8e54-e404320c1291"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2cc7cd33-c7b4-448b-8a55-a9f2412e081a"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231530"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388644</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
        <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/study/NCT01379625</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/31026897-9ffe-4527-98a2-1884e12766d3">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6f3e4cbe-cf47-4fca-99fd-75d43a8762f2"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232800"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25266922</dc:provenance>
        <rdfs:comment>Triheptanoin</rdfs:comment>
        <dc:provenance>https://www.nature.com/articles/pr19842087</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03642860</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2f6bceb7-a939-4851-ab93-e5fb2081387a"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB11677</ddiem:url>
  </ddiem:Drug>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/231950">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/172f6cdd-1243-4b4d-94cb-304d0512aa63"/>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseAccessionNumber>214</ddiem:iembaseAccessionNumber>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/214</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/231950</dc:identifier>
    <rdfs:label>GLUTATHIONURIA</rdfs:label>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5e819523-0fee-4600-bbad-dbaf00c1f988">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/aa9b15e7-006d-4681-a982-f3ed1338bf74"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564511</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0dbf90a3-89ad-4e84-bf03-89caf13e2398"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/613027">
        <ddiem:iembaseAccessionNumber>1259</ddiem:iembaseAccessionNumber>
        <rdfs:label>GLYCOGEN STORAGE DISEASE IXc; GSD9C</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ce7e9c63-2853-4457-aaa9-836999eaec97"/>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/613027</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1259</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <rdfs:comment>Uncooked cornstarch+ Beneprotein</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ef75701a-a6e2-48ad-bbbf-5331b9be3a4b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25266922</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2f6d7fca-a217-4482-8af7-01ac4824cd7b"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/307c8ffe-38cb-4638-ae1c-5b472781378b"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d6c1137f-c24a-4d72-9c84-5068df3a1623"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12930917</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/698acb99-e95a-4e4f-8612-2f1b648d5424"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/275cdbc1-150b-4f7e-8849-6f3be2bf5dd9">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2443756</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/82f23c1c-f25d-4234-af3e-1f6d24487d7c">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f4a3fa32-164f-4156-a7f6-18adfe298155"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220407</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/da0f83ed-31e7-4d21-b7ea-be4f04760a47">
        <dc:identifier>HP:0002155</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002155</ddiem:url>
        <rdfs:label>High triglyceride levels</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Tauroursodeoxycholic acid</rdfs:comment>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/268200">
        <rdfs:label>MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/750</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/724415d4-8699-4639-a9fb-cf3aefa1350c"/>
        <dc:identifier>https://www.omim.org/entry/268200</dc:identifier>
        <ddiem:iembaseAccessionNumber>750</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30420558</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26997609</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b114e474-2e7f-4cf0-ac4d-53f2aba2d633">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>ER (endoplasmic reticulum) stress</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4494408b-79a4-4b11-acf8-1700e5b0cd6c"/>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/1fa6bc4b-b58b-4a4a-a638-b0c7947b1b49">
        <rdfs:label>Functional intearction (Mecahnistic B)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1886403</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f1453adc-f9a3-4abc-b657-e40f83621463">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16434679</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/232600">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/489</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>489</ddiem:iembaseAccessionNumber>
        <rdfs:label>GLYCOGEN STORAGE DISEASE V; GSD5</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/232600</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/83c6904c-db83-4ecf-9e0f-ce81abaacad6"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ca320f8f-eec7-4e39-a257-ceb859bf01f6">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1ba93785-93b0-4924-b365-e8ff9cc0976c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <rdfs:comment>GENTAMICIN</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b96373c9-9bb1-4196-a5dc-4886a3992706">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5d014511-b622-4c6a-83d6-90c173617374">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9259bb97-4bb8-4319-ba1f-820301e54793"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/60eb4008-cfaf-4437-a86b-1d5c83e64118"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16635485</dc:provenance>
    <rdfs:comment>Topiramate+lamotrigine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24777537</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/614462">
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>836</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/c1e43e28-224e-4dfb-a186-5e621b67f688"/>
        <dc:identifier>https://www.omim.org/entry/614462</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/836</ddiem:iembaseUrl>
        <rdfs:label>HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES; HGCLAS</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d8562063-debe-47b1-90ec-02096b47fe97"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2e23a0a3-de38-45e1-b8eb-ccdc0bee76ea">
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
    <rdfs:label>glomerular proteinuria</rdfs:label>
    <dc:identifier>HP:0000100</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000100</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6c3cf7b7-ba5b-4982-9c85-9d0b792b8c34">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/298f193b-e6d7-472c-a8a1-ac3d22c506d5">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/888bfe1b-f202-48cd-a88a-39dd2e565fcd"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/309000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301653</dc:provenance>
    <dc:provenance>https://www.paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/59/33</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>Potassium citrate</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5a9a6573-1264-4a08-9481-520258be45d2">
        <rdfs:label>Metabolic acidosis (Hyperchloremic metabolic acidosis)</rdfs:label>
        <dc:identifier>HP:0004918</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004918</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c20e1970-9d55-431f-88e9-5b58d65e178c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/607014">
    <rdfs:label>HURLER SYNDROME</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseAccessionNumber>241</ddiem:iembaseAccessionNumber>
    <dc:identifier>https://www.omim.org/entry/607014</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/241</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/3e1abf48-b1ab-4188-ba39-e217d7d16cbb"/>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/dd06761f-60f0-4e33-9049-dadc7b980fa3">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <rdfs:comment>Antisense oligonucleotide</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21979053</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5da79f2e-9af5-4c21-8a4d-ea00a35bd4ab">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7f827072-f685-4a19-b3cf-19b8f9e0b9b4"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/0ad70eb7-90f3-487c-875c-31d2d4a0ae7d">
        <rdfs:label>Direct interaction (Mechanistic A)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/253800">
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/5fd877a4-ce97-4299-8ea9-37035ab06a8c"/>
        <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4</rdfs:label>
        <ddiem:iembaseAccessionNumber>642</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/253800</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/642</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/76123d11-47ab-4e2a-b7db-3a28a8ebdfae">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Abnormal Fukutin function</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9e2aa577-7f1f-438a-9bba-53b6db7d75d6">
    <dc:identifier>HP:0002150</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002150</ddiem:url>
    <rdfs:label>High calcium excretion</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/523e5589-6a8c-402e-b82e-9eae58cee0da">
    <rdfs:label>Obsessive-compulsive behavior</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000722</ddiem:url>
    <dc:identifier>HP:0000722</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3692d1b8-45c3-44a8-a56c-722bf9659a1c">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19304794</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/271245"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27551684</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e4ef1cd4-790c-4c9e-b816-cdfa0286f386"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <rdfs:comment>valproate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/615181">
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1121</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/615181</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11</rdfs:label>
    <ddiem:iembaseAccessionNumber>1121</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/093e37b2-7300-4bd5-9476-b922a1a41b43"/>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ff0934af-8eaf-4d05-86af-0ca933689f98">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12069112</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5d237eb7-db00-4fa9-9989-e206d52b2d82">
        <dc:identifier>HP:0010438*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010438</ddiem:url>
        <rdfs:label>Interventricular septal thickning (Ventricular septum abnormality)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/72e88d0c-8169-4d8d-9e72-e7ca0314262f">
        <rdfs:label>High left ventricular mass index ( Left ventricular hypertrophy)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001712</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001712*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e5bea7f8-801a-41f1-8ec8-d00a573413a3"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d2b23f09-5cf9-4b3e-9839-40ffcb18bf8f"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/deb49109-0fc3-4ff3-a0ef-29aaefc2c141">
        <rdfs:label>Disease progression (Rapid progression)*</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003678</ddiem:url>
        <dc:identifier>HP:0003678</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/56215b83-f7f0-4cc2-86b0-26098acba320">
        <dc:identifier>HP:0000639</dc:identifier>
        <rdfs:label>Nystagmus</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000639</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12771265</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/229300"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12368988</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c1702acd-4333-4391-b0e9-2f7e247ac0c2">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000570</ddiem:url>
        <dc:identifier>HP:0000570</dc:identifier>
        <rdfs:label>Saccadic ocular movement abnormality (Abnormality of saccadic eye movements)</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Idebenone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11907009</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/160387be-79af-423c-99b1-e038ba4dfb21">
        <rdfs:label>Cerebellar dysfunction</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001332</ddiem:url>
        <dc:identifier>HP:0001332</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18234531</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12771264</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4196c999-8684-4237-a847-7603238286cd">
        <dc:identifier>HP:0001251</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001251</ddiem:url>
        <rdfs:label>Ataxia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17826341</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bc8a5902-d793-4d3b-9aa6-9be91cee378f">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ff0fdbac-5589-49c5-a3b2-cb2aff951cbf"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25638506</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/253260">
        <ddiem:iembaseAccessionNumber>93</ddiem:iembaseAccessionNumber>
        <rdfs:label>BIOTINIDASE DEFICIENCY</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/93</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/253260</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/8e866274-773c-49dd-8d05-df5fc75f464b"/>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f8b55671-472e-4a1d-b4ed-b9fda12b2f95"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <rdfs:comment>baclofen</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28649539</dc:provenance>
    <dc:provenance>https://emedicine.medscape.com/article/942055-treatment</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a895f806-31ec-4ad7-816b-ddbe826777da"/>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26577040</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/acaeff1a-6952-4232-a2b3-6ae3c2c48623">
    <dc:identifier>HP:0000083</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000083</ddiem:url>
    <rdfs:label>Kidney failure</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d1917031-0105-4183-a4f0-2c3388c37541">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02376751</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a1940ed3-76e8-4623-9c53-ae4ec49ddcad">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8dc22130-4e21-45ae-8b42-e9b4ea33696e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27878737</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>sebelipase alfa</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2e306140-e369-4137-a34c-c45574dfa0e4">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003119</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003119</ddiem:url>
        <rdfs:label>Dyslipidemia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2170dc7c-c3d5-495d-972e-7abd19374be5"/>
    <dc:provenance>https://rarediseases.org/rare-diseases/cholesteryl-ester-storage-disease</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e33d1e72-e2f3-44fc-aad8-d7bff0367516">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002155</ddiem:url>
        <rdfs:label>hypertriglycemia</rdfs:label>
        <dc:identifier>HP:0002155</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9ac0fecb-b6e1-4aa4-997a-eb3ad085c731">
        <dc:identifier>HP:0003107</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003107</ddiem:url>
        <rdfs:label>High plasma cholesterol level*</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/278000"/>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/acd878d6-11a1-420e-8675-e4d10de10c99">
        <rdfs:label>Direct Interaction ( Mechanistic A)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/31bc9c63-7433-49bb-a831-1d7c278a65d9">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/4929571</dc:provenance>
    <rdfs:comment>Clioquinol</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a6b29bcf-5f9d-4e16-9715-2edcd0d79442">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011123</ddiem:url>
        <rdfs:label>Dermatitis</rdfs:label>
        <dc:identifier>HP:0011123</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/201100">
        <rdfs:label>ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/1ac80a26-c5ab-4592-a729-8f8e18db4a32"/>
        <ddiem:iembaseAccessionNumber>202</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/202</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/201100</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30669644</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1275520</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/13044560</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/375935</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a65c9236-e861-43c2-9597-ecfabed69eac">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/4acb7c8f-74a5-47bf-8d0a-00a85e2e307c"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/611105">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/611105</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/446</ddiem:iembaseUrl>
    <ddiem:iembaseAccessionNumber>446</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/97638dc7-0e83-454a-ae20-2175b4fa1337"/>
    <rdfs:label>LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL</rdfs:label>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d10ea3b9-9078-4cce-a795-643e37784c9c">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/754a90a7-f6af-4c50-bdcc-4fd31c9d7898">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000704</ddiem:url>
        <dc:identifier>HP:0000704</dc:identifier>
        <rdfs:label>Periodontitis</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897870</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/245010">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1110</ddiem:iembaseUrl>
        <rdfs:label>HAIM-MUNK SYNDROME; HMS</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/245010</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/e412280d-3598-4ddc-8041-c17d961a95c6"/>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>1110</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02534844</dc:provenance>
    <rdfs:comment>Acitretin</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2541f9ba-00f6-44b4-b578-99f4476a3391">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b42d829c-2816-43be-aa82-b1ba6a09734f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c1fc6958-4355-4e05-a582-4c825335fa7e">
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <dc:identifier>HP:0012279</dc:identifier>
    <rdfs:label>Low plasma serine levels</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012279</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/04a5b731-1351-4dd3-9aab-276ebf58133f">
    <dc:identifier>DB01592</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7ca427da-30e0-45c8-be75-425c37da906a"/>
    <rdfs:label>Iron</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01592</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/48954f3f-c451-4a18-9f4e-6a229dd33dc4"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/45745e4b-c86c-48e3-bba6-47ebc2edba27">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4097061f-14a2-4c4d-92da-bc7bbdc425b0">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/EC:0007121"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4721bc5d-016e-48dd-b72e-f2ac0eb4e382"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/79580e16-8baa-4b0a-a63f-2a1aa9164726"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/601678"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/results</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <rdfs:comment>Acetazolamide</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
        <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dd1cd505-08b7-4c9b-b737-d58d4052af8a"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Acetazolamide</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e8844ac0-0534-495b-8cfe-73868a28f35a">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/611105"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/bb32c6b8-da7e-442d-84a4-d07cfefb0117"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21749991</dc:provenance>
        <rdfs:comment>acetazolamide</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4721bc5d-016e-48dd-b72e-f2ac0eb4e382"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0a740550-fefb-41b5-a44b-af223563e0db">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/241200"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
        <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4721bc5d-016e-48dd-b72e-f2ac0eb4e382"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <rdfs:comment>Acetazolamide</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4abf0f12-373c-48e3-95fb-7cb92f7e3229"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00819</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4e262eb7-768b-4185-a239-a46212549226">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2268db48-48b9-43b3-89c9-b6e219d74f32"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/615398"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4721bc5d-016e-48dd-b72e-f2ac0eb4e382"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0387760417301742</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <rdfs:comment>acetazolamide</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00819</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7dd89407-ae91-46b1-9031-6905a6e55532">
    <rdfs:label>abnormal carbohydrate metabolism*</rdfs:label>
    <dc:identifier>HP:0011013</dc:identifier>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011013</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a60ca7f0-0b06-4cef-93a5-6cdfea43c8e3">
    <rdfs:comment>Recombinant human Aspartylglucosamidase</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27906067</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/17fa2cc0-ec24-494a-86f8-310bf729cb40">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <dc:identifier>HP:0001939*</dc:identifier>
        <rdfs:label>accumulating substance aspartylglucosamine from ( Metaboic abnormality)*</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10657992</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5b719ebc-af93-4309-981b-35e3335fdfb4"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20607610</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15342551</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/42880328-8fc7-42b3-9a49-fb75a1aeb93e"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28967191</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4c4514ce-27df-4873-a912-c2f2217e3a7a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/07645610-fd2b-4e68-b860-020cc6b509ec"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/09d0c68e-3325-4ef5-8e22-d267a4f2a900"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6967a638-dd20-4d56-ba40-c7492ab190ee">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0001939*</dc:identifier>
        <rdfs:label>High amount of aspartylglucosamine in brain tissue (( Metabolism abnormality)*)</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/208400"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b7013447-5001-4cfc-a9a8-8f8a6dd4c891"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3194e732-88cc-42a9-a7e7-55dad09a5788">
        <dc:identifier>HP:0000924*</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>pathology in many somatic tissues</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000924</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c3004eff-bac2-49cc-9b39-805f7fee67c9">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <rdfs:label>High amount of Man2GlcNAc2-Asn in in nonneuronal tissues ( Metabolism abnormality)*</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0001939*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6928fd06-bf16-452f-9adf-21667d147ab8">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00163</ddiem:url>
    <dc:identifier>DB00163</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ae1c99d4-7877-40f5-abf9-746f14a3f088">
        <dc:provenance>an enzyme-replacement therapy</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/275630"/>
        <dc:provenance>was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number</dc:provenance>
        <dc:provenance>"ENB-0040</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>NCT00744042.)."</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6c1ff06e-80a8-4bb2-b686-82d45be25f7a"/>
        <dc:provenance>https://www.researchgate.net/publication/8668575_A_successful_treatment_with_pyridoxal_phosphate_for_West_syndrome_in_hypophosphatasia</dc:provenance>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
        <dc:provenance>https://onlinelibrary.wiley.com/doi/abs/10.1111/pde.12170</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <rdfs:comment>vitamin E</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/062aea5a-fbfa-4083-b4e7-d8ec7c6d2b1e">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24751931</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/81acf49f-8aab-4077-92e0-2aa2905171a9"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d5b37736-0491-4901-9dbc-970bc9ffa0ce"/>
        <dc:provenance>https://link.springer.com/article/10.1007%2Fs00223-011-9562-5</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ace22609-5737-4441-8ef1-839a21e1f35a"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6de8c97d-bc64-43ae-a73f-13d2e401e34f"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
        <rdfs:comment>Vitamin E</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0891584915002671</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26086616</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/615558"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/76a7dc35-fdd3-48e0-ad93-e995b4f13875">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c4417832-d291-4bde-9761-9dfd8cbb17aa"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4f27ac92-656d-4b2b-9cf2-06d5d07ea122"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11554913</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301419</dc:provenance>
        <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27906067</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:comment>vitamin E</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9931538</dc:provenance>
        <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01797055</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e42919bc-a2c4-4c99-bdb8-2dd7d073ccc1"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4196c999-8684-4237-a847-7603238286cd"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277460"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/cdeee968-c942-429b-b8e5-5cc19f1d2dfc">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cd23f4e4-69c2-4321-a8c6-552ab59f491f"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17206463</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/77b92498-50d0-4d9c-8207-497f6088e2ac"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4cd15bc7-c49a-4c3c-938a-6be9f355a0d4"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2cda2783-38d6-463c-9f3f-87ab9fb7d852"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29340523</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/46a6998a-2d37-4013-9235-892123ae1a18"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7375069</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
        <rdfs:comment>alpha-tocopherol</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7caaf8f0-18ea-47bd-a455-2a6fd6f0690d"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ac1e22e6-2ee6-46bf-9cbe-97f37939831d"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5089ee78-362c-4d3e-a6ca-08d871a23fd1">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30358967</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7a97b45f-65f1-4a62-9273-3be3e0c3a471"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/200100"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/17092020-f6b8-4377-ac8f-d94a57c83bf8"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/34ed81c9-3a03-49a0-ba85-446a283aec0c"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26086616</dc:provenance>
        <dc:provenance>https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-3-20</dc:provenance>
        <rdfs:comment>vitamin E therapy</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25488886</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3954973</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Vitamin E</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9b5b2e4e-7899-4e0f-b89c-35770e4b189d">
        <dc:provenance>https://rarediseases.info.nih.gov/diseases/9683/chylomicron-retention-disease</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915691</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23329770</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <dc:provenance>https://www.nature.com/articles/nrrheum.2010.182</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246700"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
        <rdfs:comment>vitamin E</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/23277932-c1b1-4564-99a8-e06286110c44"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/50806ea0-e754-461b-a88c-41e14ef1bd65">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231530"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/study/NCT00840112</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1268113f-437f-4aa9-afd6-38ad5e2a94b0"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9379d84c-7971-4391-a049-81c2b21867e0"/>
        <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
        <rdfs:comment>vitamin E supplements</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c6e1ad06-7278-43a6-a183-20941b9e5d7d">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <rdfs:comment>vitamin E</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19066956</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18996862</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232220"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cc4e12ab-cdfa-43bf-9212-89a5c9fced8c"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2eb846fa-a76a-4739-90f0-34adc9963b88"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/42c07e0b-488f-405a-8000-d6f6ff392f9c">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0030390</ddiem:url>
    <rdfs:label>High urinary LTE4 excretion (Abnormality of leukotriene metabolism)*</rdfs:label>
    <dc:identifier>HP:0030390*</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3f08eefb-0732-4665-a5b1-9d287118abc1">
    <rdfs:comment>Zonisamide</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2c0eccc8-86c5-4054-bbd2-9a61224ff46f">
        <dc:identifier>HP:0002360</dc:identifier>
        <rdfs:label>sleep cycle disturbance</rdfs:label>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002360</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277400"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1e344a40-7f46-4d54-9248-e7550463113b">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b70e6a3e-ddb9-42f1-b194-43902b098586"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25511120</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e217dabd-b7b1-414e-9ed5-f5c2352a370e">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22812641</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/096606d5-6d70-42c1-b9da-f7287aba8616">
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
        <dc:identifier>HP:0031884</dc:identifier>
        <rdfs:label>Abnormal CSF glucose levels</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0031884</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/690a1bf8-149e-46bb-957d-6c195d358958"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23196212</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/35fea634-e6c5-4e64-9126-25556b6dda8a"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/774ee9d1-e9cc-408f-b1ca-e8ad6f031694"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29303961</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29624790</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b1178ad9-5dc0-42f1-bf42-cbc6cadd937b">
        <rdfs:label>Abnormal motor function</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004302</ddiem:url>
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
        <dc:identifier>HP:0004302</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/606777">
        <dc:identifier>https://www.omim.org/entry/606777</dc:identifier>
        <ddiem:iembaseAccessionNumber>480</ddiem:iembaseAccessionNumber>
        <rdfs:comment>The currently established or investigated precision medicine treatments include the ketogenic diet in patients with GLUT1 deficiency. https://www.ncbi.nlm.nih.gov/pubmed/27781560/ https://www.ncbi.nlm.nih.gov/pubmed/22812641/ https://www.ncbi.nlm.nih.gov/pubmed/12029447?dopt=Abstract
Clinical exacerbation in Glut 1 DS could happen with certain AEDs based on their mechanism of action or effects on the Glut 1 transporter. Common AEDs known to inhibit the Glut 1 transporter in vitro, for example, 1) phenobarbital https://www.ncbi.nlm.nih.gov/pubmed/12029447?dopt=Abstract , 2) Valporate https://www.ncbi.nlm.nih.gov/pubmed/16149077?dopt=Abstract 3) Benzodiazepines https://www.ncbi.nlm.nih.gov/pubmed/12029447?dopt=Abstract are relatively contraindicated in Glut 1 DS. https://www.ncbi.nlm.nih.gov/pubmed/22812641/
In addition, combination therapy of KD and carbonic anhydrase inhibitors—for example, topiramate, zonisamide, and acetazolamide—may increase risk of non–anion gap metabolic acidosis and urolithiasis, and should be avoided if possible https://www.ncbi.nlm.nih.gov/pubmed/20466520?dopt=Abstract</rdfs:comment>
        <rdfs:label>GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/879be4f5-b2c7-4af9-b477-b440c4db8080"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/480</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02000960</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a12d6b7c-71a3-4eb7-b5ee-206a495344c9">
        <dc:identifier>HP:0007166</dc:identifier>
        <rdfs:label>Paroxysmal exertion-induced dyskinesia (Paroxysmal dyskinesia)</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007166</ddiem:url>
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02014883</dc:provenance>
    <rdfs:comment>AAV-GLUT1</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2ab33bf8-0d27-41a2-b105-27bdde4663af">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1048e803-c5b6-4ef2-946e-bc8fed7d0631"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fc042b29-edc6-463f-8055-3504281049cc">
    <rdfs:label>Low lumbar spine bone mineral density(bnormality of bone mineral density)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004348</ddiem:url>
    <dc:identifier>HP:0004348</dc:identifier>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/509aa598-6282-42f5-bccb-50494386aa52">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17065067</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22198833</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300322"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27179999</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/96abab13-51ab-4618-abdf-6684c5b3dd5c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8f5c6ff7-0b96-4a7a-9201-6a82628aff5f"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3d1a49fd-7b68-4b94-86a9-4e115d9bea29">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001997</ddiem:url>
        <rdfs:label>gouty arthritis</rdfs:label>
        <dc:identifier>HP:0001997</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://rarediseases.org/rare-diseases/lesch-nyhan-syndrome</dc:provenance>
    <rdfs:comment>Allopurinol</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/37e6a791-ba00-4b04-b3df-7e04f29f4bba">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00641</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5fc817cc-9b12-4f94-8527-4d432035eab1">
        <rdfs:comment>simvastatin</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c5688c76-3b45-483f-8e31-81b740b81205"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e615b6a3-fb9a-40aa-b643-a19826e2cba1"/>
        <dc:provenance>"ENB-0040</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6a4b4c01-2130-434e-99c5-03e9f4e79a59"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <dc:provenance>an enzyme-replacement therapy</dc:provenance>
        <dc:provenance>NCT00744042.)."</dc:provenance>
        <dc:provenance>https://www.researchgate.net/publication/8668575_A_successful_treatment_with_pyridoxal_phosphate_for_West_syndrome_in_hypophosphatasia</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096504</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cc94b431-39aa-42a1-8dd8-eb8b172a73bc"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909487</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b3c4afc9-72ef-4997-bb9c-dae2e4acaa69"/>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
        <dc:provenance>was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/55d50f41-5630-4427-a998-8e2cefabd1b1"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/308050"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/655bc1a9-eae0-491b-ab87-310c35490a51">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28098593</dc:provenance>
        <rdfs:comment>simvastatin</rdfs:comment>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0021915015001379</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b3c4afc9-72ef-4997-bb9c-dae2e4acaa69"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25768710</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3bf6c992-71de-460c-8e7f-272b250296d0"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/af4a382c-d530-4a2c-90fd-45e36835c99b"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10385780</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00641</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3d03cede-aa0c-4e3c-9cc3-1f8bb0b5c9c2">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16848116</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27878737</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b3c4afc9-72ef-4997-bb9c-dae2e4acaa69"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/02e697d4-329e-4fd3-8227-5806370c078e"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/278000"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <rdfs:comment>Simvastatin</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4dce9890-b785-4745-9b52-f6bd1c92fe38">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22740624</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b3c4afc9-72ef-4997-bb9c-dae2e4acaa69"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6e3eb3d9-a85f-4dfb-9e0b-3dcd0375b502"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19011501</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <rdfs:comment>steroids + simvastatin</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7936305</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/260920"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Simvastatin</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/23d4450e-d1a2-4db0-a931-f14129d1597e">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24142275</dc:provenance>
        <obo:RO_0003304>p.K148E and p.D210E</obo:RO_0003304>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/40c9cdf8-66d1-40ba-a764-16e52ecfe412"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b3c4afc9-72ef-4997-bb9c-dae2e4acaa69"/>
        <ddiem:failedToContributeToCondition>c.479C&gt;G p.(Pro160Arg) and c.630C&gt;A p.(Asp210Glu)</ddiem:failedToContributeToCondition>
        <rdfs:comment>Simvastatin</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/28f9aa83-f122-4837-9b0f-8e567977df85"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607330"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30097991</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/87d92598-33f1-4315-a96a-a919a96ec3ef">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30297385</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/614080">
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>1145</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f9c8cb7b-0e47-4363-973f-6863b11c0d5a"/>
        <dc:identifier>https://www.omim.org/entry/614080</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1145</ddiem:iembaseUrl>
        <rdfs:label>MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>levetiracetam</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00923247</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00704730</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886552</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5ca28c24-9eac-4f3c-aebe-d4fc037deded"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/22b95a8b-490a-4cb2-89e1-6d987f745b85">
    <dc:identifier>DB01001</dc:identifier>
    <rdfs:label>Salbutamol</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01001</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6638bc6a-2d36-4006-a06c-88947e8c83a7">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2117c3fe-1150-45fd-bef1-ca91e61eca52"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <rdfs:comment>salbutamol</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c3c39daf-a44b-4718-a5f1-b212491b5f76"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/151800"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/189284e5-b37a-409c-8ca1-046aac6b85db"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b8518e35-c60b-46ed-bc46-d66ffbec7fe9"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2897261</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ce6c3cac-55a5-4ecf-b0e6-c80960b88c65">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24912437</dc:provenance>
    <rdfs:comment>phosphorus</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7564233</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/202ec454-8fbe-41cf-90c5-871a2901ba8d">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002748</ddiem:url>
        <dc:identifier>HP:0002748</dc:identifier>
        <rdfs:label>Rickets</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27155573</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/227810"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/de56e25c-4255-43e8-bf25-341c3da98c2a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/643481c7-52af-408e-8cc1-169762d76c38"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ca211275-2bde-4976-a700-7c2714348859">
    <rdfs:label>choroidal neovascularization</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011506</ddiem:url>
    <dc:identifier>HP:0011506</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6593d153-b920-4ee1-ac7d-58671e9d00a0">
    <rdfs:comment>idebenone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28125198</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15326254</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24164873</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/612016">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/2b660442-6b34-4946-8348-fd590ff0d8c0"/>
        <dc:identifier>https://www.omim.org/entry/612016</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e5bea7f8-801a-41f1-8ec8-d00a573413a3"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9176bbd9-6613-43d4-962d-24f36e8b9fd6">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24854628</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3dad3439-0d4b-46b5-b8d3-c3a969efac73">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003233</ddiem:url>
        <rdfs:label>Low HDL cholesterol concentration</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003233</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.clinicaltrials.gov/ct2/show/NCT01942291</dc:provenance>
    <obo:RO_0003304>R219K</obo:RO_0003304>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/604091"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19770656</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/29649530-bd21-4c42-9a2c-7754b5e5aae8">
        <dc:identifier>HP:0003141</dc:identifier>
        <rdfs:label>Increased low-density lipoprotein cholesterol concentration</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003141</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28225998</dc:provenance>
    <rdfs:comment>Pravastatin</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a25cf4dc-afeb-4fcd-b207-cac882636231">
        <rdfs:label>hypoalphalipoproteinemia</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003233</ddiem:url>
        <dc:identifier>HP:0003233</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18993152</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1211d4c5-c5f8-47d5-b2d1-59477d0292e0"/>
    <dc:provenance>https://www.clinicaltrials.gov/ct2/show/NCT00458055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f255997f-e9d5-4850-9360-e2b02daf4a71">
    <rdfs:label>Chloroquine</rdfs:label>
    <dc:identifier>DB00608</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00608</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/306d24ff-f6a5-43af-8761-610a578b58ef">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/5080345</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/bab07633-cc70-4a18-83a9-75d9e9d864bb"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12622622</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0003304>C282Y/H63D  heterozygosity or compound heterozygosity</obo:RO_0003304>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0a25a06b-877b-4cab-ae83-3bee43708f1d"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/4739135</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/f6f31b55-0553-4ec2-a9b5-e98daae597fe"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b9e2beb2-b9ea-4429-b1ad-2a6e94c6dd24"/>
        <ddiem:failedToContributeToCondition>C282Y(Homozygous mutation)</ddiem:failedToContributeToCondition>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a87c5af8-3171-4ef3-a674-e8dcc07c1c25"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7324107</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dcd847d5-f908-4d6f-9f9f-097bfe075e8b"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/176100"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2170dc7c-c3d5-495d-972e-7abd19374be5"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3cc64808-1486-4cfd-9e11-2b3253d0b95c"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0022202X15441491</dc:provenance>
        <rdfs:comment>Chloroquine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c4fd9ef9-7d24-4f5a-8d73-567f78485bb7">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a8725253-b87e-4e5a-b733-4f38507d6f32"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5c734584-ad68-4c58-822f-8e035f006227"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ea9b99e8-a7c3-4566-aa47-5063ec6e9fc6">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/e7ef8ad5-3f16-42f6-8c74-6854065e2254"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0003304>G11778A</obo:RO_0003304>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e46e5ff1-e129-41ee-94d2-4961bef4d452">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000648</ddiem:url>
        <dc:identifier>HP:0000648</dc:identifier>
        <rdfs:label>Optic atrophy</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30208599</dc:provenance>
    <rdfs:comment>MTS-AAV carrying the wild type ND4 gene (mitochondrial targeting signal peptide Adeno-Associated Virus)</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/535000"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0f16a777-6922-4720-9790-73f96ea67f17"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d045cd97-8d78-4052-8809-46854d184580">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025464</ddiem:url>
        <rdfs:label>Low ATP synthesis</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0025464</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03153293</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fac069c4-b3c0-41ba-acb1-d0f5330c3a76">
        <rdfs:label>Abnormal visual acuity</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0030532</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0030532</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ee4a0880-fb2d-4f08-b8ab-369ce030e955"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/25b06abb-2e6d-4c27-a04b-9529a33429bf">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0031429</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0031429</dc:identifier>
    <rdfs:label>low bone formation biomarkers</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cff5ad14-37fc-4cc2-8a2b-6a64e90c0d89">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004396</ddiem:url>
    <dc:identifier>HP:0004396</dc:identifier>
    <rdfs:label>Poor appetite</rdfs:label>
    <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d6a09491-5812-42c3-93f1-85ab8d591539">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1f7852d5-ab4b-4dc9-a238-6d6e8dc30f4f">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fa2ab50d-525a-4059-9f35-e3b061ea0697"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/162000"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/96abab13-51ab-4618-abdf-6684c5b3dd5c"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/66627da1-d563-45fd-9f7c-1289bf6bc60d"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12205338</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11068651</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:comment>Allopurinol</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fef3cab2-d697-4892-9a75-0375d901fffa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02527343</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/509aa598-6282-42f5-bccb-50494386aa52"/>
    <dc:identifier>DB00437</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ee5b11be-91fb-4a4b-9ba3-1fbbb665ae17">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29241594</dc:provenance>
        <rdfs:comment>allopurinol</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/b36f76db-0236-40b5-bbf3-1f048a61940a"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c94b730b-118b-4845-bc60-db7803d46608"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7371c4d5-8d20-49c3-8bb8-67e00562ca18"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8d858f21-a336-45e4-886d-521178973a5f"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0c60442d-2216-4830-bce9-82a95d7e259f"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK100238</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c95bb30d-30ea-4b6c-b21b-1d469c4a5d59"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dbfa5a46-1f7b-495e-b543-48b66dc9ac57"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/81bd1bb5-5160-4b34-912d-f3687bf6093b"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f7576e15-49a9-4b69-a3c2-6a50a28a476d"/>
        <dc:provenance>https://academic.oup.com/ckj/article/9/6/800/2709623</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/614723"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02752633</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15767622</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/96abab13-51ab-4618-abdf-6684c5b3dd5c"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00437</ddiem:url>
    <rdfs:label>Allopurinol</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/66091996-ff0d-4cac-92b5-670a411ac69a">
        <dc:provenance>https://www.semanticscholar.org/paper/Glycogen-storage-diseases%3A-Diagnosis%2C-treatment-and-Chen-Weinstein/439025d057229db1b3a117cb02b3c7e6f2bd3580</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/96abab13-51ab-4618-abdf-6684c5b3dd5c"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26835382</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:comment>Allopurinol</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20975743</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a3cb2805-5c7c-49f6-894f-01abcdabbd25"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/74cdd155-71da-4b10-a023-783d7f9f1545">
    <rdfs:label>ARC-AAT</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5c9d999d-c294-4411-970d-e0022d708cd2">
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508465</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30477028</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02363946</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30049652</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/beac3d8c-1e79-4f96-a6d1-60b38e63fe93"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/613490"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d191df51-db35-4d64-8357-598dae89aaa6"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23527792</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02900183</dc:provenance>
        <rdfs:comment>ARC-AAT</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/497b9786-8808-49aa-a2d6-62222205f1f5">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Granulocyte colony stimulating factor (G‐CSF)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7caaf8f0-18ea-47bd-a455-2a6fd6f0690d"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/302060">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a8f05d4d-cbf8-4925-bb5f-1e3beb03c69d"/>
        <rdfs:label>BARTH SYNDROME; BTHS</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/59</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>59</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/302060</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0f5ea12d-6321-4ccf-8ba8-7a2374803109"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cbbe3a29-20f5-416e-9c0c-1da74982444f">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/566fc670-a396-47e6-876e-a5ea7c33d4c9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15098233</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/bdf55f6b-b526-49b5-b8c8-a35d352ae890">
    <dc:identifier>DB01324</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7dc88e23-360e-47c0-9f3a-20878f1c186d">
        <dc:provenance>https://www.clinicaltrials.gov/ct2/show/NCT01554800</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/245900"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fdd54c06-67dd-41ec-b416-d98ae771b968"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23391322</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02527343</dc:provenance>
        <rdfs:comment>Thiazide</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c2c00c0e-5e04-4e20-8d96-a1830c732336"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01324</ddiem:url>
    <rdfs:label>Polythiazide</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e8a85692-d733-4ab2-a52a-fc2c85bd5ca5">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/219800"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016220</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c2c00c0e-5e04-4e20-8d96-a1830c732336"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f06f6404-3120-4143-83cc-67726d61d4d2"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27102039</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3550461</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8444253</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505515</dc:provenance>
        <rdfs:comment>Thiazide</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/a02d68f3-d860-4045-81b1-85d4ac40680a">
    <rdfs:label>Phenylacetic acid</rdfs:label>
    <dc:identifier>DB09269</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09269</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d9084a3e-3cc8-4057-9065-80d1e1dc83e3">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c5cb1f61-3d36-4ce8-ac54-216d75160f69"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12948744</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6c37d423-92c1-45fa-96c6-3440a6085ae1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719215300895</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9156798</dc:provenance>
        <rdfs:comment>sodium phenylacetate</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608158"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0006a2ee-bb72-4795-8670-f1fde6208830">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <rdfs:comment>flavanols</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/604250"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/144c84b9-c73a-4b93-bb82-1efd8b82c105">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8491e08a-6991-4092-916d-c2f3cabd6340"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ef9f70eb-c532-475f-af9e-a08738131a0c"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/96bf0b70-640d-4855-9df3-efb662012d8c">
        <dc:identifier>HP:0011031*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011031</ddiem:url>
        <rdfs:label>iron overload(Abnormality of iron homeostasis)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03453918</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/71bbc2c0-66af-4354-99fa-ae8650ffa62a">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2271f49e-138b-4510-b9d5-303852c8608b">
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277400"/>
        <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/caa4fe0b-e6ba-43c6-8d8f-8ba11c714932"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e8ec0612-d996-40e6-8803-326cfe5c6506"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
        <rdfs:comment>Fluoxetine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
        <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2ef24f64-8f70-4b4a-bbd2-9a3c2e28db23"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25511120</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Fluoxetine</rdfs:label>
    <dc:identifier>DB00472</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00472</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/462e81d3-234b-4cb9-b6f5-0c1d203ee686">
    <rdfs:label>Geneticin</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB04263</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/edaeeb2e-ad08-4c5e-8f53-4c09235ea257">
        <rdfs:comment>Aminoglycoside (Geneticin)</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23772144</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607364"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
        <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/7e2fb6e5-7eef-4c22-b542-36d9057b6125"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <obo:RO_0003304>W610X</obo:RO_0003304>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5235cad0-6d5d-48cb-b5be-96b3e0be4239"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4a507c00-3886-461b-8d2f-e399f74f9b95"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB04263</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a348755f-9b79-4e58-82ef-2824c6911577">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fac09895-cee9-4a7e-b5b8-58347021b092">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c6553506-0f29-407a-8ba3-f2dfd479d96f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719212002971</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8836184e-41e9-4ec6-9968-4a1911ee7e6b">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002353</ddiem:url>
        <dc:identifier>HP:0002353*</dc:identifier>
        <rdfs:label>Slow background activity in the EEG(EEG abnormality)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1bf591ef-d853-42c1-bd5b-0ad546c81cc3">
        <dc:identifier>HP:0001250</dc:identifier>
        <rdfs:label>Epileptic seizures</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/be4d8a50-91ec-4650-b54b-64d4cba19585">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002453</ddiem:url>
        <rdfs:label>Bilateral abnormal signal intensities in the globus pallidus (Abnormality of the globus pallidus)*</rdfs:label>
        <dc:identifier>HP:0002453*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719213003107</dc:provenance>
    <rdfs:comment>l-ornithine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29506905</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11749046</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719213003661</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/612736">
        <rdfs:label>CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/104</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/612736</dc:identifier>
        <ddiem:iembaseAccessionNumber>104</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/bdd044cf-6842-4f46-b71f-1eee00e8f425"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01328587</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2679ee93-1d05-4a37-a74e-7a62c7a2ccc2">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0001939</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
    <rdfs:label>Elevated serum toxic intermediates in isoleucine pathway</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9eda26fa-ba92-411f-b88c-9e4d347fa959">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c59c2836-6a3b-4762-b29e-27815f2edb5c">
        <dc:identifier>HP:0010819</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010819</ddiem:url>
        <rdfs:label>astatic seizures</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/79d106d9-49be-4436-a3af-bc6d3f7e0534">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002123</ddiem:url>
        <rdfs:label>Myoclonic seizures</rdfs:label>
        <dc:identifier>HP:0002123</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22734130</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/613068">
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>71</ddiem:iembaseAccessionNumber>
        <rdfs:label>NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/71</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/613068</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/e9e57ce6-fc1c-4c97-8a2f-ff53cae17180"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2f7e2a09-b2e1-4eab-97d7-781d8e735454">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000735</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000735</ddiem:url>
        <rdfs:label>Impaired social interaction</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a48d4417-25f3-42b4-abed-702601b53e07"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301583</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1316120</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <rdfs:comment>folinic acid</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5c58afe7-c648-40b3-8989-9f406302cd99">
        <rdfs:label>Movement disorder</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100022</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0100022</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ab77f8f7-af95-49bd-a101-6a5cb132e5ac"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727671</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/66745254-345f-4d9e-93bb-79b442e123f2">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cdb292a2-691c-49c8-ad7b-ce6d5da146c0">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ed0e945a-6daa-4e01-bc5c-6af88d018197"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2885f764-42aa-46a0-a0d8-6b57f2977496"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.clinicaltrials.gov/ct2/show/NCT01554800</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1530bf3b-22b5-4801-8448-ec4384a92c83">
        <dc:identifier>HP:0000093</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000093</ddiem:url>
        <rdfs:label>proteinuria</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f75e0048-7bb3-4495-8969-214e3b1ff7d0">
        <rdfs:label>low HDL-C level</rdfs:label>
        <dc:identifier>HP:0003233</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003233</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bffbfcf8-00c2-4519-9ba6-def5d8ffc01a"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/65b6cee5-37e1-4d38-ab2d-ab02966f9d40"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5b7926cf-41a4-4db7-986d-7d09f099cebe">
        <ddiem:url>http://purl.obolibrary.org/obo/MP_0011598</ddiem:url>
        <rdfs:label>Abnormal lecithin:cholesterol acyltransferase activity</rdfs:label>
        <dc:identifier>MP:0011598</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ec097a3c-6e9e-4d4d-bc30-22dc2a09ff9a"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a296f458-f99c-4068-a1a1-01d8fec389f4">
        <rdfs:label>dyslipidemia</rdfs:label>
        <dc:identifier>MP:0003949</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/MP_0003949</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0b8c3258-20ad-4afe-8c88-639465d2ebc3">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003233</ddiem:url>
        <rdfs:label>low HDL level</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003233</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826469</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/72503413-10b1-4d3b-9352-e0e0298f8a11"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fdf4384c-8c82-4cfb-aa70-b7fd521f88af">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001903</dc:identifier>
        <rdfs:label>anemia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001903</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1c2851d9-5194-47d9-bf85-18a30785d0e4"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ed4e74fc-e2f5-49cd-a781-285dd898b927">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/MP_0003193</ddiem:url>
        <dc:identifier>MP:0003193</dc:identifier>
        <rdfs:label>Abnormal cholesterol efflux from cells</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/acc20c5b-137e-45ba-8274-b43fc4189fd0">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003119</ddiem:url>
        <dc:identifier>HP:0003119</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>abnormal plasma lipids levels</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a7ca6dd8-d0f1-498c-a3af-b2013ffb3554"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5a8c00ac-664e-4fcc-8f21-f7e81df205ff">
        <rdfs:label>Low Apo B protein level</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025201</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0025201*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/98709acf-7d33-4637-b04a-02c1acb192d3"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c7561940-d6a3-493e-ae83-ef2f0c5ef06b"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4a8c7dee-9f16-4dbd-aea4-fbc772d624ee"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/245900">
        <rdfs:label>LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY</rdfs:label>
        <ddiem:iembaseAccessionNumber>380</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/380</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/fb4f3a1b-6601-43be-90e0-5bc8d25d9530"/>
        <dc:identifier>https://www.omim.org/entry/245900</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d4aab048-1fdc-4d14-b582-8732e485a394"/>
    </obo:RO_0000057>
    <rdfs:comment>recombinant human LCAT (ACP-501)</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02527343</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c5cb1f61-3d36-4ce8-ac54-216d75160f69">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a02d68f3-d860-4045-81b1-85d4ac40680a"/>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/74652e03-7b41-43dc-8b15-869e3e827ffe">
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <rdfs:comment>Sodium Pyruvate</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e1ddf8e4-a1ec-422a-b8cc-4bad472a9650">
        <rdfs:label>High serum GDF15 level</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b6d06603-dfef-41aa-8d04-29d3bbf57545"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/540000"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6dc68e13-9ec4-4ba5-9504-c70e04bb6d4e">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Increased lateral ventricular lactate level</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bd5c9eca-0945-4845-a992-9014b4ecc579">
        <rdfs:label>High lactate ,pyruvate ratio</rdfs:label>
        <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>http://ichgcp.net/clinical-trials-registry/NCT03432871</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30738201</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/390a5d5e-0207-4319-8f10-e21dd3dcd9b3">
        <rdfs:label>Elevated serum lactate level</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002151</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002151</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f59643a1-22c1-490e-8061-220308784cec">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/230650">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b1e3e3e8-a5e9-453e-a947-0d77e8dd2b22"/>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>GM1-GANGLIOSIDOSIS, TYPE III</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/230650</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>miglustat</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c36f79c8-ad54-4119-9f76-7f1d1b0e6a21">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002066</ddiem:url>
        <rdfs:label>ataxic gait</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002066</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.tandfonline.com/doi/full/10.3109/0886022X.2014.900422</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c7a11941-2d00-4d77-8190-1589b6729c29"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e728a26a-66ad-44e6-ba16-d318c573f7b2">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>High ganglioside accumulation</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02030015</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/53b52a7d-649b-4a36-82b8-d1f7f8d3d56f">
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0166432805003657</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/239500">
        <dc:identifier>https://www.omim.org/entry/239500</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>40</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/08d0e46f-eb28-4e86-b6c0-d3ed563af859"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/40</ddiem:iembaseUrl>
        <rdfs:label>HYPERPROLINEMIA, TYPE I; HYRPRO1</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>α-Tocopherol+ascorbic acid</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e34cb317-1033-4c3d-8e21-54afb53b5291">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>cerebral cortex acetylcholinesterase inhibition</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/47e29ab6-c894-4551-8fcd-d56f01c860d9"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b3ac5274-74da-4beb-bbaa-fe3f26372567"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b48fcfb6-ff3c-4c3b-9701-482eab643888"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4a808543-0b95-4bd1-a3a4-b72e83fd1ad8">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0100753</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100753</ddiem:url>
        <rdfs:label>impairment of reference</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0c73fa71-9f40-4b7a-9e6d-f37602681eb9"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bd791b0f-53fd-4b98-b132-d46e9ab14c04"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2c4fe7e4-6620-42ce-a964-4d7dc0a619de"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24980685</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2d741476-7975-4373-835d-7a022fb3f7f6">
        <rdfs:label>"hippocampal Na+, K+-ATPase reduced activity"</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/41b93049-ecc2-4de8-ae0a-d492cf61c32f">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7e0fac39-f7fb-4049-b9c0-4539dec653d5"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d979b073-3682-4606-88ae-3da6d96aa5f4"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/91761b55-5c5e-4bb9-8281-543d5e7eaeb9">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14517515</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f4757265-de2b-4bc9-983b-73d094b60df5">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8b14f50a-d8b4-4025-b409-a3c775e4bc51"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/736f1487-58d7-4c16-83a3-6e449b00e851">
        <rdfs:label>high plasma level of unconjugated bilirubin concentration</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008282</ddiem:url>
        <dc:identifier>HP:0008282</dc:identifier>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <rdfs:comment>orlistat</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00461799</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/218800"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17957158</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6990c767-3cf0-404b-b5e6-95943c805fbb">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001903</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0001903</dc:identifier>
    <rdfs:label>Decreased hemoglobin</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4cad9017-039d-4f83-a700-4b9c5eedd631">
    <rdfs:label>abnormal fat metabolism</rdfs:label>
    <dc:identifier>HP:0004359</dc:identifier>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004359</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/859b0212-2f63-4de2-84c2-50cbe9bd14fe">
    <rdfs:label>Delayed motor development</rdfs:label>
    <dc:identifier>HP:0001270</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001270</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/237400">
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/161</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/237400</dc:identifier>
    <rdfs:label>HYPER-BETA-ALANINEMIA</rdfs:label>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/840540d2-6223-46ce-a4e8-92011ddd0cef"/>
    <ddiem:iembaseAccessionNumber>161</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/551ad276-a312-485c-88aa-3c483c4676ba">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002904</ddiem:url>
    <dc:identifier>HP:0002904</dc:identifier>
    <rdfs:label>Hyperbilirubinemia</rdfs:label>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c3426d64-5f2b-4063-bd74-27ca873b8e2c">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23770102</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/86da0bba-0b3b-4bf3-b23a-e2b18a4d127d">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002463</ddiem:url>
        <dc:identifier>HP:0002463</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>language impairment</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ece8d914-0146-4aa5-9909-d070e3618eb4">
        <rdfs:label>communicative skills abnormalities</rdfs:label>
        <dc:identifier>HP:0002474*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002474</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/26b42350-d9a5-45df-a4ec-c7b4afdfd760"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b751bc0f-6e70-496c-a0aa-ad41dfb70f4c">
        <rdfs:label>neurodevelopmental delay</rdfs:label>
        <dc:identifier>HP:0012758</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012758</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/234c0395-5627-4bd6-9a46-1b8025a64c34">
        <dc:identifier>HP:0012113*</dc:identifier>
        <rdfs:label>Low cerebral creatine content</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012113</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24355692</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/08ba9657-fd93-43d5-a691-9b2f620df8af"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2a8e1951-9c4c-4823-b47a-da4a1b6525af">
        <rdfs:label>Low developmental score</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012759</ddiem:url>
        <dc:identifier>HP:0012759*</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>creatine/Creatine phosphate</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b8cc8b59-d057-4d0b-aff0-735096484d6d">
        <rdfs:label>behavior al abnormalities</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000708</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <dc:identifier>HP:0000708</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20682460</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20625172</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8bd12c75-8508-4607-909e-913687e2bf28">
        <rdfs:label>psychomotor retardation</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <dc:identifier>HP:0001263</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001263</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/338b9e14-f1de-459a-9444-42150610e92c">
        <rdfs:label>Low IQ score</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001249</ddiem:url>
        <dc:identifier>HP:0001249</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14739681</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22386973</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9a340340-89ed-4b39-b300-a614a5a801ae">
        <rdfs:label>METABOLIC ENCEPHALOMYOPATHY</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/ee41b521-2653-4540-b72c-053f925f032d">
        <rdfs:label>Functional interaction(Mechinistic B)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/602360">
        <dc:identifier>https://www.omim.org/entry/602360</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/3da4d3db-e1d2-487c-9c78-b8d88c37d8b6"/>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>L-ARGININE:GLYCINE AMIDINOTRANSFERASE; GATM</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8428e22d-ca6c-4206-ad06-b996a65fe219">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f0243d95-d0cc-4afd-b2f6-e970dac7dc82"/>
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b5e4ee94-6c63-4827-b33b-f3266f8dee78"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/415bb0ef-74d0-4a2c-b925-9b7440e4a785">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ef424344-369f-476b-9ca8-f2468fe60809">
        <ddiem:url>https://www.drugbank.ca/drugs/DB13178</ddiem:url>
        <rdfs:label>Inositol</rdfs:label>
        <dc:identifier>DB13178</dc:identifier>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7b83bc4f-dd0d-4b02-9595-7323193526dd"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4208c66a-4a3f-48f5-b1ff-0a1229625507">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/62861ca0-08f1-455c-8f4b-3c144129754d">
        <rdfs:label>Glyoxal-bis(N(4)-methylthiosemicarbazonato)-copper(II) CuGTSM</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/5037c8ff-0b45-43e9-91bc-d8ed0e3be089"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8b45413f-1aa8-48ea-b40f-41aa8404d2e9">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ef75701a-a6e2-48ad-bbbf-5331b9be3a4b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564511</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3e97d301-6650-4d36-b1aa-15bbcda55677"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25266922</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261750"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC324959</dc:provenance>
    <rdfs:comment>Complex Carbohydrates</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5ad24800-b38c-4e1a-8855-ff6c0ef907d4"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/dbc698fa-9afa-41e2-8ff3-03bc2b9bdff3">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/adfd9f50-734e-4187-8975-569a5e40f41e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0903f5e5-26e2-4a8a-ba88-5a82e652135d"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1ed0b517-71ff-460d-8e5d-03625ffb7d1a">
    <rdfs:label>Recombinant alpha 1-antitrypsin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/672eace9-0392-4c67-9a57-9c22ce3cb4e2"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB05481</ddiem:url>
    <dc:identifier>DB05481</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7b913187-383d-43cc-80c2-6107771627f0">
    <dc:identifier>HP:0002910</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002910</ddiem:url>
    <rdfs:label>abnormal aspartate transaminase</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2c2d9c73-67dd-4112-ba21-28ef7138df5c">
    <rdfs:label>LJPC-401(Synthetic human hepcidin)</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/67b37800-c2be-4c01-b268-d1d930521280">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/604250"/>
        <rdfs:comment>LJPC-401(Synthetic human hepcidin)</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e2a9f175-e619-41d9-b7f0-72911aa4c9ba"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03395704</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/64a3cefd-09f6-497d-837e-331e5e19f94a"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00001203</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9052a9b8-f668-459c-9aab-7509daea11af"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/af5f4cd1-ae1c-4607-b49b-1c7476695018">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/239500"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28285122</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/7199c277-e274-40f1-b74e-be9b419517f4">
        <rdfs:label>Symptomatic(C)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <rdfs:comment>Pyridoxine phosphate</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9fef7edd-4aa1-4163-bf31-ecb058857290">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b684f056-f5ad-4327-9ae1-652267ec3a20"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs10545-013-9660-9</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e24ce5f7-5846-4455-9369-ea722d103166">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03021941</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2f2617ff-e92a-4281-9a93-830579272fa3">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1a6cf0d6-a4a8-49e7-af15-f78b072b3186"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e9880d1f-dfa8-468f-878c-59e876c1c19c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28381550</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT01422187</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/90b0d1da-41c6-4af5-bae7-665c57daa286">
        <dc:identifier>HP:0001744</dc:identifier>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <rdfs:label>Splenomegaly</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001744</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0d71fb46-feed-4596-b46c-814f63907bb5">
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <rdfs:label>low bone marrow fat fraction value</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27839981</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23860343</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30066229</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29471850</dc:provenance>
    <rdfs:comment>Taliglucerase alfa</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/230800"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507263</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27499018</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28131618</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27102949</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21503667</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/82a3bad3-c345-4fcc-ba5d-c41fe6d92912">
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025547</ddiem:url>
        <dc:identifier>HP:0025547</dc:identifier>
        <rdfs:label>low mean hemoglobin concentration</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/81e1419e-62bf-436a-bd47-1390125ea3c2"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b6b1b260-a41d-411d-a6bd-f2e8a75a6b75"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29388611</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22916340</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fea38ed2-e9bf-4adb-b525-cc52e830ab52">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e58f36c2-f2f0-4c43-b367-71f19293d573">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/55cfdae5-d380-4db4-b244-2f920869f1c7"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7db6aba5-ef7d-48cb-ab4a-bab47726f2cf">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>MP:0009587</dc:identifier>
        <rdfs:label>abnormal sphingosine level(Abnormality of lipid metabolism)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/MP_0009587</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d295467f-0658-41d1-ac2f-737547ab0135"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23681708</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/228000">
        <ddiem:iembaseAccessionNumber>1297</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/228000</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1297</ddiem:iembaseUrl>
        <rdfs:label>FARBER LIPOGRANULOMATOSIS; FRBRL</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/024bd978-5a30-4ab0-9682-46b2ea51c72c"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3cf1b605-d839-4707-9870-6e2eb17a3239">
        <rdfs:label>high plasma MCP-1</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bd10bcfe-49ed-4f06-91c0-250b7f8d8629">
        <rdfs:label>Abnormal tissue lipid profiles(Abnormality of lipid metabolism)*</rdfs:label>
        <dc:identifier>HP:0003119</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003119</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/762255c2-83b7-4df4-9a77-058ec5995373">
        <ddiem:url>http://purl.obolibrary.org/obo/MP_0020582</ddiem:url>
        <dc:identifier>MP:0020582*</dc:identifier>
        <rdfs:label>High intracellular cermaid level</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2931ebdf-9ae3-4cce-9411-610530b5a399">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Delayed growth</rdfs:label>
        <dc:identifier>HP:0001510</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001510</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/654e775a-f530-4c6e-8b5c-3e354bbd4b6b"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6d85c475-f300-46a5-9762-2e14c1e6e9fa"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28275553</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cea8dc73-6129-46bc-a01f-ad1ba12f8a6f"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c5aed638-488d-41c5-acc1-4c98b69f5808">
        <rdfs:label>Abnormal spleen size</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001744</ddiem:url>
        <dc:identifier>HP:0001744</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fd317648-b7f6-4f0a-a42f-88749e1d6e7e">
        <rdfs:label>High cermaide level</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/MP_0020582</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>MP:0020582</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1e7f8296-5f7b-4fc8-a26e-ca1bacaa3910"/>
    </obo:RO_0000057>
    <rdfs:comment>human recombinant acid ceramidase/human ACDase-encoding lentivector</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c3fc79c6-c24f-4805-895d-92f04ab38392"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5a4c9455-d5a1-40c3-b7cb-0d81cf321cbf">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001369</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001369</dc:identifier>
        <rdfs:label>Joint inflammation</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/81d19bc4-8d79-43c8-aa96-1e3c2afc27bb">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>High macrophage infiltration into tissues(Abnormal inflammatory response)*</rdfs:label>
        <dc:identifier>HP:0012647*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012647</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/72d46345-6660-445d-bd11-a41c231d1353"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c8e63c31-f1de-4a38-a824-156d0ef514f1"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27155573</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e4cb2d71-ce20-415b-8b0e-fb3cec4d1b88"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8376947d-3701-46d5-9edd-c7a21cbc12f7"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/258450">
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseAccessionNumber>418</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/d2d2d0c0-9a5b-4b2e-a876-f1784eb97054"/>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/418</ddiem:iembaseUrl>
    <rdfs:label>PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1; PEOB1</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/258450</dc:identifier>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6f28b5f0-99a8-46d9-b41a-fef83bce20c4">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24746802</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <rdfs:comment>Coenzyme Q10+Vitamin C+Vitamin B+Vitamin K +Carnitine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23806424</dc:provenance>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/520000"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/87773692-3665-4b9d-8e9c-762077ce7b16">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003287</ddiem:url>
        <dc:identifier>HP:0003287</dc:identifier>
        <rdfs:label>Mitochondrial dysfunction</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7798b7ba-bc20-450a-aac6-4ba6f338d82d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/5421ee3f-7a80-4ec1-a63d-7553ef14e057"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c60f80ad-2485-4478-b1ac-3dc13410274d"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/84d55bd8-97ff-4e08-b9c0-fa9eed2e906a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9200e256-9ef9-4d65-a2ee-1218b5553cb0"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/290bbf4c-77c6-4481-93c7-3b19728d400e">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503963</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/44ca0053-a516-4dcc-be2d-ec7fe45db75d">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>production of toxic intermediates</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <dc:identifier>HP:0001939*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20619503</dc:provenance>
    <dc:provenance>https://rarediseases.info.nih.gov/diseases/9813/congenital-bile-acid-synthesis-defect-type-2</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/105d2f0c-5d6f-4228-a4cd-e5672c13d5c7">
        <rdfs:label>Atypical bile acids</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://rarediseases.info.nih.gov/diseases/9813/congenital-bile-acid-synthesis-defect-type-1</dc:provenance>
    <rdfs:comment>cholic acid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18570303</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/906349f4-ea1c-4d48-9d89-f1cd884a7221"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/11a7996e-c8d5-4ec7-86b2-ebd7ae527730">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0500014</dc:identifier>
        <rdfs:label>Histologic abnormalities in liver (Abnormal test result)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0500014</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/69e33faa-ecd4-4e7e-9e22-365f03f67e4e"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/43d1e83d-0333-42b7-958b-47fa340fdd23">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001394</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Cirrhosis</rdfs:label>
        <dc:identifier>HP:0001394</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8225213</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/485203db-8a54-4bfd-a3db-f40cc8032484">
        <dc:identifier>HP:0001939*</dc:identifier>
        <rdfs:label>Hepatic Biochemical abnormalities (Laboratory abnormality)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20938027</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/607765">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/fd39b3a3-a779-4e36-9ebb-15c2f26a7b1b"/>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/607765</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a8232704-bbb7-4df3-b015-368acaa147bb">
        <rdfs:label>fat soluble vitamin malabsorption(Fat malabsorption)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002630</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0002630*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16819396</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19087156</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1bdc9411-f6ff-4df6-9eae-4cae142579c8"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30373615</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/97cc2cc7-7005-48ae-98e1-72430ecbb253">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001396</ddiem:url>
        <rdfs:label>Defected bile flow</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001396</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/eafc8b72-2ace-4f8b-b86f-48dbdf83a675">
        <rdfs:label>progression of the disease (Rapidly progressive)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003678</ddiem:url>
        <dc:identifier>HP:0003678*</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a4164c40-ac7f-454e-8ab7-72817c605a3f">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0001987</dc:identifier>
    <rdfs:label>High blood ammonia levels</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001987</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/136120">
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/528</ddiem:iembaseUrl>
    <ddiem:iembaseAccessionNumber>528</ddiem:iembaseAccessionNumber>
    <rdfs:comment>Fat restriction is recommended as it leads to progressive mesangial and glomerular sclerosis.https://www.ncbi.nlm.nih.gov/pubmed/2068059. 
and as well another author have suggested that low fat/calorie diet mainly consisting of vegetables may inhibit the progression of the renal disease.https://www.ncbi.nlm.nih.gov/pubmed/2634146</rdfs:comment>
    <rdfs:label>FISH-EYE DISEASE; FED</rdfs:label>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/fb4f3a1b-6601-43be-90e0-5bc8d25d9530"/>
    <dc:identifier>https://www.omim.org/entry/136120</dc:identifier>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/12c317c3-92b8-4eee-9f4f-bdbb15d898f7">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841061</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03466463</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282099</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bd733de5-08c1-4c3e-b649-0b740fa1bd0b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c5d3d937-936d-48df-854a-4b2d287516bd"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606785"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8caf38b2-8154-47c3-b194-58ac1bd3bc93"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <rdfs:comment>GNT0003</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/614921">
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseAccessionNumber>600</ddiem:iembaseAccessionNumber>
    <rdfs:label>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/600</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/df167332-9809-49b3-a078-be46ca8cab4f"/>
    <dc:identifier>https://www.omim.org/entry/614921</dc:identifier>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4e161553-101d-4ba1-8af7-2f5b51f0701d">
    <rdfs:comment>Hydroxicobalamin</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/037eca80-0374-4364-a174-ca5fcf49d142">
        <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
        <dc:identifier>HP:0002160</dc:identifier>
        <rdfs:label>Elevated plasma homocysteine concentration</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002160</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7d2bc1e6-9a69-4da0-9c13-2e42f10c559f">
        <rdfs:label>Microhematuria</rdfs:label>
        <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002907</ddiem:url>
        <dc:identifier>HP:0002907</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2bcb7434-9beb-483f-84fd-18c143330213">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001913</ddiem:url>
        <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
        <dc:identifier>HP:0001913</dc:identifier>
        <rdfs:label>Granulocytopenia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01793090</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/41ccba98-2a20-4e5d-b22a-b129aa7a3cbb"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d2b23f09-5cf9-4b3e-9839-40ffcb18bf8f"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/34fe216e-6e58-432a-808c-c2e1b33903ea"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/56866be6-5dd7-460b-84b7-73208cc82bec"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/34101d64-08c5-415b-b02e-399803061228"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/250940">
        <dc:identifier>https://www.omim.org/entry/250940</dc:identifier>
        <ddiem:iembaseAccessionNumber>30</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/bb96e655-44eb-4230-9e99-e13cb3d4a015"/>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/30</ddiem:iembaseUrl>
        <rdfs:label>HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28210839</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2a36a8c1-4ba6-4c76-8373-b066043fed11">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00098</ddiem:url>
    <dc:identifier>DB00098</dc:identifier>
    <rdfs:label>Antithymocyte immunoglobulin (rabbit)</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/55d68190-aa9e-4bcb-a85b-4f3349e9c113">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <rdfs:comment>Antithymocyte globulin+Cyclosporine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22734070</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/78baf126-9d56-4ef3-8622-d99b0c988d2a"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/105650"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00001749</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25098371</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ef4720c8-6d94-49bb-b501-2bf28ce742cd"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2bb579f7-ebe3-41e5-81d5-e5af9d53f24c"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/307bbb6d-c7be-4779-a335-2822647e0a76"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c93a9304-ae08-48d1-8c28-ff16900430eb">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001013</ddiem:url>
    <dc:identifier>HP:0001013*</dc:identifier>
    <rdfs:label>Tuberoeruptive xanthomas</rdfs:label>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a2938fbd-31c7-4b98-8c81-dddcae359471">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d1db5564-91b4-449a-85e2-4f099b6062c1"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27120771</dc:provenance>
    <rdfs:comment>Indomethacin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/300971">
        <dc:identifier>https://www.omim.org/entry/300971</dc:identifier>
        <rdfs:comment>Among antenatal Bartter syndrome, the transient form was defined as a regression of clinical symptoms and normalization of biologic parameters allowing the arrest of treatment. https://www.ncbi.nlm.nih.gov/pubmed/29146702
This condition can be successfully treated with close monitoring and fluid and electrolyte replacement, avoiding the potential harmful effects of indomethacin. This diagnosis is important for clinical management and parental counseling regarding overall patient prognosis. https://www.ncbi.nlm.nih.gov/pubmed/29594084</rdfs:comment>
        <rdfs:label>BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT; BARTS5</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/50bee4b8-98ce-4fe8-95d7-dd0841681cad"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/26fc9247-c0de-41c9-81ae-3f24f9030d14">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3fe65f4f-46f4-4341-ab56-a740aca61558">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d8f94458-9bcc-4c8b-8f8f-fb5650c2c004"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2c0e2db6-de71-4097-a328-6d5dd457768d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18458702#</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27853336</dc:provenance>
    <rdfs:comment>Estrogen replacement (                                                             
Estradiol)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26161337#</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/202110"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8ba3f285-f271-412b-8236-1b880b00d657">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/dc9b8c52-3c02-4a6a-a96e-110d87571cfc"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301746</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <rdfs:comment>Oxcarbazepine</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/271245"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5ae0011f-82db-4e1c-9337-e0c8ccd7b324">
        <dc:identifier>HP:0031951</dc:identifier>
        <rdfs:label>Short nocturnal tonic seizures</rdfs:label>
        <rdfs:comment>The hypoglycemia is not a disesae phenotype, rather its a side effect of Mecasermin medication.The new combination in Mecasermin rinfabate has over come this side effect.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0031951</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19304794</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e7d7f1df-323b-40bd-bb15-5bd063dfb728">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/bd7cf5ce-2d27-4cf5-96dd-9d0d36780e60"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6c639999-3a46-4527-ac23-bcbb58e19958">
        <dc:identifier>HP:0002014</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002014</ddiem:url>
        <rdfs:label>diarrhea</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ebc59fe3-520b-4780-907e-e06d77dfe5da">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000712</ddiem:url>
        <dc:identifier>HP:0000712</dc:identifier>
        <rdfs:label>emotional disturbances</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24718477</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d2578552-ead5-4304-8608-a6526f9be913">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0011123</dc:identifier>
        <rdfs:label>skin inflammation</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011123</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902399</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12044538</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0802ee16-ec48-467a-884c-978d109fd089"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1dba9972-ef39-4ae3-ab56-a5474843ecac"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/201100"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <rdfs:comment>zinc</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/afb0b962-0fe4-48c6-bd6a-c604b3783dc1">
        <rdfs:label>Agitation</rdfs:label>
        <dc:identifier>HP:0000713</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000713</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415789</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/10534ea3-b98a-4811-87fa-97d31d06f37a">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783980</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18958581</dc:provenance>
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/abs/pii/S1386634602003315</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15670720</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6c37d423-92c1-45fa-96c6-3440a6085ae1"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ccd5ca66-5fca-4730-96e9-4f2850100dcf">
        <dc:identifier>HP:0001298</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001298</ddiem:url>
        <rdfs:label>Encephalopathy</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.jstage.jst.go.jp/article/kanzo1960/43/11/43_11_492/_article</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6c1ab060-239c-42a4-b2f7-9131cd3318da"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c4417832-d291-4bde-9761-9dfd8cbb17aa"/>
    <rdfs:comment>L-Arginine</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/603471"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b5d4b812-32bb-46f3-8ea9-3dbc8652d6f7">
    <rdfs:label>Abnormal linear growth (Decreased linear growth ,Abnormal body height)*</rdfs:label>
    <dc:identifier>HP:0000002</dc:identifier>
    <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000002</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a828ef11-0679-4f8e-bd4b-8f21a77396c6">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/615398">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1147</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/615398</dc:identifier>
        <ddiem:iembaseAccessionNumber>1147</ddiem:iembaseAccessionNumber>
        <rdfs:label>MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/97f33aaf-31c7-48ed-9fba-558103d2098d"/>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>Potassium bromide</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/64a00968-be06-4afb-ae56-c9d96b122b9b">
        <rdfs:label>tonic seizures ( Focal tonic seizures)</rdfs:label>
        <dc:identifier>HP:0011167*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011167</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0387760417301742</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ae6cd329-0b1c-4759-9333-0025c00947c7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/16e3f35f-4490-4222-9ba4-29ac253ddac1"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f42aa3db-3502-45c7-8a96-c9769620f380">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/457b1b0b-1ae5-4219-abb6-982dd82b8498">
        <rdfs:label>Muscular hypotonia</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001252</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001252</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9585615</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24204001</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9760199</dc:provenance>
    <rdfs:comment>Tetrahydrobiopterin</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f4206553-2250-464f-a5cf-3f4030d5e10d"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/264070">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/6</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/88ba3735-64c4-4787-83a9-b9278116d8a4"/>
        <ddiem:iembaseAccessionNumber>6</ddiem:iembaseAccessionNumber>
        <rdfs:comment>Protein and phenylalanine restriction should be maintained in order to avoid disease progression.</rdfs:comment>
        <rdfs:label>HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/264070</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/746bdc89-f478-49ce-889d-5dbe457c6c04">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>High urinary levels of primapterin (7-biopterin)</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs10545-012-9506-x</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/600f9630-83b1-4a24-a752-2ec66a36aa83"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c1d28c82-72dd-45f2-917f-1eea9583452f"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fd8cf6e3-3371-48f8-aa90-cbf69bfcf2fe"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/deedd4d1-649e-4cf9-8696-a8c8a64bb3e3">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3dad3439-0d4b-46b5-b8d3-c3a969efac73"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18993152</dc:provenance>
    <dc:provenance>https://www.clinicaltrials.gov/ct2/show/NCT01942291</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28225998</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a25cf4dc-afeb-4fcd-b207-cac882636231"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988622</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8ba62687-4f50-4312-96a1-5490d2289da9">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2decf71e-2cc1-4232-af4e-bd6c16898547"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/604091"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/0ad70eb7-90f3-487c-875c-31d2d4a0ae7d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19770656</dc:provenance>
    <rdfs:comment>Niacin</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/fc712031-13ed-4cce-ae3a-373f24d14502">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4ca27dbf-d8d8-4b2c-8728-5ac4fe42565e">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28057010</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27567650</dc:provenance>
        <rdfs:comment>sodium benzoate</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6c37d423-92c1-45fa-96c6-3440a6085ae1"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bda4b943-5e3b-40e3-ab23-a03792c92217"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301535</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c480100c-4a02-4115-a3b5-31fdc29cd946">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6c37d423-92c1-45fa-96c6-3440a6085ae1"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bda4b943-5e3b-40e3-ab23-a03792c92217"/>
        <rdfs:comment>sodium benzoate</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608158"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9156798</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12948744</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719215300895</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB03793</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b23efb79-8818-47d8-8d6a-a085fe9f14ed">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/25cd20ae-014d-413d-ab6f-4da0eae494bf"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01328587</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/38f22af0-f30b-4275-8173-98e82f02bd3a"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24071436</dc:provenance>
        <dc:provenance>https://rarediseases.info.nih.gov/diseases/2578/guanidinoacetate-methyltransferase-deficiency</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/973f13f1-a72b-4be2-a4de-8ad11b118cab"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/612736"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6327904f-f76f-4f0d-8170-02a7cd21f0e3"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16855203</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bda4b943-5e3b-40e3-ab23-a03792c92217"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e8c05ded-0faa-4463-98db-804397db7355"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719213003661</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d27643ff-d12e-4be7-9ea2-29f035b17b1e"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719212002971</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1c48c0bc-e3f2-4bd4-b755-83cd5e48d696"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ae72e116-7db0-4fbb-a673-428edc8bf920"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24268530</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29506905</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719213003107</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
        <rdfs:comment>sodium benzoate+ornithin +carnitine</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB03793</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/323ef25b-ab85-41c4-bfad-fa934cb454cf"/>
    <rdfs:label>Benzoic Acid</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/25c76e69-b976-4fb9-aa4f-853926f06e2c">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9f4da0b7-bc68-4593-a7c4-e98ccf7624da"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/237300">
        <ddiem:iembaseAccessionNumber>11</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/237300</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/e9856a4b-0fb7-44fc-b96b-ee1219c90fa4"/>
        <rdfs:label>CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/11</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ddde459e-0713-49dd-a947-ede106f7ec00">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/cb266cdb-127f-46e2-bd1e-960258e95171"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14213380</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23649895</dc:provenance>
    <rdfs:comment>Gene Therapy ??</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31392111</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/13992367</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cce01f42-00eb-4178-8959-eb6751be7c9f"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://www.semanticscholar.org/paper/Cell-and-Gene-Therapy-for-Carbamoyl-Phosphate-1-Zhang-Li/2099b4f31e1fe5e8825f03deff088f7702694f02</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ffe8c17b-f5e0-40b5-a15c-74e82b5a7a6b">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0007663</dc:identifier>
    <rdfs:label>decreased visual acuity</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0007663</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1b6f7c2e-769e-450f-b723-b86729a6e8e7">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3298f2d5-5f62-4f11-827c-fef31bc6abf3">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427298</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4bd77efe-eb0f-40e0-9c6f-058b6b8d0468"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607091"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263309</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <rdfs:comment>galactose supplementation</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24164873</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02955264</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Galactose</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB11735</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a7cf4c51-ad06-472d-85f9-66336c353117">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ef8c3db0-e5aa-4794-aa8e-94d20a24f771"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8a928c9a-7aec-495f-9259-bbf5333fda3e"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02955264</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b9ce4703-a12e-408b-973a-49f02846aa2e"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a86cd875-a9fb-4700-a550-337c1f12b9c3"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9732974</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c819e700-5e34-4d3e-88bd-3c65dc6a767b"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4bd77efe-eb0f-40e0-9c6f-058b6b8d0468"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263309</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
        <rdfs:comment>D- Galactose</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/559b7517-d987-45ec-b139-626ac842380c"/>
        <dc:provenance>https://pdfs.semanticscholar.org/7753/abad26acee41547592d5a3a65b0483eff767.pdf</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12756558</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/00651c84-2f38-4865-a5d5-362345549601"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7b913187-383d-43cc-80c2-6107771627f0"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28617415</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c2184503-d76d-40bc-9b4e-c9710de0d9de"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24499211</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/614921"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB11735</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/53cf0885-d018-4548-b455-1903039460e1">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7da0ff17-c3a9-4628-8a63-050426001f2a">
        <rdfs:label>iminosugar DGJNAc( 2-acetamido-1,2-dideoxy-d-galactonojirimycin)</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c51c3fef-897c-422e-a0e3-9cb464164513"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/25cd20ae-014d-413d-ab6f-4da0eae494bf">
    <rdfs:label>low urinary creatine excretion</rdfs:label>
    <dc:identifier>HP:0012113</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012113</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/38a30cce-9f1a-4033-8fdb-336514ca6ac3">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/744e09a0-d46d-4ee4-992a-2d951947c857"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/619dc802-622e-4bf0-905e-70ec9359043d">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <dc:identifier>HP:0010919*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010919</ddiem:url>
        <rdfs:label>Abnormal Hcy level</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d8d2faad-7820-494a-b343-54467b0d3bdb">
        <dc:identifier>HP:0002156</dc:identifier>
        <rdfs:label>Homocystinuria</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002156</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/236200"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14739681</dc:provenance>
    <rdfs:comment>ONX-0912</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23592311</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24355692</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16619244</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/cfc6b333-03a6-4b97-a867-eb80d30921e2"/>
    <obo:RO_0003304>S466L /I278T</obo:RO_0003304>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b7d83331-6d48-4ef3-b397-6695f8a1fe1a">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>deferiprone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925531</dc:provenance>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/15804998</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/224120">
        <dc:identifier>https://www.omim.org/entry/224120</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/c84d44c9-237c-443f-8916-ddc29898c51e"/>
        <rdfs:label>ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cd635574-7b5e-4621-9e8f-7e45361234c2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1bb52e8b-092a-4149-881c-6b34260126ad"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bb33c622-e598-4c52-a732-7dae626473da">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003281</ddiem:url>
        <rdfs:label>Elevated serum ferritin concentrations</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003281</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16141353</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a5f6e0ff-20c7-45cf-a4a8-0d2eadb46546">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f7574280-10d6-45f5-bd2b-8b25dccebca1">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007166</ddiem:url>
        <rdfs:label>Paroxysmal movements</rdfs:label>
        <dc:identifier>HP:0007166</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5c58afe7-c648-40b3-8989-9f406302cd99"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261640"/>
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c986b6b3-2af2-4272-91b0-e45978033c3e"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16601879</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25304915</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
    <rdfs:comment>levodopa (L-dopa)</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2d8bccbd-b697-4edd-b40a-f3623ef591cf">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003073</ddiem:url>
    <dc:identifier>HP:0003073</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Hypoalbuminemia</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/106e3220-93e6-4a8d-9876-223830310d06">
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/15804998</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/224120"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3221dd31-98b4-4447-b38f-8fd197ae3fb2"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/477cb185-55c2-40ac-a782-37a74e1a8b13"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925531</dc:provenance>
    <rdfs:comment>deferoxamine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4aff5014-c752-44f1-9116-43e6675b0d24">
    <dc:identifier>HP:0012514</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012514</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Lower limb pain</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/76290e91-0f76-4eda-ada7-a1db22f78cdd">
    <dc:identifier>HP:0012238</dc:identifier>
    <rdfs:label>High total plasma cholesterol leve</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012238</ddiem:url>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e78fe2f5-1ae8-4e95-afc4-d804a5e266f3">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f03049fd-d583-4b3b-8c2d-705b5d29d76a"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9732974</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16544179</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/610768"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/33a926c6-1da9-4cc7-9a19-06e6abee2f8e">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025142</ddiem:url>
        <rdfs:label>affected functional activity</rdfs:label>
        <dc:identifier>HP:0025142*</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>desmopressin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2d71ff43-cae1-4101-b7a8-8d978203011d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23890587</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a5bd2304-0523-44f7-ac59-c7041dc451ac">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004355</ddiem:url>
    <rdfs:label>abnormality of proteoglycan metabolism</rdfs:label>
    <dc:identifier>HP:0004355</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/05a471bd-3e9c-4c22-a4c0-e9667511f377">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/93016766-43fe-4d19-bc34-2c9779ef1756">
        <rdfs:label>Decreased activity of mitochondrial complex I</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011923</ddiem:url>
        <dc:identifier>HP:0011923</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <rdfs:comment>L-carnitine</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02176733</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02805790</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c065328b-b4b6-4ec5-a991-65e68e009f5a">
        <dc:identifier>HP:0025464</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025464</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Increased ROS production</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25835550</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25620325</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21788663</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/220111">
        <ddiem:iembaseAccessionNumber>425</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/425</ddiem:iembaseUrl>
        <rdfs:comment>Antioxidants (idebenone, N-acetyl cysteine, resveratrol) exacerbate palmitate plus lactate-induced cell death Collectively, our results raise some concerns about the potential negative impact of a high-fat diet and of antioxidant treatments in LSFC patients.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383560/</rdfs:comment>
        <rdfs:label>LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/220111</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/d302afdf-f12d-4c7a-b300-a3aadd9dfd1c"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2c147a3e-8619-48e6-833b-47189425717f">
        <rdfs:label>PL-induced cytotoxicity</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b8c3c7d9-1b61-468c-b5ac-1175c90391fd">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008347</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0008347</dc:identifier>
        <rdfs:label>Decreased activity of mitochondrial complex IV</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1494ad5f-8f40-4562-8543-4dc0226216b2">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <rdfs:comment>Rosuvastatin therapy (20 mg per day) could be used as a preventive therapy.https://www.ncbi.nlm.nih.gov/pubmed/22798447</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7f1e7a6a-74fe-49a0-94d2-0d7c2088f0d1">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003119</ddiem:url>
        <dc:identifier>HP:0003119*</dc:identifier>
        <rdfs:label>High low-density lipoprotein (LDL)-C(Abnormality of lipid metabolism)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/7199c277-e274-40f1-b74e-be9b419517f4"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22798447</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/151670">
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/693340af-03ce-4beb-9e7f-84b136e3f7ad"/>
        <rdfs:label>LIPASE, HEPATIC; LIPC</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/151670</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3f4b0ebf-fc08-490c-8bed-6c4518cf3c28">
        <dc:identifier>HP:0003119*</dc:identifier>
        <rdfs:label>High Apolipoprotein B (ApoB)(Abnormality of lipid metabolism)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003119</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>http://www.malacards.org/card/hepatic_lipase_deficiency</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c89cb4a1-518b-4a12-873d-799c433a5b9d">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003119</ddiem:url>
        <rdfs:label>High atherogenic lipoprotein(Abnormality of lipid metabolism)*</rdfs:label>
        <dc:identifier>HP:0003119*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/06aa3e54-a667-4043-a027-bcd2c6fa70f4"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7a4fb0f8-2baf-4a0b-b91e-283c530aa7f0">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/144650">
        <rdfs:label>HYPERLIPOPROTEINEMIA, TYPE V</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/144650</dc:identifier>
        <ddiem:iembaseAccessionNumber>1086</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/3fc32b95-cf49-42f5-bdbd-31907de13098"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1086</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dcf5b822-064e-491f-95ce-421ac69b4aa0">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002155</ddiem:url>
        <dc:identifier>HP:0002155</dc:identifier>
        <rdfs:label>hypertriglyceridemia</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/06aa3e54-a667-4043-a027-bcd2c6fa70f4"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23323877</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/529f9125-300d-4b47-b1b1-925c1d522503">
        <rdfs:label>High LDL level</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003141</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003141</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d12013bc-3d9f-43fb-8aaa-fc02dd3ffdd9">
        <rdfs:label>High total cholesterol</rdfs:label>
        <dc:identifier>HP:0003124</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003124</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0ccccd84-888a-4482-9972-256df6b463d0">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025201</ddiem:url>
        <rdfs:label>High Apoliporprotein B level(Abnormal abpolipoprotein level)*</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0025201*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00473655</dc:provenance>
    <rdfs:comment>rosuvastatin</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558>
      <ddiem:Evidence rdf:about="http://ddiem.phenomebrowser.net/ECO:00007121">
        <dc:identifier>ECO:00007121</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/ECO_00007121</ddiem:url>
      </ddiem:Evidence>
    </obo:RO_0002558>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d35b8308-914c-421c-9a18-a5822c00de9f">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>Metformin</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/262cc661-72ec-41e4-88eb-7049bae58d47"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16635485</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246650"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0bca9681-c605-4865-a5bb-1ecc6b1600c9">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ac948adf-f46d-4266-b824-c01f64378a09"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17994020</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/870cfd06-192b-4a7b-9fe3-bcdd7bd8ce8e">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4de1eeb8-80e7-4abb-b968-0af5b863140d">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010978</ddiem:url>
        <dc:identifier>HP:0010978</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Abnormal immune function</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4b820e86-2cb1-4e68-aa08-ea5cd0cb8a36">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011123</ddiem:url>
        <dc:identifier>HP:0011123</dc:identifier>
        <rdfs:label>dermatitis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7a3d427f-b15c-4fb3-8079-53aaaf442e3f">
        <dc:identifier>HP:0001888</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001888</ddiem:url>
        <rdfs:label>lymphopenia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ae2680eb-1927-4198-a22d-87f01bd5396a">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Hemolysis</rdfs:label>
        <dc:identifier>HP:0001878</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001878</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01420627</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://adisinsight.springer.com/trials/700243447</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/0ad70eb7-90f3-487c-875c-31d2d4a0ae7d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488882</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/81c505cf-82d9-429e-be1d-602323eef0ec">
        <rdfs:label>Abnormal eosinophil counts</rdfs:label>
        <dc:identifier>HP:0001879</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001879</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.asgct.org/education/disease-treatments/inherited-immunodeficiencies</dc:provenance>
    <rdfs:comment>Elapegademase (Polyethylene Glycol Recombinant Adenosine Deaminase/PEGylated recombinant adenosine deaminase)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29241594</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7cedef17-0c97-4c99-a891-32a89bb4fd9a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/91c281c6-7436-4951-b38a-850822b90c97"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15767622</dc:provenance>
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/26b0dd82-a563-43a5-998a-79295c160c31">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0002910</dc:identifier>
        <rdfs:label>Elevated liver enzyme levels</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002910</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1ac79ba2-c46f-4df4-9c6b-1eefadf4e40d"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/077bb415-f5d0-4950-b02c-6f9e0f5a6920">
        <rdfs:label>Low weight</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0004325</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004325</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1182205</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ba17d8be-c4a4-4c42-b9bc-459723a8c936">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002960</ddiem:url>
        <rdfs:label>Thyroid antibodies (autoimmunity)*</rdfs:label>
        <dc:identifier>HP:0002960</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/102700">
        <ddiem:iembaseAccessionNumber>142</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/142</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/e6b30d21-9303-4727-9957-d450267381cd"/>
        <dc:identifier>https://www.omim.org/entry/102700</dc:identifier>
        <rdfs:label>SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/377ad8b2-af57-40a0-93b2-9460c8250298">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/125370">
        <dc:identifier>https://www.omim.org/entry/125370</dc:identifier>
        <rdfs:label>DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/07b2f925-48e3-4d03-a598-f4a8cc554e14"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>levetiracetam</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1bf591ef-d853-42c1-bd5b-0ad546c81cc3"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25558587</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5ca28c24-9eac-4f3c-aebe-d4fc037deded"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24816443</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/74a2435e-8b12-4313-9d3a-33487a5fec5a">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b1fdeb95-d2cd-49f3-bead-78e59b17056f">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d3c20219-805c-418b-85f6-c0518e91cbdf"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25797485</dc:provenance>
        <rdfs:comment>l-carnitine +propranolol</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e59131d5-26b5-4980-864e-c8b1d9707c2f"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/501ff55e-0e0c-4b91-8eba-7432504d1641"/>
        <dc:provenance>https://link.springer.com/article/10.1007%2Fs10048-015-0444-2</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/615395"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00571</ddiem:url>
    <dc:identifier>DB00571</dc:identifier>
    <rdfs:label>Propranolol</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c9e56bf1-7674-486a-ad0a-83e9dc4a3426">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/94daedb7-0d1c-42bd-aefe-1ff9900cb2f0">
        <dc:identifier>HP:0008281</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008281</ddiem:url>
        <rdfs:label>acute hyperammonemia</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>carglumic acid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26884075</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21403788</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/74f687a3-e9fa-4ec4-8786-9e0a9d4f4678"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21207059</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/243500"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/daf4d76c-3a50-43e9-81e9-0e90de459774">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b5049a65-9977-4961-a75c-46da2eb7c27e">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002149</ddiem:url>
        <rdfs:label>hyperuricaemia</rdfs:label>
        <dc:identifier>HP:0002149</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c18f477e-6574-4d5f-8a9f-37570432ab40">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6b15dc6a-c452-461a-916d-ff3b48bcd42b"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dc44f9ef-3a57-44fd-aaec-a634c98f95a8">
        <rdfs:label>Delayed Growth</rdfs:label>
        <dc:identifier>HP:0001510</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001510</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <rdfs:comment>Pantothenic acid</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7caaf8f0-18ea-47bd-a455-2a6fd6f0690d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d091a79d-80cb-43dc-9dda-a8fac10327c7">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0005135</dc:identifier>
        <rdfs:label>T wave abnormalities</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0005135</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7833193</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5588c387-02ae-494d-9326-f1270f19f7ec">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003146</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003146</dc:identifier>
        <rdfs:label>hypocholesterolaemia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/302060"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/34eb7043-3f68-488f-98ae-90f2ba96a043">
        <rdfs:label>Low myocardial function</rdfs:label>
        <dc:identifier>HP:0001638</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001638</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/31a6365d-e2d8-4362-875a-1d6733cf1d36">
    <dc:identifier>DB09422</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09422</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8c962e89-d40f-42ad-b0a7-5bb68d971622">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246700"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/78e1511d-1910-443b-a044-fe9a768ff6fe"/>
        <rdfs:comment>fat emulsion</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956717</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.nature.com/articles/nrrheum.2010.182</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bf979e98-a240-4266-bad3-f090d6282a75"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2596948</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23329770</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Soybean oil</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3fd62392-5add-4076-94c8-54d6780716d7">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011804</ddiem:url>
    <dc:identifier>HP:0011804</dc:identifier>
    <rdfs:label>Imapired muscle function</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/84006154-8366-445a-bcd9-d2d6eee37d4c">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6d615ca2-d3ed-437f-bc5c-6a3655aa0d51">
        <rdfs:label>Hypertriglycerdemia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/done</ddiem:url>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <dc:identifier>done</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fa2ab50d-525a-4059-9f35-e3b061ea0697"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20357432</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232220"/>
    <rdfs:comment>medium chain triglycerides</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f4206553-2250-464f-a5cf-3f4030d5e10d"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/369e2d68-3b59-4a4f-9422-0a8eb69cbe01"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18996862</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a7de0cca-15c3-47d7-97ec-35809c63e3c4">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/50a54dad-0ea2-40ee-ab79-a2c542153168"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9930336</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/42be0c83-c8e6-4e1c-b60a-e0870b5e72a0">
        <dc:identifier>HP:0001939*</dc:identifier>
        <rdfs:label>Low expression of AGA enzyme</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c46f48f3-2285-42e6-8000-6c9a0146ded6">
        <rdfs:label>Brain lysosomal storage disease</rdfs:label>
        <dc:identifier>HP:0001939*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20607610</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cdf05e29-768a-4c00-a81f-fb29b2dc0c34"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15342551</dc:provenance>
    <rdfs:comment>Gene therapy (wild-type Ad-AGA)</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4bae48f4-882e-4abf-8f9c-dc063efa2c29"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16518877</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e4d15e10-0ce1-415b-adc6-eaaac0e40686">
        <dc:identifier>HP:0001939*</dc:identifier>
        <rdfs:label>Liver lysosomal storage abnormality</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1a356172-ea90-44c7-9cfc-d8494f5f8c7e">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/cfca40fc-859c-4eeb-82eb-92846bb4963d"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/208400"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/12137b5f-3a0e-470c-84f9-eed94ffb3d93"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/159de041-ce82-488b-8399-61b932632397">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <rdfs:label>ipsilateral brain neuronal storage abnormalities</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0001939*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28967191</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27906067</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/986cb047-1b68-4c82-956f-b65c81449470">
    <dc:identifier>DB06720</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e75a814e-1ed9-4a13-8fc0-dbb4425f9009">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6990c767-3cf0-404b-b5e6-95943c805fbb"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e9880d1f-dfa8-468f-878c-59e876c1c19c"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29358012</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <rdfs:comment>velaglucerase alfa</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30247105</dc:provenance>
        <dc:provenance>http://clinicaltrials.gov/show/NCT00358150</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7814809</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15895716</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT01685216</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d932e39e-c904-4166-ace9-dd9e7f2eb5e0"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3bd87000-77a4-45a2-add8-083df8ed70d7"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231005"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03519646</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/78913f65-98be-43c7-adf0-57e4acdcc774"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Velaglucerase alfa</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB06720</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/706ee753-5ffe-484a-9972-8fd51b0e56a5"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ae0c41b9-189a-4a2a-95bf-53ef08a0591b">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ea11c963-11c7-4d7c-8aac-65d2723edd07">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/90583717-81a7-42d5-986e-a87e1650c56f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488882</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585601</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29241594</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/102700"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0f5ea12d-6321-4ccf-8ba8-7a2374803109"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01420627</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <rdfs:comment>Immune Globulin Human</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4c1fb088-980e-4b35-adf0-e28f2e50e2de">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3f0914b8-9e9e-4fd3-8fdb-76d744bafa31">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1c68924f-d710-4b5c-a191-723417afcf10"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02211209</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/77bba107-e2dc-43b8-964c-74b233bbf2a9">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Abnormal fasting triglycerides</rdfs:label>
        <dc:identifier>HP:0002155*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002155</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>volanesorsen (IONIS-APOCIIIRx)</rdfs:comment>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/151660">
        <rdfs:label>LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/151660</dc:identifier>
        <rdfs:comment>Data regarding TZD therapy and the restoration of adipose tissue in lipoatrophic areas has been conflicting; it appears as though TZDs do not improve lipoatrophy in patients with FPLD2. https://www.ncbi.nlm.nih.gov/pubmed/19040647/</rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/eb1c1702-9908-4f68-b543-344324b9fb47"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b6300713-1ab6-4cfc-879f-9dcd63db393b"/>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02300233</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02527343</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/aa85314e-1e1a-430b-8c80-74e8ce674a9c">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d67580e8-fafd-448b-b28d-59a0870b17e3">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Study was Terminated (Interim analysis demonstrated the treatment was not effective)</rdfs:label>
        <dc:identifier>HP:0000992</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000992</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <rdfs:comment>Isoniazid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31395332</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26979527</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01550705</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00004940</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23884489</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e1baee43-1eef-4088-8a3b-daa6f40b7a14"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/177000"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22092997</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3f447e33-b394-4519-804b-123ad3f22a9f">
    <dc:provenance>https://www.paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/59/33</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2017228</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cd691278-7b5e-4c3a-b0a9-c8e91e4f71eb">
        <dc:identifier>HP:0000867</dc:identifier>
        <rdfs:label>Hyperparathyrodism</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000867</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b1d655a1-e228-4ff3-a3f6-328bb9a98719"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0a06f709-190e-43d1-8ae6-b03f1a49dc95"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ba8760db-3dc5-4164-98e6-2b87cac063f9"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301653</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5ebc7522-24a2-45bf-b683-baeb6a58f9e7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/89762ebc-38d1-4e95-94a5-f9530da20a0d"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/309000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b7df14dd-7d8b-4968-bce7-b22304299939"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b85d689d-145e-4f74-9147-7367e62a5087">
        <rdfs:label>Renal rickets</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002748</ddiem:url>
        <dc:identifier>HP:0002748</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/22790d57-4089-42cd-84c0-eb47de05a225"/>
    </obo:RO_0000057>
    <rdfs:comment>phosphate+calcitriol</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c2fc92b9-9e6d-435c-a4b2-e4b478079457">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2072042</dc:provenance>
    <rdfs:comment>ursodeoxycholic acid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18570303</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19087156</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607765"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8225213</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7915305</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20619503</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5dfdb19c-2a01-4a8e-9051-ca6a3315a184">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b98d7f33-d242-4c0c-8396-9bd20cfd2cf4"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503963</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/94024323-6d96-4884-9316-b90cbed5cae0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c8e4f2ae-a145-47be-b15f-7825d232452e">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28098593</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs11883-014-0440-2</dc:provenance>
    <rdfs:comment>Niacin</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ba62687-4f50-4312-96a1-5490d2289da9"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25079293</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3162680</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9cd6fb08-79a3-4383-8ca6-888c761744fe">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e944fa7e-d96b-4362-b221-88dfc375d0df"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/079ca058-939a-48f1-a2b7-fb74fd1a91c5">
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <rdfs:label>premature degradation of misfolded UROS mutants</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28334762</dc:provenance>
    <rdfs:comment>bortezomib</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2e08578e-a2b3-4292-8b09-c114b8a8beb8">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012187</ddiem:url>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <dc:identifier>HP:0012187</dc:identifier>
        <rdfs:label>high porphyrin accumulation in circulating RBCs</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719215300895</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831495</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24145442</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/263700">
        <dc:identifier>https://www.omim.org/entry/263700</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ac8cc855-94ef-4edd-8df3-cc2716bfe943"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/111</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>111</ddiem:iembaseAccessionNumber>
        <rdfs:label>PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b4a53029-1cb1-47d6-9650-68669e735d46"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7b7c0057-d446-43c7-8f28-630222b030ce">
        <rdfs:label>skin photosensitivity</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000992</ddiem:url>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <dc:identifier>HP:0000992</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e125c203-2403-41b2-80bb-0f7c3a62dd8b">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20657580</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/03851be3-fe3d-4a40-bf8c-8cb2611c7644"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1d9593bb-94eb-4172-af06-eaf00771c785"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0022202X15352507</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602473"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fbf30458-d2db-4f83-822c-2f3c4b6dc8bd"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/88f56d19-0bf9-498a-bd83-ec6d49922fe9">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003219</ddiem:url>
        <rdfs:label>high EMA levels</rdfs:label>
        <dc:identifier>HP:0003219</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>(Metronidazole+Acetylcysteine)+Dietary restricting sulfur containing amino acids treatment</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29526615</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1a6ef42a-f9a0-4f01-9147-2ca50ed6c4ae"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c82a6755-459e-446d-a509-2ba1dc1f93a5"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6c639999-3a46-4527-ac23-bcbb58e19958"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/78aef101-30b7-4d6c-bfa3-bde44a0f77e2"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3b496593-b9ff-4597-b34e-b31f261434b9">
    <rdfs:comment>AAV9-MCK-fukutin</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/987899c9-217d-402c-ae26-e12244c75b8d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/26a5bd96-3d32-40cb-be21-177a108c1b30"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3fd62392-5add-4076-94c8-54d6780716d7"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/253800"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27421908</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://academic.oup.com/hmg/article/22/15/3003/652530</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3452d8df-2ba4-4745-bd62-083f3435a9a4"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ebafe53d-c84d-46da-ab8d-d1be3e793a58">
    <dc:identifier>HP:0002275</dc:identifier>
    <rdfs:label>motor malperformance</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002275</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e704fcca-6bb5-4e63-8b0b-2c87456e9eba">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fd942d1b-c0ea-4247-8840-1d544659dc4c">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025464</ddiem:url>
        <rdfs:label>oxidative stress</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0025464</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <rdfs:comment>Polycitra (citric acid +potassium citrate + sodium citrate)+vitamin C+vitamin E+selenium</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27207470</dc:provenance>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/26984560</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/7de815b7-d34f-4609-8760-31b313ccaaf4"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/094dba56-00de-4bd9-9591-c2fc586a6038">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608643"/>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/eb2ab32b-f72c-4c72-9a61-4aad73cdb98d"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01395641</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fbf30458-d2db-4f83-822c-2f3c4b6dc8bd"/>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/05e18122-de84-4815-99e4-c46336ad7ca7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3bc4342d-2aa3-460e-b909-4652871f82f2"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23390030</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955971</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ac60c5c2-0e7b-43c2-953b-2987a19b098f"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241937</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e0b8e415-235b-40a0-aa46-e0ddac1a572f"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7571aa97-cba0-4c28-94fe-5538a5cafad6">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100022</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0100022*</dc:identifier>
        <rdfs:label>Voluntary movement abnormalities (Abnormality of movement)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Pergolide</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6461f584-2c0b-4d97-b6b2-010ac75de5e9">
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <rdfs:label>Left ventricle dysfunction</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0030872</ddiem:url>
    <dc:identifier>HP:0030872</dc:identifier>
  </ddiem:Phenotype>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/metabolic_disease_treatment">
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/OGMS_0000112"/>
    <dc:creator xml:lang="en">https://orcid.org/0000-0002-5111-7263</dc:creator>
    <rdfs:label xml:lang="en">metabolic disease treatment</rdfs:label>
    <obo:IAO_0000115 xml:lang="en">a treatment strategy or plan which the clinician beleives will cure or ameliorate a disease caused by a deleterious genetic variation in a patient, affecting their metabolism. It may modify some or all of its signs or symptoms, or alter the prognosis and course of the disease, either by severity, timecourse or phenotypic quality.</obo:IAO_0000115>
  </owl:Class>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/610006">
    <dc:identifier>https://www.omim.org/entry/610006</dc:identifier>
    <rdfs:label>2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/56e7ff5e-f85a-4c5a-8b1c-21f880304bb1"/>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/63</ddiem:iembaseUrl>
    <ddiem:iembaseAccessionNumber>63</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/602390">
    <rdfs:label>HEMOCHROMATOSIS, TYPE 2A; HFE2A</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/581</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/35293dd3-c447-41e0-9cb6-2932052a37e5"/>
    <ddiem:iembaseAccessionNumber>581</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/7a366813-ed9b-456f-8761-4f37c12b97f4"/>
    <dc:identifier>https://www.omim.org/entry/602390</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f06f6404-3120-4143-83cc-67726d61d4d2">
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004910</ddiem:url>
    <dc:identifier>HP:0004910*</dc:identifier>
    <rdfs:label>low proximal tubular reabsorption of bicarbonates</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ec841c59-aa58-4c4c-b0e9-2dcc2f54ea66">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30373890</dc:provenance>
    <rdfs:comment>Glutathione [N‐acetyl‐cysteine]</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/271245"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19304794</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007764"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/dddcface-813a-4a80-b794-470fa96c76a7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d82e331c-326d-498b-bc36-048e47009325"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/741dfc90-c128-4cc9-8ee0-2b0a1610adce">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>EEG abnormality</rdfs:label>
    <dc:identifier>HP:0002353</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002353</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6240d189-1def-4b04-8304-cf06068f619f">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00847</ddiem:url>
    <rdfs:label>Cysteamine</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/398df0bd-24ca-4d87-a2df-5766534d8ab9">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/256730"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/36378db6-72d2-4a5f-8023-a1c3ca950ce1"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00028262</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2de16642-dba7-431c-b0c2-a9e6a77502d7"/>
        <rdfs:comment>Cystagon</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755542</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/32b758fc-5790-4086-80c8-56d6b9224db3"/>
    <dc:identifier>DB00847</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d7bf104c-1642-43c5-8968-e5c86331dd69">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/36378db6-72d2-4a5f-8023-a1c3ca950ce1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26884075</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7bc67a35-0b1b-42c7-99de-57fb84731813"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/530000"/>
        <rdfs:comment>cysteamine bitartrate</rdfs:comment>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02023866</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02473445</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f49cd935-2b16-482a-8307-acf33a80b161">
        <rdfs:comment>cysteamine</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/82fd11be-26fc-440d-8f83-d781a361a528"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/628ad6d4-20e3-4788-a4ce-9d9ed86585e0"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/36378db6-72d2-4a5f-8023-a1c3ca950ce1"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/219800"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158338</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/14fa1b3a-1b9a-48f5-88b4-6b7aa5762272"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3550461</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8444253</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1da366fa-aede-4f92-9540-c9fc443f5b88"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/18cbaa7e-04bc-4d92-a37c-89d61cf02290"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/110e9847-19e7-494a-a855-766348dc8f05"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/81e1ad95-7e6c-441d-a032-cf953e9911b8"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6f36863e-f84f-4635-bdbb-8a18d9906473"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016220</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9758713</dc:provenance>
        <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/21897743</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11001803</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/80ba8210-99cd-4d4f-8659-ce5f962bb409"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2931ebdf-9ae3-4cce-9411-610530b5a399"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505515</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a069889d-fea1-4688-8e0b-21c8e8102419"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/adc1fd74-4a79-45e0-8e37-b33a7b9dbdf2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23416144</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3dc5c559-eb74-49ee-b334-aaaad0b67b08">
    <dc:identifier>DB14098</dc:identifier>
    <rdfs:label>Cobalamin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/021bcbc3-4d95-4134-8edb-e7bfd4e35de4"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14098</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/17092020-f6b8-4377-ac8f-d94a57c83bf8">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>nervous system abnormalities</rdfs:label>
    <dc:identifier>HP:0002011</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002011</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4402bb55-1835-4f76-b248-9a46b5781c88"/>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fa58f39b-caec-4628-89f7-c594e9d8a06a">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bbef1879-e4ae-44e5-a33b-6d3e87accd0e"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5ccc41a5-5a6a-4b23-9d12-14ad7b393be6"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b8518e35-c60b-46ed-bc46-d66ffbec7fe9"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/213700">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>CEREBROTENDINOUS XANTHOMATOSIS; CTX</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/183</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>183</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/213700</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/07c850c9-abe5-44eb-ba05-165746dc1db0"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7964884</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1316120</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6e5c5813-8919-49d6-96c1-61f7488cb0a5">
        <rdfs:label>Xanthoma</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001114</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001114</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1211d4c5-c5f8-47d5-b2d1-59477d0292e0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1a2164c8-0be2-4874-a4c0-0a9cb2b1a440"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e10aac94-9a01-49af-b6cc-166839ea9915">
        <rdfs:label>Elevated serum cholesterol</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003124</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003124</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8c6d4986-4e49-497a-ba43-3178c58ec295"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
    <rdfs:comment>Pravastatin+Chenodeoxycholic acid</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/33a1e293-ef1d-4d33-8504-acb6fed7afc8">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01907087</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00151216</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/204500"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24938720</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3b013c50-da5d-4c98-ade1-8dee9cd4485c"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7782a55c-6958-4e94-b25d-269ef5456ba3">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3431e7a6-f339-486b-b7ee-83d7eff11c54"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28589525</dc:provenance>
    <dc:provenance>https://emedicine.medscape.com/article/1178391-treatment</dc:provenance>
    <rdfs:comment>AAV2CUhCLN2</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d369931e-dfd2-42fc-bb51-b22501730f33">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/603471"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15670720</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/58fcba01-868d-4c32-a8dd-b6ae76adbeeb">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/297c77b8-2e9e-41f0-a2bb-c8d7c89784da"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c7f655ba-be97-4ed6-82f4-1676146a391a">
        <dc:identifier>HP:0002181</dc:identifier>
        <rdfs:label>Brain oedema</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002181</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>D-mannitol</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1181</dc:provenance>
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16449956</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/abs/pii/S1386634602003315</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/22432332-0801-43c5-a8fa-ffc4d8b0f855">
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/28126686</dc:provenance>
    <rdfs:comment>galactose+Uridine</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/56784e39-7342-4230-b680-31ff278f9701"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d90eb3a2-26ba-46c5-94c0-ee73ced46682">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/28d8aa92-466a-4bb7-9cbb-afe65875c45e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18996862</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/df30415c-a1d8-45fe-96f4-4d0dc9762639"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4bd77efe-eb0f-40e0-9c6f-058b6b8d0468">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1b6f7c2e-769e-450f-b723-b86729a6e8e7"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232220"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7c58173a-6090-4596-94e2-85e536e4952b">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fe43328f-54fa-428e-83c0-4de3093ce92f">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8582405</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S109671921200265X</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3276166f-41e7-4027-b73f-bb43285e4b4a"/>
        <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
        <rdfs:comment>Sodium citrate</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052756/#S10title</dc:provenance>
        <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/207900"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/69b4d866-9b87-4af9-bab8-a13b3923e87a"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB09154</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09154</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2b4b7903-57da-4ba3-94b8-867a87a11893">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/203750"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <dc:provenance>Abstract</dc:provenance>
        <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
        <rdfs:comment>Bicitra</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b26846fd-e165-4645-af42-051945afa653"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3276166f-41e7-4027-b73f-bb43285e4b4a"/>
        <dc:provenance>http://www.babysfirsttest.org/newborn-screening/conditions/beta-ketothiolase-deficiency</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Sodium citrate</rdfs:label>
  </ddiem:Drug>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/601987">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/1626b85b-505b-4674-ae78-67b04ace6d63"/>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>CARNITINE PALMITOYLTRANSFERASE I, MUSCLE; CPT1B</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/601987</dc:identifier>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fe087a99-44a3-4bdc-a716-5d9341e3a74d">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4c38f6ce-0130-41a6-9e19-d6f76f1333b1">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001877</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001877</dc:identifier>
        <rdfs:label>NA</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bc60dca3-dee6-4529-8c90-8a18661fde8c">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8e42ffb4-ab3a-4878-ba7e-fb2d5e044a42"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT00001962</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25098371</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/105650"/>
    <rdfs:comment>Daclizumab</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22734070</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bb4dfd58-8d12-4b5d-911b-97e55712fe62">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23806424</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <rdfs:comment>Vitamins</rdfs:comment>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/520000"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/48fd1c7d-5812-4ce9-8ff9-70044271a1b2">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004395</ddiem:url>
        <rdfs:label>Malnutrition</rdfs:label>
        <dc:identifier>HP:0004395</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5d617dde-76d8-4be9-94a5-201e08eb46b4">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/fd017192-1bc1-4b24-a2d1-d80e4f6851f6"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24746802</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/35506db9-7883-4ce5-9e61-ecd31922eded">
    <dc:identifier>HP:0000707</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
    <rdfs:label>neurological dysfunctions</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/260f163c-d7a1-4522-a815-1ff5e49b1363">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/608099">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b8201ee7-2920-44e9-a3b7-79c6284745fa"/>
        <dc:identifier>https://www.omim.org/entry/608099</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 3; LGMDR3</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/94ff9868-08a8-494d-8029-04f7700782f3">
        <rdfs:label>Direct interaction(Mechanistic A)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/02a2761d-c97b-4802-899d-b0146eee553a"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5aa769b7-e948-43fe-9dd4-89464ba91657"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/27dcf15d-56ca-4bd6-b4c5-ca103704e8d3">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001324</dc:identifier>
        <rdfs:label>Decreased muscle mass</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001324</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>AAV2/1-MCK-Sgca</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/650f8a84-1255-45ca-966e-e90d27cb99da">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4b39dd2f-7186-4ddd-b11e-765bf5277ee5">
        <ddiem:url>https://www.drugbank.ca/drugs/DB01329</ddiem:url>
        <rdfs:label>Cefoperazone</rdfs:label>
        <dc:identifier>DB01329</dc:identifier>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7b3839e4-8d20-4bf0-bf23-bf8f32c5df2e"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6feb0fa0-14b1-4635-9cab-d31705ad110f">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/236795">
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/928a54cd-f1e2-463e-91e9-aaecd5062190"/>
        <dc:identifier>https://www.omim.org/entry/236795</dc:identifier>
        <rdfs:label>3-HYDROXYISOBUTYRIC ACIDURIA</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
    <rdfs:comment>Carnitine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>http://eknygos.lsmuni.lt/springer/365/81-92.pdf</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/088789949400109F</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cf94f02a-5526-4aee-b903-802198d23a2c">
        <rdfs:label>acidemia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001941</ddiem:url>
        <dc:identifier>HP:0001941</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0daa7e0e-7d73-4a56-a0ee-13d85925b62b">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0005961</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0005961</ddiem:url>
    <rdfs:label>Low plasma arginine levels</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7e963898-9a97-4b9b-8b3a-4ff60aaf7d40">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000127</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Renal salt wasting</rdfs:label>
    <dc:identifier>HP:0000127</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/33b2d811-1ad3-4d3a-b086-739552aa362e">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01399047</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT01399047</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29631617</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/204200"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b5b96bd2-d176-4599-a76f-48529aa6521e">
        <rdfs:label>The primary outcome of the study was to check tolaribilty to treatment. The drug was well tolarated</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004356</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0004356*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1efe4db5-b496-4018-ba56-9cebf5e9a8de"/>
    <rdfs:comment>Mycophenolate mofetil</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29923092</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/bcb8f70a-5840-4bad-8d21-35cfd2deb1a2">
    <dc:identifier>DB12273</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB12273</ddiem:url>
    <rdfs:label>Ecopipam</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1240dbad-78b1-4d74-b6a7-17b0cdff40ec"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2946feee-2222-4277-86af-79aeaca78fab">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <rdfs:comment>Angiotensin-converting enzyme inhibitors / angiotensin II receptor blockers/ beta-blockers/ diuretics + anticoagulate</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0359e03a-892f-4989-9f79-5d0bec5a13f1">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/74e3f7e7-105c-455a-af72-76cf06903bed"/>
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/5bb4576b-3cd0-4d0b-9281-16d61751ff30"/>
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/79a4d0d8-604f-4958-a73e-edbde341deca"/>
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/852019f2-1778-47b5-bf09-0669fa982c73"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/29d04144-b519-4426-8064-8253a1322077">
        <rdfs:label>Atrial fibrillation</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0005110</ddiem:url>
        <dc:identifier>HP:0005110</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2393224e-09fe-4075-a95f-287cb93174ad"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/302060"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cad27e08-c72e-41db-9634-9b06464c1943">
    <rdfs:label>High desmosterol levels (Abnormality of cholesterol metabolism)*</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003107*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003107</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cdbcca14-b1f0-4924-b7db-475c00c00317">
    <rdfs:label>Erythroderma</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001019</ddiem:url>
    <dc:identifier>HP:0001019</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a8acc9fe-7106-40e6-9217-eea4c44f6cd5">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27423595</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0f45409b-7540-463a-b80e-6a6f426e8448">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/893b61c6-b749-4d7f-a13a-78d676e3db70"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8d143ef5-d7bb-41d8-9c0e-308711ef1f5a">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002174</ddiem:url>
        <dc:identifier>HP:0002174</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Postural tremor</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26817292</dc:provenance>
    <rdfs:comment>Rotigotine+L-dopa+carbidopa</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25707872</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4dea14c3-c8ce-48ca-952d-8197ce8123c6">
        <dc:identifier>HP:0001300</dc:identifier>
        <rdfs:label>parkinsonian symptoms</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001300</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261630"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8a5bd96d-2399-44b5-82f8-2b66f2c21f88">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002067</ddiem:url>
        <rdfs:label>Bradykinesia</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002067</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fd8cf6e3-3371-48f8-aa90-cbf69bfcf2fe"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/57725780-7ce9-458d-81ce-db581867c4d7">
        <rdfs:label>Kinetic tremor</rdfs:label>
        <dc:identifier>HP:0030186</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0030186</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0022510X16303495</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18425437</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d035370c-7a11-44c2-9bf3-a9460bc018f3">
    <dc:identifier>HP:0002160</dc:identifier>
    <rdfs:label>High total homocysteine levels</rdfs:label>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002160</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/91c281c6-7436-4951-b38a-850822b90c97">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/870cfd06-192b-4a7b-9fe3-bcdd7bd8ce8e"/>
    <dc:identifier>DB14712</dc:identifier>
    <rdfs:label>Elapegademase</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14712</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2bdad668-d1af-4f41-a87a-cc25ac2c49a9">
    <rdfs:comment>Deferoxamine</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/96bf0b70-640d-4855-9df3-efb662012d8c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17124037</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602390"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28624580</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3221dd31-98b4-4447-b38f-8fd197ae3fb2"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/919f6c6d-8e4a-4ba3-bf07-0e9380dc68e4">
    <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
    <rdfs:label>Thrombotic microangiopathy</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6fb1ef56-8cbe-4678-a62b-3b36f529deea">
    <rdfs:label>Hepatic prophyria(Abnormality of the heme biosynthetic pathway)*</rdfs:label>
    <dc:identifier>HP:0010472*</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010472</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d08375ae-f562-4a96-b84e-c4d2832537b9">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e258861b-dea9-4f9f-8f9b-c4231acda871"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602473"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27830356</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bf463dc8-fe5f-430e-bcd9-8c0665485dd4">
        <dc:identifier>HP:0011943</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011943</ddiem:url>
        <rdfs:label>abnormal thiosulfates level</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29526615</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1d9593bb-94eb-4172-af06-eaf00771c785"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/01315d43-9dbc-433a-bc49-f12118b138f0">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b47abfc4-b066-4d9f-b396-fc8e2e2f719f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0022202X15352507</dc:provenance>
    <rdfs:comment>neomycin+Acetylcysteine</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3e81ea87-1984-4958-86c6-dcad844b19a0">
    <rdfs:label>myoclonuic Jerk</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001336</ddiem:url>
    <dc:identifier>HP:0001336</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5edb1712-da17-4178-8e23-46bd0eee307b">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/26b42350-d9a5-45df-a4ec-c7b4afdfd760"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/213700"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301583</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1316120</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>coenzyme Q10</rdfs:comment>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/00f191bd-4fef-4027-8fb7-0be2dddc954b">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22410442</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3fe65f4f-46f4-4341-ab56-a740aca61558"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/ee41b521-2653-4540-b72c-053f925f032d"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/535000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21788663</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/87773692-3665-4b9d-8e9c-762077ce7b16"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <rdfs:comment>Estrogens</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01495715</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20943885</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4ec5b893-8b33-4928-b730-e9fc4aeabb34">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/74d1a724-4af5-4532-8126-7c0dd642485a">
        <dc:provenance>https://www.nature.com/articles/nature10456</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/26390bda-97dc-4709-8a99-cb6e38f3ca40"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/253800"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d1f4c68d-c568-427a-8654-93b43a0750eb"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3ba6493c-fb20-45ae-ac93-075a86f27138"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4f6fb3fd-b14c-4429-a7cf-de34a4433e9e"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27421908</dc:provenance>
        <rdfs:comment>antisense oligonucleotide (VMO AED cocktail)</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bbf6c6fc-3096-48ad-a1c7-92147a430bf9"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>antisense oligonucleotide (VMO AED cocktail)</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1ffc374a-7e2d-4a4d-ae6f-9892396f5be7">
    <rdfs:label>Regramostim</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB05386</ddiem:url>
    <dc:identifier>DB05386</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/dc3e4077-931f-404f-9fa7-d990ecae2434">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25335805</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5499489c-5d73-4465-a9c2-9c2d7c0d260b"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21110863</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a5253d61-bf77-4e88-a835-3c577a26497c"/>
        <rdfs:comment>rGM CSF</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29058386</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3391ceca-8049-42f4-a823-96a368f247c6"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28649527</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7f0cb351-9f34-4b83-9d5d-0c618f85ca88">
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <rdfs:label>low reproductive capacity (infertility)</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000144</ddiem:url>
    <dc:identifier>HP:0000144</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fc56a770-f4ad-41f3-ba5d-e2a5980d1633">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ba30a74f-f3ac-4d86-91c2-5e7c5992fc24">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2299ce1f-0836-40aa-b38a-f4bcc159cea2"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cbcb72f6-1503-4ebc-9aea-7b162cf92e0f">
        <rdfs:label>Sulfide toxicity</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Dehydroascorbic acid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29526615</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0005272811001447#bb0230</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17712735</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602473"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0022202X15352507</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0aedeece-6b95-4a09-adba-b3cdeb1e09f4">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/262c3794-8cfa-4544-ba04-30e4d982f97d"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/249900">
        <dc:identifier>https://www.omim.org/entry/249900</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b2303e49-9319-4ef2-9626-7733e6fe586e"/>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/293</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>293</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/abs/pii/088789949190052M</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9511979</dc:provenance>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/76abffbc-3c49-48c6-988d-df22e3fae429">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/af880734-bfc6-4b68-abfb-1924d6ca83e8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30384011</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30090842</dc:provenance>
    <rdfs:comment>No medical treatment is available in DDIEM</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/cf5e34fd-598c-4854-b262-883c4b8bcccc">
    <ddiem:url>https://www.drugbank.ca/drugs/DB09270</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1612401e-a663-4999-9c5d-4ffd6a0c9aa4">
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719215300895</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9156798</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2170dc7c-c3d5-495d-972e-7abd19374be5"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608158"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12948744</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
        <rdfs:comment>CoQ</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bd86e31a-c48d-4e72-b3ea-d6b3a8b067dd">
        <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625994</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26823911</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29596118</dc:provenance>
        <rdfs:comment>Coenzyme Q10</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10601810</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/540000"/>
        <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e6a48bf3-b1ab-43b3-9211-86e37a845e94"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/257ba681-37f6-4b96-b1f9-9dbfa4fbd2e3"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/938d03bc-de01-4dbe-a9b7-8b69224699e5">
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
        <rdfs:comment>Coenzyme Q10</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
        <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4494408b-79a4-4b11-acf8-1700e5b0cd6c"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19323589</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/520000"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24746802</dc:provenance>
        <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/614643a5-b078-44fd-83cf-a40347dd1cda">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/609056"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
        <rdfs:comment>CoQ10</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/52298db7-8729-4c1f-9457-c133db82899d"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2a4c5500-9d53-49ad-ab26-9f0769351df2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22990144</dc:provenance>
        <dc:provenance>https://www.tandfonline.com/doi/full/10.3109/0886022X.2014.900422</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c9615658-5956-4024-bd5f-3a94a8a2dd2a">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27442316</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c1871150-0692-49d5-9801-d0afc84ec086"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2ade1c7c-1de9-46f1-be48-afaf68b06736"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/610131"/>
        <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
        <rdfs:comment>coenzyme Q10</rdfs:comment>
        <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01793090</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB09270</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/5edb1712-da17-4178-8e23-46bd0eee307b"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f29d0d8c-74a5-4ba0-bc85-58d0832d8993"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8a3395f8-81cd-45d5-a01f-9f5430f2330a">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
        <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/26669244</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <rdfs:comment>coenzyme Q10</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9004f061-6687-4c22-b999-9930d2cd13b5"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26669244</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c7ff6357-6824-474c-894b-edf0246a0315">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246900"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1567724914001299</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25251739</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
        <rdfs:comment>coenzyme Q</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e3ec89a7-6f3f-4f6d-8c75-0e9bbf1904f3"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Ubidecarenone</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fb3782ed-593c-44e5-864c-625beb04d3ec">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26884075</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27709644</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27442316</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5f51e3eb-16d9-403b-9930-0407fab916ad"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26118651</dc:provenance>
        <rdfs:comment>coenzyme Q10</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/530000"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/dc7167d5-caf1-421f-9d55-4a799052c41e">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2579714b-dda2-46c7-afec-88f9b8616ae2"/>
        <obo:RO_0003304>comp. htz c.[895C &gt; T] + [1358delT] exons 7 and 11 p.[Arg299Trp] + [ Leu453Argfs*24]</obo:RO_0003304>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843540</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/17f2e59e-d6f4-42f5-b086-d1287d482ebc"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b5342a4f-2f01-43d5-b16a-8efdbeb0098c"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29159460</dc:provenance>
        <obo:RO_0003304>comp. htz c.1523 T &gt; C exon13 + del exons 3 to 15 p.Phe508Ser</obo:RO_0003304>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427193</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cefa5609-067b-4fb0-81a7-5a24ff1f5c38"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/bbd26fcb-81e9-4423-8185-aa629db379ac"/>
        <obo:RO_0003304>G272D https://www.ncbi.nlm.nih.gov/pubmed/18319072</obo:RO_0003304>
        <obo:RO_0003304>homozygous frameshift mutation (c.1844_1845insG) in the C-terminus of mitochondrial atypical kinase COQ8A</obo:RO_0003304>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cf8a413b-fc65-47f0-a4bb-455176be093d"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fd8cf6e3-3371-48f8-aa90-cbf69bfcf2fe"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c36f79c8-ad54-4119-9f76-7f1d1b0e6a21"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6ce4f760-ed2f-47e7-b456-697550d26030"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/612016"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263309</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26818466</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7c36dc7c-4316-4411-be30-781c71a6a7ec"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d0550636-583d-4be4-ad5d-8c37b4c15c01"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18319074</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28125198</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15326254</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d7eea769-847b-45c9-86ed-d282a5478c13"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a9b59208-3e93-45cb-b16f-771c43c5f96d"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/57ef7c29-331f-44cf-89e4-c1fa39c1b128"/>
        <obo:RO_0003304>Homozygous deletion (c.1511_1512delCT) that leads to a premature truncation of the protein (p. Ala504fs)</obo:RO_0003304>
        <obo:RO_0003304>Homozygous deletion (c.504del_CT)</obo:RO_0003304>
        <rdfs:comment>CoQ10(ubiquinone)</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24164873</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ce61879f-80f3-4e80-82a1-28c66b4976aa"/>
        <obo:RO_0003304>Hetero c.[1541A→G] + [1750_1752 delACC]</obo:RO_0003304>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2b2658b9-05f9-4d1f-a55a-a3b4162db96e">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>NCT00744042.)."</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6c1ff06e-80a8-4bb2-b686-82d45be25f7a">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001397</ddiem:url>
        <rdfs:label>steatohepatitis</rdfs:label>
        <dc:identifier>HP:0001397</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.researchgate.net/publication/8668575_A_successful_treatment_with_pyridoxal_phosphate_for_West_syndrome_in_hypophosphatasia</dc:provenance>
    <dc:provenance>an enzyme-replacement therapy</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/275630"/>
    <dc:provenance>was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number</dc:provenance>
    <dc:provenance>"ENB-0040</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://onlinelibrary.wiley.com/doi/abs/10.1111/pde.12170</dc:provenance>
    <rdfs:comment>Ursodeoxycholic acid</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5dfdb19c-2a01-4a8e-9051-ca6a3315a184"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/0b4da3ba-8f90-4567-a0db-476d587639be">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1baa5322-e06e-4c3b-87d2-8bd1a0dbc9dd">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15670720</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/18763701-c630-428a-9ea3-8bda7a73fde4"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300100"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28976817</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/28636a95-7bbf-46ff-9508-6f13bcbee95c"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
        <rdfs:comment>Sobetirome (NV1205)</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28200172</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03196765</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB07425</dc:identifier>
    <rdfs:label>Sobetirome</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB07425</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d7c5c0d3-845d-48a6-8c87-ec89d9df1b97">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0f68460c-347f-4a2a-81a6-0bd77e694847">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/220110"/>
        <rdfs:comment>carbamazepine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a7136ba9-4f45-4789-899d-da83dd21de6f"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22149023</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00593</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00593</ddiem:url>
    <rdfs:label>Ethosuximide</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/16c13595-ed4a-4c4e-bc34-2902869807fe">
    <rdfs:comment>carnitine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25614308</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/38506d80-a332-499a-b536-a012195e123c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19452263</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/212138"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7cec6943-5e10-4e46-9c27-d7eee71400fb">
    <dc:identifier>HP:0001332</dc:identifier>
    <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
    <rdfs:label>Limb dystonia</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001332</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c85b04d4-9928-475d-81ac-eac84e85c65a">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6feb0fa0-14b1-4635-9cab-d31705ad110f"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5713a1ec-65a1-4db8-ae68-f2c046c7b7df">
        <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dc44f9ef-3a57-44fd-aaec-a634c98f95a8"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f4855437-f840-410d-981e-1aeb49d65b9a"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/250950"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
        <rdfs:comment>L-carnitine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/942d6b2d-fae4-4aa5-a984-d42a21a9e274"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <dc:provenance>https://www.researchgate.net/publication/46821474_The_3-methylglutaconic_acidurias_What%27s_new</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11400757</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358122</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4494408b-79a4-4b11-acf8-1700e5b0cd6c"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/399a328e-5bff-4687-bf85-00fac740f5b1">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/530000"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:comment>l-carnitine</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19891905</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26884075</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27709644</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/7199c277-e274-40f1-b74e-be9b419517f4"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/257ba681-37f6-4b96-b1f9-9dbfa4fbd2e3"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f048123f-16ad-4c00-9530-0bfcb64ffb16"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/bedd1c1d-7692-4958-95bd-e2c18803c5ec"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5a028d0a-e124-42d2-a330-2d352142a43d">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/610006"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11102558</dc:provenance>
        <rdfs:comment>L-Carnitine</rdfs:comment>
        <dc:provenance>http://www.babysfirsttest.org/newborn-screening/conditions/2-methylbutyrylglycinuria</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9c8d6591-d793-4e7c-aef4-22d1ec756755"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2679ee93-1d05-4a37-a74e-7a62c7a2ccc2"/>
        <dc:provenance>https://www.newbornscreening.info/Parents/organicaciddisorders/2MBC.html#4</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/da9e83e3-8f3d-4b72-aba8-d571da5e1cc7"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/08df148f-745f-431c-a394-1139a5de0c28">
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4494408b-79a4-4b11-acf8-1700e5b0cd6c"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231530"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388644</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
        <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/65f0e718-e826-42ae-a5bb-1c96525d1092"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4191c3ff-1ae7-44d5-8f97-6a685e696bd2"/>
        <dc:provenance>https://link.springer.com/article/10.1023%2FA%3A1024031714659</dc:provenance>
        <rdfs:comment>L-carnitine</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ff3f66f9-2139-437d-837d-ed0b34e0e8f2">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301535</dc:provenance>
        <rdfs:comment>carnitine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28057010</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9f4da0b7-bc68-4593-a7c4-e98ccf7624da"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23430827</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2501105c-06d1-47d0-b962-80165f35b36d">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/65f0e718-e826-42ae-a5bb-1c96525d1092"/>
        <rdfs:comment>L-Carnitine</rdfs:comment>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/210200"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18155631</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17968484</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dcd4e33f-fc5c-46d1-a5a6-1a6994c4791f"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9c8d6591-d793-4e7c-aef4-22d1ec756755"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8831079</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10485305</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/94b755af-379b-4085-97ba-af45a18b1a43">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ad80f96f-a5f8-460d-a992-2fc0364ad7d1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
        <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26006750</dc:provenance>
        <rdfs:comment>L-carnitine</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602541"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d90a04b5-1e00-4b03-840c-997911b3fd55"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bc768f80-e1a6-4fb5-8ea5-08068e1f3f0f">
        <dc:provenance>Abstract</dc:provenance>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/203750"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
        <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1110863016300763</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5bf5f0cf-9a98-435a-b7cd-9e5a39c672f0"/>
        <rdfs:comment>carnitine</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3b588c74-e1db-4e24-8be1-69e5fe049303">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4179eb33-3756-4822-bae1-3eb1b6c593cb"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/af09b6b0-e5bb-41af-a67d-b78016ba0308"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/7a649270-4fb1-46d5-a09c-806497121d1b"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a1908b1a-f9bf-4460-93a2-84ee4aa2ad3a"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/215822d0-31d5-41bd-9310-782ce126378b"/>
        <rdfs:comment>Lysine/Arginine/carnitine/Citrulline</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25614305</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301535</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27567650</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/84ed718f-650b-4f15-837d-2b4e0c13017a">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26997609</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220407</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b8518e35-c60b-46ed-bc46-d66ffbec7fe9"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1886403</dc:provenance>
        <rdfs:comment>Carnitine+high-carbohydrate+low-protein and low-fat diet</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246450"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2443756</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/13af3f8b-359d-400e-94ed-20a1031f7643"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29565174</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00583</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1d31008c-9f28-4c0c-980a-904cc7eba515"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9634d4c0-db44-4e7a-83f0-224ac854f8a4">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22132097</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9199c3d6-cc4d-4dfc-befa-b567dec868da"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:comment>Carnitine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300438"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11102558</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/cc205029-88f9-42bb-bfdf-7db6271c111f">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/387f787c-cf1e-489c-85ce-1f00a59468f7"/>
        <rdfs:comment>Carnitine</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28649527</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24613099</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/248360"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26858006</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28781843</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a3633672-aea1-4a2a-acec-6913c3763cce"/>
    <rdfs:label>Levocarnitine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/16c13595-ed4a-4c4e-bc34-2902869807fe"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00583</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a68af3fd-cc0a-4bb6-8cb9-dd9ffb03d1ed">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18996862</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007764"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f7ec7159-1d8e-4aec-b7a3-5dd4d6c15638"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
        <rdfs:comment>l-carnitine</rdfs:comment>
        <dc:provenance>https://www.nature.com/articles/srep44408</dc:provenance>
        <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/28317891</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/05a471bd-3e9c-4c22-a4c0-e9667511f377"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/976551f8-2f36-45f9-84d3-2f3fc6670ba0">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/abf6d12f-b307-45b5-be88-ec8fc89ed757"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606175"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2931ebdf-9ae3-4cce-9411-610530b5a399"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415789</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12044538</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/290153ae-27c7-4a4d-a3e5-1d8cea978533"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
        <rdfs:comment>L-Carnitine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1493</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/258606c4-1f54-4967-8857-7ac2041599bf"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2f031d84-68c7-41ab-b66a-af6297f92901">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00923247</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886552</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00704730</dc:provenance>
    <rdfs:comment>topiramate</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/614080"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d8562063-debe-47b1-90ec-02096b47fe97"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30297385</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7b5c923a-1ad3-4476-a6c1-593bf913fdcd">
    <rdfs:comment>Baclofen</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27179999</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a895f806-31ec-4ad7-816b-ddbe826777da"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300322"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f8b55671-472e-4a1d-b4ed-b9fda12b2f95"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://rarediseases.org/rare-diseases/lesch-nyhan-syndrome</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22198833</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16549399</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/baa0e810-94c4-452a-bfbb-86de7bca651b">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ca9b9a58-7a04-4c26-b381-ca81e83461cd">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/study/NCT00229619</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f2e6d002-aa3e-4ae4-84d7-e63aa648033a"/>
        <rdfs:comment>Rituximab</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22734070</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25098371</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/105650"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/94a6dc10-61e6-4adf-8204-7b21207fe512"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00073</ddiem:url>
    <rdfs:label>Rituximab</rdfs:label>
    <dc:identifier>DB00073</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1c584f55-1ceb-4ae9-9429-6e2e8819681e">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/11c19a33-e68e-42c0-995e-c869fffa536b">
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <dc:identifier>HP:0001250</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
        <rdfs:label>Lip-smacking automatisms(Epilepsy)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0003304>R229W</obo:RO_0003304>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ecc82379-0802-42fd-8392-61894440947c">
        <dc:identifier>HP:0001250</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
        <rdfs:label>Clonic contractions</rdfs:label>
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/610090">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/610090</dc:identifier>
        <rdfs:label>PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD</rdfs:label>
        <ddiem:iembaseAccessionNumber>76</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/76</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/079acc1e-a9c5-4bc1-a86f-72a1047063dc"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <rdfs:comment>Pyridoxine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8757046</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/955aec1c-b7b7-4d8d-a657-f536e409df1d">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232220"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19066956</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f68c2fd3-00be-4071-998f-e62fe783cbf2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19541498</dc:provenance>
    <rdfs:comment>Adalimumab</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25288127</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18172743</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1285f3b7-b1f5-4001-aaf2-8c1b6c732d5c">
        <rdfs:label>GSD-associated enterocolitis(enterocolitis)</rdfs:label>
        <dc:identifier>HP:0004387</dc:identifier>
        <rdfs:comment>Preventive calcium and vitamin D3 supplementation is also recommended to prevent osteoporosis.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004387</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4ada7120-edb0-4d9a-b826-3a2438508c55">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d136e33a-9e99-4761-a8e3-e2c181c8c57a">
        <dc:identifier>HP:0002028</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Chronic diarrhea</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002028</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Niacin</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ba62687-4f50-4312-96a1-5490d2289da9"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/234500">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/50</ddiem:iembaseUrl>
        <rdfs:label>HARTNUP DISORDER; HND</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/8a4bb2af-4867-47d4-a088-fe00bcf38f43"/>
        <ddiem:iembaseAccessionNumber>50</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/234500</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02534844</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/bc81a2fd-b16f-4dd0-974c-c7bc128da15f"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2d8bccbd-b697-4edd-b40a-f3623ef591cf"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25526748</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f49f1150-0973-4abf-a19a-fba0db733a8d">
    <rdfs:label>Difficulty breathing</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002098</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0002098</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/bb9232fd-a365-4872-a321-4f97790eb062">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01205</ddiem:url>
    <dc:identifier>DB01205</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b6101ffb-cc1a-4886-972a-599f1579c274">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/741dfc90-c128-4cc9-8ee0-2b0a1610adce"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dfad68fe-4687-4744-a762-2b07c75ffc8a"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29480352</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/5707897</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fba10fee-66ff-47ac-8029-2fdd52a19f6a"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <rdfs:comment>flumazenil</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/613163"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15895716</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8b40d071-7704-4998-b67d-36963a9022d8"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/56866be6-5dd7-460b-84b7-73208cc82bec"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7814809</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5d9b1b28-7932-4b86-acb2-639550e93a56"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19428278</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29358012</dc:provenance>
        <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/28411234</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0fd8f9ff-79f3-4286-9c92-96d509756a5e"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5d9dc51c-2ae1-43d2-ad3b-5684b8c1f486"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Flumazenil</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/979b6e9e-09f3-4c96-814b-3229d09ef9e6">
    <dc:identifier>DB01914</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01914</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/472d978f-fbbb-48d3-8a6f-0112521d1ea9">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26997609</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246450"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17628222</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a56e3d88-5b3b-4dc2-9801-f87fe8d1ff25"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/143052ab-60ff-415d-b706-9dc598cf9c69"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90adf2c0-fb99-45bc-bcb4-3ef1422aaef1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220407</dc:provenance>
        <rdfs:comment>Glucose+leucine-restricted diet</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2443756</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1886403</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/09c23282-33fb-4d16-93cc-ae451c49916a"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/61cedf62-c21f-442f-8c5d-e6a27b7c5fb7"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5e60755f-db30-4087-8c2c-53151d95126b">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26835382</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18996862</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956916</dc:provenance>
        <rdfs:comment>Glucose</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d6c1137f-c24a-4d72-9c84-5068df3a1623"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/143052ab-60ff-415d-b706-9dc598cf9c69"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>D-glucose</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8676234d-5fc4-49b4-ad6b-87972d904b52">
    <rdfs:comment>Indapamide</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12016800</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10510995</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/46b444f7-450d-4071-8f56-18338cb8ed09"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/92f99810-4698-488a-8e79-b31815f064e2">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003158</dc:identifier>
        <rdfs:label>Reduced urinary osmolality</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003158</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2ae9ab72-c9d7-42ce-ad0e-3e20b973e4ee"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c9b65ab8-6cd7-414e-9576-9f9f14a056c6">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>High serum osmolality</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/125700"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
  </ddiem:TheraputicProcedure>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000002">
    <rdfs:label xml:lang="en">complementation therapy</rdfs:label>
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure in which a treatment directly or indirectly compensates for the loss or gain of activity of a genetically defective protein within the network or pathway of which that protein is a member. [PNS]</obo:IAO_0000115>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000005"/>
  </owl:Class>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c3d46faa-741f-4999-a429-f0a5bede184b">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/80cf2637-b84c-4131-9b91-5de68faf4c7f"/>
    </obo:RO_0000057>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/240600">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/21e6ff8b-921a-45a4-9996-32b54d51106a"/>
        <rdfs:label>GLYCOGEN STORAGE DISEASE 0, LIVER; GSD0A</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/240600</dc:identifier>
        <rdfs:comment>GS deficiency has a good long term prognosis: it is usually associated with a normal intellectual outcome, symptoms can be prevented if the condition is recognized and treated by avoidance of prolonged fasting and tolerance to fasting improves with age. https://www.ncbi.nlm.nih.gov/pubmed/12794686
Patients are treated with a diet high in protein with complex, low glycemic index carbohydrates. Since gluconeogenesis is intact, protein supplementation provides gluconeogenic precursors that can be used for endogenous glucose production. In turn, there is also less dependence upon fatty acid oxidation, and accumulation of free fatty acids and ketones is prevented. This not only reduces systemic acidosis, but prevention of hyperketonemia also enhances gluconeogenesis since more alanine can be released from skeletal muscle. https://www.ncbi.nlm.nih.gov/pubmed/106027
Simple carbohydrates should be limited since they can increase blood lactate concentrations. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1474809/</rdfs:comment>
        <ddiem:iembaseAccessionNumber>497</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/497</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/54e5297c-7989-45bd-9ba8-7d983720ad58"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/26486999-62ac-412e-af84-4ddc0495e21e">
        <rdfs:comment>Patient transaminases  slowly decreased with time in https://www.ncbi.nlm.nih.gov/pubmed/12930917</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002360</ddiem:url>
        <dc:identifier>HP:0002360*</dc:identifier>
        <rdfs:label>Poor sleep quality(Sleep disturbance)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2c4a2d48-1267-446c-9efd-2767b7cda6ed"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02054832</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29223626</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <rdfs:comment>Glycosade</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564511</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/76cecbc7-ac4c-4244-9725-cbb83b03679f">
        <dc:identifier>HP:0001943*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001943</ddiem:url>
        <rdfs:label>Nocturnal Hypoglycemia(Hypoglycemia)*</rdfs:label>
        <rdfs:comment>Patient transaminases  slowly decreased with time in https://www.ncbi.nlm.nih.gov/pubmed/12930917</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/46b645c4-08a4-40ac-bb56-6b1936de58b9">
    <dc:identifier>DB01432</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01432</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/08364832-bf2c-41e5-af0d-cc15aacafe83">
        <rdfs:comment>Colestyramine+Simivastatin</rdfs:comment>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1521691810001101</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b3c4afc9-72ef-4997-bb9c-dae2e4acaa69"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9c4eeb10-58b6-476d-b335-d5f0fe99c558"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/40cb8f7d-d181-4382-b2f0-a3f73016b007"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1a9aaa07-3326-4267-b8ae-9071b877eab2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1801793</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2170dc7c-c3d5-495d-972e-7abd19374be5"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/278000"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2e306140-e369-4137-a34c-c45574dfa0e4"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ffd43e83-794f-4974-85ed-0654f71adde0"/>
    <rdfs:label>Cholestyramine</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/18763701-c630-428a-9ea3-8bda7a73fde4">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Elevated long chain fatty acids</rdfs:label>
    <dc:identifier>HP:0003455</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003455</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f90ddb4f-c1ce-4361-b3bf-6505c9e9ead3">
    <dc:identifier>HP:0000841</dc:identifier>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000841</ddiem:url>
    <rdfs:label>high angiotensin- converting enzyme</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fdac19d1-7815-4640-85fa-db3d5d63adef">
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c4df69a9-9b2e-46b3-ab61-3cfeeddbdf34">
        <rdfs:label>abnormal Biotinidase activity in plasma</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9360655e-61b8-4361-89e5-cb2996d14c4a">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Increased 3-hydroxyisovaleric acid excretion</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16773504</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/67494418-6247-4bf1-bea6-bf252087a25e">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Increased 3-methylcrotonylglycine excretion</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e0867496-530c-4284-849e-e8a64e44497b"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/210200"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/741dfc90-c128-4cc9-8ee0-2b0a1610adce"/>
    <rdfs:comment>vigabatrin</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18155630</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15877210</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470948</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/893d7efd-e55d-4312-923a-cad4b41e7988">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/610090"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21310277</dc:provenance>
    <rdfs:comment>Phenobarbitone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cb6d935c-97ca-4752-9652-5786a9767154"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8757046</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c6f2f77b-0dd7-44e7-b098-e9baee2e5ed3">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f86de4db-4715-4d60-a0b4-b24e2183458b">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001324</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001324</dc:identifier>
        <rdfs:label>Low muscle mass</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6e3fed1e-f51e-491a-9b07-19bc107d1d6a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/16c70007-33cb-4bca-933f-77edd460966d"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/78810650-bc65-4102-a0a9-bf1999511f1e"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/253600"/>
    <rdfs:comment>(r) AAV2/1-mediated calpain 3</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17330087</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/99328c1e-52a0-43c1-a8ba-a05da58a6b17">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0006462</ddiem:url>
    <rdfs:label>defect in skeletal mineralization</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0006462</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/541a5aea-c60e-4424-9e7e-6c1c54f3dd62">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5abda18f-6bae-4c13-bdb4-369f96ded629">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02527343</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/151660"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03508687</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/16246f9f-72ee-4244-9c43-e2602c03b729"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02211209</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
        <rdfs:comment>Gemcabene</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/db786810-8848-4b8e-a56f-5322fdc9b71d"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB05123</ddiem:url>
    <dc:identifier>DB05123</dc:identifier>
    <rdfs:label>Gemcabene</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2d532444-c84b-4397-bb17-05f06dcc11af">
    <rdfs:label>Cutaneous abnormalities</rdfs:label>
    <dc:identifier>MP:00011911</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/MP_00011911</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/58a587da-b3a5-42a5-9f57-4386c3340478">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3bf6c992-71de-460c-8e7f-272b250296d0">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003119</ddiem:url>
        <dc:identifier>HP:0003119*</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>high non-HDL-C (Abnormality of lipid metabolism)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25768710</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2e1b6ccd-a467-4de3-afca-875fddb3ce64"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28098593</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3162680</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0021915015001379</dc:provenance>
    <rdfs:comment>clofibrate</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a8952e75-ce42-4739-9d85-d90473ea46a5">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8faa8412-3c17-4023-bb5f-dbefff1da94b">
        <rdfs:label>Setrusumab</rdfs:label>
        <dc:identifier>DB14778</dc:identifier>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/72198eac-c110-4c09-a040-d09b65a38335"/>
        <ddiem:url>https://www.drugbank.ca/drugs/DB14778</ddiem:url>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5fdcea32-4e15-40ac-8b54-31e3d9975a96">
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000613</ddiem:url>
    <rdfs:label>photophobia</rdfs:label>
    <dc:identifier>HP:0000613</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/003592cd-8bb6-4c1c-ac6e-f9df77a651d5">
    <ddiem:url>https://www.drugbank.ca/drugs/DB12536</ddiem:url>
    <dc:identifier>DB12536</dc:identifier>
    <rdfs:label>N-acetylmannosamine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/fbb34413-a4d8-448d-9171-8dd0788f7695"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b0402d03-99e4-4892-94a9-c6df4be9739a">
    <rdfs:label>epileptic seizures</rdfs:label>
    <dc:identifier>HP:0001250</dc:identifier>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f8223eed-e9fc-4e4d-8f5d-19a6701d9134">
    <dc:identifier>DB00682</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/09ff8776-d01d-4f16-9273-c0869fe882b3"/>
    <rdfs:label>Warfarin</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00682</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/084e6735-84a1-4b6c-bd74-a34da3c06513">
    <rdfs:label>Intellectual disability</rdfs:label>
    <dc:identifier>HP:0001249</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001249</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1ee6f5a5-51c1-416a-a568-17b8ce65febd">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301535</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6056fdf7-6de8-464c-9689-d23aba0e7121">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/43cd4137-a87a-43bc-a7d2-fe19fe88d60f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27567650</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a1908b1a-f9bf-4460-93a2-84ee4aa2ad3a">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001987</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001987</ddiem:url>
        <rdfs:label>hypolysinemia</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Lysine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28057010</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d4a64ff3-a356-4de7-872c-67b9d246dace">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29654911</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28388263</dc:provenance>
    <rdfs:comment>Gene therapy *</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01328587</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c5f016c7-e62b-4f0c-839c-fabe27cb25bd"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/258870"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c47c20cb-6717-40e3-89d5-396f855992ff">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/aafcd42a-0d0d-47ec-b906-8d327ab6e2e8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00001735</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c3fa34b3-54e2-4caf-95c3-decec5354f60">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7d2bc1e6-9a69-4da0-9c13-2e42f10c559f"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28210839</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/919f6c6d-8e4a-4ba3-bf07-0e9380dc68e4"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/41ccba98-2a20-4e5d-b22a-b129aa7a3cbb"/>
    <rdfs:comment>Eculizumab</rdfs:comment>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4873312d-60f0-4ecd-8eac-5c490850935d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01793090</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/59ab0422-b6f1-4d8e-aa20-33e2533c61c5">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9b56f4ae-66cf-4b6d-94d6-5a254485ea05"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/250940"/>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4f720593-27e4-4d0c-9be7-98c4a631599e">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012594</ddiem:url>
        <rdfs:label>Microalbuminura</rdfs:label>
        <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
        <dc:identifier>HP:0012594</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/235200">
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/203</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/65163055-9983-4e90-832f-2b1c1507d473"/>
    <rdfs:label>HEMOCHROMATOSIS, TYPE 1; HFE1</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/235200</dc:identifier>
    <ddiem:iembaseAccessionNumber>203</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0742e6db-9683-441d-b2a7-68290003eb9b">
    <rdfs:comment>pyridoxine</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/aca8d660-060e-438b-80ea-a6956af58200">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
        <rdfs:label>"No remarkable clinical improvement was observed and therefore, treatment was discontinued"</rdfs:label>
        <dc:identifier>HP:0001250</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23890588</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/238700"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24204001</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/847ee402-9d9f-48c5-9303-7b47a1b69e2e">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02180412</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/79d5bea1-08ba-4d6a-b7a0-9e9db68fc68f">
        <dc:identifier>HP:0011009</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Accumulated  plasma porphobilinogen</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011009</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/23c08290-4916-4e15-bd26-f5cf6afb1cc2">
        <rdfs:label>Direct intercation (Mechanistic A)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3acaa534-f89a-493f-8775-f7e8cc928ff1">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1d997883-ba32-4163-b1e6-ac32323b4cab"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/75a8b7c9-abe8-4b27-b353-24db16afeb96"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358544</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15767622</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3f8fbe14-8a5a-4ab0-8a01-85c9a5ab9b51">
        <dc:identifier>HP:0012217</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012217</ddiem:url>
        <rdfs:label>Accumulated  urine porphobilinogen</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <rdfs:comment>rh-HMBS</rdfs:comment>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/176000">
        <rdfs:label>PORPHYRIA, ACUTE INTERMITTENT; AIP</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/112</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/9e49c15c-01e9-41f8-903d-d217043eb542"/>
        <dc:identifier>https://www.omim.org/entry/176000</dc:identifier>
        <ddiem:iembaseAccessionNumber>112</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4ec6e48a-a042-481c-a4eb-d38a5d35a367"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17375984</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/e2238719-78c2-4c44-82d1-57196aa102ab">
    <ddiem:url>https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_17012</ddiem:url>
    <dc:identifier>CHEBI_17012</dc:identifier>
    <rdfs:label>NeuAc</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/369a684b-bff5-4c24-8eaa-4418d12399ab">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26546927</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/605820"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01517880</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4494408b-79a4-4b11-acf8-1700e5b0cd6c"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/12d605f7-3dee-46ea-a901-7b421a21f5d4"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21517694</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20030229</dc:provenance>
        <rdfs:comment>Sialic acid</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ee946ffa-38d9-4c13-a52c-b098f65aa78d">
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01517880</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/605820"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b532794d-485a-4c2d-92e9-f79c5a324e97"/>
        <rdfs:comment>Sialic Acid Extended Release (SA-ER)+ManNac (N-acetylmannosamine)</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26546927</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/269622ab-4c3e-4f00-bf22-a1c18149b7c3"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/12d605f7-3dee-46ea-a901-7b421a21f5d4"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20030229</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/7d8e8d90-19f5-43ea-842f-c21445d2b9b1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/410bf561-5769-4325-bf07-f42fd5e266f7"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28641925</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4494408b-79a4-4b11-acf8-1700e5b0cd6c"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/590aab39-64f7-4878-b001-279860f54600">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8681e141-c364-4700-a5b6-3d0654368e7a">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15978931</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30477028</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/24d03b80-a7e0-4c42-96c4-95aad128e958"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/7199c277-e274-40f1-b74e-be9b419517f4"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30049652</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f9bbb908-21ed-4b98-a088-c61742637bb9"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02900183</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/613490"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1868655e-e525-4cd0-9d8c-4626996f2026"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f49f1150-0973-4abf-a19a-fba0db733a8d"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508465</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:comment>Retinoic acid</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22282548</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00755</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00755</ddiem:url>
    <rdfs:label>Tretinoin</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/36f95181-b8ec-416c-9f5e-9e3910fb3bad">
    <dc:identifier>DB09115</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09115</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bed3518e-f60d-45ea-94de-8d0d21eb6e9c">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/59eeb13e-1d81-434d-adb4-20bd03be1881"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/13044560</dc:provenance>
        <rdfs:comment>Diiodoquinoline</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/196e1779-a16f-4068-8bd9-6269706e31af"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2101e92d-1a3b-44c1-993b-ad60a1b915a8"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1275520</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14354277</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/145afb9f-03e8-4053-9e47-0984126c52d6"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/201100"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/4929571</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/bd7cf5ce-2d27-4cf5-96dd-9d0d36780e60"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Diiodohydroxyquinoline</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9fa6dffc-d2ce-4e3a-acb5-b0ca6da01965">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9156798</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15753292</dc:provenance>
    <rdfs:comment>Chimeric oligonucleotide(oligonucleotide-based gene therapy)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4663270c-3644-41ec-b7d2-4e56939edff0">
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <rdfs:label>UDP-glucuronosyltransferase gene defect</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bd970177-f9a9-496d-b23b-57066c16f76d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/95b32ad9-e7a0-4f6e-b380-ffd2967b8731"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/218800"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10468611</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/009e193b-87b2-40b3-a335-e21e7a7f1614"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a18b65a6-afd0-41d5-a884-43d0aa1e12fa">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24746802</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/520000"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <rdfs:comment>Non-steroidal anti-inflammatory agents</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/564cf6a0-f620-4ae3-8395-d8935adcfbfe">
        <rdfs:label>Intraretinal cystoid spaces (Retinal disease)*</rdfs:label>
        <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
        <dc:identifier>HP:0000479*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000479</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f8c561d0-9e97-49d6-9976-849237d5d622">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d8eeec26-ad31-4bac-befe-9acf852e1b11"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23806424</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/618098">
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1336</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/618098</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/11885817-f3a7-4920-bcdc-8acd216c6b25"/>
    <ddiem:iembaseAccessionNumber>1336</ddiem:iembaseAccessionNumber>
    <rdfs:label>PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5</rdfs:label>
  </ddiem:Disease>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8ebb1b07-a259-4b6c-bfd7-839c5b50be25"/>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ea5f7ca3-8f52-4f3e-a881-2638825aa332">
    <dc:provenance>http://www.medlink.com/scripts/mpdf/print_friendly.php</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e0867496-530c-4284-849e-e8a64e44497b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11102558</dc:provenance>
    <rdfs:comment>Vigabatrin</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/300438">
        <ddiem:iembaseAccessionNumber>64</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/300438</dc:identifier>
        <rdfs:label>HSD10 MITOCHONDRIAL DISEASE; HSD10MD</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/df2578ae-6240-4119-bf17-00a99d7060c8"/>
        <rdfs:comment>Treatment attempts with isoleucine and protein restriction did not clearly alter or improve the course of the disease despite reduction in the excretion of 2-methyl-3-hydroxybutyrate and tiglylglycine. https://www.ncbi.nlm.nih.gov/pubmed/22132097. https://www.ncbi.nlm.nih.gov/pubmed/11102558</rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/64</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8e8a6686-58cf-461c-a08d-a39928e91bdc">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4b0990f7-3b2a-483a-9929-49bf73394997">
        <rdfs:label>mitochonic acid 5</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/83bfbaa6-f9eb-4112-91b6-d051302db2bf"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/219500">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/28d5ffd8-d9a2-41f2-93eb-f39b8830ce9b"/>
    <rdfs:comment>Cystathioninuria not associated with vitamin B6 dependency is an evidence of genetic heterogeneity in primary cystathioninuria. https://www.ncbi.nlm.nih.gov/pubmed/417288        https://www.ncbi.nlm.nih.gov/pubmed/5707897</rdfs:comment>
    <ddiem:iembaseAccessionNumber>28</ddiem:iembaseAccessionNumber>
    <dc:identifier>https://www.omim.org/entry/219500</dc:identifier>
    <rdfs:label>CYSTATHIONINURIA</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/28</ddiem:iembaseUrl>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/597b3266-7f31-415c-ae0d-3a7cac4f3747">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ab995397-8cf1-4316-869f-d5a68362554f"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fa5d9bec-f66c-445d-bc7a-ce336a44412c"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cd76a7d5-4947-4a94-992f-5e5bebcda4e2">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012103</ddiem:url>
        <rdfs:label>Mitochondrial oxidative stress</rdfs:label>
        <dc:identifier>HP:0012103</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17296905</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/10e84745-fc94-498b-b574-a3943e6dc20b">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/05689f83-ee66-48f1-8aba-b04fd09b8c4f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/535000"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0003304>G11778A</obo:RO_0003304>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5d330aef-9195-4c31-b847-09bb8a35a49d">
        <rdfs:label>Optic nerve damage</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001138</ddiem:url>
        <dc:identifier>HP:0001138</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>AAV-SOD2 (adeno-associated viral vector containing the human mitochondrial superoxide dismutase (SOD2) gene)</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/ee41b521-2653-4540-b72c-053f925f032d"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a345ce46-4921-447c-9311-48ccddacf451">
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280294</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503963</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18570303</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19087156</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20619503</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8727391c-c9c5-4d48-822f-95d234aad8b5"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607765"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a8232704-bbb7-4df3-b015-368acaa147bb"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0a0dd760-3840-4042-b675-81a8b938663d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2694725f-7ef4-4d79-80d1-3b257ddc6617"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Glycocholic Acid</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6327904f-f76f-4f0d-8170-02a7cd21f0e3">
    <rdfs:label>High plasma guanidinoacetate levels</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/236270">
    <dc:identifier>https://www.omim.org/entry/236270</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/31</ddiem:iembaseUrl>
    <ddiem:iembaseAccessionNumber>31</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/7e3f82f7-1261-4d94-bbc7-f5d2bf28efdf"/>
    <rdfs:label>HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE</rdfs:label>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/90adf2c0-fb99-45bc-bcb4-3ef1422aaef1">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001958</ddiem:url>
    <dc:identifier>HP:0001958</dc:identifier>
    <rdfs:label>Acute decompensation</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f2505834-66d4-46ea-9238-6400ce9cc98b">
    <rdfs:label>Velmanase alfa</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/13380f1e-9d4b-4dd1-8c76-3bf080371d31">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/acd5574a-7ad7-41be-af0d-248d72e9314d"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26827607</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ebd7e299-4829-41be-9c90-3076edc23a0e"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/667e0fc6-4bb0-4aa6-9b37-ae7dc65e486b"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c37c0efe-af43-4efd-be6d-2bc6eb4dd225"/>
        <rdfs:comment>Lamazym(rhLAMAN)</rdfs:comment>
        <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
        <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/609458"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ee297785-c35c-4416-be7c-07037e4241d8"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f5a67aab-fc1f-4921-86a1-fdca0acc6762"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f705416d-fa64-40fc-a630-cfefb116e8a8"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/efe6096b-79e6-4a03-8918-7eb9d521451f"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01681940</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02998879</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508465</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB12374</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB12374</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9ccd827b-180d-484d-9b5b-336a1bb48abf">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0000707</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
    <rdfs:label>Status epilepticus</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7e0989e0-f6d9-42e2-b6e9-d7ac459bf55a">
    <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
    <dc:identifier>HP:0001635</dc:identifier>
    <rdfs:label>Congestive heart failure</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001635</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ea294f91-6ea5-4376-abed-916f16f266cf">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/5cd1c121-7c17-440a-861f-f2886ad1cafa">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/40029f08-5fbd-435f-a949-b8836220966f"/>
        <dc:identifier>N05A</dc:identifier>
        <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=N05A</ddiem:url>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a7c77696-cda0-4b05-81d2-c59866036ab2">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30384011</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/933bbf7a-2c58-48ad-85f0-0c7ae41628e2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/45875502-f3f6-47af-9259-f998f8760536"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/adc79c0f-2dd4-4a73-8fd3-859ce967d783"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9511979</dc:provenance>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/309400"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9f7e880d-c8a7-4f28-a14d-09b0cbd1dc3b">
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <dc:identifier>HP:0040006*</dc:identifier>
        <rdfs:label>Low survival rate (Mortality)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040006</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Copper nitrilotriacetate (Cu-NTA)</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/40fa08dc-cfa8-4fb6-a090-88b64b99f67e">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/692a3094-a31e-4870-a218-6869f35a33e6"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6e32db05-0541-45ea-b236-19403ffdfb33">
    <dc:identifier>DB00542</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00542</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/213c4d5d-4316-4267-903a-167086401a14">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22402328</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/6777479</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <rdfs:comment>ACEI (Benazepril)</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16868861</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1530bf3b-22b5-4801-8448-ec4384a92c83"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c5ca01f1-fcbf-438e-bf5b-c6c7d368bab1"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/acaeff1a-6952-4232-a2b3-6ae3c2c48623"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25335805</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/831c9741-a176-47b2-846d-4175924abfa4"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Benazepril</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0b359b25-f66a-44b9-9a62-7bc5db254965">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/300818">
        <dc:identifier>https://www.omim.org/entry/300818</dc:identifier>
        <rdfs:label>PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1; PNH1</rdfs:label>
        <rdfs:comment>PNH is caused by somatic mutations in PIGA https://www.ncbi.nlm.nih.gov/pubmed/28516949</rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/2f323cf6-6d36-455e-bbda-5f8d1772c646"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1141</ddiem:iembaseUrl>
        <ddiem:iembaseAccessionNumber>1141</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28516949</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e94128e3-fc11-4391-8952-d954d874ffc6">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004818</ddiem:url>
        <rdfs:label>Paroxysmal nocturnal hemoglobinuria</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0004818</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Eculizumab</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/59ab0422-b6f1-4d8e-aa20-33e2533c61c5"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/aebaf223-3271-40a8-ac81-bc6da532aa9b">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02300753</dc:provenance>
    <rdfs:comment>EPI-743(Vatiquinone)</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/535000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01495715</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22410442</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21788663</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4a1cfcb3-fcc4-4c70-bb22-d1f7e3ae640b">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/83b39bb5-4a9f-40c6-9727-2adee41b2ffa"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fac069c4-b3c0-41ba-acb1-d0f5330c3a76"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c4417832-d291-4bde-9761-9dfd8cbb17aa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/607330">
    <ddiem:iembaseAccessionNumber>196</ddiem:iembaseAccessionNumber>
    <rdfs:label>LATHOSTEROLOSIS</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/110a8446-5aec-47fd-be63-98f750d735cd"/>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/196</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/607330</dc:identifier>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a2befc1d-7839-48d5-9cb5-b4278b116811">
    <dc:identifier>HP:0006670*</dc:identifier>
    <rdfs:label>left ventricularc contractility abnormalities</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0006670</ddiem:url>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/65f0e718-e826-42ae-a5bb-1c96525d1092">
    <rdfs:label>secondary carnitine deficiency</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003234</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003234*</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/186e10cb-f0d7-4a78-a831-4770f3cc3f1c">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/796774fc-01c5-4ba5-9282-7215c53d4e74">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21744491</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/601776"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/397c3839-1c2b-4322-8865-59d4a7a6fb37"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
        <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3137dac7-e95a-4db2-8f2c-c90720d66eb0"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <rdfs:comment>Magnesium</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB14513</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/affbe6f4-51c1-40da-8ebe-071894857659"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14513</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/372b7232-bd06-4ba7-8a7e-22520d066c8a">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
        <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <rdfs:comment>Magnesium</rdfs:comment>
        <dc:provenance>https://www.sciencedirect.com/science/article/abs/pii/S0002962915356895</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3137dac7-e95a-4db2-8f2c-c90720d66eb0"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/aef0377c-e1c3-4146-b3ae-02c6018ea2d0"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607364"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Magnesium</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/acd0f96a-e9bd-466e-a578-15f403e0fea5">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20803213</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9ccd827b-180d-484d-9b5b-336a1bb48abf"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3137dac7-e95a-4db2-8f2c-c90720d66eb0"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S109037980800010X</dc:provenance>
        <rdfs:comment>Magnesium</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/203700"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/609242">
    <dc:identifier>https://www.omim.org/entry/609242</dc:identifier>
    <rdfs:label>KANZAKI DISEASE</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/263</ddiem:iembaseUrl>
    <ddiem:iembaseAccessionNumber>263</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a765a16e-3ee4-44a8-ae48-99cd441d2013"/>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/75392c73-d957-49ba-9a0b-e3274a919ee2">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0001250</dc:identifier>
    <rdfs:label>Seizure</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0389ccd7-35b8-4f61-a9ef-fead9d6792cb">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7f392164-619f-4a26-a3ab-b42743ba8c92">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008344</ddiem:url>
        <rdfs:label>High plasma branched chain amino acids</rdfs:label>
        <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
        <dc:identifier>HP:0008344</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28919799</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0166432812001830</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/248600"/>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/eb047ef5-c106-4fba-b1ce-88203292bf88">
        <rdfs:label>Direct interaction ( Mechanistic  A)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <rdfs:comment>Sodium phenylbutyrate</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/372ff356-fa46-415d-8366-81b17c89b6cf">
        <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
        <rdfs:label>High plasma branched chain keto acids</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3ee032dc-c022-4a8e-92f6-dd40d135ecdb"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/51917c4a-0e08-4ecd-99ac-51d4738406db">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1fc3de06-a9af-4a5a-8e90-b7f221d86b8a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3c98c452-a0f6-4a2a-ab63-01ff3acc98b0"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24746802</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/54f23551-31cc-4485-801b-6c92c8b571ce">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001271</ddiem:url>
        <dc:identifier>HP:0001271</dc:identifier>
        <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
        <rdfs:label>Diabetic polyneuropathy</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28766015</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <rdfs:comment>Vitamin B12+imipramine</rdfs:comment>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4402bb55-1835-4f76-b248-9a46b5781c88"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/520000"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/05e0e82a-9bed-4b0a-bef4-d3b2b940f041"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/49548d36-039e-4e42-b68f-1779ae3fb560">
    <rdfs:label>Noctornal difficulty breathing</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0002098</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002098</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3431e7a6-f339-486b-b7ee-83d7eff11c54">
    <rdfs:label>AAV2CUhCLN2</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/33a1e293-ef1d-4d33-8504-acb6fed7afc8"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e5e6c970-2987-4019-a79c-06e90142d701">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/609056">
        <dc:identifier>https://www.omim.org/entry/609056</dc:identifier>
        <ddiem:iembaseAccessionNumber>360</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/360</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/658edc4b-2650-44c1-8300-77fd32c54765"/>
        <rdfs:label>SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>Gangliosides</rdfs:comment>
    <dc:provenance>https://www.tandfonline.com/doi/full/10.3109/0886022X.2014.900422</dc:provenance>
    <obo:RO_0002558>
      <ddiem:Evidence rdf:about="http://ddiem.phenomebrowser.net/EC0:0007121">
        <dc:identifier>EC0:0007121</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/EC0_0007121</ddiem:url>
      </ddiem:Evidence>
    </obo:RO_0002558>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9350865d-8c70-4d45-8370-b87e97f36002">
        <dc:identifier>HP:0001263</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001263</ddiem:url>
        <rdfs:label>Delayed Develoment</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02234024</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5134cb0b-b21b-4d7f-9d79-26d6c659c054">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/34689bd3-5529-4088-aaaf-40579518ff69"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/dc1adb32-9d21-41e8-8d3f-0440818b6663">
        <rdfs:label>Direct action (Mechanistic A) Replacement</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1bb52e8b-092a-4149-881c-6b34260126ad">
    <dc:identifier>DB08826</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b167f222-c1c8-4c0a-9ef0-3656a37a2e52">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00350662</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/48bec87f-13d4-4613-8638-830114db312d"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/604250"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cd635574-7b5e-4621-9e8f-7e45361234c2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
        <rdfs:comment>Deferiprone (L1)</rdfs:comment>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Deferiprone</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b7d83331-6d48-4ef3-b397-6695f8a1fe1a"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB08826</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/aca30dc0-ef13-44f9-ad05-31c849036396">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/cfc6b333-03a6-4b97-a867-eb80d30921e2"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <rdfs:comment>Ambroxol</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25801797</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23085429</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3ef1ad0a-6274-4f08-9763-909b86cf6fdf">
        <rdfs:label>High chitotriosidase level</rdfs:label>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21503667</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16199246</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11227045</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28381550</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01463215</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15895716</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3d975613-64db-4473-bfc1-f42d5fde6148">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002240</ddiem:url>
        <dc:identifier>HP:0002240</dc:identifier>
        <rdfs:label>hepatomegly</rdfs:label>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f0f06644-e384-4637-a7e8-20f8c33824b1">
        <rdfs:label>Splenomegly</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001744</ddiem:url>
        <dc:identifier>HP:0001744</dc:identifier>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16285070</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b6b1b260-a41d-411d-a6bd-f2e8a75a6b75"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12064906</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/230800"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15505381</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b3580caf-96cf-48eb-a71e-9b5099969ba3">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001873</ddiem:url>
        <rdfs:label>Thrombocytpenia</rdfs:label>
        <dc:identifier>HP:0001873</dc:identifier>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b0d1da-41c6-4af5-bae7-665c57daa286"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/70e5b859-984d-44f2-8484-9b6d88c376d2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/022c7942-ad26-4cbc-83cb-a9c838756157"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00391625</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4873312d-60f0-4ecd-8eac-5c490850935d"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02574286</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c2c00c0e-5e04-4e20-8d96-a1830c732336">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/bdf55f6b-b526-49b5-b8c8-a35d352ae890"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6585e913-ccd7-4ba4-ba1c-75432c217822">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011021</ddiem:url>
    <dc:identifier>HP:0011021</dc:identifier>
    <rdfs:label>Abnormality of circulating enzyme level</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d0b9c968-a9f8-41e5-9d75-a09ec890b34f">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0000870</dc:identifier>
    <rdfs:label>High prolactin level</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000870</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9200e256-9ef9-4d65-a2ee-1218b5553cb0">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6f28b5f0-99a8-46d9-b41a-fef83bce20c4"/>
    <rdfs:label>Vitamin B-complex with vitamin C</rdfs:label>
    <dc:identifier>A11EB</dc:identifier>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=A11EB</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/44cb0dc6-24fc-47bd-b65d-0e075dbe1bc1">
    <dc:identifier>HP:0002353</dc:identifier>
    <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
    <rdfs:label>Abnormal EEG results</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002353</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d8f04159-dbee-4d11-935d-45b79278f4e5">
    <rdfs:label>Abnormality in serotonin turnover (Abnormality of circulating hormone level)</rdfs:label>
    <dc:identifier>HP:0003117</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003117</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fcc4f0ff-ddff-44cf-8aa5-4b01b335d30c">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ff0fdbac-5589-49c5-a3b2-cb2aff951cbf"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S109037980800010X</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>Benzhexol</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fbcde779-66d4-49f7-b695-a5859bc11333">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/32e3bd83-ef74-402d-8b4c-37fb76e3e246"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d7eea769-847b-45c9-86ed-d282a5478c13">
        <dc:identifier>HP:0001337</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>tremor</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001337</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300438"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0ca3cdc2-d227-486c-a7ec-52f86a6f7830">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9d0cc5d3-11c2-4d88-b30b-131f49f35557">
        <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
        <dc:identifier>HP:0009071</dc:identifier>
        <rdfs:label>Inflammatory myopathy</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0009071</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a02bc2c4-07fa-465c-bccc-5e028c4099f2"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b11da811-7f32-4bc5-876d-aceb6144ca5f"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25674260</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/68e60c6a-0f55-4427-8571-21dc0e8e4fa7">
        <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
        <rdfs:label>dysarthria</rdfs:label>
        <dc:identifier>HP:0001260</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001260</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e9669e2c-76ab-4815-a183-b26babb732b0">
        <rdfs:label>neck muscle weakness</rdfs:label>
        <dc:identifier>HP:0000467</dc:identifier>
        <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000467</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>prednisone</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/610131"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01793090</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d79987a3-7694-4e20-a2af-970e01b01c60">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0031517</ddiem:url>
    <rdfs:label>verruciform xanthomas</rdfs:label>
    <dc:identifier>HP:0031517</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5cdbf36f-e454-469f-bbb8-9e7261129851">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004732</ddiem:url>
    <dc:identifier>HP:0004732</dc:identifier>
    <rdfs:label>Impaired renal uric acid clearance</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/aa1434b6-8bf3-4559-808b-74ab76e9515f">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21788663</dc:provenance>
    <obo:RO_0003304>"m.3460G&gt;A, m.11778G&gt;A, and m.14484T&gt;C"</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fac069c4-b3c0-41ba-acb1-d0f5330c3a76"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4efce489-397f-4b84-b824-87ec9f877379">
        <rdfs:label>Abnormal retinal ganglion cell function</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001112</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001112</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/535000"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00747487</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e5bea7f8-801a-41f1-8ec8-d00a573413a3"/>
    <rdfs:comment>Idebenone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11001192</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11723211</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02771379</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01495715</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17573650</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/77b92498-50d0-4d9c-8207-497f6088e2ac">
    <rdfs:label>abnormal microtubule assembly</rdfs:label>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/703fc142-63f4-4874-bbaf-78885c05ccf7">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/053f6afe-1bef-4b84-8bab-08448a3592a2">
        <rdfs:label>Lorazepam</rdfs:label>
        <ddiem:url>https://www.drugbank.ca/drugs/DB00186</ddiem:url>
        <dc:identifier>DB00186</dc:identifier>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e6d4cbb9-226f-446c-b753-ed4340c9702a"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6f2e916f-fb2f-4993-b9bb-2149d0d87e43">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29392821</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ec1b4529-0fb4-43e4-9bc0-de21c7b3f87d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/60cdad1a-53b4-4b7e-9f24-8a9773e6a1f3"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Retinoids</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>"ENB-0040</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/308050"/>
    <dc:provenance>was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number</dc:provenance>
    <dc:provenance>an enzyme-replacement therapy</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096504</dc:provenance>
    <dc:provenance>https://www.researchgate.net/publication/8668575_A_successful_treatment_with_pyridoxal_phosphate_for_West_syndrome_in_hypophosphatasia</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ae74419c-a2c4-41b7-b5a9-d487ef7bddde"/>
    <dc:provenance>NCT00744042.)."</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/abc12ae2-cfc0-4536-8ff7-0675cacb8d3c">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d7eea769-847b-45c9-86ed-d282a5478c13"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
    <rdfs:comment>carbidopa</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300438"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30013934</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11102558</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6ef1e31d-760c-402f-b93c-b7a210c194f3"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b6fea1ff-2981-4f60-bc95-d095f3e02905">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/98e1cc64-cd35-4e52-b772-33720b1aef7d">
        <rdfs:label>Salt wasting</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000127</ddiem:url>
        <dc:identifier>HP:0000127</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607364"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b0909d3c-8bb9-4b85-9035-ba1944aae8dc">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Decreased life expectancy</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0cf0f100-d3c1-42b0-8ad4-9ebab70ed4e5">
        <rdfs:label>Deleterious prognosis</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/816804d8-49e5-44d4-ba15-75ad9ee78ef0">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001510</ddiem:url>
        <dc:identifier>HP:0001510</dc:identifier>
        <rdfs:label>Growth retardation</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30387909</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <rdfs:comment>POTASSIUM-SPARING AGENTS</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e057ec64-504e-417c-b6e8-6f8a30185f98">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/813bb8bc-4645-40b8-99a3-b83e5fc8b71f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f87089b4-a9a6-45f7-ace6-2168fce5da97">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850427</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28967191</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1ca63e55-900e-4d6c-9d3c-752e98b2ae3a"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/208400"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <rdfs:comment>Amlexanox</rdfs:comment>
    <dc:provenance>https://www.semanticscholar.org/topic/amlexanox/510418</dc:provenance>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9b0cfde0-39e1-40f9-8bb7-f44e537e5c04">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/aeb2437a-85df-4658-9516-b7c16a2d9e43"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0003304>Ser72Pro/Trp168X</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29247835</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c62c61dd-390d-4cc9-85df-597ffd905cbc">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29058386</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21110863</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cbbe3a29-20f5-416e-9c0c-1da74982444f"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3391ceca-8049-42f4-a823-96a368f247c6">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0006517</ddiem:url>
        <rdfs:label>Pulmonary Alveolar Proteinosis</rdfs:label>
        <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
        <dc:identifier>HP:0006517</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27783330</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a5253d61-bf77-4e88-a835-3c577a26497c">
        <dc:identifier>HP:0005952</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0005952</ddiem:url>
        <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
        <rdfs:label>Low pulmonary function</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25335805</dc:provenance>
    <rdfs:comment>Sargramostim</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f0505d6b-67c9-4f3a-8eac-6c9f82fc977e">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0003304>m.8344A &gt; G</obo:RO_0003304>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/79d106d9-49be-4436-a3af-bc6d3f7e0534"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/545000"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28717435</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>piracetam</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8fa59e0b-0709-4e96-95c2-3cf13dfc3d14">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/98fcebcb-4327-47ba-91d4-6cc7aed2234a"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8459f4b6-ddd5-4456-b7b2-8cbc7bf04e09">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3b95667e-0ec6-4f48-af9a-2ffdb4606f81">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/209f1dc7-3ee5-4764-9a68-e70828d2e9d5"/>
        <ddiem:url>https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_23456</ddiem:url>
        <dc:identifier>CHEBI_23456</dc:identifier>
        <rdfs:label>cyclodextrins</rdfs:label>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/42b51d32-5409-4618-80f6-4d0da5075c26">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b9413849-2b14-4667-b8cf-d006f85bb125"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27139922</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19656325</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/de280646-3cc8-493b-931c-b9e5fa0391c4">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b83d35e4-2f08-43f5-b60d-15ef9be79b31"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23884489</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26979527</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1aa87da0-cff4-43c1-afbb-9c98e5325f09">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000989</ddiem:url>
        <rdfs:label>Pruritus</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0000989</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>corticosteroids</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19744342</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/177000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25402764</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d384b546-4139-4cba-a50f-7cee0a6c5026">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d4ead902-bd23-437b-a310-5ee742eb6d3d">
        <rdfs:label>Hydroxychloroquine</rdfs:label>
        <ddiem:url>https://www.drugbank.ca/drugs/DB01611</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2e2e654e-8c9f-41ba-9fc0-0b5f92f3ccfc"/>
        <dc:identifier>DB01611</dc:identifier>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/57339eb1-159e-4436-b175-27ce846ee2c9">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/74f687a3-e9fa-4ec4-8786-9e0a9d4f4678"/>
    <rdfs:comment>N-Carbamylglutamate</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28281899</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23649895</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9f4da0b7-bc68-4593-a7c4-e98ccf7624da"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/237300"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/13992367</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31392111</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14213380</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7bc67a35-0b1b-42c7-99de-57fb84731813">
    <dc:identifier>HP:0000819</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000819</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Terminated (Sponsor decision to end development of RP103 for mitochondrial disease due to lack of efficacy demonstrated in base study RP103-MITO-001</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6140ab9d-9ed0-4e5c-bf97-6e8132a0ce54">
    <rdfs:label>Dextrothyroxine</rdfs:label>
    <dc:identifier>DB00509</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00509</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/27463883-5b44-48d3-8859-b3daec2c2816"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ce46f4b3-1e9b-44d3-86ba-c59206b26b36"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/37897103-8a16-46e5-a0c2-9a350381bb8f">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2733f85d-4484-4b48-93af-3b10d0945a14">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/26123913-44a2-443e-83c9-9daca4be025b"/>
        <rdfs:label>Eliglustat</rdfs:label>
        <dc:identifier>DB09039</dc:identifier>
        <ddiem:url>https://www.drugbank.ca/drugs/DB09039</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b25c060c-6490-4920-bcfb-8b88e5704c2f"/>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a9984b75-e640-48c5-b748-6777299de1aa"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e615b6a3-fb9a-40aa-b643-a19826e2cba1">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
    <rdfs:label>Accumulation of toxic metabolites in cholesterol biosynthetic pathway</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0001939*</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/32e3bd83-ef74-402d-8b4c-37fb76e3e246">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00376</ddiem:url>
    <rdfs:label>Trihexyphenidyl</rdfs:label>
    <dc:identifier>DB00376</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/deeaed3f-dca6-4071-84a1-0cf8273c7e54">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29390242</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/47ba32e2-490f-4e47-b261-0374af1de1eb"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7c28c3ad-a7a4-4adb-809f-b9fa8e2b197a"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21735565</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27491218</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ff0fdbac-5589-49c5-a3b2-cb2aff951cbf"/>
        <rdfs:comment>baclofen/tizanidine/trihexyphenidyl/benzodiazepine/dantrolene</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/612319"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/fcc4f0ff-ddff-44cf-8aa5-4b01b335d30c"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b275c0ab-91b7-434f-b058-f00a8ed5e7a7">
    <rdfs:label>Diffuse scaling(Skin Scaling)*</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0040189</ddiem:url>
    <dc:identifier>HP:0040189*</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/a2422a26-a782-42cc-b2e6-76f4bffd7651">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2d49433e-33f7-4a59-9c9f-96912847b5d3">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/239500"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28285122</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
        <rdfs:comment>Vitamen B6</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/7199c277-e274-40f1-b74e-be9b419517f4"/>
        <dc:provenance>https://link.springer.com/article/10.1007%2Fs10545-013-9660-9</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/39f1ef3f-5905-43d6-8b70-4cbca85bb029">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17490880</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232600"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/edc52bb7-a69b-46ea-8570-0d9082721e79"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/58266610-1bb2-4021-a97e-364230ac155e"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <rdfs:comment>vitamin B6</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24493026</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6ce4f760-ed2f-47e7-b456-697550d26030"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22334182</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Pyridoxine</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8b738722-2661-4e3f-ada2-7e0dc79af8c4">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01328587</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24082780</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29654911</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c2e7ac04-16be-4123-8f1c-8c08ebd15449"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17921858</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29757052</dc:provenance>
        <rdfs:comment>vitamin B6</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/258870"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/90978790-b14a-4f92-928b-d7388a76e2a5">
        <rdfs:comment>Pyridoxine</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16619244</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24355692</dc:provenance>
        <ddiem:failedToContributeToCondition>"R125Q, E176K, T191M, T262M, or G307S"</ddiem:failedToContributeToCondition>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14739681</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29119254</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/236200"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f332fef4-ce87-45f9-a62b-c389cbd3aeb5"/>
        <obo:RO_0003304>"P49L, A114V, I278T, R266K, or R336H"</obo:RO_0003304>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/65980c6b-5def-4a3e-97fb-24af55f2e1f7">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7936305</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/6198500</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/237400"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/73a031fa-df2a-4245-89c9-318aea1a8e95"/>
        <rdfs:comment>Pyridoxine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9908ce96-ab1c-4ff4-bf71-19752a537120">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
        <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073162</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608643"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01395641</dc:provenance>
        <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3427f497-df05-4dba-8d10-5930df197bfc"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241937</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955971</dc:provenance>
        <rdfs:comment>Pyridoxine</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1c584f55-1ceb-4ae9-9429-6e2e8819681e"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/dd9d2301-4a86-431d-8838-b6fe67e170ed">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/741dfc90-c128-4cc9-8ee0-2b0a1610adce"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29358012</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19428278</dc:provenance>
        <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/20584029</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7814809</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/42984511-b99c-40e5-bb40-cca5f39c9d99"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ec984a25-0714-4e57-bc0a-039212f69dbc"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ef4bd053-4dc4-4436-b61e-01827c9ddadc"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3f7925b0-e829-4d80-926b-bb810f10a265"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/417288</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
        <rdfs:comment>pyridoxine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15895716</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/219500"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/5707897</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00165</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2c5ab07e-2191-4ab3-87ed-f7e9807ebd27">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14739681</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e2eb8ee4-ddfd-4dad-bb2e-a48624af4e8a"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c1fc6958-4355-4e05-a582-4c825335fa7e"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/94bda73e-40be-42ab-bd45-f06034b61338"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d035370c-7a11-44c2-9bf3-a9460bc018f3"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dcd5e561-a6db-409b-a583-6c98518d93a2"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/236200"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16619244</dc:provenance>
        <rdfs:comment>pyridoxine/betaine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24355692</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00165</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0742e6db-9683-441d-b2a7-68290003eb9b"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/59c1c7c1-ed99-42bb-ab48-c97971caaa15">
        <rdfs:comment>Vitamin B6</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/75392c73-d957-49ba-9a0b-e3274a919ee2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/241500"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20739387</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
        <dc:provenance>https://link.springer.com/article/10.1007%2Fs00223-011-9562-5</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17395561</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/564e40b2-b3b0-469c-a19b-e344fe7add17">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a48d4417-25f3-42b4-abed-702601b53e07"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03269045</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26577040</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <rdfs:comment>Biotin</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/253260"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28649539</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25638506</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/aec0ae51-5bcd-42b1-853c-46f1cec67d1c">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/4f16792d-fea9-4f08-90d7-7468a407c828"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8b647916-d3d5-4323-8591-498b5eb2f9e9">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6891418b-54d7-438f-b1f1-5ac5790d5095">
        <rdfs:label>Abnormal cardiac protein (TAZ) expression</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/87773692-3665-4b9d-8e9c-762077ce7b16"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/acd878d6-11a1-420e-8675-e4d10de10c99"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30788385</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0bd76f13-b2ee-4247-9b14-6c6eefc3f0d2">
        <rdfs:label>Mueculoskeletal dysfunction</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001324</ddiem:url>
        <dc:identifier>HP:0001324</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/302060"/>
    <rdfs:comment>AAV9-TAZ</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/909dd3c1-a101-462f-b992-d3428baaa055"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/22e43fbf-9d74-4605-8bdb-ec4645e5447d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/0e1c7661-9d02-4385-ba28-1935c4290a42"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30070157</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ca98d290-c0a3-4d29-a714-a214f822444a"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f81849f2-a029-4c45-8251-4c27f8bd9132"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/713dcab3-9010-4612-b117-8e9ed21ad336">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956916</dc:provenance>
    <rdfs:comment>FIV-hAAT-G6Pase</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/92b72b2c-20ed-4af0-b262-e6f664d8280a"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4fd16b06-89a4-48ac-8f4d-ff3c86f1d9d6">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/85a4e5fe-68c4-47ff-8b19-93e6ec442b56"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d6c1137f-c24a-4d72-9c84-5068df3a1623"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20163245</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7782e88f-9d51-4165-b980-b19fdc29ec61">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
    <rdfs:comment>erythropoietin + iron+folic acid + vitamin B12</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0ba8ec79-87e6-474f-bcb3-18e094c42743"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16435214</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/81e1419e-62bf-436a-bd47-1390125ea3c2"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3d5433c0-4e1d-44a6-b0d1-8ffa2f4a517d"/>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/16435214</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/20528d4e-7bb3-401d-9739-c276c15f5ae5"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/833c397b-7674-499e-b5c1-8bac2d234545"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e6a48bf3-b1ab-43b3-9211-86e37a845e94">
    <dc:identifier>HP:0008972*</dc:identifier>
    <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
    <rdfs:label>Reduced electron transport chain activity(Decreased activity of mitochondrial respiratory chain)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0008972</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a32fc4bd-ea0b-4734-9889-9d84720fa362">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/79b8e4c5-150d-4b81-bd9e-191e7daf7f0b">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7b72d7dc-54ab-4e2f-89e8-9a18db997163"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f255630e-8671-491a-8a92-4a40198fd925"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fac069c4-b3c0-41ba-acb1-d0f5330c3a76"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT01267422</dc:provenance>
    <obo:RO_0003304>G11778A</obo:RO_0003304>
    <rdfs:comment>rAAV2-ND4 (recombinant Adeno-Associated Virus-NADH dehydrogenase, subunit 4 (complex I)（rAAV2-ND4))</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03153293</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/535000"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7fe9a99e-e5ae-49ee-8fa4-ca1035a71dd3">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cd1c85a0-59c6-4910-bce4-03eeead8161f">
        <rdfs:label>increased fecal fat excretion</rdfs:label>
        <dc:identifier>HP:0002570</dc:identifier>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002570</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606785"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f4757265-de2b-4bc9-983b-73d094b60df5"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788912</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/736f1487-58d7-4c16-83a3-6e449b00e851"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00461799</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841061</dc:provenance>
    <rdfs:comment>orlistat</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a2135c7f-1153-431d-9c99-a12360c061d6">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008282</ddiem:url>
        <rdfs:label>low fecal excretion of unconjugated bilirubin (Unconjugated hyperbilirubinemia)*</rdfs:label>
        <dc:identifier>HP:0008282*</dc:identifier>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4dafdf92-c878-476e-86ae-495f25a9283f">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bddd042c-6747-4ce2-9653-b86b979f2290">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a126e09d-1451-4ba2-92ac-20dac3260078"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8f97beaa-31dc-4d18-84f8-51f18d1cc3ee">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>pseudoexon activation</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.researchgate.net/publication/46821474_The_3-methylglutaconic_acidurias_What%27s_new</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21542064</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/0ad70eb7-90f3-487c-875c-31d2d4a0ae7d"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261640"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f7768f5f-df3a-4334-a5b0-e6c112cc95e3"/>
    </obo:RO_0000057>
    <rdfs:comment>Antisense morpholino oligonucleotides (AMOs)</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0003304>"c.84−322A&gt;T, c.163 + 695_163 + 751del57, or c.164−712A&gt;T"</obo:RO_0003304>
    <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/01f24fcc-6d75-45eb-b240-28b518060c38">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12012642</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b8511f81-59b9-413f-9d74-1eefab220840">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/19b8cd95-8d82-4098-a731-964f6de519fc"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16952291</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16083704</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/29bf3735-f5da-468c-90c0-438f6902b274"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a931fbf3-e60b-4ed3-a85a-a544a06afa55"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a0e40258-1dca-4cff-a0b3-809357b13b85">
        <rdfs:label>High biliary cholesterol saturation index</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f8f7b1a0-ba68-4a41-8faf-ed69f2c76645">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012202</ddiem:url>
        <rdfs:label>elevated serum concentrations of bile acids</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0012202</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/58dc334e-f502-42df-88bb-0f64c998518d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26264947</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/237500">
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/e84580de-7f26-42ec-91e7-fc37f24f939b"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/554</ddiem:iembaseUrl>
        <rdfs:label>DUBIN-JOHNSON SYNDROME; DJS</rdfs:label>
        <ddiem:iembaseAccessionNumber>554</ddiem:iembaseAccessionNumber>
        <dc:identifier>https://www.omim.org/entry/237500</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/aa9f5d16-75e6-427a-be65-fb06ad14ad32"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/63ec1711-2e9b-4285-9404-50adb01a250a"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/08ef2633-0f9f-495d-8c13-d631f1b27334"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c12d3a96-3866-4b79-915b-2a97bf3a1c3a"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5dfdb19c-2a01-4a8e-9051-ca6a3315a184"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8142561a-3383-4a87-965c-1a07f54578e8">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003155</ddiem:url>
        <rdfs:label>high serum alkaline phosphatase</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003155</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>rifampicin+UDCA</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9d2cd5e1-9b14-4868-a3ce-546f53528543"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ceda9a81-5ebf-4100-bc48-5e83413db129">
        <rdfs:label>pruritus</rdfs:label>
        <dc:identifier>HP:0000989</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000989</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/037f243b-6e19-4bf8-be1c-8628ea890f71">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8cec333d-59bd-4e5d-b401-e0dda154aca7">
        <rdfs:label>Neutropenia with IBD</rdfs:label>
        <rdfs:comment>Preventive calcium and vitamin D3 supplementation is also recommended to prevent osteoporosis.</rdfs:comment>
        <dc:identifier>HP:0001875+HP:0002037</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001875+HP_0002037</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232220"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12373585</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25288127</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19066956</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5c7d9390-c658-4aa4-afb5-f46eb677e8e0"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19541498</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/88de6160-ec60-4b4e-a9b6-b700992edf93">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/4e825ddd-486d-40ac-a87d-beb4fbe6ac1f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0949ad0f-9ebc-458f-b20c-3bd0d7e781b8">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/25a11b1e-43dd-4942-a11b-ba31d11200b7"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>G‐CSF + 5‐aminosalicylic acid</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ff539c22-27fa-48a3-b754-c33c4da14bfc">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382922</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017326</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1080/21678707.2017.1405807</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6a77ec5f-4255-4736-b3fc-df14b51b8f3c">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0025142*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025142</ddiem:url>
        <rdfs:label>low quality of life(Constitutional symptom )*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/207800"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508465</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/caa2520e-3096-4ebc-8008-243d0c4e6d7e">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9ac641e0-7831-41e5-aa94-94eb6ce883d8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Glycerol phenylbutyrate</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3e17c77d-963f-4cf9-801e-9db05d8a58e6">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00252</ddiem:url>
    <rdfs:label>Phenytoin</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/03e2ef20-db1b-4d4a-b3d8-c9f47761e56f">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27884013</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0ea1009e-03b6-4447-918c-71b69f5508fe"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301746</dc:provenance>
        <rdfs:comment>Benzodiazepines</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/271245"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e29b07b2-eb5b-4058-9ea4-8d9e569cb68c">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0ea1009e-03b6-4447-918c-71b69f5508fe"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
        <rdfs:comment>phenytoin</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/220110"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22149023</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00252</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2b502600-7b90-4335-b1bb-efaedcd228eb">
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <rdfs:label>behavioral abnormalities</rdfs:label>
    <dc:identifier>HP:0000708</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000708</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/39d892d3-db37-488c-9de2-aafcfa20a1b3">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ff0fdbac-5589-49c5-a3b2-cb2aff951cbf"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/607483">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/bee451f6-bc28-49b9-9b2a-9d8ee702555e"/>
        <rdfs:label>THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/607483</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <dc:provenance>Abstract</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <rdfs:comment>L-dopa</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8b8e6519-5637-43d5-907a-ad39a910d5b8">
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002500</ddiem:url>
    <dc:identifier>HP:0002500</dc:identifier>
    <rdfs:label>white matter abnormalities</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0e7a33a7-85f9-43cf-95cf-50220edb1e34">
    <rdfs:label>High α-ketoisocaproate level</rdfs:label>
    <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ceee4030-2756-402b-8642-c5a508943e93">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
    <dc:identifier>HP:0000707</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>neurological malfunction</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a9578c2e-6d3b-4ac8-9ff2-c3974fbf8270">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20089612</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/241500"/>
    <ddiem:failedToContributeToCondition>N461L</ddiem:failedToContributeToCondition>
    <obo:RO_0003304>compound heterozygotes for a p.G339R and p.E191K ALPL mutation</obo:RO_0003304>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs00198-015-3272-1</dc:provenance>
    <dc:provenance>https://academic.oup.com/jcem/article/95/12/5174/2835157</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1e076674-b563-4285-a323-775e19f49f80">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003239</ddiem:url>
        <rdfs:label>High urine phosphoethanolamine</rdfs:label>
        <dc:identifier>HP:0003239</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs00223-011-9562-5</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/99289356-5af4-4714-9f89-1dcd91a9ef4a">
        <rdfs:label>High serum pyridoxal 5'-phosphate</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/99328c1e-52a0-43c1-a8ba-a05da58a6b17"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d0bcc149-dc1d-4269-87a7-64ce5213ab10">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100036</ddiem:url>
        <dc:identifier>HP:0100036</dc:identifier>
        <rdfs:label>proximal femur pseudofractures</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a72d48c6-0e78-4742-85a8-e75f7ee1b66c">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002756</ddiem:url>
        <dc:identifier>HP:0002756*</dc:identifier>
        <rdfs:label>stress fractures(Pathologic fracture)*</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4f728973-14df-487d-83f5-9ab2d8d14351">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003260</ddiem:url>
        <rdfs:label>High bone turnover markers</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003260*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20739387</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/ee41b521-2653-4540-b72c-053f925f032d"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b9413849-2b14-4667-b8cf-d006f85bb125"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dc5c6f30-3d3d-4cc3-aef2-c83c7003c1de">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001376</ddiem:url>
        <dc:identifier>HP:0001376</dc:identifier>
        <rdfs:label>mobility problems</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Teriparatide</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
    <obo:RO_0003304>Ala176Thr/Val423Ala/Val522Ala</obo:RO_0003304>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/77941433-ac21-4de9-bdae-fde707d2944c">
        <dc:identifier>HP:0001832</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001832</ddiem:url>
        <rdfs:label>metatarsal stress fractures</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0003304>D378V /G339R/E191K/A176T/V423A</obo:RO_0003304>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c4385cdd-ef1e-4282-86e5-4a6c34e0be28">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/19351d0e-6251-4942-be86-1a5ca9068c8f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27042741</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3ecf615f-49f6-4e4f-bf7f-e0277fe835cb">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26984560</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ef769212-e58e-4f61-8a6c-83ed0483fe2a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/adce6135-ee8b-46d4-8a78-4abecddbb053"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6cfd587f-aac2-4b35-a430-c7dea5132018"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/76c92114-07a7-4500-85d9-b53c66ce7b00"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22830360</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/298f193b-e6d7-472c-a8a1-ac3d22c506d5"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3276166f-41e7-4027-b73f-bb43285e4b4a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7c58173a-6090-4596-94e2-85e536e4952b"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Citric acid+Sodium citrate+ Potassium citrate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25896882</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27775558</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bb32c6b8-da7e-442d-84a4-d07cfefb0117">
    <rdfs:label>paroxysmal exercise-induced gait ataxia(exercise-induced episodic ataxia )</rdfs:label>
    <dc:identifier>HP:0002066*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002066</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e5cce571-cd25-4ff4-88be-64ee48fa2898">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e213c560-8679-4ed2-ba4b-dbfe0e7a4470">
        <dc:identifier>HP:0010978</dc:identifier>
        <rdfs:label>hemophagocytic-lymphohistiocytosis (Abnormality of immune system physiology)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010978</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28057010</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/6777479</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/de280646-3cc8-493b-931c-b9e5fa0391c4"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22402328</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25335805</dc:provenance>
    <rdfs:comment>corticosteroids(Amcinonide)</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9e7def7a-d23b-4977-b087-91e4bac373ef">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25485164</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29358012</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7814809</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fd942d1b-c0ea-4247-8840-1d544659dc4c"/>
    <rdfs:comment>rapamycin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/5707897</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007764"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29480352</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/613163">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>GABA-TRANSAMINASE DEFICIENCY</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4ac0f5b8-1476-4629-8c76-94758602bc2d"/>
        <dc:identifier>https://www.omim.org/entry/613163</dc:identifier>
        <ddiem:iembaseAccessionNumber>36</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/36</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15895716</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bdbfd74f-b6c4-4e0d-9edd-c4bcbaa8a6c8">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7dd07896-7101-4a83-bd9e-01aad7cdee1c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7a0756c3-1df6-41fc-a7f8-ac15e9eaa6bc">
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <rdfs:label>elevated CSF GHB levels</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24578415</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2279fdb2-5653-4ff8-96c3-73dc2c8e1347">
    <rdfs:comment>Levetiracetam</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28621098</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9f4da0b7-bc68-4593-a7c4-e98ccf7624da"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25781533</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10969108</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26962538</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606762"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5ca28c24-9eac-4f3c-aebe-d4fc037deded"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/69e6597a-8169-4c06-8483-1fe1197ec7c5">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/125d7b7b-8229-4dbb-8b16-e0de621feb91">
        <rdfs:label>behavioural disturbance</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000708</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000708</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>olanzapine</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/239500"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0387760417300086</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/758d8c63-0cc7-4bd1-a328-ad416d95d276">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ce4b1e55-e0d5-49bd-af44-d1f509e7ecb6"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28285122</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8e176aac-6334-44d3-bd8d-4960891f6a27">
    <rdfs:label>High calcium excretion in urine</rdfs:label>
    <dc:identifier>HP:0002150</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002150</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9e476d55-cb14-45d6-aad3-9fb8e85597a6">
    <rdfs:comment>Corticosteroid</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/40b67531-4e1d-43cd-a28f-2b3bb7bc9473">
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
        <dc:identifier>HP:0004295</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004295</ddiem:url>
        <rdfs:label>Gastric mucosal atrophy(Abnormality of gastric mucosa)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24424200</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/6823973</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/261000">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b2ccfdf7-aa5e-447e-8ddb-3e5427ebd913"/>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>INTRINSIC FACTOR DEFICIENCY; IFD</rdfs:label>
        <ddiem:iembaseAccessionNumber>80</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/80</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/261000</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/921733</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9694707</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/db78bec9-3b2f-468c-bbaa-4c104b2eba97"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ab65ee76-7e5e-48f9-aaf5-1a33b32b6a0c">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0002275</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002275</ddiem:url>
    <rdfs:label>Poor motor coordination</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7c2573dd-918f-4f6a-96e6-a9f7e7fd76fe">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/74652e03-7b41-43dc-8b15-869e3e827ffe"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00119</ddiem:url>
    <rdfs:label>Pyruvic acid</rdfs:label>
    <dc:identifier>DB00119</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a15bb48b-afae-4d3d-93cc-5296f5ed01f3"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b76d17b5-25ca-4395-a226-ac3fac14b1b6">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6dc68e13-9ec4-4ba5-9504-c70e04bb6d4e"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02473445</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b6d06603-dfef-41aa-8d04-29d3bbf57545"/>
        <rdfs:comment>Sodium Pyruvate</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26884075</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/390a5d5e-0207-4319-8f10-e21dd3dcd9b3"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a813d4c1-2b13-4463-bce9-7193b912dc3b"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f8c725f9-f803-46e7-9140-58db876c8278"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/530000"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e1ddf8e4-a1ec-422a-b8cc-4bad472a9650"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30738201</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/93185b2c-0773-4cba-9d8f-59759d6ec64c">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <rdfs:comment>Sodium Bicarbonate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29340523</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26669244</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18d743df-a56f-4189-a89b-78393fc3b371"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/76c92114-07a7-4500-85d9-b53c66ce7b00"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/affdcb55-38c2-4479-9352-ee3c75e32850">
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261640"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6ef1e31d-760c-402f-b93c-b7a210c194f3"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25304915</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
    <rdfs:comment>carbidopa</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16601879</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c986b6b3-2af2-4272-91b0-e45978033c3e"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/13af3f8b-359d-400e-94ed-20a1031f7643">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003234</ddiem:url>
    <dc:identifier>HP:0003234</dc:identifier>
    <rdfs:label>Decreased plasma carnitine</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fa59e242-37a8-46df-964c-cb3eb805b00c">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18d0909a-0c1f-4c79-b11d-8483d4d9f6f4"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/615398"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/64a00968-be06-4afb-ae56-c9d96b122b9b"/>
    <rdfs:comment>Clonzepam</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0387760417301742</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/051bc356-1db7-47cf-b80d-ecef3a9fd8f7">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/612953">
        <dc:identifier>https://www.omim.org/entry/612953</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f94e5fcc-1485-42ab-a4ec-3735672bccd9"/>
        <rdfs:label>PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503963</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20938027</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18570303</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4a9a1c5e-6b96-4816-ad5c-0b021f184bc0">
        <rdfs:label>parkinsonism</rdfs:label>
        <dc:identifier>HP:0001300</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001300</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>L- dopa</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19087156</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20619503</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25660576</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1e8cb5ab-7e9a-46c4-974f-1f9ce0ddee8a">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f5d2d267-6c5f-4399-af0c-5e8fb0e0fb0a">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7f262add-6b2e-4117-ad79-5e1a55e41d1a"/>
        <rdfs:label>Infliximab</rdfs:label>
        <ddiem:url>https://www.drugbank.ca/drugs/DB00065</ddiem:url>
        <dc:identifier>DB00065</dc:identifier>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/758e72f7-afcc-4f80-84d2-201877ed2c81">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21503667</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25852896</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d1db5564-91b4-449a-85e2-4f099b6062c1"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25012174</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23196212</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28381550</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>Indometacin</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/88f0d6b9-53f7-4820-b3af-742895c4d003">
        <dc:identifier>HP:0040084</dc:identifier>
        <rdfs:label>Abnormal serum renin level</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040084</ddiem:url>
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ce6a9384-2271-44fd-ab9d-e93643c9479a">
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
        <rdfs:label>Abnormally reduced levels of aldosterone</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004319</ddiem:url>
        <dc:identifier>HP:0004319</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507263</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/28f9aa83-f122-4837-9b0f-8e567977df85"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/263800"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/20715d8a-fd14-4c2f-b5c6-841ac16fa3e5">
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
        <rdfs:label>high plasma RAAS activity</rdfs:label>
        <dc:identifier>HP:0000847*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000847</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2ebdeb7a-ee5f-4d3a-9548-1cb8db344699">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016220</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/219800">
        <ddiem:iembaseAccessionNumber>525</ddiem:iembaseAccessionNumber>
        <rdfs:label>CYSTINOSIS, NEPHROPATHIC; CTNS</rdfs:label>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/525</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/219800</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/a30daaf6-37e8-411a-9318-d232651f09b8"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158338</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841061</dc:provenance>
    <rdfs:comment>growth hormone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8444253</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dd2f6d9a-ee40-4ab3-8fd1-96d1b015431a">
        <dc:identifier>HP:0001510</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001510</ddiem:url>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <rdfs:label>retarded growth</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505515</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cb2c1f89-8843-42f8-b042-3d03caefd2a5">
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <dc:identifier>HP:0000117</dc:identifier>
        <rdfs:label>low phosphate reabsorption</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000117</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/341cb69d-951b-4061-9460-1b8ed6c1ceb7"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/53b5f489-775d-48b4-9843-4cbd98ab0f41">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d3164ddd-73e2-4d7c-8ec5-5c8128be4cbf">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/48e78af0-e64d-4199-a7a8-6e43e693f2aa"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/245010"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02534844</dc:provenance>
    <rdfs:comment>salicylic acid+urea</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897870</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9868dc31-4394-4f57-ada7-5828ee19a238"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d205f48a-363a-4b63-96ab-e0a808f89605">
        <dc:identifier>HP:0000972</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000972</ddiem:url>
        <rdfs:label>Palmoplantar hyperkeratosis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/64baa022-b181-46d8-b2e9-d8becaf76cde"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9df59fb5-93da-44eb-9cee-49c5774da922">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/fde43a81-5852-4ca3-b6b8-e742acd3cfaf">
        <rdfs:label>Alprazolam</rdfs:label>
        <dc:identifier>DB00404</dc:identifier>
        <ddiem:url>https://www.drugbank.ca/drugs/DB00404</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/78b6c270-0dce-4be4-a62d-1794c7082774"/>
      </ddiem:Drug>
    </rdf:li>
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2463cd22-332d-4831-8fae-103fed1fb96f">
        <ddiem:url>https://www.drugbank.ca/drugs/DB00829</ddiem:url>
        <dc:identifier>DB00829</dc:identifier>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/78b6c270-0dce-4be4-a62d-1794c7082774"/>
        <rdfs:label>Diazepam</rdfs:label>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8b67c677-7b22-425a-a53e-5b24f7edf4cd">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/439c5deb-2621-4110-9889-1841a765519b">
        <rdfs:label>swollen joint</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001386</ddiem:url>
        <dc:identifier>HP:0001386</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
    <dc:provenance>https://www.nature.com/articles/nrrheum.2010.182</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25315665</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
    <rdfs:comment>methotrexate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e2f10e65-40c5-4af8-8e95-e4b3e4b495ab">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002829</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Arthralgia</rdfs:label>
        <dc:identifier>HP:0002829</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379613</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/118600"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/02bdaa4a-5822-469c-a93a-4c7b1d42bf5e">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/712fed98-7244-4b42-b602-09e4b22d1d7c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29675606</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/df0124bf-76a1-4d02-aeeb-a6e951eccfde">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Decreased cellular ATP level</rdfs:label>
    <dc:identifier>HP:0011925*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011925</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3f357e2e-05d6-435c-9a60-9f58c3a7adf7">
    <dc:identifier>HP:0000707</dc:identifier>
    <rdfs:label>Restricted diffusion in the corpus callosum in MRI (Abnormality of the nervous system)*</rdfs:label>
    <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b25c060c-6490-4920-bcfb-8b88e5704c2f">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21503667</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00962260</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/41ccba98-2a20-4e5d-b22a-b129aa7a3cbb"/>
    <rdfs:comment>Eliglustat tartrate</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/37897103-8a16-46e5-a0c2-9a350381bb8f"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT00376168</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fc042b29-edc6-463f-8055-3504281049cc"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b0d1da-41c6-4af5-bae7-665c57daa286"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01074944</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28381550</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/608013">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>GAUCHER DISEASE, PERINATAL LETHAL</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b4c7f310-1e02-4bfd-8cbc-931b7c324369"/>
        <dc:identifier>https://www.omim.org/entry/608013</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27499018</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20439622</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b6b1b260-a41d-411d-a6bd-f2e8a75a6b75"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b370adb7-ebc2-4477-80b8-4c3546cc40d8">
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/207800"/>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2bab4f15-fe68-42d0-8f69-a175ba12d050"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6904eedc-bd21-49d7-ac19-ebc4c1284a09">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/970a252d-bc3c-489c-ba05-f7b2bc3bb4d8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cb8ad57d-e334-429f-b2a0-c70743382998"/>
    </obo:RO_0000057>
    <rdfs:comment>AAV-based gene therapy</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052756/#S10title</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cbe37090-1bae-4242-a9b7-2c07108c7f3f">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>neurotoxicity</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/23277932-c1b1-4564-99a8-e06286110c44">
        <rdfs:label>neurological abnormalities</rdfs:label>
        <dc:identifier>HP:0000707</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23388701</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25474440</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/08ba9657-fd93-43d5-a691-9b2f620df8af"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/93b7a432-d375-41e2-b4ab-4a3087a01043"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7e539d4a-18b9-4715-964f-9769b405c3c0">
    <rdfs:label>AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM</rdfs:label>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=C09</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1fe5693e-edc3-4c25-9962-bc30148493e0">
        <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d757009b-048c-4488-ba26-906e60f9ffdd"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cb262901-1527-401a-8b50-82fe2852abd1"/>
        <rdfs:comment>B-Blockers+Angiotensin-converting enzyme inhibitors</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26067811</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602541"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d064e456-22eb-4c11-aced-5f1caab372b2"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6002ec55-40ba-42c4-9d8f-72757f143e97"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>C09</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8215eb86-27b6-40f1-9700-5714f8d73da0">
    <rdfs:label>Vitamin D insufficiency</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000938</ddiem:url>
    <dc:identifier>HP:0000938</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/146c4e13-0477-4310-aedb-1ec5520e9db8">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01345</ddiem:url>
    <rdfs:label>Potassium cation</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d96cc1de-58aa-4007-a506-bc3eef92c53c">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/863a55a0-7f09-4eea-b931-9efa4399984d"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505515</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a2cf9baf-843c-455b-b00a-65c062657076"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3550461</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8444253</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9f1c881c-4608-4f01-9002-48d5cfaed661"/>
        <rdfs:comment>Bicarbonate+potassium supplements</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158338</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016220</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/219800"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18d743df-a56f-4189-a89b-78393fc3b371"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB01345</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5373541b-16c0-4c47-8adc-0eb10701e735">
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01395641</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ab77f8f7-af95-49bd-a101-6a5cb132e5ac"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23390030</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955971</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4dda8c70-181b-45ee-bae7-07a07eb96ccb">
        <rdfs:label>cerebral folate depletion</rdfs:label>
        <dc:identifier>HP:0012446</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012446</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25001633</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <rdfs:comment>Folinic acid</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608643"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d5e17364-3b70-44e0-94e3-8a27ef11f528">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/deeaed3f-dca6-4071-84a1-0cf8273c7e54"/>
    <rdfs:label>Dantrolene</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01219</ddiem:url>
    <dc:identifier>DB01219</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/965a516a-4893-46de-9842-75fe9d480fa2">
    <dc:identifier>A11E</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c4b432ba-f483-4828-9559-a53629c2406d">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cc4e01de-f611-4bea-ad1c-c6b289dade1c"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11102558</dc:provenance>
        <dc:provenance>https://www.semanticscholar.org/paper/Clinical-Diagnosis-and-Treatment-of-Dehydrogenase-A-Cui-Wang/f6e88d647f2e2c7df2897e939ec33f9d86899b37</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300438"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9ae80196-231c-4e0b-b8b5-d4bcc82337b0"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:comment>B vitamins</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=A11E</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/90c06114-94ae-4964-af6a-8dbed035a302">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e2f10e65-40c5-4af8-8e95-e4b3e4b495ab"/>
    <rdfs:comment>naproxen sodium</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/118600"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c9718f8f-065b-4e20-ba10-96965b6ce38b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411330</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9c1af909-f820-4b36-b486-37d3dfea12a9">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2f3323ee-baf3-4d74-879f-7d35ccccb9a2"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://acrabstracts.org/abstract/anakinra-compared-to-prednisone-on-the-treatment-of-acute-cppd-crystal-arthritis-a-randomized-controlled-double-blind-study</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045115</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/72198eac-c110-4c09-a040-d09b65a38335">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/25b06abb-2e6d-4c27-a04b-9529a33429bf"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451251</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/241500"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <rdfs:comment>BPS804 (setrusumab)</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01406977</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a8952e75-ce42-4739-9d85-d90473ea46a5"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c0406959-edfb-4533-8d69-c819f8503325">
        <rdfs:label>bone weakness</rdfs:label>
        <dc:identifier>HP:0002749</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002749</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7fa448a2-c062-4ea2-b760-fdf4c76cbe64">
        <rdfs:label>low bone mineral density</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004349</ddiem:url>
        <dc:identifier>HP:0004349</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs00223-011-9562-5</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a70772e4-8203-4366-aca6-226e75f53a59">
        <dc:identifier>HP:0002757</dc:identifier>
        <rdfs:label>bone fructure</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002757</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ea8aa992-da03-4bfd-a1bc-cd7f6b1ee536">
    <dc:identifier>HP:0003362</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003362</ddiem:url>
    <rdfs:label>High level of very low-density lipoprotein</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/40029f08-5fbd-435f-a949-b8836220966f">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f51532ca-094e-43f1-87d3-b188c3c61f03"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dd633412-8b2e-47f0-995a-958a76101b7e">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000718</ddiem:url>
        <dc:identifier>HP:0000718</dc:identifier>
        <rdfs:comment>The hypoglycemia is not a disesae phenotype, rather its a side effect of Mecasermin medication.The new combination in Mecasermin rinfabate has over come this side effect.</rdfs:comment>
        <rdfs:label>Generalized convulsion</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e79998b0-0b2f-49dd-ab1c-bf03a9826c46"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/271245"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ea294f91-6ea5-4376-abed-916f16f266cf"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/aa854fef-9405-4a83-8d5e-25fa3a6a7c3c">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/bd9866d1-1e3f-4d59-a744-50e241c11ee9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19304794</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <rdfs:comment>Selective serotonin reuptake inhibitors+Antipsychotics</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/afb0b962-0fe4-48c6-bd6a-c604b3783dc1"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e5b80ade-1c7f-432f-a1c6-c811bf52f300"/>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/801f0fca-cdad-42c6-a243-33def8be49ff">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000718</ddiem:url>
        <rdfs:label>Complex partial seizure</rdfs:label>
        <dc:identifier>HP:0000718</dc:identifier>
        <rdfs:comment>The hypoglycemia is not a disesae phenotype, rather its a side effect of Mecasermin medication.The new combination in Mecasermin rinfabate has over come this side effect.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e0029c3e-5ed2-4fd3-a819-9b6668f00791"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9dfcc4b1-d845-41e8-b612-4caf45da8af8"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/79642d0b-3888-4c7b-b293-d817ceea2a27">
    <dc:identifier>HP:0002135</dc:identifier>
    <rdfs:label>Progressive basal ganglia calcification</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002135</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4e815c09-0511-4adf-b353-4b90cccb78e5">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c5961ba9-4c33-4752-84c8-d5334d486a70">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0b7df37b-9cba-4bcc-8704-28ea440179c9"/>
        <rdfs:label>GNE gene lipoplex</rdfs:label>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/af1ad934-63c2-49b1-b592-710d81906e33">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003713</ddiem:url>
    <rdfs:label>fiber necrosis</rdfs:label>
    <dc:identifier>HP:0003713</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2f3323ee-baf3-4d74-879f-7d35ccccb9a2">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00788</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a0134bda-f3b4-4f69-a823-53535c526f00">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
        <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
        <dc:provenance>https://www.nejm.org/doi/full/10.1056/NEJM197807132990214</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602522"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9c1af909-f820-4b36-b486-37d3dfea12a9"/>
        <rdfs:comment>Naproxen</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5ebbbf5b-caa6-4751-a827-fa118cece9ef"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00788</dc:identifier>
    <rdfs:label>Naproxen</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e141b5d9-198e-416c-b6c2-ba941340aaa1">
        <rdfs:comment>NSAIDs</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/118610"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411330</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/588fa562-b98e-42e3-bae2-0094b8ece5f1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17541659</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9c1af909-f820-4b36-b486-37d3dfea12a9"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.nature.com/articles/nrrheum.2010.182</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/90c06114-94ae-4964-af6a-8dbed035a302"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d82e331c-326d-498b-bc36-048e47009325">
    <dc:identifier>DB00143</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ec841c59-aa58-4c4c-b0e9-2dcc2f54ea66"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00143</ddiem:url>
    <rdfs:label>Glutathione</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1e652f91-d02c-4255-bb00-10d101d4a7c5">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/15aacf77-65d2-47d2-8d7f-8b1870d9df98">
        <rdfs:label>keto-analogues of essential amino acids</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e94590cd-926e-4800-9f1c-431e40f52e9f"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3c83b60d-06b4-452e-8365-409b22d5c67a">
    <rdfs:label>conjunctival irritation</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0030953</ddiem:url>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <dc:identifier>HP:0030953</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/66c6149e-d134-489a-bac0-527916be7855">
    <ddiem:url>https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_84293</ddiem:url>
    <dc:identifier>CHEBI_84293</dc:identifier>
    <rdfs:label>dimethyldithiocarbamic acid anion</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b9f4b572-d521-4df8-9c32-f2fd3d7a3160">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/810de608-6ce2-4e3c-a9c8-b775e77770e7"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22815746</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30384011</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
        <rdfs:comment>Thiuram + Copper Dimethyldithiocarbamate (Cu-DMDTC )</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/68ab2cc7-30cd-4c78-b6a3-30df167f8d96"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cecd6aa1-1704-413e-82cf-c0a71efb998f"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9511979</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/70d4122c-a7af-4634-a97f-87bff6dd2b71"/>
        <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d0bdac65-f96a-486b-90ef-5af32f87fd67"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/40fa08dc-cfa8-4fb6-a090-88b64b99f67e"/>
        <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/309400"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d4bec7eb-dc0b-4271-bdac-e0dc827c937b"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8d50abe8-c59c-4d8e-a691-61cb641abf52">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27155573</dc:provenance>
    <rdfs:comment>Amitriptyline</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0b8b7816-d498-4b33-adeb-4ac67931b856">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3006e7ae-b7a9-4fa8-b758-e91f1b96724a"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/228000"/>
    <obo:RO_0002558>
      <ddiem:Evidence rdf:about="http://ddiem.phenomebrowser.net/ECO:0000305">
        <dc:identifier>ECO:0000305</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/ECO_0000305</ddiem:url>
      </ddiem:Evidence>
    </obo:RO_0002558>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18376404</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28275553</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6f917cfb-e791-4274-a5ab-832d6cc3eca4">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Abnormal pulmonary ceramide level</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a0feac40-a1b0-4a7a-8e73-37fa58691517">
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/088789949400109F</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/231530">
        <ddiem:iembaseAccessionNumber>236</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/095c454f-8eb7-46dc-89eb-83c3e10e9063"/>
        <dc:identifier>https://www.omim.org/entry/231530</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/236</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c7a81364-6eda-4f03-8738-4a3bda1734d6">
        <rdfs:label>Defected neuronal plasma membrane</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040129</ddiem:url>
        <dc:identifier>HP:0040129</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b11da811-7f32-4bc5-876d-aceb6144ca5f"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bea36ac7-9470-4e4b-bc9f-44f363012dd0">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040129</ddiem:url>
        <rdfs:label>Impaired nerve conduction</rdfs:label>
        <dc:identifier>HP:0040129</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/07db6a78-5f31-4dd3-945f-80291ca232fe">
        <rdfs:label>Defected mucle plasma membrane</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040129</ddiem:url>
        <dc:identifier>HP:0040129</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cefa5609-067b-4fb0-81a7-5a24ff1f5c38"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7748366</dc:provenance>
    <rdfs:comment>Prednisone</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5c85a080-1c0b-4553-8ba4-5ad30e71e35a">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17430128</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b3c61125-ae75-474c-b966-3a22e5f77044"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d6c1137f-c24a-4d72-9c84-5068df3a1623"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16672983</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20163245</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cd059827-8452-4154-8c81-75f9b169c58a"/>
    </obo:RO_0000057>
    <rdfs:comment>AAV-cG6PGH</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c3adb877-a6b3-457c-a88c-9f82e499e6ee">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/cfde690a-7eef-4059-8e7f-39896af2f2e4"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2e72b3dd-241d-4731-85fb-38ec94610ab2">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002240</ddiem:url>
        <rdfs:label>Growth Failure</rdfs:label>
        <dc:identifier>HP:0002240</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/730fb49e-7e0b-4304-a5a5-711f99dd807e"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/02e697d4-329e-4fd3-8227-5806370c078e">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003077</ddiem:url>
        <rdfs:label>Hyperlipidemia</rdfs:label>
        <dc:identifier>HP:0003077</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/85a4e5fe-68c4-47ff-8b19-93e6ec442b56">
    <rdfs:label>FIV-hAAT-G6Pase</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/713dcab3-9010-4612-b117-8e9ed21ad336"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/641b9a34-220b-4f0e-9f2d-4a61fd45dcfb">
    <rdfs:label>Nocturnal hypopnea</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002877</ddiem:url>
    <dc:identifier>HP:0002877</dc:identifier>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/31f9e18f-0315-42a7-98f4-5d3858e2a591">
    <dc:identifier>HP:0001395</dc:identifier>
    <rdfs:label>liver fibrosis progression</rdfs:label>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001395</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b69c1eb6-d1f9-4394-84af-aa30dd0092ad">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9694707</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4ec6e94a-a81d-4f76-9761-bd29ed964da6">
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
        <rdfs:label>Low levels of serum vitamin B12</rdfs:label>
        <dc:identifier>HP:0100502</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100502</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24424200</dc:provenance>
    <rdfs:comment>Vitamin B12</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261000"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ce339349-b682-4056-b15a-c6133052fe4d">
        <dc:identifier>HP:0025548</dc:identifier>
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
        <rdfs:label>High RBC's mean corpuscular volume</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025548</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25308559</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/49c6619b-8c93-4f0c-b105-dbbb73d8d890">
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
        <dc:identifier>HP:0020062</dc:identifier>
        <rdfs:label>Low Hemoglobin concentration</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0020062</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/6823973</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/208d44d7-1d4b-439d-99ea-2dc193c15b09">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004312</ddiem:url>
        <dc:identifier>HP:0004312</dc:identifier>
        <rdfs:label>Abnormal reticulocyte count</rdfs:label>
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/9218e9de-2968-43b5-aef3-55d48d157c5b">
        <rdfs:label>Functional interaction(m</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/05e0e82a-9bed-4b0a-bef4-d3b2b940f041"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/117b6784-958d-4b05-b575-3b97d5adf385">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02527343</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0a9fc84c-1e69-4df0-bced-068cb693ea60"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fa2ab50d-525a-4059-9f35-e3b061ea0697"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Probenecid</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8842764</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/162000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fbb6cd51-c2bb-40f6-be20-04c33ade9299">
    <dc:identifier>HP:0008166</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0008166</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Abnormally decreased rate of beta-galactosidase activity</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/78069a2f-bbbb-4ff8-a7a0-cd80d43709c1">
    <rdfs:label>Growth impairment</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0008897</ddiem:url>
    <dc:identifier>HP:0008897</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8ea0d282-e7ca-4b59-a32c-74397df333ec">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28057010</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16868861</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ef4720c8-6d94-49bb-b501-2bf28ce742cd"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25335805</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>cyclosporin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22402328</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/20853e51-9232-43f1-a5e6-f495d5452f7b">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000938</ddiem:url>
        <rdfs:label>Osteopenia</rdfs:label>
        <dc:identifier>HP:0000938</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/6777479</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c255d5aa-ac7c-4117-8a7a-9fa840022126">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/306000"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/733456f6-6dc5-4dd0-b8e1-942819cb53f8">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f3b29897-a34e-48d1-a029-b0823fc93603"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ef75701a-a6e2-48ad-bbbf-5331b9be3a4b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25266922</dc:provenance>
    <rdfs:comment>CoCarbs + HPro</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3207e0b4-f2fe-4975-aff2-d17234e00bbc"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC324959</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564511</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/67f20795-f624-479b-9c8b-cb0d53b61988">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c1d28c82-72dd-45f2-917f-1eea9583452f"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261640"/>
    <dc:provenance>https://rarediseases.org/rare-diseases/tetrahydrobiopterin-deficiency</dc:provenance>
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <dc:provenance>https://www.researchgate.net/publication/46821474_The_3-methylglutaconic_acidurias_What%27s_new</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19323589</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/38a47102-b026-4c24-a572-b136d38e04af"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/600f9630-83b1-4a24-a752-2ec66a36aa83"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Sapropterin</rdfs:comment>
    <dc:provenance>https://www.jci.org/articles/view/11948</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/099e8d33-806d-41e7-a7ea-dfc3111342de"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/34ffc1f1-cbbd-498c-975f-73281c0ce162">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30081189</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11916316</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/34101d64-08c5-415b-b02e-399803061228"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e968f7be-4705-47b2-ab0f-2a9af29fcac0"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/603174"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00638547</dc:provenance>
    <rdfs:comment>Methyltetrahydrofolic acid+Hydroxocobalamin+pyridoxine+ betaine</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7ebe75a3-5af9-413e-b5ef-e94c11025837">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/bb7c5a4e-3260-4df3-8b8b-6f88b3c2b76e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0424c09c-b8c6-425a-b120-37b27e5f710f">
        <dc:identifier>HP:0040087</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040087</ddiem:url>
        <rdfs:label>Abnormal Folate level</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ee7cdf8b-18e3-4abe-abf9-e324b00eb623"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6cd8dd19-6bc2-494f-94ab-05974800f7d1"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/56fe6e8b-d9d7-41ff-857e-19ee7160267c">
        <rdfs:label>Abnormal serum Methylfolate Level</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/82ee3912-9588-4be1-a099-6a307d012a6c">
    <rdfs:label>Delayed development</rdfs:label>
    <dc:identifier>HP:0001263</dc:identifier>
    <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001263</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e2a52997-3a9e-4b50-a596-ef0738526973">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29223626</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/261cc9c0-ed6f-4f66-9e81-53dfe17f8b58"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564511</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/240600"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f045daf4-9a93-40fb-8246-2116bd9f0e82"/>
    <rdfs:comment>Cornstarch</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12794686</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d975ccc1-ef61-460a-8c64-788585485163">
        <dc:identifier>HP:0012051</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012051</ddiem:url>
        <rdfs:label>MorningHypoglycemia (Hypoglycemia)*</rdfs:label>
        <rdfs:comment>Patient transaminases  slowly decreased with time in https://www.ncbi.nlm.nih.gov/pubmed/12930917</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/10dac04b-b86c-4b34-b606-a8496d3ab9c8">
    <rdfs:comment>Digoxin</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/302060"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1025545</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/764c4cf7-d28c-4c5d-86c9-46831142b419">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/110ed263-dbe6-46a3-aefe-40267fb205f1"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/aaf25ba3-513e-424e-8fad-11bec4ba3230">
        <rdfs:label>Mitral incomptence</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001653</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001653</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dc1ae0ea-c941-4d44-a782-64959e29b350">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0005180</ddiem:url>
        <dc:identifier>HP:0005180</dc:identifier>
        <rdfs:label>Tricusped incompetence</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f26eb273-01b2-4a18-9276-81be638da73f">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0012664</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012664</ddiem:url>
        <rdfs:label>Low ejection fraction</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/eac1250d-b60d-4d8d-8932-7eccc9163f52">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9754d464-e922-4729-9249-536199793554"/>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ce1710e2-8d26-440c-979f-f234b60ecad0">
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/790774ab-151e-406a-ba94-7e6e35191100">
        <rdfs:label>defected excertion of 3- MCG</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7474896</dc:provenance>
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8831079</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18155630</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2a670529-dd20-49ff-9fa0-05f19bd47c1f"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Glycine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/210200"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a1e319e1-11d3-41e2-9196-1d04366b661a"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/46d093a0-5e0d-4dd6-ae7b-de1262fa11e1">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/341955</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22092997</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d034d4c1-4deb-42d3-9593-a4071e108c79">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Pain in the skin</rdfs:label>
        <dc:identifier>HP:0025280*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025280</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5342f892-fe3f-42da-b584-0f792e16b4bd">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d824b5db-6154-4874-a88c-719c0a49f493"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23884489</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/177000"/>
    <rdfs:comment>β-carotene</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26979527</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0d2b8406-65d5-4399-940f-2d2724f8ed84">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>intolerance to sunlight</rdfs:label>
        <dc:identifier>HP:0000992</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000992</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19656325</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791288</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/49fa1abf-09e1-4cee-9962-7f4d51c29391">
    <rdfs:label>Givosiran</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7060e782-5fb1-41fb-a2a0-10a9bc90021f">
        <rdfs:comment>Givosiran</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0ba52dd3-860d-4c56-9a77-2aaa1e4f1c75"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24821812</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/176000"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30726693</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8a7b1798-e087-4471-b938-3ad2da866cb1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30766957</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15767622</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02452372</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB15066</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB15066</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1768ec24-f5cb-4e3b-95fa-236e3c351a89">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8757046</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2066b1ee-f3f2-431b-a62e-260e909616c1">
        <dc:identifier>HP:0011925</dc:identifier>
        <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
        <rdfs:label>Decreased activity of mitochondrial ATP synthase complex</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011925</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00887562</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/540000"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e5bea7f8-801a-41f1-8ec8-d00a573413a3"/>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <rdfs:comment>Idebenone</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/36a75882-970d-4174-8730-4375d4b2f81a"/>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4a1f4895-6da6-4285-a0c2-6640da936570">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00004831</dc:provenance>
    <rdfs:comment>cysteine hydrochloride</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22092997</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dc7ac287-533e-46a1-bf24-dac8a0e1be84">
        <dc:identifier>HP:0000992</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000992</ddiem:url>
        <rdfs:label>photosensitivity</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/177000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12535027</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26979527</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d323db42-0420-46cd-9b11-d9d4f77dfe9a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d873e57b-d60d-4dcb-a1e8-3a92ab34fec4"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23884489</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00004940</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/22e95721-ca3a-4a45-8279-df2cfa77b7a6">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02527343</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7f210050-85fe-4bca-9f85-d2a10756484f"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/245900"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Captopril</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23391322</dc:provenance>
    <dc:provenance>https://www.clinicaltrials.gov/ct2/show/NCT01554800</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ec2b826a-5264-45c3-b9bd-31793885e995">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3d9ba582-5e79-4c38-b1a0-5deb9ccc65ce"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/e8e90270-e143-4299-82aa-b124c48435d8">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d7330462-56bd-48f7-b533-4286354d0b98"/>
    <rdfs:label>Thiamine</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0f49be26-289c-4248-9d5c-5a8d13b6eccc">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24816443</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/22186859-4065-462a-ba51-b3b3c7a0efb8"/>
        <rdfs:comment>thiamine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995031</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602398"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00152</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/dc434f15-4481-4d48-b4b2-d22935363e20">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/22186859-4065-462a-ba51-b3b3c7a0efb8"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7f392164-619f-4a26-a3ab-b42743ba8c92"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/248600"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28919799</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:comment>Thiamine</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00152</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/60a44075-77cf-4d55-9972-e2d3542e6603"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/26a76882-b7f7-4b7d-bb0c-23e6c118a500">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26577040</dc:provenance>
        <rdfs:comment>Biotin+thiamine</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d546fbcb-eb94-4ca4-b026-34e293e33bdb"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8078e536-b011-49be-9eff-b2537d25f610"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/216d0d87-f598-4273-841b-bffd8b02da3c"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/221c46d7-b0a2-4042-a3a1-b8daf2c6d581"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2d5cb48d-44f0-4b2b-9aac-337a92e203b1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e3825af6-be59-4444-abb7-0e94c6fbff30"/>
        <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a50038d9-191d-4ac3-8c84-f441bee5ec42"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fd8cf6e3-3371-48f8-aa90-cbf69bfcf2fe"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607483"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c6f18b08-c2a9-4fc8-9895-528a23c0effa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31061755</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f4a65699-6b2b-4083-b9c7-76a3d43fb659"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/7bf01178-e321-46dc-a0b9-57795442f142"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27749535</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/22186859-4065-462a-ba51-b3b3c7a0efb8"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/aec0ae51-5bcd-42b1-853c-46f1cec67d1c"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a7be9294-85f5-4684-9473-fa20ca562aff">
    <rdfs:comment>prednisolone</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b98ef4c3-1e78-4e7e-a460-b453c064fcf2">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025034</ddiem:url>
        <dc:identifier>HP:0025034*</dc:identifier>
        <rdfs:label>erythroid progenitor depletion</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs12185-016-2044-9</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/105650"/>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/26758319</dc:provenance>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/26305041</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/207b4fb1-1153-4f67-9fbc-bc1ace5d7787">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0012130*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012130</ddiem:url>
        <rdfs:label>premature differentiation of erythroid cells</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9c97e679-fcba-44fc-baac-0e45aecce282">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Pathological apoptosis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.13632</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b11da811-7f32-4bc5-876d-aceb6144ca5f"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dfcecbbd-070c-4d95-a5da-ff5e977e1fc0">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001903</dc:identifier>
        <rdfs:label>low hb level</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001903</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d5a47fe4-0713-47b6-9e64-89e63445724c"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/09f9e7ed-47ed-4781-81b7-aa1e7685fe10">
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <rdfs:label>"The approach is likely unsuccessful due to reactive properties, intrinsic instability, and charged character of SAM."</rdfs:label>
    <dc:identifier>HP:0002156</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002156</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/66d8aa34-d885-4b6c-9657-db0b43052bec">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f812ca94-6ce7-47eb-a32d-0eac9e1ed3bb">
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c38f17b2-5825-4a92-be31-749e97593bb5"/>
        <rdfs:comment>Nicotinamide Riboside</rdfs:comment>
        <dc:provenance>http://ichgcp.net/clinical-trials-registry/NCT03432871</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03432871</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/540000"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
        <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/84178bc5-35f1-4c95-8aec-c28d3f0a6c33"/>
        <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB03227</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB03227</ddiem:url>
    <rdfs:label>Nicotinamide Mononucleotide</rdfs:label>
  </ddiem:Drug>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/613150">
    <ddiem:iembaseAccessionNumber>353</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/c8b1bfec-3719-4130-8dc9-755b17f2e911"/>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/613150</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/353</ddiem:iembaseUrl>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a7636d31-7372-48dd-b527-4109a855f804">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/600fa950-41c0-451b-a994-6b41c195e73a">
        <rdfs:label>abnormal folate homeostasis in the CNS</rdfs:label>
        <dc:identifier>HP:0012335</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012335</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>folinic acid</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <dc:provenance>https://link.springer.com/referenceworkentry/10.1007%2F978-3-540-29676-8_1729</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12003346</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719208000048</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10078749</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ab77f8f7-af95-49bd-a101-6a5cb132e5ac"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/233910">
        <dc:identifier>https://www.omim.org/entry/233910</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ed3ada91-26ac-4c19-be7b-99681d6777af"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/3</ddiem:iembaseUrl>
        <rdfs:label>HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>3</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19234759</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18276179</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/115f8d34-794f-4520-bd00-d6078b0041ae">
        <dc:identifier>HP:0012446</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012446</ddiem:url>
        <rdfs:label>depletion of cerebral folate</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20818608</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c4de69fa-3c4c-4cdc-a350-b5382d84fd93">
    <rdfs:label>Spirapril</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01348</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/496f6638-11cb-49ff-a3e8-1de0c04a5483">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <rdfs:comment>ACE inhibitors</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8444253</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6fe047fc-f231-4a9c-9dc3-96e41931b4ea"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505515</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9de0116c-cd01-4f85-9e2e-a7e8af9fa8f4"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14690254</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/219800"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158338</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841061</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2e23a0a3-de38-45e1-b8eb-ccdc0bee76ea"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016220</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB01348</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e312fa1d-dc13-4719-bbda-9c18f7c766dd">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/160387be-79af-423c-99b1-e038ba4dfb21"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9886460</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fd8cf6e3-3371-48f8-aa90-cbf69bfcf2fe"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/efaec280-85f2-441c-b718-bcbead9ec263">
        <dc:identifier>HP:0001332</dc:identifier>
        <rdfs:label>Parkinsonism</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001332</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11346370</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/128230">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/c0358a64-ede1-4e97-b17c-6045f25fc312"/>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/2722719d-176e-4e5f-919c-d96ca1a9a031"/>
        <rdfs:label>DYSTONIA, DOPA-RESPONSIVE; DRD</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ed3ada91-26ac-4c19-be7b-99681d6777af"/>
        <dc:identifier>https://www.omim.org/entry/128230</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cefa5609-067b-4fb0-81a7-5a24ff1f5c38"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <rdfs:comment>levedopa/carbidopa</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4727cc56-b384-4756-94b9-05fd9346b553">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b6495443-58fe-43ca-968d-236e7d6a7012"/>
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/fd930177-3e81-49e3-a2b6-45c9ff516717"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16908750</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6a9d278d-26ae-4429-ac53-36fb1833a5aa">
    <dc:identifier>DB01626</dc:identifier>
    <rdfs:label>Pargyline</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01626</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3435fb25-7134-46a0-9ca0-04321fac72af">
        <rdfs:comment>Pargyline</rdfs:comment>
        <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c7e00359-2b2f-4fe5-8347-566f8cbf9304"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608643"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01395641</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955971</dc:provenance>
        <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fbf30458-d2db-4f83-822c-2f3c4b6dc8bd"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241937</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23390030</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3bb694a9-dc90-4393-8d4c-7c7eec529472">
    <ddiem:url>https://www.drugbank.ca/drugs/DB13245</ddiem:url>
    <rdfs:label>Thiram</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b9f4b572-d521-4df8-9c32-f2fd3d7a3160"/>
    <dc:identifier>DB13245</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/25c73bf9-3d66-4c70-8dd0-95a79968a1f5">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4f63e612-0130-4c1b-8a52-cd6f5eb9e417">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/79a2ee51-fb17-4315-92c4-017131d02b81"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e2f10e65-40c5-4af8-8e95-e4b3e4b495ab"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045115</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/118600"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03128905</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2d4427da-ba30-489f-8f07-724480217642"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <rdfs:comment>Colchicine(COL)</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9c1fabdc-cc5a-4fb7-8b8e-c0a5f555aadc">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01328587</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/870f9ad0-5613-4088-b2c5-367ca1a4f233">
        <rdfs:label>low visual acuity</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007663</ddiem:url>
        <dc:identifier>HP:0007663</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>lysine supplementation</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28388263</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29654911</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6056fdf7-6de8-464c-9689-d23aba0e7121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17921858</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
    <dc:provenance>https://link.springer.com/content/pdf/10.1023%2FA%3A1010545811361.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/258870"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/34a17c4a-bbe7-4f32-bbd2-42728a8ed49e"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/230600">
    <dc:identifier>https://www.omim.org/entry/230600</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b1e3e3e8-a5e9-453e-a947-0d77e8dd2b22"/>
    <rdfs:label>GM1-GANGLIOSIDOSIS, TYPE II</rdfs:label>
  </ddiem:Disease>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2d249db9-f424-4118-992c-429768af092c">
    <ddiem:url>https://www.drugbank.ca/drugs/DB04540</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/151c722d-153d-4226-a95e-ae0db916cdcb">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e9abd6ed-6ee0-4c4f-b870-c39dcbd32da8"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/74980813-712f-4b1a-9a90-baa2660d5bb9"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607330"/>
        <rdfs:comment>cholesterol</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24142275</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4a2b3f3b-f39c-49e2-bddd-c32772b311fc">
        <dc:provenance>https://jhu.pure.elsevier.com/en/publications/inborn-errors-of-cholesterol-biosynthesis-6</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e9abd6ed-6ee0-4c4f-b870-c39dcbd32da8"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cad27e08-c72e-41db-9634-9b06464c1943"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24816443</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
        <rdfs:comment>cholesterol</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602398"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/448bcd4e-ae07-4b16-84a0-248a660f762b">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909487</dc:provenance>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/898115c7-2054-4893-b291-24af656d4ae9"/>
        <dc:provenance>"ENB-0040</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e1031574-2cdb-4e6e-bc18-b27a78645c76"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ea5955ad-c114-458d-a5a5-e44eb8a24c2e"/>
        <dc:provenance>an enzyme-replacement therapy</dc:provenance>
        <dc:provenance>NCT00744042.)."</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096504</dc:provenance>
        <dc:provenance>https://www.researchgate.net/publication/8668575_A_successful_treatment_with_pyridoxal_phosphate_for_West_syndrome_in_hypophosphatasia</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/308050"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2d532444-c84b-4397-bb17-05f06dcc11af"/>
        <dc:provenance>was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e9abd6ed-6ee0-4c4f-b870-c39dcbd32da8"/>
        <rdfs:comment>lovastatin+cholesterol</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/36a75882-970d-4174-8730-4375d4b2f81a"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB04540</dc:identifier>
    <rdfs:label>Cholesterol</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/215822d0-31d5-41bd-9310-782ce126378b">
    <rdfs:label>hyperproteinemia</rdfs:label>
    <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
    <dc:identifier>HP:0002152</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002152</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f8eab484-fc08-47a6-8179-874f25e7c362"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5b263806-e571-4c4d-a2de-76ab87da8a39">
    <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
    <dc:identifier>HP:0002123</dc:identifier>
    <rdfs:label>Myoclonic epilepsy</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002123</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/612319">
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseAccessionNumber>1054</ddiem:iembaseAccessionNumber>
    <rdfs:label>SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE; SPG35</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1054</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/0f533fe1-dfda-48f2-bddb-5922bc9197aa"/>
    <dc:identifier>https://www.omim.org/entry/612319</dc:identifier>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f82088b8-e73f-4337-943f-a1108122064a">
    <rdfs:comment>The hypoglycemia is not a disesae phenotype, rather its a side effect of Mecasermin medication.The new combination in Mecasermin rinfabate has over come this side effect.</rdfs:comment>
    <dc:identifier>HP:0000496</dc:identifier>
    <rdfs:label>Defective eye motor function</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000496</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/36639034-f0e7-4778-ae72-2745a0be7f4e">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/81f7a500-c599-45cc-ab12-979353db6074">
        <dc:identifier>DB06372</dc:identifier>
        <rdfs:label>Rilonacept</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3360937d-4725-40b9-9f89-7a876f7aec81"/>
        <ddiem:url>https://www.drugbank.ca/drugs/DB06372</ddiem:url>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/45069e30-391f-4478-af13-6c23b700d9e3">
    <dc:identifier>HP:0100543</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100543</ddiem:url>
    <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
    <rdfs:label>Abnormal mental status</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9f201629-2411-4f8c-ba61-f4dc119d0468">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2170dc7c-c3d5-495d-972e-7abd19374be5"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2e306140-e369-4137-a34c-c45574dfa0e4"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/278000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1521691810001101</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29374495</dc:provenance>
    <rdfs:comment>Ezetimibe</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c0621162-b116-425e-94be-d7da2469176a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2bba6e5a-87ed-4903-b9b5-3c7048e0a3ba"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3635a129-6339-478b-abe5-231c41cb6985">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9d059244-0c53-4fae-af73-6e795ee03d50"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22132097</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11102558</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300438"/>
    <rdfs:comment>Carbamazepine</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3dc8dd57-2ebf-47c5-8e54-e404320c1291">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011025</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Abnormal cardiac function</rdfs:label>
    <dc:identifier>HP:0011025</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/50fc9013-3727-43f7-9a24-0cc3d1c97487">
    <dc:identifier>HP:0001510</dc:identifier>
    <rdfs:label>delayed growth</rdfs:label>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001510</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/e82b16fc-255c-4583-ab8e-b295c9cb82a0">
    <rdfs:label>Dorzolamide</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00869</ddiem:url>
    <dc:identifier>DB00869</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ad17ba69-48c8-4fbd-902d-031eaf5a9d01">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26669244</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a87ff146-9fbc-4ad9-ae72-8d041a541777"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4721bc5d-016e-48dd-b72e-f2ac0eb4e382"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <rdfs:comment>dorzolamide+acetazolamide</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/34a17c4a-bbe7-4f32-bbd2-42728a8ed49e"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b6ee773-210d-4d68-8144-345a6a869b42"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29395598</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0bf2816d-81ba-4807-9a7f-3d83c3035d86">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28980384</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/613150"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Diuretics</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8d31d238-aa6e-4300-a793-db3a8ce4dc5a"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5da79f2e-9af5-4c21-8a4d-ea00a35bd4ab"/>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a8c20f24-e338-42de-82c9-a42983bfecbc">
        <rdfs:label>tachypnea</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002789</ddiem:url>
        <dc:identifier>HP:0002789</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f6568d31-139d-41dd-9736-812d1ef1b4c3">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001635</dc:identifier>
        <rdfs:label>congestive cardiac failure</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001635</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/af4a382c-d530-4a2c-90fd-45e36835c99b">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003119</ddiem:url>
    <dc:identifier>HP:0003119*</dc:identifier>
    <rdfs:label>High VLDL triglycerides</rdfs:label>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c3eefd01-8cec-476e-a483-3b5466d9593f">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <rdfs:comment>chlorpropamide</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/7800d039-a51f-43b2-bbe3-6407774b3776"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1517999</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/125700"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1316120</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fddd166c-6af9-41f7-85af-89b462944930">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000103</ddiem:url>
        <dc:identifier>HP:0000103</dc:identifier>
        <rdfs:label>Polyurea</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bc7b032b-0b40-4776-b24c-7da180f3d332"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f35113e8-76de-4f67-9159-5f1d7dc25a29">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/57486793-315f-4b08-9075-0176abb6bc74">
        <rdfs:label>Lenalidomide</rdfs:label>
        <dc:identifier>DB00480</dc:identifier>
        <ddiem:url>https://www.drugbank.ca/drugs/DB00480</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/528a74fe-fe24-4298-b1c3-6f98e250ce7d"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8db40dd3-1bd0-431a-8e06-ae47311613cc">
    <rdfs:comment>Pergolide</rdfs:comment>
    <dc:provenance>https://www.sciencedirect.com/science/article/abs/pii/S1386634602003315</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/612953"/>
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4a9a1c5e-6b96-4816-ad5c-0b021f184bc0"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/05e18122-de84-4815-99e4-c46336ad7ca7"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24613933</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15670720</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1181</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/266552c8-14b4-4cc2-9862-25b02924bd83">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fa5d5285-39f0-45bd-9d4f-4739f99ec17d">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2f270d4f-a586-4911-8293-65401d2a558f"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02805790</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a4844ef3-ad09-4202-a6b0-94d11107c0fb"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02176733</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22202226</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21788663</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/220111"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1d594c22-2d03-4089-b1f7-8869cb92464f"/>
        <rdfs:comment>methylene blue</rdfs:comment>
        <obo:RO_0003304>A354V</obo:RO_0003304>
        <obo:RO_0003304>A354V and C12775STOP</obo:RO_0003304>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Methylene blue</rdfs:label>
    <dc:identifier>DB09241</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09241</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/96627a6e-20bd-4af1-aaa6-bad26789f550">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4dfeba25-d788-4736-945c-52b281f9cfe4">
        <dc:provenance>NCT00744042.)."</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <dc:provenance>"ENB-0040</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/898115c7-2054-4893-b291-24af656d4ae9"/>
        <dc:provenance>an enzyme-replacement therapy</dc:provenance>
        <rdfs:comment>Glycolic acid+lovastatin+cholesterol</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d79987a3-7694-4e20-a2af-970e01b01c60"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/308050"/>
        <dc:provenance>was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29392821</dc:provenance>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b2921e86-da03-49b5-832a-6aee3a351245"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096504</dc:provenance>
        <dc:provenance>https://www.researchgate.net/publication/8668575_A_successful_treatment_with_pyridoxal_phosphate_for_West_syndrome_in_hypophosphatasia</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9938bdde-7d48-4694-bf4e-222c1b2eb00a"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e9abd6ed-6ee0-4c4f-b870-c39dcbd32da8"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Glycolic acid</rdfs:label>
    <dc:identifier>DB03085</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB03085</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bbe51873-62d8-4d16-98f0-e99afb0bdcff">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10630918</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ecacfe1-43c1-48f2-896f-9205e9310612"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8473b659-07f4-4aba-a5bb-33f7d8b139c8"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0adeee68-a6de-408d-9775-5598dc19ca4f"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231670"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3ff33ba7-c29c-49e2-91f1-9f092cb3feb7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9af5d129-c87a-4c97-a96e-e5510ba380a2"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23326493</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4355d2a2-55c8-46fe-bd2c-4e220ec8ee87">
        <rdfs:label>Brain damage</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001298</ddiem:url>
        <dc:identifier>HP:0001298</dc:identifier>
        <rdfs:comment>Initiation of treatment after the onset of symptoms is generally not effective in preventing permanent damage. The combination is suggested to given in presymptomatic patients to prevent brain damage.https://www.ncbi.nlm.nih.gov/pubmed/21431622</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16435214</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4acfaf6b-eff5-47bf-aa49-229ca111cf9a">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100021</ddiem:url>
        <dc:identifier>HP:0100021</dc:identifier>
        <rdfs:label>Cerebral palsy</rdfs:label>
        <rdfs:comment>Early diagnosis can prevent the phenotype, Initiation of treatment after the onset of symptoms is generally not effective in preventing permanent damage. https://www.ncbi.nlm.nih.gov/pubmed/21431622. https://www.ncbi.nlm.nih.gov/pubmed/10630918</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f0115c54-e39b-4ce2-bd1e-7b03976f8da3"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6013024e-d764-4c60-9b48-b7b2271cfef0"/>
    <rdfs:comment>Carnitine +anti-catabolic drugs(eg.Glutamine)+ Amino Acid supplements</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fb293d89-d859-4e9f-bde5-d63163d8c229"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7b72d7dc-54ab-4e2f-89e8-9a18db997163">
    <rdfs:label>rAAV2-ND4 (recombinant Adeno-Associated Virus-NADH dehydrogenase, subunit 4 (complex I)（rAAV2-ND4))</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a32fc4bd-ea0b-4734-9889-9d84720fa362"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/27f4aab0-c205-4a0f-9a36-366914e08f2b">
    <ddiem:url>https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_32362</ddiem:url>
    <rdfs:label>enanthate</rdfs:label>
    <dc:identifier>CHEBI_32362</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3568b94d-728e-40e3-93f1-4700a7da8417">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24997711</dc:provenance>
        <rdfs:comment>heptanoate</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ffb6a06c-6da5-4cae-b66c-f9f331c9ac83"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9ae09a9f-e7fa-483d-92ae-b8d116924c7e"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/600890"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d0bdac65-f96a-486b-90ef-5af32f87fd67">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/66c6149e-d134-489a-bac0-527916be7855"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0f0e2b63-88e9-4165-a7e5-7ec3a1531c39">
    <dc:identifier>HP:0011015</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011015</ddiem:url>
    <rdfs:label>Abnormal blood glucose concentration</rdfs:label>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f021b035-e29e-4f60-8eac-456a5e689793">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18425437</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/23f852d1-da7c-49f2-8e77-9d6cc78944a6"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7760062</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0c55981d-3e45-40da-afa3-5b2ec1a80c3c"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261630"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ac06a685-6de0-4b4d-a07c-5ea08f25b673"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cda98d19-f0d3-4eb6-8fa7-84c5a91247d0">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/dc7a7607-00d5-4b9c-a694-4bbc04cb01a9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26817292</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <rdfs:comment>l‐dopa+5-hydroxytryptophan+BH4+entacapone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c1d28c82-72dd-45f2-917f-1eea9583452f"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25667865</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a59a341f-540b-4698-933a-78583219cbd6">
    <rdfs:comment>aminomidazole carboxamide riboside</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3163818e-c473-448e-8111-9ed56db5151d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/50a653b2-8fb7-42f1-818c-1690a1e11dd8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27179999</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/14d2288f-f161-4d18-a879-0c66d917c1cf">
        <rdfs:label>No result was added</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100851</ddiem:url>
        <dc:identifier>HP:0100851</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00004314</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT01065558</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26922636</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/04337293-50d4-4c6b-9ef4-a5677d9b606d"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300322"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7d966ab5-4d34-486e-8cf0-d0f376384d08">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30420558</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/af1ad934-63c2-49b1-b592-710d81906e33"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/257ba681-37f6-4b96-b1f9-9dbfa4fbd2e3">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003198</dc:identifier>
        <rdfs:label>Myopathy</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003198</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1886403</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b21b157f-04f5-4d64-b958-f793cbe41703">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7674d9e5-68ea-4481-9a9d-aba5f07616e1"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>bezafibrate</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8ef92ffe-a90c-4294-ad7f-9e774c8419b3">
        <rdfs:label>Increased muscle lipid droplets</rdfs:label>
        <dc:identifier>HP:0012240</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012240</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1fa6bc4b-b58b-4a4a-a638-b0c7947b1b49"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/268200"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220407</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26997609</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b114e474-2e7f-4cf0-ac4d-53f2aba2d633"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2443756</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/26b42350-d9a5-45df-a4ec-c7b4afdfd760"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/253280">
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/354</ddiem:iembaseUrl>
    <rdfs:label>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/08c64cf9-06aa-4cc3-b0cb-8598100707e8"/>
    <ddiem:iembaseAccessionNumber>354</ddiem:iembaseAccessionNumber>
    <dc:identifier>https://www.omim.org/entry/253280</dc:identifier>
  </ddiem:Disease>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/15f3c450-f3ad-435a-a116-e54097bb7bf7">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c90d6fda-f5da-443a-879f-a168b4472986">
        <dc:identifier>DB03766</dc:identifier>
        <rdfs:label>Propanoic acid</rdfs:label>
        <ddiem:url>https://www.drugbank.ca/drugs/DB03766</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/24f47da3-7f02-435d-9d26-d72ead70d4af"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3360937d-4725-40b9-9f89-7a876f7aec81">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368924</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25922564</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23022422</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c9718f8f-065b-4e20-ba10-96965b6ce38b"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18240249</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/36639034-f0e7-4778-ae72-2745a0be7f4e"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
    <rdfs:comment>rilonacept</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/118600"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a4aca3ba-e2e3-4d66-99aa-ecfc320050f2">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Abnormal chondrocyte growth</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7e0bd5ec-07c1-44d8-b75a-34961a271a09">
    <rdfs:label>rAAV-GPE-G6PT</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/94977730-3d28-46ac-aa87-b75c2701f3b5"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a5f700a4-98d0-4ace-848e-4113eefc796b"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/11f70c63-07d3-44cf-b96d-75a867cee7c4">
    <dc:identifier>DB00419</dc:identifier>
    <rdfs:label>Miglustat</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f59643a1-22c1-490e-8061-220308784cec"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00419</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7d861633-cd36-420b-8b65-6a7e94bae4e4">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24441827</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/5d2b234f-9a42-418b-bc6e-a95a7e865a28"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c9edd9ed-c5fd-420e-bdbf-399e6870967c"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7814809</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/97d6c09d-0825-45db-aae8-2e180cd41bc7"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c7a11941-2d00-4d77-8190-1589b6729c29"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b0ee997d-a92f-4e23-8e88-1676593b0bac"/>
        <rdfs:comment>Miglustat (Substrate reduction therapy)+imiglucerase</rdfs:comment>
        <dc:provenance>https://link.springer.com/article/10.1007%2Fs11011-018-0236-1</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15895716</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02520934</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231005"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18952590</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/996848e0-e394-4a94-b9b4-292f06503ad0"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/563ea534-a9cc-41eb-a436-dc13f9fbbae7"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/483a5c14-5d4b-4a6c-96cc-27ec00036005"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/09090b75-ec0f-4f9b-8219-235a80a3eb10"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17433057</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/46fccbf9-3280-4ec5-b7aa-4c9a4c8b5ff9">
    <dc:identifier>DB00672</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00672</ddiem:url>
    <rdfs:label>Chlorpropamide</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c3eefd01-8cec-476e-a483-3b5466d9593f"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b83f9b27-77f3-4265-863d-968b2fd5fdae">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19755409</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00151710</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/63617787-19d9-4a65-a604-44019c9705cc">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000855</ddiem:url>
        <rdfs:label>Insulin resistance</rdfs:label>
        <dc:identifier>HP:0000855</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Pioglitazone</rdfs:comment>
    <dc:provenance>https://www.orpha.net/consor/cgi-bin/ResearchTrials_ClinicalTrials.php</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/202110"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/81dc267b-e3d2-4915-884c-7ba8be2443f0">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/0cf066cd-cce1-4dca-bdab-9e227459fdfe"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7f210050-85fe-4bca-9f85-d2a10756484f"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5d4383bd-1586-4cb4-90d2-0d54b30b6ed8">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0001298*</dc:identifier>
    <rdfs:label>Relapse of hyperammonemic encephalopathy</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001298</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8078e536-b011-49be-9eff-b2537d25f610"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/559b7517-d987-45ec-b139-626ac842380c">
    <dc:identifier>HP:0003645</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003645</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>abnormal activated partial thromboplastin time</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4dfeec87-d174-4548-940b-811e2905ca22">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Low PBGD expression in liver</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/68965f27-64cc-48b8-8c6b-b500d18f8db9">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002240</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Abormal liver size</rdfs:label>
    <dc:identifier>HP:0002240</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/602398">
    <rdfs:label>DESMOSTEROLOSIS</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/195</ddiem:iembaseUrl>
    <ddiem:iembaseAccessionNumber>195</ddiem:iembaseAccessionNumber>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/68bbc5c0-b2d4-4b2a-86f1-9e4e69408c1a"/>
    <dc:identifier>https://www.omim.org/entry/602398</dc:identifier>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/139adc70-c74c-45af-80d4-d55c21dc2c57">
    <rdfs:label>Voice tremor</rdfs:label>
    <dc:identifier>HP:0012477</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012477</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e1ef0cd2-2655-4491-84c8-fa3d38ab2c41">
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <rdfs:label>Atherogenic dyslipidemia(Dyslipidemia)*</rdfs:label>
    <dc:identifier>HP:0003119*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003119</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/dc8b408f-38f3-4f0d-bcf6-847885dc89a9">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/230500">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b1e3e3e8-a5e9-453e-a947-0d77e8dd2b22"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/284</ddiem:iembaseUrl>
        <rdfs:label>GM1-GANGLIOSIDOSIS, TYPE I</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/230500</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>284</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b775607a-1f47-496d-adc9-b50f549177bb"/>
    </obo:RO_0000057>
    <rdfs:comment>purified recombinant human -GalWT</rdfs:comment>
    <dc:provenance>https://www.tandfonline.com/doi/full/10.3109/0886022X.2014.900422</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6512dc9a-59ae-416c-882b-e3f56aaea4c4">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008166</ddiem:url>
        <rdfs:label>Decreased beta-galactosidase activity</rdfs:label>
        <dc:identifier>HP:0008166</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/74d8e241-4daa-4145-99bc-6332cf68104b">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2707d394-ecbc-4868-bb60-0fee546ac0a7"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26766614</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b3fe3f7a-ce61-4189-9c38-0f182ac2e212">
    <ddiem:url>https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_113373</ddiem:url>
    <rdfs:label>sodium beta-hydroxybutyrate</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f003822f-a0f5-42e4-9dbb-32f526464c9c">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b3648bc1-a07d-4d44-aa9c-216cac5524e6"/>
        <rdfs:comment>sodium-d,l-3-hydroxybutyrate</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12727399</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0c2bd029-597e-4638-a489-07aa5d491f7e"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231680"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/fb34503b-6972-4c98-ad09-17c527fed3f7"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/aaccdf66-787d-47d4-8c8c-3331bd4b00e7"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d4810beb-7456-416b-98bd-fc56f39e683d"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>CHEBI_113373</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/97f11430-244c-4d69-8840-ccabd25fad58">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28589525</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/10ba66d2-b547-4a9f-8957-401c4395062b"/>
    <rdfs:comment>recombinant human tripeptidyl peptidase-1 (rhTPP1)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263309</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/204500"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24938720</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3a3247ee-572b-47d4-9371-c5a0dedf6005"/>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01907087</dc:provenance>
    <dc:provenance>https://www.prnewswire.com/news-releases/new-england-journal-of-medicine-published-open-label-study-showing-brineura-cerliponase-alfa-reduced-the-rate-of-clinical-decline-of-children-with-cln2-disease-a-form-of-batten-disease-300635669.html</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/07b43784-bc17-464f-b1e2-ca8800383a10">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/cd29e9f5-635f-436d-8a53-969d69283b6b"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/692b1cc8-3f9d-48e7-8c57-c7c787b3a2d1">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12872260</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/258450"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a8a72a77-2d34-44ed-87de-d6c452edeead"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/efaec280-85f2-441c-b718-bcbead9ec263"/>
    <rdfs:comment>levodopa</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01793090</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/601776">
    <ddiem:iembaseAccessionNumber>1130</ddiem:iembaseAccessionNumber>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/1ba54d9d-6041-4894-a6cb-a607a77b3464"/>
    <dc:identifier>https://www.omim.org/entry/601776</dc:identifier>
    <rdfs:label>EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1130</ddiem:iembaseUrl>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/72578577-a708-40f2-995f-30f10326c790">
    <dc:identifier>HP:0012450</dc:identifier>
    <rdfs:label>Chronic constipation</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012450</ddiem:url>
    <rdfs:comment>The hypoglycemia is not a disesae phenotype, rather its a side effect of Mecasermin medication.The new combination in Mecasermin rinfabate has over come this side effect.</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/483a5c14-5d4b-4a6c-96cc-27ec00036005">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002069</ddiem:url>
    <rdfs:label>generalized tonic-clonic seizures</rdfs:label>
    <dc:identifier>HP:0002069</dc:identifier>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/07df196e-5e8f-43d8-a4ea-283bdc0642c5">
    <rdfs:label>abnormal mental status</rdfs:label>
    <dc:identifier>HP:0100543</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100543</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8e42ffb4-ab3a-4878-ba7e-fb2d5e044a42">
    <dc:identifier>DB00111</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/fe087a99-44a3-4bdc-a716-5d9341e3a74d"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00111</ddiem:url>
    <rdfs:label>Daclizumab</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/863a55a0-7f09-4eea-b931-9efa4399984d">
    <dc:identifier>HP:0001941</dc:identifier>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001941</ddiem:url>
    <rdfs:label>acidosis</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/13f1009a-6eae-41d6-8b1c-328a8fdb8f4d">
    <rdfs:comment>Potassium</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607364"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c20e1970-9d55-431f-88e9-5b58d65e178c"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/da7c2662-bfe5-4463-a63e-057b003f3e3a"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17185149</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c51c3fef-897c-422e-a0e3-9cb464164513">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26884075</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/609242"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/572fbc4b-b6dc-4e55-bf94-f9953a1d4983"/>
    </obo:RO_0000057>
    <obo:RO_0002558>
      <ddiem:Evidence rdf:about="http://ddiem.phenomebrowser.net/EC0:0005542">
        <dc:identifier>EC0:0005542</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/EC0_0005542</ddiem:url>
      </ddiem:Evidence>
    </obo:RO_0002558>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/53cf0885-d018-4548-b455-1903039460e1"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23045655</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/17890390-49bd-493c-a686-9df90b33afb2">
        <rdfs:label>Abnormal enzyme activity</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002069</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002069</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/cfc6b333-03a6-4b97-a867-eb80d30921e2"/>
    <rdfs:comment>iminosugar DGJNAc( 2-acetamido-1,2-dideoxy-d-galactonojirimycin)</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02473445</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4d90dfc2-3f82-4b1d-b10d-331a1d3eb748">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/cdfddc98-19c7-4994-8d3e-c188916255ca"/>
    <rdfs:label>Complex carbohydrates+Beneprotein+Low fats</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6a48cf62-ba5d-4dd0-89dc-786844ce4fe1">
    <dc:identifier>DB00034</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00034</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/76feda14-c828-4d4a-819f-7c16a098503a">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/224120"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/00d3a054-4ea8-4011-bf0b-3efb1e05c36e"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
        <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/15804998</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0ed6a4b8-b21f-4906-bf49-088a9f2adc64"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16141353</dc:provenance>
        <rdfs:comment>interferon α-2a</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a7494a80-deb2-4b67-8fdc-adc9bb33b80f"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Interferon Alfa-2a, Recombinant</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d546fbcb-eb94-4ca4-b026-34e293e33bdb">
    <dc:identifier>HP:0001298</dc:identifier>
    <rdfs:label>encephalopathy</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001298</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bc0c9c7b-a556-45e4-845b-c35c2c7f4f37">
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
    <dc:identifier>HP:0002904</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002904</ddiem:url>
    <rdfs:label>Calcium makes phototherapy more efficient</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/96d730c7-a454-475c-a796-5da0952544fc">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0025464</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Oxidative Stress</rdfs:label>
    <dc:identifier>HP:0025464</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9130f827-e748-4733-b4b5-13b1643f9f93">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3d9b955d-20d5-47f9-ad11-c0feb52544db">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ecca082e-1e5c-4da5-b2bb-0cecbee99650"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/96bf0b70-640d-4855-9df3-efb662012d8c"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/604250"/>
    <rdfs:comment>Nifedipine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00712738</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dc3ad24f-c1a5-484a-a6b6-81d131ffa020">
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <dc:identifier>HP:0001397</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001397</ddiem:url>
    <rdfs:label>Fatty liver</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1d997883-ba32-4163-b1e6-ac32323b4cab">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/847ee402-9d9f-48c5-9303-7b47a1b69e2e"/>
    <rdfs:label>rh-HMBS</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/15c5eb77-0d15-4449-9d24-c78f1ff8a12d">
    <rdfs:comment>creatine</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/28932990</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24493026</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6ce4f760-ed2f-47e7-b456-697550d26030">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012211</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>exercise intolerance</rdfs:label>
        <dc:identifier>HP:0012211</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://link.springer.com/content/pdf/10.1016%2Fj.nurt.2008.08.006.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17490880</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232600"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f24a6cb0-fc7a-4229-8c3b-98c78cc27199"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25391139</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f9a70f46-8096-4f39-9d4c-cfb6cb5a08d8"/>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8e57a64b-7265-4a34-a09f-def382357321">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4ecb7d6d-c3d8-4938-9533-f84f298d2662"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21981352</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cdbcca14-b1f0-4924-b7db-475c00c00317"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d583f5e5-1dd6-4ed1-81a6-afadbbbcced0"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5f89a6cf-d732-487e-ad46-43955be0f710"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2541f9ba-00f6-44b4-b578-99f4476a3391"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>"ENB-0040</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e450c22a-688f-40a0-b3b3-087654c286c6">
        <rdfs:label>Collodion membrane(Nonbullous congenital ichthyosiform erythroderma)*</rdfs:label>
        <dc:identifier>HP:0007479*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007479</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>an enzyme-replacement therapy</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7fa61949-b6e0-4da2-99a1-d22e6690f132"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/275630"/>
    <dc:provenance>https://www.researchgate.net/publication/8668575_A_successful_treatment_with_pyridoxal_phosphate_for_West_syndrome_in_hypophosphatasia</dc:provenance>
    <dc:provenance>was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3442eeb0-9b67-4a77-83ae-16ab5335f787"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/52418a78-b157-4638-8342-73fa91d5c6c5">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0040189</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040189</ddiem:url>
        <rdfs:label>Scaling</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://onlinelibrary.wiley.com/doi/abs/10.1111/pde.12170</dc:provenance>
    <dc:provenance>NCT00744042.)."</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fa06c70b-b468-4b85-918d-45ac62b50ddb"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28979034</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0628ceb5-fb52-4a0c-b5ce-5567405e34a7"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c8b7817c-8cee-4999-aaea-6e7cc8654d6e"/>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b275c0ab-91b7-434f-b058-f00a8ed5e7a7"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9d022f05-7cd1-413d-bb20-7bdbcce56b0a"/>
    <rdfs:comment>Emollients +acitretin</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d5e9e5b1-a850-4eff-88cb-b467f403e90a">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/190ec7d7-d4d7-47b2-ba63-615c4ea476bf"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0c2bd029-597e-4638-a489-07aa5d491f7e">
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <dc:identifier>HP:0001638</dc:identifier>
        <rdfs:label>cardiomyopathy</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001638</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ae082e72-3eba-45f4-a6c5-4642ca8b2683"/>
    </obo:RO_0000057>
    <rdfs:comment>high protein diet</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8245377</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fb554df0-f2cf-42d1-aa0e-ff00666b4098">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a17a404f-953b-45f1-b12f-76128f68c740"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232400"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e3ec89a7-6f3f-4f6d-8c75-0e9bbf1904f3">
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <rdfs:label>myopathy</rdfs:label>
        <dc:identifier>HP:0003198</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003198</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302571</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2fa95cbc-e7f7-4ce5-9d44-bb06818aa117"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24613482</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/50fc9013-3727-43f7-9a24-0cc3d1c97487"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/46d07269-3d0c-4e4b-82cb-08863e57216d">
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2a670529-dd20-49ff-9fa0-05f19bd47c1f"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29247835</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120323</dc:provenance>
    <rdfs:comment>Glycine</rdfs:comment>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://www.nature.com/articles/srep37583/figures/5</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28967191</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23601642</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/208400"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1ca63e55-900e-4d6c-9d3c-752e98b2ae3a"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2decf71e-2cc1-4232-af4e-bd6c16898547">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/deedd4d1-649e-4cf9-8696-a8c8a64bb3e3"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00627</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0685243c-fc4d-406c-a6c1-2cefd7b38a20">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ba62687-4f50-4312-96a1-5490d2289da9"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2019216/pdf/archdisch01582-0040.pdf</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2ed69e11-fc5b-4347-b0ce-60bf217edecd"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/236800"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17334708</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4b820e86-2cb1-4e68-aa08-ea5cd0cb8a36"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14169454</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/36660b2d-411e-47c3-858e-ab8ca423bd8d"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26516243</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <rdfs:comment>Niacin</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24561416</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Niacin</rdfs:label>
    <dc:identifier>DB00627</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/4ada7120-edb0-4d9a-b826-3a2438508c55"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c8e4f2ae-a145-47be-b15f-7825d232452e"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/58df64fa-f007-4dc8-905e-0fd99bd9798d">
        <rdfs:comment>nicotinic acid</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2653622</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c8993b5c-a44d-4819-b144-c37a8a06365d"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/65e3caed-1414-4493-9310-f37dc554ebb3"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ba62687-4f50-4312-96a1-5490d2289da9"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6bdf1821-f881-4c40-8fa1-18ec9dc1c245"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1894760</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/bc4048b5-dd91-4e39-8e00-7ce8bcafa02a"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dcf5b822-064e-491f-95ce-421ac69b4aa0"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/144650"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/643481c7-52af-408e-8cc1-169762d76c38">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ce6c3cac-55a5-4ecf-b0e6-c80960b88c65"/>
    <dc:identifier>DB14151</dc:identifier>
    <rdfs:label>Phosphorus</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14151</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/63e15758-86a6-47b7-b5da-ca1f80c25e7a">
    <dc:identifier>DB12907</dc:identifier>
    <rdfs:label>Mannose</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c27ae143-ad60-4cb9-9565-a8f4a21a55a3"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB12907</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/72e4958d-9297-4a53-b03f-2e2deeb1499f">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955971</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/eb2ab32b-f72c-4c72-9a61-4aad73cdb98d"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fc300a43-85b2-495f-82e1-d7c0db635881">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2fd62332-069c-45bd-a6e7-6ec4648414aa"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fbf30458-d2db-4f83-822c-2f3c4b6dc8bd"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01395641</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241937</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ac60c5c2-0e7b-43c2-953b-2987a19b098f"/>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6be4df89-8703-4e6d-a648-b93e56065174">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100022</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Voluntary movement abnormalities(Abnormality of movement)*</rdfs:label>
        <dc:identifier>HP:0100022*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e0b8e415-235b-40a0-aa46-e0ddac1a572f"/>
    <rdfs:comment>pramipexole</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/89eec729-ac9b-46c7-8a9c-d98ff2504ed4">
        <rdfs:label>Consider PLP trial if pyridoxine gives too many side effects or is not effective. Chronic use in high dose can cause severe sensorimotor polyneuropathy. https:,www.ncbi.nlm.nih.gov,pubmed,25001633</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073162</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608643"/>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8f711736-aced-4f8f-b87a-e89302dc9ded">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/cf33b585-7ebc-4255-8996-8e927bfc0cb4">
        <dc:identifier>DB00603</dc:identifier>
        <rdfs:label>Medroxyprogesterone acetate</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d22558ca-b344-46d0-a36e-3a4e4c9fd4d7"/>
        <ddiem:url>https://www.drugbank.ca/drugs/DB00603</ddiem:url>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/caa301d2-eaa1-4413-b0f8-910f81e0eddf">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f0504f84-b825-4978-9c38-a1c38f239135">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>http://www.scielo.br/pdf/jiems/v5/2326-4594-jiems-5-e170016.pdf</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18d743df-a56f-4189-a89b-78393fc3b371"/>
        <dc:provenance>https://link.springer.com/article/10.1007%2Fs10545-016-9963-8</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/666346c2-bf4b-4339-8fe7-07fc9c61681a"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <rdfs:comment>sodium bicarbonate</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/140350"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/93185b2c-0773-4cba-9d8f-59759d6ec64c"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c44e8dcb-2540-4e25-be1c-6500a3f902d9"/>
    <dc:identifier>DB01390</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ce27e722-c489-4cdc-b9a2-86de2ff3b224">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/220120"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/76c92114-07a7-4500-85d9-b53c66ce7b00"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26247153</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18d743df-a56f-4189-a89b-78393fc3b371"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <rdfs:comment>Sodium bicarbonate</rdfs:comment>
        <dc:provenance>http://www.scielo.br/scielo.php</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01390</ddiem:url>
    <rdfs:label>Sodium bicarbonate</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1a9dfd0b-8c1d-47a8-b885-d0822ebcf930"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c35bc604-fe67-493b-9155-1eb9ad4f5cbe">
        <dc:provenance>https://www.tandfonline.com/doi/full/10.3109/0886022X.2014.900422</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22970607</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18d743df-a56f-4189-a89b-78393fc3b371"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8f1851c9-9e94-40cf-b3e2-d3ce15c386f7"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/603358"/>
        <rdfs:comment>Sodium bicarbonate</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7d515155-2933-47fc-be41-4b55c15ede5e">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/116387c9-2a90-4990-bb34-1e6d972eafa9"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7c971528-97fd-48cd-90b2-835790f611b6"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/200100"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30731125</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/be7a739f-cc96-47fd-8ade-311027868913"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14749227</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/81acf49f-8aab-4077-92e0-2aa2905171a9">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0000546</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000546</ddiem:url>
        <rdfs:label>Retinal degeneration</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>vitamin A+ Vitamin E</rdfs:comment>
    <dc:provenance>https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-3-20</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11767031</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25488886</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e5065af6-dd16-4deb-8535-db3598870de7">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/256540"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e38c797f-128c-4c43-8fe6-f6e711086c72">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001288</ddiem:url>
        <rdfs:label>Low β-gal activity (Abnormal enzyme,coenzyme activity )*</rdfs:label>
        <dc:identifier>HP:0001288</dc:identifier>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fb691566-169c-490f-891e-f2a5ccc88dd3"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25485164</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26259553</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29358012</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a5529b20-db62-484c-a094-65cf29eec51b">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/e2ab0d25-6b76-41de-b3b4-73e887c5da2e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>N-octyl-4-epi-β-valienamine (NOEV)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22008912</dc:provenance>
    <obo:RO_0003304>SpDEx7];/p.[Q49R;Y395C]/c.[478_480delTTC];[?]* no mutation was in the second all</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15084520</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7814809</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15895716</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7e0fac39-f7fb-4049-b9c0-4539dec653d5">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/53b52a7d-649b-4a36-82b8-d1f7f8d3d56f"/>
    <dc:identifier>DB14476</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14476</ddiem:url>
    <rdfs:label>DL-alpha-Tocopherol</rdfs:label>
  </ddiem:Drug>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/232800">
    <dc:identifier>https://www.omim.org/entry/232800</dc:identifier>
    <ddiem:iembaseAccessionNumber>491</ddiem:iembaseAccessionNumber>
    <rdfs:label>GLYCOGEN STORAGE DISEASE VII; GSD7</rdfs:label>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/15dd9613-2934-4881-b48c-68d3ecb7331e"/>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/491</ddiem:iembaseUrl>
    <rdfs:comment>The infantile form of PFK deficiency is characterized by the early onset of muscle weakness and multisystem involvement, which often leads to death in infancy or early childhood. Early diagnosis and improved understanding would enable clinicians to provide better clinical care. https://www.ncbi.nlm.nih.gov/pubmed/26108272</rdfs:comment>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/aa0c25e5-06f5-4809-95f8-f34add508dc1">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d6c1137f-c24a-4d72-9c84-5068df3a1623"/>
    <rdfs:comment>HDAd-G6Pase</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fc26318d-dc64-4855-9dac-283b162518ea">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/64a4be7c-71e1-4122-8701-9fa019f77b81"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17505475</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/68a1ec30-6e0f-445b-8635-d2f388d599db"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17430128</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/a6b77e8a-b547-4e22-8d88-9e5a8a1dc017">
    <rdfs:label>AAV2/1-MCK-Sgca</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/260f163c-d7a1-4522-a815-1ff5e49b1363"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f3b8b6c1-1cfb-4e7e-9e1d-e4bcb0f59536">
    <rdfs:comment>ISIS 703802 (AKCEA-ANGPTL3-LRx)</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03514420</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/7199c277-e274-40f1-b74e-be9b419517f4"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27155573</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/61add675-0606-4382-9139-d5823daffda5"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/151660"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8317a700-36d1-458b-8cbf-30974c8315ba">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002155</ddiem:url>
        <dc:identifier>HP:0002155*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>high fasting triglycerides</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/dfb84df9-959d-4b27-a373-79167c78a816">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8fd7f9af-0407-411f-bf6f-d4632a8086b1"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23456528</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1e7b6804-84d2-4b5d-9e92-3c8088584780">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22198833</dc:provenance>
    <rdfs:comment>Risperidone</rdfs:comment>
    <dc:provenance>https://rarediseases.org/rare-diseases/lesch-nyhan-syndrome</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/df100fe5-2d9c-408f-abe0-7dc569062046">
        <rdfs:label>Self-mutilation</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000742</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000742</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8870064</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/80dba52f-3650-436f-8eba-d37c62171bba">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9fc15d48-0517-4676-bdd5-c883b45d64b9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300322"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27179999</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c9e37fbf-2474-4958-b3d2-019892fbe614">
    <dc:identifier>HP:0005180</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0005180</ddiem:url>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <rdfs:label>tricuspid regurgitation</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5dcdc801-4128-4e74-ae9c-fb0068a3b17a">
    <dc:provenance>https://www.semanticscholar.org/paper/Clinical-Diagnosis-and-Treatment-of-Dehydrogenase-A-Cui-Wang/f6e88d647f2e2c7df2897e939ec33f9d86899b37</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300438"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11102558</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ac4f4c84-14e2-4ac3-a0da-c22434f8133d">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0012647</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012647</ddiem:url>
        <rdfs:label>Abnormal inflammatory response</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f381888f-4cd5-47f0-b415-c9de47ad9456">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/bc743179-2142-485b-a8bc-e094d8d50ab1"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>tazobactam sodium</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c38f17b2-5825-4a92-be31-749e97593bb5">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/66d8aa34-d885-4b6c-9657-db0b43052bec"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ebd361dc-166a-420b-ab99-885a1388d4eb">
    <ddiem:url>https://www.drugbank.ca/drugs/DB11251</ddiem:url>
    <dc:identifier>DB11251</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c2a2fc24-0a1a-4813-8876-9c39aa4a8f71">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/204500"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29631617</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263309</dc:provenance>
        <rdfs:comment>δ-tocopherol (DT)</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01907087</dc:provenance>
        <dc:provenance>https://emedicine.medscape.com/article/1178391-treatment</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ada19f55-fc53-42c7-b955-76e1dd3646b3"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28589525</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f5a67aab-fc1f-4921-86a1-fdca0acc6762"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4b3c23d7-ec82-42f5-a138-a8500588de8a">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155</dc:provenance>
        <rdfs:comment>Alpha-tocopherol</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ada19f55-fc53-42c7-b955-76e1dd3646b3"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23329770</dc:provenance>
        <dc:provenance>https://www.nature.com/articles/nrrheum.2010.182</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915691</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://rarediseases.info.nih.gov/diseases/9683/chylomicron-retention-disease</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246700"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/23277932-c1b1-4564-99a8-e06286110c44"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3c2e3e41-95e4-4167-8f3e-cb27bf6d5d23"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982212</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Tocopherol</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/db65c3a6-7398-4b2c-a266-786c61c61517">
        <rdfs:comment>δ-tocopherol (DT)</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/38618e44-17c5-4b79-b025-b747b77ca325"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/256730"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ada19f55-fc53-42c7-b955-76e1dd3646b3"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f5a67aab-fc1f-4921-86a1-fdca0acc6762"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7370f6c3-f93e-4bb2-a91c-fff3e0e2b296"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00028262</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29631617</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c1353a23-3d11-4f0d-8f1b-2983b18dcf85">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e1c7834d-6204-4bae-a75d-0893beb7cd47">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004369</ddiem:url>
        <rdfs:label>low levels of purines</rdfs:label>
        <dc:identifier>HP:0004369</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23190330</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/301835">
        <rdfs:label>ARTS SYNDROME; ARTS</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/9e593953-1877-4e32-b6d9-9ee40b10dd54"/>
        <dc:identifier>https://www.omim.org/entry/301835</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28967191</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/49548d36-039e-4e42-b68f-1779ae3fb560"/>
    <rdfs:comment>S-adenosylmethionine</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1ac90d20-9a02-4363-b4ee-d86ac16a294c">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003678</ddiem:url>
        <dc:identifier>HP:0003678*</dc:identifier>
        <rdfs:label>Progression of retinal degeneration ( Rapidly Progressive)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20380929</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850427</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0f5ea12d-6321-4ccf-8ba8-7a2374803109"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f0da1c05-1645-4cfc-8047-19b4e22af094">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Hearing impairment progression(Rapid progression)*</rdfs:label>
        <dc:identifier>HP:0003678*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003678</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/93841c7a-5f60-4996-8607-a3812f8179d9">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>frequent hospital admission</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6bcff7f7-430a-4692-ac54-05fc63b0813b"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4df92945-1be5-48a0-8568-408a3be56a0e">
        <rdfs:label>Ataxia Progression(Rapid progression)</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002719</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0002719</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17701896</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0002929707613470</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8f1851c9-9e94-40cf-b3e2-d3ce15c386f7">
    <dc:identifier>HP:0003128</dc:identifier>
    <rdfs:label>lactic acidosis</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003128</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/789463c3-30af-46d6-880c-3329c8a2c7c8">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/369e2d68-3b59-4a4f-9422-0a8eb69cbe01"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <rdfs:comment>Medium-chain triglycerides</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19452263</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/49bffb10-3f28-4064-aa10-51a9cede4fe8"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b44f0b0b-7f4e-4270-bf80-943e0bededdb">
        <rdfs:label>neurological damage</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000707</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/601987"/>
    <dc:provenance>https://rarediseases.info.nih.gov/diseases/10325/carnitine-palmitoyltransferase-i-deficiency-muscle</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/956e4e2a-01e5-448c-bd2d-40f383a07cd1">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00638547</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25024447</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/603174"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d8562063-debe-47b1-90ec-02096b47fe97"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Topiramate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30081189</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d7b72d9f-b599-471c-99e3-857d01679812">
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719208000048</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10078749</dc:provenance>
    <dc:provenance>https://link.springer.com/referenceworkentry/10.1007%2F978-3-540-29676-8_1729</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7122a711-0824-4562-a8fd-7430f81a4f3a">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c50090e2-5c4e-431c-a17f-c78cbeac64ed"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20818608</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18276179</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19234759</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/233910"/>
    <rdfs:comment>Amantadine</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1e79bc8e-6423-485a-a01c-9009b32fe497">
        <rdfs:label>levodopa‐induced choreic dyskinesia(Dyskinesia)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100660</ddiem:url>
        <dc:identifier>HP:0100660*</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15389992</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b8a0bb6f-035d-4d55-a7ca-e5deb495754d">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/277460">
        <ddiem:iembaseAccessionNumber>658</ddiem:iembaseAccessionNumber>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/7ae57c49-2f70-4649-8b23-bb68fe50e185"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/658</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/277460</dc:identifier>
        <rdfs:label>VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>RRR-α-tocopherol</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7e5c3961-34cf-40ae-95d2-f72978649531">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2f2619e1-2871-451a-9b2a-c1837dbe581f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/42c07e0b-488f-405a-8000-d6f6ff392f9c"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d83f9368-ca53-4ef4-a43e-711852d4bc20">
        <rdfs:label>Abnormal H50 (The erythrocyte resistance to oxidative stress)</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0022347699704245</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27906067</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9e95e4e1-e89a-43e4-a869-edd80eb290bc">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002904</ddiem:url>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
    <dc:identifier>HP:0002904</dc:identifier>
    <rdfs:label>High serum bilirubin level</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4f08b18a-51da-4843-ac17-55e3eff682db">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ac403bb8-feb5-4f30-9256-a6b5fa04b399">
        <rdfs:comment>DTX401</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03517085</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20163245</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/23b2cd43-b4a5-4cc9-91c0-35646d87e7f9"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/addc25bc-6e47-4a88-bd76-efa6f05700a6"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/33df5d27-f339-46f2-804d-5bacfa768b86"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>DTX401</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8b3557a0-efd8-4159-ac1f-6a193ad2c070">
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000002</ddiem:url>
    <rdfs:label>linear growth velocity(Abnormality of body height)*</rdfs:label>
    <dc:identifier>HP:0000002*</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8bd447cf-6a4f-4c1d-bd86-1de5f97dfc41">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2880ad0e-5275-4347-bdf6-1871e06492e9">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010535</ddiem:url>
        <dc:identifier>HP:0010535</dc:identifier>
        <rdfs:label>Sleep apnea</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3c83b60d-06b4-452e-8365-409b22d5c67a"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/67b4e4b5-0b3c-46a5-827b-e4c4c0280f51">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <dc:identifier>HP:0002119</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002119</ddiem:url>
        <rdfs:label>brain ventricular dilatation</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/afa0546f-af99-41f8-b34a-d223076ef294">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003541</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>Urinary glycosaminoglycan excretion</rdfs:label>
        <dc:identifier>HP:0003541</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19748810</dc:provenance>
    <dc:provenance>https://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fdcea32-4e15-40ac-8b54-31e3d9975a96"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8b8e6519-5637-43d5-907a-ad39a910d5b8"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5a03f16c-b558-433a-bf52-37b3eb458e71">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002360</ddiem:url>
        <rdfs:label>low quality of sleep</rdfs:label>
        <dc:identifier>HP:0002360</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/cfc6b333-03a6-4b97-a867-eb80d30921e2"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c14aae48-b9d6-4c49-bc54-a80165aeefbd"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b5e8f716-27b3-4aa0-be60-4c74be5c77ff">
        <rdfs:label>low exercise endurance</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a9979a0f-2db7-44d9-bbdf-7091e1d64f4c"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607014"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d41fa2a4-393a-4821-a786-958e8d00b482">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011729</ddiem:url>
        <dc:identifier>HP:0011729</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>Abnormality of joint mobility</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9b83df26-d856-4508-95ee-c5fcf205b1ca">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010444</ddiem:url>
        <rdfs:label>pulmonary regurgitation</rdfs:label>
        <dc:identifier>HP:0010444</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5cab6dd4-5c70-41f9-ace1-c4e12516f07a">
        <rdfs:label>dyspnea at rest</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012763</ddiem:url>
        <dc:identifier>HP:0012763</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00638547</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7c5cc87b-02f5-48ed-81c5-452784531a44">
        <dc:identifier>HP:0002189</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002189</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>Daytime somnolence</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c9e37fbf-2474-4958-b3d2-019892fbe614"/>
    <rdfs:comment>Laronidase (IRT)</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ba19116b-9171-476d-a433-6c2fcce77705">
        <dc:identifier>HP:0000969</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>pitting edema</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000969</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11172140</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/748a5212-81fc-4b8c-8f11-2279015f524f"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4572342b-a16a-4a2b-b92c-76991cfa60e5">
        <rdfs:label>Abnormal apnea–hypopnea index</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/641b9a34-220b-4f0e-9f2d-4a61fd45dcfb"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a538c323-7e79-4afc-b330-b07de68e42d0">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <dc:identifier>HP:0002500</dc:identifier>
        <rdfs:label>brain MRI abnormalities</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002500</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8d91ef9d-08f0-4146-9251-e86d26587bde">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02386267</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8e20e4a0-0323-42c7-8e94-caf37c8fb055">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010876</ddiem:url>
        <rdfs:label>Defect in protein synthesis (Abnormality of circulating protein level)*</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0010876*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01362595</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <rdfs:comment>L-leucine</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3eaaa2cc-82b3-4b6f-955e-cbc3a0a81fad">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/5f5766d5-1b14-4199-b741-4674ce504151"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/105650"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25098371</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22734070</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ec162c7c-8921-4060-a55b-560bc0990754">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001903</dc:identifier>
        <rdfs:label>low heamoglobin leval</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001903</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c6002681-fa90-4fef-be61-66f39c83fe03">
        <rdfs:label>Decreased red blood cell production</rdfs:label>
        <dc:identifier>HP:0012133*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012133</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9e6f5158-bc7c-4d2b-bfad-611d35fff08f">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0001992*</dc:identifier>
    <rdfs:label>pyroglutamic aciduria(Organic aciduria)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001992</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/361c02e6-7280-43d7-a512-2d9553381bfd">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/85b70bde-3f98-4846-a38c-3818fe3b30c8">
        <rdfs:label>Doconexent</rdfs:label>
        <ddiem:url>https://www.drugbank.ca/drugs/DB03756</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/5588747b-6e4d-4a6e-bbb5-d6268c50de31"/>
        <dc:identifier>DB03756</dc:identifier>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e0bc1445-06c8-4b36-98f8-93b182eb1049">
    <rdfs:label>Malabsorption of lipid-soluble vitamins (Fat malabsorption)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002630</ddiem:url>
    <dc:identifier>HP:0002630</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d8eeec26-ad31-4bac-befe-9acf852e1b11">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a18b65a6-afd0-41d5-a884-43d0aa1e12fa"/>
    <rdfs:label>Antiinflammatory preparations, non-steroids for topical use</rdfs:label>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=M02AA</ddiem:url>
    <dc:identifier>M02AA</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7857e6e4-99f4-4e3b-8835-8ce62f60271a">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5dc4bd81-c687-4889-81f9-6abed11c8507"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246900"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/26b42350-d9a5-45df-a4ec-c7b4afdfd760"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK220444</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <rdfs:comment>sodium dichloroacetate</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ccd5ca66-5fca-4730-96e9-4f2850100dcf"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23478190</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fd9bf38d-3093-4f49-98dd-871c1811bcb5">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c25ded75-c15c-434d-b2b6-29cc680b81ee">
        <ddiem:url>https://www.drugbank.ca/drugs/DB00232</ddiem:url>
        <rdfs:label>Methyclothiazide</rdfs:label>
        <dc:identifier>DB00232</dc:identifier>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2bd4b6b2-81ee-4212-801e-115f2390159e"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/62870faf-3e39-4c08-a04d-5039d2482054">
    <dc:identifier>DB01403</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01403</ddiem:url>
    <rdfs:label>Methotrimeprazine</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9aa10b1a-5d38-4a24-b4f5-f90b628c04d5">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24816443</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953024</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/882c42fd-56cf-4b14-8e53-85f51bd3f37e"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/125370"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/732d84bf-075d-4781-8eba-ffbc5913eb6b"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/306a80c0-e18d-490c-ab15-b8550e97523b"/>
        <rdfs:comment>levomepromazine</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/95b2c04a-8f2f-408d-85f0-6132474ecc50">
    <rdfs:comment>Chlofibrate</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2e1b6ccd-a467-4de3-afca-875fddb3ce64"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c5d3d937-936d-48df-854a-4b2d287516bd"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7483726</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19752526</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282099</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26692114</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606785"/>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/34f3117e-e999-489c-a10a-32c73b1bbb49">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c72600f1-75ad-4964-8835-89ce76e8d83a">
        <rdfs:label>Ferrous sulfate anhydrous</rdfs:label>
        <dc:identifier>DB13257</dc:identifier>
        <ddiem:url>https://www.drugbank.ca/drugs/DB13257</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b6b090c3-5364-4623-bc46-088cf7c0bfe0"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a1fa3fc7-65c3-4c20-a958-b4e2d0f74052">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <rdfs:comment>AT342</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2619994f-072f-4e09-80a8-0de0f6dba4e7"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c5d3d937-936d-48df-854a-4b2d287516bd"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606785"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03223194</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788912</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/341d9b18-dfc2-4be9-922b-52fd1b185a26"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841061</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/97e6f3e3-50c9-4295-885a-05241873e201">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28381550</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29471850</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b6b1b260-a41d-411d-a6bd-f2e8a75a6b75"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27499018</dc:provenance>
    <rdfs:comment>Imiglucérase (ISU302)</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/153624c0-f5e8-4c27-8e95-a67ba5dc04c9">
        <dc:identifier>HP:0001744</dc:identifier>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <rdfs:label>splenomegaly</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001744</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27102949</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/36bfec3a-6644-4f8f-bd34-c85e057b95da">
        <dc:identifier>HP:0004356</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004356</ddiem:url>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <rdfs:label>high  Chitotriosidase Level(Abnormality of lysosomal metabolism)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1edfed82-8156-4a2d-b482-4e054ac6deef">
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001903</ddiem:url>
        <dc:identifier>HP:0001903*</dc:identifier>
        <rdfs:label>primary low heamoglobin level</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30066229</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e297c807-22ff-4809-b983-ecb6d34c6cac">
        <rdfs:label>elevated Chemokine Ligand (CCL-18) Level [ng,mL]</rdfs:label>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT02770625</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21503667</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f90ddb4f-c1ce-4361-b3bf-6505c9e9ead3"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/230800"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e9880d1f-dfa8-468f-878c-59e876c1c19c"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/09090b75-ec0f-4f9b-8219-235a80a3eb10">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/bf7226be-7ef3-436a-8884-3a5f2581fde8"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2b82d8c5-4653-4215-807d-55a2280252c9">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003111</ddiem:url>
    <rdfs:label>electrolyte disturbances</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003111</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9d72c030-67f2-47ba-a2d5-2f9703195a54">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23045655</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26884075</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/609242"/>
    <rdfs:comment>1-deoxygalactonojirimycin (DGJ</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/EC0:0005542"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3851d75c-665e-463c-8148-9bc557a14d50">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c3202995-5b58-4af2-a071-1d9eb1ad714e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/cfc6b333-03a6-4b97-a867-eb80d30921e2"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02473445</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/aaccdf66-787d-47d4-8c8c-3331bd4b00e7">
    <rdfs:label>paralysis</rdfs:label>
    <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
    <dc:identifier>HP:0003470</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003470</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8b488c8a-af52-4552-9331-430d4f5f0704">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01161576</dc:provenance>
    <dc:provenance>https://emedicine.medscape.com/article/1178391-treatment</dc:provenance>
    <rdfs:comment>AAVrh.10CUhCLN2</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01907087</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28589525</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/204500"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24938720</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/928b3930-9446-4770-8462-c5d9a718db79"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ff8833dd-22a3-49b7-8f16-b240dc8f2877">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f01fb855-4be8-4251-8fac-2bfccbe3948e"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2cda2783-38d6-463c-9f3f-87ab9fb7d852">
    <rdfs:label>abnormal polymorphonuclear leukocyte function</rdfs:label>
    <dc:identifier>HP:0001874</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001874</ddiem:url>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0a8e3390-ecfc-44d1-9ac9-58872afd486d">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
    <rdfs:comment>Intravitreal bevacizumab</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/beb440bf-4ba2-44a3-a47a-a01cb1666dba">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3405aba6-7923-40ff-8e32-afae9bd6a4b7"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01328587</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28388263</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8c2e7f0a-e029-4601-9c32-fa2e99a2eaa8">
        <rdfs:label>abnormal central vision</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000504</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000504</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ffe8c17b-f5e0-40b5-a15c-74e82b5a7a6b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/258870"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28560651</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ca211275-2bde-4976-a700-7c2714348859"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29654911</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17921858</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e74c0831-b9ed-4203-83e2-f4793905a130">
    <rdfs:label>abnormal energy production in damaged mitochondria</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003287</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003287</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8de13bf5-a902-44eb-9bac-645e71953485">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/40343ad7-8df7-48a0-926f-bf5577abae52">
        <rdfs:label>Liver fibrosis</rdfs:label>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001395</ddiem:url>
        <dc:identifier>HP:0001395</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7ed86640-6b80-4ad4-8697-e08d06e49a5a">
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <dc:identifier>HP:0001397</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001397</ddiem:url>
        <rdfs:label>Liver steatosis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606664"/>
    <rdfs:comment>Nicotinamide</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9b474b28-76d7-44f5-89ce-91f0eaf3d571"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dc3ad24f-c1a5-484a-a6b6-81d131ffa020"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dd19ff4f-48ad-4f9c-86b3-9083966bc0a7">
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <rdfs:label>DNA hypermethylation</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20578266</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27207470</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19585268</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3b3a69d7-c910-4a42-927c-35a5f8f16362">
    <rdfs:comment>The hypoglycemia is not a disesae phenotype, rather its a side effect of Mecasermin medication.The new combination in Mecasermin rinfabate has over come this side effect.</rdfs:comment>
    <rdfs:label>Bulbar dysfunction</rdfs:label>
    <dc:identifier>HP:0001283</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001283</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8e5e25d2-6c80-4c31-80f7-be6e8307ddb8">
    <rdfs:label>AEB1102(Pegzilarginase) – Co-ArgI-PEG modified human Arginase I</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/810399d4-98c2-474b-8b7b-b3af626bd29e"/>
  </ddiem:Drug>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/203750">
    <dc:identifier>https://www.omim.org/entry/203750</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/64a86466-786a-4375-9def-0076ce8d6250"/>
    <rdfs:label>ALPHA-METHYLACETOACETIC ACIDURIA</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/65</ddiem:iembaseUrl>
    <ddiem:iembaseAccessionNumber>65</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d757009b-048c-4488-ba26-906e60f9ffdd">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/5bb4576b-3cd0-4d0b-9281-16d61751ff30">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/104461c0-66d3-4840-a584-950ee2b77f03"/>
        <dc:identifier>C07</dc:identifier>
        <rdfs:label>BETA BLOCKING AGENTS</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1fe5693e-edc3-4c25-9962-bc30148493e0"/>
        <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=C07</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2946feee-2222-4277-86af-79aeaca78fab"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7be066bb-c46e-449e-9926-25984d1cb5ab">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12872260</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24076137</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/efaec280-85f2-441c-b718-bcbead9ec263"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/609286">
        <dc:identifier>https://www.omim.org/entry/609286</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f358e0bb-188e-4d78-91cc-c9350d2bf03d"/>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a8a72a77-2d34-44ed-87de-d6c452edeead"/>
    <rdfs:comment>Levodopa</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b9ce4703-a12e-408b-973a-49f02846aa2e">
    <dc:identifier>HP:0002910</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>"abnormal alanine transaminase,"</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002910</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9c04d0e6-2600-4dd9-aade-cb6e70fe78d7">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602522"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0003304>"L155A, G345S and A349E"</obo:RO_0003304>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d16ea2a0-a768-4a44-a495-42bebf5d00ab">
        <rdfs:label>Abnormal ClC-Ka function</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20649569</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2164af0d-85a8-44d7-8c82-6cea5f6285aa">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/98a8c222-fe37-4454-bcc5-d34f2e0959ad"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Niflumic acid</rdfs:comment>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0003304>L155/ G345/ A349</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
    <ddiem:failedToContributeToCondition>G167A / F213A</ddiem:failedToContributeToCondition>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2d4b6bdf-f623-4418-adca-62faeb6bc541">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9957ff50-7b04-4dd7-b0d6-bd9485e6a186">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f7f7217c-fdf2-4929-88d4-474fa6def96e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25391139</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24493026</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6ce4f760-ed2f-47e7-b456-697550d26030"/>
    <rdfs:comment>sucrose</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17490880</dc:provenance>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/28932990</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232600"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4187796c-f13f-4b3d-bd5d-553140f3476f">
    <rdfs:label>Neurodevelopmental abnormality</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0012759</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012759</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/241510">
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/57486a65-e6df-462c-8153-670517dc6472"/>
    <dc:identifier>https://www.omim.org/entry/241510</dc:identifier>
    <rdfs:label>HYPOPHOSPHATASIA, CHILDHOOD</rdfs:label>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d00d9e6a-74e1-4623-939a-ad07e0cbaac1">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28279226</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c1618022-f2c3-41b8-8e0f-163e0a1cb1d9">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001635</ddiem:url>
        <dc:identifier>HP:0001635</dc:identifier>
        <rdfs:label>Cardiac dysfunction</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
    <rdfs:comment>Bezafibrate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b21b157f-04f5-4d64-b958-f793cbe41703"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/302060"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/86ee66fb-4ed6-4a3f-be48-7938f9c9eb6b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29695963</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4f16792d-fea9-4f08-90d7-7468a407c828">
    <dc:identifier>DB00121</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00121</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/564e40b2-b3b0-469c-a19b-e344fe7add17"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/07ea90e9-62bf-4be0-8a1d-90a27e39b918">
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470948</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16773504</dc:provenance>
        <rdfs:comment>Biotin</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/210200"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
        <ddiem:failedToContributeToCondition>MCCB-(IVS16þ1G&gt;A)/ MCCB-missense mutation E99Q Homozygous mutation</ddiem:failedToContributeToCondition>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5bf5f0cf-9a98-435a-b7cd-9e5a39c672f0"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/741dfc90-c128-4cc9-8ee0-2b0a1610adce"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18155630</dc:provenance>
        <obo:RO_0003304>MCCA-R385S(heterozygote mutation)</obo:RO_0003304>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15877210</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/aec0ae51-5bcd-42b1-853c-46f1cec67d1c"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1b22385d-76de-4da9-a02c-ea62d9191b27"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1182108</dc:provenance>
        <obo:RO_0003304>"heterozygote missense mutation, MCCA-R385S"</obo:RO_0003304>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f6ef13d6-e70e-4edb-ab65-a098c223b1ae">
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1567724914001299</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/aec0ae51-5bcd-42b1-853c-46f1cec67d1c"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5bba4ff5-af91-49ec-8f5d-f7aea5a26000"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25251739</dc:provenance>
        <rdfs:comment>biotin</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246900"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Biotin</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cc94b431-39aa-42a1-8dd8-eb8b172a73bc">
    <dc:identifier>HP:0008064</dc:identifier>
    <rdfs:label>ichthyosiform erythematous plaques</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0008064</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/24f47da3-7f02-435d-9d26-d72ead70d4af">
    <rdfs:comment>propionate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25835550</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/15f3c450-f3ad-435a-a116-e54097bb7bf7"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21788663</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/618c58ec-d3e4-40a5-890c-c3943a560f4e">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Palmitate plus lactate-induced cell death</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02805790</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/220111"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02176733</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0b7df37b-9cba-4bcc-8704-28ea440179c9">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01517880</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21517694</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bb54f929-0a0a-496b-867e-75664c733fbb">
        <rdfs:label>Decline of muscle strength (Muscle weakness)</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001324</ddiem:url>
        <rdfs:comment>In the mouse model syudy</rdfs:comment>
        <dc:identifier>HP:0001324</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>GNE gene lipoplex</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4e815c09-0511-4adf-b353-4b90cccb78e5"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/605820"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20030229</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a5eb0f8b-c9e9-4926-be48-f3dfc7c7407d"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26546927</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/67685640-2654-40ad-9f12-28e37181e26f">
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c4fe825a-e77d-450e-b84c-6eee1d7c31f0">
        <rdfs:label>Rigidity</rdfs:label>
        <dc:identifier>HP:0002063</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002063</ddiem:url>
        <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a2df4bc1-3ff7-446a-b231-1f4e1877ef06">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002530</ddiem:url>
        <dc:identifier>HP:0002530</dc:identifier>
        <rdfs:label>Axial dystonia</rdfs:label>
        <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/157640">
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/418</ddiem:iembaseUrl>
        <dc:identifier>https://www.omim.org/entry/157640</dc:identifier>
        <ddiem:iembaseAccessionNumber>418</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/d2d2d0c0-9a5b-4b2e-a876-f1784eb97054"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01793090</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ef4bd053-4dc4-4436-b61e-01827c9ddadc">
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
        <dc:identifier>HP:0001337</dc:identifier>
        <rdfs:label>Tremor</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001337</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a8a72a77-2d34-44ed-87de-d6c452edeead"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7cec6943-5e10-4e46-9c27-d7eee71400fb"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/efaec280-85f2-441c-b718-bcbead9ec263"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7c36dc7c-4316-4411-be30-781c71a6a7ec">
        <dc:identifier>HP:0001288</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001288</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Gait abnormality</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30941926</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24943079</dc:provenance>
    <rdfs:comment>levodopa</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30838265</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8a5bd96d-2399-44b5-82f8-2b66f2c21f88"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/528a74fe-fe24-4298-b1c3-6f98e250ce7d">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01034592</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17562599</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f35113e8-76de-4f67-9159-5f1d7dc25a29"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22734070</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25098371</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/105650"/>
    <rdfs:comment>lenalidomide</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/25b16cdc-150a-41fa-a916-0b92333fc10d">
    <dc:identifier>HP:0004305</dc:identifier>
    <rdfs:label>Involuntary movement</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004305</ddiem:url>
    <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/53fe510c-c91b-4184-b11b-d6d62ad9715b">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0002715</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002715</ddiem:url>
    <rdfs:label>immune dysfunctions</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/175a3736-5e10-495b-857a-3ad946ca2b43">
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/26a02dfc-4349-4f04-b6e0-48418c2a069e">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>tissue damage</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415789</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1493</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/867cb85f-4c50-41d9-b732-7d4bbf116a0c"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fd006fa6-7a2c-4a63-97db-b2e7ecd5c527"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b69d20c3-5c03-4c95-a90c-0847b626eeab"/>
    </obo:RO_0000057>
    <rdfs:comment>vitamin E+ Zinc</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ba79f04c-0071-46bb-b6e9-6f6e6d5836c0"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1dba9972-ef39-4ae3-ab56-a5474843ecac"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/49d72c25-a968-4706-9673-92c99af62827">
        <rdfs:label>Liver dysfunction</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0001410</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001410</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/604290"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/76d8ec19-b08d-4c96-9e33-fa7e15a3b2fe">
        <rdfs:label>pancreatic dysfunction</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0001738</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001738</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12044538</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/163acea0-d86e-4a62-bad9-267a204b1975">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607364"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24189473</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/14c5d744-855f-4b71-bade-8eb6b9d3d7fa">
        <rdfs:label>Elevated prostaglandin E2</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003566</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003566</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c20e1970-9d55-431f-88e9-5b58d65e178c"/>
    <rdfs:comment>Nonsteroidal anti-inflammatory drugs</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8e176aac-6334-44d3-bd8d-4960891f6a27"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ee50c04d-5861-4a94-9e33-dd439255ae26">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c6f2754d-58fa-4f26-aad9-4f53c009e71e"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/22a1210a-09fe-408b-b860-c42beb61d387">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001347</ddiem:url>
    <dc:identifier>HP:0001347</dc:identifier>
    <rdfs:label>Hyperreflexia</rdfs:label>
    <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/12abaeef-1566-4be1-bea2-8e478861d8f7">
    <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
    <rdfs:label>movement disorders</rdfs:label>
    <dc:identifier>HP:0100022</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100022</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f0ce7936-fd5d-44e1-959f-17100e94c2e6">
    <rdfs:label>leucine-restricted diet</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fe21218b-147e-4fc1-b914-7e80b1794757">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2443756</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0e997a52-4326-4210-9cd5-0aa15240b033"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e226021c-2a88-4385-a432-a8068a78c450"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29565174</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/70efffdf-7905-4ddf-ac06-f63648ce2b2d"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220407</dc:provenance>
        <rdfs:comment>leucine-restricted diet</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26997609</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17628222</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1886403</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246450"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c4a31c51-9a60-45c8-8201-f146ecf1fef6">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20818608</dc:provenance>
    <rdfs:comment>benserazide</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/233910"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6aaeef67-ff85-47b7-9c61-c1365c3aba20">
        <dc:identifier>HP:0012048</dc:identifier>
        <rdfs:label>oromandibular dystonia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012048</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19234759</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10078749</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12003346</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719208000048</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5d3bcb17-bc37-40be-8451-0242d6677cf5">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/be442aeb-68e8-4b0f-b5d3-000b4159b2cb"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://link.springer.com/referenceworkentry/10.1007%2F978-3-540-29676-8_1729</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/64f15447-8f7b-40ed-8c6a-08f6dce361a4">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/043a79b0-cbeb-4619-8f8c-145306c347ff">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ce9aeb3c-a830-484d-ab97-867b436aa491"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/504e8273-bda7-48ed-aa38-961cf5448dd9"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/125700"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3940717</dc:provenance>
    <rdfs:comment>Pitressin tannate in oil</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/46b444f7-450d-4071-8f56-18338cb8ed09"/>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1316120</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/26998626-5a1f-47ca-ae18-2ffa99baa865">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ebc578e1-e0b2-49d7-a654-f2654a10720a">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0003304>compound V377I and I126T mutations</obo:RO_0003304>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/621c2dee-39a9-4adc-a823-cfe8703a3755"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/fd57c8f9-bfb0-4675-9048-8baf05f3bea0"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22740624</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/db78bec9-3b2f-468c-bbaa-4c104b2eba97"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/260920"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8e90416f-46e2-418f-9578-7fa212144578"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18839211</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ea11c963-11c7-4d7c-8aac-65d2723edd07"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7936305</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <rdfs:comment>prednisolone + azathioprine + immunoglobulins</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ce3592b2-7983-469e-b55f-debcb2d475cd"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00860</ddiem:url>
    <rdfs:label>Prednisolone</rdfs:label>
    <dc:identifier>DB00860</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9e476d55-cb14-45d6-aad3-9fb8e85597a6"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ea828d83-2cdd-4349-89fa-7e9cfa5e3cbf">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00889135</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/42eddcee-d5ad-4a86-9f0c-3ed00fda0823">
        <rdfs:label>orthostatic hypotension</rdfs:label>
        <dc:identifier>HP:0001278</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001278</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301647</dc:provenance>
    <rdfs:comment>droxidopa</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/223360">
        <ddiem:iembaseAccessionNumber>101</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/101</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b8b77c6e-5b66-4a90-8969-3d2bff1352d1"/>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/223360</dc:identifier>
        <rdfs:label>ORTHOSTATIC HYPOTENSION 1; ORTHYP1</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.sciencedirect.com/topics/medicine-and-dentistry/dopamine-beta-hydroxylase-deficiency</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f827895f-4f69-4b88-a0fc-9217507a27bb">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3f6096bf-0c66-495a-aaed-be5b5745134c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d0ad4663-4654-41c8-bc6d-948a67c8ef14">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d1db5564-91b4-449a-85e2-4f099b6062c1"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607364"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b1f5e5b6-65d9-428f-8651-52b88bbe9cbe">
        <rdfs:label>Decreased life expectancy (Mortality)*</rdfs:label>
        <dc:identifier>HP:0040006*</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040006</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0cf0f100-d3c1-42b0-8ad4-9ebab70ed4e5"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17185149</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30387909</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
    <rdfs:comment>Indomethacin</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/98e1cc64-cd35-4e52-b772-33720b1aef7d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f4855437-f840-410d-981e-1aeb49d65b9a">
    <dc:identifier>HP:0001939</dc:identifier>
    <rdfs:label>Metabolic Decompensation</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/be2a14b9-78c4-40bd-afd5-cf97ca99e556">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/136120"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9ca00b7e-ab23-4677-862d-489761cd7125"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1211d4c5-c5f8-47d5-b2d1-59477d0292e0"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24636183</dc:provenance>
    <rdfs:comment>statin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27491218</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29390242</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/79a4d0d8-604f-4958-a73e-edbde341deca">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2946feee-2222-4277-86af-79aeaca78fab"/>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=C09A</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/58b4c4b1-735a-4555-a60c-3b27956b9731">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2b82d8c5-4653-4215-807d-55a2280252c9"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c5651fb4-8a69-4143-86a8-b7090f73edef"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/601678"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233707</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/63d340ba-deef-467f-8e78-273fa94cda48"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/da7c2662-bfe5-4463-a63e-057b003f3e3a"/>
        <rdfs:comment>spironolactone+potassium+ACE-inhibitor</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cde7e40c-5496-4d14-85ce-01e1e20c9bf8"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/104461c0-66d3-4840-a584-950ee2b77f03">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8775f387-cb8d-4bcd-aa46-d9de03741161"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/302060"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5364fa32-0aa4-4f45-9cfb-f34a98521e5b"/>
        <rdfs:comment>Angiotensin-converting enzyme inhibitors / angiotensin II receptor blockers/ beta-blockers/ diuretics</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>C09A</dc:identifier>
    <rdfs:label>ACE INHIBITORS, PLAIN</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a7fc3ba9-2935-4085-9ebc-3aac1e3b3a8a">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5c3f976a-ea6b-4bc8-aedc-513c93520e4d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/04299039-51be-433e-b7a2-ef3f7d679d2c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953024</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24816443</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>haloperidol</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/125370"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4c60b9a0-ba77-4db4-ab93-5f9b789c89cc">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011999</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>hallucinatory-paranoid state</rdfs:label>
        <dc:identifier>HP:0011999*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/aeb2437a-85df-4658-9516-b7c16a2d9e43">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01025</ddiem:url>
    <rdfs:label>Amlexanox</rdfs:label>
    <dc:identifier>DB01025</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f87089b4-a9a6-45f7-ace6-2168fce5da97"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c533956c-00ab-4713-9ca0-2c1f0f34adc7">
    <rdfs:label>Thrombosis</rdfs:label>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <dc:identifier>HP:0001977</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001977</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c3950586-7693-40f6-99a1-9484c942049c">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/614080"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30297385</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00704730</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886552</dc:provenance>
    <rdfs:comment>oxcarbazepine</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/dc9b8c52-3c02-4a6a-a96e-110d87571cfc"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00923247</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/10c0cada-0d11-45bb-81cf-bc0e560b3f5e">
    <rdfs:label>Painful neuropathy(neuropathy)*</rdfs:label>
    <dc:identifier>HP:0009830*</dc:identifier>
    <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0009830</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c31f00d4-e2e6-409b-b679-6a1973b85f49">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9f5a6e00-37a8-46e0-9d91-deeb5c5f212c">
        <rdfs:comment>Uncooked Cornstarch</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/227810"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8727391c-c9c5-4d48-822f-95d234aad8b5"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f045daf4-9a93-40fb-8246-2116bd9f0e82"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27155573</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7564233</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353876</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB11599</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e2a52997-3a9e-4b50-a596-ef0738526973"/>
    <rdfs:label>Starch, corn</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4f29600b-1d6d-4b9d-b83b-5fd9421cf19f">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d6c1137f-c24a-4d72-9c84-5068df3a1623"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f045daf4-9a93-40fb-8246-2116bd9f0e82"/>
        <dc:provenance>PMC2676979</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/255120"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15669684</dc:provenance>
        <rdfs:comment>cornstarch</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a18a41cc-4c26-48ca-979a-c68409616e1d"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3ea6e30e-dd2b-4ec1-b954-a4c65d2eb867">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25153581</dc:provenance>
        <rdfs:comment>Cornstarch</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f045daf4-9a93-40fb-8246-2116bd9f0e82"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24613482</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/68c1cea6-9a86-4caa-af51-74ca70d7d2c0"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20631546</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c4fbed18-b24c-4484-8e5c-37eda2c23f68"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232400"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8b3557a0-efd8-4159-ac1f-6a193ad2c070"/>
        <dc:provenance>https://www.nature.com/articles/gim201069</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB11599</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3c5a59c8-c2b0-4111-a3cc-2f0b88fb6ee3">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232700"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25266922</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0f0e2b63-88e9-4165-a7e5-7ec3a1531c39"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f045daf4-9a93-40fb-8246-2116bd9f0e82"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b62b964e-1db8-4b96-836c-c17c91f28bc9"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6878e45b-0f22-49fd-a9ad-66f55072d6fb"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16434679</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/50748751-1b2c-4cb7-97ff-78153b537c8b"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8727391c-c9c5-4d48-822f-95d234aad8b5"/>
        <rdfs:comment>Cornstarch(Uncooked)</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301760</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9ea5d425-3dfd-427a-9b60-3169e0112cc7">
    <ddiem:url>https://www.drugbank.ca/drugs/DB02329</ddiem:url>
    <rdfs:label>Carbenoxolone</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/45e79756-6cf6-4ce5-9eb6-27042aaafaf0"/>
    <dc:identifier>DB02329</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8eda880b-7a06-44c6-8e41-864414bca947">
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01793090</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884027</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
    <rdfs:comment>Vatiquinone (Epi-743)</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4a1cfcb3-fcc4-4c70-bb22-d1f7e3ae640b"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277400"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7e3955fd-7681-424d-8474-c3f43b294f1b">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01124</ddiem:url>
    <rdfs:label>Tolbutamide</rdfs:label>
    <dc:identifier>DB01124</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ee914b6b-04e8-4945-9527-019c3362fc4f">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24848070</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/049d5ada-2010-48d1-b9cb-0f6078f4e2d9"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <rdfs:comment>Salfonylureas</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b1e571a9-410e-45cf-9377-23280045b57d"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24204001</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/264070"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9cb69db2-6089-4951-888b-863084dc7a57">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT00376168</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/230800"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9a24cde2-8c8a-4b26-a791-e6193698d21e"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <rdfs:comment>prGCD</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f839cf3b-d350-48a0-b04e-b7d3de5d4925">
        <rdfs:label>Trial is no longer available</rdfs:label>
        <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28381550</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00705939</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21503667</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00962260</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29471850</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27499018</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c16fd6ff-4008-4b91-bebf-fddcfc7ee1d0">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606785"/>
    <rdfs:comment>hypericum extract</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f77f9c9a-c1e0-4bdc-8e01-a8b9507db5eb">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/127683ac-ebde-47e7-86bb-5761e14e0353"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841061</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26692114</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282099</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ee75335f-78ac-4c28-ad0e-a3e3b880ce80">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0012531</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012531</ddiem:url>
    <rdfs:label>pain</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/90583717-81a7-42d5-986e-a87e1650c56f">
    <rdfs:label>Immune Globulin Human</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00028</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/790c8321-6781-45d4-881e-126934f4ca24">
        <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
        <rdfs:comment>Immunoglobulin replacement therap</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/208900"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
        <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27906067</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0f5ea12d-6321-4ccf-8ba8-7a2374803109"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28318010</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ea11c963-11c7-4d7c-8aac-65d2723edd07"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ae0c41b9-189a-4a2a-95bf-53ef08a0591b"/>
    <dc:identifier>DB00028</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b8883f2b-813b-4bbf-a474-0861c1e34988">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ca1d711c-6425-454f-a13c-0201940fef65">
        <rdfs:label>Nimodipine</rdfs:label>
        <dc:identifier>DB00393</dc:identifier>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/476dcf29-eeba-4bb4-bc4d-08d6f14fe4d3"/>
        <ddiem:url>https://www.drugbank.ca/drugs/DB00393</ddiem:url>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e53c9f0a-bf32-445f-b72a-6cd703cbc141">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/efdb2fc0-808a-4ec8-be53-427363382a50">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/cf112898-9d2e-459d-b366-2b2df6965ae1"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/182b0755-8980-448f-bd3f-6517fdba148a"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f287c2a5-5159-4b0f-b7da-ad059e833549"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/eb2ab32b-f72c-4c72-9a61-4aad73cdb98d"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/91b7b70b-e8af-4704-996d-14096663b876"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03570931</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3b3a69d7-c910-4a42-927c-35a5f8f16362"/>
    <dc:provenance>http://n.neurology.org/content/90/15_Supplement/P3.327</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/256600"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e0ed7070-78d5-40c1-a6f9-64d29684016a"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e9b28381-88f7-4594-a53b-7985f667f1f3"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f82088b8-e73f-4337-943f-a1108122064a"/>
    <rdfs:comment>RT001 (11,11-di-deutero-linoleic acid ethyl ester)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/72578577-a708-40f2-995f-30f10326c790"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4ff930f8-0193-4951-b07e-171e9406fab7">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004302</ddiem:url>
        <rdfs:label>Functional motoe deficit</rdfs:label>
        <rdfs:comment>The hypoglycemia is not a disesae phenotype, rather its a side effect of Mecasermin medication.The new combination in Mecasermin rinfabate has over come this side effect.</rdfs:comment>
        <dc:identifier>HP:0004302</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7e468a13-8134-44d7-812a-ac1372dc2832"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b04541f7-9bbf-4e36-9f9c-52669a138a22">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/72fb5a66-3d43-4c2e-b7bf-b929f92c1810">
        <rdfs:label>Pegvaliase</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a9035d1c-9c03-414f-864f-7f44657a36fc"/>
        <ddiem:url>https://www.drugbank.ca/drugs/DB12839</ddiem:url>
        <dc:identifier>DB12839</dc:identifier>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b8912945-4bfb-4c08-9ce6-cbc29da5e500">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>http://www.scielo.br/pdf/jiems/v5/2326-4594-jiems-5-e170016.pdf</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/df406773-08a3-4cd7-8342-4f02dfec07f9">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001878</ddiem:url>
        <dc:identifier>HP:0001878</dc:identifier>
        <rdfs:label>hemolytic anemia</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3b5b8356-65b2-484b-983c-1115ece9579d">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>low β2 microglobulin,creatinine ratio</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cb3c8a46-55e4-4be0-8e54-eeffef85b1ac"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/369e2d68-3b59-4a4f-9422-0a8eb69cbe01"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>Medium-chain triglyceride oil</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/75042a8a-c3b4-4545-9f1d-a744a48688fa">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001508</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>failure to thrive</rdfs:label>
        <dc:identifier>HP:0001508</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/140350"/>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs10545-016-9963-8</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/34743385-1c7b-4bdf-ba79-482e4b9e3a5a">
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7a795862-50a1-4e0f-93db-459874ba4885">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Elevated Phe level in blood</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004923</ddiem:url>
        <dc:identifier>HP:0004923</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>BH4</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d2b23f09-5cf9-4b3e-9839-40ffcb18bf8f"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c1d28c82-72dd-45f2-917f-1eea9583452f"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8433887</dc:provenance>
    <dc:provenance>https://rarediseases.org/rare-diseases/tetrahydrobiopterin-deficiency</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7110811</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261630"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dcd5e561-a6db-409b-a583-6c98518d93a2">
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <rdfs:label>High total cysteine levels</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010918</ddiem:url>
    <dc:identifier>HP:0010918</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8017db44-0dd8-43de-8380-437d2be503fa">
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=L04</ddiem:url>
    <dc:identifier>L04</dc:identifier>
    <rdfs:label>IMMUNOSUPPRESSANTS</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e859b253-aa0f-41fe-a428-a48293daec8f"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fd13eee7-4994-4611-a2dd-0c784ed86031">
    <rdfs:label>myoclonic seizures</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002123</ddiem:url>
    <dc:identifier>HP:0002123</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1a4e34b2-b334-40d5-894d-c889dac0ebe2">
    <rdfs:label>Omega-3 fatty acids</rdfs:label>
    <dc:identifier>DB11133</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB11133</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f996b1c6-cd02-4004-a898-ea0a961a2626">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/145750"/>
        <rdfs:comment>Omega 3 FA</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25993639</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10925336</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a6ec4fb8-4bbf-49a8-bcc6-e7ae50eff90f"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22142470</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0673ddba-4d36-45d2-9490-9236f9899cac">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a6ec4fb8-4bbf-49a8-bcc6-e7ae50eff90f"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e0eb37af-7c11-470d-ba5e-2ca765240272"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02211209</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2e1b6ccd-a467-4de3-afca-875fddb3ce64"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27710244</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/33e0453c-ae54-41ed-a871-a2b0bb32f9c7"/>
        <rdfs:comment>fibrates + omega-3 fatty acids (OMG-3)</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/151660"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02527343</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2cc7cd33-c7b4-448b-8a55-a9f2412e081a">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003326</ddiem:url>
    <dc:identifier>HP:0003326</dc:identifier>
    <rdfs:label>Myalgia</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/eac55a48-7195-4aa1-b409-dbb2c5b21c81">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01420627</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/615511">
        <rdfs:label>MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b18000f2-d0f3-494c-aeb9-0dad0b360ab6"/>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/615511</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c3d88087-f5cb-4f8e-84a8-c5947e2ba4d4">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d0ce026d-ba99-479a-ae11-f601e0f39f7b"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a784bb65-98a4-458f-9bf0-66d779f5befe">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003394</ddiem:url>
        <dc:identifier>HP:0003394</dc:identifier>
        <rdfs:label>Muscle cramps</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://pdfs.semanticscholar.org/99dc/08fa85d5728e08f29b8c13177aac3206f4ec.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488882</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fd7832a3-41f0-4b78-add9-036c1df49648">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003690</ddiem:url>
        <rdfs:label>Limb muscle weakness</rdfs:label>
        <dc:identifier>HP:0003690</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29241594</dc:provenance>
    <rdfs:comment>D- Ribose</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e4e120eb-9891-464f-9407-8e148c3e3eb8"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0629ccbb-a4fe-4dd2-a567-e8cd131a8c84">
        <rdfs:label>Exercise-induced muscle fatigue</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0009020</ddiem:url>
        <dc:identifier>HP:0009020</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a64f50c3-3032-43d5-b888-2e2b2c5f798a">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2b502600-7b90-4335-b1bb-efaedcd228eb"/>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/12757858</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0db538e1-93b8-451e-85eb-512e25498293">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/aa206fee-4116-41be-9dfc-4cd47efa5a24"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9370e43a-12cb-4961-a3ce-2e0d546da38e"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1855d929-541e-408e-adbe-7e8c1ac81930"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27207470</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231950"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a89658a3-41a7-4b45-9c29-3b513f682959">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003343</ddiem:url>
        <rdfs:label>GSH deficiency</rdfs:label>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <dc:identifier>HP:0003343</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>OTZ (L-2-oxothiazoline-4-carboxylic acid</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20578266</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/436a320e-337f-409b-b3f9-0b2e50dde645"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2b9016df-61c3-4fea-88bf-4907fe14cdf8">
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <dc:identifier>HP:0010918</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010918</ddiem:url>
        <rdfs:label>low intracellular cysteine*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e8acaab8-c06b-43c6-937d-02fcc4a9397b">
    <dc:provenance>https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-3-20</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26396722</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25488886</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3858882b-2dce-4287-8bd6-db7b7be71db1">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0000821</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000821</ddiem:url>
        <rdfs:label>subclinical hypothyroidism</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>levothyroxine</rdfs:comment>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6b7fbfc1-2867-4d0b-a7dd-d5685259becd">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/afef4e62-087e-40c4-9db3-55b6b7cf4849"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/200100"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17132287</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/813bb8bc-4645-40b8-99a3-b83e5fc8b71f">
    <dc:identifier>C03D</dc:identifier>
    <rdfs:label>POTASSIUM-SPARING AGENTS</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b6fea1ff-2981-4f60-bc95-d095f3e02905"/>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=C03D</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/350adb89-8c25-4662-a590-7407f2853855">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e859b253-aa0f-41fe-a428-a48293daec8f"/>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=S01EC</ddiem:url>
    <rdfs:label>Carbonic anhydrase inhibitors</rdfs:label>
    <dc:identifier>S01EC</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/34cbeeb4-2a44-4fdf-818d-72ae6ce46274">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/209300">
        <rdfs:label>ATRANSFERRINEMIA</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/209300</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>206</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/206</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ac8d33c8-d2fe-46ed-8499-bacbe9074a3b"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8317485</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2de90206-c044-4acc-803b-e3971d93b567">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001931</ddiem:url>
        <rdfs:label>hypochromic anemia</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0001931</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3221dd31-98b4-4447-b38f-8fd197ae3fb2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
    <rdfs:comment>Deferoxamine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8187613</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a848fb51-d2f8-4ae7-bbee-c34f77e10e6f">
    <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
    <rdfs:label>Lack of emotional expressions</rdfs:label>
    <dc:identifier>HP:0030213</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0030213</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/209f1dc7-3ee5-4764-9a68-e70828d2e9d5">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/67c8acb2-0965-4d4a-9b7e-8753fcc65d1c"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25400034</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1eee4c37-2896-4ff7-9965-c7f9a4e87c83">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Increased number of splenic myeloid cells</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f84e9299-aae6-4362-a8e7-6953d39aee3d"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02534844</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/470c09a9-71dd-4bee-9970-98afc8a09cdd"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fdb9b9ed-d22b-41b2-a0d4-9b60617f66fd"/>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bd6e574a-c705-4f89-9b69-8985b2e86c64">
        <dc:identifier>HP:0002180*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002180</ddiem:url>
        <rdfs:label>Cerebeller neurodegeneration( neurodegeneration)*</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/257220"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/68cb1437-02f6-4ebf-9a42-4bb9c9a3143e"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/36687e43-a53c-499f-893b-c743591b4497"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23948640</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/56215552-6406-476a-8150-6a52edf8a20d"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a41d1739-afef-4512-a582-c1be31d1c2cc">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002275</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002275</dc:identifier>
        <rdfs:label>Motor function impairment</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Miglustat + Allopregnanolone+Cyclodextrin</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c7a11941-2d00-4d77-8190-1589b6729c29"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b0d1da-41c6-4af5-bae7-665c57daa286"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31248418</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8459f4b6-ddd5-4456-b7b2-8cbc7bf04e09"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/17dbe4d6-ea4a-4c68-ad4b-d507885ecb4f">
        <rdfs:label>Abnormality of lipid metabolism</rdfs:label>
        <dc:identifier>HP:0003119</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003119</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/75ac782c-316f-443c-9320-38031ab0a941">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/256730"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bfbeb87a-c12d-45f0-8f48-3d251b99f579"/>
    <rdfs:comment>Recombinant human palmitoyl-protein thioesterase 1 ( PPT1)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29631617</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8ebb1b07-a259-4b6c-bfd7-839c5b50be25"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c4c0709a-fe63-4dfa-b7ef-59c0e1da6b1c">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004356</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0004356*</dc:identifier>
        <rdfs:label>Enlarged lysosomes in NCL NSCs and fibroblasts (Abnormality of lysosomal metabolism)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00028262</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3cc64808-1486-4cfd-9e11-2b3253d0b95c">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003452</ddiem:url>
    <dc:identifier>HP:0003452</dc:identifier>
    <rdfs:label>Increased serum iron</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2ef24f64-8f70-4b4a-bbd2-9a3c2e28db23">
    <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
    <rdfs:label>Poor eye contact</rdfs:label>
    <dc:identifier>HP:0000817</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000817</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/712eacf2-5156-4d0c-af44-95d7baac4af4">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <rdfs:comment>NAD+ [nicotinamide riboside]</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5109fba1-5db5-460b-b522-99348da49483">
        <dc:identifier>HP:0001250</dc:identifier>
        <rdfs:label>Decreased niacinamide level</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
        <rdfs:comment>The hypoglycemia is not a disesae phenotype, rather its a side effect of Mecasermin medication.The new combination in Mecasermin rinfabate has over come this side effect.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30373890</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/29b72c11-1f4d-43c0-b036-0d1e34a12d68">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/4b533072-015b-4405-884e-1f9468bbae38"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19304794</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007764"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/271245"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/dc9610d9-3b29-4350-8d4c-4e11b053708f">
    <rdfs:comment>Cinacalcet</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22142470</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2c0aeb02-7b5d-4809-90f3-38f379107c32"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f38083ce-b15e-47fa-8350-5893809680a9"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/38568331-74c5-48f6-beba-0316122e888d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/145981">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f0cab8d2-a988-4848-9611-461fe290e03c"/>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/145981</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28833550</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b6daf903-ddf7-4909-aadb-adaa816a341d">
    <dc:identifier>DB00155</dc:identifier>
    <rdfs:label>L-Citrulline</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00155</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/746d1eee-f407-421e-83e1-0ed7b3e9bcad">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25335805</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27567650</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cbdfd36a-8602-4983-9949-85ef10bba2ec"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22402328</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9f4da0b7-bc68-4593-a7c4-e98ccf7624da"/>
        <rdfs:comment>Citrulline</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/6777479</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ec984a25-0714-4e57-bc0a-039212f69dbc">
    <dc:identifier>HP:0007010</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0007010</ddiem:url>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
    <rdfs:label>Impaired fine motor skillls</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/56278464-1728-4142-bb9c-2c6d6dbabc24">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d6c1137f-c24a-4d72-9c84-5068df3a1623"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b6b1b260-a41d-411d-a6bd-f2e8a75a6b75"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/00a2b0ff-013d-478b-9d4c-3cdd8f40f762"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/938dd649-e4ee-4343-94e9-0a30d162032c"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20163245</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b2cac4c6-ecab-4a2e-8022-7073757f507b"/>
    </obo:RO_0000057>
    <rdfs:comment>Ad-mG6Pase</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8a4d084b-f26d-427d-af59-c486ea6bf149"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2ecba232-71a6-4b87-aa5e-d19538fb468c">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6635355a-17c3-49ec-9541-7e0f44ccb6a7"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1c315232-bd90-4224-b498-546affd5ba26"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/02e697d4-329e-4fd3-8227-5806370c078e"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/11533432-fc55-439f-9430-a1e10e75eeca"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/816804d8-49e5-44d4-ba15-75ad9ee78ef0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10625614</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b210d966-3d0c-4efe-87d4-a2a2ccd20fb3">
        <rdfs:label>Enlarged kidney</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000105</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000105</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/329b2e58-b4ae-4f76-a86e-5a80f138dd65"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ef969eb8-594f-4069-a6cd-e137763d8681">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9d059244-0c53-4fae-af73-6e795ee03d50"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00925301</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01458119</dc:provenance>
    <rdfs:comment>Carbamazepine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30723321</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27834756</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK6803</dc:provenance>
    <dc:provenance>https://www.nature.com/articles/s41436-019-0451-z</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01218659</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/612073"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/04299039-51be-433e-b7a2-ef3f7d679d2c">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00502</ddiem:url>
    <rdfs:label>Haloperidol</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a7fc3ba9-2935-4085-9ebc-3aac1e3b3a8a"/>
    <dc:identifier>DB00502</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/fc361ea4-a4cd-4bcf-b5fb-91b0a2cbd3d9">
    <dc:identifier>DB11672</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB11672</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f1b57978-1ca9-4b85-b4f6-6aadd6ca2fd7"/>
    <rdfs:label>Curcumin</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/40c5c729-272c-48d8-b5f3-c65841217d58">
    <rdfs:label>Hyposthenuria</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003158</ddiem:url>
    <dc:identifier>HP:0003158</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/882c42fd-56cf-4b14-8e53-85f51bd3f37e">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0008765</dc:identifier>
    <rdfs:label>auditory hallucinations</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0008765</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f6a74312-8530-4a57-9080-6e8b64417139">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/bcc4abf5-fa7f-43d5-bcc0-eea6f185530a">
        <ddiem:url>https://www.drugbank.ca/drugs/DB00855</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6cd4043c-eff5-42ff-bd84-d7c3b3a37d53"/>
        <rdfs:label>Aminolevulinic acid</rdfs:label>
        <dc:identifier>DB00855</dc:identifier>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2559f8b3-43ca-4cd4-bd86-ac6a3a376209">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4420fb74-0257-4f57-a4f7-f33b59b6c443">
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
        <rdfs:label>Bacterial glutric acid production</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/2cc84d9d-f180-46cf-a781-5f048ea22984">
        <rdfs:label>Functional intercation ( Mechanistic B)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
    <rdfs:comment>Metronidazole</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28766179</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/231690">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>GLUTARIC ACIDURIA III; GA3</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/231690</dc:identifier>
        <ddiem:iembaseAccessionNumber>537</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/537</ddiem:iembaseUrl>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/366801cd-db53-4d14-abbb-29df212c1c88"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:00007121"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4dc46664-5833-495f-9c89-a01b76811d60">
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002013</ddiem:url>
        <rdfs:label>Cyclic vomiting (Vomiting)*</rdfs:label>
        <dc:identifier>HP:0002013</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1787217c-d524-478c-9258-097a4cd40a96">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
    <rdfs:comment>Sodium</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b0a5fd86-099b-474e-83c2-bb5944f0bbd7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/75ed6c1f-27f8-4020-8441-9a0d4dc3a65a"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/199ef95c-c37d-4a2b-8b6b-93666de47024">
        <dc:identifier>HP:0002902</dc:identifier>
        <rdfs:label>Hyponatremia</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002902</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607364"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17185149</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/13d5976d-580a-4edb-bd27-6b4cfd444059">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bf0e480c-ae46-4f72-8985-64383c8b9df2">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/125700"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/40c5c729-272c-48d8-b5f3-c65841217d58"/>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23884783</dc:provenance>
        <rdfs:comment>Clofibrate</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1316120</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2e1b6ccd-a467-4de3-afca-875fddb3ce64"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/46b444f7-450d-4071-8f56-18338cb8ed09"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00636</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/58a587da-b3a5-42a5-9f57-4386c3340478"/>
    <dc:identifier>DB00636</dc:identifier>
    <rdfs:label>Clofibrate</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/95b2c04a-8f2f-408d-85f0-6132474ecc50"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2a19ec2e-d094-41cc-8e55-b6efefb954c6">
    <rdfs:comment>zonisamide</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1e344a40-7f46-4d54-9248-e7550463113b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22149023</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/220110"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b5c5ef98-6973-4b1a-8939-8958284594d9">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15637709</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300559"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f000d0aa-6160-483e-bfd7-7dd42cf34501">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f62d10aa-ee3a-4833-b236-d8e995af88e6"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>cortisone</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/457b1b0b-1ae5-4219-abb6-982dd82b8498"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ead0f128-7268-43fa-81d9-d0c4d41f7123">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/57339eb1-159e-4436-b175-27ce846ee2c9"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c9e56bf1-7674-486a-ad0a-83e9dc4a3426"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB06775</ddiem:url>
    <rdfs:label>Carglumic acid</rdfs:label>
    <dc:identifier>DB06775</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/dccb60cb-3656-4bd4-8a94-03b8fb2285c6">
    <rdfs:label>Chlorpromazine</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00477</ddiem:url>
    <dc:identifier>DB00477</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3a3ec1ce-34e1-4e0f-8382-c50581a02ee8">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10222465</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3eab04ee-b7a5-4a58-ae12-b61b70816b85"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/161134bc-1b1f-4359-8740-b1cd3496cb0b"/>
        <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231670"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17397529</dc:provenance>
        <rdfs:comment>chlorpromazine</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3ae91452-c48f-4283-a92f-49d2e8a9caf7">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00159</ddiem:url>
    <rdfs:label>Icosapent</rdfs:label>
    <dc:identifier>DB00159</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5721cb50-794d-4f22-b091-509a4aca5342">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/361c02e6-7280-43d7-a512-2d9553381bfd"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246650"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/fd0bd6e6-8d2f-45f4-9fb2-931ae1ccc565"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19820022</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a6ec4fb8-4bbf-49a8-bcc6-e7ae50eff90f"/>
        <rdfs:comment>Fenofibrate+ω-3 fatty acids+EPA+DHA</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16635485</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/70fa3609-a244-4fc0-a80b-f8e75d29998f"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5dbdb316-39f7-4c9b-a777-b03f8a078bfa"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/262cc661-72ec-41e4-88eb-7049bae58d47"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d637f473-c6c9-4d0b-b0db-4e6b34811442">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Low pancreatic zymogens</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/08ebd2bd-1a14-4132-8f41-372022daddf8">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0040144</ddiem:url>
    <rdfs:label>low urinary excretion of TCA cycle intermediates malate and succinate</rdfs:label>
    <dc:identifier>HP:0040144</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/db46f40d-67b9-4e28-ada5-81ec5a0b2733">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/76d4caac-e864-47e4-aed2-9f4c964222f2">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>esotropia</rdfs:label>
        <dc:identifier>HP:0000565</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000565</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/253280"/>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2716378f-9ce0-4ed0-b452-b25caedb1a82">
        <rdfs:label>strabismus</rdfs:label>
        <dc:identifier>HP:0000486</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000486</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29555514</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>botulinum toxin</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b40db580-d382-40b6-b331-d92476228868">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/74d00fc0-4cda-4f6f-9f54-4e72bec47493"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5c2fbaf7-c0a8-4307-b3d8-81b51fcfa7e6">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b9f386cb-608b-4d1d-ae74-04e25827073b">
        <dc:identifier>HP:0011025</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011025</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Abnormality of cardiovascular system physiology</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
    <rdfs:comment>creatine phosphate sodium</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300438"/>
    <dc:provenance>https://www.semanticscholar.org/paper/Clinical-Diagnosis-and-Treatment-of-Dehydrogenase-A-Cui-Wang/f6e88d647f2e2c7df2897e939ec33f9d86899b37</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11102558</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6a293207-ab08-46cb-a728-ba74520d0589">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b5e4ee94-6c63-4827-b33b-f3266f8dee78"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7370f6c3-f93e-4bb2-a91c-fff3e0e2b296">
    <rdfs:label>Lipid accumulation( Abnorality in lipid meabolism)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003119</ddiem:url>
    <dc:identifier>HP:0003119*</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/60cdad1a-53b4-4b7e-9f24-8a9773e6a1f3">
    <dc:identifier>CHEBI_26537</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6f2e916f-fb2f-4993-b9bb-2149d0d87e43"/>
    <ddiem:url>https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_26537</ddiem:url>
    <rdfs:label>retinoid</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f7ec7159-1d8e-4aec-b7a3-5dd4d6c15638">
    <rdfs:label>mitochondrial dysfunction</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003287</ddiem:url>
    <dc:identifier>HP:0003287</dc:identifier>
    <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/821c7bb7-7249-4c34-8320-62a7483608e4">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30387909</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8727391c-c9c5-4d48-822f-95d234aad8b5"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Growth hormone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/341cb69d-951b-4061-9460-1b8ed6c1ceb7"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607364"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8a509ece-86c5-46a4-8cd0-e8dd64315108"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ba137e34-6001-4ca6-9a3a-0d3f2302f79a">
        <rdfs:label>Decreased serum IGF‐1</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0030353</ddiem:url>
        <dc:identifier>HP:0030353</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/970a252d-bc3c-489c-ba05-f7b2bc3bb4d8">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b370adb7-ebc2-4477-80b8-4c3546cc40d8"/>
    <rdfs:label>AAV-based gene therapy</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c6553506-0f29-407a-8ba3-f2dfd479d96f">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00129</ddiem:url>
    <dc:identifier>DB00129</dc:identifier>
    <rdfs:label>Ornithine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a348755f-9b79-4e58-82ef-2824c6911577"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b585c680-c9ab-4627-acc3-2790a1a5a246">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/0b612d3c-da82-4e58-8add-55a452e31c96">
        <ddiem:url>https://www.drugbank.ca/drugs/DB00996</ddiem:url>
        <rdfs:label>Gabapentin</rdfs:label>
        <dc:identifier>DB00996</dc:identifier>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f528d87a-9e0b-47b6-9fe4-98835ab1d662"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b03839b4-a6f4-4bf0-a431-2c77c0e6858c">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Abnormal Unified Parkinson's Disease Rating Scale (UPDRS )score(Abnormality of neurotransmitter metabolism)*</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7dd07896-7101-4a83-bd9e-01aad7cdee1c">
    <dc:identifier>DB00877</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00877</ddiem:url>
    <rdfs:label>Sirolimus</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5248d4e3-4233-4b22-9179-e23ef529d469">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24613482</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/502a9041-c2eb-4f80-adc7-ea3126abf6c1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bdbfd74f-b6c4-4e0d-9edd-c4bcbaa8a6c8"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8e3098b3-6ba8-478a-8ba3-3897594e5c18"/>
        <rdfs:comment>Rapamycin</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29223626</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24509886</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232400"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/31f9e18f-0315-42a7-98f4-5d3858e2a591"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9e7def7a-d23b-4977-b087-91e4bac373ef"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/40c9cdf8-66d1-40ba-a764-16e52ecfe412">
    <rdfs:label>Abnormal neurodevelopmental profile</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012759</ddiem:url>
    <dc:identifier>HP:0012759</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/50a653b2-8fb7-42f1-818c-1690a1e11dd8">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a59a341f-540b-4698-933a-78583219cbd6"/>
    <rdfs:label>aminomidazole carboxamide riboside</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/40c4dcdd-cc69-47b2-a7c4-b8e06549c0eb">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12872260</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/618098"/>
    <rdfs:comment>Levodopa</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24076137</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b11c931d-d9df-4997-a869-76233c2a3660">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2eb846fa-a76a-4739-90f0-34adc9963b88">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0002719</dc:identifier>
        <rdfs:label>"Frequent, severe infections"</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002719</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26835382</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25288127</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0949ad0f-9ebc-458f-b20c-3bd0d7e781b8"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a7db7cd3-ad7a-4a1a-87c5-8add6d316c37">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002718</ddiem:url>
        <rdfs:comment>Preventive calcium and vitamin D3 supplementation is also recommended to prevent osteoporosis.</rdfs:comment>
        <rdfs:label>Recurrent bacterial infection</rdfs:label>
        <dc:identifier>HP:0002718</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8447561</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232220"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1709246</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1719175</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19066956</dc:provenance>
    <rdfs:comment>Human granulocyte-colony-stimulating-factor</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7caaf8f0-18ea-47bd-a455-2a6fd6f0690d"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/86764c64-1c02-47d5-8aa6-13d6ee2f1357">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232600"/>
    <rdfs:comment>Sodium Valproate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302571</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03112889</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8e045f30-fe3a-4946-aab7-d0adefd2d933"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25455802</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25762569</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e4ef1cd4-790c-4c9e-b816-cdfa0286f386"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7f7e86bb-4208-418d-b508-f9829bcb50b1">
    <rdfs:label>proximal tubule salt losses (Proximal tubular defect)</rdfs:label>
    <dc:identifier>HP:0000114</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000114</ddiem:url>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/44b0a845-4c29-4989-bded-9bcdf8faa8f6">
    <rdfs:label>Lipoic Acid</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00166</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/635c724f-4e36-45b3-9548-035d62dc45bf">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024040</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/17e99bcb-3af9-410b-bfdc-f2b92c85b8f1"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1b7d779a-3e96-4986-a51a-687e6ab4346d"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246900"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/55a9600f-f580-4a5a-a99f-825c49d34d43"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK220444</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23478190</dc:provenance>
        <rdfs:comment>Lipoic acid</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d835ae16-393d-4543-9764-f0872109cdf7">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/6474c20e-05b1-4fa9-8b9f-2514aa912dc7"/>
        <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5d6a149c-d6ae-49bf-a187-06ef6b364c34"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9511979</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/309400"/>
        <rdfs:comment>Alpha-lipoic acid</rdfs:comment>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30384011</dc:provenance>
        <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/abs/pii/088789949190052M</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1b7d779a-3e96-4986-a51a-687e6ab4346d"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00166</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c381bc12-dbe5-4e41-b9af-691944c9a1da">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
        <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
        <rdfs:comment>Alpha lipoic acid</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/208900"/>
        <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1b7d779a-3e96-4986-a51a-687e6ab4346d"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9348ec55-4e7d-444c-b7a1-dbb12f974e03"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27906067</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6cbfabc8-7f6c-41a4-af4e-940606802691">
    <rdfs:label>Abnormal facial expression</rdfs:label>
    <dc:identifier>HP:0005346</dc:identifier>
    <rdfs:comment>Niacin was the only effective drug to increase HDL cholesterol.</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0005346</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c52c8fe6-4f3c-495b-80b6-524766b324fb">
    <dc:identifier>DB06210</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/120ad4fd-d1ec-4da8-9c4d-36c8857b318f"/>
    <rdfs:label>Eltrombopag</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB06210</ddiem:url>
  </ddiem:Drug>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000008">
    <dc:creator>leechuck</dc:creator>
    <rdfs:label xml:lang="en">dietary regime modification</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000005"/>
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure in which the diet is supplemented with or depleted in molecules  closely related to the products or end processes of a genetically defective protein which occur as natural products in the diet. [PNS]</obo:IAO_0000115>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T18:03:52+00:00</dc:date>
  </owl:Class>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fa13763e-a5ab-4381-8ad8-f9e4cf1c6cc1">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0aa47d20-1e2a-4a5d-828e-fb1f24e2cc0c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096481</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ade8cfec-315a-43c2-b2b0-afbd341176dd">
        <dc:identifier>HP:0000842</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000842</ddiem:url>
        <rdfs:label>Hyperinsulinism</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/49bffb10-3f28-4064-aa10-51a9cede4fe8"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23295286</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10969108</dc:provenance>
    <rdfs:comment>diazoxide</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606762"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20936362</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b0402d03-99e4-4892-94a9-c6df4be9739a"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25781533</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28621098</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7b83bc4f-dd0d-4b02-9595-7323193526dd">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27906067</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ceee4030-2756-402b-8642-c5a508943e93"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/208900"/>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/415bb0ef-74d0-4a2c-b925-9b7440e4a785"/>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <rdfs:comment>myo-inositol</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/53fe510c-c91b-4184-b11b-d6d62ad9715b"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7a6f5459-0e3c-44b1-a2e4-e8287f31048d">
    <rdfs:label>Nicotinamide</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c3564fc4-0902-4ce3-ae8d-629ffc6cc096">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9b474b28-76d7-44f5-89ce-91f0eaf3d571"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/208900"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27906067</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9269caeb-1026-4aee-8ba5-3091b95b675f"/>
        <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
        <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
        <rdfs:comment>nicotinamide</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8de13bf5-a902-44eb-9bac-645e71953485"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b18d1e10-a850-4b4f-8124-57bd1a647091">
        <rdfs:comment>nicotinamide</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24816443</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602398"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9b474b28-76d7-44f5-89ce-91f0eaf3d571"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/da882d31-2e55-4444-bae9-30380615493b"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995031</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB02701</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB02701</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f889296e-0bef-44fe-936f-f045e828476a">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25896882</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22830360</dc:provenance>
        <rdfs:comment>Nicotinamide</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9b474b28-76d7-44f5-89ce-91f0eaf3d571"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d138227e-ad25-4e34-8290-81f332c7d6c7"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27775558</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/027ef64d-b2f5-4dde-9b7d-1cc04f828592">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c456e94c-1424-47f4-8f92-30252c438207">
        <dc:identifier>HP:0002071</dc:identifier>
        <rdfs:label>Extrapyramidal movement disorders</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002071</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f24a6cb0-fc7a-4229-8c3b-98c78cc27199"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719212002971</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719213003107</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/612736"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29506905</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719213003661</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01328587</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24268530</dc:provenance>
    <rdfs:comment>creatine-monohydrate</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/83eebf55-29e3-4859-b12b-92ce364e7994">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8537c04e-14c0-4d93-b69a-244a4e310081"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23605132</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4bd66db5-5df4-4fcb-9574-bb863c2e2e2e">
        <rdfs:label>Mild attack</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012825</ddiem:url>
        <dc:identifier>HP:0012825</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1275520</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Glucose</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/32593410-c452-4343-b2e7-55cf9e6c5c3b">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002027, HP_0002017</ddiem:url>
        <rdfs:label>"(abdominal pain, nausea, vomiting)"</rdfs:label>
        <dc:identifier>HP:0002027, HP:0002017</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02180412</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/176000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8447598d-ad70-48ee-8d1b-9ecd2b0504f3"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1e132378-5ceb-4d9c-9b5f-db44bbc66fc6">
    <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
    <rdfs:label>Low height velocity</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004322</ddiem:url>
    <dc:identifier>HP:0004322</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a27f4caf-3eaf-4154-afbf-23228859ae2e">
    <dc:identifier>HP:0005952</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>deteriorating pulmonary function</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0005952</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3a6e4c61-3cf1-4f1d-b7a1-49127d7cb7b9">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/878670d2-235f-4fa6-ab54-3b95b632eb53">
        <dc:identifier>HP:0031034</dc:identifier>
        <rdfs:label>Abnormal circulating IGFBP level</rdfs:label>
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0031034</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27884013</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/7d2e48de-9e12-476c-810e-8638521e0472"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b5d4b812-32bb-46f3-8ea9-3dbc8652d6f7"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/67c15365-f415-4fa6-97e7-004e3f682666"/>
    <rdfs:comment>Recombinant human IGF1(Mecasermin)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6b5b9688-cfe7-4fb3-9981-9b05ff4a001a">
        <rdfs:label>Abnormal circulating insulin level</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040215</ddiem:url>
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
        <dc:identifier>HP:0040215</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/aa3f53e1-0d0c-4e8b-a8a5-7d189316e75b">
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025521</ddiem:url>
        <rdfs:label>Abnormal Body fat composition</rdfs:label>
        <dc:identifier>HP:0025521</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1e132378-5ceb-4d9c-9b5f-db44bbc66fc6"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10770174</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3748421a-9ecb-4c3a-9487-a7b53b542764">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0045082</ddiem:url>
        <dc:identifier>HP:0045082</dc:identifier>
        <rdfs:label>Low lean body mass</rdfs:label>
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608747"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f9ce9cee-90d9-42be-938f-f397a773204a">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008189</ddiem:url>
        <rdfs:label>low insulin senstivity</rdfs:label>
        <dc:identifier>HP:0008189</dc:identifier>
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10323388</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/63617787-19d9-4a65-a604-44019c9705cc"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/75b8408f-9d7a-4e37-a9b3-8cea1ec014af">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0045082</ddiem:url>
        <dc:identifier>HP:0045082</dc:identifier>
        <rdfs:label>Decreased body mass index</rdfs:label>
        <rdfs:comment>The regimen maximally increases isovaleryl conjugate excretion during metabolic stress rather than under stable conditions.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/36e2b8dd-d3fa-45a8-b301-40f7712ffcb7">
    <dc:identifier>HP:0001257</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001257</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>abnormal muscular co-contraction</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/11fd0681-3446-4c24-ad0a-336f208cdb57">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0fe77684-489e-4849-b591-7ba6ff4d5fdf">
        <rdfs:comment>Riboflavin</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25251739</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12927581</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/86ee66fb-4ed6-4a3f-be48-7938f9c9eb6b"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/257ba681-37f6-4b96-b1f9-9dbfa4fbd2e3"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6ce4f760-ed2f-47e7-b456-697550d26030"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1567724914001299</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2759e167-c294-4ba7-bc4f-230bca60ff66"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246900"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ff74f292-08d5-4724-9ea6-4a9ea93060d9"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00140</dc:identifier>
    <rdfs:label>Riboflavin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2559f8b3-43ca-4cd4-bd86-ac6a3a376209"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ec32af6d-65fe-42fc-9d6a-3aac70cf81d2">
        <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ad80f96f-a5f8-460d-a992-2fc0364ad7d1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602541"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26006750</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
        <rdfs:comment>Riboflavin</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e41341e8-95b9-4a2b-8093-92360a14acae">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/231680"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/0009bf9f-a858-4490-9b97-e39408cfbf1a"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10581232</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
        <rdfs:comment>Riboflavin</rdfs:comment>
        <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00140</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7f12b92e-fbb5-4554-a5de-083d7a43609c">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cad27e08-c72e-41db-9634-9b06464c1943"/>
        <rdfs:comment>riboflavin</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24816443</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995031</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602398"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4256081b-7ed3-4d3a-a134-7fc674c8bda2">
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00151710</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c0f06aae-88b2-41f9-819e-9f95f7ac1b9a"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19755409</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ab65ee76-7e5e-48f9-aaf5-1a33b32b6a0c"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/236792"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22391998</dc:provenance>
        <rdfs:comment>Riboflavin</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24321868</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dc2ce1ce-8264-4042-9abb-91a8f3414d03"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d96d05cc-f58d-409f-8aca-87ba0bdd8d17"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dcd847d5-f908-4d6f-9f9f-097bfe075e8b">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003281</dc:identifier>
    <rdfs:label>Increased serum ferritin</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003281</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9fc15d48-0517-4676-bdd5-c883b45d64b9">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1e7b6804-84d2-4b5d-9e92-3c8088584780"/>
    <dc:identifier>DB00734</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00734</ddiem:url>
    <rdfs:label>Risperidone</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0dd08e7b-303e-41bd-a33f-99c2dec3a519">
        <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e0433680-3bb8-415a-8f01-ef72ca06dbaf"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17431913</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25511120</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277400"/>
        <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/80dba52f-3650-436f-8eba-d37c62171bba"/>
        <rdfs:comment>Risperidone</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/deec2e37-1619-457b-aa71-69041b762c15">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c5c6a5da-44e9-41c1-bcb2-cb749521569a"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01012</ddiem:url>
    <dc:identifier>DB01012</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/dc9610d9-3b29-4350-8d4c-4e11b053708f"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/31872973-5b9c-457b-a9b1-13c4a889b896">
        <rdfs:comment>Cinacalcet</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16882283</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5cdbf36f-e454-469f-bbb8-9e7261129851"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17803689</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f38083ce-b15e-47fa-8350-5893809680a9"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/084acb5b-b218-4b6a-8073-b0d21d039bb9"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/145980"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e253bd8e-6e42-408b-b880-fb384e865997"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2f76c007-590e-4adc-b3eb-3d8fce60a3c5"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22142470</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28459040</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Cinacalcet</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a38e87c0-f364-4ce4-a89d-fd1d4a988621">
    <rdfs:label>Pancreatic beta-cell dysfunction</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0006279</ddiem:url>
    <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
    <dc:identifier>HP:0006279</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bbb11c2b-991e-4271-96cb-67b82b439273">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7dd616e7-a5f4-4175-8525-7f49734c536a">
        <rdfs:label>Irritability</rdfs:label>
        <dc:identifier>HP:0000737</dc:identifier>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000737</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/48965385-66c6-4440-b89f-a5a9a09cad87">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002353</ddiem:url>
        <rdfs:label>Abnormal Awake EEG</rdfs:label>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <dc:identifier>HP:0002353</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d3521986-1e63-4df6-811d-cee5a400af91"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27671893</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27671891</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/82ee3912-9588-4be1-a099-6a307d012a6c"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f9956eed-4f5c-49d1-a74f-ea3133547f02">
        <rdfs:label>Foot clouns</rdfs:label>
        <dc:identifier>HP:0011448</dc:identifier>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011448</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27671894</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3f357e2e-05d6-435c-9a60-9f58c3a7adf7"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d8a3aaf7-f2fe-4a4a-b1eb-c8512a616409">
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <rdfs:label>Delayed mylination</rdfs:label>
        <dc:identifier>HP:0012449</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012449</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6bcff7f7-430a-4692-ac54-05fc63b0813b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27671892</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/25f1a107-2d89-43a9-b753-0e8d8d2488f3">
        <rdfs:label>Delayed motor milestone</rdfs:label>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001270</ddiem:url>
        <dc:identifier>HP:0001270</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/278b0c4b-7900-48ce-96e9-0dfe469f4dda">
        <rdfs:label>Behavioural abnormalities</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000708</ddiem:url>
        <dc:identifier>HP:0000708</dc:identifier>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27671895</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/effe6065-24cd-46c2-ad94-19825a4b63be">
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <rdfs:label>Neurodevelopmental abnormalities</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012759</ddiem:url>
        <dc:identifier>HP:0012759</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6b382b31-5580-44dc-b8dd-fa219b07f92c">
        <dc:identifier>HP:0001290</dc:identifier>
        <rdfs:label>Poor traction response (Poor muscle tone)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001290</ddiem:url>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719211006093#bb0025</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/250850">
        <dc:identifier>https://www.omim.org/entry/250850</dc:identifier>
        <rdfs:label>METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/0bdc02d5-2d24-4d39-9638-ae11eac5c352"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1283</ddiem:iembaseUrl>
        <rdfs:comment>Recommendation and guidlines in treating this disease and other inherited methylation disorders can be found in this link: https://www.ncbi.nlm.nih.gov/pubmed/27671891</rdfs:comment>
        <ddiem:iembaseAccessionNumber>1283</ddiem:iembaseAccessionNumber>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/22a1210a-09fe-408b-b860-c42beb61d387"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6f6af33e-f094-44d2-b2bb-9819425e6d73">
        <dc:identifier>HP:0001249</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001249</ddiem:url>
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <rdfs:label>Low IQ</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9511979</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4187796c-f13f-4b3d-bd5d-553140f3476f"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cff5ad14-37fc-4cc2-8a2b-6a64e90c0d89"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/011ad7f2-c8d9-4061-9af3-9ed4998242f7">
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <rdfs:label>Poor traction response</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27671896</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19585268</dc:provenance>
    <rdfs:comment>S-adenosylmethionine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30389272</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/014067369192373A</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a4bf1f1c-5fc0-4048-aa22-f22231ba66c1">
        <rdfs:comment>Phenotype was improved in combination of  AdoMat and disetry restriction. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930/</rdfs:comment>
        <dc:identifier>HP:0007266</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007266</ddiem:url>
        <rdfs:label>Brain demylination</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/84d17594-adb3-4c03-8b33-d585be516b16"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30384011</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6bdf1821-f881-4c40-8fa1-18ec9dc1c245">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003233</ddiem:url>
    <rdfs:label>Low HDL-C</rdfs:label>
    <dc:identifier>HP:0003233</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/adfd9f50-734e-4187-8975-569a5e40f41e">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8b45413f-1aa8-48ea-b40f-41aa8404d2e9"/>
    <rdfs:label>Complex Carbohydrates</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/57ef7c29-331f-44cf-89e4-c1fa39c1b128">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0000707</dc:identifier>
    <rdfs:label>Neurological abormalities</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/617070">
    <dc:identifier>https://www.omim.org/entry/617070</dc:identifier>
    <rdfs:label>PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4; PEOB4</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/33636784-6435-482f-80fc-b8b835aaf95e"/>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5625ef54-80af-430f-99c3-3314aa708658">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155</dc:provenance>
    <dc:provenance>https://www.nature.com/articles/nrrheum.2010.182</dc:provenance>
    <rdfs:comment>medium-chain triglycerides</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/de049929-0cdf-4f4a-bde4-5e8e4b3728fd">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0004325</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004325</ddiem:url>
        <rdfs:label>Low weight,growth</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0929693X16302044</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/48fd1c7d-5812-4ce9-8ff9-70044271a1b2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956717</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/369e2d68-3b59-4a4f-9422-0a8eb69cbe01"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23329770</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/145afb9f-03e8-4053-9e47-0984126c52d6">
        <rdfs:label>Diarrhea</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002014</ddiem:url>
        <dc:identifier>HP:0002014</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246700"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3b80c536-05d5-41f8-b804-bf9ee4e38b83">
    <dc:provenance>https://www.degruyter.com/downloadpdf/j/pteridines.1995.6.issue-3/pteridines.1995.6.3.144/pteridines.1995.6.3.144.pdf</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dad7c6d9-e87f-473b-aeb5-fee4d5142562">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040087</ddiem:url>
        <dc:identifier>HP:0040087</dc:identifier>
        <rdfs:label>Abnormal serum folate</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261640"/>
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <rdfs:comment>folinic acid</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/928214ea-cd79-4af8-9876-2b285791d753"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://rarediseases.org/rare-diseases/tetrahydrobiopterin-deficiency</dc:provenance>
    <dc:provenance>https://www.researchgate.net/publication/233414693_Deprenyl_in_6-Pyruvoyl_Tetrahydropterin_Synthase_Deficiency</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/255b214e-9d7e-4b8d-9018-ae8c7920b988">
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <rdfs:label>Abnormal exercise physiology</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0009020</ddiem:url>
    <dc:identifier>HP:0009020</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2d4980ec-1926-4d8b-bdee-a4a4d022a66e">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <rdfs:comment>Vitamin B+Betaine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f4534e0a-1ee9-4256-af1d-8fb7a6c636e2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d2b217be-f984-4350-809c-81a7631e0035"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/603174"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00638547</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20356773</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30081189</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/55fd6fe1-15fe-4a99-b1a5-6464ca1978a2"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4b3531a9-9a65-4c04-b25e-bb71f52029e1"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/caf6f043-92a5-48ca-b777-8fdf123508aa">
        <dc:identifier>HP:0012759</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>Developmental abnormality</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012759</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5d9dc51c-2ae1-43d2-ad3b-5684b8c1f486">
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000657</ddiem:url>
    <rdfs:label>Oculomotor apraxia</rdfs:label>
    <dc:identifier>HP:0000657</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/973f13f1-a72b-4be2-a4de-8ad11b118cab">
    <rdfs:label>low cerebral creatine</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0025051</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0025051</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7fa94d2d-60ef-4628-97c0-169873bcad65">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK6803</dc:provenance>
    <rdfs:comment>L-DOPA</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19666145</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01458119</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6cbfabc8-7f6c-41a4-af4e-940606802691"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dfad68fe-4687-4744-a762-2b07c75ffc8a"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00925301</dc:provenance>
    <dc:provenance>https://www.nature.com/articles/s41436-019-0451-z</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01218659</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30723321</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/612073"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f6b9ddf4-58a3-4c74-9a55-6ab42449216c">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fcb3067e-5943-49c8-a17b-abaeb28bb68c">
        <dc:identifier>HP:0004302*</dc:identifier>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <rdfs:label>disability(Functional motor problems)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004302</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <rdfs:comment>ramipril</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18098237</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/255b214e-9d7e-4b8d-9018-ae8c7920b988"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232600"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f50b4a0a-ade3-4d0e-af28-07813fe59ba9">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b6f19875-8a5c-49c6-be30-7ff267825c4b"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19019309</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24493026</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/adc1fd74-4a79-45e0-8e37-b33a7b9dbdf2">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Kidney disease progression ( Progressive disorder)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003678</ddiem:url>
    <dc:identifier>HP:0003678*</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/feb9cbc2-c7ea-4434-b6df-393617323894">
    <dc:identifier>HP:0001508</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001508</ddiem:url>
    <rdfs:label>failure-to-thrive</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2bd4b6b2-81ee-4212-801e-115f2390159e">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f67b9171-95f6-45c4-aaaa-68964dc68ea2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8d271a5a-68b5-4988-abc9-df84f53a055e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/530000"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/65d72ce2-8a15-4fa6-8b74-77790ed4adb6">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/654f5381-7e35-4dee-bb6f-f84f0234785b"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1ff18a2f-a73c-4941-854a-3a37f5306795">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d2796f48-f404-47ff-bad0-fd9ca71fb064"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9be947fe-7bbe-4f9f-89f2-0cf159d50e39"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/fd9bf38d-3093-4f49-98dd-871c1811bcb5"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27709644</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26884075</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/7199c277-e274-40f1-b74e-be9b419517f4"/>
    <rdfs:comment>dopamine, dobutamine, thiazide and milrinone</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/df990b33-c5e0-4f4f-aed3-b720ed100edb">
        <rdfs:label>acute congestive heart failure</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001635</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001635</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3baf30a6-a395-4233-aabc-cc5d9cb455db">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e901a3ff-3aa7-411c-8f1b-8fd34e3f0018"/>
    <dc:identifier>DB13173</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB13173</ddiem:url>
    <rdfs:label>Cerliponase alfa</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/245e8691-bd3a-424d-bb73-e505a50a7b5d">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/369e2d68-3b59-4a4f-9422-0a8eb69cbe01"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/200100"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25488886</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/78069a2f-bbbb-4ff8-a7a0-cd80d43709c1"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3954973</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <rdfs:comment>medium-chain fatty acid supplements</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26086616</dc:provenance>
    <dc:provenance>https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-3-20</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/948cd063-bb0e-4851-a0d9-164a72cc1e7b">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1f377c5b-1e52-492b-a2c5-a9e9f5c4f0ac"/>
    <rdfs:comment>carnitine</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25251739</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246900"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1567724914001299</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f24a6cb0-fc7a-4229-8c3b-98c78cc27199"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6cd4043c-eff5-42ff-bd84-d7c3b3a37d53">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0003304>R125Q</obo:RO_0003304>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f332fef4-ce87-45f9-a62b-c389cbd3aeb5">
        <dc:identifier>HP:0012379*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012379</ddiem:url>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <rdfs:label>Misfolding of cystathionine β-synthase(Abnormal enzyme activity)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14739681</dc:provenance>
    <ddiem:failedToContributeToCondition>H65R</ddiem:failedToContributeToCondition>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24355692</dc:provenance>
    <obo:RO_0003304>R266K</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20490928</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16619244</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/236200"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d8d2faad-7820-494a-b343-54467b0d3bdb"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f6a74312-8530-4a57-9080-6e8b64417139"/>
    <rdfs:comment>δ-aminolevulinate</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/6474c20e-05b1-4fa9-8b9f-2514aa912dc7">
    <rdfs:label>symptomatic (C)</rdfs:label>
  </ddiem:TheraputicProcedureType>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c592a367-a1a1-4654-81fa-51aa314cc940">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5ebbbf5b-caa6-4751-a827-fa118cece9ef">
        <dc:identifier>HP:0002900</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>hypokalemia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002900</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK442019</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602522"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
    <rdfs:comment>Potassium Chloride</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ad68a954-1230-4055-9bc2-967bc42c809e">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/5cead080-06cb-4312-bed6-380018745746"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/710177b3-4cb2-4fed-9c9a-511427266c10">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/207900"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073162</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6c1ab060-239c-42a4-b2f7-9131cd3318da"/>
    <rdfs:comment>Arginine</rdfs:comment>
    <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19585269</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a58a22a8-7133-4b49-95a9-c5e60e8197f0">
        <rdfs:label>abnormal hepatic function tests</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0002910</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002910</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0daa7e0e-7d73-4a56-a0ee-13d85925b62b"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3506c099-4af0-4e0b-999a-e5cacbd48e4c">
        <rdfs:label>Acute hyperammonemia</rdfs:label>
        <dc:identifier>HP:0008281</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0008281</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23040521</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d22558ca-b344-46d0-a36e-3a4e4c9fd4d7">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/202110"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18458702#</dc:provenance>
    <rdfs:comment>Cyclic medroxyprogesterone</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8f711736-aced-4f8f-b87a-e89302dc9ded"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2c0e2db6-de71-4097-a328-6d5dd457768d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26161337#</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8dad719c-3282-413b-ba30-58bfdff31601">
        <dc:identifier>HP:0000141</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000141</ddiem:url>
        <rdfs:label>Amenorrhea</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/250950">
    <ddiem:iembaseAccessionNumber>58</ddiem:iembaseAccessionNumber>
    <rdfs:label>3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1</rdfs:label>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/36a0c86b-3426-486d-bc0d-480697e83445"/>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/58</ddiem:iembaseUrl>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/250950</dc:identifier>
  </ddiem:Disease>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/dd97cb35-c269-4ca3-827b-408664b3b411">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01068</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4b6b24a2-e957-4fc4-a62d-641d8bb38d95">
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24746802</dc:provenance>
        <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/520000"/>
        <rdfs:comment>clonazepam</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28756475</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/25b16cdc-150a-41fa-a916-0b92333fc10d"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18d0909a-0c1f-4c79-b11d-8483d4d9f6f4"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/fa59e242-37a8-46df-964c-cb3eb805b00c"/>
    <dc:identifier>DB01068</dc:identifier>
    <rdfs:label>Clonazepam</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ca5efb11-4eba-4c0e-a963-3a2a09506c93">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/545000"/>
        <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d0fcd4ab-1939-4d6f-97d0-1fa394d5df08"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3a1240b1-79e5-4168-be06-007710215c6b"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
        <rdfs:comment>Levetiracetam/Clonazepam/Zonisamide</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14981187</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/36ef4ede-4f8e-467a-9f8a-9eec8b97f119">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/613163"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15895716</dc:provenance>
        <rdfs:comment>Phenobarbital/clonazepam/valproate/ midazolam</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/5707897</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29480352</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/06a2514b-7504-482e-87ff-232fc86fb93e"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7814809</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29358012</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19428278</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fac4bcc5-2bd0-4185-9ff2-002c496b8fd6">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/545000"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1490314</dc:provenance>
        <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/db6374f9-c8b2-4895-8207-3507a0ace131"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18d0909a-0c1f-4c79-b11d-8483d4d9f6f4"/>
        <rdfs:comment>Clonazepam</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6126c9ca-272f-4b23-8067-2a31df1b97e1">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26232052</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/18d0909a-0c1f-4c79-b11d-8483d4d9f6f4"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/208900"/>
        <rdfs:comment>clonazepam</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27906067</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4a72be18-3cb3-4ef8-9188-ebd570d0e3ce"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88faaf3d-4787-4e01-8c89-3fc2705fcbd1"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/139adc70-c74c-45af-80d4-d55c21dc2c57"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
        <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3e81ea87-1984-4958-86c6-dcad844b19a0"/>
        <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b6f19875-8a5c-49c6-be30-7ff267825c4b">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00178</ddiem:url>
    <rdfs:label>Ramipril</rdfs:label>
    <dc:identifier>DB00178</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f6b9ddf4-58a3-4c74-9a55-6ab42449216c"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/cf857336-4361-4eaf-8149-9812cd8f4940">
    <ddiem:url>https://www.drugbank.ca/drugs/DB11635</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/365ac0fd-09e1-4280-a757-9284569ca948">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27520363</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155</dc:provenance>
        <rdfs:comment>Tocofersolan</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/492fb91d-9feb-4c51-a0a0-d74ecb2a9903"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3fd430f1-afae-428a-8eaa-d127252651b3"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956717</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23329770</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/246700"/>
        <dc:provenance>https://www.nature.com/articles/nrrheum.2010.182</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Tocofersolan</rdfs:label>
    <dc:identifier>DB11635</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/55824b9a-d0f6-476c-9662-9e4395a18636">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/615398"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/64a00968-be06-4afb-ae56-c9d96b122b9b"/>
    <rdfs:comment>Phenobarbital</rdfs:comment>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0387760417301742</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cb6d935c-97ca-4752-9652-5786a9767154"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0b043726-7076-41ff-bb48-774fe39a44f1">
    <rdfs:comment>Vitamin K</rdfs:comment>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e0bc1445-06c8-4b36-98f8-93b182eb1049"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/200100"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25488886</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/af9bcc02-798b-41dd-b1a6-bbe58296adc3"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26086616</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26396722</dc:provenance>
    <dc:provenance>https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-3-20</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/220120">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/beeb1a6a-5eed-4801-ac11-37cac1597223"/>
    <rdfs:label>D-GLYCERIC ACIDURIA</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/220120</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/34e722d9-6d8e-4903-a3e1-85ef1e8bfadb">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5a4c0b3b-c68b-4ef7-8ad0-1d7bdd5c7120"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9525311</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/dafb0172-23b0-4ba6-9391-b9812659c129">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1a96590d-acaa-4e96-a78c-14b1bd138654"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Ad5/CMV/hUG-Br1</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/551ad276-a312-485c-88aa-3c483c4676ba"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9156798</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/218800"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15753292</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/aedf5679-926d-4abc-84a4-2e83fe1b2a6f">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/44a34bc9-b702-435e-a4f7-dfbe3ba3bc80"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5d9b1b28-7932-4b86-acb2-639550e93a56">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/bb9232fd-a365-4872-a321-4f97790eb062"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/059c1eb9-85ec-4790-80c7-d8ff16cd7556">
    <dc:identifier>DB14307</dc:identifier>
    <rdfs:label>Green tea leaf</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14307</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/21032cc7-d0c6-49c9-9fc4-02ee20f280f1">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/239500"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24980685</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S075333221630645X</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/96d730c7-a454-475c-a796-5da0952544fc"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <rdfs:comment>green tea extract</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/336fe7cb-51a1-4936-81e7-fbfea451908c"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/87a356e3-cb7f-45d2-8ab2-b876b1d5ca0d">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/253601">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/253601</dc:identifier>
        <rdfs:label>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2; LGMDR2</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/348a0c39-b65c-426f-99a8-b75998a229bc"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>Resolaris (ATYR1940)</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ca4aa5e9-0905-431d-8c4f-4accd4d502ad"/>
    </obo:RO_0000057>
    <dc:provenance>https://musculardystrophynews.com/resolaris-atyr1940</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02579239</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3c016ca8-d572-421e-aa3d-5e99c8851b73"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/19455619-af44-47cb-95fa-3c1b0f0e47f2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f3a27cff-0e8d-40ae-b4ea-e8f04367d4ac"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e36a779e-f7de-44c1-9b17-693118937a03">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.sciencedirect.com/topics/medicine-and-dentistry/crigler-najjar-syndrome</dc:provenance>
    <dc:provenance>http://pediatrics.aappublications.org/content/86/1/152</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5d379574-2b78-4f29-9cda-70f7a7f9bed0">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6f60d851-3f1b-4d3c-bf0d-7ac3a5cab0e3"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9e95e4e1-e89a-43e4-a869-edd80eb290bc"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <dc:provenance>https://www.nature.com/articles/pr1989488</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19752526</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/218800"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <rdfs:comment>Tin-protoporphyrin</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fc50c5d8-999c-4b88-8a4c-e9e17fbadcdb">
    <rdfs:label>low energetic state of heart(Abnormality of cardiovascular system physiology)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011025</ddiem:url>
    <dc:identifier>HP:0011025*</dc:identifier>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/86f4aae6-1c69-4478-a5b8-3fc9241fdc72">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ef969eb8-594f-4069-a6cd-e137763d8681"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00564</ddiem:url>
    <rdfs:label>Carbamazepine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3635a129-6339-478b-abe5-231c41cb6985"/>
    <dc:identifier>DB00564</dc:identifier>
  </ddiem:Drug>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/607091">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ae813101-c5b3-4d28-8a1b-120f8e2f96e1"/>
    <ddiem:iembaseAccessionNumber>338</ddiem:iembaseAccessionNumber>
    <rdfs:label>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/607091</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/338</ddiem:iembaseUrl>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d8f94458-9bcc-4c8b-8f8f-fb5650c2c004">
    <dc:identifier>DB00783</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/26fc9247-c0de-41c9-81ae-3f24f9030d14"/>
    <rdfs:label>Estradiol</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00783</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/00f191bd-4fef-4027-8fb7-0be2dddc954b"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d932e39e-c904-4166-ace9-dd9e7f2eb5e0">
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
    <rdfs:label>High spleen volume</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001744</ddiem:url>
    <dc:identifier>HP:0001744</dc:identifier>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ed67671c-7925-4a8a-88ba-cfa6471e2321">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/14761b48-f923-4086-9ebb-c10240ddad03">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/26e52b0b-382b-4dc4-ac36-c38356b5f7e7"/>
        <rdfs:label>Retrovirus</rdfs:label>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/83bfbaa6-f9eb-4112-91b6-d051302db2bf">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cc623263-81e0-42ea-8de7-cfede56fe2ba"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2a613dff-a385-49f4-b127-52e3dae89ac3"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26118651</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9c337fd0-142f-4f86-89aa-9acbe6aad488"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27709644</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/87773692-3665-4b9d-8e9c-762077ce7b16"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8e8a6686-58cf-461c-a08d-a39928e91bdc"/>
    <rdfs:comment>mitochonic acid 5</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/df0124bf-76a1-4d02-aeeb-a6e951eccfde"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26884075</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/530000"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f62d10aa-ee3a-4833-b236-d8e995af88e6">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b5c5ef98-6973-4b1a-8939-8958284594d9"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14681</ddiem:url>
    <rdfs:label>Cortisone</rdfs:label>
    <dc:identifier>DB14681</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e1796b5f-8fa4-4342-b6ed-d8a16486a153">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/612319"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29390242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21735565</dc:provenance>
    <rdfs:comment>botulinum toxin</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b40db580-d382-40b6-b331-d92476228868"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27491218</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/36e2b8dd-d3fa-45a8-b301-40f7712ffcb7"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7a97b45f-65f1-4a62-9273-3be3e0c3a471">
    <dc:identifier>HP:0000707</dc:identifier>
    <rdfs:label>neurologic dysfunction</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ad606954-2370-4dfa-b6c3-d2f11689a63f">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000739</ddiem:url>
    <rdfs:label>anxiety</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0000739</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d5b37736-0491-4901-9dbc-970bc9ffa0ce">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003434</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Progressive ataxic neuropathy</rdfs:label>
    <dc:identifier>HP:0003434</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/145f732d-b1d4-47e1-bbbd-47caeca39394">
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>Duloxetine</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e6a37d8b-9da8-4b53-adbc-376a4c0c5ede">
        <rdfs:label>Depression</rdfs:label>
        <dc:identifier>HP:0000716</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000716</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/540000"/>
    <dc:provenance>http://ichgcp.net/clinical-trials-registry/NCT03432871</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29596118</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d8469d49-8f45-4caf-9d9c-513c5b906995">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c0e6ccf5-dc0d-4f9a-97f5-e042ec490545"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/11e93ecd-6c07-4368-bb80-fb940e42a179">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001892</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0001892</dc:identifier>
    <rdfs:label>Vitamin K insufficiency</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/65dd3260-0893-4e08-92a2-67b2e208f92e">
    <rdfs:label>Symptomatic (C) + Functional interaction( Mechanistis B)</rdfs:label>
  </ddiem:TheraputicProcedureType>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ffd76157-6d39-443d-9ab4-270bc6aaf525">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003201</ddiem:url>
    <rdfs:label>rhabdomyolysis</rdfs:label>
    <dc:identifier>HP:0003201</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/46feb19a-f257-4967-a9ef-a0956682bddc">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20975743</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>Calcium+ vitamin D3</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/89fdd0e0-a33e-4303-b9d4-dcaf6df4e853"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bc7b032b-0b40-4776-b24c-7da180f3d332"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.semanticscholar.org/paper/Glycogen-storage-diseases%3A-Diagnosis%2C-treatment-and-Chen-Weinstein/439025d057229db1b3a117cb02b3c7e6f2bd3580</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/873a62e3-7f54-46b9-8d98-76d7277f38ed"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/de6107f4-1119-4109-82c6-045b70dc63ff">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b0f4fa07-673a-4208-b42c-39a0a4d09d15"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/591a678f-992c-43e3-bc48-dd11fa3ae7c7">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/0ad70eb7-90f3-487c-875c-31d2d4a0ae7d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/dea6ae96-b836-4f17-ad97-43d8b37ca573">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/77ba39b2-293b-4c12-b218-84db24624951"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c0dfe8c9-600b-4b9a-a290-5c67798f28d9"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02998879</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508465</dc:provenance>
    <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/609458">
        <rdfs:label>MANNOSIDASE, ALPHA, CLASS 2B, MEMBER 1; MAN2B1</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/2696acca-9544-45e1-bed5-afcbfef2c901"/>
        <dc:identifier>https://www.omim.org/entry/609458</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26827607</dc:provenance>
    <rdfs:comment>AAV1vector expressing α-Mannosidase</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/367914ff-d0f1-4852-82ab-2847f2103108"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6c2d6178-ce0e-4030-9f03-e21ee74641e4">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/deeaed3f-dca6-4071-84a1-0cf8273c7e54"/>
    <dc:identifier>DB00182</dc:identifier>
    <rdfs:label>Amphetamine</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00182</ddiem:url>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6d718d78-3f80-4ee2-9cea-edff9addf399">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b0ea1251-bb53-4727-a5fd-64bdac27f633"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/27cdd756-1118-45e1-aac2-c850c8df5ef4">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00926</ddiem:url>
    <dc:identifier>DB00926</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/92d15d70-7fc5-427b-b1ff-cd1b9902d5ff">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/472333b9-c892-4437-bb4c-b3d49c8eba92"/>
        <rdfs:comment>etretinate</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/41d03c5d-6f66-498e-b2d9-a485319398a9"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10738634</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/245010"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02534844</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b1b35dc4-3444-491d-be3f-613e0972571c"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Etretinate</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dc2ce1ce-8264-4042-9abb-91a8f3414d03">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0040144</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0040144</dc:identifier>
    <rdfs:label>L-2-hydroxyglutaric aciduria</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6edf2460-2896-42b4-8739-85b319f0b0af">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ff0fdbac-5589-49c5-a3b2-cb2aff951cbf"/>
    <dc:provenance>https://link.springer.com/referenceworkentry/10.1007%2F978-3-540-29676-8_1729</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12391354</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19234759</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12003346</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719208000048</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10078749</dc:provenance>
    <rdfs:comment>L-dopa</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20818608</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/233910"/>
  </ddiem:TheraputicProcedure>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000004">
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure in which a genetically defective protein is replaced by a canonical source of the same protein, genetically as in gene therapy, or by some other means of delivery, whose completion is hypothesized by a health care provider to eliminate a disorder or to alleviate the signs and symptoms of a disorder or pathological process. [PNS]</obo:IAO_0000115>
    <dc:creator>leechuck</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T10:19:07+00:00</dc:date>
    <rdfs:label xml:lang="en">direct complementation of genetically defective protein</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000002"/>
  </owl:Class>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2f0c9dd6-4816-4773-a8a8-5c13503c6c30">
    <dc:identifier>HP:0030980*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0030980</ddiem:url>
    <rdfs:label>Low CSF glutamine level</rdfs:label>
    <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e19bc033-3859-42bb-93e9-002374d3f3cb">
    <dc:identifier>HP:0010836</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010836</ddiem:url>
    <rdfs:label>hypocupraemia</rdfs:label>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cc4e01de-f611-4bea-ad1c-c6b289dade1c">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/965a516a-4893-46de-9842-75fe9d480fa2"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ae72e116-7db0-4fbb-a673-428edc8bf920">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000708</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0000708</dc:identifier>
    <rdfs:label>behavioral abnormalities</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/da32d686-aa8d-4bef-b16b-4a3033bff226">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e190f83e-63df-4e23-acbd-d528bd02fbb0">
        <rdfs:label>Elevated intraneuronal cholesterol (Abnormality of cholesterol metabolism)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003107</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003107*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cc018caf-58af-44fd-9df1-8f960008ea90"/>
    <dc:provenance>https://www.tandfonline.com/doi/full/10.3109/0886022X.2014.900422</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/607625">
        <dc:identifier>https://www.omim.org/entry/607625</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/795875bf-e40e-440e-ac94-c956e986e35f"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/304</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <ddiem:iembaseAccessionNumber>304</ddiem:iembaseAccessionNumber>
        <rdfs:label>NIEMANN-PICK DISEASE, TYPE C2; NPC2</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>2-hydroxypropyl-beta-cyclodextrin</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2162b5ee-6aae-4131-b398-b7531ccf59b6"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/21a78484-b5a3-410c-a446-4bef7e938326"/>
    <dc:provenance>https://www.intechopen.com/books/cyclodextrin-a-versatile-ingredient/use-of-2-hydroxypropyl-beta-cyclodextrin-for-niemann-pick-type-c-disease</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/be6d3e84-a74a-4adf-9b65-31938bc240af">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2a7689bf-05f5-488f-ad12-0d9b7f6ee2cf"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7d82eacb-bbbc-4964-a2b1-4bc779f938d7">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/eaf7661e-b620-41d5-8c07-b1d4fa6f4b19">
        <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=B01</ddiem:url>
        <dc:identifier>B01</dc:identifier>
        <rdfs:label>ANTITHROMBOTIC AGENTS</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/65b2cd23-74b9-4742-837a-60c3e13f0eca"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/451728e4-3dbe-4a69-bfcd-cbdbab18e63e">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0040006</ddiem:url>
    <rdfs:label>mortality</rdfs:label>
    <dc:identifier>HP:0040006</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6c17b35d-a792-4eff-9be8-d0e6f40fa0bb">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/239500"/>
    <rdfs:comment>lithium</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/67f20c4d-0178-4909-9b47-803ac72742c4">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000725</dc:identifier>
        <rdfs:label>psychotic  disorder</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000725</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0387760417300086</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/55cbc2a3-c6d1-4cee-8b95-74ea92204d59">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/84ee9818-ce72-448a-a7c4-decfdd34b3ed"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28285122</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8ae01d77-d96a-4959-a70e-e7620bb060f5">
    <rdfs:label>Vigabatrin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ea5f7ca3-8f52-4f3e-a881-2638825aa332"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/72ff7ece-5736-468d-a11b-67741b0cc6fd">
        <rdfs:comment>vigabatrin</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22149023</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e0867496-530c-4284-849e-e8a64e44497b"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/220110"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b44e26a0-e21b-4fd2-a0e8-e49264b14e5c"/>
    <dc:identifier>DB01080</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/fdac19d1-7815-4640-85fa-db3d5d63adef"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01080</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/36ccadaf-1a5e-4dcf-967e-825fcd418fbd">
    <rdfs:label>Diclofenac</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ee0e16f1-7930-4c93-b3a9-2332e28a8eb0"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00586</ddiem:url>
    <dc:identifier>DB00586</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b0ee997d-a92f-4e23-8e88-1676593b0bac"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/aef0377c-e1c3-4146-b3ae-02c6018ea2d0">
    <dc:identifier>HP:0002917</dc:identifier>
    <rdfs:label>Hypomagnesemia</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002917</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a0591cb9-3098-4cd7-a5da-7607cc9c2b55">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22830360</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <rdfs:comment>l-glutamine</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a848fb51-d2f8-4ae7-bbee-c34f77e10e6f"/>
    <dc:provenance>http://www.ncbi.nlm.nih.gov/pubmed/16368216</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514707</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25896882</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/44cb0dc6-24fc-47bd-b65d-0e075dbe1bc1"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fba10fee-66ff-47ac-8029-2fdd52a19f6a">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002329</ddiem:url>
        <dc:identifier>HP:0002329</dc:identifier>
        <rdfs:label>unalertness</rdfs:label>
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27775558</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9d7084bd-c9ab-4438-8f2c-2c37ee4cefcd">
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0030980</ddiem:url>
        <dc:identifier>HP:0030980</dc:identifier>
        <rdfs:label>Low brain glutamine concentration</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d138227e-ad25-4e34-8290-81f332c7d6c7">
        <rdfs:label>Secondary NAD+ deficiency in leucocytes</rdfs:label>
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2cc84d9d-f180-46cf-a781-5f048ea22984"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fc1e8c22-d97b-4f68-95c1-d3f26b1e0de4">
        <dc:identifier>HP:0010903</dc:identifier>
        <rdfs:label>Abnormal plasma glutamine levels</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010903</ddiem:url>
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/266130"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2f0c9dd6-4816-4773-a8a8-5c13503c6c30"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8473b659-07f4-4aba-a5bb-33f7d8b139c8"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4b53b15f-7b79-4afa-86ae-490e012fc713">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/604250"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/96bf0b70-640d-4855-9df3-efb662012d8c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00001203</dc:provenance>
    <rdfs:comment>Deferoxamine</rdfs:comment>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs12185-017-2365-3</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3221dd31-98b4-4447-b38f-8fd197ae3fb2"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/74e3f7e7-105c-455a-af72-76cf06903bed">
    <rdfs:label>Angiotensin II receptor blockers (ARBs), plain</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/104461c0-66d3-4840-a584-950ee2b77f03"/>
    <dc:identifier>C09CA</dc:identifier>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=C09CA</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2946feee-2222-4277-86af-79aeaca78fab"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/87ca9847-7b7e-41b9-86fe-18a6b3298a5e">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9c3cae6c-322f-48f4-a15a-d0c57cdc8e45">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001649</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>tachycardia</rdfs:label>
        <dc:identifier>HP:0001649</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ee75335f-78ac-4c28-ad0e-a3e3b880ce80"/>
    <rdfs:comment>Panhematin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358544</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15767622</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f510a06a-1988-4100-844e-5abf4c5da37b">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/dde23fc9-b94b-4137-8c52-d1f0dfeb46a0"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c5ca01f1-fcbf-438e-bf5b-c6c7d368bab1"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dceaa3d6-583a-4d3c-bbfe-a701c6eafa04">
        <dc:identifier>HP:0011009</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011009</ddiem:url>
        <rdfs:label>Acute attack</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02922413</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/07df196e-5e8f-43d8-a4ea-283bdc0642c5"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02180412</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/176000"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/de89c759-c68a-4368-8c88-4aea52f28197">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02180412</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19861948</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c685ea27-56d3-4ecb-9941-24fe8048baf9">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0001939*</dc:identifier>
        <rdfs:label>Hepatic metabolic abnormalities ( Metabolism abnormality)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/176000"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/23c08290-4916-4e15-bd26-f5cf6afb1cc2"/>
    <rdfs:comment>rAAV8-mediated gene therapy expressing murine HMB-synthase</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358544</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ddd88dcd-b227-4349-b792-3419eced315f"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ef13032f-9ca6-4733-a879-c9e2cb54e8aa">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/cacf19f6-b6df-4cbd-ac0c-62c55ce223a2"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15767622</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/05d1d3fb-3906-4817-af6c-3625b6cf19c9"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b5422e82-3325-42d7-868c-e616560fff7b">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002333</ddiem:url>
        <dc:identifier>HP:0002333</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Abnormal neuromotor function</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5f927cb3-5af2-4ad1-b434-1379f98d3ca9">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12181212</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21354122</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2065040</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e1ef0cd2-2655-4491-84c8-fa3d38ab2c41"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0c075898-d9c6-40da-832b-e31f47f90caf">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7674d9e5-68ea-4481-9a9d-aba5f07616e1"/>
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/10c33a6c-d0f6-466f-9880-63cd64130ec8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3162680</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Bezafibrate/ atorvastatin</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5bdb50f5-03c4-4042-9655-5e187b061328">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/177000"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23884489</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7fa61949-b6e0-4da2-99a1-d22e6690f132"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28003770</dc:provenance>
    <rdfs:comment>Afamelanotide (Scenesse)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26979527</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25402764</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/52396400-40d3-4a90-a221-f73fcff263d2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d759014b-24b5-4b66-bae5-2c095bf7e192"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1f584a7a-29d8-4e4d-8933-4c9964998ab6">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000992</ddiem:url>
        <rdfs:label>Cutaneous photosensitivity</rdfs:label>
        <dc:identifier>HP:0000992</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19656325</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b98d7f33-d242-4c0c-8396-9bd20cfd2cf4">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c2fc92b9-9e6d-435c-a4b2-e4b478079457"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01586</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2b2658b9-05f9-4d1f-a55a-a3b4162db96e"/>
    <dc:identifier>DB01586</dc:identifier>
    <rdfs:label>Ursodeoxycholic acid</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/092a66a3-aacb-46f2-917f-b1336b36d9fd">
    <rdfs:comment>Valproic acid</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e4ef1cd4-790c-4c9e-b816-cdfa0286f386"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/220110"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22149023</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f5f12e11-cba6-4af8-a524-d42876d016ea">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Abnormal prostaglandin level</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011023</ddiem:url>
    <dc:identifier>HP:0011023</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0caa53da-8b5a-4491-8f4a-3574875004c0">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004359</ddiem:url>
    <dc:identifier>HP:0004359*</dc:identifier>
    <rdfs:label>Abnormal Fatty acid oxidation</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fd31825e-dc4b-4304-a327-798d7406814e">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/bba0530a-acff-4e5b-966a-913451038643">
        <rdfs:label>Nitisinone</rdfs:label>
        <ddiem:url>https://www.drugbank.ca/drugs/DB00348</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b8a7db86-d18a-4205-9e3a-61718498b455"/>
        <dc:identifier>DB00348</dc:identifier>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/bf9e99fc-b5aa-468d-9119-7f0234ce80ed"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9379d84c-7971-4391-a049-81c2b21867e0">
    <rdfs:label>Abnormality of peripheral nerves</rdfs:label>
    <dc:identifier>HP:0045010</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0045010</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/84d31cb2-afaf-4e93-a0da-2a5e6c34c90d"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/805b702e-77cf-4343-93db-cefc88abf9df">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/34cbeeb4-2a44-4fdf-818d-72ae6ce46274"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/4b53b15f-7b79-4afa-86ae-490e012fc713"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2bdad668-d1af-4f41-a87a-cc25ac2c49a9"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/106e3220-93e6-4a8d-9876-223830310d06"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00746</ddiem:url>
    <dc:identifier>DB00746</dc:identifier>
    <rdfs:label>Deferoxamine</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/309473e7-3313-4f25-94fd-6188a5bea2e8">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/520000"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24746802</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28756474</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/083ff325-ce40-47d6-a081-d2e242baea05">
        <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
        <rdfs:label>Diabetes</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000819</ddiem:url>
        <dc:identifier>HP:0000819</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/56c59939-e4bf-45b8-8025-88728b3347a7"/>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <rdfs:comment>insulin</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6b15dc6a-c452-461a-916d-ff3b48bcd42b">
    <dc:identifier>DB01783</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/daf4d76c-3a50-43e9-81e9-0e90de459774"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01783</ddiem:url>
    <rdfs:label>Pantothenic acid</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b6b090c3-5364-4623-bc46-088cf7c0bfe0">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6990c767-3cf0-404b-b5e6-95943c805fbb"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/209300"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8317485</dc:provenance>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4eb66bda-c604-4014-ab16-d03970e7b964"/>
    <rdfs:comment>Ferrous sulfate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28895280</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/34f3117e-e999-489c-a10a-32c73b1bbb49"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b3648bc1-a07d-4d44-aa9c-216cac5524e6">
    <rdfs:label>Impaired myocardial contractility</rdfs:label>
    <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0006670</ddiem:url>
    <dc:identifier>HP:0006670</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6f3e4cbe-cf47-4fca-99fd-75d43a8762f2">
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <rdfs:label>Trial is still in the Recruiting stage.</rdfs:label>
    <dc:identifier>HP:0002155</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002155</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/cb7ab3ab-67fc-43ce-b297-6baab286c2c6">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5d4383bd-1586-4cb4-90d2-0d54b30b6ed8"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/49b0b874-21b1-41ad-9f33-5893b4c04ba3">
        <rdfs:label>High plasma citrulline levels</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011966</ddiem:url>
        <dc:identifier>HP:0011966</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/369e2d68-3b59-4a4f-9422-0a8eb69cbe01"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29651749</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/603471"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26427088</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10870849</dc:provenance>
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/781bdc3d-1053-45a4-93b4-dd44ba4b87e6">
        <dc:identifier>HP:0001987</dc:identifier>
        <rdfs:label>High blood ammonia level</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001987</ddiem:url>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2d29332a-d685-45b9-8e55-63c79fec4e8a">
        <rdfs:label>low plasma glutamine levels</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010903</ddiem:url>
        <dc:identifier>HP:0010903</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Medium-chain triglycerides</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15670720</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c0e6ccf5-dc0d-4f9a-97f5-e042ec490545">
    <dc:identifier>DB00476</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00476</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/145f732d-b1d4-47e1-bbbd-47caeca39394"/>
    <rdfs:label>Duloxetine</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/eeee5ff0-425b-452a-b377-404778299abe">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232200"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20195241</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/eefb9cb7-62e4-4958-a173-5ce3ccc15ceb">
        <dc:identifier>HP:0012211</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012211</ddiem:url>
        <rdfs:label>Abnormal renal function</rdfs:label>
        <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558>
      <ddiem:Evidence rdf:about="http://ddiem.phenomebrowser.net/ECO:0005242">
        <dc:identifier>ECO:0005242</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/ECO_0005242</ddiem:url>
      </ddiem:Evidence>
    </obo:RO_0002558>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5e64a8d3-8b07-4a74-a89d-1f78874cc126"/>
    <dc:provenance>https://www.nature.com/articles/srep44408</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9c90713a-3619-4bad-9cb1-ea76790d3a2d">
        <rdfs:label>Renal disease progression( Progressive disorder)*</rdfs:label>
        <dc:identifier>HP:0003676*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003676</ddiem:url>
        <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/89277781-fd8d-4745-8e18-53132657ad95"/>
    <rdfs:comment>Tempol</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18996862</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/110ba0d8-10f6-4a18-8b2f-3c920c57f88d">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c31c0e16-4a1f-4dfa-8307-6d7f0c34f4e9">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612542</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25781533</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17442906</dc:provenance>
        <rdfs:comment>Sodium phenylbutyrate</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3ee032dc-c022-4a8e-92f6-dd40d135ecdb"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/307030"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Phenylbutyric acid</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0389ccd7-35b8-4f61-a9ef-fead9d6792cb"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB06819</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8c14e4b9-e5a0-45b9-aeaa-feb51aabd4ea">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9f4da0b7-bc68-4593-a7c4-e98ccf7624da"/>
        <rdfs:comment>sodium phenylbutyrate</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052756/#S10title</dc:provenance>
        <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508465</dc:provenance>
        <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3ee032dc-c022-4a8e-92f6-dd40d135ecdb"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/207800"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11148549</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382922</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7b19e59e-8775-4276-b262-a7edb66d5fca">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28057010</dc:provenance>
        <rdfs:comment>sodium phenylbutyrate</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27567650</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26865117</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6c37d423-92c1-45fa-96c6-3440a6085ae1"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3ee032dc-c022-4a8e-92f6-dd40d135ecdb"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301535</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB06819</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/28dbcd66-aa16-46a2-b924-1cb9227ffd09">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a1ccef47-db94-409a-8704-81af1aee0482">
        <rdfs:comment>Niacin was the only effective drug to increase HDL cholesterol.</rdfs:comment>
        <rdfs:label>High mean number of GL-3 inclusions,kidney interstitial capillary(KIC)</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>migalastat hydrochloride (AT1001)</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01218659</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/10dad6b8-006e-4743-b1d8-eab43f3fdf6f">
        <rdfs:label>High plasma lyso-globotriaosylsphingosine level</rdfs:label>
        <rdfs:comment>Niacin was the only effective drug to increase HDL cholesterol.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30875019</dc:provenance>
    <ddiem:failedToContributeToCondition>"E48K, R49P, S65I, I117S, G183V, G261D, G271S, S276G, R342Q (n=8), L414S"</ddiem:failedToContributeToCondition>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27509102</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3851d75c-665e-463c-8148-9bc557a14d50"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30765910</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/01b9184a-4fdc-4cb4-8253-5df449a59491">
        <rdfs:label>Left ventricular hypertrophy</rdfs:label>
        <rdfs:comment>Niacin was the only effective drug to increase HDL cholesterol.</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001712</ddiem:url>
        <dc:identifier>HP:0001712</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/301500">
        <ddiem:iembaseAccessionNumber>296</ddiem:iembaseAccessionNumber>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/296</ddiem:iembaseUrl>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>FABRY DISEASE</rdfs:label>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/542093ba-0d47-40b6-a8b4-5f99581d5533"/>
        <dc:identifier>https://www.omim.org/entry/301500</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/0ad70eb7-90f3-487c-875c-31d2d4a0ae7d"/>
    <dc:provenance>https://www.nature.com/articles/s41436-019-0451-z</dc:provenance>
    <obo:RO_0003304>"p.D33G/p.L36W (n=2)/p.D55V/p.Q57L /p.G85D/p.R112H/G144V/p.I253T (n=4)/p.G258R (n=2) ,.A156T (n=3)                             p.P293T (n=2) /p.C174R                                                                                                           p.F295C                                                                  p.G183D (n=2)                                    p.L300P                                                                      p.M187I                                                                             p.R301Q   (n=3)                                                                           p.P205T (n=2)                                p.I317T                                                                  p.Y216C (n=3) /                             p.D322E (n=2)                                                    33p.L243F                                                                              p.G325R (n=2)/p.G373S / p.D244N/ p.R356W"</obo:RO_0003304>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01458119</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00925301</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30723321</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27834756</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5c078c61-8cef-47b7-8c17-b53fafae2932">
    <rdfs:label>deambulation</rdfs:label>
    <dc:identifier>HP:0100022</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100022</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/05e01909-416a-463b-83d5-3721c0f6f426">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9176bbd9-6613-43d4-962d-24f36e8b9fd6"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00175</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/fa58f39b-caec-4628-89f7-c594e9d8a06a"/>
    <rdfs:label>Pravastatin</rdfs:label>
    <dc:identifier>DB00175</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/be2a14b9-78c4-40bd-afd5-cf97ca99e556"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a9035d1c-9c03-414f-864f-7f44657a36fc">
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/246604c0-52d2-47d6-afdd-12dbe65c543a">
        <rdfs:label>Abnormal blood Phenylalanine levels</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004923</ddiem:url>
        <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
        <dc:identifier>HP:0004923</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b04541f7-9bbf-4e36-9f9c-52669a138a22"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719218300210</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1525001605000845</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <rdfs:comment>Pegvaliase</rdfs:comment>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261600"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/32efc9dc-0737-41f9-b5b0-06a075057713">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/67ecc339-e2aa-4db0-860c-570caf76e21b">
        <rdfs:label>Progressive ataxic retinopathy</rdfs:label>
        <dc:identifier>HP:0000488</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000488</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs00223-011-9562-5</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/615558">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/e3928e64-a8f6-4174-a1ae-b2fec8d42653"/>
        <rdfs:label>HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/615558</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/116387c9-2a90-4990-bb34-1e6d972eafa9"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/efc6d42d-64bd-48e1-ad15-a1aa4db6f36b">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Fat soluble vitamin  Malabsorption</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002630</ddiem:url>
        <dc:identifier>HP:0002630</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26086616</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9f728f71-f9ff-4172-896f-2a997758048e">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Fat soluble vitamin  Malabsorption (Fat malabsorption)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002630</ddiem:url>
        <dc:identifier>HP:0002630</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <rdfs:comment>Vitamin A</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24751931</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/86d4928b-9e64-4ed1-b0ff-bb48252b640f">
    <dc:identifier>HP:0001367</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Joint disesae</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001367</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/aaba4f92-5d31-487b-aad1-2cd51c097158">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18425437</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25667865</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7760062</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5ca28c24-9eac-4f3c-aebe-d4fc037deded"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261630"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <rdfs:comment>Levetiracetam</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26817292</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/88b23ae1-3b09-4c5f-8470-21c4e414dccc">
    <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
    <dc:identifier>HP:0011197</dc:identifier>
    <rdfs:label>EEG with focal spike waves</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011197</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b26846fd-e165-4645-af42-051945afa653">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001941</ddiem:url>
    <dc:identifier>HP:0001941</dc:identifier>
    <rdfs:label>Acidosis</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/adf09f53-7c7b-4321-8118-54e5eb451b64">
    <rdfs:label>renal salt wasting</rdfs:label>
    <dc:identifier>HP:0000127</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000127</ddiem:url>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2cd5693d-f92f-44b6-843e-80eacabbeba6">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01218659</dc:provenance>
    <rdfs:comment>Lucerastat</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02930655</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0518dc4e-a3d5-4af4-9f3f-beb33692c56d">
        <rdfs:label>High Gb3(globotriaosylceramide) accumulation.</rdfs:label>
        <rdfs:comment>Niacin was the only effective drug to increase HDL cholesterol.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29982630</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28088251</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/84e68f97-a492-4a09-9035-eb5c0ddf60dd">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/46519762-60df-4225-aac9-e4861713e6c8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03425539</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03737214</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/301500"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e0433680-3bb8-415a-8f01-ef72ca06dbaf">
    <dc:identifier>HP:0000708</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000708</ddiem:url>
    <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
    <rdfs:label>Psychiatric disturbance</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f048123f-16ad-4c00-9530-0bfcb64ffb16">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0200125</ddiem:url>
    <dc:identifier>HP:0200125</dc:identifier>
    <rdfs:label>Mitochondrial respiratory chain defects</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f37082c6-06da-43ba-8b5b-cc772b054d3c">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/615182">
        <ddiem:iembaseAccessionNumber>924</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/7c21eac7-22d4-4bb3-a450-5aa533e1d70d"/>
        <dc:identifier>https://www.omim.org/entry/615182</dc:identifier>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/924</ddiem:iembaseUrl>
        <rdfs:label>COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD</rdfs:label>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S109037980800010X</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b014e4ff-6164-48a1-b42f-7b2c31ec2206">
        <dc:identifier>HP:0012405</dc:identifier>
        <rdfs:label>Hypocitraturia</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012405</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/08ebd2bd-1a14-4132-8f41-372022daddf8"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dc2ce1ce-8264-4042-9abb-91a8f3414d03"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ab5e2a81-744f-4db7-93c2-80f4c8e2cc90">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012321</ddiem:url>
        <rdfs:label>D-2-hydroxyglutaric aciduria</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0012321</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/79ba0332-010f-4fc7-add3-f417209585c5"/>
    <rdfs:comment>Citrate treatment</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/298f193b-e6d7-472c-a8a1-ac3d22c506d5"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24687295</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d2b20689-7817-4a56-b94f-d9c3f79ccfe5">
    <dc:identifier>HP:0001939*</dc:identifier>
    <rdfs:label>secondary glutathione deficiency(Abnormality of metabolism,homeostasis)*</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/0a705795-e60e-412e-8ef3-aafc2ec4d15c">
    <rdfs:label>Pyridoxal</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0b0fb918-8245-4388-93e5-93c715bb64ca">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096504</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316461</dc:provenance>
        <dc:provenance>https://www.researchgate.net/publication/8668575_A_successful_treatment_with_pyridoxal_phosphate_for_West_syndrome_in_hypophosphatasia</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/990aceab-2de4-45c8-b7aa-ce77c3b8807b"/>
        <rdfs:comment>pyridoxal</rdfs:comment>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/241510"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ff162398-4209-408c-bf89-f8030b034ca1"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>an enzyme-replacement therapy</dc:provenance>
        <dc:provenance>"ENB-0040</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <dc:provenance>NCT00744042.)."</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00147</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00147</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dfd511e1-23c5-4c8e-ac2d-c323cfd043bf">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0000093</dc:identifier>
    <rdfs:label>Proteinuria</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000093</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0c1b14ce-6e73-47b3-aeb4-86863237c668">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0f5ea12d-6321-4ccf-8ba8-7a2374803109"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488882</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6f2e0e99-5b8f-42bd-844c-d1b1ff94bf59">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3ad2b87e-290a-4bbc-a028-689df1014791"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Pegademase bovine ((PEG-ADA))</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01420627</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/102700"/>
    <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726071</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5f40330d-fb4e-4c0b-905d-cf61a3233f7b"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4de1eeb8-80e7-4abb-b968-0af5b863140d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29241594</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/0ad70eb7-90f3-487c-875c-31d2d4a0ae7d"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b50e2842-6e1a-4ee2-ada3-6422b9b721eb">
        <dc:identifier>HP:0010975</dc:identifier>
        <rdfs:label>Abnormal number of b cells</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010975</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2eb846fa-a76a-4739-90f0-34adc9963b88"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5878500a-556f-4b57-bfa3-69d19ea40912">
    <rdfs:label>abnormal SF-36 physical composite scores</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/40a4b19d-1b0f-4902-b8ed-8d5f1a4cc5cb">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7f2827c0-c681-40fe-8057-fd4b1c21783d"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f15b6478-5005-426e-ac88-e28c4cf39cbc"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/40e82c50-2ba7-4f80-afa3-4d99ceb0e9ca"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24613482</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/aef396a0-835b-40f1-af55-56f464f15951">
        <dc:identifier>HP:0001939</dc:identifier>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
        <rdfs:label>abnormal blood levels of ketone bodies</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f7cd1061-ab0c-4615-a078-ce4d2cbe9ae6">
        <rdfs:label>high creatine kinase</rdfs:label>
        <dc:identifier>HP:0003236</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003236</ddiem:url>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8cb7ab8f-c428-4e90-a1d2-c0a9da413bd3"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f8eab484-fc08-47a6-8179-874f25e7c362"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0c2bd029-597e-4638-a489-07aa5d491f7e"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7d77b1fd-9cc2-4205-9bab-d5f66ae02e30"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/86a58681-1069-4002-a34d-6858a99ec5e1">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/546c51f7-2eaa-4f63-8371-582f0927636f"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c651d04c-7593-4f26-9354-b886133c2ebc"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fc50c5d8-999c-4b88-8a4c-e9e17fbadcdb"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ceb18142-1e9d-45c5-9224-cbfb91fbd2ec">
        <dc:identifier>HP:0004359</dc:identifier>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004359</ddiem:url>
        <rdfs:label>Abnormal blood levels of  fatty acids</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/503d7da2-b23c-4b72-8f2e-ab726ebf1a49">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003236</ddiem:url>
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <rdfs:label>Increased creatine kinase activity</rdfs:label>
        <dc:identifier>HP:0003236</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302571</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20631546</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8b8b950d-0ad6-4254-9a6f-2f14d558b145">
        <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
        <rdfs:label>low energetic state of skeletal muscle</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011804</ddiem:url>
        <dc:identifier>HP:0011804</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3d09026e-8a52-4595-b796-0819f86bf86f"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232400"/>
    <rdfs:comment>Modified Atkins diet</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3b518883-a562-40a3-b578-801f69eeef43">
    <dc:identifier>DB09539</dc:identifier>
    <rdfs:label>Omega-3-acid ethyl esters</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0136b231-1516-4c72-b410-172c43a98700">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22142470</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4e47e97d-8ecf-49b0-8455-203d98089e9e"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25993639</dc:provenance>
        <rdfs:comment>Omega-3-acid ethyl esters</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/145750"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16390715</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09539</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e84b91fa-1766-4621-85b2-a7be145c04c8">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/309000"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/59/33</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26251718</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/431e2624-36a6-46f1-943c-24083e7649e2">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6b58a916-8cd6-4fc3-8318-9634dc36755d"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Thiazide</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/9e2aa577-7f1f-438a-9bba-53b6db7d75d6"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f9bbb908-21ed-4b98-a088-c61742637bb9">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Lung inflammation (Abnormality of respiratory system)</rdfs:label>
    <dc:identifier>HP:0002086</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002086</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ec486280-2dbf-4257-a84b-ed693d389cef">
    <dc:identifier>HP:0001640</dc:identifier>
    <rdfs:label>cardiomegaly</rdfs:label>
    <rdfs:comment>Niacin was the only effective drug to increase HDL cholesterol.</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001640</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/495a7306-bb7f-4725-9d68-ac84b5fdfaa7">
    <dc:identifier>HP:0011804</dc:identifier>
    <rdfs:label>abnormal muscle function</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011804</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ed8ffd6a-4e74-4d6c-974e-4b6e1e7fc338">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/80456c1a-61a9-49d9-8bb2-3939e099f2c5">
        <dc:identifier>HP:0000982</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000982</ddiem:url>
        <rdfs:label>Palmoplantar keratoderma</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/754a90a7-f6af-4c50-bdcc-4fd31c9d7898"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/245010"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c4ba35b3-ba40-456c-be61-4b8f0b2a560e">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/622448d6-dc02-4027-bc16-4060c94ed5eb"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02534844</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2541f9ba-00f6-44b4-b578-99f4476a3391"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21393975</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c2fd9efa-370b-493f-82f7-8b9ab1079027">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b52fbfe1-cc9d-4b0a-85eb-199a71000127"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>(Trimethoprim+Sulfamethoxazole)+Acitretin</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5a1cf5f4-2940-4879-887e-0dabf3ea0f8d"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6cb8316d-3b12-4f14-a1a3-48c9684c4ac7"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000006">
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000002"/>
    <dc:creator>leechuck</dc:creator>
    <rdfs:label xml:lang="en">compensatory complementation of a genetically defective protein</rdfs:label>
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure in which the normal product of a defective enzyme or protein is provided to alter its concentration or availability by delivery, stabilisation or modulation of turnover. [PNS]</obo:IAO_0000115>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T18:02:30+00:00</dc:date>
  </owl:Class>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/af3ed0ba-e98e-4bf1-adb2-259b4f7c2413">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012656</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>dopamine deficiency</rdfs:label>
    <dc:identifier>HP:0012656</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/efe6096b-79e6-4a03-8918-7eb9d521451f">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>High CSF MAN2-oligosaccharides</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/608158">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/636b5338-d064-4a7e-8e3b-93b09908ac39"/>
    <rdfs:label>CoQ-RESPONSIVE OXPHOS DEFICIENCY</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/608158</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/80ba8210-99cd-4d4f-8659-ce5f962bb409">
    <rdfs:label>renal function declines</rdfs:label>
    <dc:identifier>HP:0012622</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012622</ddiem:url>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/62dd20aa-4332-46e0-89f5-29ab65212687">
    <dc:identifier>DB00060</dc:identifier>
    <rdfs:label>Interferon beta-1a</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/86559b6f-2581-41e3-9eaf-7541f8e83404"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00060</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a5c0126f-f62f-44ae-b674-c5b65cf3ccc6">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>https://academic.oup.com/jcem/article/98/10/3958/2833930</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/125700"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0b8a21fb-0f46-4eda-81ca-e47db98bfeee">
        <rdfs:label>polydipsia</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/MP_0001426</ddiem:url>
        <dc:identifier>MP:0001426</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1316120</dc:provenance>
    <rdfs:comment>Vasopressin</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/61c99d16-5a0d-48bc-a718-60e26cf461c3">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001959</ddiem:url>
        <rdfs:label>thirst</rdfs:label>
        <dc:identifier>HP:0001959</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e4c2a29b-ce23-4aba-8cfa-54a3611da5dc">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a31ad793-86c1-4fce-97b5-b3511bfb9298"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d873e57b-d60d-4dcb-a1e8-3a92ab34fec4">
    <dc:identifier>DB00151</dc:identifier>
    <rdfs:label>L-Cysteine</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00151</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/4a1f4895-6da6-4285-a0c2-6640da936570"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e30d93a7-30e2-477a-bca5-9625f79b63a7">
    <dc:identifier>HP:0012103</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012103</ddiem:url>
    <rdfs:label>mitochondrial toxicity*</rdfs:label>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/269920">
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/267</ddiem:iembaseUrl>
    <rdfs:label>INFANTILE SIALIC ACID STORAGE DISEASE; ISSD</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/269920</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4ee68861-88b3-46fe-bb6b-9d8ac535aa99"/>
    <ddiem:iembaseAccessionNumber>267</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d6a69a33-9bf9-4798-9bb4-2f3a180d00f7">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23430827</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301535</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27567650</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28057010</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
    <rdfs:comment>Azathioprine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fd57c8f9-bfb0-4675-9048-8baf05f3bea0">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/79ecee81-6b15-42b6-b908-8dec7a3cccfa"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f2aa58db-fad6-43f5-a746-1414a78e8fff">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8ff268d3-228c-408a-9aa5-faeae5af8ada">
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30731125</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/200100"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25488886</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ce3bcdc5-11e4-448c-b9d5-ec4eca0463f9"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/54604c1f-f7fa-42bf-abca-478196b46ae1"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-3-20</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
        <rdfs:comment>Progesteron</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB00396</dc:identifier>
    <rdfs:label>Progesterone</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00396</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/75dc3a97-3526-4c47-9f3e-662ac19e411f">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/827529f9-5b7a-4b63-b7ab-48177f77aedc"/>
    <rdfs:label>rAAV-PPCR</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f2e6d002-aa3e-4ae4-84d7-e63aa648033a">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/baa0e810-94c4-452a-bfbb-86de7bca651b"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e226021c-2a88-4385-a432-a8068a78c450">
    <dc:identifier>HP:0007103</dc:identifier>
    <rdfs:label>White matter changes</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0007103</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/34ed81c9-3a03-49a0-ba85-446a283aec0c">
    <rdfs:label>Retinopathy</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000488</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0000488</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f45f29f5-1519-4c57-8b01-e3d07c52454d">
    <dc:identifier>DB12537</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB12537</ddiem:url>
    <rdfs:label>Benzodiazepine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/deeaed3f-dca6-4071-84a1-0cf8273c7e54"/>
  </ddiem:Drug>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/606175">
    <rdfs:label>CARNITINE ACETYLTRANSFERASE DEFICIENCY</rdfs:label>
    <ddiem:iembaseAccessionNumber>671</ddiem:iembaseAccessionNumber>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/671</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/7dc61fac-cd3e-43ca-808f-08770e2705de"/>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/606175</dc:identifier>
  </ddiem:Disease>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/622448d6-dc02-4027-bc16-4060c94ed5eb">
    <dc:identifier>DB01015)</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ed8ffd6a-4e74-4d6c-974e-4b6e1e7fc338"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01015)</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/43cd4137-a87a-43bc-a7d2-fe19fe88d60f">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9c1fabdc-cc5a-4fb7-8b8e-c0a5f555aadc"/>
    <rdfs:label>L-Lysine</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00123</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1ee6f5a5-51c1-416a-a568-17b8ce65febd"/>
    <dc:identifier>DB00123</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3b588c74-e1db-4e24-8be1-69e5fe049303"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/397c3839-1c2b-4322-8865-59d4a7a6fb37">
    <dc:identifier>HP:0002019</dc:identifier>
    <rdfs:label>constipation</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002019</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/93f809f9-7214-4c36-85ac-77ffdcd904db">
    <rdfs:label>Bromocriptine</rdfs:label>
    <dc:identifier>DB01200</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01200</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/218f8009-2c3e-4420-9796-e60207a87b98"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/563ea534-a9cc-41eb-a436-dc13f9fbbae7">
    <rdfs:label>speech impairment</rdfs:label>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
    <dc:identifier>HP:0002167</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002167</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/38621226-9178-4247-86a3-6e24054601ee">
    <dc:identifier>HP:0001288</dc:identifier>
    <rdfs:label>abnormal gait</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001288</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b26aa589-2ddc-4c8f-93cd-69e1fb98b2f2">
    <dc:identifier>DB00999</dc:identifier>
    <rdfs:label>Hydrochlorothiazide</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/79b33eb4-ac2e-4413-8eee-d9a4a5177224"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00999</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/460cb535-6d75-4973-9534-99bc24895903">
    <rdfs:label>Vandetanib</rdfs:label>
    <dc:identifier>DB05294</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8c5b258c-898d-4458-ab02-07be0133fb66"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB05294</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5f51e3eb-16d9-403b-9930-0407fab916ad">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Corneal Oedema</rdfs:label>
    <dc:identifier>HP:0012040</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012040</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1e821f6d-088c-4784-aa60-c6ce1e6b9e88">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/220110"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cb6d935c-97ca-4752-9652-5786a9767154"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
    <rdfs:comment>phenobarbital</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22149023</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d9923615-5755-4fdc-9488-f4984d27e326">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7dcb0a1d-e43e-4e60-8dba-5203b7ed8d8c"/>
    </obo:RO_0000057>
    <rdfs:comment>5aR)-5a-C-Pentyl-4-epi-isofagomine</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/568163d8-77db-44b2-b346-8bfb8de7c4f2">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000707</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
        <rdfs:label>Neurologic abnormalities</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27750150</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/230500"/>
    <dc:provenance>https://www.tandfonline.com/doi/full/10.3109/0886022X.2014.900422</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/abf095f4-f55d-4aba-827c-faf70554f581">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7b4bc236-2ca8-4f75-9138-c1146044bba3"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/64a3cefd-09f6-497d-837e-331e5e19f94a">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2c2d9c73-67dd-4112-ba21-28ef7138df5c"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/fd017192-1bc1-4b24-a2d1-d80e4f6851f6">
    <rdfs:label>VITAMINS</rdfs:label>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=A11</ddiem:url>
    <dc:identifier>A11</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/bb4dfd58-8d12-4b5d-911b-97e55712fe62"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6373a4c0-f58e-446b-8c20-c53474aeb752">
    <rdfs:label>Copper Histidine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/77cb83f5-1de3-410d-a8db-3be61f3a204d"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ea476127-db1d-4659-b2c3-3f1acb2c9750">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003117</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003117*</dc:identifier>
    <rdfs:label>Serotonin deficiency</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/5792da5b-f8c2-41f1-863f-4debf60efa2b">
    <dc:identifier>DB00090</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00090</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8bd447cf-6a4f-4c1d-bd86-1de5f97dfc41"/>
    <rdfs:label>Laronidase</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/788d45b9-d096-4e79-9b53-639cc432c628"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/45f2a792-a9a0-45c8-b505-316b333745bd">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2653622</dc:provenance>
    <rdfs:comment>strong statins (atorvastatin, pitavastatin, and rosuvastatin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22129523</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/488865fb-56fb-40f6-b1b9-d1c4c9a161b4">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/10c33a6c-d0f6-466f-9880-63cd64130ec8"/>
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/673c1938-6f0c-48b1-a5a4-45e17517e835"/>
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1011c5a9-97cd-44dd-8465-85306e1e3734"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/dcf5b822-064e-491f-95ce-421ac69b4aa0"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/144650"/>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/535a894a-2301-4969-8b8a-30c273e0200a">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8345cf05-62be-4378-9447-1c35b6f3d6cb">
        <rdfs:label>Albiglutide</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/414579d7-7d7f-4366-a03c-05f482d2ae12"/>
        <ddiem:url>https://www.drugbank.ca/drugs/DB09043</ddiem:url>
        <dc:identifier>DB09043</dc:identifier>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8011ab37-d5ae-4327-b7fc-c2b5a20596fe">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/da3e4219-ff12-4607-8be7-0df09090bd90"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/274270"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27622829</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29908244</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/451728e4-3dbe-4a69-bfcd-cbdbab18e63e"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16544179</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <rdfs:comment>uridine triacetate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9732974</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/67c903c7-3867-464d-b96c-dbeb31f9556f">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/60202377-e02e-4fa2-9cf1-5b3d96fae454"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://link.springer.com/chapter/10.1007%2F8904_2017_14</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000305"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/8046c08b-6ad2-4567-99cd-c62c395c1daf">
    <rdfs:comment>Levodopa</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24076137</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617070"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12872260</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b8a7db86-d18a-4205-9e3a-61718498b455">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26891864</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6a5df735-3272-4021-875f-393bbdfa6bdb"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30049652</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/203500">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/884f1569-1d10-406f-a8bb-07755a7448a3"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/23</ddiem:iembaseUrl>
        <rdfs:label>ALKAPTONURIA; AKU</rdfs:label>
        <ddiem:iembaseAccessionNumber>23</ddiem:iembaseAccessionNumber>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/203500</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0a3b94b3-1048-452d-8e89-6f031c25c0f2">
        <rdfs:label>ochronosis</rdfs:label>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <dc:identifier>HP:0030764</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0030764</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01828463</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00107783</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c4417832-d291-4bde-9761-9dfd8cbb17aa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/fd31825e-dc4b-4304-a327-798d7406814e"/>
    <rdfs:comment>Nitisinone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508465</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/86d4928b-9e64-4ed1-b0ff-bb48252b640f"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28813744</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30477028</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b9e2beb2-b9ea-4429-b1ad-2a6e94c6dd24">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Elevated transferrin saturation</rdfs:label>
    <dc:identifier>HP:0012463</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012463</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bf9e99fc-b5aa-468d-9119-7f0234ce80ed">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/fd31825e-dc4b-4304-a327-798d7406814e"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <rdfs:comment>Nitisinone (NTBC)</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c1dd0f48-2a48-453d-af23-2e2e1ca203b3"/>
    <dc:provenance>https://pubs.acs.org/doi/abs/10.1021/bi1008112</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/140350"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/cfc6b333-03a6-4b97-a867-eb80d30921e2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20677779</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/28d8aa92-466a-4bb7-9cbb-afe65875c45e">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/22432332-0801-43c5-a8fa-ffc4d8b0f855"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB02745</ddiem:url>
    <dc:identifier>DB02745</dc:identifier>
    <rdfs:label>Uridine</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/38618e44-17c5-4b79-b025-b747b77ca325">
    <dc:identifier>HP:0004356*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004356</ddiem:url>
    <rdfs:label>Lysosomal enlargment (Abnormality of lysosomal metabolism)*</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/cf61d846-a432-474a-8178-a9a0ceaaf94b">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649943</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/230000"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2d4427da-ba30-489f-8f07-724480217642"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27491218</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26537923</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/43d8156c-c2c0-4034-a743-fb11d12f482a"/>
    <rdfs:comment>Tocilizumab</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9004f061-6687-4c22-b999-9930d2cd13b5">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001941</ddiem:url>
    <dc:identifier>HP:0001941*</dc:identifier>
    <rdfs:label>high-anion gap acidosis</rdfs:label>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/19351d0e-6251-4942-be86-1a5ca9068c8f">
    <rdfs:label>Teriparatide</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB06285</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a9578c2e-6d3b-4ac8-9ff2-c3974fbf8270"/>
    <dc:identifier>DB06285</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a1d53aac-d63a-47c5-bc99-d62fb0f76aae">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9511979</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5b263806-e571-4c4d-a2de-76ab87da8a39"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19585268</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/014067369192373A</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e4ef1cd4-790c-4c9e-b816-cdfa0286f386"/>
    <rdfs:comment>Valproic acid</rdfs:comment>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/250850"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545930</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9261acf8-63a9-47d4-a0ac-d6241e8bd8e5">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c9ceb2f6-6caf-4174-ad15-75f1494a4f67"/>
    <rdfs:label>Nanotechnology-based gene therapy</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f600c5cb-94be-4896-af67-401acff381a7">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a32621f9-2394-444f-b1e0-bc3ec5b238b7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/4da219ce-af41-4e42-9b5b-8c00e7db2379"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20712835</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e2f10e65-40c5-4af8-8e95-e4b3e4b495ab"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7936305</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Anakinra</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25758134</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/260920"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0ad1e2b0-2bb2-4d8c-a7c3-f0572c1073ce">
        <rdfs:label>joint swelling</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001386</ddiem:url>
        <dc:identifier>HP:0001386</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d0b5e411-5876-4bb3-894b-83d2baa10a5c">
    <rdfs:comment>chenodeoxycholic acid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28980151</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c0f06aae-88b2-41f9-819e-9f95f7ac1b9a"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25424010</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8c6d4986-4e49-497a-ba43-3178c58ec295"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/213700"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e10aac94-9a01-49af-b6cc-166839ea9915"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/baf6d396-78c9-4f29-8da8-a389b7d531f5">
        <dc:identifier>HP:0000518</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000518</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>cataracts</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31115677</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/38621226-9178-4247-86a3-6e24054601ee"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f444fc3c-f4ce-4ec9-9ce9-536fdffed95f">
        <dc:identifier>HP:0040129</dc:identifier>
        <rdfs:label>Abnormal nerve conduction velocity</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040129</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/782122ee-bdd8-4f40-b332-8c19e50e56fa">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002311</ddiem:url>
        <rdfs:label>Incoordination</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002311</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a48d4417-25f3-42b4-abed-702601b53e07"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1316120</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5c58afe7-c648-40b3-8989-9f406302cd99"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/41396ae7-981f-4f38-a0d5-6516d242a144">
        <rdfs:label>chronic diarrhoea</rdfs:label>
        <dc:identifier>MP:0001665</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/MP_0001665</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/35506db9-7883-4ce5-9e61-ecd31922eded"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/33300238-ce15-4037-8ace-6bf7b9a9bc6d">
        <dc:identifier>HP:0002353</dc:identifier>
        <rdfs:label>EEG abnormalities</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002353</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29260356</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6e5c5813-8919-49d6-96c1-61f7488cb0a5"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/740ffc4b-1f6b-4ffd-84f4-d79c4d32c46d">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003233</ddiem:url>
    <rdfs:label>Low HDL-C  level</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003233</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/58a40a77-8c3d-4315-96d3-6e92f21f18df">
    <rdfs:label>Abnormal muscle tone</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003808</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003808</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d06309f1-d28f-49b2-b047-9ca02d887394">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00273</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/48d1460e-3346-47bb-8b42-23ef6b635367">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/220110"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <rdfs:comment>topiramate</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d8562063-debe-47b1-90ec-02096b47fe97"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22149023</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/956e4e2a-01e5-448c-bd2d-40f383a07cd1"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2f031d84-68c7-41ab-b66a-af6297f92901"/>
    <dc:identifier>DB00273</dc:identifier>
    <rdfs:label>Topiramate</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/04630f70-0cb2-478d-af84-9b53fc99627e">
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
    <dc:identifier>HP:0025460</dc:identifier>
    <rdfs:label>concentration of myo-inositol in brain</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0025460</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b6b93a14-3b63-427c-9b18-21c584f86d46">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000164</ddiem:url>
    <rdfs:label>Dental Defects</rdfs:label>
    <dc:identifier>HP:0000164</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2236380d-32e6-438f-b94f-e555df6d4b30">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28225998</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19770656</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25993639</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22142470</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/145750"/>
    <rdfs:comment>Insulin</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/622737b9-25a9-43c3-bc5a-70e2bc7a4799"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dcd4e33f-fc5c-46d1-a5a6-1a6994c4791f">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
    <dc:identifier>HP:0001939</dc:identifier>
    <rdfs:label>elevated serum toxic intermediates (</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/16e3f35f-4490-4222-9ba4-29ac253ddac1">
    <dc:identifier>CHEBI_32030</dc:identifier>
    <rdfs:label>Kaliumbromid</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a828ef11-0679-4f8e-bd4b-8f21a77396c6"/>
    <ddiem:url>https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_32030</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3bc4342d-2aa3-460e-b909-4652871f82f2">
    <rdfs:label>Pergolide</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8db40dd3-1bd0-431a-8e06-ae47311613cc"/>
    <dc:identifier>DB01186</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/094dba56-00de-4bd9-9591-c2fc586a6038"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01186</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/52776aec-b9c3-4304-aae5-7638d4d93f3f">
    <rdfs:comment>Thalidomide</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7936305</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11504824</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e013b992-430d-4061-b4fb-2759d04c78b5">
        <rdfs:label>Limited Efficacy of the drug.</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001954</ddiem:url>
        <dc:identifier>HP:0001954</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/260920"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22740624</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0acc0750-bf8d-431a-b7a9-419f6406e435"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/307030">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/840540d2-6223-46ce-a4e8-92011ddd0cef"/>
    <dc:identifier>https://www.omim.org/entry/307030</dc:identifier>
    <ddiem:iembaseAccessionNumber>542</ddiem:iembaseAccessionNumber>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>GLYCEROL KINASE DEFICIENCY; GKD</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/542</ddiem:iembaseUrl>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/77ac88a9-f5e8-437a-ac47-4096a28d8fa0">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/cfc6b333-03a6-4b97-a867-eb80d30921e2"/>
    <obo:RO_0003304>I278T</obo:RO_0003304>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b4a53029-1cb1-47d6-9650-68669e735d46"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14739681</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f332fef4-ce87-45f9-a62b-c389cbd3aeb5"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/236200"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24355692</dc:provenance>
    <rdfs:comment>bortezomib</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23592311</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16619244</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b89cc7d3-423a-429a-a405-c0e687164cf4">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/201100"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <rdfs:comment>Zinc+ linoleic acid</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1dba9972-ef39-4ae3-ab56-a5474843ecac"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415789</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24288038</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1106f288-0fa0-4c2b-9c82-5df7b768ba82">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b4c51aa9-7250-47db-a54d-06377f0134d8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12044538</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a5f700a4-98d0-4ace-848e-4113eefc796b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779298</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24718477</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4990a0ae-09a7-4c35-950c-2219ad220149">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01218659</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a2e4bb6d-141b-4ee1-9461-89f14c899aea">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/240667f7-737c-4481-a2ab-914251cf87fa"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/301500"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01678898</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/0ad70eb7-90f3-487c-875c-31d2d4a0ae7d"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01981720</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8c3afdc3-ad81-451a-a4bf-87664b1d8e01">
        <dc:identifier>HP:0012211</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012211</ddiem:url>
        <rdfs:comment>Niacin was the only effective drug to increase HDL cholesterol.</rdfs:comment>
        <rdfs:label>Abnormal kidney function</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>Pegunigalsidase alfa ( PRX-102)</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03180840</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01769001</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d5bef24f-7f2a-47d6-ac8d-3fecd4854f61">
    <dc:identifier>DB06777</dc:identifier>
    <rdfs:label>Chenodeoxycholic acid</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d0b5e411-5876-4bb3-894b-83d2baa10a5c"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/01c3a5b4-6130-4570-af7b-d883daeddfb2"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB06777</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/beb15850-d0f9-4014-91f3-2c5d6dbb5e02">
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18570303</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8225213</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2072042</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607765"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/1aa87da0-cff4-43c1-afbb-9c98e5325f09"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19087156</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503963</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8c6d4986-4e49-497a-ba43-3178c58ec295"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/94024323-6d96-4884-9316-b90cbed5cae0"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88a24a43-0a48-4255-8c60-2aed9d209ec6"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fc4cd899-938e-4e1a-8da2-507845e63643"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20619503</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ed7bea12-d77e-480d-bd71-3c7564d0bbcf"/>
        <rdfs:comment>chenodeoxycholic acid</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1e327fe9-d2bb-4abe-9aa5-4070e20df1ac"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c9888b07-78ab-40f5-b80d-beea61796da3">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2fdc2166-8972-427d-81b1-c855542cb8e2">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/40f3614a-177a-487d-83e6-282ac6ec6265"/>
        <rdfs:comment>perampanel</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/456b073b-da78-4cf8-b13c-7b18306a043d"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953024</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24816443</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c156cffb-f862-416e-946b-41f7b6f9d8fb"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fd13eee7-4994-4611-a2dd-0c784ed86031"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/125370"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Perampanel</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB08883</ddiem:url>
    <dc:identifier>DB08883</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7b3839e4-8d20-4bf0-bf23-bf8f32c5df2e">
    <rdfs:comment>cefoperazone sodium</rdfs:comment>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
    <dc:provenance>https://www.semanticscholar.org/paper/Clinical-Diagnosis-and-Treatment-of-Dehydrogenase-A-Cui-Wang/f6e88d647f2e2c7df2897e939ec33f9d86899b37</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300438"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11102558</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/650f8a84-1255-45ca-966e-e90d27cb99da"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ac4f4c84-14e2-4ac3-a0da-c22434f8133d"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/48e78af0-e64d-4199-a7a8-6e43e693f2aa">
    <dc:identifier>DB00936</dc:identifier>
    <rdfs:label>Salicylic acid</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00936</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/53b5f489-775d-48b4-9843-4cbd98ab0f41"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6bfa4b8b-d5e6-4cde-a08b-82ce0e76e7ac">
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bac844b9-e61c-45a3-a63c-346144b51691">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/de2288fb-9fbd-4102-8f0a-daf582118b7b"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <rdfs:comment>Methylprednisolone sodium succinate +
Immune Globulin</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25511120</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ea11c963-11c7-4d7c-8aac-65d2723edd07"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277400"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2c5d8a23-777d-41bf-9059-bb1dd964be68"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/fd64661b-584f-4e5c-bce3-08355d33c303"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d006d676-978e-4c1a-b6f8-59d358c2edb1">
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <rdfs:comment>Taurine</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88ebd68b-d84a-4d45-a972-8b62a4e1685d"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/87773692-3665-4b9d-8e9c-762077ce7b16"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/540000"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4aef1bff-a647-432c-b0f1-eb50533a7b60">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ac4cac4c-4cdd-486c-a4c2-a875b4f17ebc"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>http://ichgcp.net/clinical-trials-registry/NCT03432871</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29596118</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4e209543-0560-4750-86c6-5a77a2c83be1">
    <rdfs:label>Acid regurgitation</rdfs:label>
    <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002020</ddiem:url>
    <dc:identifier>HP:0002020</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6878e45b-0f22-49fd-a9ad-66f55072d6fb">
    <dc:identifier>HP:0012378</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012378</ddiem:url>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <rdfs:label>Low energy level(Tiredness)*</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c8b5870f-0b77-4b30-8d34-9861bdf86c1a">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6ce4f760-ed2f-47e7-b456-697550d26030"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24613482</dc:provenance>
    <rdfs:comment>fructose</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b93e405f-4ecc-4d84-a810-a2d5c3dcd5ee"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29223626</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25832663</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232400"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/30ce4cd0-229c-45f9-9acb-a4a0b2d2e732">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/68965f27-64cc-48b8-8c6b-b500d18f8db9"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/764c4cf7-d28c-4c5d-86c9-46831142b419"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/80491492-3ed8-4660-87fb-571e4ebc3314">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001640</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001640</dc:identifier>
        <rdfs:label>Cardiomegaly</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bca6abe3-6fcd-42c4-83ed-53974ff84622">
        <rdfs:label>Developmetal delay</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001263</ddiem:url>
        <dc:identifier>HP:0001263</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/06790425-ba7e-4f6c-941f-cc1fd4c3b853">
        <dc:identifier>HP:0012664</dc:identifier>
        <rdfs:label>Reduced ejection fraction</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012664</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7a7c7714-4a7a-42c8-99a3-634a0a69fc88"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/302060"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249181</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20981509</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3a5a33b0-0208-4b3e-9920-95ab2ac54b64"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2051ff2f-447d-495a-8d11-3ac84fa1af75">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/51e8d287-29a2-4775-a816-23605c2ec1db"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30070157</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bc2e93e5-e10a-441c-8392-e911ae9b2eb6"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ac46dd82-a55c-4e4a-acf8-0c18ec373afc"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ec2b826a-5264-45c3-b9bd-31793885e995"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18632498</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a240c81c-6c96-4c84-a522-802a34c08cd4"/>
    </obo:RO_0000057>
    <rdfs:comment>Digoxin+furosemide+captopril</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/98a8c222-fe37-4454-bcc5-d34f2e0959ad">
    <rdfs:label>Niflumic acid</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB04552</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9c04d0e6-2600-4dd9-aade-cb6e70fe78d7"/>
    <dc:identifier>DB04552</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/5d24f87b-e26f-42fc-a5c5-a94d89969411">
    <rdfs:label>Functional interaction(Mechanistic B)+Supportive (C)</rdfs:label>
  </ddiem:TheraputicProcedureType>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2268db48-48b9-43b3-89c9-b6e219d74f32">
    <dc:identifier>HP:0002872*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002872</ddiem:url>
    <rdfs:label>"Epileptic apnea(Apneic episodes precipitated by illness, fatigue, stress)"</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/fe2d9cd3-cc30-400e-a56a-7f7f3e9b13dd">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00091</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8ea0d282-e7ca-4b59-a32c-74397df333ec"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/55d68190-aa9e-4bcb-a85b-4f3349e9c113"/>
    <dc:identifier>DB00091</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c7cec4e0-86f9-45a6-b07b-a7af19a227a4">
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02176733</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ef4720c8-6d94-49bb-b501-2bf28ce742cd"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02805790</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b8518e35-c60b-46ed-bc46-d66ffbec7fe9"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24161764</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <rdfs:comment>Cyclosporine</rdfs:comment>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/535000"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21788663</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Ciclosporin</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/cdb04d60-5760-4615-8f62-a94cb0bb3f4b">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5eb752c9-f92d-4e23-8d60-6976cbe25a5c">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>high intraneuronal GSL storage</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19750228</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/21a78484-b5a3-410c-a446-4bef7e938326"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5cf024d4-a56a-454a-8bdc-f9cc087ce4ad">
        <rdfs:label>elevated intraneuronal cholesterol</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/230650"/>
    <rdfs:comment>Allopregnanolone+2-hydroxypropyl-β-cyclodextrin</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/56215552-6406-476a-8150-6a52edf8a20d"/>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/113884b3-f6d0-4b90-85d2-a66b5379d8ba">
        <rdfs:label>Symptomativc (C)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2ae5f767-9e0a-4392-b820-2af75a6a720a"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/67e421a6-a17a-4ccb-896e-aa073e45827c"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.tandfonline.com/doi/full/10.3109/0886022X.2014.900422</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/05e498fe-0722-40b8-9a8f-308fc21d9310">
    <dc:identifier>DB04844</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB04844</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d0b9db3a-13da-49f2-ae86-0ecc117c42a9"/>
    <rdfs:label>Tetrabenazine</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/049d5ada-2010-48d1-b9cb-0f6078f4e2d9">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0005978</ddiem:url>
    <rdfs:label>PCBD1-diabetes (Noninsulin-dependent diabetes)*</rdfs:label>
    <dc:identifier>HP:0005978*</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/456b073b-da78-4cf8-b13c-7b18306a043d">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001249</ddiem:url>
    <dc:identifier>HP:0001249</dc:identifier>
    <rdfs:label>Diminished intellectual abilities</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ef469565-c5a3-4095-bc11-a10c985f1eb6">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/274270"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b6831e2d-f36c-400a-aff9-542620c434a6">
        <dc:identifier>HP:0012011</dc:identifier>
        <rdfs:label>EEG with parito-occipital spike waves</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012011</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/156c1ad5-b853-457e-b7c5-5d982839a24d">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001270</ddiem:url>
        <dc:identifier>HP:0001270</dc:identifier>
        <rdfs:label>Developmental impairment</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>HP:0000750</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27622829</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bf022da7-c257-4b9d-9e98-9ef5fcbe86e5">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0001270</dc:identifier>
        <rdfs:label>Speech and languague delay</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001270</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://link.springer.com/chapter/10.1007%2F8904_2017_14</dc:provenance>
    <rdfs:comment>Valproic acid</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e4ef1cd4-790c-4c9e-b816-cdfa0286f386"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6a504f67-7f4d-4a34-b7be-68b122b15d25">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001290</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Generalized muscular hypotonia</rdfs:label>
        <dc:identifier>HP:0001290</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28275972</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4da219ce-af41-4e42-9b5b-8c00e7db2379">
    <rdfs:label>Anakinra</rdfs:label>
    <dc:identifier>DB00026</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1b1fb53b-ff79-4600-99aa-4e86f212abff"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00026</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f600c5cb-94be-4896-af67-401acff381a7"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/33c52f73-3090-4388-9db3-7a7956dae4cd">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17164772</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ed47fe46-3625-4b48-8164-c63de21fcf40"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.tandfonline.com/doi/full/10.3109/0886022X.2014.900422</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3cfe137b-d3bf-4112-8f17-204ca299884b">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/8d64f389-2164-47c3-9a03-47cb50a7f9a0"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/230650"/>
    <rdfs:comment>AAV-treated βgal</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/dc1adb32-9d21-41e8-8d3f-0440818b6663"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fbb6cd51-c2bb-40f6-be20-04c33ade9299"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/854de67d-882b-473d-a6df-55e61f529865">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15728297</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26095523</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/540000"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/10c0cada-0d11-45bb-81cf-bc0e560b3f5e"/>
    <rdfs:comment>arginine hydrochloride</rdfs:comment>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a38e87c0-f364-4ce4-a89d-fd1d4a988621"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6c1ab060-239c-42a4-b2f7-9131cd3318da"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7e0989e0-f6d9-42e2-b6e9-d7ac459bf55a"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/13c16439-98dc-4dce-81ea-a6c1a1a47751">
        <rdfs:comment>Mitochondrial diabetes is treated as other forms of diabetes; however, the use of metformin should be avoided due to the increased risk of lactic acidosis. https://www.ncbi.nlm.nih.gov/pubmed/27966441 Cases were treated with metformin at some stage and also received statins which could be harmful in such patients. https://www.ncbi.nlm.nih.gov/pubmed/24746802</rdfs:comment>
        <dc:identifier>HP:0002401</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002401</ddiem:url>
        <rdfs:label>Stroke-like episodes</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26954033</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/905b120e-f134-4591-ac1c-edbc95dd1064">
    <rdfs:comment>botulinum toxin</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b40db580-d382-40b6-b331-d92476228868"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/238700"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/859b0212-2f63-4de2-84c2-50cbe9bd14fe"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24204001</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23570448</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/449e24cf-7137-46ab-8f88-757610bbbc14">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00435</ddiem:url>
    <dc:identifier>DB00435</dc:identifier>
    <rdfs:label>Nitric Oxide</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a5b49164-a20c-4d56-81df-078fc5a7c201"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e11fe0d8-adaf-46f5-a977-61038946f846">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7b8c2b12-2dc2-4133-ae0a-f4c37ed13cd0">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007346</ddiem:url>
        <rdfs:label>Subcortical calcification</rdfs:label>
        <dc:identifier>HP:0007346</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16835865</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12003346</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0378378210006055</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
    <dc:provenance>https://www.babysfirsttest.org/newborn-screening/conditions/3-methylcrotonyl-coa-carboxylase-deficiency</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/75392c73-d957-49ba-9a0b-e3274a919ee2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2785251</dc:provenance>
    <rdfs:comment>folinic acid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23138986</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/928214ea-cd79-4af8-9876-2b285791d753"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/79642d0b-3888-4c7b-b293-d817ceea2a27"/>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261630"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b6495443-58fe-43ca-968d-236e7d6a7012">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e312fa1d-dc13-4719-bbda-9c18f7c766dd"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b2a61aa8-d78c-4b25-9885-55fee1a08e70"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/abc12ae2-cfc0-4536-8ff7-0675cacb8d3c"/>
    <dc:identifier>DB00190</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00190</ddiem:url>
    <rdfs:label>Carbidopa</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/affdcb55-38c2-4479-9352-ee3c75e32850"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/761ca9c8-39cd-4f2a-bd43-7e3a15ee3152">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12872260</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24076137</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/617069">
        <rdfs:label>PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3; PEOB3</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/5b48f004-fddf-48c0-9803-62b4fb6ae872"/>
        <dc:identifier>https://www.omim.org/entry/617069</dc:identifier>
      </ddiem:Disease>
    </obo:RO_0002606>
    <rdfs:comment>Levodopa</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d0fcd4ab-1939-4d6f-97d0-1fa394d5df08">
    <dc:identifier>HP:0002123</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002123</ddiem:url>
    <rdfs:label>Myoclonic epliepsy</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/5a4c1e33-d23d-4270-a86a-659c08cff7ec">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6e176d4f-e463-4947-9aaf-1d5dc93ee823"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3dd03047-4d2d-4ef8-897d-afe4384eb683"/>
    <dc:identifier>DB01119</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01119</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/fa13763e-a5ab-4381-8ad8-f9e4cf1c6cc1"/>
    <rdfs:label>Diazoxide</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6881ccdd-8414-448b-894b-90655031bad0">
    <ddiem:url>https://www.drugbank.ca/drugs/DB05990</ddiem:url>
    <rdfs:label>Obeticholic acid</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b6fe5dc0-e957-4a24-9a52-d94a2bdfd8ee">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/30214c42-9b20-4e63-bfb1-18541b3e6491"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
        <rdfs:comment>Obeticholic Acid</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02211209</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/16246f9f-72ee-4244-9c43-e2602c03b729"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/400bb209-d396-4f82-9cc3-2d22ccb321c6"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/151660"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02527343</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02430077</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB05990</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a03fd2e1-00d1-4940-b69a-9baf77aae691">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e252acd3-5286-4700-b3ec-6b8a214455b5">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/4360ca6b-ad4b-4880-bf1b-1d9f0007ad8a"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/47aff16b-0324-4b3f-8081-5a5c77dab25b"/>
    </obo:RO_0000057>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/218800"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <rdfs:comment>Ad-hBUGT1</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9156798</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15753292</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/551ad276-a312-485c-88aa-3c483c4676ba"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8900123</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3585a2cd-7ec4-4ba3-82d0-271d79deb8db">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/942a2f6c-3733-42d8-8d37-cce983650a65"/>
    <dc:identifier>DB15146</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/da32d686-aa8d-4bef-b16b-4a3033bff226"/>
    <rdfs:label>Adrabetadex</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/cdb04d60-5760-4615-8f62-a94cb0bb3f4b"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB15146</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/fd930177-3e81-49e3-a2b6-45c9ff516717">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/692b1cc8-3f9d-48e7-8c57-c7c787b3a2d1"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/919d742e-3649-4439-8674-52e773d69509">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/613077"/>
        <rdfs:comment>Levodopa</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24076137</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12872260</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB01235</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3dde11aa-f26f-46ff-ac98-9535091652f8">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30013934</dc:provenance>
        <rdfs:comment>levodopa</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11102558</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300438"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ff0fdbac-5589-49c5-a3b2-cb2aff951cbf"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22840416</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0303846712003952</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a5f6e0ff-20c7-45cf-a4a8-0d2eadb46546"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/67685640-2654-40ad-9f12-28e37181e26f"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/051bc356-1db7-47cf-b80d-ecef3a9fd8f7"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/761ca9c8-39cd-4f2a-bd43-7e3a15ee3152"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6edf2460-2896-42b4-8739-85b319f0b0af"/>
    <rdfs:label>Levodopa</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/caabdbb5-8916-4f53-a4e7-eeeee8581671">
        <rdfs:comment>levodopa</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
        <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01793090</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b68f9fa9-a036-49df-8d97-543d6dd7e840"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/609283"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12872260</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
        <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e312fa1d-dc13-4719-bbda-9c18f7c766dd"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7be066bb-c46e-449e-9926-25984d1cb5ab"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/40c4dcdd-cc69-47b2-a7c4-b8e06549c0eb"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8046c08b-6ad2-4567-99cd-c62c395c1daf"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01235</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7fa94d2d-60ef-4628-97c0-169873bcad65"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/39d892d3-db37-488c-9de2-aafcfa20a1b3"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/075f5c5b-d481-41d3-9f04-452ca1f1723d">
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=B05BB01</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/25aecaf4-cba3-4081-bac7-98ddc0174ea2">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27120771</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <rdfs:comment>Electrolytes</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2646391</dc:provenance>
        <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0711674f-d22a-4023-85fb-729259b67e4c"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7e963898-9a97-4b9b-8b3a-4ff60aaf7d40"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300971"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-Bartter.pdf</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>electrolytes</rdfs:label>
    <dc:identifier>B05BB01</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/65b2cd23-74b9-4742-837a-60c3e13f0eca">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Antithrombotic agents</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c533956c-00ab-4713-9ca0-2c1f0f34adc7"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/7d82eacb-bbbc-4964-a2b1-4bc779f938d7"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/307030"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16767100</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25781533</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612542</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/169bde28-0502-4ec5-80d7-c3f885acfa2d">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31392111</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9f5b8656-3fa5-4e2f-ba3a-394e570fa8eb">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001941</ddiem:url>
        <dc:identifier>HP:0001941</dc:identifier>
        <rdfs:label>Acidemia</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23649895</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14213380</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ab76e288-f5f9-4bae-867b-95e6ba15d4bf">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/543aa5bf-b68e-4a55-bba0-6924a81fef2e"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>N-acetyl-l-glutamate</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/237300"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/13992367</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/85592d4c-1e89-4edd-80d1-8495f757056f">
    <dc:identifier>HP:0200034</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0200034</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Mucosal lesions</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2a4c5500-9d53-49ad-ab26-9f0769351df2">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>abnormal interactivity</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012433</ddiem:url>
    <dc:identifier>HP:0012433</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f0243d95-d0cc-4afd-b2f6-e970dac7dc82">
    <dc:identifier>DB00148</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c3426d64-5f2b-4063-bd74-27ca873b8e2c"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/027ef64d-b2f5-4dde-9b7d-1cc04f828592"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/eb5c5f1c-1b39-4ace-837f-cb219b72f54c"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/15c5eb77-0d15-4449-9d24-c78f1ff8a12d"/>
    <rdfs:label>Creatine</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00148</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/948cd063-bb0e-4851-a0d9-164a72cc1e7b"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ed7bea12-d77e-480d-bd71-3c7564d0bbcf">
    <dc:identifier>HP:0012030</dc:identifier>
    <rdfs:label>Abnormal urinary steroid level</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012030</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c3e50a1f-e83f-4530-a0d5-182029f8f379">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/578fb905-e833-48e8-9855-b814c142bb9b"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b3449b59-83ae-4807-be2e-29b98cadcd68"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <rdfs:comment>Ad5-LARGE-eGFP</rdfs:comment>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15184894</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a72baa14-1fd0-4130-84da-f78ba33c216d"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/253280"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/60bce3e1-e52b-4d63-abff-5212dc63ef7c"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/615ba6f3-5a93-4a49-99d5-cf36287400aa">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8317485</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01797055</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1188bf91-80ee-4ae9-870b-e3ae75504017">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2306cc5a-ee45-4668-bd57-3b39a82aabe3"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2de90206-c044-4acc-803b-e3971d93b567"/>
    <rdfs:comment>Human apotransferrin</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/209300"/>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e7ad952b-01c6-4bc8-9348-70f9f6f957f0">
    <rdfs:comment>olanzapine</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/758d8c63-0cc7-4bd1-a328-ad416d95d276"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/125370"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/08b3c5d1-8c62-495f-ae43-fcd158e5aeb4">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>psychosis</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000709</ddiem:url>
        <dc:identifier>HP:0000709</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953024</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24816443</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/cd29e9f5-635f-436d-8a53-969d69283b6b">
    <rdfs:label>recombinant human tripeptidyl peptidase-1 (rhTPP1)</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/97f11430-244c-4d69-8840-ccabd25fad58"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/98fcebcb-4327-47ba-91d4-6cc7aed2234a">
    <ddiem:url>https://www.drugbank.ca/drugs/DB09210</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f0505d6b-67c9-4f3a-8eac-6c9f82fc977e"/>
    <rdfs:label>Piracetam</rdfs:label>
    <dc:identifier>DB09210</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b1114590-3f0b-4084-9403-2d2f4c44cc5c">
    <rdfs:label>Prednisone</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0ca3cdc2-d227-486c-a7ec-52f86a6f7830"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00635</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a0feac40-a1b0-4a7a-8e73-37fa58691517"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/16358968-3371-4705-a20f-7a35bdbd7580">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045115</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27790033</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03128905</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2d4427da-ba30-489f-8f07-724480217642"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b11da811-7f32-4bc5-876d-aceb6144ca5f"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
        <dc:provenance>https://acrabstracts.org/abstract/anakinra-compared-to-prednisone-on-the-treatment-of-acute-cppd-crystal-arthritis-a-randomized-controlled-double-blind-study</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23432031</dc:provenance>
        <rdfs:comment>prednisone</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/118600"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/31239752</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a7be9294-85f5-4684-9473-fa20ca562aff"/>
    <dc:identifier>DB00635</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3509e41b-2890-4904-b85c-7d69a56bfcb1">
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <rdfs:comment>pregabalin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24746802</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/520000"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/30e2aa3d-1ebd-4dea-a269-145626e81765">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2c881bcc-cfdb-44c8-b6aa-8bad66c2b11d"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28766015</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/03326076-4f70-4d1d-bab9-4b903417c863">
        <rdfs:label>Neuropathic pain(Abnormality of pain sensation)*</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010832</ddiem:url>
        <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
        <dc:identifier>HP:0010832*</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0dbad9f0-ee9c-4864-b687-f3e7b589c155">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001903</ddiem:url>
    <rdfs:label>Low mean hemoglobin level</rdfs:label>
    <dc:identifier>HP:0001903</dc:identifier>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/277410">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/3692e5e8-aff8-4787-a456-8560c9d7d632"/>
    <rdfs:label>METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/316</ddiem:iembaseUrl>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/277410</dc:identifier>
    <ddiem:iembaseAccessionNumber>316</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3f6096bf-0c66-495a-aaed-be5b5745134c">
    <dc:identifier>DB06262</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ea828d83-2cdd-4349-89fa-7e9cfa5e3cbf"/>
    <rdfs:label>Droxidopa</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB06262</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/814b1e28-30b3-406f-a110-b733463cc37d">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
    <rdfs:comment>torcetrapib/atorvastatin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2681858</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7e41f4a1-87bf-4293-b277-1611851a3e9c"/>
    </obo:RO_0000057>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00145431</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b72a581a-8b62-474a-922b-a8c93dd15b2e"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/86c51a33-3ee0-427a-a227-bf65b3f0f64c"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/17a895e3-a3b0-46ee-a3dd-e6e69fd130a0">
    <rdfs:comment>bezafibrate</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0caa53da-8b5a-4491-8f4a-3574875004c0"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0003304>c. 1393_1479del-Del exon</obo:RO_0003304>
    <obo:RO_0003304>c.1528G &gt; C</obo:RO_0003304>
    <ddiem:failedToContributeToCondition>c.1528G &gt; C</ddiem:failedToContributeToCondition>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7eb3aeac-1b9a-4bfb-91c4-ba18303371f7">
        <rdfs:label>Low LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE activity</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0003304>c.982G &gt; A and c.1072C &gt; A</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/600890">
        <ddiem:iembaseAccessionNumber>178</ddiem:iembaseAccessionNumber>
        <rdfs:label>HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, ALPHA SUBUNIT; HADHA</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/600890</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/549244da-33b7-46f2-847d-6e5ae2a90910"/>
        <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/178</ddiem:iembaseUrl>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0003304>C2129-2A &gt; C</obo:RO_0003304>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b21b157f-04f5-4d64-b958-f793cbe41703"/>
    <obo:RO_0003304>c.914 T &gt; A</obo:RO_0003304>
    <obo:RO_0003304>c.180 + 3A &gt; G</obo:RO_0003304>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/a17a404f-953b-45f1-b12f-76128f68c740">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d5e9e5b1-a850-4eff-88cb-b467f403e90a"/>
    <rdfs:label>high protein diet</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/88faaf3d-4787-4e01-8c89-3fc2705fcbd1">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0007010</ddiem:url>
    <rdfs:label>Poor fine motor skills</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0007010</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2ade1c7c-1de9-46f1-be48-afaf68b06736">
    <dc:identifier>HP:0003473</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003473</ddiem:url>
    <rdfs:label>Low energy level</rdfs:label>
    <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/55a9600f-f580-4a5a-a99f-825c49d34d43">
    <dc:identifier>HP:0001941</dc:identifier>
    <rdfs:label>pyruvic acidemia</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001941</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/97f0d863-540d-4cd0-a19a-8edd110b4cf1">
    <dc:identifier>DB00620</dc:identifier>
    <rdfs:label>Triamcinolone</rdfs:label>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/fc209a36-8d9f-473b-9619-228b1576656d">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/520000"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
        <rdfs:comment>Triamcinolone acetonide</rdfs:comment>
        <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4f79355d-6ee7-4117-8de5-fe4b0d7adcab"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568973</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/564cf6a0-f620-4ae3-8395-d8935adcfbfe"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24746802</dc:provenance>
        <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fac069c4-b3c0-41ba-acb1-d0f5330c3a76"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1479ec8b-c25f-4b03-b7a3-6a12f5428ffa"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00620</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/628ad6d4-20e3-4788-a4ce-9d9ed86585e0">
    <dc:identifier>HP:0000821</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000821</ddiem:url>
    <rdfs:label>hypothyroidism</rdfs:label>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/01b774ba-14cf-4a13-9164-c51d5260f5a9">
    <rdfs:label>Beneprotein</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/cb81c0bd-645d-42d7-b1ba-74928b2390d7"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/127683ac-ebde-47e7-86bb-5761e14e0353">
    <rdfs:label>St. John&amp;apos;s Wort</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01323</ddiem:url>
    <dc:identifier>DB01323</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c16fd6ff-4008-4b91-bebf-fddcfc7ee1d0"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/a11c9b61-5ac3-49cc-b5a1-09775a96efa8">
    <dc:identifier>DB01247</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e1c04b7a-ddf6-4635-8fc5-707ab948d2ff"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01247</ddiem:url>
    <rdfs:label>Isocarboxazid</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/78e0f5d4-b326-4c8d-899e-889c72330514">
    <rdfs:label>Glycine</rdfs:label>
    <dc:identifier>DB00145</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/46d07269-3d0c-4e4b-82cb-08863e57216d"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ce1710e2-8d26-440c-979f-f234b60ecad0"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00145</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/110ed263-dbe6-46a3-aefe-40267fb205f1">
    <rdfs:label>Digoxin</rdfs:label>
    <dc:identifier>DB00390</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/10dac04b-b86c-4b34-b606-a8496d3ab9c8"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00390</ddiem:url>
  </ddiem:Drug>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/121270">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/636b5338-d064-4a7e-8e3b-93b09908ac39"/>
    <rdfs:label>COPPER DEFICIENCY, FAMILIAL BENIGN</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/121270</dc:identifier>
  </ddiem:Disease>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/a3130b01-5ab0-40c4-81a0-630af38de29e">
    <rdfs:label>Mecasermin rinfabate</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1f8bcb99-69ba-425e-8121-0ff097d1a5c8"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14751</ddiem:url>
    <dc:identifier>DB14751</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d7ffa088-ab52-4040-835e-1380be527dc0">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001072</ddiem:url>
    <dc:identifier>HP:0001072</dc:identifier>
    <rdfs:label>Elbow skin thickening</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9269caeb-1026-4aee-8ba5-3091b95b675f">
    <rdfs:label>Abnormal levels of urine total alkanes</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/43ea1095-39a4-4fb8-8796-55de6c362237">
    <dc:provenance>https://link.springer.com/article/10.1007%2Fs00726-017-2462-x</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/237400"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e30d93a7-30e2-477a-bca5-9625f79b63a7"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27023909</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4aef1bff-a647-432c-b0f1-eb50533a7b60"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7936305</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <rdfs:comment>Taurine</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f0d63516-6fdf-44c3-ac03-8b8522569901">
    <rdfs:comment>Testosterone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505515</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841061</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016220</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/292a25f4-0d21-45d6-8e41-7f6cfb3e9aa4"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19217094</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8444253</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/219800"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5898de47-f701-41ed-ab27-06de82302f88">
        <dc:identifier>HP:004017</dc:identifier>
        <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_004017</ddiem:url>
        <rdfs:label>Low serum testosterone levels</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e253bd8e-6e42-408b-b880-fb384e865997">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003165</ddiem:url>
    <dc:identifier>HP:0003165</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Elevated circulating parathyroid hormone level</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c2e7ac04-16be-4123-8f1c-8c08ebd15449">
    <rdfs:label>high ornithine level</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0012026</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012026</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/bce15d44-93e3-49ba-9f0f-2891a8445e21">
    <rdfs:label>Beta-Hydroxytryptophane</rdfs:label>
    <dc:identifier>DB04159</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d87a9ddb-e680-46e4-ab47-fcdd9e8899eb">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/851687fc-fd9d-4ebc-9bf2-986432e67471"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7c28c3ad-a7a4-4adb-809f-b9fa8e2b197a"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b8642259-d8b1-44d8-b041-a6cb00879b67"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719208000048</dc:provenance>
        <rdfs:comment>5-hydroxytryptophane</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c01071cf-5747-472e-b70d-4bb1e33a5bff"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/07867f8e-8104-4e6b-aee7-9fa55169629d"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19234759</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10078749</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12003346</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22729819</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20818608</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/233910"/>
        <dc:provenance>https://link.springer.com/referenceworkentry/10.1007%2F978-3-540-29676-8_1729</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB04159</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/5f5766d5-1b14-4199-b741-4674ce504151">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00149</ddiem:url>
    <rdfs:label>L-Leucine</rdfs:label>
    <dc:identifier>DB00149</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8d91ef9d-08f0-4146-9251-e86d26587bde"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f4a65699-6b2b-4083-b9c7-76a3d43fb659">
    <rdfs:label>signal abnormality of the cortex</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0030178</ddiem:url>
    <dc:identifier>HP:0030178</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/236800">
    <rdfs:label>HYDROXYKYNURENINURIA</rdfs:label>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/f0dbf82e-3665-4c41-9035-771968640580"/>
    <dc:identifier>https://www.omim.org/entry/236800</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/34689bd3-5529-4088-aaaf-40579518ff69">
    <rdfs:label>Siagoside</rdfs:label>
    <dc:identifier>DB12351</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e5e6c970-2987-4019-a79c-06e90142d701"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB12351</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9199c3d6-cc4d-4dfc-befa-b567dec868da">
    <dc:identifier>HP:0011804</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011804</ddiem:url>
    <rdfs:label>Abnormal muscle physiology</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c4fbed18-b24c-4484-8e5c-37eda2c23f68">
    <dc:identifier>HP:0002173</dc:identifier>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <rdfs:label>hypoglycemic seizures</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002173</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b1d9328e-65b3-4487-a446-bf24ece96ff8">
    <rdfs:label>behavioral disability</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0000708</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000708</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d55e4404-7d78-4e91-8e9a-d9ca9ac36206">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11425766</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12181212</dc:provenance>
    <rdfs:comment>Recombinant apolipoprotein A-I</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3162680</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2065040</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/298b4eff-3677-4c49-8061-2e46d0ceef2e">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/976dae0f-af53-4b2b-a9e9-468b10eb761c"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d655dab0-95fc-45a5-93df-5a163eedb7c5"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2bd9a418-2a18-4877-be84-4e2ac46ab914"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/831c9741-a176-47b2-846d-4175924abfa4">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6e32db05-0541-45ea-b236-19403ffdfb33"/>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/dc4570b0-a4cc-44f1-a850-48329d7eb182">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ad68a954-1230-4055-9bc2-967bc42c809e"/>
    <rdfs:comment>Potassium chloride</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/263800"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25012174</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5ebbbf5b-caa6-4751-a827-fa118cece9ef"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507263</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518128</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23196212</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21503667</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28381550</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3ef9cfea-8b7e-4833-bee1-211acc13c71e"/>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3f10afb8-01e3-4509-962c-aabfb78242c7">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b8a08b72-456b-4ca4-9a0d-2bc49071cee3"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/71418949-f8ef-47cb-beaa-8a323e5c52a7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/02fc68f4-441b-4b4a-a340-7e45e489654a"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/740ffc4b-1f6b-4ffd-84f4-d79c4d32c46d"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/136120"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e0cbdb78-95a8-4112-9135-9c201d6b83cf"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20605907</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27491218</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29390242</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9a683f47-2633-424c-95dc-eadbe3a12cf4">
        <rdfs:label>Abnormal lipoprotein profile</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0010979</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0010979</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:comment>r LCAT</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9ae80196-231c-4e0b-b8b5-d4bcc82337b0">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0000707</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
    <rdfs:label>Abnormality of the nervous system</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c3202995-5b58-4af2-a071-1d9eb1ad714e">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9d72c030-67f2-47ba-a2d5-2f9703195a54"/>
    <rdfs:label>Migalastat</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/28dbcd66-aa16-46a2-b924-1cb9227ffd09"/>
    <dc:identifier>DB05018</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB05018</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/16c70007-33cb-4bca-933f-77edd460966d">
    <rdfs:label>(r) AAV2/1-mediated calpain 3</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c6f2f77b-0dd7-44e7-b098-e9baee2e5ed3"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c50090e2-5c4e-431c-a17f-c78cbeac64ed">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00915</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d7b72d9f-b599-471c-99e3-857d01679812"/>
    <rdfs:label>Amantadine</rdfs:label>
    <dc:identifier>DB00915</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4f22151b-141f-439b-a6a1-9c04aa1b0ab5">
        <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22550086</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4196c999-8684-4237-a847-7603238286cd"/>
        <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15300460</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17586848</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27906067</dc:provenance>
        <rdfs:comment>amantadine</rdfs:comment>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/66cdd9f9-591f-4b5c-84ce-34efa4ac4a40"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/208900"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/7122a711-0824-4562-a8fd-7430f81a4f3a"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4a9a1c5e-6b96-4816-ad5c-0b021f184bc0"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3ad2b87e-290a-4bbc-a028-689df1014791">
    <dc:identifier>DB00061</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0c1b14ce-6e73-47b3-aeb4-86863237c668"/>
    <rdfs:label>Pegademase</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00061</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/297c77b8-2e9e-41f0-a2bb-c8d7c89784da">
    <rdfs:label>Mannitol</rdfs:label>
    <dc:identifier>DB00742</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00742</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d369931e-dfd2-42fc-bb51-b22501730f33"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/52fee9ce-7b1b-454d-a595-3f819e9c3876">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241937</dc:provenance>
    <rdfs:comment>Rotigotine</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01395641</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608643"/>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e0b8e415-235b-40a0-aa46-e0ddac1a572f"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ac60c5c2-0e7b-43c2-953b-2987a19b098f"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0f45409b-7540-463a-b80e-6a6f426e8448"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/eb2ab32b-f72c-4c72-9a61-4aad73cdb98d"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/fbf30458-d2db-4f83-822c-2f3c4b6dc8bd"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23390030</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955971</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7571aa97-cba0-4c28-94fe-5538a5cafad6"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c5a300ae-51ad-440d-8ff6-5169675a906b">
    <dc:identifier>HP:0100512*</dc:identifier>
    <rdfs:label>concommitant low vit D level</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100512</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/476dcf29-eeba-4bb4-bc4d-08d6f14fe4d3">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6585e913-ccd7-4ba4-ba1c-75432c217822"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000305"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b8883f2b-813b-4bbf-a474-0861c1e34988"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/612319"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <rdfs:comment>Nimodipine</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27491218</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29390242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454877</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bc459685-6919-4160-b6f4-32077d2a883f">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>apoptosis induced in chondrocytes</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1793a1a2-9f11-47c7-add8-008995553dbb">
    <rdfs:label>Methylcobalamin</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB03614</ddiem:url>
    <dc:identifier>DB03614</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9ddd9d1e-d8cc-4dac-be40-e10348f96155"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5edd71a5-bb74-4b4e-bf50-9cf73f1270e1">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012212</ddiem:url>
    <dc:identifier>HP:0012212</dc:identifier>
    <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
    <rdfs:label>Glomerular hyperfilteration (Abnormal glomerular filtration rate)</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c74b4ce4-efc7-45f3-878a-35d0b004ec88">
    <rdfs:label>Selenium</rdfs:label>
    <dc:identifier>DB11135</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e704fcca-6bb5-4e63-8b0b-2c87456e9eba"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB11135</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/30085724-d916-4aab-adb7-42030abb7846">
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/247100">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/24c45db9-b220-448e-8b52-1e2e7c5a72c0"/>
        <dc:identifier>https://www.omim.org/entry/247100</dc:identifier>
        <rdfs:label>LIPOID PROTEINOSIS OF URBACH AND WIETHE</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/699edaa7-1375-410e-9388-c72abaef823b">
        <dc:identifier>HP:0001609</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001609</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Hoarseness</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28720532</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4dc83881-8bf1-4623-8f94-96ff4d912e25">
        <rdfs:label>Skin lesion</rdfs:label>
        <dc:identifier>HP:0011122</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0011122</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28681064</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d7ffa088-ab52-4040-835e-1380be527dc0"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24748909</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/2541f9ba-00f6-44b4-b578-99f4476a3391"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23259080</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fa49e0e4-83d0-4e10-9500-773a14c14b5d">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0000962</dc:identifier>
        <rdfs:label>hyperkeratosis</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000962</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1eb8864c-ae5f-4a57-b392-e49cd2d38a23">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0200034</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Skin papules</rdfs:label>
        <dc:identifier>HP:0200034</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18808438</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/85592d4c-1e89-4edd-80d1-8495f757056f"/>
    <rdfs:comment>Acitretin</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6023ef49-6887-4f9d-a028-a56721a53afd">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012500</ddiem:url>
        <rdfs:label>verrucous lesions</rdfs:label>
        <dc:identifier>HP:0012500</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/942d6b2d-fae4-4aa5-a984-d42a21a9e274">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0100022</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100022</ddiem:url>
    <rdfs:label>Abnormality of movement</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/77ba39b2-293b-4c12-b218-84db24624951">
    <rdfs:label>AAV1vector expressing α-Mannosidase</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/591a678f-992c-43e3-bc48-dd11fa3ae7c7"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3b9ec581-cee4-4b13-9ce7-ec105e31ec18">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/227462f8-ac60-47d3-afe9-535b05377938"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15208740</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/176000"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/23c08290-4916-4e15-bd26-f5cf6afb1cc2"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/69e7a67e-a0b6-4fe4-af9e-e4f0d276195f">
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012217</ddiem:url>
        <rdfs:label>Eevated porphyrin precursors porphobilinogen</rdfs:label>
        <dc:identifier>HP:0012217</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/be1d1d02-6517-4cfa-b0f1-bdf63f34f722">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/e4262b63-322b-4541-9749-e0ea4e8e5e56"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>rhPBGD</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358544</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15767622</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02180412</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4c1a45f1-1182-4fec-bc83-328eb519edd5">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2946feee-2222-4277-86af-79aeaca78fab"/>
    <dc:identifier>B01A</dc:identifier>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=B01A</ddiem:url>
    <rdfs:label>ANTITHROMBOTIC AGENTS</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/af880734-bfc6-4b68-abfb-1924d6ca83e8">
    <rdfs:label>No medical treatment is available in DDIEM</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0aedeece-6b95-4a09-adba-b3cdeb1e09f4"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/adce6135-ee8b-46d4-8a78-4abecddbb053">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3ecf615f-49f6-4e4f-bf7f-e0277fe835cb"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB04272</ddiem:url>
    <dc:identifier>DB04272</dc:identifier>
    <rdfs:label>Citric acid</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ecca082e-1e5c-4da5-b2bb-0cecbee99650">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9130f827-e748-4733-b4b5-13b1643f9f93"/>
    <rdfs:label>Nifedipine</rdfs:label>
    <dc:identifier>DB01115</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01115</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/16736b5f-3112-4a24-b01f-3719c33c4079">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7d515155-2933-47fc-be41-4b55c15ede5e"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/32efc9dc-0737-41f9-b5b0-06a075057713"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00162</ddiem:url>
    <dc:identifier>DB00162</dc:identifier>
    <rdfs:label>Vitamin A</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/16f7928c-9b0e-43d0-bf03-d07ef4c55bef">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00624</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/10d7ecb7-6f61-447e-8b77-435c2b2b79b7"/>
    <rdfs:label>Testosterone</rdfs:label>
    <dc:identifier>DB00624</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2b4bc304-d27b-49b1-b8c3-45d7ab89eac6">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/48abc717-6fd3-4370-b622-093c2c0c47b4"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/12447614-5313-44df-b08d-b87c85315b41"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18996862</dc:provenance>
        <rdfs:comment>testosterone</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28160246</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/232220"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/292a25f4-0d21-45d6-8e41-7f6cfb3e9aa4"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17514432</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f9eeea6e-e6f4-491f-a385-4f83948838f7"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f0d63516-6fdf-44c3-ac03-8b8522569901"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/513157ea-a217-411a-afbc-a94c18bbe4e1">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00679</ddiem:url>
    <rdfs:label>Thioridazine</rdfs:label>
    <dc:identifier>DB00679</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ab84cc33-5693-44ea-bff3-caffdd56f95d"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/dda5461f-8211-43a9-bc67-cdc15a0b111c">
    <dc:identifier>DB00328</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00328</ddiem:url>
    <rdfs:label>Indometacin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/758e72f7-afcc-4f80-84d2-201877ed2c81"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ffe12bcf-9e63-4ecd-8b90-705c4c8eaa8e">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2d71ff43-cae1-4101-b7a8-8d978203011d"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158338</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3550461</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8444253</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/adf09f53-7c7b-4321-8118-54e5eb451b64"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d1db5564-91b4-449a-85e2-4f099b6062c1"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7f7e86bb-4208-418d-b508-f9829bcb50b1"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016220</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505515</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/219800"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b91f089c-2096-491e-9923-9c67000a7f6e"/>
        <rdfs:comment>indomethacin</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a2938fbd-31c7-4b98-8c81-dddcae359471"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d0ad4663-4654-41c8-bc6d-948a67c8ef14"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e6d4cbb9-226f-446c-b753-ed4340c9702a">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277400"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/45069e30-391f-4478-af13-6c23b700d9e3"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/703fc142-63f4-4874-bbaf-78885c05ccf7"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25511120</dc:provenance>
    <rdfs:comment>lorazepam</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a813d4c1-2b13-4463-bce9-7193b912dc3b">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002069</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Generalized tonic-clonic seizures</rdfs:label>
    <dc:identifier>HP:0002069</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/609283">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/9b3d51d1-8b89-4d03-863d-3fb61162ace7"/>
    <ddiem:iembaseAccessionNumber>1372</ddiem:iembaseAccessionNumber>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1372</ddiem:iembaseUrl>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/609283</dc:identifier>
  </ddiem:Disease>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/26123913-44a2-443e-83c9-9daca4be025b">
    <rdfs:comment>Eliglustat tartrate</rdfs:comment>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01074944</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/37897103-8a16-46e5-a0c2-9a350381bb8f"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00962260</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21503667</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0dbad9f0-ee9c-4864-b687-f3e7b589c155"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27499018</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20439622</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/230800"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT00376168</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28381550</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/203700">
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseAccessionNumber>411</ddiem:iembaseAccessionNumber>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/411</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/203700</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/d2d2d0c0-9a5b-4b2e-a876-f1784eb97054"/>
    <rdfs:label>MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A</rdfs:label>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/73a031fa-df2a-4245-89c9-318aea1a8e95">
    <rdfs:label>somnolence</rdfs:label>
    <dc:identifier>HP:0002360</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002360</ddiem:url>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9ac641e0-7831-41e5-aa94-94eb6ce883d8">
    <dc:identifier>DB08909</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ff539c22-27fa-48a3-b754-c33c4da14bfc"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB08909</ddiem:url>
    <rdfs:label>Glycerol phenylbutyrate</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ac1ff4e6-84bd-439f-9329-e5e9fdc98e2e">
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5c078c61-8cef-47b7-8c17-b53fafae2932"/>
    <rdfs:comment>Folinic acid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28318733</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/530000"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0c8ef8dd-c312-4584-93c3-96bc4a3effb0">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Low 5‐MTHF level</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16365882</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1ace0b97-a227-4c30-b468-d56828e7df9a">
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0002500</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002500</ddiem:url>
        <rdfs:label>White matter alteration</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ab77f8f7-af95-49bd-a101-6a5cb132e5ac"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9b9a6cf9-65fc-480e-9667-6dd94f6ff1f0">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300322"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26922636</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT01065558</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/354f7a83-3054-4c3d-89aa-5dfb99ed73ed">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/83758eda-8561-4717-ac5c-71cd38024f1a"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c1d28c82-72dd-45f2-917f-1eea9583452f"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/aac6b0be-9ea2-48b9-a624-4e2cc0654476"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27179999</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Hypoxanthine+ tetrahydrobiopterin</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/06236b69-fc17-4466-a08c-de3a55020696">
        <rdfs:label>No result was accessible</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100851</ddiem:url>
        <dc:identifier>HP:0100851</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3728152</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f1e9d3ed-92a3-4018-827d-aa63b9c9c4d7">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/61cda0a4-9ed9-4332-9eab-d67c648b1aa6">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/0a85c3bd-3185-4b90-becb-c04013496ab9"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23196212</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0085253816306020</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29624790</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/88f0d6b9-53f7-4820-b3af-742895c4d003"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/63b35f9b-3821-4ca4-a180-105b584eb708">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002900</ddiem:url>
        <dc:identifier>HP:0002900*</dc:identifier>
        <rdfs:label>Refractory hypokalemia</rdfs:label>
        <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02000960</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/263800"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02014883</dc:provenance>
    <rdfs:comment>Rofecoxib</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12141411</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ce6a9384-2271-44fd-ab9d-e93643c9479a"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c8993b5c-a44d-4819-b144-c37a8a06365d">
    <rdfs:label>High VLDL-triglycerides</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003362</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003362</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f774c71b-84b1-44c7-af8d-6512ef46010d">
    <dc:identifier>HP:0003688</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003688</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Decreased activity of cytochrome C oxidase in muscle tissue</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8a928c9a-7aec-495f-9259-bbf5333fda3e">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002910</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Abnormal AST level (Abnormal liver enzymes)*</rdfs:label>
    <dc:identifier>HP:0002910</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/92e8e4f1-9d1b-4cfd-aef5-489adad8d5bf">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/55824b9a-d0f6-476c-9662-9e4395a18636"/>
    <rdfs:label>Phenobarbital</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01174</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/893d7efd-e55d-4312-923a-cad4b41e7988"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/72739647-1acb-4486-8220-193e9aa8e4ca">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cb6d935c-97ca-4752-9652-5786a9767154"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841061</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3e9dee9b-8a7e-4885-95cb-6bec39e90b02"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23162302</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
        <rdfs:comment>phenobarbital</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788912</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606785"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/4789569f-03ed-4876-93e7-cd9487a6d716">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29273094</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/615181"/>
        <rdfs:comment>Phenobarbital</rdfs:comment>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/cb6d935c-97ca-4752-9652-5786a9767154"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/36ef4ede-4f8e-467a-9f8a-9eec8b97f119"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1e821f6d-088c-4784-aa60-c6ce1e6b9e88"/>
    <dc:identifier>DB01174</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b77fa45e-6c4f-486c-a8c1-f9a60164bac5"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1787f3b9-1d1a-4e4f-aa7c-92edc7fa6724">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602541"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830701</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/835a5904-5765-4acf-a760-cb553a3409d5">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c41d423b-f6f1-4ffa-bc98-976f490905e8"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Corticosteroid</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/43ea55d8-6420-4e46-ad36-af5623353587">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000964</ddiem:url>
        <rdfs:label>Nummular eczema (Eczema)*</rdfs:label>
        <dc:identifier>HP:0000964*</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6acaba01-3b7c-4d84-ae50-6be6a3fc40c9">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/aa1434b6-8bf3-4559-808b-74ab76e9515f"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6593d153-b920-4ee1-ac7d-58671e9d00a0"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09081</ddiem:url>
    <dc:identifier>DB09081</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ff0934af-8eaf-4d05-86af-0ca933689f98"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1768ec24-f5cb-4e3b-95fa-236e3c351a89"/>
    <rdfs:label>Idebenone</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0fd8f9ff-79f3-4286-9c92-96d509756a5e">
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100786</ddiem:url>
    <rdfs:label>hypersomnolence</rdfs:label>
    <dc:identifier>HP:0100786</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/cfde690a-7eef-4059-8e7f-39896af2f2e4">
    <rdfs:label>AAV-cG6PGH</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/5c85a080-1c0b-4553-8ba4-5ad30e71e35a"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1d7de4ee-bf12-4e7a-bfcf-bb24268b875b">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d151c977-2780-4a04-8f16-ad40af97281a"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1059131117301243</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S152500161632250X</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1007/s11940-011-0131-z</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/books/NBK1520</dc:provenance>
    <rdfs:comment>Adeno-associated Virus 9 Mediated FKRP Gene Therapy</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/495a7306-bb7f-4725-9d68-ac84b5fdfaa7"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/613153"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/23c08290-4916-4e15-bd26-f5cf6afb1cc2"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6e53a1ef-b41b-4ece-a8ad-955c605f26b9">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/9ec924f6-9922-497c-8bee-db4109a27c3f"/>
      </rdf:Alt>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ec04df75-f3b6-4724-8ab4-9b914fdff8ff">
    <dc:identifier>DB12528</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB12528</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d250e930-26ad-42d5-b479-02d07d04abb6">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
        <rdfs:comment>Lorenzo's oil(Terminated)</rdfs:comment>
        <dc:provenance>https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT03727555</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28976817</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300100"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4eaf8a48-b261-4dda-858a-6835a229617c"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b8518e35-c60b-46ed-bc46-d66ffbec7fe9"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15670720</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7666063</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/01e8c0bd-85e6-416d-bfc4-4ef66cabdb8e"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00545597</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
        <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f04a248e-2ae5-4ab8-9fd0-3e7a32720e55"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16009761</dc:provenance>
        <dc:provenance>https://www.myelin.org/tag/lenti-d</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Glyceryl Trierucate</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b1b35dc4-3444-491d-be3f-613e0972571c">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000166</ddiem:url>
    <dc:identifier>HP:0000166</dc:identifier>
    <rdfs:label>Aggressive periodontitis(Sever periodontitis)</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a728e374-472c-445e-bda6-03f46361a416">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29506905</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22791294</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205003057</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/233910"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c1d28c82-72dd-45f2-917f-1eea9583452f"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719212002971</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9667588</dc:provenance>
    <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005394-35/ES</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12003346</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Tetrahydrobiopterin</rdfs:comment>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/dc1acb01-ac9c-4d08-b869-9f53d66b1bf0">
        <rdfs:label>high serum phenylalanine</rdfs:label>
        <dc:identifier>HP:0004923</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0004923</ddiem:url>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/1e60574c-8e42-4d9d-b564-09bb313e92b2">
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9ff57f2b-1568-4576-9941-ff2b881a2d38">
        <rdfs:label>growth impairment</rdfs:label>
        <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
        <dc:identifier>HP:0001510</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001510</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301535</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25614305</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/341cb69d-951b-4061-9460-1b8ed6c1ceb7"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23430827</dc:provenance>
    <rdfs:comment>Growth hormone</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16775724</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25859380</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/222700"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8a509ece-86c5-46a4-8cd0-e8dd64315108"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/07007f35-0e4e-4ea4-86b9-bf7afb819453">
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/63235587-ef75-4182-86a6-42e8908e431e">
        <rdfs:label>Direct interaction( Mechanistic)&gt;&gt;&gt;Activity modification</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/94013a81-b843-4a8c-8295-9151ea4ae8ed">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Abnormal cellular proliferation</rdfs:label>
        <dc:identifier>HP:0031377</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0031377</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9539fd02-0728-408b-9e66-7ec2e502f50f">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/514615a7-3314-4aef-8cb1-a0ff35c41d18"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <rdfs:comment>Dexamethasone</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10947080</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/162300"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3491070</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d05d7b84-81d0-4b68-92f4-02ab16976df3"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e2a9f175-e619-41d9-b7f0-72911aa4c9ba">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003452</ddiem:url>
    <dc:identifier>HP:0003452</dc:identifier>
    <rdfs:label>High serum iron</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0b102e3b-1e09-4df9-a9d1-0f8c7001ba00">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2befc1d-7839-48d5-9cb5-b4278b116811"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30170069</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4b186a70-c180-4f14-a67b-889fb7c713fc">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <dc:identifier>HP:0001640</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001640</ddiem:url>
        <rdfs:label>cardiac dilation, Heart enlargment, cardimegaly</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00638547</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8700879</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/364c99d6-506a-44a9-b6c0-ed6c4f5c3caa"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9b795e78-4c46-4a87-8e05-ed89ff97dc1c">
        <rdfs:label>ventricular hypertrophy</rdfs:label>
        <dc:identifier>HP:0001714</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001714</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8bce363a-a1c8-4cbb-ba6f-5410c0c60907"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/73f5f5e3-9027-4060-946b-6b45e3875088"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7bd8a185-888c-457b-b42a-a7f7c5c90b60"/>
    </obo:RO_0000057>
    <rdfs:comment>Gene therapy</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/607014"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/54d06ec6-9777-4abc-b613-efa4efcd529d">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1b1f5b46-87e2-452a-8fb1-f419c2af0c64"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6461f584-2c0b-4d97-b6b2-010ac75de5e9"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30081189</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/cfc6b333-03a6-4b97-a867-eb80d30921e2"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4f3e8b1f-464d-4057-94fa-9e9865d2186e"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3887e95f-ef8d-45de-ba50-5fc3f2ee6792"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/374caf9c-7a25-49fe-8260-03da3b2e0bed">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012654</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0012654</dc:identifier>
    <rdfs:label>increased dopamine and serotonin levels (neurotransmitter levels)</rdfs:label>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/982cda1f-724a-45d7-a905-3ca929715087"/>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/bdf39a89-cb21-484d-bc72-143a488f50b9">
    <rdfs:comment>Serotonin reuptake inhibitors</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1899474</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e6a37d8b-9da8-4b53-adbc-376a4c0c5ede"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8163996</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16361586</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/aa854fef-9405-4a83-8d5e-25fa3a6a7c3c"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/523e5589-6a8c-402e-b82e-9eae58cee0da"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12084887</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16891685</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11346370</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/128230"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/dc7a7607-00d5-4b9c-a694-4bbc04cb01a9">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00494</ddiem:url>
    <dc:identifier>DB00494</dc:identifier>
    <rdfs:label>Entacapone</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f021b035-e29e-4f60-8eac-456a5e689793"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/48abc717-6fd3-4370-b622-093c2c0c47b4">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0025142</ddiem:url>
    <rdfs:label>low physical activity</rdfs:label>
    <dc:identifier>HP:0025142</dc:identifier>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/31b94bfa-ec0a-4b71-8d81-c02139193f7d">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01037</ddiem:url>
    <rdfs:label>Selegiline</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0a597cee-225a-435b-bda4-118451baaaf0"/>
    <dc:identifier>DB01037</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/654f5381-7e35-4dee-bb6f-f84f0234785b">
    <dc:identifier>DB0084</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB0084</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2bd4b6b2-81ee-4212-801e-115f2390159e"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b4c51aa9-7250-47db-a54d-06377f0134d8">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b89cc7d3-423a-429a-a405-c0e687164cf4"/>
    <rdfs:label>Linoleic acid</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14104</ddiem:url>
    <dc:identifier>DB14104</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d4a7883b-8e26-4c3e-849f-68f97913d061">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00776</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8ba3f285-f271-412b-8236-1b880b00d657"/>
    <dc:identifier>DB00776</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d4f486f5-3eb3-490a-966b-246fe5f52e32"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c3950586-7693-40f6-99a1-9484c942049c"/>
    <rdfs:label>Oxcarbazepine</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4191c3ff-1ae7-44d5-8f97-6a685e696bd2">
    <dc:identifier>HP:0001939</dc:identifier>
    <rdfs:label>high  short chain acyl-carnitine metabolite level</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4eaf8a48-b261-4dda-858a-6835a229617c">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0025142</ddiem:url>
    <rdfs:label>Functional disability(Constitutional symptom)*</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0025142</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/712e2d69-e286-48e4-9ede-74269ed033f7">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/12c317c3-92b8-4eee-9f4f-bdbb15d898f7"/>
    <rdfs:label>GNT0003</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2a406945-0a17-4eb0-9f08-762db366f946">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23016163</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6fb1ef56-8cbe-4678-a62b-3b36f529deea"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/177000"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f510a06a-1988-4100-844e-5abf4c5da37b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23884489</dc:provenance>
    <rdfs:comment>hemin</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26979527</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3335288</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22092997</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7758200</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7b4bc236-2ca8-4f75-9138-c1146044bba3">
    <rdfs:label>5aR)-5a-C-Pentyl-4-epi-isofagomine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d9923615-5755-4fdc-9488-f4984d27e326"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/08b9b9f0-50a2-4ac1-81fc-f70770890bf7">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9185508</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/2065040</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0a9c7b12-1081-4906-9e5e-192c1d3754b0">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a7c7f7fc-430d-478e-a420-399569ea181d"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d655dab0-95fc-45a5-93df-5a163eedb7c5"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3162680</dc:provenance>
    <rdfs:comment>probucol</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12181212</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/7f262add-6b2e-4117-ad79-5e1a55e41d1a">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22740624</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/515ec36c-f932-4119-8d3c-4d61beabad74">
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000559</ddiem:url>
        <dc:identifier>HP:0000559</dc:identifier>
        <rdfs:label>Corneal scar</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>Infliximab</rdfs:comment>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19656398</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5764528a-9131-4d03-b4f4-1ff4bc145c25">
        <dc:identifier>HP:0007663</dc:identifier>
        <rdfs:label>Decreased visual acuity</rdfs:label>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0007663</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1e8cb5ab-7e9a-46c4-974f-1f9ce0ddee8a"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5aeb0fe0-22ab-4267-a004-408f1d9a72b6">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0000491</ddiem:url>
        <rdfs:label>Nummular keratitis(keratitis)*</rdfs:label>
        <dc:identifier>HP:0000491</dc:identifier>
        <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7936305</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/260920"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9c0c548d-74b2-4826-826c-206ad07c0dbc">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e4ef1cd4-790c-4c9e-b816-cdfa0286f386"/>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/0ef70e6c-65fe-4b8f-a5f1-b16a05e2dbe9">
        <rdfs:label>Symptomatic (C)+Dietry restriction</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/238700"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
    <rdfs:comment>Valproic acid+Lysin restricted diet</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23570448</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24204001</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/196e1779-a16f-4068-8bd9-6269706e31af">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0040181</ddiem:url>
    <dc:identifier>HP:0040181</dc:identifier>
    <rdfs:label>Perioral dermatitis</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ca323eea-d43b-4e7e-8d2d-f10ae0befcbb">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955971</dc:provenance>
    <rdfs:comment>AAV2-hAADC ( Gene therapy)</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ebafe53d-c84d-46da-ab8d-d1be3e793a58"/>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/699d5481-6db7-4b82-b72b-269f72ced036"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/374caf9c-7a25-49fe-8260-03da3b2e0bed"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1d7853cd-1145-4142-b52f-452570c72b60">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7b3b492f-5dfb-4514-baf0-ae0c385f41c0"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/25ba00df-0084-4ba8-bbdf-ebfba4dfc8f4"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073162</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02926066</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/608643"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01395641</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/fa61a112-99bf-49a6-ac05-b5c53765fc71">
    <rdfs:label>Mycophenolate mofetil</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00688</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/33b2d811-1ad3-4d3a-b086-739552aa362e"/>
    <dc:identifier>DB00688</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/94a6dc10-61e6-4adf-8204-7b21207fe512">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>low RBC count</rdfs:label>
    <dc:identifier>HP:0001877</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001877</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7d0df96a-b02e-4780-bafd-9f07097be66c">
    <rdfs:label>Recombinant adeno-associated virus serotype 9 (rAAV9)-ATP7A +sc copper histidine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/22312179-21ec-4a8d-8367-094d25cc15da"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8124fb2a-5963-486f-a7b3-3bc70127025a">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003233</ddiem:url>
    <rdfs:label>Low serum HDL-cholesterol</rdfs:label>
    <dc:identifier>HP:0003233</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ccb197cc-ba82-4d1b-9351-3a071b40db93">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/95c29982-69b4-42a3-92a7-3a9d2e8d5143"/>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=H02</ddiem:url>
    <rdfs:label>CORTICOSTEROIDS FOR SYSTEMIC USE</rdfs:label>
    <dc:identifier>H02</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/58266610-1bb2-4021-a97e-364230ac155e">
    <rdfs:label>insufficient anaerobic glycolysis of skeletal muscle</rdfs:label>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <dc:identifier>HP:0003547</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003547</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/97d6c09d-0825-45db-aae8-2e180cd41bc7">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0009830</ddiem:url>
    <rdfs:label>neuropathy</rdfs:label>
    <dc:identifier>HP:0009830</dc:identifier>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/94bda73e-40be-42ab-bd45-f06034b61338">
    <rdfs:label>high blood S -adenosylhomocysteine level</rdfs:label>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d41236c5-7ea4-462f-bfdc-16cf265bafde">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/42b59791-5555-4fbe-8987-88306acfd83d"/>
    <rdfs:label>Ademetionine</rdfs:label>
    <dc:identifier>DB00118</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/972e80ed-5f9e-4d6b-959b-64ca608b1685">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6bcff7f7-430a-4692-ac54-05fc63b0813b"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
        <rdfs:comment>S-Adenosylmethionine</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20506325</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/236200"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14739681</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/09f9e7ed-47ed-4781-81b7-aa1e7685fe10"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24355692</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16619244</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/cfc6b333-03a6-4b97-a867-eb80d30921e2"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/bbb11c2b-991e-4271-96cb-67b82b439273"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00118</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c1353a23-3d11-4f0d-8f1b-2983b18dcf85"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8b40d071-7704-4998-b67d-36963a9022d8">
    <dc:identifier>HP:0100022*</dc:identifier>
    <rdfs:label>excessive adventitious movements</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100022</ddiem:url>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/543aa5bf-b68e-4a55-bba0-6924a81fef2e">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/169bde28-0502-4ec5-80d7-c3f885acfa2d"/>
    <dc:identifier>DB04075</dc:identifier>
    <rdfs:label>N-Acetyl-L-Glutamate</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB04075</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/ea3e1776-b4a1-4d21-b672-74f518e3f1d9">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b6b93a14-3b63-427c-9b18-21c584f86d46"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a27f4caf-3eaf-4154-afbf-23228859ae2e"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cc3759cd-b208-4f3b-a05b-7c369cee98d7">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Decreased physical function</rdfs:label>
        <dc:identifier>HP:0025142</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0025142</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/76120769-0c1f-4b44-9891-6d5307349686">
        <rdfs:label>Abnormal developmental milestones</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0012759</ddiem:url>
        <dc:identifier>HP:0012759</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/241510"/>
    <dc:provenance>NCT00744042.)."</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/feb9cbc2-c7ea-4434-b6df-393617323894"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/bf89bff4-129e-4ccf-9efc-7fa676de2c4d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824800</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144124</dc:provenance>
    <dc:provenance>"ENB-0040</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>an enzyme-replacement therapy</dc:provenance>
    <rdfs:comment>Asfotase Alfa</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12756558</dc:provenance>
    <dc:provenance>was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22397652</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a87c5af8-3171-4ef3-a674-e8dcc07c1c25">
    <dc:identifier>HP:0012465</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Increased liver iron level</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012465</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2f2619e1-2871-451a-9b2a-c1837dbe581f">
    <ddiem:url>https://www.drugbank.ca/drugs/DB14002</ddiem:url>
    <rdfs:label>D-alpha-Tocopherol acetate</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b8a0bb6f-035d-4d55-a7ca-e5deb495754d"/>
    <dc:identifier>DB14002</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/492fb91d-9feb-4c51-a0a0-d74ecb2a9903">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>No Studies were done on this drug.</rdfs:label>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/804d30ee-2898-46d1-ae94-5998d616d782"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/46a6998a-2d37-4013-9235-892123ae1a18">
    <dc:identifier>HP:0000556</dc:identifier>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000556</ddiem:url>
    <rdfs:label>retinal dystrophy</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6b787c1e-b7a1-4281-993e-61f8803b18b3">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427298</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263309</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e4ef1cd4-790c-4c9e-b816-cdfa0286f386"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/612016"/>
    <rdfs:comment>Sodium Valproate</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28125198</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24164873</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/a57abbcd-455f-481f-914c-ae87c1ac22d2">
    <dc:identifier>DB04854</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/70e3adaa-d339-4065-991b-0b6c32e86cf5"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB04854</ddiem:url>
    <rdfs:label>Febuxostat</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/025e3e77-ea17-40c2-92ef-88a7a32e5c9d">
    <dc:identifier>HP:0004396</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>decreased appetite</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004396</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/91c342b3-1f1b-49df-a6ef-3df5e26e4d5f">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f045daf4-9a93-40fb-8246-2116bd9f0e82"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/79244226-2868-49dd-af9a-f421cf2933da"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6d424b64-6c12-49c7-82a1-3d5eadb2d0b6"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/61cf0b8c-c4d4-449d-bec9-0c96bcc9f597"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564511</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/306000"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/702df761-4121-40d8-a576-b930b3da356a"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/aae3dcff-3f8f-4306-bdf0-5f3fe49c8885"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/8727391c-c9c5-4d48-822f-95d234aad8b5"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25266922</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5f06b480-bfbd-461b-9c8b-0fd90c37f192"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ef75701a-a6e2-48ad-bbbf-5331b9be3a4b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC324959</dc:provenance>
    <rdfs:comment>Uncooked cornstarch+ Beneprotein+Low fats diet</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b47abfc4-b066-4d9f-b396-fc8e2e2f719f">
    <dc:identifier>DB00994</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00994</ddiem:url>
    <rdfs:label>Neomycin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d08375ae-f562-4a96-b84e-c4d2832537b9"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c18ff4b7-e340-4ff6-83f8-54d30bb860a3">
    <ddiem:url>https://www.drugbank.ca/drugs/DB11098</ddiem:url>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/43054adf-4a54-4fc7-81ef-3818522ffa24">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/309000"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17339125</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301653</dc:provenance>
        <dc:provenance>https://www.paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/59/33</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c20e1970-9d55-431f-88e9-5b58d65e178c"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/071efdaf-274a-472d-a4c7-38aaedc641f2"/>
        <rdfs:comment>potassium bicarbonate</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <dc:identifier>DB11098</dc:identifier>
    <rdfs:label>Potassium bicarbonate</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f7f7217c-fdf2-4929-88d4-474fa6def96e">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2d4b6bdf-f623-4418-adca-62faeb6bc541"/>
    <dc:identifier>DB02772</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB02772</ddiem:url>
    <rdfs:label>Sucrose</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2bba6e5a-87ed-4903-b9b5-3c7048e0a3ba">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00973</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9f201629-2411-4f8c-ba61-f4dc119d0468"/>
    <dc:identifier>DB00973</dc:identifier>
    <rdfs:label>Ezetimibe</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/96217615-b29c-40f0-a123-3de3babf92a9">
    <rdfs:label>Cholic Acid</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/290bbf4c-77c6-4481-93c7-3b19728d400e"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/036af790-e5d9-46e4-b8a8-b717a3c75eef"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB02659</ddiem:url>
    <dc:identifier>DB02659</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ce61879f-80f3-4e80-82a1-28c66b4976aa">
    <rdfs:label>dysarthric speech</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001260</ddiem:url>
    <dc:identifier>HP:0001260</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f2ad6f99-cb55-499c-8457-46de51986dcb">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100753</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>schizophrenia</rdfs:label>
    <dc:identifier>HP:0100753</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/77e98115-9019-4bb2-9658-219fdb3b18cf">
    <rdfs:label>high facial soft tissue volume</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000287</ddiem:url>
    <dc:identifier>HP:0000287</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/084acb5b-b218-4b6a-8073-b0d21d039bb9">
    <rdfs:label>Hypercalcemia</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003072</ddiem:url>
    <dc:identifier>HP:0003072</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d759014b-24b5-4b66-bae5-2c095bf7e192">
    <rdfs:label>Afamelanotide</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/5bdb50f5-03c4-4042-9655-5e187b061328"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB04931</ddiem:url>
    <dc:identifier>DB04931</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/52efb5e9-21f5-4ee8-95bf-959a987e67a9">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100851</ddiem:url>
    <rdfs:label>Behaviour abnormalities</rdfs:label>
    <dc:identifier>HP:0100851</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1d594c22-2d03-4089-b1f7-8869cb92464f">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Low COX content and activity</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/e94590cd-926e-4800-9f1c-431e40f52e9f">
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S109671921200265X</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052756/#S10title</dc:provenance>
    <rdfs:comment>keto-analogues of essential amino acids</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5c18ce76-246d-411f-83f1-589b3716f052"/>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a48d4417-25f3-42b4-abed-702601b53e07"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693626</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/838395d3-75d9-4aa3-b35b-22c2dd586dba"/>
    </obo:RO_0000057>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/668730</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4497f62d-1c68-44ec-9c30-0a40f4041eeb">
        <dc:identifier>HP:0001939*</dc:identifier>
        <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
        <rdfs:label>Defective argininosuccinic acid excretion</rdfs:label>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a4164c40-ac7f-454e-8ab7-72817c605a3f"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/1e652f91-d02c-4255-bb00-10d101d4a7c5"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/207900"/>
    <dc:provenance>https://www.clinicaltrialsregister.eu/ctr-search/search</dc:provenance>
    <dc:provenance>http://www.orpha.net/consor/cgi-bin/Disease_Search.php</dc:provenance>
    <dc:provenance>https://www.nature.com/scitable/content/Progress-and-problems-with-the-use-of-14813</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23494656</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3ef9cfea-8b7e-4833-bee1-211acc13c71e"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9ec924f6-9922-497c-8bee-db4109a27c3f">
    <rdfs:label>Adeno-associated Virus 9 Mediated FKRP Gene Therapy</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1d7de4ee-bf12-4e7a-bfcf-bb24268b875b"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2299ce1f-0836-40aa-b38a-f4bcc159cea2">
    <dc:identifier>DB08830</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB08830</ddiem:url>
    <rdfs:label>Dehydroascorbic acid</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/fc56a770-f4ad-41f3-ba5d-e2a5980d1633"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/16be995f-4d6e-47e2-a10a-d11741cc73a8">
    <dc:identifier>DB00360</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00360</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/34743385-1c7b-4bdf-ba79-482e4b9e3a5a"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/992a062f-9eb5-4ca3-a770-8608b3d3f21a">
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/52efb5e9-21f5-4ee8-95bf-959a987e67a9"/>
        <rdfs:comment>sapropterin</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT01065558</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300322"/>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00935753</dc:provenance>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26922636</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27179999</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c1d28c82-72dd-45f2-917f-1eea9583452f"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Sapropterin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f42aa3db-3502-45c7-8a96-c9769620f380"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/67f20795-f624-479b-9c8b-cb0d53b61988"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a728e374-472c-445e-bda6-03f46361a416"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6ad57ee8-f0bd-470a-9c19-95458399e319">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/029817d7-33e2-48b4-863b-2c06b1d82e07"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20971365</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19323589</dc:provenance>
        <rdfs:comment>Tetrahydrobiopterin (sapropterin)</rdfs:comment>
        <dc:provenance>https://clinicaltrials.gov/ct2/show/results/NCT01977820</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261600"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/c1d28c82-72dd-45f2-917f-1eea9583452f"/>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/600f9630-83b1-4a24-a752-2ec66a36aa83"/>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0022347699701381</dc:provenance>
        <obo:RO_0003304>P407S,A373T,R241C</obo:RO_0003304>
        <ddiem:failedToContributeToCondition>Homozygotes of R252W ,Homozygotes of IVS4-1G→A ,Homozygotes of R413P</ddiem:failedToContributeToCondition>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c37c0efe-af43-4efd-be6d-2bc6eb4dd225">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Elevated GFAP(Glial fibrillary acidic protein) level in CSF</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cd23f4e4-69c2-4321-a8c6-552ab59f491f">
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <dc:identifier>HP:0002718</dc:identifier>
    <rdfs:label>Susceptibility to Bacterial infection</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002718</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f60b7d46-d435-44fc-b83d-f3c529adf89b">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a2bfab81-d227-4f4e-bb91-62c1442420a3"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9156798</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1627787</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/121270"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/40fa08dc-cfa8-4fb6-a090-88b64b99f67e"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e19bc033-3859-42bb-93e9-002374d3f3cb"/>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719215300895</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/bde904d1-767a-42a1-89c5-334e9524e5f2"/>
    <rdfs:comment>copper</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/bf7226be-7ef3-436a-8884-3a5f2581fde8">
    <dc:identifier>DB00053</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00053</ddiem:url>
    <rdfs:label>Imiglucerase</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/97e6f3e3-50c9-4295-885a-05241873e201"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bbf6c6fc-3096-48ad-a1c7-92147a430bf9">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/4ec5b893-8b33-4928-b730-e9fc4aeabb34"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/e13f3a96-9186-41f2-a7c0-b1e3eecfb878">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/11195206-7d3b-4c3e-b3d9-12c01534d9cf">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/56c59939-e4bf-45b8-8025-88728b3347a7"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26884075</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/530000"/>
        <rdfs:comment>Insulin</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25092642</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/bf38ed6c-5354-4081-ab91-20fbe2222697"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27709644</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Insulin Human</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00030</ddiem:url>
    <dc:identifier>DB00030</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/675600c9-5c20-4597-859f-2e2a4275eaeb"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/309473e7-3313-4f25-94fd-6188a5bea2e8"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/579f1212-5009-4cb7-abbd-746865777d10">
    <rdfs:label>osteopenia</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000938</ddiem:url>
    <dc:identifier>HP:0000938</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/87e49f53-0c87-4d52-826f-d0a83c52196a">
    <rdfs:comment>hepcidin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <dc:provenance>https://www.researchgate.net/publication/314493225_Clinical_management_of_hemochromatosis_current_perspectives</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007764"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/46a12f85-3ec5-4790-8d40-4bce816dd0a9"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895089</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/602390"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/02bd6c11-d9bc-4f5a-8696-9ecf9bda04ec"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>http://www.bloodjournal.org/content/107/7/2952.abstract</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/80e6f50b-1ef7-4323-aff6-6d641c7ec192"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/0a85c3bd-3185-4b90-becb-c04013496ab9">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00533</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f1e9d3ed-92a3-4018-827d-aa63b9c9c4d7"/>
    <dc:identifier>DB00533</dc:identifier>
    <rdfs:label>Rofecoxib</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/2e2e654e-8c9f-41ba-9fc0-0b5f92f3ccfc">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
    <dc:provenance>https://www.nature.com/articles/nrrheum.2010.182</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <rdfs:comment>Hydroxychloroquine</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/439c5deb-2621-4110-9889-1841a765519b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/118600"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e2f10e65-40c5-4af8-8e95-e4b3e4b495ab"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/affdb752-b621-4b60-aa5c-eb7fa3274c00">
        <rdfs:label>Arthropathy</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>HP:0003040</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003040</ddiem:url>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411330</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9195122</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d384b546-4139-4cba-a50f-7cee0a6c5026"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8d271a5a-68b5-4988-abc9-df84f53a055e">
    <dc:identifier>DB00988</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2bd4b6b2-81ee-4212-801e-115f2390159e"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00988</ddiem:url>
    <rdfs:label>Dopamine</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/071efdaf-274a-472d-a4c7-38aaedc641f2">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c18ff4b7-e340-4ff6-83f8-54d30bb860a3"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/00651c84-2f38-4865-a5d5-362345549601">
    <rdfs:label>Abnormal aPTT level</rdfs:label>
    <dc:identifier>HP:0003645</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003645</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/79ecee81-6b15-42b6-b908-8dec7a3cccfa">
    <rdfs:label>Azathioprine</rdfs:label>
    <dc:identifier>DB00993</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00993</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d6a69a33-9bf9-4798-9bb4-2f3a180d00f7"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ebc578e1-e0b2-49d7-a654-f2654a10720a"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/240667f7-737c-4481-a2ab-914251cf87fa">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/66bc6d2a-c9f0-4bc2-863a-0ac949b48e56"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/4990a0ae-09a7-4c35-950c-2219ad220149"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14992</ddiem:url>
    <rdfs:label>Pegunigalsidase alfa</rdfs:label>
    <dc:identifier>DB14992</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/78b6c270-0dce-4be4-a62d-1794c7082774">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9df59fb5-93da-44eb-9cee-49c5774da922"/>
    <dc:provenance>https://rarediseases.org/rare-diseases/lesch-nyhan-syndrome</dc:provenance>
    <obo:RO_0003304>Spa</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21126241</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21810891</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/58a40a77-8c3d-4315-96d3-6e92f21f18df"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21483849</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22198833</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ad606954-2370-4dfa-b6c3-d2f11689a63f"/>
    <rdfs:comment>diazepam or alprazolam</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202309</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29054473</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/300322"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27179999</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/712fed98-7244-4b42-b602-09e4b22d1d7c">
    <dc:identifier>DB00563</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00563</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8b67c677-7b22-425a-a53e-5b24f7edf4cd"/>
    <rdfs:label>Methotrexate</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b3b7de6b-3b78-4b60-a25f-643bb18c4524">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00016</ddiem:url>
    <rdfs:label>Erythropoietin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8c60209e-2b24-49a1-953b-eb89fefe9e7f"/>
    <dc:identifier>DB00016</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7782e88f-9d51-4165-b980-b19fdc29ec61"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c4310dc9-5cd1-4f54-b880-f5c525b43a30">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/118600"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/0a9fc84c-1e69-4df0-bced-068cb693ea60"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411330</dc:provenance>
    <rdfs:comment>Probenecid</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155</dc:provenance>
    <dc:provenance>https://www.nature.com/articles/nrrheum.2010.182</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22832289</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/92c6a7cf-6fb2-4901-acff-098bb1e6ec5a">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100529</ddiem:url>
        <dc:identifier>HP:0100529</dc:identifier>
        <rdfs:label>Abnormality of phosphate homeostasis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7520501</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169684</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/91cb9462-b28f-41ad-b038-488d846a0783">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/2da21aad-62dd-4d2c-955e-a726b92a65ac"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/530711bd-f1ec-4e73-b348-99b6ad460770"/>
    </obo:RO_0000057>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7b6c37e7-ddb9-4507-8c87-948ed38a4435">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a3efb15e-895d-4de3-8d93-73f6c8456fdd"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/0e7a33a7-85f9-43cf-95cf-50220edb1e34"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ccd5ca66-5fca-4730-96e9-4f2850100dcf"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0bfff313-161b-42ed-9e1f-180ac5e2c76b"/>
    </obo:RO_0000057>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/3756d2f0-45a0-41dd-9c3c-b3f47932590b"/>
    <rdfs:comment>Norleucine</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/248600"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668944</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/255120">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/96c6778c-73fa-4a72-9efe-0c87a359b4e3"/>
    <dc:identifier>https://www.omim.org/entry/255120</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/228</ddiem:iembaseUrl>
    <rdfs:label>CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY</rdfs:label>
    <ddiem:iembaseAccessionNumber>228</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c2184503-d76d-40bc-9b4e-c9710de0d9de">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001976</ddiem:url>
    <dc:identifier>HP:0001976</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>abnormal Antithrombin-III levels</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/151800">
    <rdfs:label>LIPOMATOSIS, MULTIPLE SYMMETRIC; MSL</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/151800</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/8da8670b-f559-4f31-b729-cf71cc42be16"/>
    <rdfs:comment>The surgical management  is the only effective treatment for the case. Patients are usually instructed to stop alcohol consumption. https://www.ncbi.nlm.nih.gov/pubmed/1696085/ https://www.ncbi.nlm.nih.gov/pubmed/8210195/</rdfs:comment>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/9ad3fddf-71d5-484b-9a95-bf2d719fe69d">
    <dc:identifier>HP:0003281</dc:identifier>
    <rdfs:label>High serum ferritin</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003281</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7272d6da-b3c0-4894-947f-54bc58a0f009">
    <dc:identifier>DB01609</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9e1aeea8-5ca2-4ca5-b2d3-a4440532ff30"/>
    <rdfs:label>Deferasirox</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01609</ddiem:url>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d064e456-22eb-4c11-aced-5f1caab372b2">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7e539d4a-18b9-4715-964f-9769b405c3c0"/>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c28f6c7d-36f2-4d0a-b2a5-d4de1dc610a7">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/241500"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10574582</dc:provenance>
    <rdfs:comment>NSAID</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16803637</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/39f95278-a587-4b34-a1d1-2bc9cc2c8cef"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4494408b-79a4-4b11-acf8-1700e5b0cd6c"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f5f12e11-cba6-4af8-a524-d42876d016ea"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4aff5014-c752-44f1-9116-43e6675b0d24"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/53dad161-8502-4d64-a8a2-0dd6d53a6a27">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1d732c54-f97f-406e-8114-89af2d46dc05"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/6efbb158-172f-4fa2-91b9-5882cb151a4a"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ac4cac4c-4cdd-486c-a4c2-a875b4f17ebc">
    <dc:identifier>DB01956</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/43ea1095-39a4-4fb8-8796-55de6c362237"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d006d676-978e-4c1a-b6f8-59d358c2edb1"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01956</ddiem:url>
    <rdfs:label>Taurine</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a0711524-c61b-4e51-8c78-b44bea29452b"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/588fa562-b98e-42e3-bae2-0094b8ece5f1">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001369</ddiem:url>
    <dc:identifier>HP:0001369</dc:identifier>
    <rdfs:label>acute arthritis</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/88a24a43-0a48-4255-8c60-2aed9d209ec6">
    <rdfs:label>Ill-being (Constitutional symptoms)*</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0025142*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0025142</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b8642259-d8b1-44d8-b041-a6cb00879b67">
    <rdfs:label>Defected neurotransmitter homeostasis in the CNS</rdfs:label>
    <dc:identifier>HP:0012535</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012535</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3c98c452-a0f6-4a2a-ab63-01ff3acc98b0">
    <dc:identifier>DB00458</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00458</ddiem:url>
    <rdfs:label>Imipramine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/51917c4a-0e08-4ecd-99ac-51d4738406db"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a9b59208-3e93-45cb-b16f-771c43c5f96d">
    <dc:identifier>HP:0001251*</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001251</ddiem:url>
    <rdfs:label>High ataxia score ( Ataxia)*</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/501ff55e-0e0c-4b91-8eba-7432504d1641">
    <rdfs:label>low physical capacity</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012378</ddiem:url>
    <dc:identifier>HP:0012378</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4e825ddd-486d-40ac-a87d-beb4fbe6ac1f">
    <rdfs:label>Mesalazine</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00244</ddiem:url>
    <dc:identifier>DB00244</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/037f243b-6e19-4bf8-be1c-8628ea890f71"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9ce317ca-757f-427d-8120-a4d1e38f2fc7">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00115</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b69c1eb6-d1f9-4394-84af-aa30dd0092ad"/>
    <dc:identifier>DB00115</dc:identifier>
    <rdfs:label>Cyanocobalamin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/48954f3f-c451-4a18-9f4e-6a229dd33dc4"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/996e6932-a829-43b1-a0ef-22960b90de81">
    <rdfs:label>Hydrocortisone</rdfs:label>
    <dc:identifier>DB00741</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3609a5d7-4f9d-4836-9cee-05035c17f245"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00741</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/54604c1f-f7fa-42bf-abca-478196b46ae1">
    <dc:identifier>HP:0008222</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0008222</ddiem:url>
    <rdfs:label>Female infertility</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/aa206fee-4116-41be-9dfc-4cd47efa5a24">
    <rdfs:label>OTZ (L-2-oxothiazoline-4-carboxylic acid</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a64f50c3-3032-43d5-b888-2e2b2c5f798a"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a2cf9baf-843c-455b-b00a-65c062657076">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/146c4e13-0477-4310-aedb-1ec5520e9db8"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bab07633-cc70-4a18-83a9-75d9e9d864bb">
    <dc:identifier>HP:0010472*</dc:identifier>
    <rdfs:label>Increased liver protoporphyrin concentration (Abnormality of the heme biosynthetic pathway)*</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010472</ddiem:url>
  </ddiem:Phenotype>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000007">
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T18:03:22+00:00</dc:date>
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure in which the composition or metabolic activity of the pathway or network in which the defective protein is found is modified, compensating for alteration of activity of that protein. [PNS]</obo:IAO_0000115>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000002"/>
    <rdfs:label xml:lang="en">functional complementation of a genetically defective protein</rdfs:label>
    <dc:creator>leechuck</dc:creator>
  </owl:Class>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f9e65008-92b8-4307-aa55-4726b7bc6a0d">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8e89e11d-856a-47e9-b873-0426177918ff">
        <ddiem:url>https://www.drugbank.ca/drugs/DB14555</ddiem:url>
        <rdfs:label>Ursadiol</rdfs:label>
        <dc:identifier>DB14555</dc:identifier>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/07213cc0-f8ae-4ce8-80a9-c44d72ecf667"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/66627da1-d563-45fd-9f7c-1289bf6bc60d">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0040006</ddiem:url>
    <rdfs:label>Mortality</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0040006</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f8a53a4c-ab5b-4754-b275-120708abea66">
    <ddiem:url>https://www.drugbank.ca/drugs/DB14500</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/13f1009a-6eae-41d6-8b1c-328a8fdb8f4d"/>
    <dc:identifier>DB14500</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/58b4c4b1-735a-4555-a60c-3b27956b9731"/>
    <rdfs:label>Potassium</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/33e0453c-ae54-41ed-a871-a2b0bb32f9c7"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/69b4d866-9b87-4af9-bab8-a13b3923e87a">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004364</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0004364</dc:identifier>
    <rdfs:label>Abnormal renal nitrogen elimination</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/fc0ed840-97c3-4a86-9814-9eb907700e82">
    <dc:identifier>DB00650</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ac1ff4e6-84bd-439f-9329-e5e9fdc98e2e"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00650</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/5373541b-16c0-4c47-8adc-0eb10701e735"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9eda26fa-ba92-411f-b88c-9e4d347fa959"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/11ab0a58-05ad-4f8d-a028-a98187979726"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a7636d31-7372-48dd-b527-4109a855f804"/>
    <rdfs:label>Leucovorin</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/502a9041-c2eb-4f80-adc7-ea3126abf6c1">
    <rdfs:label>high glycogen levels in muscles</rdfs:label>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0009051</ddiem:url>
    <dc:identifier>HP:0009051</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/78baf126-9d56-4ef3-8622-d99b0c988d2a">
    <rdfs:label>Pure red bllod cell aplasia</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012410</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0012410</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/daf4be0e-450d-430e-81ec-9711deaf315d">
    <ddiem:url>http://purl.obolibrary.org/obo/MP_0013277</ddiem:url>
    <dc:identifier>MP:0013277</dc:identifier>
    <rdfs:label>abnormal fasting glucose</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6cee1c0b-ed78-4c4d-85af-805157e65ed2">
    <rdfs:label>high Lactic acid</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003648</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003648</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f9eeea6e-e6f4-491f-a385-4f83948838f7">
    <dc:identifier>HP:0040306</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0040306</ddiem:url>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <rdfs:label>decreased male libido</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ae9917e1-d813-40a4-b444-a45c4838987c">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2ebdeb7a-ee5f-4d3a-9548-1cb8db344699"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/089459d1-ef48-427d-99c1-de072ac61fd0"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00052</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1e60574c-8e42-4d9d-b564-09bb313e92b2"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/821c7bb7-7249-4c34-8320-62a7483608e4"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/34198391-b22c-48de-b665-f0db8c0f2cb3"/>
    <dc:identifier>DB00052</dc:identifier>
    <rdfs:label>Somatotropin</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6be85261-2044-413a-aeb4-8d9aaa7563b9">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18458702#</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/202110"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/033799ec-2fce-41fd-9fc2-7c561dd1bf92"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/83f7047a-0ef3-46b3-9cc8-e9cdf7c5a0e2">
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Bone mass loss</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18458702</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c20e1970-9d55-431f-88e9-5b58d65e178c"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9539fd02-0728-408b-9e66-7ec2e502f50f"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/f22489fd-f754-49c7-ba87-120807f24acf"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/7f210050-85fe-4bca-9f85-d2a10756484f"/>
    <rdfs:comment>Dexamethasone</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27853336</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/f528d87a-9e0b-47b6-9fe4-98835ab1d662">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <rdfs:comment>gabapentin</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/b585c680-c9ab-4627-acc3-2790a1a5a246"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/220110"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/5fa2fcff-39ec-4fba-ad4c-27633567c468"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/22149023</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d4810beb-7456-416b-98bd-fc56f39e683d">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002415</ddiem:url>
    <rdfs:label>progressive leukodystrophy</rdfs:label>
    <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
    <dc:identifier>HP:0002415</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3ff6b433-a42c-4f9e-95b6-58b5f7a3e461">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/d637f473-c6c9-4d0b-b0db-4e6b34811442"/>
    <rdfs:comment>Hemin</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f510a06a-1988-4100-844e-5abf4c5da37b"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/40da3df8-383e-4779-9f92-c104d97505d9">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002574</ddiem:url>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>Acute episodic abdominal pain</rdfs:label>
        <dc:identifier>HP:0002574</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24652768</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>http://www.malacards.org/card/hepatic_lipase_deficiency</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00733811</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/613521">
        <rdfs:label>UROPORPHYRINOGEN DECARBOXYLASE; UROD</rdfs:label>
        <rdfs:comment></rdfs:comment>
        <dc:identifier>https://www.omim.org/entry/613521</dc:identifier>
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/0f77c68d-8104-4570-b1ed-5a9cb6f7e6e8"/>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14632789</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <rdfs:subClassOf>
      <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/f6f31b55-0553-4ec2-a9b5-e98daae597fe">
        <rdfs:label>Functional interaction (mechanistic B)</rdfs:label>
      </ddiem:TheraputicProcedureType>
    </rdfs:subClassOf>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/768689e4-d6cd-4b53-9d5f-fea090d496c1">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00916</ddiem:url>
    <rdfs:label>Metronidazole</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e125c203-2403-41b2-80bb-0f7c3a62dd8b"/>
    <dc:identifier>DB00916</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9c6899fa-2efd-42a1-a35d-518b0f78ee7c">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c6fe7cab-c9fe-43a4-86cb-ba2653acc3b1">
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/14a68129-72ab-4404-8293-788a4258b514"/>
        <rdfs:label>Prokinetic agents</rdfs:label>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/893b61c6-b749-4d7f-a13a-78d676e3db70">
    <rdfs:label>Rotigotine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/52fee9ce-7b1b-454d-a595-3f819e9c3876"/>
    <dc:identifier>DB05271</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a8acc9fe-7106-40e6-9217-eea4c44f6cd5"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB05271</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/74980813-712f-4b1a-9a90-baa2660d5bb9">
    <rdfs:label>Abnormal blood lathosterol level</rdfs:label>
    <dc:identifier>HP:0001939*</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001939</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6d8330ec-1a6a-4268-86ce-6bc517a9c65e">
    <dc:identifier>DB13959</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB13959</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b8912945-4bfb-4c08-9ce6-cbc29da5e500"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6d4a67bb-ef93-4104-a642-53077e18306d">
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26153518</dc:provenance>
        <rdfs:comment>Medium-chain triglycerides</rdfs:comment>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25614308</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19452263</dc:provenance>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/28f9aa83-f122-4837-9b0f-8e567977df85"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15131757</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28590052</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/212138"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/369e2d68-3b59-4a4f-9422-0a8eb69cbe01"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30804055</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/cb7ab3ab-67fc-43ce-b297-6baab286c2c6"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/84006154-8366-445a-bcd9-d2d6eee37d4c"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/789463c3-30af-46d6-880c-3329c8a2c7c8"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/5625ef54-80af-430f-99c3-3314aa708658"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b3c3ca5c-4eec-4f26-8737-2fefeabf2982"/>
    <rdfs:label>Medium-chain triglycerides</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/678b1e46-af9c-462d-a8ce-bea94a089ecd"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/245e8691-bd3a-424d-bb73-e505a50a7b5d"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b64deeee-b485-4754-9b2b-9a92a3e78376">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000870</ddiem:url>
    <dc:identifier>HP:0000870</dc:identifier>
    <rdfs:label>hyperprolactinemia</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/cb47d691-3314-4043-bdf4-9ea68788a24b">
    <dc:identifier>DB00311</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00311</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ee0e16f1-7930-4c93-b3a9-2332e28a8eb0"/>
    <rdfs:label>Ethoxzolamide</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/545b5ad7-e3c9-49a3-a611-fefc6e49192d">
    <rdfs:label>Excessive Reactive Oxidative System</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003287</ddiem:url>
    <dc:identifier>HP:0003287</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d0ce026d-ba99-479a-ae11-f601e0f39f7b">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/eac55a48-7195-4aa1-b409-dbb2c5b21c81"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB02053</ddiem:url>
    <rdfs:label>Ribose-5-phosphate</rdfs:label>
    <dc:identifier>DB02053</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6f0a2163-07ac-4055-9d88-be28c319b46a">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/96476521-af9d-48d9-bf98-d72604948a57"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7ad09945-bdeb-422d-81a7-1d6ce6361f38">
    <dc:identifier>DB01593</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e7d7f1df-323b-40bd-bb15-5bd063dfb728"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01593</ddiem:url>
    <rdfs:label>Zinc</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/175a3736-5e10-495b-857a-3ad946ca2b43"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3f4bf587-b2d6-4659-9dd5-bf17ea2f56cf"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2f270d4f-a586-4911-8293-65401d2a558f">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/266552c8-14b4-4cc2-9862-25b02924bd83"/>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c4a74089-bdd3-49e0-a46c-3ab834e5645f">
    <rdfs:comment>Levetiracetam</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19627167</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20301643</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/604369"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24639006</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00125190</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/61043cce-112b-4862-a914-47d87e3b0977">
        <dc:identifier>HP:0002069</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0002069</ddiem:url>
        <rdfs:comment>In the mouse model syudy</rdfs:comment>
        <rdfs:label>generalized tonic-clonic seizure</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/17192294</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10549306</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28662915</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/5ca28c24-9eac-4f3c-aebe-d4fc037deded"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23887143</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/18cbaa7e-04bc-4d92-a37c-89d61cf02290">
    <rdfs:label>Photophobia</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000613</ddiem:url>
    <dc:identifier>HP:0000613</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bc4048b5-dd91-4e39-8e00-7ce8bcafa02a">
    <dc:identifier>HP:0003124</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>High total plasma cholesterol</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003124</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/df0a8429-ef7f-4a7d-93f1-515af6002c7e">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/e8e00fab-aa94-4883-b42d-d1a1eaddd547"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00028262</dc:provenance>
    <rdfs:comment>hydroxypropyl-β-cyclodextrin (HPBCD)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29631617</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/631b5dbd-8a2b-4d14-beeb-9e8a7225740b"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/256730"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/c5d472e4-f55e-4fea-857a-d489be43be65"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/a0711524-c61b-4e51-8c78-b44bea29452b"/>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/83dd79a7-9251-4309-a01d-1f7d1512890b"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b5e4ee94-6c63-4827-b33b-f3266f8dee78">
    <rdfs:label>Phosphocreatine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/5c2fbaf7-c0a8-4307-b3d8-81b51fcfa7e6"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB13191</ddiem:url>
    <dc:identifier>DB13191</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c3426d64-5f2b-4063-bd74-27ca873b8e2c"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/46519762-60df-4225-aac9-e4861713e6c8">
    <dc:identifier>DB14872</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2cd5693d-f92f-44b6-843e-80eacabbeba6"/>
    <rdfs:label>Lucerastat</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14872</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7ddcbbfd-b944-408e-aac4-357eb6d6c390">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/222b1090-4d65-4da3-8aca-04b7e9b4430b"/>
    <dc:identifier>DB05134</dc:identifier>
    <rdfs:label>Tanespimycin</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB05134</ddiem:url>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/0c70acf0-c5be-4447-941d-6dbd53ac58b8">
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Corticosteroid</rdfs:comment>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4494408b-79a4-4b11-acf8-1700e5b0cd6c"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21726969</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5b773c43-0fa0-4b9f-bd0c-8c3f177b1829">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0100614</ddiem:url>
        <dc:identifier>HP:0100614</dc:identifier>
        <rdfs:label>Muscle inflammation</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27421908</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/de280646-3cc8-493b-931c-b9e5fa0391c4"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/96583d3c-9803-4f10-932f-a4531baf1729">
        <rdfs:comment></rdfs:comment>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0003713</ddiem:url>
        <rdfs:label>Muscle necrosis</rdfs:label>
        <dc:identifier>HP:0003713</dc:identifier>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/253800"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/706bbca3-88ac-4f77-8ab6-158528151409">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0040217</ddiem:url>
    <dc:identifier>HP:0040217</dc:identifier>
    <rdfs:label>high  HbA1c levels</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/3c7d6c6d-c4af-460c-b126-5344fd4d83f9">
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT02705547</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21597884</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/18759345</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/06aa3e54-a667-4043-a027-bcd2c6fa70f4"/>
    <rdfs:comment>Rosuvastatin</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/229300"/>
  </ddiem:TheraputicProcedure>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/c95f46ae-7adc-426d-98a6-ebab6ebede26">
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/873a62e3-7f54-46b9-8d98-76d7277f38ed"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19752526</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/10603107</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/bc0c9c7b-a556-45e4-845b-c35c2c7f4f37"/>
    <rdfs:comment>Calcium</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282099</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26692114</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/606785"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ac1e22e6-2ee6-46bf-9cbe-97f37939831d">
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <dc:identifier>HP:0001877*</dc:identifier>
    <rdfs:label>Short erythrocyte survival (Abnormality of erythrocytes)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001877</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/214ad663-741f-4fde-9151-b2352ae29293">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/203750"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28220409</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/8537c04e-14c0-4d93-b69a-244a4e310081"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30034506</dc:provenance>
    <dc:provenance>Abstract</dc:provenance>
    <dc:provenance>http://www.neurologyindia.com/article.asp</dc:provenance>
    <dc:provenance>http://www.bloodjournal.org/content/101/5/1705.abstract</dc:provenance>
    <dc:provenance>https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1552-6569.2012.00772.x</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24260777</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/261cc9c0-ed6f-4f66-9e81-53dfe17f8b58"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24218524</dc:provenance>
    <rdfs:comment>glucose</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3c2e3e41-95e4-4167-8f3e-cb27bf6d5d23">
    <rdfs:label>Abnormal Adipose tissue tocopherol level.</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4179eb33-3756-4822-bae1-3eb1b6c593cb">
    <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003218</ddiem:url>
    <rdfs:label>orotic aciduria</rdfs:label>
    <dc:identifier>HP:0003218</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bbdcfba7-ca49-4954-946b-c0f15dd18899">
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
    <dc:identifier>HP:0011118*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011118</ddiem:url>
    <rdfs:label>concentration of TNF-alpha in plasma</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c60869db-cead-437d-a568-1309a076cf60">
    <dc:identifier>HP:0001298</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001298</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Brain pathology</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/e1ea1726-61dc-4fff-ae7c-be5a7d740720">
    <dc:identifier>DB00683</dc:identifier>
    <rdfs:label>Midazolam</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00683</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/36ef4ede-4f8e-467a-9f8a-9eec8b97f119"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a232829e-794b-4359-956a-251ec508677d">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15767622</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648</dc:provenance>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/83358076-b944-4789-a405-c1cd8d1f4d73">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a3633441-e03e-411f-8425-11b071d60366"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24933563</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/#b96-tacg-8-201</dc:provenance>
    <dc:provenance>https://www.orpha.net/data/patho/GB/uk-MCC.pdf</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/23c08290-4916-4e15-bd26-f5cf6afb1cc2"/>
    <rdfs:comment>AAV2/5-PBGD</rdfs:comment>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/176000"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4dfeec87-d174-4548-940b-811e2905ca22"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358544</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/930323f1-6305-4f4d-846c-be08a9533f10"/>
    </obo:RO_0000057>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c3c39daf-a44b-4718-a5f1-b212491b5f76">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0009124</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Rapid progression in body fat mass( Abnormality of adipose tissue* )</rdfs:label>
    <dc:identifier>HP:0009124*</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/19b8cd95-8d82-4098-a731-964f6de519fc">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01045</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/01f24fcc-6d75-45eb-b240-28b518060c38"/>
    <rdfs:label>Rifampicin</rdfs:label>
    <dc:identifier>DB01045</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/7e2fb6e5-7eef-4c22-b542-36d9057b6125">
    <rdfs:label>Direct Interaction</rdfs:label>
  </ddiem:TheraputicProcedureType>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/02897969-28ff-49a1-8a1b-91e2f364b193">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28381550</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21503667</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507263</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23196212</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ad68a954-1230-4055-9bc2-967bc42c809e"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/263800"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25012174</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/63b35f9b-3821-4ca4-a180-105b584eb708"/>
    <rdfs:comment>Indometacin/Amiloride/Eplerenone+Potassium</rdfs:comment>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01146197</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d2e795ec-5e90-4a61-97bc-a9688f5b0452"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/176100">
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/114</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/65163055-9983-4e90-832f-2b1c1507d473"/>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>https://www.omim.org/entry/176100</dc:identifier>
    <ddiem:iembaseAccessionNumber>114</ddiem:iembaseAccessionNumber>
    <rdfs:label>PORPHYRIA CUTANEA TARDA</rdfs:label>
  </ddiem:Disease>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4b6ee773-210d-4d68-8144-345a6a869b42"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/55d50f41-5630-4427-a998-8e2cefabd1b1">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0040189*</dc:identifier>
    <rdfs:label>waxy scaling plaques</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0040189</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c1871150-0692-49d5-9801-d0afc84ec086">
    <rdfs:label>Mitochondrial myopathy</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003737</ddiem:url>
    <rdfs:comment>Doctors prescribed these drugs combination""Methylprednisolone sodium succinate +
Immune Globulin "" as they presumed that the patient had autoimmune encephalopathy. https://www.ncbi.nlm.nih.gov/pubmed/25511120</rdfs:comment>
    <dc:identifier>HP:0003737</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ce4b1e55-e0d5-49bd-af44-d1f509e7ecb6">
    <rdfs:label>Olanzapine</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00334</ddiem:url>
    <dc:identifier>DB00334</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/69e6597a-8169-4c06-8483-1fe1197ec7c5"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e7ad952b-01c6-4bc8-9348-70f9f6f957f0"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fb34503b-6972-4c98-ad09-17c527fed3f7">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b3fe3f7a-ce61-4189-9c38-0f182ac2e212"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/a31ad793-86c1-4fce-97b5-b3511bfb9298">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a5c0126f-f62f-44ae-b674-c5b65cf3ccc6"/>
    <dc:identifier>DB00067</dc:identifier>
    <rdfs:label>Vasopressin</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00067</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/faea8728-ba7d-4e76-94b4-73ccd8c2fb25">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01277</ddiem:url>
    <dc:identifier>DB01277</dc:identifier>
    <rdfs:label>Mecasermin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3a6e4c61-3cf1-4f1d-b7a1-49127d7cb7b9"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/be442aeb-68e8-4b0f-b5d3-000b4159b2cb">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c4a31c51-9a60-45c8-8201-f146ecf1fef6"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB12783</ddiem:url>
    <rdfs:label>Benserazide</rdfs:label>
    <dc:identifier>DB12783</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c9995b56-6fa7-4d75-ae52-ff750ad6d92e"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3ba6493c-fb20-45ae-ac93-075a86f27138"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4f6fb3fd-b14c-4429-a7cf-de34a4433e9e"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/08b82475-5a29-4d86-80f5-2879fba902af">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01032</ddiem:url>
    <dc:identifier>DB01032</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c4310dc9-5cd1-4f54-b880-f5c525b43a30"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/117b6784-958d-4b05-b575-3b97d5adf385"/>
    <rdfs:label>Probenecid</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1b22385d-76de-4da9-a02c-ea62d9191b27">
    <rdfs:label>Hypsarrhythmia</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0002521</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002521</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/07645610-fd2b-4e68-b860-020cc6b509ec">
    <rdfs:label>Recombinant human Aspartylglucosamidase</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a60ca7f0-0b06-4cef-93a5-6cdfea43c8e3"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4f27ac92-656d-4b2b-9cf2-06d5d07ea122">
    <rdfs:label>Neurological abnormalitis</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000707</ddiem:url>
    <dc:identifier>HP:0000707</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/64202417-a68d-4123-9ba2-4c399fbd2895">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c8b5870f-0b77-4b30-8d34-9861bdf86c1a"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB04173</ddiem:url>
    <dc:identifier>DB04173</dc:identifier>
    <rdfs:label>Fructose</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5bf5f0cf-9a98-435a-b7cd-9e5a39c672f0">
    <dc:identifier>HP:0001992</dc:identifier>
    <rdfs:label>Organic aciduria</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001992</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/36660b2d-411e-47c3-858e-ab8ca423bd8d">
    <dc:identifier>HP:0002014</dc:identifier>
    <rdfs:label>diarrhoea</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002014</ddiem:url>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f3e5a8bc-4a27-4d4c-978c-3a3600d0040d">
    <dc:identifier>DB09278</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c48a6d60-579c-4eaa-9c36-422d6e7d41bb"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09278</ddiem:url>
    <rdfs:label>Activated charcoal</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/9136432b-fb2c-43e5-a0b1-0a08c681529d">
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/06aa3e54-a667-4043-a027-bcd2c6fa70f4"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <rdfs:comment>Rosuvastatin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25781533</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612542</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/307030"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/472333b9-c892-4437-bb4c-b3d49c8eba92">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000982</ddiem:url>
    <dc:identifier>HP:0000982</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Keratoderma</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d85b42e7-3474-4a47-9796-810281becede">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8bbf9e32-cf77-453f-8faa-445c62d1ac1c"/>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/d78a1a65-bad6-49ed-964d-88a097ba9747">
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/617347"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3162680</dc:provenance>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/25768710</dc:provenance>
        <dc:provenance>https://www.sciencedirect.com/science/article/pii/S0021915015001379</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28098593</dc:provenance>
        <rdfs:comment>lovastatin</rdfs:comment>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/898115c7-2054-4893-b291-24af656d4ae9"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/3bf6c992-71de-460c-8e7f-272b250296d0"/>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <rdfs:label>Lovastatin</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00227</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/46a23563-9f5a-42e6-8291-4d4aa3e09ddb"/>
    <dc:identifier>DB00227</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5588747b-6e4d-4a6e-bbb5-d6268c50de31">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/600890"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/666346c2-bf4b-4339-8fe7-07fc9c61681a">
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001942</ddiem:url>
        <dc:identifier>HP:0001942</dc:identifier>
        <rdfs:comment></rdfs:comment>
        <rdfs:label>metabolic acidosis</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/361c02e6-7280-43d7-a512-2d9553381bfd"/>
    <rdfs:comment>Docosahexaenoic acid (DHA)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/16040264</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/65e3caed-1414-4493-9310-f37dc554ebb3">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003141</ddiem:url>
    <rdfs:label>Elevated LDL-C level</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003141</dc:identifier>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e8ec0612-d996-40e6-8803-326cfe5c6506">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/71bbc2c0-66af-4354-99fa-ae8650ffa62a"/>
  </rdf:Alt>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/603358">
    <rdfs:comment></rdfs:comment>
    <ddiem:iembaseAccessionNumber>208</ddiem:iembaseAccessionNumber>
    <rdfs:label>GRACILE SYNDROME</rdfs:label>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/208</ddiem:iembaseUrl>
    <dc:identifier>https://www.omim.org/entry/603358</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ac9c1b63-982c-43d2-9a76-cb366956a2af"/>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d0550636-583d-4be4-ad5d-8c37b4c15c01">
    <dc:identifier>HP:0003128</dc:identifier>
    <rdfs:label>hyperlactatemia</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003128</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/336fe7cb-51a1-4936-81e7-fbfea451908c">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/059c1eb9-85ec-4790-80c7-d8ff16cd7556"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/732d84bf-075d-4781-8eba-ffbc5913eb6b">
    <rdfs:label>elicited hyperactivity</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000752</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0000752</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d883bc14-cb26-4fb6-aec6-eb004d9b4bea">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/710177b3-4cb2-4fed-9c9a-511427266c10"/>
    <dc:identifier>DB00125</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3b588c74-e1db-4e24-8be1-69e5fe049303"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00125</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/854de67d-882b-473d-a6df-55e61f529865"/>
    <rdfs:label>L-Arginine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/10534ea3-b98a-4811-87fa-97d31d06f37a"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ef8c3db0-e5aa-4794-aa8e-94d20a24f771">
    <rdfs:label>Abnormal Antithrombin-III levels</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0001976</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001976</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2117c3fe-1150-45fd-bef1-ca91e61eca52">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0008993</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Increased intraabdominal fat</rdfs:label>
    <dc:identifier>HP:0008993</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1c68924f-d710-4b5c-a191-723417afcf10">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/4c1fb088-980e-4b35-adf0-e28f2e50e2de"/>
    <rdfs:label>volanesorsen (IONIS-APOCIIIRx)</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/161134bc-1b1f-4359-8740-b1cd3496cb0b">
    <dc:identifier>HP:0001945*</dc:identifier>
    <rdfs:label>hyperpyrexia in case of acute encephalopathic crises(Fever)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001945</ddiem:url>
    <rdfs:comment>The phenotype has been reported in association to treatment with baclofen as</rdfs:comment>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/6f30052a-7403-4e50-8c6d-f8011460e21f">
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b13c5fff-2184-4ae2-96c6-efbd40de4608">
        <dc:identifier>DB01109</dc:identifier>
        <rdfs:label>Heparin</rdfs:label>
        <ddiem:url>https://www.drugbank.ca/drugs/DB01109</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6f30fe7e-fb13-48eb-b75e-864b092ab1e6"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/de8451ec-16d1-4e0c-8490-98850996f01d">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/277410"/>
    <rdfs:comment>Vatiquinone (Epi-743)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884027</dc:provenance>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01793090</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4a1cfcb3-fcc4-4c70-bb22-d1f7e3ae640b"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/81e1ad95-7e6c-441d-a032-cf953e9911b8">
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
    <rdfs:label>shorter life expectancy</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9fca88c6-8cb2-4841-87c6-f56d1f0c4bb7">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00188</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9cd6fb08-79a3-4383-8ca6-888c761744fe"/>
    <dc:identifier>DB00188</dc:identifier>
    <rdfs:label>Bortezomib</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/77ac88a9-f5e8-437a-ac47-4096a28d8fa0"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c5651fb4-8a69-4143-86a8-b7090f73edef"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7d8e8d90-19f5-43ea-842f-c21445d2b9b1"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6de8c97d-bc64-43ae-a73f-13d2e401e34f">
    <rdfs:label>Central nervous degeneration</rdfs:label>
    <dc:identifier>HP:0007009</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0007009</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/888bfe1b-f202-48cd-a88a-39dd2e565fcd">
    <ddiem:url>https://www.drugbank.ca/drugs/DB09125</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f37082c6-06da-43ba-8b5b-cc772b054d3c"/>
    <rdfs:label>Potassium Citrate</rdfs:label>
    <dc:identifier>DB09125</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6c3cf7b7-ba5b-4982-9c85-9d0b792b8c34"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/a9984b75-e640-48c5-b748-6777299de1aa">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/14695410</dc:provenance>
    <obo:RO_0002606>
      <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/231005">
        <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/b4c7f310-1e02-4bfd-8cbc-931b7c324369"/>
        <rdfs:label>GAUCHER DISEASE, TYPE IIIC</rdfs:label>
        <dc:identifier>https://www.omim.org/entry/231005</dc:identifier>
        <rdfs:comment></rdfs:comment>
      </ddiem:Disease>
    </obo:RO_0002606>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15895716</dc:provenance>
    <obo:RO_0003304>CYP2D6</obo:RO_0003304>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30264864</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30247105</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <dc:provenance>http://clinicaltrials.gov/show/NCT00358150</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/82a3bad3-c345-4fcc-ba5d-c41fe6d92912"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28935503</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29358012</dc:provenance>
    <rdfs:comment>Eliglustat(Substrate reduction therapy)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/7814809</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/37897103-8a16-46e5-a0c2-9a350381bb8f"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29680197</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/e9880d1f-dfa8-468f-878c-59e876c1c19c"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/ae63ed05-10b7-47da-bbea-d7d4c7c1defe"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/a9979a0f-2db7-44d9-bbdf-7091e1d64f4c"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/2090ab25-2aa2-45c6-9cc6-a5f20d13226e"/>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/23b2cd43-b4a5-4cc9-91c0-35646d87e7f9">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/4f08b18a-51da-4843-ac17-55e3eff682db"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/0ac6ca08-ea5d-4046-8928-bbd79563311c">
    <rdfs:label>(6R)-Folinic acid</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e11fe0d8-adaf-46f5-a977-61038946f846"/>
    <dc:identifier>DB03256</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3b80c536-05d5-41f8-b804-bf9ee4e38b83"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB03256</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b52fbfe1-cc9d-4b0a-85eb-199a71000127">
    <dc:identifier>(DB00440</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ed8ffd6a-4e74-4d6c-974e-4b6e1e7fc338"/>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=(DB00440</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0da41c19-b94c-47bb-bb06-2d855ce50cd3">
    <rdfs:label>defected  L-2-HGDH enzyme activity</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/387f787c-cf1e-489c-85ce-1f00a59468f7">
    <dc:identifier>HP:0012120</dc:identifier>
    <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
    <rdfs:label>High urinary malonic acid</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012120</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/68c1cea6-9a86-4caa-af51-74ca70d7d2c0">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002240</ddiem:url>
    <dc:identifier>HP:0002240</dc:identifier>
    <rdfs:label>Enlarged size of the liver</rdfs:label>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/a3633441-e03e-411f-8425-11b071d60366">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a232829e-794b-4359-956a-251ec508677d"/>
    <rdfs:label>AAV2/5-PBGD</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/edc52bb7-a69b-46ea-8570-0d9082721e79">
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <rdfs:label>abnormal muscle phosphorylase activity</rdfs:label>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4721bc5d-016e-48dd-b72e-f2ac0eb4e382">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/45745e4b-c86c-48e3-bba6-47ebc2edba27"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c41d423b-f6f1-4ffa-bc98-976f490905e8">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1787f3b9-1d1a-4e4f-aa7c-92edc7fa6724"/>
    <dc:identifier>D07A</dc:identifier>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=D07A</ddiem:url>
    <rdfs:label>CORTICOSTEROIDS, PLAIN</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4a72be18-3cb3-4ef8-9188-ebd570d0e3ce">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001249</ddiem:url>
    <rdfs:label>Poor intelligibility</rdfs:label>
    <dc:identifier>HP:0001249</dc:identifier>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/306a80c0-e18d-490c-ab15-b8550e97523b">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/62870faf-3e39-4c08-a04d-5039d2482054"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9f1c881c-4608-4f01-9002-48d5cfaed661"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/cb4c052d-bc30-4f72-b73c-7b658eab59ae">
    <rdfs:label>Glycine betaine</rdfs:label>
    <dc:identifier>DB06756</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2c5ab07e-2191-4ab3-87ed-f7e9807ebd27"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/32620431-e0cc-4431-b97b-ac601623a350"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB06756</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a3cb2805-5c7c-49f6-894f-01abcdabbd25">
    <rdfs:comment>The therapy may allow patients with GSD to sleep through the night without awakening for therapy https://www.ncbi.nlm.nih.gov/pubmed/18996862</rdfs:comment>
    <dc:identifier>HP:0002149</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002149</ddiem:url>
    <rdfs:label>High plasma uric acid levels</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e42919bc-a2c4-4c99-bdb8-2dd7d073ccc1">
    <dc:identifier>HP:0100513*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100513</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Abnormal vitamin E level(Vitamin E deficiency)*</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fa64800d-46ae-4d34-9935-72a60ec0e440">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001892</ddiem:url>
    <rdfs:label>Bleeding tendency</rdfs:label>
    <dc:identifier>HP:0001892</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/03b69c45-9c30-453b-9e86-01f2e32c11ce">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00051</ddiem:url>
    <rdfs:label>Adalimumab</rdfs:label>
    <dc:identifier>DB00051</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/955aec1c-b7b7-4d8d-a657-f536e409df1d"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/6f30fe7e-fb13-48eb-b75e-864b092ab1e6">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/20495831</dc:provenance>
    <rdfs:comment>Heparin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/12114919</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/145750"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/20929d74-f4cb-4abb-99a1-84f9598e5514">
        <dc:identifier>HP:0001735</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0001735</ddiem:url>
        <rdfs:label>Acute pancreatitis</rdfs:label>
        <rdfs:comment></rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19770656</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28225998</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/1800965</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/21289269</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6f30052a-7403-4e50-8c6d-f8011460e21f"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/90b4dc20-52e3-4198-8ed1-c026f9a0fc26"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/10c33a6c-d0f6-466f-9880-63cd64130ec8">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/814b1e28-30b3-406f-a110-b733463cc37d"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/5f927cb3-5af2-4ad1-b434-1379f98d3ca9"/>
    <rdfs:label>Atorvastatin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6e356c50-1e0f-4813-ae1d-d256ff267a33"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01076</ddiem:url>
    <dc:identifier>DB01076</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/45f2a792-a9a0-45c8-b505-316b333745bd"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1f518ece-3566-4eca-a453-2e97b6c9f48a">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/87e49f53-0c87-4d52-826f-d0a83c52196a"/>
    <rdfs:label>hepcidin</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d1f4c68d-c568-427a-8654-93b43a0750eb">
    <rdfs:label>pathogenic exon trapping</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d2b217be-f984-4350-809c-81a7631e0035">
    <ddiem:url>https://www.drugbank.ca/drugs/DB6756</ddiem:url>
    <dc:identifier>DB6756</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2d4980ec-1926-4d8b-bdee-a4a4d022a66e"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1a6cf0d6-a4a8-49e7-af15-f78b072b3186">
    <rdfs:label>Taliglucerase alfa</rdfs:label>
    <dc:identifier>DB08876</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB08876</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e24ce5f7-5846-4455-9369-ea722d103166"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/51e8d287-29a2-4775-a816-23605c2ec1db">
    <rdfs:label>Furosemide</rdfs:label>
    <dc:identifier>DB00695</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00695</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/30ce4cd0-229c-45f9-9acb-a4a0b2d2e732"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/cc4e12ab-cdfa-43bf-9212-89a5c9fced8c">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001875</ddiem:url>
    <dc:identifier>HP:0001875</dc:identifier>
    <rdfs:label>neutropenia</rdfs:label>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/414579d7-7d7f-4366-a03c-05f482d2ae12">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/151660"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/706bbca3-88ac-4f77-8ab6-158528151409"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/535a894a-2301-4969-8b8a-30c273e0200a"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338723</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/26584826</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/29044799</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/daf4be0e-450d-430e-81ec-9711deaf315d"/>
    <rdfs:comment>Albiglutide (glucagon-like peptide-1 receptor agonist)</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/27155573</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/afef4e62-087e-40c4-9db3-55b6b7cf4849">
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/69e7e85e-5812-47fb-8188-dab6e50d1855">
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505515</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/8444253</dc:provenance>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/219800"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158338</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841061</dc:provenance>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/6b7fbfc1-2867-4d0b-a7dd-d5685259becd"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/628ad6d4-20e3-4788-a4ce-9d9ed86585e0"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016220</dc:provenance>
        <rdfs:comment>Thyroxine</rdfs:comment>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00451</ddiem:url>
    <dc:identifier>DB00451</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e8acaab8-c06b-43c6-937d-02fcc4a9397b"/>
    <rdfs:label>Levothyroxine</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b7cef933-ca1c-4c95-bcaf-de6edd3c744c">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f5412a39-0463-40aa-b57b-0f40f55573f2"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c819e700-5e34-4d3e-88bd-3c65dc6a767b">
    <dc:identifier>HP:0002910</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002910</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Abnormal ALT level(Abnormal liver enzymes)*</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/26e52b0b-382b-4dc4-ac36-c38356b5f7e7">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491300</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/218800"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15726662</dc:provenance>
    <rdfs:comment>Retrovirus</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3306242</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9457971</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/a7e13039-0a0c-41e5-9322-6e017a2abb1d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/15753292</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/84d31cb2-afaf-4e93-a0da-2a5e6c34c90d"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9156798</dc:provenance>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/551ad276-a312-485c-88aa-3c483c4676ba"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583863</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/ed67671c-7925-4a8a-88ba-cfa6471e2321"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/16246f9f-72ee-4244-9c43-e2602c03b729">
    <rdfs:label>Hepatic steatosis</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001397</ddiem:url>
    <dc:identifier>HP:0001397</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/33df5d27-f339-46f2-804d-5bacfa768b86">
    <rdfs:label>"The study is still recruting. The primary objective of the study is to determine the safety of single doses of DTX401, including the incidence of dose-limiting toxicities (DLTs) at each dose level."</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/done</ddiem:url>
    <dc:identifier>done</dc:identifier>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1b1f5b46-87e2-452a-8fb1-f419c2af0c64">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0b102e3b-1e09-4df9-a9d1-0f8c7001ba00"/>
    <rdfs:label>Gene therapy</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ef4b3a04-2b81-47c6-a080-5608f7cbe597">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a4e4a049-f87c-41c8-8dbd-b506b0221a99"/>
    <rdfs:label>Etanercept</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00005</ddiem:url>
    <dc:identifier>DB00005</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/a126e09d-1451-4ba2-92ac-20dac3260078">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/4dafdf92-c878-476e-86ae-495f25a9283f"/>
    <rdfs:label>Antisense morpholino oligonucleotides (AMOs)</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b96078bb-81dd-4c21-9ee2-81509b6c5b33">
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/230600"/>
    <rdfs:comment>6S-NBI-DGJ</rdfs:comment>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a2ac9082-f98e-4129-9ff8-05e4982743d7">
        <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d583229a-44cd-449b-a8e7-625da75cb27a"/>
      </rdf:Alt>
    </obo:RO_0000057>
    <dc:provenance>https://www.tandfonline.com/doi/full/10.3109/0886022X.2014.900422</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/982cda1f-724a-45d7-a905-3ca929715087"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0001565"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/c60869db-cead-437d-a568-1309a076cf60"/>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/d4988c4c-a2a8-4138-8300-866f8b5f51f0"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23337983</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/cf112898-9d2e-459d-b366-2b2df6965ae1">
    <rdfs:label>RT001 (11,11-di-deutero-linoleic acid ethyl ester)</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e53c9f0a-bf32-445f-b72a-6cd703cbc141"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1ac7c98e-baee-424d-b447-079dea5d443a">
    <dc:identifier>HP:0000867</dc:identifier>
    <rdfs:label>secondary hyperparathyrodism</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000867</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/5cead080-06cb-4312-bed6-380018745746">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c592a367-a1a1-4654-81fa-51aa314cc940"/>
    <rdfs:label>Potassium chloride</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00761</ddiem:url>
    <dc:identifier>DB00761</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/dc4570b0-a4cc-44f1-a850-48329d7eb182"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/06a2514b-7504-482e-87ff-232fc86fb93e">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/dd97cb35-c269-4ca3-827b-408664b3b411"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/92e8e4f1-9d1b-4cfd-aef5-489adad8d5bf"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/e1ea1726-61dc-4fff-ae7c-be5a7d740720"/>
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/39ec466e-b8b4-4293-b216-335e4f674e32">
        <rdfs:label>Valproic Acid</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ef469565-c5a3-4095-bc11-a10c985f1eb6"/>
        <dc:identifier>DB00313</dc:identifier>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9c0c548d-74b2-4826-826c-206ad07c0dbc"/>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/092a66a3-aacb-46f2-917f-b1336b36d9fd"/>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3692d1b8-45c3-44a8-a56c-722bf9659a1c"/>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/36ef4ede-4f8e-467a-9f8a-9eec8b97f119"/>
        <ddiem:url>https://www.drugbank.ca/drugs/DB00313</ddiem:url>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/86764c64-1c02-47d5-8aa6-13d6ee2f1357"/>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a1d53aac-d63a-47c5-bc99-d62fb0f76aae"/>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6b787c1e-b7a1-4281-993e-61f8803b18b3"/>
      </ddiem:Drug>
    </rdf:li>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/bb7c5a4e-3260-4df3-8b8b-6f88b3c2b76e">
    <ddiem:url>https://www.drugbank.ca/drugs/DB04789</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/34ffc1f1-cbbd-498c-975f-73281c0ce162"/>
    <rdfs:label>5-methyltetrahydrofolic acid</rdfs:label>
    <dc:identifier>DB04789</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e380cedc-e73f-4323-893a-0a7dbd67e7b3">
    <dc:identifier>HP:0012238</dc:identifier>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012238</ddiem:url>
    <rdfs:label>Hyperchylomicronemia</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9259bb97-4bb8-4319-ba1f-820301e54793">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b96373c9-9bb1-4196-a5dc-4886a3992706"/>
    <rdfs:label>Lamotrigine</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00555</ddiem:url>
    <dc:identifier>DB00555</dc:identifier>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/14a68129-72ab-4404-8293-788a4258b514">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/24746802</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/baf8db32-5614-4d96-945f-bf3f1b14c2e0"/>
    </obo:RO_0000057>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7019db19-c0bf-48df-9914-53b840fabecd">
        <rdfs:label>Epigastric pain</rdfs:label>
        <dc:identifier>HP:0410019</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0410019</ddiem:url>
        <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/83dd79a7-9251-4309-a01d-1f7d1512890b"/>
    <rdfs:comment>Prokinetic agents</rdfs:comment>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/9c6899fa-2efd-42a1-a35d-518b0f78ee7c"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01212744</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/520000"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/4e209543-0560-4750-86c6-5a77a2c83be1"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28766015</dc:provenance>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b684f056-f5ad-4327-9ae1-652267ec3a20">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/af5f4cd1-ae1c-4607-b49b-1c7476695018"/>
    <dc:identifier>DB02209</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB02209</ddiem:url>
    <rdfs:label>Pyridoxine phosphate</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/83b39bb5-4a9f-40c6-9727-2adee41b2ffa">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/de8451ec-16d1-4e0c-8490-98850996f01d"/>
    <rdfs:label>Vatiquinone</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/aebaf223-3271-40a8-ac81-bc6da532aa9b"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB11917</ddiem:url>
    <dc:identifier>DB11917</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8eda880b-7a06-44c6-8e41-864414bca947"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/194ad692-87c0-4c6e-b87f-bdc41cc1efce">
    <rdfs:label>Phosphate imbalance (Abnormality of phosphate homeostasis)</rdfs:label>
    <dc:identifier>HP:0100529</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100529</ddiem:url>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f5a67aab-fc1f-4921-86a1-fdca0acc6762">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100543</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>cognitive deficits</rdfs:label>
    <dc:identifier>HP:0100543</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/12447614-5313-44df-b08d-b87c85315b41">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001324</ddiem:url>
    <dc:identifier>HP:0001324</dc:identifier>
    <rdfs:label>decrease muscle strenght</rdfs:label>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9af5d129-c87a-4c97-a96e-e5510ba380a2">
    <dc:identifier>DB09393</dc:identifier>
    <rdfs:label>Amino acids</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09393</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/bbe51873-62d8-4d16-98f0-e99afb0bdcff"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/16be0ad5-5afb-4ebf-bef7-e479c2babdc8">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00697</ddiem:url>
    <rdfs:label>Tizanidine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/deeaed3f-dca6-4071-84a1-0cf8273c7e54"/>
    <dc:identifier>DB00697</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/95b32ad9-e7a0-4f6e-b380-ffd2967b8731">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9fa6dffc-d2ce-4e3a-acb5-b0ca6da01965"/>
    <rdfs:label>Chimeric oligonucleotide(oligonucleotide-based gene therapy)</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2f76c007-590e-4adc-b3eb-3d8fce60a3c5">
    <dc:identifier>HP:0001959</dc:identifier>
    <rdfs:label>Polydipsia</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001959</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6fb113d5-4f43-4a33-9a8d-74d832f83453">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/50270b54-1945-4b65-a100-08015083d68e"/>
    <rdfs:label>recombinant canine α-l-fucosidase enzyme</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ebd7e299-4829-41be-9c90-3076edc23a0e">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0005952</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0005952</dc:identifier>
    <rdfs:label>Reduced pulmonary function</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/5037c8ff-0b45-43e9-91bc-d8ed0e3be089">
    <obo:RO_0000057>
      <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/450640ce-1f04-4857-9a6b-191cf463c456"/>
    </obo:RO_0000057>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/96577766-5862-42bb-96e4-f7def9616b0d"/>
    <dc:provenance>https://www.tandfonline.com/doi/abs/10.1081/BIO-120006117</dc:provenance>
    <rdfs:comment>Glyoxal-bis(N(4)-methylthiosemicarbazonato)-copper(II) CuGTSM</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30384011</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/30127521</dc:provenance>
    <dc:provenance>https://www.sciencedirect.com/science/article/abs/pii/088789949190052M</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/9511979</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0005542"/>
    <obo:RO_0002212>
      <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bf707e04-ff67-46ed-8af2-89847d9bbdd9">
        <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
        <dc:identifier>HP:0040006*</dc:identifier>
        <ddiem:url>http://purl.obolibrary.org/obo/HP_0040006</ddiem:url>
        <rdfs:label>Low life span (Mortality)*</rdfs:label>
      </ddiem:Phenotype>
    </obo:RO_0002212>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/309400"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/4208c66a-4a3f-48f5-b1ff-0a1229625507"/>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
  </ddiem:TheraputicProcedure>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/fd0bd6e6-8d2f-45f4-9fb2-931ae1ccc565"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2759e167-c294-4ba7-bc4f-230bca60ff66">
    <rdfs:label>Lactic acidosis</rdfs:label>
    <dc:identifier>HP:0003128</dc:identifier>
    <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003128</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/24d03b80-a7e0-4c42-96c4-95aad128e958">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/590aab39-64f7-4878-b001-279860f54600"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2306cc5a-ee45-4668-bd57-3b39a82aabe3">
    <ddiem:url>https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_2786</ddiem:url>
    <dc:identifier>CHEBI_2786</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/615ba6f3-5a93-4a49-99d5-cf36287400aa"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/290153ae-27c7-4a4d-a3e5-1d8cea978533">
    <dc:identifier>HP:0011025</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011025</ddiem:url>
    <rdfs:label>cardiac dysfunction</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6a4b4c01-2130-434e-99c5-03e9f4e79a59">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100725</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>skin thickening</rdfs:label>
    <dc:identifier>HP:0100725</dc:identifier>
  </ddiem:Phenotype>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000012">
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure in which  generally small molecules are delivered to the organism in order to to directly increase, decrease or alter the activity or stability of a genetically defective protein.[PNS]</obo:IAO_0000115>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/DDIEM_0000006"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T18:07:23+00:00</dc:date>
    <rdfs:label xml:lang="en">activity modification of a genetically defective protein</rdfs:label>
    <dc:creator>leechuck</dc:creator>
  </owl:Class>
  <ddiem:Evidence rdf:about="http://ddiem.phenomebrowser.net/EC:0007121">
    <dc:identifier>EC:0007121</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/EC_0007121</ddiem:url>
  </ddiem:Evidence>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/810de608-6ce2-4e3c-a9c8-b775e77770e7">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010836</ddiem:url>
    <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
    <dc:identifier>HP:0010836*</dc:identifier>
    <rdfs:label>Copper accumulation in kidney(Abnormal copper levels)*</rdfs:label>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5499489c-5d73-4465-a9c2-9c2d7c0d260b">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/1ffc374a-7e2d-4a4d-ae6f-9892396f5be7"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b70e6a3e-ddb9-42f1-b194-43902b098586">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2a19ec2e-d094-41cc-8e55-b6efefb954c6"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00909</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ca5efb11-4eba-4c0e-a963-3a2a09506c93"/>
    <rdfs:label>Zonisamide</rdfs:label>
    <dc:identifier>DB00909</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3f08eefb-0732-4665-a5b1-9d287118abc1"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/398ada33-d63a-4560-bbff-2538698c5016">
    <ddiem:url>https://www.drugbank.ca/drugs/DB08809</ddiem:url>
    <rdfs:label>Dichloroacetic acid</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7857e6e4-99f4-4e3b-8835-8ce62f60271a"/>
    <dc:identifier>DB08809</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ae06b559-77a1-449e-9081-48912b37b3cc">
    <ddiem:url>https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_28384</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0b043726-7076-41ff-bb48-774fe39a44f1"/>
    <rdfs:label>vitamine K</rdfs:label>
    <dc:identifier>CHEBI_28384</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ace22609-5737-4441-8ef1-839a21e1f35a">
    <rdfs:label>Neuromuscular degeneration</rdfs:label>
    <dc:identifier>HP:0002180</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002180</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/7c28c3ad-a7a4-4adb-809f-b9fa8e2b197a">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001257</ddiem:url>
    <dc:identifier>HP:0001257</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>spasticity</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b83d35e4-2f08-43f5-b60d-15ef9be79b31">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/42b51d32-5409-4618-80f6-4d0da5075c26"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00288</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0c70acf0-c5be-4447-941d-6dbd53ac58b8"/>
    <dc:identifier>DB00288</dc:identifier>
    <obo:RO_0000056>
      <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/b0cd5785-c534-47c1-a7b8-c7e680730814">
        <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/de280646-3cc8-493b-931c-b9e5fa0391c4"/>
        <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/8aa7a02a-1b75-4ea1-811e-5aa54c3508fa"/>
        <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/611105"/>
        <rdfs:comment>glucocorticosteroid.</rdfs:comment>
        <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
        <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/b8748fa1-9141-4a7e-af91-aa67d21aa0fa"/>
        <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/23644316</dc:provenance>
      </ddiem:TheraputicProcedure>
    </obo:RO_0000056>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e5cce571-cd25-4ff4-88be-64ee48fa2898"/>
    <rdfs:label>Amcinonide</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f7576e15-49a9-4b69-a3c2-6a50a28a476d">
    <rdfs:label>Kidney stones</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012622</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0012622</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/401855c5-f345-445c-88e2-4376c8c3e954">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c4a74089-bdd3-49e0-a46c-3ab834e5645f"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ca5efb11-4eba-4c0e-a963-3a2a09506c93"/>
    <rdfs:label>Levetiracetam</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01202</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2279fdb2-5653-4ff8-96c3-73dc2c8e1347"/>
    <dc:identifier>DB01202</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/377ad8b2-af57-40a0-93b2-9460c8250298"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/87d92598-33f1-4315-a96a-a919a96ec3ef"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/aaba4f92-5d31-487b-aad1-2cd51c097158"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/78e1511d-1910-443b-a044-fe9a768ff6fe">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001324</ddiem:url>
    <rdfs:label>Fat malabsorption</rdfs:label>
    <dc:identifier>HP:0001324</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f3b29897-a34e-48d1-a029-b0823fc93603">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c255d5aa-ac7c-4117-8a7a-9fa840022126"/>
    <rdfs:label>CoCarbs + HPro</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/668bedf3-30f7-477e-bc40-3a31641bb203">
    <rdfs:label>low renal glomerular filtration rate</rdfs:label>
    <rdfs:comment>Niacin was the only effective drug to increase HDL cholesterol.</rdfs:comment>
    <dc:identifier>HP:0012213</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012213</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/74d00fc0-4cda-4f6f-9f54-4e72bec47493">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e1796b5f-8fa4-4342-b6ed-d8a16486a153"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00083</ddiem:url>
    <rdfs:label>Botulinum toxin type A</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/db46f40d-67b9-4e28-ada5-81ec5a0b2733"/>
    <dc:identifier>DB00083</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/905b120e-f134-4591-ac1c-edbc95dd1064"/>
  </ddiem:Drug>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/601678">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/587d9996-3e22-4ba2-b531-7c892d2b704b"/>
    <dc:identifier>https://www.omim.org/entry/601678</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>BARTTER SYNDROME, TYPE 1, ANTENATAL; BARTS1</rdfs:label>
  </ddiem:Disease>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/5421ee3f-7a80-4ec1-a63d-7553ef14e057">
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=B02BA</ddiem:url>
    <dc:identifier>B02BA</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6f28b5f0-99a8-46d9-b41a-fef83bce20c4"/>
    <rdfs:label>Vitamin K</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b5342a4f-2f01-43d5-b16a-8efdbeb0098c">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002167</ddiem:url>
    <rdfs:label>Speech problem</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0002167</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/07213cc0-f8ae-4ce8-80a9-c44d72ecf667">
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206929</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19622360</dc:provenance>
    <rdfs:subClassOf rdf:resource="http://ddiem.phenomebrowser.net/1dc39365-e4bf-4541-aeeb-acf43741fb67"/>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963001</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/d05d7b84-81d0-4b68-92f4-02ab16976df3"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT00004442</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/11067870</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/971536</dc:provenance>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/261515"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/f9e65008-92b8-4307-aa55-4726b7bc6a0d"/>
    <obo:RO_0002212 rdf:resource="http://ddiem.phenomebrowser.net/cbdfaec6-a5fa-4f9c-b55e-14effdf6db35"/>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0007121"/>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/906349f4-ea1c-4d48-9d89-f1cd884a7221"/>
    <rdfs:comment>cholic acid+ursodiol</rdfs:comment>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ed0e945a-6daa-4e01-bc5c-6af88d018197">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/66745254-345f-4d9e-93bb-79b442e123f2"/>
    <rdfs:label>recombinant human LCAT (ACP-501)</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ffb6a06c-6da5-4cae-b66c-f9f331c9ac83">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003236</dc:identifier>
    <rdfs:label>elevation of creatine kinase</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003236</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d2796f48-f404-47ff-bad0-fd9ca71fb064">
    <rdfs:label>Milrinone</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00235</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2bd4b6b2-81ee-4212-801e-115f2390159e"/>
    <dc:identifier>DB00235</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3d9ba582-5e79-4c38-b1a0-5deb9ccc65ce">
    <rdfs:label>Captopril</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01197</ddiem:url>
    <dc:identifier>DB01197</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/22e95721-ca3a-4a45-8279-df2cfa77b7a6"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/30ce4cd0-229c-45f9-9acb-a4a0b2d2e732"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2de16642-dba7-431c-b0c2-a9e6a77502d7">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002344</ddiem:url>
    <dc:identifier>HP:0002344</dc:identifier>
    <rdfs:label>progression of neurodegeneration</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ccc0d205-8322-4f81-981e-6ed7a9c0f1d6">
    <ddiem:url>https://www.drugbank.ca/drugs/DB09449</ddiem:url>
    <rdfs:label>Sodium phosphate, monobasic</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1b367bae-9501-4f84-96fb-19416240ecb4"/>
    <dc:identifier>DB09449</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/68ab2cc7-30cd-4c78-b6a3-30df167f8d96">
    <rdfs:label>Low Brain Copper (Abnormal copper levels)*</rdfs:label>
    <dc:identifier>HP:0010836*</dc:identifier>
    <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010836</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/145980">
    <dc:identifier>https://www.omim.org/entry/145980</dc:identifier>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/93e60839-fc53-4c3e-9721-ee1a3819f669"/>
    <rdfs:comment>In majority of cases, there is no need for treatment until thecalcium level is very high, it becomes necessary to treat FHH.https://www.ncbi.nlm.nih.gov/pubmed/21986511</rdfs:comment>
    <rdfs:label>HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1</rdfs:label>
  </ddiem:Disease>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/e38eedfe-7cbe-4a30-9846-a88c9a8a944e">
    <dc:identifier>DB00035</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00035</ddiem:url>
    <rdfs:label>Desmopressin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/057ffa77-dd63-4501-b30c-241b350cf973"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e78fe2f5-1ae8-4e95-afc4-d804a5e266f3"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b2561baa-3400-4f82-b11a-2500be0479e6">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00133</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/da55f146-1acd-4221-bde8-4814f0616457"/>
    <dc:identifier>DB00133</dc:identifier>
    <rdfs:label>Serine</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0711674f-d22a-4023-85fb-729259b67e4c">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/075f5c5b-d481-41d3-9f04-452ca1f1723d"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6002ec55-40ba-42c4-9d8f-72757f143e97">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0001638</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001638</ddiem:url>
    <rdfs:label>Cardiomyopathy</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/42984511-b99c-40e5-bb40-cca5f39c9d99">
    <dc:identifier>HP:0003153</dc:identifier>
    <rdfs:label>Cystathioninuria</rdfs:label>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003153</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3427f497-df05-4dba-8d10-5930df197bfc">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>boost residual AADC activity with a cofactor excess</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2d5cb48d-44f0-4b2b-9aac-337a92e203b1">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100022</ddiem:url>
    <rdfs:label>Abnormal movement</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0100022</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/89762ebc-38d1-4e95-94a5-f9530da20a0d">
    <rdfs:label>Calcitriol</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3f447e33-b394-4519-804b-123ad3f22a9f"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00136</ddiem:url>
    <dc:identifier>DB00136</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2fd62332-069c-45bd-a6e7-6ec4648414aa">
    <dc:identifier>DB12890</dc:identifier>
    <rdfs:label>Dihydrexidine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/72e4958d-9297-4a53-b03f-2e2deeb1499f"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB12890</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/05689f83-ee66-48f1-8aba-b04fd09b8c4f">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/597b3266-7f31-415c-ae0d-3a7cac4f3747"/>
    <rdfs:label>AAV-SOD2 (adeno-associated viral vector containing the human mitochondrial superoxide dismutase (SOD2) gene)</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1d732c54-f97f-406e-8114-89af2d46dc05">
    <rdfs:label>Antiinflammatory agents, non-steroids</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c28f6c7d-36f2-4d0a-b2a5-d4de1dc610a7"/>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=S01BC</ddiem:url>
    <dc:identifier>S01BC</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/851687fc-fd9d-4ebc-9bf2-986432e67471">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/bce15d44-93e3-49ba-9f0f-2891a8445e21"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8978dcb2-fea9-4485-b149-f48ed40c71b6">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/eeee5ff0-425b-452a-b377-404778299abe"/>
    <rdfs:label>Tempol</rdfs:label>
    <dc:identifier>DB12449</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB12449</ddiem:url>
  </ddiem:Drug>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/118610">
    <rdfs:label>CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/7a0f16c2-2b4f-4467-940e-b186148785ee"/>
    <dc:identifier>https://www.omim.org/entry/118610</dc:identifier>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4a507c00-3886-461b-8d2f-e399f74f9b95">
    <rdfs:label>Defected ClC-Kb expression</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/610198">
    <rdfs:label>3-METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5</rdfs:label>
    <dc:identifier>https://www.omim.org/entry/610198</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/1012</ddiem:iembaseUrl>
    <rdfs:comment></rdfs:comment>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/4ed2e0c8-20d6-4bb3-8f99-aa04c200373d"/>
    <ddiem:iembaseAccessionNumber>1012</ddiem:iembaseAccessionNumber>
  </ddiem:Disease>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3abe31fb-291d-47eb-a46a-26312e1cba7c">
    <ddiem:url>https://www.drugbank.ca/drugs/DB14573</ddiem:url>
    <rdfs:label>Phosphate ion P-32</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2100017f-a1d0-4fc9-94b0-d8cf65d8052a"/>
    <dc:identifier>DB14573</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/25a11b1e-43dd-4942-a11b-ba31d11200b7">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b11c931d-d9df-4997-a869-76233c2a3660"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00099</ddiem:url>
    <dc:identifier>DB00099</dc:identifier>
    <rdfs:label>Filgrastim</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/66cdd9f9-591f-4b5c-84ce-34efa4ac4a40">
    <rdfs:label>involuntary movements</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0004305</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004305</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7674d9e5-68ea-4481-9a9d-aba5f07616e1">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/5f927cb3-5af2-4ad1-b434-1379f98d3ca9"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7d966ab5-4d34-486e-8cf0-d0f376384d08"/>
    <rdfs:label>Bezafibrate</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d00d9e6a-74e1-4623-939a-ad07e0cbaac1"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/17a895e3-a3b0-46ee-a3dd-e6e69fd130a0"/>
    <dc:identifier>DB01393</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01393</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3006e7ae-b7a9-4fa8-b758-e91f1b96724a">
    <rdfs:label>Amitriptyline</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8d50abe8-c59c-4d8e-a691-61cb641abf52"/>
    <dc:identifier>DB00321</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00321</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9a2b840b-fafd-4940-bd27-8a29acd39960">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01563</ddiem:url>
    <dc:identifier>DB01563</dc:identifier>
    <rdfs:label>Chloral hydrate</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ab84cc33-5693-44ea-bff3-caffdd56f95d"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f04a248e-2ae5-4ab8-9fd0-3e7a32720e55">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0003455</dc:identifier>
    <rdfs:label>Abnormal elevated level of VLCFA in plasma</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003455</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/976dae0f-af53-4b2b-a9e9-468b10eb761c">
    <rdfs:label>Recombinant apolipoprotein A-I</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d55e4404-7d78-4e91-8e9a-d9ca9ac36206"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3ecf4b0b-2aa7-4627-88c1-c95837b02081">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/29cca417-b968-4f7b-8b8b-dfe2eea93ddf"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0a25a06b-877b-4cab-ae83-3bee43708f1d">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f255997f-e9d5-4850-9360-e2b02daf4a71"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/bc743179-2142-485b-a8bc-e094d8d50ab1">
    <rdfs:label>Tazobactam</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01606</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/5dcdc801-4128-4e74-ae9c-fb0068a3b17a"/>
    <dc:identifier>DB01606</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/db786810-8848-4b8e-a56f-5322fdc9b71d">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/541a5aea-c60e-4424-9e7e-6c1c54f3dd62"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2c881bcc-cfdb-44c8-b6aa-8bad66c2b11d">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00230</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3509e41b-2890-4904-b85c-7d69a56bfcb1"/>
    <rdfs:label>Pregabalin</rdfs:label>
    <dc:identifier>DB00230</dc:identifier>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5364fa32-0aa4-4f45-9cfb-f34a98521e5b">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001635</ddiem:url>
    <dc:identifier>HP:0001635</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>Heart failure</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/667e0fc6-4bb0-4aa6-9b37-ae7dc65e486b">
    <dc:identifier>HP:0030878*</dc:identifier>
    <rdfs:label>Low FVC%</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0030878</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/07867f8e-8104-4e6b-aee7-9fa55169629d">
    <dc:identifier>HP:0001270</dc:identifier>
    <rdfs:label>abnormal motor development</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001270</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c156cffb-f862-416e-946b-41f7b6f9d8fb">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c9888b07-78ab-40f5-b80d-beea61796da3"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e1031574-2cdb-4e6e-bc18-b27a78645c76"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1734c3a3-21f9-4829-9293-eb4f435c0ffe">
    <rdfs:label>Trimethylaminoxid</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c5b4238f-3887-4ddd-8806-b17b19d3e43e"/>
    <ddiem:url>https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_15724</ddiem:url>
    <dc:identifier>CHEBI_15724</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d824b5db-6154-4874-a88c-719c0a49f493">
    <rdfs:label>Beta carotene</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB06755</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/46d093a0-5e0d-4dd6-ae7b-de1262fa11e1"/>
    <dc:identifier>DB06755</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8d64f389-2164-47c3-9a03-47cb50a7f9a0">
    <rdfs:label>AAV-treated βgal</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/33c52f73-3090-4388-9db3-7a7956dae4cd"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ff74f292-08d5-4724-9ea6-4a9ea93060d9">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003200</ddiem:url>
    <dc:identifier>HP:0003200</dc:identifier>
    <rdfs:label>Mitochondrial proliferation in the muscle</rdfs:label>
    <rdfs:comment>The study was done on mice, The phenotype enephalopathey was not treated, however, the aim is to delay the incidence. Norleucine substantially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein diet that mimics the catabolic stress shown to cause encephalopathy in human maple syrup urine disease.</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a56e3d88-5b3b-4dc2-9801-f87fe8d1ff25">
    <rdfs:label>Nonketotic hypoglycemia</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001958</ddiem:url>
    <dc:identifier>HP:0001958</dc:identifier>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9ae09a9f-e7fa-483d-92ae-b8d116924c7e">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/27f4aab0-c205-4a0f-9a36-366914e08f2b"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/0cf066cd-cce1-4dca-bdab-9e227459fdfe">
    <dc:identifier>DB01132</dc:identifier>
    <rdfs:label>Pioglitazone</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01132</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b83f9b27-77f3-4265-863d-968b2fd5fdae"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/64f01144-6c1b-432d-8747-000bf1941225">
    <dc:identifier>DB01306</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01306</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2236380d-32e6-438f-b94f-e555df6d4b30"/>
    <rdfs:label>Insulin Aspart</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/af09b6b0-e5bb-41af-a67d-b78016ba0308">
    <rdfs:label>intracellular defect of arginine</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0005961</ddiem:url>
    <dc:identifier>HP:0005961</dc:identifier>
    <rdfs:comment>The drug works through preventing the aciduria and the hyperammonemia rather than treating it.</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6052b753-9030-49b8-9679-8fbc7b114725">
    <ddiem:url>https://www.drugbank.ca/drugs/DB03485</ddiem:url>
    <rdfs:label>Alpha-D-Fucose</rdfs:label>
    <dc:identifier>DB03485</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/95857702-adb6-404e-ba87-02d3e4618260"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/aafcd42a-0d0d-47ec-b906-8d327ab6e2e8">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d4a64ff3-a356-4de7-872c-67b9d246dace"/>
    <rdfs:label>Gene therapy *</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1868655e-e525-4cd0-9d8c-4626996f2026">
    <dc:identifier>HP:0006530</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0006530</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Alveoli damage ( interstitial pulmonary abnormality)*</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d329df45-ffe7-4866-a634-9a05d389e8b0">
    <rdfs:comment>Treatment with clofibrate decreased cerebral and hepatic concentrations of glutaric acid in glutaryl-coenzyme A dehydrogenase-deficient mice. This finding opens new therapeutic perspectives such as pharmacological stimulation of alternative L-lysine oxidation in peroxisomes.https://www.ncbi.nlm.nih.gov/pubmed/20923787</rdfs:comment>
    <rdfs:label>Nonepileptic paroxysmal abnormalities</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/022c7942-ad26-4cbc-83cb-a9c838756157">
    <ddiem:url>https://www.drugbank.ca/drugs/DB06742</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/aca30dc0-ef13-44f9-ad05-31c849036396"/>
    <rdfs:label>Ambroxol</rdfs:label>
    <dc:identifier>DB06742</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ce9aeb3c-a830-484d-ab97-867b436aa491">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/64f15447-8f7b-40ed-8c6a-08f6dce361a4"/>
    <rdfs:label>Pitressin tannate in oil</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/48bec87f-13d4-4613-8638-830114db312d">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0040134</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0040134</ddiem:url>
    <rdfs:label>elevated liver iron concentration</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8491e08a-6991-4092-916d-c2f3cabd6340">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0006a2ee-bb72-4795-8670-f1fde6208830"/>
    <rdfs:label>flavanols</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b2921e86-da03-49b5-832a-6aee3a351245">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/96627a6e-20bd-4af1-aaa6-bad26789f550"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/2101e92d-1a3b-44c1-993b-ad60a1b915a8">
    <dc:identifier>HP:0011123</dc:identifier>
    <rdfs:label>Acrodermatitis (Dermatitis)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011123</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/546c51f7-2eaa-4f63-8371-582f0927636f">
    <rdfs:label>Modified Atkins diet</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/40a4b19d-1b0f-4902-b8ed-8d5f1a4cc5cb"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8b5093be-5162-49ca-8b26-a75bca147333">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00421</ddiem:url>
    <rdfs:label>Spironolactone</rdfs:label>
    <dc:identifier>DB00421</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/58b4c4b1-735a-4555-a60c-3b27956b9731"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/8775f387-cb8d-4bcd-aa46-d9de03741161">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/79a4d0d8-604f-4958-a73e-edbde341deca"/>
    <rdf:li>
      <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7f827072-f685-4a19-b3cf-19b8f9e0b9b4">
        <rdfs:label>DIURETICS</rdfs:label>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0bf2816d-81ba-4807-9a7f-3d83c3035d86"/>
        <dc:identifier>C03</dc:identifier>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/dd06761f-60f0-4e33-9049-dadc7b980fa3"/>
        <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/104461c0-66d3-4840-a584-950ee2b77f03"/>
        <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=C03</ddiem:url>
      </ddiem:Drug>
    </rdf:li>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/74e3f7e7-105c-455a-af72-76cf06903bed"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/5bb4576b-3cd0-4d0b-9281-16d61751ff30"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/66d5f44e-3fd3-4e12-b06c-b26df80a0cc9">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/df0a8429-ef7f-4a7d-93f1-515af6002c7e"/>
    <rdfs:label>hydroxypropyl-β-cyclodextrin (HPBCD)</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/a3efb15e-895d-4de3-8d93-73f6c8456fdd">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/91cb9462-b28f-41ad-b038-488d846a0783"/>
    <rdfs:label>Norleucine</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/221c46d7-b0a2-4042-a3a1-b8daf2c6d581"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/cb266cdb-127f-46e2-bd1e-960258e95171">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/25c76e69-b976-4fb9-aa4f-853926f06e2c"/>
    <rdfs:label>Gene Therapy ??</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/4e47e97d-8ecf-49b0-8455-203d98089e9e">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3b518883-a562-40a3-b578-801f69eeef43"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a7494a80-deb2-4b67-8fdc-adc9bb33b80f">
    <dc:identifier>HP:0001931</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001931</ddiem:url>
    <rdfs:label>low hemoglobin concentration</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/b36f76db-0236-40b5-bbf3-1f048a61940a">
    <rdfs:label>Functional intearction ( Mechanistic B)</rdfs:label>
  </ddiem:TheraputicProcedureType>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3fd430f1-afae-428a-8eaa-d127252651b3">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/cf857336-4361-4eaf-8149-9812cd8f4940"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/904f06bc-cb56-444c-bae5-77c6b05c9ec1">
    <rdfs:label>CER 001, a recombinant high-density lipoprotein (HDL)</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1a964572-5df3-4028-a96a-30c946d253d0"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/59af31be-4f62-487a-97f4-c4d9347c7d63">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d737e973-7bed-4401-809d-497fe18fb6a5"/>
    <rdfs:label>Metoclopramide</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01233</ddiem:url>
    <dc:identifier>DB01233</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/47ba32e2-490f-4e47-b261-0374af1de1eb">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f45f29f5-1519-4c57-8b01-e3d07c52454d"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/32e3bd83-ef74-402d-8b4c-37fb76e3e246"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d5e17364-3b70-44e0-94e3-8a27ef11f528"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/16be0ad5-5afb-4ebf-bef7-e479c2babdc8"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6c2d6178-ce0e-4030-9f03-e21ee74641e4"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ee297785-c35c-4416-be7c-07037e4241d8">
    <rdfs:label>High NFL (neurofilament light signature ) in CSF</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/f93413e2-9289-49e2-a616-6512ab9a02b7">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>abnormal free fatty acid levels</rdfs:label>
    <dc:identifier>HP:0040300</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0040300</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a86cd875-a9fb-4700-a550-337c1f12b9c3">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>abnormal nucleotide sugars</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6f36863e-f84f-4635-bdbb-8a18d9906473">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010918</ddiem:url>
    <rdfs:label>Elevated intralysosomal cystine accumulation( abnormality of cysteine metabolism)</rdfs:label>
    <dc:identifier>HP:0010918*</dc:identifier>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/70efffdf-7905-4ddf-ac06-f63648ce2b2d"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a4844ef3-ad09-4202-a6b0-94d11107c0fb">
    <rdfs:label>acidotic crises</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001941</ddiem:url>
    <dc:identifier>HP:0001941*</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/9b56f4ae-66cf-4b6d-94d6-5a254485ea05">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01257</ddiem:url>
    <dc:identifier>DB01257</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0b359b25-f66a-44b9-9a62-7bc5db254965"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c3fa34b3-54e2-4caf-95c3-decec5354f60"/>
    <rdfs:label>Eculizumab</rdfs:label>
  </ddiem:Drug>
  <ddiem:TheraputicProcedure rdf:about="http://ddiem.phenomebrowser.net/776f6acd-6094-4c90-9aac-bc3905bc2387">
    <dc:provenance>https://www.sciencedirect.com/science/article/pii/S1096719205001733</dc:provenance>
    <dc:provenance>https://www.pnas.org/content/96/5/2339.short</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/19821145</dc:provenance>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/28210839</dc:provenance>
    <obo:RO_0000057 rdf:resource="http://ddiem.phenomebrowser.net/34101d64-08c5-415b-b02e-399803061228"/>
    <obo:RO_0002606 rdf:resource="http://ddiem.phenomebrowser.net/236270"/>
    <dc:provenance>https://clinicaltrials.gov/ct2/show/NCT01793090</dc:provenance>
    <rdfs:comment>Hydroxycobalamin</rdfs:comment>
    <dc:provenance>https://www.ncbi.nlm.nih.gov/pubmed/3950820</dc:provenance>
    <dc:provenance>https://link.springer.com/article/10.1023/A:1005353530303</dc:provenance>
    <obo:RO_0002558 rdf:resource="http://ddiem.phenomebrowser.net/ECO:0000352"/>
  </ddiem:TheraputicProcedure>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2969634b-0c34-40b4-aa77-9b9ef1abc751">
    <rdfs:label>AAV2 /1-mSeAP-propmyoD76A</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/fff9f841-6bde-466b-aaea-7119127203ff"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/de2288fb-9fbd-4102-8f0a-daf582118b7b">
    <dc:identifier>DB14644</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6bfa4b8b-d5e6-4cde-a08b-82ce0e76e7ac"/>
    <rdfs:label>Methylprednisolone hemisuccinate</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14644</ddiem:url>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e8d4b7a5-defd-4b32-b4e5-9e9a3f630d16"/>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/DDIEM_0000005">
    <dc:creator>leechuck</dc:creator>
    <obo:IAO_0000115 xml:lang="en">A therapeutic procedure which directly addresses the effects of a protein defect produced by the mutation, its structure, activity or end product. Therapies which target the local interaction or regulatory network or pathway in which the affected proten lies are also regarded as mechanistic therapies. [PNS]</obo:IAO_0000115>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/metabolic_disease_treatment"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-07-15T17:59:32+00:00</dc:date>
    <rdfs:label xml:lang="en">mechanistically predicated therapeutic procedure</rdfs:label>
  </owl:Class>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/b1e571a9-410e-45cf-9377-23280045b57d">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7e3955fd-7681-424d-8474-c3f43b294f1b"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/00d3a054-4ea8-4011-bf0b-3efb1e05c36e">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6a48cf62-ba5d-4dd0-89dc-786844ce4fe1"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fdd54c06-67dd-41ec-b416-d98ae771b968">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000969</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0000969</dc:identifier>
    <rdfs:label>Oedema</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/db6374f9-c8b2-4895-8207-3507a0ace131">
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100022</ddiem:url>
    <rdfs:label>Asterixis-like movement(Abnormality of movement)</rdfs:label>
    <dc:identifier>HP:0100022</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/b91f089c-2096-491e-9923-9c67000a7f6e">
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0004324</ddiem:url>
    <dc:identifier>HP:0004324</dc:identifier>
    <rdfs:label>weight gain</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5228d50f-c225-4507-933d-5bc47176c52f">
    <dc:identifier>HP:0011227</dc:identifier>
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <rdfs:label>Elevated C-reactive protein</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011227</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/673c1938-6f0c-48b1-a5a4-45e17517e835">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9136432b-fb2c-43e5-a0b1-0a08c681529d"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7a4fb0f8-2baf-4a0b-b91e-283c530aa7f0"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/45f2a792-a9a0-45c8-b505-316b333745bd"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01098</ddiem:url>
    <dc:identifier>DB01098</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3c7d6c6d-c4af-460c-b126-5344fd4d83f9"/>
    <rdfs:label>Rosuvastatin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1494ad5f-8f40-4562-8543-4dc0226216b2"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/02fc68f4-441b-4b4a-a340-7e45e489654a">
    <rdfs:label>r LCAT</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3f10afb8-01e3-4509-962c-aabfb78242c7"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7b3b492f-5dfb-4514-baf0-ae0c385f41c0">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ca323eea-d43b-4e7e-8d2d-f10ae0befcbb"/>
    <rdfs:label>AAV2-hAADC ( Gene therapy)</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/0131c157-65ce-4423-97c9-29f9b8f4af00">
    <dc:identifier>DB01041</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01041</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/52776aec-b9c3-4304-aae5-7638d4d93f3f"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/86559b6f-2581-41e3-9eaf-7541f8e83404"/>
    <rdfs:label>Thalidomide</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/dde23fc9-b94b-4137-8c52-d1f0dfeb46a0">
    <rdfs:label>Hemin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/87ca9847-7b7e-41b9-86fe-18a6b3298a5e"/>
    <dc:identifier>DB03404</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB03404</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3ff6b433-a42c-4f9e-95b6-58b5f7a3e461"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2a406945-0a17-4eb0-9f08-762db366f946"/>
  </ddiem:Drug>
  <owl:Class rdf:about="http://purl.obolibrary.org/obo/OGMS_0000112"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/692a3094-a31e-4870-a218-6869f35a33e6">
    <rdfs:label>Copper</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f60b7d46-d435-44fc-b83d-f3c529adf89b"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09130</ddiem:url>
    <dc:identifier>DB09130</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1011c5a9-97cd-44dd-8465-85306e1e3734">
    <dc:identifier>DB08860</dc:identifier>
    <rdfs:label>Pitavastatin</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB08860</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/45f2a792-a9a0-45c8-b505-316b333745bd"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/26a5bd96-3d32-40cb-be21-177a108c1b30">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3b496593-b9ff-4597-b34e-b31f261434b9"/>
    <rdfs:label>AAV9-MCK-fukutin</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1ef01055-b2a5-4638-83c7-9f8afb534f85">
    <rdfs:label>Abnormal gait</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0001288</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001288</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/62144a4f-836f-4a10-afa3-e5f4ef1db031">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00130</ddiem:url>
    <rdfs:label>L-Glutamine</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/bbe51873-62d8-4d16-98f0-e99afb0bdcff"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a0591cb9-3098-4cd7-a5da-7607cc9c2b55"/>
    <dc:identifier>DB00130</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/84ee9818-ce72-448a-a7c4-decfdd34b3ed">
    <dc:identifier>DB14507</dc:identifier>
    <rdfs:label>Lithium citrate</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6c17b35d-a792-4eff-9be8-d0e6f40fa0bb"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14507</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/6fe047fc-f231-4a9c-9dc3-96e41931b4ea">
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
    <rdfs:label>Albuminuria</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012592</ddiem:url>
    <dc:identifier>HP:0012592</dc:identifier>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/de78ee14-d30b-474a-a088-896e16756333">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0100022</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100022</ddiem:url>
    <rdfs:label>movement disability</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1da366fa-aede-4f92-9540-c9fc443f5b88">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000095</ddiem:url>
    <dc:identifier>HP:0000095*</dc:identifier>
    <rdfs:label>glomerular damage</rdfs:label>
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/e4262b63-322b-4541-9749-e0ea4e8e5e56">
    <rdfs:label>rhPBGD</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3b9ec581-cee4-4b13-9ce7-ec105e31ec18"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2d327911-1078-4005-81a1-3d6af8f43512">
    <ddiem:url>https://www.drugbank.ca/drugs/DB09105</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/ea3e1776-b4a1-4d21-b672-74f518e3f1d9"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3d0a710a-96db-48ec-9115-248835cdd561"/>
    <dc:identifier>DB09105</dc:identifier>
    <rdfs:label>Asfotase alfa</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/beac3d8c-1e79-4f96-a6d1-60b38e63fe93">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/74cdd155-71da-4b10-a023-783d7f9f1545"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b138065e-ba93-47c0-9586-15852cdd9334">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7b5c923a-1ad3-4476-a6c1-593bf913fdcd"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00181</ddiem:url>
    <dc:identifier>DB00181</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/bc8a5902-d793-4d3b-9aa6-9be91cee378f"/>
    <rdfs:label>Baclofen</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2707d394-ecbc-4868-bb60-0fee546ac0a7">
    <rdfs:label>purified recombinant human -GalWT</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/dc8b408f-38f3-4f0d-bcf6-847885dc89a9"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3d8d66a5-d786-424f-8357-a2ac94fe4990">
    <dc:identifier>MP:0012604*</dc:identifier>
    <rdfs:label>Low blood glutathione redox ratios</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/MP_0012604</ddiem:url>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0f1ff3c6-7c09-4b1d-bdad-fec75336de2f">
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <dc:identifier>HP:0100022</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0100022</ddiem:url>
    <rdfs:label>Movement Disability</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1268113f-437f-4aa9-afd6-38ad5e2a94b0">
    <dc:identifier>HP:0009830</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0009830</ddiem:url>
    <rdfs:label>Neuropathy</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/64a4be7c-71e1-4122-8701-9fa019f77b81">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/aa0c25e5-06f5-4809-95f8-f34add508dc1"/>
    <rdfs:label>HDAd-G6Pase</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7a649270-4fb1-46d5-a09c-806497121d1b">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c85b04d4-9928-475d-81ac-eac84e85c65a"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/43cd4137-a87a-43bc-a7d2-fe19fe88d60f"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d883bc14-cb26-4fb6-aec6-eb004d9b4bea"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/59eeb13e-1d81-434d-adb4-20bd03be1881">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/36f95181-b8ec-416c-9f5e-9e3910fb3bad"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/8a7b1798-e087-4471-b938-3ad2da866cb1">
    <dc:identifier>HP:0010472</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Abnormal circulating porphyrin concentration</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010472</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9052a9b8-f668-459c-9aab-7509daea11af"/>
  <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/5d2b234f-9a42-418b-bc6e-a95a7e865a28">
    <rdfs:label>Functional interaction(Mechanistic B)+Direct interaction (Mechanistic A)</rdfs:label>
  </ddiem:TheraputicProcedureType>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5bba4ff5-af91-49ec-8f5d-f7aea5a26000">
    <dc:identifier>HP:0003200</dc:identifier>
    <rdfs:label>mitochondrial proliferation in the muscle.</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003200</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b0f4fa07-673a-4208-b42c-39a0a4d09d15">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00169</ddiem:url>
    <rdfs:label>Cholecalciferol</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/46feb19a-f257-4967-a9ef-a0956682bddc"/>
    <dc:identifier>DB00169</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/e873742d-bcbe-42c1-a9ac-63337c8059c0">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01373</ddiem:url>
    <rdfs:label>Calcium</rdfs:label>
    <dc:identifier>DB01373</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c95f46ae-7adc-426d-98a6-ebab6ebede26"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1479ec8b-c25f-4b03-b7a3-6a12f5428ffa">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/97f0d863-540d-4cd0-a19a-8edd110b4cf1"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/342143b3-0fd3-45bf-9c3b-38c3c0db9372">
    <dc:identifier>HP:0002188</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002188</ddiem:url>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Delayed CNS mylinaton</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ddb7a833-b7ff-4598-abad-7f3abaae3483">
    <ddiem:url>https://www.drugbank.ca/drugs/DB00200</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/34ffc1f1-cbbd-498c-975f-73281c0ce162"/>
    <dc:identifier>DB00200</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9174ffee-721d-4ea4-8cea-7cbfddaaacdc"/>
    <rdfs:label>Hydroxocobalamin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/4e161553-101d-4ba1-8af7-2f5b51f0701d"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/776f6acd-6094-4c90-9aac-bc3905bc2387"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/b42d829c-2816-43be-aa82-b1ba6a09734f">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d10ea3b9-9078-4cce-a795-643e37784c9c"/>
    <dc:identifier>DB00459</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8e57a64b-7265-4a34-a09f-def382357321"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00459</ddiem:url>
    <rdfs:label>Acitretin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/30085724-d916-4aab-adb7-42030abb7846"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2bb579f7-ebe3-41e5-81d5-e5af9d53f24c"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/82fd11be-26fc-440d-8f83-d781a361a528">
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
    <rdfs:label>cystine accumulation in muscle parenchyma</rdfs:label>
    <dc:identifier>HP:0003358</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003358</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/45875502-f3f6-47af-9259-f998f8760536">
    <rdfs:label>nitrilotriacetate</rdfs:label>
    <dc:identifier>CHEBI_25548</dc:identifier>
    <ddiem:url>https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_25548</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a7c77696-cda0-4b05-81d2-c59866036ab2"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/514615a7-3314-4aef-8cb1-a0ff35c41d18">
    <rdfs:label>Dexamethasone</rdfs:label>
    <dc:identifier>DB01234</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01234</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/07007f35-0e4e-4ea4-86b9-bf7afb819453"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6be85261-2044-413a-aeb4-8d9aaa7563b9"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5d6a149c-d6ae-49bf-a187-06ef6b364c34">
    <rdfs:comment>There was partial improvement then patients died</rdfs:comment>
    <dc:identifier>HP:0010836*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010836</ddiem:url>
    <rdfs:label>Copper storage abnormalities (Copper storage abnormalities)*</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c6f2754d-58fa-4f26-aad9-4f53c009e71e">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/163acea0-d86e-4a62-bad9-267a204b1975"/>
    <dc:identifier>M01AX</dc:identifier>
    <rdfs:label>Other antiinflammatory and antirheumatic agents, non-steroids</rdfs:label>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=M01AX</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/83758eda-8561-4717-ac5c-71cd38024f1a">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9b9a6cf9-65fc-480e-9667-6dd94f6ff1f0"/>
    <dc:identifier>DB04076</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB04076</ddiem:url>
    <rdfs:label>Hypoxanthine</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/eb911b11-cc41-41b2-ac22-04c8e2370c45">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7782e88f-9d51-4165-b980-b19fdc29ec61"/>
    <dc:identifier>DB00158</dc:identifier>
    <rdfs:label>Folic acid</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00158</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/79580e16-8baa-4b0a-a63f-2a1aa9164726">
    <dc:identifier>HP:0002900</dc:identifier>
    <rdfs:label>Hypokalemia Metabolic Alkalosis</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002900</ddiem:url>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/1756082d-433f-40cb-9195-5635ade8890c">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/de6a6845-3f24-4f5c-825b-6ab98954d993"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4b533072-015b-4405-884e-1f9468bbae38">
    <dc:identifier>DB14933</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/712eacf2-5156-4d0c-af44-95d7baac4af4"/>
    <rdfs:label>Nicotinamide riboside</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB14933</ddiem:url>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7d436344-19c2-4974-a067-bfef20261f74">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/aaf54191-e861-4676-9de5-4d6760c5d5da"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ccc0d205-8322-4f81-981e-6ed7a9c0f1d6"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/75ed6c1f-27f8-4020-8441-9a0d4dc3a65a">
    <rdfs:label>Sodium acetate</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/1787217c-d524-478c-9258-097a4cd40a96"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09395</ddiem:url>
    <dc:identifier>DB09395</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/27781c84-466a-44e1-970a-64149cf5ce5c">
    <dc:identifier>A11EA</dc:identifier>
    <rdfs:label>Vitamin B-complex, plain</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/3118f935-e2a2-430e-986c-a85897b52d66"/>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=A11EA</ddiem:url>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a50038d9-191d-4ac3-8c84-f441bee5ec42">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001347</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0001347</dc:identifier>
    <rdfs:label>Abnormal reflexes</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/566fc670-a396-47e6-876e-a5ea7c33d4c9">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/497b9786-8808-49aa-a2d6-62222205f1f5"/>
    <dc:identifier>DB00020</dc:identifier>
    <rdfs:label>Sargramostim</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00020</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c62c61dd-390d-4cc9-85df-597ffd905cbc"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6f60d851-3f1b-4d3c-bf0d-7ac3a5cab0e3">
    <rdfs:label>Protoporphyrin</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e36a779e-f7de-44c1-9b17-693118937a03"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB02285</ddiem:url>
    <dc:identifier>DB02285</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cde7e40c-5496-4d14-85ce-01e1e20c9bf8">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/79a4d0d8-604f-4958-a73e-edbde341deca"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/60202377-e02e-4fa2-9cf1-5b3d96fae454">
    <ddiem:url>https://www.drugbank.ca/drugs/DB09144</ddiem:url>
    <dc:identifier>DB09144</dc:identifier>
    <rdfs:label>Uridine triacetate</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8011ab37-d5ae-4327-b7fc-c2b5a20596fe"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3eff8236-b725-4b9c-8fc7-39ba14ce690f"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/3405aba6-7923-40ff-8e32-afae9bd6a4b7">
    <rdfs:label>Bevacizumab</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00112</ddiem:url>
    <dc:identifier>DB00112</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/0a8e3390-ecfc-44d1-9ac9-58872afd486d"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1ba93785-93b0-4924-b365-e8ff9cc0976c">
    <dc:identifier>DB04729</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB04729</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f1453adc-f9a3-4abc-b657-e40f83621463"/>
    <rdfs:label>Gentamicin C1a</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/acd5574a-7ad7-41be-af0d-248d72e9314d">
    <rdfs:label>Elevated Tau-p level in CSF</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/4cd15bc7-c49a-4c3c-938a-6be9f355a0d4">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0007367</ddiem:url>
    <dc:identifier>HP:0007367</dc:identifier>
    <rdfs:comment>In this study, the amount of oral galactose and uridine sufficient to correct PGM1-deficiency, 322 could not improve the hypoglycosylation of neutrophils in a GSD-Ib patient.https://www.ncbi.nlm.nih.gov/pubmed/28126686?dopt=Abstract</rdfs:comment>
    <rdfs:label>CNS damage progression</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/3f7925b0-e829-4d80-926b-bb810f10a265">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0010919</ddiem:url>
    <dc:identifier>HP:0010919</dc:identifier>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
    <rdfs:label>High total homocysteine level</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/38f22af0-f30b-4275-8173-98e82f02bd3a">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>High CSF guanidinoacetate levels</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/0f5ae389-dd4d-43e0-bf5d-5dd1e6c715d3">
    <rdfs:label>AAV-mediated gene therapy</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e1cf5c61-3601-4d51-98e3-42093a6b041e"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/265442c0-aba5-4dab-88ce-4fe0f01dae7c">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c3d46faa-741f-4999-a429-f0a5bede184b"/>
    <rdfs:label>Glycosade</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f4a3fa32-164f-4156-a7f6-18adfe298155">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/275cdbc1-150b-4f7e-8849-6f3be2bf5dd9"/>
    <dc:identifier>DB08834</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB08834</ddiem:url>
    <rdfs:label>Tauroursodeoxycholic acid</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0e997a52-4326-4210-9cd5-0aa15240b033">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f0ce7936-fd5d-44e1-959f-17100e94c2e6"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4e044425-b830-4c94-b97a-703230238b43">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8fdf0f17-b8bc-42a6-ab95-50af656a333b"/>
    <dc:identifier>DB06273</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/cf61d846-a432-474a-8178-a9a0ceaaf94b"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB06273</ddiem:url>
    <rdfs:label>Tocilizumab</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e2eb8ee4-ddfd-4dad-bb2e-a48624af4e8a">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/a2422a26-a782-42cc-b2e6-76f4bffd7651"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/cb4c052d-bc30-4f72-b73c-7b658eab59ae"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/ff162398-4209-408c-bf89-f8030b034ca1">
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001250</ddiem:url>
    <dc:identifier>HP:0001250</dc:identifier>
    <rdfs:label>epilepsy</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/d8580f77-8038-4ecd-a460-e0aba75a8efc">
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0002415</dc:identifier>
    <rdfs:label>Leukodystrophy</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002415</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/c5688c76-3b45-483f-8e31-81b740b81205">
    <dc:identifier>MP:0001845</dc:identifier>
    <rdfs:label>inflammation</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/MP_0001845</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/da712ab0-a54b-40df-acd6-29c8c8c74cca">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/83eebf55-29e3-4859-b12b-92ce364e7994"/>
    <dc:identifier>DB09341</dc:identifier>
    <rdfs:label>Dextrose, unspecified form</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/214ad663-741f-4fde-9151-b2352ae29293"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB09341</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f01fb855-4be8-4251-8fac-2bfccbe3948e">
    <rdfs:label>AAVrh.10CUhCLN2</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8b488c8a-af52-4552-9331-430d4f5f0704"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1c48c0bc-e3f2-4bd4-b755-83cd5e48d696">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>abnormal coordination of movements</rdfs:label>
    <dc:identifier>HP:0011443</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011443</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f26bf665-cd45-4a0a-bac3-9eb87847c4e9">
    <dc:identifier>DB00282</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00282</ddiem:url>
    <rdfs:label>Pamidronic acid</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/192d8da9-536a-40c8-94ef-97d855a7d682"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6635355a-17c3-49ec-9541-7e0f44ccb6a7">
    <rdfs:label>Ad-mG6Pase</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/56278464-1728-4142-bb9c-2c6d6dbabc24"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/6b58a916-8cd6-4fc3-8318-9634dc36755d">
    <ddiem:url>https://www.drugbank.ca/drugs/DB01325</ddiem:url>
    <dc:identifier>DB01325</dc:identifier>
    <rdfs:label>Quinethazone</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e84b91fa-1766-4621-85b2-a7be145c04c8"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0ed6a4b8-b21f-4906-bf49-088a9f2adc64">
    <rdfs:label>Abnormal upregulated enteral iron uptake (Abnormality of iron homeostasis)*</rdfs:label>
    <dc:identifier>HP:0011031*</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0011031</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/0852cdd1-90fc-4d47-8560-a5a9a2110264">
    <rdfs:comment>The phenotype was controlled with diet, withdrawal from ethanol use, and the fibric acid derivative gemfibrozil.https://www.ncbi.nlm.nih.gov/pubmed/2702860</rdfs:comment>
    <rdfs:label>High serum amyloid A protein</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/613077">
    <dc:identifier>https://www.omim.org/entry/613077</dc:identifier>
    <rdfs:label>PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5</rdfs:label>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/3b7eb5ee-bed5-410a-8d3c-a38b3ff8a593"/>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e59131d5-26b5-4980-864e-c8b1d9707c2f"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9938bdde-7d48-4694-bf4e-222c1b2eb00a"/>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/246450">
    <dc:identifier>https://www.omim.org/entry/246450</dc:identifier>
    <ddiem:iembaseUrl>http://iembase.org/app/#!/disorder/62</ddiem:iembaseUrl>
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/6f327b7c-41a7-4424-918f-ede50b7add95"/>
    <ddiem:iembaseAccessionNumber>62</ddiem:iembaseAccessionNumber>
    <rdfs:comment></rdfs:comment>
    <rdfs:label>3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD</rdfs:label>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/a5c37584-f6d1-4e6a-8906-ac47803bddcb">
    <dc:identifier>HP:0003233</dc:identifier>
    <rdfs:label>Low HDL-cholesterol</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003233</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d30ce5e3-fc1b-450c-9f82-9d3b3dfaa1b4">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/7de6702b-82ef-4b39-ad4c-1df81865fd97"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/79a2ee51-fb17-4315-92c4-017131d02b81">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/25c73bf9-3d66-4c70-8dd0-95a79968a1f5"/>
    <dc:identifier>DB01394</dc:identifier>
    <rdfs:label>Colchicine</rdfs:label>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01394</ddiem:url>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/55cfdae5-d380-4db4-b244-2f920869f1c7">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/fea38ed2-e9bf-4adb-b525-cc52e830ab52"/>
    <rdfs:label>human recombinant acid ceramidase/human ACDase-encoding lentivector</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/e8c05ded-0faa-4463-98db-804397db7355">
    <rdfs:comment></rdfs:comment>
    <rdfs:label>low brain creatine phosphate</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/e0f49fbd-9068-4be9-b207-ce620c95d067">
    <rdfs:label>GNeo-IDUA</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e2ba1c8f-7aa3-4039-afa2-a19fe76d6487"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8fd7f9af-0407-411f-bf6f-d4632a8086b1">
    <rdfs:label>ISIS 703802 (AKCEA-ANGPTL3-LRx)</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/f3b8b6c1-1cfb-4e7e-9e1d-e4bcb0f59536"/>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/14fa1b3a-1b9a-48f5-88b4-6b7aa5762272">
    <rdfs:comment>lifelong and diligent cysteamine therapy prevents hypothyroidism, enhances growth, depletes muscle parenchyma of cystine, and prevents a host of nonrenal complications</rdfs:comment>
    <rdfs:label>Reduction of WBC cystine levels</rdfs:label>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c8afce85-cbde-418b-94f9-cc6e8719ee4a">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/6e5bb0b8-8b0c-4c99-b7c6-d53cfc66c5bf"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB13961</ddiem:url>
    <rdfs:label>Fish oil</rdfs:label>
    <dc:identifier>DB13961</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/ac948adf-f46d-4266-b824-c01f64378a09">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d35b8308-914c-421c-9a18-a5822c00de9f"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB00331</ddiem:url>
    <rdfs:label>Metformin</rdfs:label>
    <dc:identifier>DB00331</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a7136ba9-4f45-4789-899d-da83dd21de6f">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/d7c5c0d3-845d-48a6-8c87-ec89d9df1b97"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/5309c679-ef78-4694-bec7-8180b45eb138">
    <rdfs:label>Low activity of the immature 4-HPPD enzyme</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/990aceab-2de4-45c8-b7aa-ce77c3b8807b">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/0a705795-e60e-412e-8ef3-aafc2ec4d15c"/>
  </rdf:Alt>
  <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/8e3098b3-6ba8-478a-8ba3-3897594e5c18">
    <rdfs:label>functional complementation of a defective protein by inhibition</rdfs:label>
  </ddiem:TheraputicProcedureType>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/2694725f-7ef4-4d79-80d1-3b257ddc6617">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a345ce46-4921-447c-9311-48ccddacf451"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB02691</ddiem:url>
    <rdfs:label>Glycocholic acid</rdfs:label>
    <dc:identifier>DB02691</dc:identifier>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/e7ef8ad5-3f16-42f6-8c74-6854065e2254">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c4fd9ef9-7d24-4f5a-8d73-567f78485bb7"/>
    <rdfs:label>MTS-AAV carrying the wild type ND4 gene (mitochondrial targeting signal peptide Adeno-Associated Virus)</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/251f7b8d-3481-4cc0-85f3-dd229e50814b"/>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/30214c42-9b20-4e63-bfb1-18541b3e6491">
    <rdfs:label>High liver triglyceride level(hyperlipidemia)*</rdfs:label>
    <dc:identifier>HP:0003077*</dc:identifier>
    <rdfs:comment></rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003077</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/2503885e-dd5f-48ed-9dfc-f74a717790c8"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d5462090-2c91-43c3-a208-eb821385e1aa">
    <dc:identifier>DB06667</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b0bbe3a5-abbb-4900-a1f8-c13cce70fa5d"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB06667</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/9cb69db2-6089-4951-888b-863084dc7a57"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c7e00359-2b2f-4fe5-8347-566f8cbf9304">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6a9d278d-26ae-4429-ac53-36fb1833a5aa"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a87ff146-9fbc-4ad9-ae72-8d041a541777">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/e82b16fc-255c-4583-ab8e-b295c9cb82a0"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/1c7df7aa-92af-4bc8-8a73-1e47f9e5a743">
    <dc:identifier>HP:0000708</dc:identifier>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <rdfs:label>Behavioural Disability</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000708</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/da882d31-2e55-4444-bae9-30380615493b">
    <rdfs:label>High desmosterol,cholesterol ratio (Abnormality of cholesterol metabolism)*</rdfs:label>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0003107</ddiem:url>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0003107*</dc:identifier>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f705416d-fa64-40fc-a630-cfefb116e8a8">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f2505834-66d4-46ea-9238-6400ce9cc98b"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/bd9866d1-1e3f-4d59-a744-50e241c11ee9">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/bdf39a89-cb21-484d-bc72-143a488f50b9"/>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=N06AB</ddiem:url>
    <dc:identifier>N06AB</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/189284e5-b37a-409c-8ca1-046aac6b85db">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/22b95a8b-490a-4cb2-89e1-6d987f745b85"/>
  </rdf:Alt>
  <ddiem:Disease rdf:about="http://ddiem.phenomebrowser.net/241200">
    <obo:RO_0004020 rdf:resource="http://ddiem.phenomebrowser.net/ed90939b-895b-4211-8ec3-38a264ad21d4"/>
    <dc:identifier>https://www.omim.org/entry/241200</dc:identifier>
    <rdfs:label>BARTTER SYNDROME, TYPE 2, ANTENATAL; BARTS2</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Disease>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/52298db7-8729-4c1f-9457-c133db82899d">
    <dc:identifier>HP:0000817</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0000817</ddiem:url>
    <rdfs:label>defect in eye contect</rdfs:label>
    <rdfs:comment></rdfs:comment>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/bf979e98-a240-4266-bad3-f090d6282a75">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/31a6365d-e2d8-4362-875a-1d6733cf1d36"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/215b9cea-f4d2-4ccd-bbcf-e61fd97e041d">
    <rdfs:label> Softeners, emollients</rdfs:label>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=A06AA</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e9f9ff5d-b0d6-4f07-877e-3c9c319f8186"/>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8e57a64b-7265-4a34-a09f-def382357321"/>
    <dc:identifier>A06AA</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/28636a95-7bbf-46ff-9508-6f13bcbee95c">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/0b4da3ba-8f90-4567-a0db-476d587639be"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1048e803-c5b6-4ef2-946e-bc8fed7d0631">
    <rdfs:label>AAV-GLUT1</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e217dabd-b7b1-414e-9ed5-f5c2352a370e"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/7e934252-f3ef-4411-8263-b3ecbd8b96b9">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/cdb04d60-5760-4615-8f62-a94cb0bb3f4b"/>
    <dc:identifier>DB11859</dc:identifier>
    <ddiem:url>https://www.drugbank.ca/drugs/DB11859</ddiem:url>
    <rdfs:label>Brexanolone</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/fc4cd899-938e-4e1a-8da2-507845e63643">
    <dc:identifier>HP:0012029</dc:identifier>
    <rdfs:label>Abnormal urinary steroids levels(Abnormality of urine hormone level)*</rdfs:label>
    <rdfs:comment>The finding of abnormalities inMRImerits further exploration of metabolites in the brainby MR spectroscopy for optimization of dosages of BH4,levodopa and 5-HTP. https://www.ncbi.nlm.nih.gov/pubmed/16601879</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0012029</ddiem:url>
  </ddiem:Phenotype>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/12d605f7-3dee-46ea-a901-7b421a21f5d4">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/e2238719-78c2-4c44-82d1-57196aa102ab"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/0ef03e4f-5a82-4a4c-8ef7-90923ba409f1">
    <rdfs:label>NA</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/91c342b3-1f1b-49df-a6ef-3df5e26e4d5f"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/1a96590d-acaa-4e96-a78c-14b1bd138654">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/34e722d9-6d8e-4903-a3e1-85ef1e8bfadb"/>
    <rdfs:label>Ad5/CMV/hUG-Br1</rdfs:label>
  </ddiem:Drug>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/bbd26fcb-81e9-4423-8185-aa629db379ac">
    <rdfs:label>Myoclonic abnormalities(Myoclouns)*</rdfs:label>
    <rdfs:comment></rdfs:comment>
    <dc:identifier>HP:0001336*</dc:identifier>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0001336</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/852019f2-1778-47b5-bf09-0669fa982c73">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/2946feee-2222-4277-86af-79aeaca78fab"/>
    <dc:identifier>C04</dc:identifier>
    <rdfs:label>PERIPHERAL VASODILATORS</rdfs:label>
    <ddiem:url>https://www.whocc.no/atc_ddd_index/?code=C04</ddiem:url>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cecd6aa1-1704-413e-82cf-c0a71efb998f"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/e2ab0d25-6b76-41de-b3b4-73e887c5da2e">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/e5065af6-dd16-4deb-8535-db3598870de7"/>
    <rdfs:label>N-octyl-4-epi-β-valienamine (NOEV)</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/d583229a-44cd-449b-a8e7-625da75cb27a">
    <rdfs:label>6S-NBI-DGJ</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/b96078bb-81dd-4c21-9ee2-81509b6c5b33"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/7bf01178-e321-46dc-a0b9-57795442f142"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/70d4122c-a7af-4634-a97f-87bff6dd2b71">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3bb694a9-dc90-4393-8d4c-7c7eec529472"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/5235cad0-6d5d-48cb-b5be-96b3e0be4239">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/462e81d3-234b-4cb9-b6f5-0c1d203ee686"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3eab04ee-b7a5-4a58-ae12-b61b70816b85">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/dccb60cb-3656-4bd4-8a94-03b8fb2285c6"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/de60022c-caad-4500-87b6-89a046d3f726"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/c0f1f7d9-06b8-4254-a6b8-05fdb3f2c024">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7ccd2605-17d8-40fd-bd92-0a493429ed98"/>
    <rdfs:label>scAVV9.CB.CLN6</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c9edd9ed-c5fd-420e-bdbf-399e6870967c"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/17120c5a-1606-4d17-b9c4-85eb34af7380">
    <rdfs:label>Ad5-LARGE-eGFP</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/c3e50a1f-e83f-4530-a0d5-182029f8f379"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/0ba52dd3-860d-4c56-9a77-2aaa1e4f1c75">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/49fa1abf-09e1-4cee-9962-7f4d51c29391"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/a7c7f7fc-430d-478e-a420-399569ea181d">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/08b9b9f0-50a2-4ac1-81fc-f70770890bf7"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01599</ddiem:url>
    <dc:identifier>DB01599</dc:identifier>
    <rdfs:label>Probucol</rdfs:label>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/cacf19f6-b6df-4cbd-ac0c-62c55ce223a2">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/de89c759-c68a-4368-8c88-4aea52f28197"/>
    <rdfs:label>rAAV8-mediated gene therapy expressing murine HMB-synthase</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/96360fc9-bab5-492a-a25c-ee37dbb998b4">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/12d5b691-f03f-4fca-952c-3b7556f61396"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/cfca40fc-859c-4eeb-82eb-92846bb4963d">
    <rdfs:label>Gene therapy (wild-type Ad-AGA)</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a7de0cca-15c3-47d7-97ec-35809c63e3c4"/>
  </ddiem:Drug>
  <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/029817d7-33e2-48b4-863b-2c06b1d82e07">
    <rdfs:label>Direct interaction (Mechanistic A)&gt;&gt;Functional interaction( Functional complementation or a defective protein by stimulation)</rdfs:label>
  </ddiem:TheraputicProcedureType>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8dc22130-4e21-45ae-8b42-e9b4ea33696e">
    <dc:identifier>DB11563</dc:identifier>
    <rdfs:label>Sebelipase alfa</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/d1917031-0105-4183-a4f0-2c3388c37541"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB11563</ddiem:url>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/81b3448f-a5ef-46c8-81ba-9dbc659b1722"/>
  <ddiem:TheraputicProcedureType rdf:about="http://ddiem.phenomebrowser.net/0009bf9f-a858-4490-9b97-e39408cfbf1a">
    <rdfs:label>Direct Interaction (activity modification)*</rdfs:label>
  </ddiem:TheraputicProcedureType>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d3c20219-805c-418b-85f6-c0518e91cbdf">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/74a2435e-8b12-4313-9d3a-33487a5fec5a"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e0eb37af-7c11-470d-ba5e-2ca765240272"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/8b14f50a-d8b4-4025-b409-a3c775e4bc51">
    <dc:identifier>DB01083</dc:identifier>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/7fe9a99e-e5ae-49ee-8fa4-ca1035a71dd3"/>
    <ddiem:url>https://www.drugbank.ca/drugs/DB01083</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/91761b55-5c5e-4bb9-8281-543d5e7eaeb9"/>
    <rdfs:label>Orlistat</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/3a1240b1-79e5-4168-be06-007710215c6b">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/401855c5-f345-445c-88e2-4376c8c3e954"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/dd97cb35-c269-4ca3-827b-408664b3b411"/>
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/b70e6a3e-ddb9-42f1-b194-43902b098586"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9de0116c-cd01-4f85-9e2e-a7e8af9fa8f4">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/c4de69fa-3c4c-4cdc-a350-b5382d84fd93"/>
  </rdf:Alt>
  <ddiem:Phenotype rdf:about="http://ddiem.phenomebrowser.net/78913f65-98be-43c7-adf0-57e4acdcc774">
    <dc:identifier>HP:0002240</dc:identifier>
    <rdfs:label>high liver volume</rdfs:label>
    <rdfs:comment>In the presence of hypomagnesemia, magnesium supplementation should be considered first, because magnesium repletion will facilitate potassium repletion and reduce the risk of tetany and other complications</rdfs:comment>
    <ddiem:url>http://purl.obolibrary.org/obo/HP_0002240</ddiem:url>
  </ddiem:Phenotype>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/31c71dfa-335d-46fb-a526-db69257c77f2">
    <rdfs:label>AT342</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a1fa3fc7-65c3-4c20-a958-b4e2d0f74052"/>
  </ddiem:Drug>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/0e1c7661-9d02-4385-ba28-1935c4290a42">
    <rdfs:label>AAV9-TAZ</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/8b647916-d3d5-4323-8591-498b5eb2f9e9"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/01e8c0bd-85e6-416d-bfc4-4ef66cabdb8e">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ec04df75-f3b6-4724-8ab4-9b914fdff8ff"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/e3825af6-be59-4444-abb7-0e94c6fbff30"/>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4360ca6b-ad4b-4880-bf1b-1d9f0007ad8a">
    <rdfs:label>Ad-hBUGT1</rdfs:label>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/a03fd2e1-00d1-4940-b69a-9baf77aae691"/>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d4bec7eb-dc0b-4271-bdac-e0dc827c937b"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/40cb8f7d-d181-4382-b2f0-a3f73016b007"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ac98262e-4437-4bf2-a4b6-8917bae72413"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ada19f55-fc53-42c7-b955-76e1dd3646b3">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/ebd361dc-166a-420b-ab99-885a1388d4eb"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ce3bcdc5-11e4-448c-b9d5-ec4eca0463f9">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/f2aa58db-fad6-43f5-a746-1414a78e8fff"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/4acb7c8f-74a5-47bf-8d0a-00a85e2e307c">
    <ddiem:url>https://www.drugbank.ca/drugs/DB04815</ddiem:url>
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/31bc9c63-7433-49bb-a831-1d7c278a65d9"/>
    <rdfs:label>Clioquinol</rdfs:label>
    <dc:identifier>DB04815</dc:identifier>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/41d03c5d-6f66-498e-b2d9-a485319398a9">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/27cdd756-1118-45e1-aac2-c850c8df5ef4"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/307bbb6d-c7be-4779-a335-2822647e0a76">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/2a36a8c1-4ba6-4c76-8373-b066043fed11"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/cb262901-1527-401a-8b50-82fe2852abd1"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/addc25bc-6e47-4a88-bd76-efa6f05700a6"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/aa194167-715a-44e0-8d35-53ebed9bf312"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/70fa3609-a244-4fc0-a80b-f8e75d29998f">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/3ae91452-c48f-4283-a92f-49d2e8a9caf7"/>
  </rdf:Alt>
  <ddiem:Drug rdf:about="http://ddiem.phenomebrowser.net/f3a27cff-0e8d-40ae-b4ea-e8f04367d4ac">
    <obo:RO_0000056 rdf:resource="http://ddiem.phenomebrowser.net/87a356e3-cb7f-45d2-8ab2-b876b1d5ca0d"/>
    <rdfs:label>Resolaris (ATYR1940)</rdfs:label>
  </ddiem:Drug>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/400bb209-d396-4f82-9cc3-2d22ccb321c6">
    <rdf:li rdf:resource="http://ddiem.phenomebrowser.net/6881ccdd-8414-448b-894b-90655031bad0"/>
  </rdf:Alt>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/216d0d87-f598-4273-841b-bffd8b02da3c"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/9c4eeb10-58b6-476d-b335-d5f0fe99c558"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d6cec5ba-eb4b-4c5b-a28d-e395bc44b47b"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/07f1336e-136b-487a-ba6d-eb6c1a02ecfe"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/07e62a0f-3e67-4d2b-8ae5-b8bd6104354f"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/d191df51-db35-4d64-8357-598dae89aaa6"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f81387c6-9510-4547-847d-752c89866546"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/a84eb9c5-7786-437e-95b7-5a8b9a11fef1"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/996848e0-e394-4a94-b9b4-292f06503ad0"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/eb937ac7-1884-4c52-ab91-9e57aaaed1b7"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c0156041-29bd-4a95-b5bc-7b16c02780a5"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/621c2dee-39a9-4adc-a823-cfe8703a3755"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/c6f18b08-c2a9-4fc8-9895-528a23c0effa"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f344ce94-b33a-4227-a8c9-d6d023c22296"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/ec696bba-7235-4763-89ec-6e3d8b42d45b"/>
  <rdf:Alt rdf:about="http://ddiem.phenomebrowser.net/f3653224-2445-4568-9104-b270b4e798d8"/>
</rdf:RDF>
